<?xml version='1.0' encoding='utf-8'?>
<PubmedArticleSet>
  <PubmedArticle>
    <ArticleTitle>Cellular and functional actions of tofacitinib related to the pathophysiology of hibernoma development.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29074274</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30335-5</DOI>
    <KeywordList>
      <Keywords>Hibernoma</Keywords>
      <Keywords>JAK inhibition</Keywords>
      <Keywords>Sympathetic stimulation</Keywords>
      <Keywords>Tofacitinib</Keywords>
      <Keywords>pSTAT</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zaher A. Radi</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, One Burtt Road, Andover, MA 01810, USA. Electronic address: Zaher.Radi@Pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>W. Mark Vogel</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, One Burtt Road, Andover, MA 01810, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Phillip M. Bartholomew</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, Eastern Point Road, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Petra Koza-Taylor</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, Eastern Point Road, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandros Papanikolaou</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, Eastern Point Road, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Todd Wisialowski</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, Eastern Point Road, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Prashant Nambiar</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, One Burtt Road, Andover, MA 01810, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas J. Ball</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety R&amp;D, Eastern Point Road, Groton, CT 06340, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the potential human health risks from exposure to complex substances in accordance with REACH requirements. "White spirit" as a case study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29069582</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30330-6</DOI>
    <KeywordList>
      <Keywords>Derived No effect level (DNEL)</Keywords>
      <Keywords>Hazard index</Keywords>
      <Keywords>High production volume (HPV)</Keywords>
      <Keywords>Hydrocarbon solvents</Keywords>
      <Keywords>Mineral spirit</Keywords>
      <Keywords>REACH regulation</Keywords>
      <Keywords>Risk characterization ratio</Keywords>
      <Keywords>Risk management measure</Keywords>
      <Keywords>UVCB</Keywords>
      <Keywords>White spirit</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard H. McKee</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 US Highway 22 East, Annandale, NJ 08801, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rosalie Tibaldi</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 US Highway 22 East, Annandale, NJ 08801, USA. Electronic address: Rosalie.S.Tibaldi@exxonmobil.com.</Affiliation>
      </Author>
      <Author>
        <Name>Moyinoluwa D. Adenuga</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 US Highway 22 East, Annandale, NJ 08801, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Carlos Carrillo</Name>
        <Affiliation>Shell Health, Shell International B.V., The Hague, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Alison Margary</Name>
        <Affiliation>Shell Health, Shell International B.V., The Hague, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Aligning nanotoxicology with the 3Rs: What is needed to realise the short, medium and long-term opportunities?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29069581</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30336-7</DOI>
    <KeywordList>
      <Keywords>3rs</Keywords>
      <Keywords>Alternative approaches</Keywords>
      <Keywords>In vitro/in silico</Keywords>
      <Keywords>Nanosafety</Keywords>
      <Keywords>Nanotoxicology</Keywords>
      <Keywords>Regulatory testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Natalie Burden</Name>
        <Affiliation>NC3Rs, Gibbs Building, 215 Euston Road, London NW1 2BE, UK. Electronic address: natalie.burden@nc3rs.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Aschberger</Name>
        <Affiliation>EU Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM), European Commission - Joint Research Centre (JRC), JRC F3 Chemical Safety and Alternative Methods in JRC Directorate F - Health, Consumers and Reference Materials, Via E. Fermi 2749, I-21027 Ispra, Italy. Electronic address: karin.aschberger@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Qasim Chaudhry</Name>
        <Affiliation>Institute of Food Science and Innovation, University of Chester, Parkgate Road, Chester CH1 4BJ, UK. Electronic address: q.chaudhry@chester.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Martin J. D. Clift</Name>
        <Affiliation>Institute of Life Science/Centre for NanoHealth, Swansea University Medical School, Wales SA2 8PP, UK. Electronic address: m.j.d.clift@swansea.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Fowler</Name>
        <Affiliation>Safety &amp; Environmental Assurance Centre (SEAC) Colworth, Unilever, Colworth Science Park, Sharnbrook, Bedford MK44 1LQ, UK. Electronic address: fstoxconsulting@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Helinor Johnston</Name>
        <Affiliation>Institute of Biological Chemistry, Biophysics and Bioengineering, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK. Electronic address: h.Johnston@hw.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE, RB/TB - Z470, 67056 Ludwigshafen, Germany. Electronic address: robert.landsiedel@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Rowland</Name>
        <Affiliation>National Centre for Environmental Toxicology, WRc plc, Frankland Rd, Swindon SN5 8YF, UK. Electronic address: Joanna.Rowland@rb.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vicki Stone</Name>
        <Affiliation>Institute of Biological Chemistry, Biophysics and Bioengineering, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK. Electronic address: v.stone@hw.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Shareen H. Doak</Name>
        <Affiliation>Institute of Life Science/Centre for NanoHealth, Swansea University Medical School, Wales SA2 8PP, UK. Electronic address: s.h.doak@swansea.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety investigation on total steroid saponins extracts from Dioscorea zingiberensis C.H. Wright: Sub-acute and chronic toxicity studies on dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29066336</pubmedLink>
    <GrantList>
      <Grant>Z99 HL999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30329-X</DOI>
    <KeywordList>
      <Keywords>Chronic toxicity</Keywords>
      <Keywords>Dioscorea zingiberensis C.H. Wright</Keywords>
      <Keywords>Steroid saponins</Keywords>
      <Keywords>Sub-acute toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xinxin Zhang</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Jin</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Nigatu Tadesse</Name>
        <Affiliation>School of International Education, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Xian</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Zhang</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sicen Wang</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Dang</Name>
        <Affiliation>Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, Qinghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhang</Name>
        <Affiliation>Xi'an Medical University, Xi'an 710021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zengjun Guo</Name>
        <Affiliation>College of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China. Electronic address: guozj@mail.xjtu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yoichiro Ito</Name>
        <Affiliation>Laboratory of Bioseparation Technology, Biochemistry and Biophysics Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: itoy@nhlbi.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of toxicity and tolerability of a combination vehicle; 5% Pharmasolve, 45% Propylene glycol and 50% Polyethylene glycol 400 in rats following repeated intravenous administration.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29066335</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30331-8</DOI>
    <KeywordList>
      <Keywords>Combination vehicle</Keywords>
      <Keywords>Pharmasolve (NMP)</Keywords>
      <Keywords>Polyethylene glycol (PEG) 400</Keywords>
      <Keywords>Propylene glycol (PG)</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Tolerability</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Santosh Kumar Pandey</Name>
        <Affiliation>Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad, 500034, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vinod Kumar Goyal</Name>
        <Affiliation>Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad, 500034, India. Electronic address: vinod_goyal@suven.com.</Affiliation>
      </Author>
      <Author>
        <Name>Prashant Nalge</Name>
        <Affiliation>Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad, 500034, India.</Affiliation>
      </Author>
      <Author>
        <Name>Purnachander Are</Name>
        <Affiliation>Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad, 500034, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sthevaan Vincent</Name>
        <Affiliation>Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad, 500034, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ramakrishna Nirogi</Name>
        <Affiliation>Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad, 500034, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Making sense of SEND; the Standard for Exchange of Nonclinical Data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29066334</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30327-6</DOI>
    <KeywordList>
      <Keywords>Data mining</Keywords>
      <Keywords>KNIME</Keywords>
      <Keywords>Open access</Keywords>
      <Keywords>SEND</Keywords>
      <Keywords>eTOX</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katharine Briggs</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, United Kingdom. Electronic address: Katharine.briggs@lhasalimited.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Resolution of contradiction between in silico predictions and Ames test results for four pharmaceutically relevant impurities.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29061373</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30326-4</DOI>
    <KeywordList>
      <Keywords>Ames assay</Keywords>
      <Keywords>Aromatic amines</Keywords>
      <Keywords>ICHM7</Keywords>
      <Keywords>Impurities</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Micro colonies</Keywords>
      <Keywords>Mutagenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>William C. Gunther</Name>
        <Affiliation>Pfizer Research and Development, Groton, CT, USA. Electronic address: william.c.gunther@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle O. Kenyon</Name>
        <Affiliation>Pfizer Research and Development, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer R. Cheung</Name>
        <Affiliation>Pfizer Research and Development, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert W. Dugger</Name>
        <Affiliation>Pfizer Research and Development, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Krista L. Dobo</Name>
        <Affiliation>Pfizer Research and Development, Groton, CT, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The relationship of snus use to diabetes and allied conditions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29061372</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30332-X</DOI>
    <KeywordList>
      <Keywords>Diabetes</Keywords>
      <Keywords>Smokeless</Keywords>
      <Keywords>Tobacco</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd., 17 Cedar Road, Sutton, Surrey SM2 5DA, United Kingdom. Electronic address: PeterLee@pnlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Alison J. Thornton</Name>
        <Affiliation>Oak Cottage, Beer Farm, Okehampton, Devon, EX20 1SG, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Framework for the quantitative weight-of-evidence analysis of 'omics data for regulatory purposes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29037774</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30325-2</DOI>
    <KeywordList>
      <Keywords>Data relevance</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Mode-of-action</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Strength of evidence</Keywords>
      <Keywords>Study quality (reliability)</Keywords>
      <Keywords>Weight-of-evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jim Bridges</Name>
        <Affiliation>Surrey University, UK. Electronic address: j.bridges@surray.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Roland Buesen</Name>
        <Affiliation>BASF SE, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lize Deferme</Name>
        <Affiliation>ExxonMobil Petroleum and Chemical, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Knut E. Tollefsen</Name>
        <Affiliation>Norwegian Institute for Water Research (NIVA), Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Tewes Tralau</Name>
        <Affiliation>Department of Chemical and Product Safety, German Federal Institute of Risk Assessment (BfR), Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ben van Ravenzwaay</Name>
        <Affiliation>BASF SE, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Poole</Name>
        <Affiliation>European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Pemberton</Name>
        <Affiliation>Systox Ltd., UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Erratum to "A dynamic population model for estimating all-cause mortality due to lifetime exposure history" [Regul. Toxicol. Pharmacol. 67 (2013) 246-251].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29029996</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30296-9</DOI>
    <AuthorList>
      <Author>
        <Name>Annette M. Bachand</Name>
        <Affiliation>Ramboll Environ, Amherst, MA, USA. Electronic address: abachand@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra I. Sulsky</Name>
        <Affiliation>Ramboll Environ, Amherst, MA, USA. Electronic address: ssulsky@ramboll.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Proposal of a flow scheme for the chemical-form-based quantitative analysis of chlorine compounds in pulp for sanitary products and verification of safety.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29024715</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30311-2</DOI>
    <KeywordList>
      <Keywords>Bleaching</Keywords>
      <Keywords>Dermal exposure</Keywords>
      <Keywords>ECF</Keywords>
      <Keywords>GC-MS</Keywords>
      <Keywords>Insoluble organically bound chlorine</Keywords>
      <Keywords>Pulp</Keywords>
      <Keywords>Sanitary product</Keywords>
      <Keywords>Water-soluble chlorides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Takeharu Wada</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kei Iwasaki</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasushi Minobe</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mitsuhiro Wada</Name>
        <Affiliation>Unicharm Corporation, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shigeo Imai</Name>
        <Affiliation>Unicharm Corporation, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Satoko Ishii</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan. Electronic address: ishii-satoko@ceri.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>On selecting a minimal set of in vitro assays to reliably determine estrogen agonist activity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28993267</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30294-5</DOI>
    <KeywordList>
      <Keywords>Alternative testing methods</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Estrogen receptor</Keywords>
      <Keywords>In vitro</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard S. Judson</Name>
        <Affiliation>U.S. Environmental Protection Agency, RTP, NC, United States. Electronic address: judson.richard@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Keith A. Houck</Name>
        <Affiliation>U.S. Environmental Protection Agency, RTP, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Eric D. Watt</Name>
        <Affiliation>U.S. Environmental Protection Agency, RTP, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Russell S. Thomas</Name>
        <Affiliation>U.S. Environmental Protection Agency, RTP, NC, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of tobacco heating product THP1.0. Part 4: Characterisation of indoor air quality and odour.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28989082</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30289-1</DOI>
    <KeywordList>
      <Keywords>Environmental tobacco smoke</Keywords>
      <Keywords>Indoor air quality</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Tobacco heating product</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark Forster</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>John McAughey</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK. Electronic address: john_mcaughey@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Krishna Prasad</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Eleni Mavropoulou</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Proctor</Name>
        <Affiliation>Research and Development, British American Tobacco Investments Ltd, Regents Park Road, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of tobacco heating product THP1.0. Part 1: Series introduction.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28989081</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30282-9</DOI>
    <KeywordList>
      <Keywords>Comprehensive assessment framework</Keywords>
      <Keywords>Modified risk tobacco products</Keywords>
      <Keywords>Tobacco harm reduction</Keywords>
      <Keywords>Tobacco heating product</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christopher Proctor</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, UK. Electronic address: christopher_proctor@bat.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-clinical efficacy-related studies for human medicines: An overview and retrospective analysis of data for a group of approved medicines.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28989080</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30305-7</DOI>
    <KeywordList>
      <Keywords>Animal studies</Keywords>
      <Keywords>Anticancer medicines</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Clinical development</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>Efficacy</Keywords>
      <Keywords>In vitro studies</Keywords>
      <Keywords>Monoclonal antibodies</Keywords>
      <Keywords>Preclinical studies</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ana Cláudia Figueiredo</Name>
        <Affiliation>INFARMED - National Authority of Medicines and Health Products, I.P., Portugal. Electronic address: anaclaudia.figueiredo@infarmed.pt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Framework for the quality assurance of 'omics technologies considering GLP requirements.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28987912</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30309-4</DOI>
    <KeywordList>
      <Keywords>Data storage</Keywords>
      <Keywords>Documentation</Keywords>
      <Keywords>Good laboratory practice (GLP)</Keywords>
      <Keywords>Independent quality assurance</Keywords>
      <Keywords>Quality assurance inspection</Keywords>
      <Keywords>Raw data definition</Keywords>
      <Keywords>Reproducibility</Keywords>
      <Keywords>Software validation</Keywords>
      <Keywords>Standard operating procedure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hans Martin Kauffmann</Name>
        <Affiliation>BASF SE, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Hennicke Kamp</Name>
        <Affiliation>BASF SE, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Regine Fuchs</Name>
        <Affiliation>Metanomics GmbH, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Brian N. Chorley</Name>
        <Affiliation>U.S. Environmental Protection Agency, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lize Deferme</Name>
        <Affiliation>ExxonMobil Petroleum and Chemical B.V.B.A., Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy Ebbels</Name>
        <Affiliation>Imperial College London, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Jörg Hackermüller</Name>
        <Affiliation>Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research - UFZ, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stefania Perdichizzi</Name>
        <Affiliation>Center for Environmental Toxicology, Agency for Prevention, Environment and Energy (Arpae), Emilia-Romagna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Poole</Name>
        <Affiliation>European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Knut E. Tollefsen</Name>
        <Affiliation>Norwegian Institute for Water Research (NIVA), Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Tewes Tralau</Name>
        <Affiliation>Department of Chemical and Product Safety, German Federal Institute of Risk Assessment (BfR), Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Carole Yauk</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ben van Ravenzwaay</Name>
        <Affiliation>BASF SE, Germany. Electronic address: bennard.ravenzwaay@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of tobacco heating product THP1.0. Part 5: In vitro dosimetric and cytotoxic assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28987911</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30288-X</DOI>
    <KeywordList>
      <Keywords>Dosimetry</Keywords>
      <Keywords>In vitro cytotoxicity</Keywords>
      <Keywords>Neutral Red Uptake</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>RM20S</Keywords>
      <Keywords>Tobacco heating products</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tomasz Jaunky</Name>
        <Affiliation>British American Tobacco, R&amp;D, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Adamson</Name>
        <Affiliation>British American Tobacco, R&amp;D, Southampton, SO15 8TL, UK. Electronic address: jason_adamson@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Simone Santopietro</Name>
        <Affiliation>British American Tobacco, R&amp;D, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Anya Terry</Name>
        <Affiliation>British American Tobacco, R&amp;D, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Thorne</Name>
        <Affiliation>British American Tobacco, R&amp;D, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Damien Breheny</Name>
        <Affiliation>British American Tobacco, R&amp;D, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Proctor</Name>
        <Affiliation>British American Tobacco, R&amp;D, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Marianna Gaça</Name>
        <Affiliation>British American Tobacco, R&amp;D, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and subchronic toxicity studies of seabuckthorn (Hippophae rhamnoides L.) oil in rodents.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28986179</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30304-5</DOI>
    <KeywordList>
      <Keywords>Hippophae rhamnoides</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Seabuckthorn oil</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peng Zhao</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaolong Wang</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chuan Liang</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanwu Wang</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pingjing Wen</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Wang</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangqiu Qin</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning, China; School of Public Health, Guangxi Medical University, Nanning, China. Electronic address: qinguangqiu@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neuropharmacological and acute toxicological evaluation of ethanolic extract of Allamanda cathartica L. flowers and plumieride.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28986178</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30307-0</DOI>
    <KeywordList>
      <Keywords>Allamanda cathartica</Keywords>
      <Keywords>Antidepressant-like effect</Keywords>
      <Keywords>Plumieride</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tiago J. Bonomini</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NiQFar), Programa de Mestrado em Ciências Farmacêuticas, Universidade do Vale do Itajaí (UNIVALI), P.o. Box 360, 88302-202 Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Iandra Holzmann</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NiQFar), Programa de Mestrado em Ciências Farmacêuticas, Universidade do Vale do Itajaí (UNIVALI), P.o. Box 360, 88302-202 Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Liliani Carolini Thiesen</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NiQFar), Programa de Mestrado em Ciências Farmacêuticas, Universidade do Vale do Itajaí (UNIVALI), P.o. Box 360, 88302-202 Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Eduarda Fratoni</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NiQFar), Programa de Mestrado em Ciências Farmacêuticas, Universidade do Vale do Itajaí (UNIVALI), P.o. Box 360, 88302-202 Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Flavia Fischer Muller</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NiQFar), Programa de Mestrado em Ciências Farmacêuticas, Universidade do Vale do Itajaí (UNIVALI), P.o. Box 360, 88302-202 Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth M. Lucinda-Silva</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NiQFar), Programa de Mestrado em Ciências Farmacêuticas, Universidade do Vale do Itajaí (UNIVALI), P.o. Box 360, 88302-202 Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rosendo Augusto Yunes</Name>
        <Affiliation>Programa de Pós-Graduação em Química, Universidade Federal de Santa Catarina - UFSC, CEP 88040-970 Florianópolis, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Angela Malheiros</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NiQFar), Programa de Mestrado em Ciências Farmacêuticas, Universidade do Vale do Itajaí (UNIVALI), P.o. Box 360, 88302-202 Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Elisa Gonçalves</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NiQFar), Programa de Mestrado em Ciências Farmacêuticas, Universidade do Vale do Itajaí (UNIVALI), P.o. Box 360, 88302-202 Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Paula Dalmagro</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NiQFar), Programa de Mestrado em Ciências Farmacêuticas, Universidade do Vale do Itajaí (UNIVALI), P.o. Box 360, 88302-202 Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Kathryn Ana Bortolini Simão da Silva</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NiQFar), Programa de Mestrado em Ciências Farmacêuticas, Universidade do Vale do Itajaí (UNIVALI), P.o. Box 360, 88302-202 Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Márcia Maria de Souza</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NiQFar), Programa de Mestrado em Ciências Farmacêuticas, Universidade do Vale do Itajaí (UNIVALI), P.o. Box 360, 88302-202 Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>José Roberto Santin</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NiQFar), Programa de Mestrado em Ciências Farmacêuticas, Universidade do Vale do Itajaí (UNIVALI), P.o. Box 360, 88302-202 Itajaí, SC, Brazil. Electronic address: jrs.santin@univali.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Weight of evidence approaches for the identification of endocrine disrupting properties of chemicals: Review and recommendations for EU regulatory application.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28986177</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30306-9</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Endocrine disrupting properties</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melanie Gross</Name>
        <Affiliation>wca, Brunel House, Volunteer Way, Faringdon, SN7 7YR, UK. Electronic address: melanie.gross@wca-consulting.com.</Affiliation>
      </Author>
      <Author>
        <Name>Richard M. Green</Name>
        <Affiliation>Dow AgroSciences, 3b, Milton Park, Abingdon, Oxfordshire, OX14 4RN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Lennart Weltje</Name>
        <Affiliation>BASF SE, Crop Protection - Ecotoxicology, Speyerer Strasse 2, 67117 Limburgerhof, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>James R. Wheeler</Name>
        <Affiliation>Dow AgroSciences, 3b, Milton Park, Abingdon, Oxfordshire, OX14 4RN, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of predictivity of volatile organic compounds carcinogenicity and mutagenicity by freeware in silico models.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28970106</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30302-1</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Computational toxicology</Keywords>
      <Keywords>In silico methods</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>QSAR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lília Ribeiro Guerra</Name>
        <Affiliation>Post-Graduation Program on Science and Biotechnology, Fluminense Federal University, Niteroi, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandra Mendonça Teles de Souza</Name>
        <Affiliation>Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juliana Alves Côrtes</Name>
        <Affiliation>Post-Graduation Program on Science and Biotechnology, Fluminense Federal University, Niteroi, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Viviane de Oliveira Freitas Lione</Name>
        <Affiliation>Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Helena Carla Castro</Name>
        <Affiliation>Cell and Molecular Biology Department, Institute of Biology, Fluminense Federal University, Niteroi, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gutemberg Gomes Alves</Name>
        <Affiliation>Cell and Molecular Biology Department, Institute of Biology, Fluminense Federal University, Niteroi, Brazil. Electronic address: gutopepe@yahoo.com.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fish cell lines as a tool for the ecotoxicity assessment and ranking of engineered nanomaterials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28966106</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30301-X</DOI>
    <KeywordList>
      <Keywords>Cell lines</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Engineered nanomaterials</Keywords>
      <Keywords>Fish</Keywords>
      <Keywords>Hazard ranking</Keywords>
      <Keywords>IATA</Keywords>
      <Keywords>Nanomaterial grouping</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Bermejo-Nogales</Name>
        <Affiliation>Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Departamento de Medio Ambiente, Carretera de la Coruña, Km 7.5, 28040 Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>M. L. Fernández-Cruz</Name>
        <Affiliation>Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Departamento de Medio Ambiente, Carretera de la Coruña, Km 7.5, 28040 Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>J. M. Navas</Name>
        <Affiliation>Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Departamento de Medio Ambiente, Carretera de la Coruña, Km 7.5, 28040 Madrid, Spain. Electronic address: jmnavas@inia.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oligonucleotide-based pharmaceuticals: Non-clinical and clinical safety signals and non-clinical testing strategies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28966105</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30300-8</DOI>
    <KeywordList>
      <Keywords>Antisense oligonucleotide</Keywords>
      <Keywords>Aptamer</Keywords>
      <Keywords>Immunostimulation</Keywords>
      <Keywords>Immunosuppression</Keywords>
      <Keywords>Non-clinical</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>siRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Enni Kaisa Mustonen</Name>
        <Affiliation>University of Eastern Finland, Faculty of Health Sciences, School of Pharmacy, P.O. Box 1627, 70211 Kuopio, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Tiina Palomäki</Name>
        <Affiliation>P.O. Box 55, FI-00034 FIMEA, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Markku Pasanen</Name>
        <Affiliation>University of Eastern Finland, Faculty of Health Sciences, School of Pharmacy, P.O. Box 1627, 70211 Kuopio, Finland. Electronic address: markku.pasanen@uef.fi.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Citrus aurantium (bitter orange) extract: Safety assessment by acute and 14-day oral toxicity studies in rats and the Ames Test for mutagenicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28966104</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30299-4</DOI>
    <KeywordList>
      <Keywords>Ames Test</Keywords>
      <Keywords>Bitter orange</Keywords>
      <Keywords>Citrus aurantium</Keywords>
      <Keywords>LD50</Keywords>
      <Keywords>Reverse mutation assay</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Salmonella typhimurium</Keywords>
      <Keywords>p-synephrine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>N. S. Deshmukh</Name>
        <Affiliation>INTOX Private LTD., 375, Urawade, Tal. Mulshi, Maharashtra, India.</Affiliation>
      </Author>
      <Author>
        <Name>S. J. Stohs</Name>
        <Affiliation>Creighton University Medical Center, Omaha, NE 68178, USA. Electronic address: sid.stohs9@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>C. C. Magar</Name>
        <Affiliation>INTOX Private LTD., 375, Urawade, Tal. Mulshi, Maharashtra, India.</Affiliation>
      </Author>
      <Author>
        <Name>S. B. Kadam</Name>
        <Affiliation>INTOX Private LTD., 375, Urawade, Tal. Mulshi, Maharashtra, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hazard characterization of an anti-human tissue factor antibody by combining results of tissue cross-reactivity studies and distribution of hemorrhagic lesions in monkey toxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28964847</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30297-0</DOI>
    <KeywordList>
      <Keywords>Hazard characterization</Keywords>
      <Keywords>Hemorrhagic lesion</Keywords>
      <Keywords>Target antigen</Keywords>
      <Keywords>Therapeutic antibody</Keywords>
      <Keywords>Tissue cross-reactivity study</Keywords>
      <Keywords>Tissue factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Etsuko Fujii</Name>
        <Affiliation>Research Division, Chugai Pharmaceutical, Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan. Electronic address: fujiietk@chugai-pharm.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuto Watanabe</Name>
        <Affiliation>Research Division, Chugai Pharmaceutical, Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kaori Nishihara</Name>
        <Affiliation>Research Division, Chugai Pharmaceutical, Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masami Suzuki</Name>
        <Affiliation>Research Division, Chugai Pharmaceutical, Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Atsuhiko Kato</Name>
        <Affiliation>Research Division, Chugai Pharmaceutical, Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Applicability of in silico genotoxicity models on food and feed ingredients.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28964846</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30298-2</DOI>
    <KeywordList>
      <Keywords>Ames</Keywords>
      <Keywords>Chromosomal aberration</Keywords>
      <Keywords>Computational toxicology</Keywords>
      <Keywords>Feed ingredient</Keywords>
      <Keywords>Food ingredient</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Micronucleus test</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anna Vuorinen</Name>
        <Affiliation>DSM Nutritional Products Ltd, Wurmisweg 576, 4303 Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Phillip Bellion</Name>
        <Affiliation>DSM Nutritional Products Ltd, Wurmisweg 576, 4303 Kaiseraugst, Switzerland. Electronic address: phillip.bellion@dsm.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Beilstein</Name>
        <Affiliation>DSM Nutritional Products Ltd, Wurmisweg 576, 4303 Kaiseraugst, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In chemico, in vitro and in vivo comparison of the skin sensitizing potential of eight unsaturated and one saturated lipid compounds.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28958912</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30295-7</DOI>
    <KeywordList>
      <Keywords>Classification and labelling of substances</Keywords>
      <Keywords>Cosmetic Products Regulation</Keywords>
      <Keywords>Direct Peptide Reactivity Assay (DPRA)</Keywords>
      <Keywords>Human cell line activation test (h-CLAT)</Keywords>
      <Keywords>KeratinoSens™ assay</Keywords>
      <Keywords>Non-animal test methods</Keywords>
      <Keywords>Octanol-water partition coefficient (log K(ow))</Keywords>
      <Keywords>Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Reinhard Kreiling</Name>
        <Affiliation>Clariant Produkte (DE) GmbH, Germany. Electronic address: reinhard.kreiling@clariant.com.</Affiliation>
      </Author>
      <Author>
        <Name>Helge Gehrke</Name>
        <Affiliation>Eurofins BioPharma Product Testing Munich GmbH, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas H. Broschard</Name>
        <Affiliation>Merck KGaA, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Birte Dreeßen</Name>
        <Affiliation>Sasol Germany GmbH, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Dorothea Eigler</Name>
        <Affiliation>Evonik Nutrition &amp; Care GmbH, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>David Hart</Name>
        <Affiliation>Akzo Nobel Specialty Chemicals, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Veronika Höpflinger</Name>
        <Affiliation>Eurofins BioPharma Product Testing Munich GmbH, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Marcus Kleber</Name>
        <Affiliation>BASF Personal Care and Nutrition GmbH, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Kupny</Name>
        <Affiliation>Ashland Specialties Poland Sp. z o.o., Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Li</Name>
        <Affiliation>Clariant Produkte (DE) GmbH, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Ungeheuer</Name>
        <Affiliation>European Federation for Cosmetic Ingredients (EFfCI), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Applying 'omics technologies in chemicals risk assessment: Report of an ECETOC workshop.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28958911</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
      <Grant>MC_PC_U127574433</Grant>
      <Grant>MR/K018310/1</Grant>
      <Grant>MR/M009157/1</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30274-X</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway (AOP)</Keywords>
      <Keywords>Differentially expressed genes</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Good laboratory practice (GLP)</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Mode-of-action (MoA)</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Transcriptomics</Keywords>
      <Keywords>Weight-of-evidence (WoE)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Roland Buesen</Name>
        <Affiliation>BASF SE, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Brian N. Chorley</Name>
        <Affiliation>U.S. Environmental Protection Agency, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Beatriz da Silva Lima</Name>
        <Affiliation>iMED.Ulisboa and Faculty of Pharmacy, Universidade de Lisboa, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>George Daston</Name>
        <Affiliation>Procter and Gamble, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lize Deferme</Name>
        <Affiliation>ExxonMobil Petroleum and Chemical, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy Ebbels</Name>
        <Affiliation>Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy W. Gant</Name>
        <Affiliation>Centre for Radiation, Chemical and Environmental Hazards (CRCE), Harwell Science and Innovation Campus, Public Health England (PHE), United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Amber Goetz</Name>
        <Affiliation>Syngenta Crop Protection LLC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Greally</Name>
        <Affiliation>Albert Einstein College of Medicine, Yeshiva University, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Gribaldo</Name>
        <Affiliation>European Commission, Joint Research Centre, European Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Jörg Hackermüller</Name>
        <Affiliation>Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research - UFZ, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Hubesch</Name>
        <Affiliation>Hubesch Consult BVBA, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Danyel Jennen</Name>
        <Affiliation>Department of Toxicogenomics, GROW School for Oncology and Developmental Biology, Maastricht University, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Kamin Johnson</Name>
        <Affiliation>Dow Chemical Company, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Kanno</Name>
        <Affiliation>Japan Organization of Occupational Health and Safety, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Martin Kauffmann</Name>
        <Affiliation>BASF SE, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Madeleine Laffont</Name>
        <Affiliation>European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick McMullen</Name>
        <Affiliation>ScitoVation, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Meehan</Name>
        <Affiliation>MRC Human Genetics Unit, IGMM, University of Edinburgh, Scotland, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Pemberton</Name>
        <Affiliation>Systox Ltd., United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Stefania Perdichizzi</Name>
        <Affiliation>Center for Environmental Toxicology, Agency for Prevention, Environment and Energy (Arpae), Emilia-Romagna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Aldert H. Piersma</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), The Netherlands; IRAS Institute for Risk Assessment Sciences, Utrecht University, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Kerstin Schmidt</Name>
        <Affiliation>BioMath GmbH, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Hervé Seitz</Name>
        <Affiliation>Institut de Génétique Humain (IGH), Centre National de la Recherche Scientifique - National Centre of Scientific Research (CNRS), France.</Affiliation>
      </Author>
      <Author>
        <Name>Kayo Sumida</Name>
        <Affiliation>Sumitomo Chemical Co. Ltd., Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Knut E. Tollefsen</Name>
        <Affiliation>Norwegian Institute for Water Research (NIVA), Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Weida Tong</Name>
        <Affiliation>National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tewes Tralau</Name>
        <Affiliation>Department of Chemical and Product Safety, German Federal Institute of Risk Assessment (BfR), Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ben van Ravenzwaay</Name>
        <Affiliation>BASF SE, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ralf J. M. Weber</Name>
        <Affiliation>Phenome Centre Birmingham, School of Biosciences, University of Birmingham, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Worth</Name>
        <Affiliation>European Commission, Joint Research Centre, European Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Carole Yauk</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Poole</Name>
        <Affiliation>European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), Belgium. Electronic address: alan.poole@ecetoc.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing modified risk tobacco and nicotine products: Description of the scientific framework and assessment of a closed modular electronic cigarette.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28954704</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30280-5</DOI>
    <KeywordList>
      <Keywords>Assessment framework</Keywords>
      <Keywords>Modified Risk Tobacco Products</Keywords>
      <Keywords>Public health</Keywords>
      <Keywords>Risk reduction</Keywords>
      <Keywords>Tobacco harm reduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James Murphy</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom. Electronic address: james_murphy@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Marianna Gaca</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Frazer Lowe</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Emmanuel Minet</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Damien Breheny</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Krishna Prasad</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Oscar Camacho</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Ian M. Fearon</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Chuan Liu</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Wright</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin McAdam</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Proctor</Name>
        <Affiliation>British American Tobacco, R&amp;D Centre, Southampton, SO15 8TL, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute toxicity, 28-day repeated-dose toxicity and toxicokinetic study of timosaponin BII in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28947379</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30293-3</DOI>
    <KeywordList>
      <Keywords>NOAEL</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Timosaponin BII</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ni Lin</Name>
        <Affiliation>Capital Medical University, Beijing 100069, People's Republic of China; New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Baofeng Liu</Name>
        <Affiliation>Shandong Xinbo Pharmaceutical R&amp;D., Ltd., Shandong 251500, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Zhang</Name>
        <Affiliation>Beijing Institute of Radiation Medicine, Beijing 100850, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongpeng Long</Name>
        <Affiliation>Beijing Hwellso Pharmaceutical Corporation Ltd., Beijing 100081, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Guoming Dong</Name>
        <Affiliation>Beijing Hwellso Pharmaceutical Corporation Ltd., Beijing 100081, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongtao Jin</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, People's Republic of China. Electronic address: jinhongtao@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Baiping Ma</Name>
        <Affiliation>Beijing Institute of Radiation Medicine, Beijing 100850, People's Republic of China. Electronic address: mabaiping@sina.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The challenge of the application of 'omics technologies in chemicals risk assessment: Background and outlook.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28927750</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30292-1</DOI>
    <KeywordList>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Omics</Keywords>
      <Keywords>Plant protection products</Keywords>
      <Keywords>Registration, Evaluation, Authorisation, and Restriction (REACH)</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Test method standardisation</Keywords>
      <Keywords>Test method validation</Keywords>
      <Keywords>Transcriptomics</Keywords>
      <Keywords>Weight-of-evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lize Deferme</Name>
        <Affiliation>ExxonMobil Petroleum and Chemical, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Gribaldo</Name>
        <Affiliation>European Commission, Joint Research Centre, European Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Jörg Hackermüller</Name>
        <Affiliation>Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research - UFZ, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tewes Tralau</Name>
        <Affiliation>Department of Chemical and Product Safety, German Federal Institute of Risk Assessment (BfR), Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ben van Ravenzwaay</Name>
        <Affiliation>BASF SE, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Carole Yauk</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Poole</Name>
        <Affiliation>European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Weida Tong</Name>
        <Affiliation>National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy W. Gant</Name>
        <Affiliation>Centre for Radiation, Chemical and Environmental Hazards (CRCE), Harwell Science and Innovation Campus, Public Health England (PHE), UK. Electronic address: tim.gant@phe.gov.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and subacute toxicities of biogenic tellurium nanorods in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28923501</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30286-6</DOI>
    <KeywordList>
      <Keywords>Biogenic Te nanorods</Keywords>
      <Keywords>Lethal dose</Keywords>
      <Keywords>Nanotoxicity</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sara Najimi</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: sarahnajimi@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mojtaba Shakibaie</Name>
        <Affiliation>Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: shakiba@kmu.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Elham Jafari</Name>
        <Affiliation>Department of Pathology and Stem Cell Research, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: ejfarda@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Atefeh Ameri</Name>
        <Affiliation>Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: ameri1363@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nazanin Rahimi</Name>
        <Affiliation>Queensland Micro- and Nanotechnology Centre, Griffith University, QLD 4111, Brisbane, Australia. Electronic address: nazanin.rahimi@griffithuni.edu.au.</Affiliation>
      </Author>
      <Author>
        <Name>Hamid Forootanfar</Name>
        <Affiliation>Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran; Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: forootanfar@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mahnaz Yazdanpanah</Name>
        <Affiliation>Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: dr.yazdanpanahlab@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hamid Reza Rahimi</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran; Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: hamidrrt@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oral mucosal irritation study in hamster to evaluate a therapeutic apparatus using hydrogen peroxide photolysis for periodontitis treatment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28919392</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30291-X</DOI>
    <KeywordList>
      <Keywords>Hamster</Keywords>
      <Keywords>Hydrogen peroxide</Keywords>
      <Keywords>Hydroxyl radicals</Keywords>
      <Keywords>Oral mucosa irritation</Keywords>
      <Keywords>Periodontal therapy</Keywords>
      <Keywords>Photolysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yoshimi Niwano</Name>
        <Affiliation>Tohoku University Graduate School of Dentistry, 4-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. Electronic address: niwano@m.tohoku.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kazunori Konno</Name>
        <Affiliation>Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano, Kanagawa 257-8523, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeshi Matayoshi</Name>
        <Affiliation>Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano, Kanagawa 257-8523, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Keisuke Nakamura</Name>
        <Affiliation>Tohoku University Graduate School of Dentistry, 4-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Taro Kanno</Name>
        <Affiliation>Tohoku University Graduate School of Dentistry, 4-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Keiichi Sasaki</Name>
        <Affiliation>Tohoku University Graduate School of Dentistry, 4-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The added value of the 90-day repeated dose oral toxicity test for industrial chemicals with a low (sub)acute toxicity profile in a high quality dataset: An update.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28919391</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30290-8</DOI>
    <KeywordList>
      <Keywords>European Chemicals Agency</Keywords>
      <Keywords>Low toxicity</Keywords>
      <Keywords>Oral</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Repeated dose</Keywords>
      <Keywords>Sub-acute</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katy Taylor</Name>
        <Affiliation>Cruelty Free International (formerly BUAV) Charitable Trust, 16a Crane Grove, London N7 8NN, United Kingdom. Electronic address: katy.taylor@crueltyfreeinternational.org.</Affiliation>
      </Author>
      <Author>
        <Name>David J. Andrew</Name>
        <Affiliation>TSGE Consulting Ltd., Concordia House, St James Business Park, Knaresborough HG5 8QB, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cleaning and asthma: A systematic review and approach for effective safety assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28918194</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30285-4</DOI>
    <KeywordList>
      <Keywords>Acetic acid</Keywords>
      <Keywords>Asthma</Keywords>
      <Keywords>Cleaning</Keywords>
      <Keywords>Hazard characterization</Keywords>
      <Keywords>Irritation</Keywords>
      <Keywords>Sensitization</Keywords>
      <Keywords>Systematic review</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melissa J. Vincent</Name>
        <Affiliation>Department Environmental Health, University Cincinnati College of Medicine, Cincinnati, OH, USA. Electronic address: melissa.vincent@uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ann Parker</Name>
        <Affiliation>Department Environmental Health, University Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Maier</Name>
        <Affiliation>Department Environmental Health, University Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dermal absorption for pesticide health risk assessment: Harmonization of study design and data reporting for North American Regulatory submissions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28916468</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30284-2</DOI>
    <KeywordList>
      <Keywords>Dermal absorption</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>North America</Keywords>
      <Keywords>Pesticide</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Triple-pack</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kristie M. Sullivan</Name>
        <Affiliation>Physicians Committee for Responsible Medicine, 5100 Wisconsin Ave NW, Suite 400, Washington, DC 20016, United States. Electronic address: ksullivan@pcrm.org.</Affiliation>
      </Author>
      <Author>
        <Name>Manoj Aggarwal</Name>
        <Affiliation>Dow AgroSciences Ltd, 3B Park Square, Milton Park, Abingdon, Oxfordshire OX14 4RN, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan M. Akins</Name>
        <Affiliation>Tessenderlo Kerley, Inc., 2255 North 44th Street, Suite 300, Phoenix, AZ 85008, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Fabian</Name>
        <Affiliation>BASF SE, GB/TB - Z470, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jon R. Heylings</Name>
        <Affiliation>Dermal Technology Laboratory, Ltd, Med IC4, Keele University, Science and Business Park, Keele, Staffordshire ST5 5NL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Raabe</Name>
        <Affiliation>Institute for In Vitro Sciences, 30 W. Watkins Mill Road, Suite 100, Gaithersburg, MD 20878, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Prakashchandra P. V. Shah</Name>
        <Affiliation>US EPA Headquarters, Ariel Rios Building, 1200 Pennsylvania Avenue, N.W., Mail Code: 7505P, Washington, DC 20460, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Christiane Wiemann</Name>
        <Affiliation>BASF Österreich GmbH, Millennium Tower, 25. OG, Handelskai 94-96, A-1200 Wien, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Peffer</Name>
        <Affiliation>Syngenta Crop Protection, LLC, P.O. Box 18300, 410 Swing Road, Greensboro, NC 27419-8300, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation for ingredients used in baby care products: Consideration of diaper rash.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28916467</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30283-0</DOI>
    <KeywordList>
      <Keywords>Compromised skin</Keywords>
      <Keywords>Dermal penetration</Keywords>
      <Keywords>Diaper rash</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susan P. Felter</Name>
        <Affiliation>Procter and Gamble, Central Product Safety, Mason, OH, United States. Electronic address: Felter.sp@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew N. Carr</Name>
        <Affiliation>Procter and Gamble, Global Clinical Sciences, Cincinnati, OH, 45224, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tingting Zhu</Name>
        <Affiliation>Procter and Gamble, Central Product Safety, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Taryn Kirsch</Name>
        <Affiliation>Procter and Gamble, Central Product Safety, Schwalbach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gloria Niu</Name>
        <Affiliation>Procter and Gamble, Global Clinical Sciences, Beijing, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of airborne sensory irritants for setting exposure limits or guidelines: A systematic approach.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28911939</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30287-8</DOI>
    <KeywordList>
      <Keywords>Alarie test</Keywords>
      <Keywords>Animals</Keywords>
      <Keywords>Chemesthesis</Keywords>
      <Keywords>Evaluation</Keywords>
      <Keywords>Humans</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Sensory irritation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gunnar Damgaard Nielsen</Name>
        <Affiliation>National Research Centre for the Working Environment, Lersø Parkallé 105, Copenhagen Ø DK-2100, Denmark. Electronic address: gdn@nrcwe.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Peder Wolkoff</Name>
        <Affiliation>National Research Centre for the Working Environment, Lersø Parkallé 105, Copenhagen Ø DK-2100, Denmark. Electronic address: pwo@nrcwe.dk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute oral toxicity study of magnesium oxide nanoparticles and microparticles in female albino Wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28899817</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30277-5</DOI>
    <KeywordList>
      <Keywords>Antioxidant assays</Keywords>
      <Keywords>Biodistribution</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Hematological alterations</Keywords>
      <Keywords>Magnesium oxide nanoparticles</Keywords>
      <Keywords>Wistar rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bhanuramya Mangalampalli</Name>
        <Affiliation>Toxicology Unit, Pharmacology and Toxicology Division, CSIR - Indian Institute of Chemical Technology, Hyderabad, Telangana 500007, India; Academy of Scientific and Innovative Research, CSIR - Indian Institute of Chemical Technology, Hyderabad, Telangana 500007, India.</Affiliation>
      </Author>
      <Author>
        <Name>Naresh Dumala</Name>
        <Affiliation>Toxicology Unit, Pharmacology and Toxicology Division, CSIR - Indian Institute of Chemical Technology, Hyderabad, Telangana 500007, India; Academy of Scientific and Innovative Research, CSIR - Indian Institute of Chemical Technology, Hyderabad, Telangana 500007, India.</Affiliation>
      </Author>
      <Author>
        <Name>Paramjit Grover</Name>
        <Affiliation>Toxicology Unit, Pharmacology and Toxicology Division, CSIR - Indian Institute of Chemical Technology, Hyderabad, Telangana 500007, India. Electronic address: paramgrover@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of supratherapeutic dose of Maytenus ilicifolia Mart. ex Reissek extracts on fertility and neurobehavioral status of male and pregnant rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28889966</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30279-9</DOI>
    <KeywordList>
      <Keywords>Fertility</Keywords>
      <Keywords>Maytenus ilicifolia</Keywords>
      <Keywords>Neurobehavioral</Keywords>
      <Keywords>Pregnancy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Assis Ecker</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Federal University of Santa Maria (UFSM), Campus Universitário - Camobi, CEP 97105-900, Santa Maria, RS, Brazil. Electronic address: assisecker@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Carla Giane Loss</Name>
        <Affiliation>Department of Health Sciences, Universidade Regional Integrada do Alto Uruguai e das Missões (URI), Avenida Sete de Setembro, 1621, CEP 99700-000, Erechim, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen A. Adefegha</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Federal University of Santa Maria (UFSM), Campus Universitário - Camobi, CEP 97105-900, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Aline Augusti Boligon</Name>
        <Affiliation>Phytochemical Research Laboratory, Department of Industrial Pharmacy, Federal University of Santa Maria (UFSM), Build 26, Room 1115, Santa Maria, CEP 97105-900, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Silvane Souza Roman</Name>
        <Affiliation>Department of Health Sciences, Universidade Regional Integrada do Alto Uruguai e das Missões (URI), Avenida Sete de Setembro, 1621, CEP 99700-000, Erechim, RS, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxicity and sub-chronic toxicity of MYOLUTION</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28888959</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30276-3</DOI>
    <KeywordList>
      <Keywords>BCKA</Keywords>
      <Keywords>Branched chain keto acids</Keywords>
      <Keywords>Food additive</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Keto-isoleucine</Keywords>
      <Keywords>Keto-leucine</Keywords>
      <Keywords>Keto-valine</Keywords>
      <Keywords>MYOLUTION(®)</Keywords>
      <Keywords>Repeated dose toxicity</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Caroline Hall</Name>
        <Affiliation>Evonik Nutrition &amp; Care GmbH, Rodenbacher Chaussee 4, 63457 Hanau-Wolfgang, Federal Republic of Germany. Electronic address: caroline.hall@evonik.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Grayson</Name>
        <Affiliation>Evonik Nutrition &amp; Care GmbH, Rodenbacher Chaussee 4, 63457 Hanau-Wolfgang, Federal Republic of Germany. Electronic address: ian.grayson@evonik.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Establishing maximum tolerated doses for a 2-year combined chronic/carcinogenicity rat study based on toxicokinetic and toxicity gender differences.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28888958</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30278-7</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Chronic toxicity</Keywords>
      <Keywords>Gender difference</Keywords>
      <Keywords>Maximum tolerated dose</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhiwei Liu</Name>
        <Affiliation>FMC Corporation, Ewing, NJ, 08628, USA. Electronic address: Zhiwei.Liu@fmc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda Wasniewski</Name>
        <Affiliation>FMC Corporation, Ewing, NJ, 08628, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sara Lamperti</Name>
        <Affiliation>Isagro Spa, Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Katia Mainolfi</Name>
        <Affiliation>Isagro Spa, Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Appavu Chandrasekaran</Name>
        <Affiliation>FMC Corporation, Ewing, NJ, 08628, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigating toxicity specific to adjuvanted vaccines.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28888957</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30275-1</DOI>
    <KeywordList>
      <Keywords>Adjuvanted vaccines</Keywords>
      <Keywords>Cytokine storm</Keywords>
      <Keywords>Local tolerance</Keywords>
      <Keywords>Off-target toxicity</Keywords>
      <Keywords>On-target toxicity</Keywords>
      <Keywords>Relevant animal species</Keywords>
      <Keywords>Safety pharmacology</Keywords>
      <Keywords>Time–toxicity profiles</Keywords>
      <Keywords>WHO guidelines</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mineo Matsumoto</Name>
        <Affiliation>Review Division, Pharmaceuticals and Medical Devices Agency (PMDA)(1), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan. Electronic address: matsumoto-mineo@pmda.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Shin Ichi Komatsu</Name>
        <Affiliation>Product Development Division, POC Clinical Research Inc.(1), Akasaka 1-11-44, Minato-ku, Tokyo 107-0052, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takanori Ikeda</Name>
        <Affiliation>Safety Assessment, MSD K.K.(1), Kudan-kita 1-13-12, Chiyoda-ku, Tokyo 102-8667, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuhiro Shimomura</Name>
        <Affiliation>Vaccine Research Laboratories, Kitasato Daiichi Sankyo Vaccine Co. Ltd.(1), Kita-Kasai 1-16-13, Edogawa-ku, Tokyo 134-8630, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuto Watanabe</Name>
        <Affiliation>Research Division, Chugai Pharmaceutical Co. Ltd.(1), Komakado, 1-135, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Keiji Hirabayashi</Name>
        <Affiliation>Review Division, Pharmaceuticals and Medical Devices Agency (PMDA)(1), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Ichi Sawada</Name>
        <Affiliation>Review Division, Pharmaceuticals and Medical Devices Agency (PMDA)(1), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazushige Maki</Name>
        <Affiliation>Review Division, Pharmaceuticals and Medical Devices Agency (PMDA)(1), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazutoshi Shinoda</Name>
        <Affiliation>Review Division, Pharmaceuticals and Medical Devices Agency (PMDA)(1), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Osamu Fueki</Name>
        <Affiliation>Review Division, Pharmaceuticals and Medical Devices Agency (PMDA)(1), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Onodera</Name>
        <Affiliation>Review Division, Pharmaceuticals and Medical Devices Agency (PMDA)(1), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28887049</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30273-8</DOI>
    <KeywordList>
      <Keywords>CD3 bispecific</Keywords>
      <Keywords>First-in-human dose</Keywords>
      <Keywords>MABEL</Keywords>
      <Keywords>Oncology drug development</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haleh Saber</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States. Electronic address: haleh.saber@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Pedro Del Valle</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tiffany K. Ricks</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John K. Leighton</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bisphenol A and immunotoxic potential: A commentary.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28870489</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30272-6</DOI>
    <KeywordList>
      <Keywords>Allergy</Keywords>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Immunological tolerance</Keywords>
      <Keywords>Immunotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road, Manchester, M13 9PT, UK. Electronic address: ian.kimber@manchester.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigating the state of physiologically based kinetic modelling practices and challenges associated with gaining regulatory acceptance of model applications.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28866268</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30269-6</DOI>
    <KeywordList>
      <Keywords>Alternatives methods</Keywords>
      <Keywords>PBK models</Keywords>
      <Keywords>Physiologically based kinetic models</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alicia Paini</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate Health, Consumers and Reference Materials, Via E Fermi 2749, 21027 Ispra, Italy. Electronic address: alicia.paini@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Jeremy A. Leonard</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, Oak Ridge, TN 37831, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tomas Kliment</Name>
        <Affiliation>Klimeto, Juzna 4, Roznava, Slovakia.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Mei Tan</Name>
        <Affiliation>U.S. Environmental Protection Agency, National Research Laboratory, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Worth</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate Health, Consumers and Reference Materials, Via E Fermi 2749, 21027 Ispra, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>How well can carcinogenicity be predicted by high throughput "characteristics of carcinogens" mechanistic data?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28866267</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30271-4</DOI>
    <KeywordList>
      <Keywords>Cancer hazard classification</Keywords>
      <Keywords>Cancer prediction modeling</Keywords>
      <Keywords>High throughput screening (HTS)</Keywords>
      <Keywords>IARC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard A. Becker</Name>
        <Affiliation>American Chemistry Council, 700 Second St., NE, Washington DC 20002, USA. Electronic address: rick_becker@americanchemistry.com.</Affiliation>
      </Author>
      <Author>
        <Name>David A. Dreier</Name>
        <Affiliation>Center for Environmental &amp; Human Toxicology, University of Florida, Gainesville, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mary K. Manibusan</Name>
        <Affiliation>Exponent, Washington DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Louis A. Tony Cox</Name>
        <Affiliation>Cox Associates, Denver, CO, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ted W. Simon</Name>
        <Affiliation>Ted Simon LLC, Winston, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James S. Bus</Name>
        <Affiliation>Exponent, Alexandria, VA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic toxicity study of yttrium nitrate by 90-day repeated oral exposure in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28866266</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30270-2</DOI>
    <KeywordList>
      <Keywords>ADI</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Rare earth elements</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>Yttrium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yi Mei Wang</Name>
        <Affiliation>Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, PLA, Beijing 100071, China. Electronic address: wangyimei2006@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhou Yu</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zeng Ming Zhao</Name>
        <Affiliation>Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, PLA, Beijing 100071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Jia</Name>
        <Affiliation>Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, PLA, Beijing 100071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hai Qin Fang</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Fen Zhang</Name>
        <Affiliation>Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, PLA, Beijing 100071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Yan Yuan</Name>
        <Affiliation>Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, PLA, Beijing 100071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Lei Shu</Name>
        <Affiliation>Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, PLA, Beijing 100071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun He</Name>
        <Affiliation>Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, PLA, Beijing 100071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Peng</Name>
        <Affiliation>Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, PLA, Beijing 100071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Zhong Li</Name>
        <Affiliation>Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, PLA, Beijing 100071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Zhao</Name>
        <Affiliation>Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, PLA, Beijing 100071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Dong Jia</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing 100021, China. Electronic address: jiaxudong@cfsa.net.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shuang Qing Peng</Name>
        <Affiliation>Evaluation and Research Center for Toxicology, Institute of Disease Control and Prevention, PLA, Beijing 100071, China. Electronic address: pengsq@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical-induced asthma and the role of clinical, toxicological, exposure and epidemiological research in regulatory and hazard characterization approaches.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28866265</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30268-4</DOI>
    <KeywordList>
      <Keywords>Asthma</Keywords>
      <Keywords>Consumer products</Keywords>
      <Keywords>Hazard characterization</Keywords>
      <Keywords>Respiratory sensitization</Keywords>
      <Keywords>Risk management</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melissa J. Vincent</Name>
        <Affiliation>Department Environmental Health, University Cincinnati College of Medicine, Cincinnati, OH, United States. Electronic address: melissa.vincent@uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan A. Bernstein</Name>
        <Affiliation>Division of Immunology, Allergy &amp; Rheumatology, University of Cincinnati College of Medicine, Cincinnati, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Judy S. LaKind</Name>
        <Affiliation>LaKind Associates, LLC, Department of Epidemiology and Public Health, University of Maryland at Baltimore, School of Medicine, United States.</Affiliation>
      </Author>
      <Author>
        <Name>G. Scott Dotson</Name>
        <Affiliation>National Institute for Occupational Safety and Health (NIOSH), Education and Information Division, Cincinnati, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Maier</Name>
        <Affiliation>Department Environmental Health, University Cincinnati College of Medicine, Cincinnati, OH, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of a tool to assess the completeness of drug information sources for health care professionals: A Delphi study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28842337</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30263-5</DOI>
    <KeywordList>
      <Keywords>Clinical decision support systems</Keywords>
      <Keywords>Delphi technique</Keywords>
      <Keywords>Drug information</Keywords>
      <Keywords>Drug labelling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Blanca Arguello</Name>
        <Affiliation>Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Teresa M. Salgado</Name>
        <Affiliation>Department of Pharmacotherapy &amp; Outcomes Science, Virginia Commonwealth University School of Pharmacy, 410 N 12th Street P.O. Box 980533, Richmond, VA 23298-0533, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gert Laekeman</Name>
        <Affiliation>Clinical Pharmacology and Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, KU Leuven, O&amp;N II, Herestraat 49, PO Box 521, 3000 Leuven, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Fernandez-Llimos</Name>
        <Affiliation>Research Institute for Medicines (iMed.ULisboa), Department of Social-Pharmacy, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal. Electronic address: f-llimos@ff.ul.pt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>7-Chloro-4-phenylsulfonyl quinoline, a new antinociceptive and anti-inflammatory molecule: Structural improvement of a quinoline derivate with pharmacological activity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28842336</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30264-7</DOI>
    <KeywordList>
      <Keywords>Inflammation</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Nociception</Keywords>
      <Keywords>Quinoline</Keywords>
      <Keywords>Sulfone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mikaela P. Pinz</Name>
        <Affiliation>Laboratório de Pesquisa em Farmacologia Bioquímica (LaFarBio), Grupo de Pesquisa em Neurobiotecnologia - GPN, CCQFA Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Angélica S. Reis</Name>
        <Affiliation>Laboratório de Pesquisa em Farmacologia Bioquímica (LaFarBio), Grupo de Pesquisa em Neurobiotecnologia - GPN, CCQFA Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Renata Leivas de Oliveira</Name>
        <Affiliation>Laboratório de Pesquisa em Farmacologia Bioquímica (LaFarBio), Grupo de Pesquisa em Neurobiotecnologia - GPN, CCQFA Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Guilherme T. Voss</Name>
        <Affiliation>Laboratório de Pesquisa em Farmacologia Bioquímica (LaFarBio), Grupo de Pesquisa em Neurobiotecnologia - GPN, CCQFA Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ane G. Vogt</Name>
        <Affiliation>Laboratório de Pesquisa em Farmacologia Bioquímica (LaFarBio), Grupo de Pesquisa em Neurobiotecnologia - GPN, CCQFA Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Manoela do Sacramento</Name>
        <Affiliation>Laboratório de Síntese Orgânica Limpa - LASOL - CCQFA, Universidade Federal de Pelotas - UFP, P.O. Box 354, 96010-900, Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juliano A. Roehrs</Name>
        <Affiliation>Laboratório de Síntese Orgânica Limpa - LASOL - CCQFA, Universidade Federal de Pelotas - UFP, P.O. Box 354, 96010-900, Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Diego Alves</Name>
        <Affiliation>Laboratório de Síntese Orgânica Limpa - LASOL - CCQFA, Universidade Federal de Pelotas - UFP, P.O. Box 354, 96010-900, Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cristiane Luchese</Name>
        <Affiliation>Laboratório de Pesquisa em Farmacologia Bioquímica (LaFarBio), Grupo de Pesquisa em Neurobiotecnologia - GPN, CCQFA Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil. Electronic address: cristiane_luchese@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Ethel A. Wilhelm</Name>
        <Affiliation>Laboratório de Pesquisa em Farmacologia Bioquímica (LaFarBio), Grupo de Pesquisa em Neurobiotecnologia - GPN, CCQFA Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil. Electronic address: ethelwilhelm@yahoo.com.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological profile of IQG-607 after single and repeated oral administration in minipigs: An essential step towards phase I clinical trial.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28838610</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30265-9</DOI>
    <KeywordList>
      <Keywords>Drug development</Keywords>
      <Keywords>IQG-607</Keywords>
      <Keywords>Minipig</Keywords>
      <Keywords>Preclinical toxicology</Keywords>
      <Keywords>Tuberculosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Valnês S. Rodrigues-Junior</Name>
        <Affiliation>Centro de Pesquisas Em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia Em Tuberculose (INCT-TB), Pontifícia Universidade Católica Do Rio Grande Do Sul (PUCRS), Av. Ipiranga 6681 - Prédio 92A Tecnopuc, 90619-900 Porto Alegre, Brazil. Electronic address: valnes.junior@pucrs.br.</Affiliation>
      </Author>
      <Author>
        <Name>Luciana Cintra</Name>
        <Affiliation>Centro de Experimentação e Treinamento Em Cirurgia (CETEC), Sociedade Beneficente Israelita Brasileira Albert Einstein, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Pablo Machado</Name>
        <Affiliation>Centro de Pesquisas Em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia Em Tuberculose (INCT-TB), Pontifícia Universidade Católica Do Rio Grande Do Sul (PUCRS), Av. Ipiranga 6681 - Prédio 92A Tecnopuc, 90619-900 Porto Alegre, Brazil; Programa de Pós-Graduação Em Biologia Celular e Molecular, PUCRS, Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Adílio Dadda</Name>
        <Affiliation>Centro de Pesquisas Em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia Em Tuberculose (INCT-TB), Pontifícia Universidade Católica Do Rio Grande Do Sul (PUCRS), Av. Ipiranga 6681 - Prédio 92A Tecnopuc, 90619-900 Porto Alegre, Brazil; Programa de Pós-Graduação Em Biologia Celular e Molecular, PUCRS, Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luiz Augusto Basso</Name>
        <Affiliation>Centro de Pesquisas Em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia Em Tuberculose (INCT-TB), Pontifícia Universidade Católica Do Rio Grande Do Sul (PUCRS), Av. Ipiranga 6681 - Prédio 92A Tecnopuc, 90619-900 Porto Alegre, Brazil; Programa de Pós-Graduação Em Biologia Celular e Molecular, PUCRS, Porto Alegre, Brazil; Programa de Pós-Graduação Em Medicina e Ciências da Saúde, PUCRS, Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Carolina Cintra Nunes Mafra</Name>
        <Affiliation>Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandre Holthausen Campos</Name>
        <Affiliation>Centro de Experimentação e Treinamento Em Cirurgia (CETEC), Sociedade Beneficente Israelita Brasileira Albert Einstein, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Martha Campos</Name>
        <Affiliation>Programa de Pós-Graduação Em Medicina e Ciências da Saúde, PUCRS, Porto Alegre, Brazil; Instituto de Toxicologia e Farmacologia, PUCRS, Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Diógenes Santiago Santos</Name>
        <Affiliation>Centro de Pesquisas Em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia Em Tuberculose (INCT-TB), Pontifícia Universidade Católica Do Rio Grande Do Sul (PUCRS), Av. Ipiranga 6681 - Prédio 92A Tecnopuc, 90619-900 Porto Alegre, Brazil; Programa de Pós-Graduação Em Biologia Celular e Molecular, PUCRS, Porto Alegre, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A quantitative weight of evidence assessment of confidence in modes-of-action and their human relevance.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28838609</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30262-3</DOI>
    <KeywordList>
      <Keywords>Mode of action</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Systematic analysis</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>Department of Toxicology, University of Würzburg, 97078 Würzburg, Germany. Electronic address: dekant@toxi.uni-wuerzburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>James Bridges</Name>
        <Affiliation>University of Surrey, Guildford, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony R. Scialli</Name>
        <Affiliation>Reproductive Toxicology Center, George Washington University, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Silver nanoparticles protect acetaminophen induced acute hepatotoxicity: A biochemical and histopathological approach.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28827191</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30253-2</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Hepatoprotection</Keywords>
      <Keywords>Silver nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohd Salim Reshi</Name>
        <Affiliation>UNESCO- Trace Element Satellite Center School of Studies in Zoology, Jiwaji University, Gwalior, M.P., India. Electronic address: reshisalim@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chhavi Uthra</Name>
        <Affiliation>UNESCO- Trace Element Satellite Center School of Studies in Zoology, Jiwaji University, Gwalior, M.P., India.</Affiliation>
      </Author>
      <Author>
        <Name>Deepa Yadav</Name>
        <Affiliation>UNESCO- Trace Element Satellite Center School of Studies in Zoology, Jiwaji University, Gwalior, M.P., India.</Affiliation>
      </Author>
      <Author>
        <Name>Samta Sharma</Name>
        <Affiliation>UNESCO- Trace Element Satellite Center School of Studies in Zoology, Jiwaji University, Gwalior, M.P., India.</Affiliation>
      </Author>
      <Author>
        <Name>Asha Singh</Name>
        <Affiliation>UNESCO- Trace Element Satellite Center School of Studies in Zoology, Jiwaji University, Gwalior, M.P., India.</Affiliation>
      </Author>
      <Author>
        <Name>Anjali Sharma</Name>
        <Affiliation>UNESCO- Trace Element Satellite Center School of Studies in Zoology, Jiwaji University, Gwalior, M.P., India.</Affiliation>
      </Author>
      <Author>
        <Name>Amita Jaswal</Name>
        <Affiliation>UNESCO- Trace Element Satellite Center School of Studies in Zoology, Jiwaji University, Gwalior, M.P., India.</Affiliation>
      </Author>
      <Author>
        <Name>Neelu Sinha</Name>
        <Affiliation>UNESCO- Trace Element Satellite Center School of Studies in Zoology, Jiwaji University, Gwalior, M.P., India.</Affiliation>
      </Author>
      <Author>
        <Name>Sadhana Shrivastava</Name>
        <Affiliation>UNESCO- Trace Element Satellite Center School of Studies in Zoology, Jiwaji University, Gwalior, M.P., India.</Affiliation>
      </Author>
      <Author>
        <Name>Sangeeta Shukla</Name>
        <Affiliation>UNESCO- Trace Element Satellite Center School of Studies in Zoology, Jiwaji University, Gwalior, M.P., India. Electronic address: profsshukla@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro toxicological assessment of Arrabidaea brachypoda (DC.) Bureau: Mutagenicity and estrogenicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28823851</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30252-0</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>Arrabidaea brachypoda</Keywords>
      <Keywords>Medicinal plants</Keywords>
      <Keywords>Recombinant yeast assay (RYA)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Flávia Aparecida Resende</Name>
        <Affiliation>UNIARA- University of Araraquara, Department of Biological Sciences and Health, CEP 14801-340, Araraquara, São Paulo, Brazil. Electronic address: flaviabiomed@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Catarine Haidê Nogueira</Name>
        <Affiliation>UNESP-São Paulo State University, Faculty of Pharmaceutical Sciences of Araraquara, Department of Biological Sciences, CEP 14801-902, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lívia Greghi Espanha</Name>
        <Affiliation>UNESP-São Paulo State University, Faculty of Pharmaceutical Sciences of Araraquara, Department of Biological Sciences, CEP 14801-902, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Paula Karina Boldrin</Name>
        <Affiliation>UNESP-São Paulo State University, Faculty of Pharmaceutical Sciences of Araraquara, Department of Biological Sciences, CEP 14801-902, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Paula Oliveira-Höhne</Name>
        <Affiliation>UNESP-São Paulo State University, Faculty of Pharmaceutical Sciences of Araraquara, Department of Biological Sciences, CEP 14801-902, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mariana Santoro de Camargo</Name>
        <Affiliation>UNIARA- University of Araraquara, Department of Biological Sciences and Health, CEP 14801-340, Araraquara, São Paulo, Brazil; UFSCAR- Federal University of São Carlos, Centro de Ciências Exatas e de Tecnologia (CCET), CEP 13565-905, São Carlos, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cláudia Quintino da Rocha</Name>
        <Affiliation>UFMA-Federal University of Maranhão, Centro de Ciências Exatas e de Tecnologia (CCET), Department of Chemistry, CEP 65065-545, São Luis, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Wagner Vilegas</Name>
        <Affiliation>UNESP-São Paulo State University, Experimental Campus of the Paulista Coast, CEP 11330-900, São Vicente, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Eliana Aparecida Varanda</Name>
        <Affiliation>UNESP-São Paulo State University, Faculty of Pharmaceutical Sciences of Araraquara, Department of Biological Sciences, CEP 14801-902, Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro method to evaluate the barrier properties of medical devices for cutaneous use.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28822878</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30249-0</DOI>
    <KeywordList>
      <Keywords>Barrier cream</Keywords>
      <Keywords>Caffeine</Keywords>
      <Keywords>Franz diffusion cell</Keywords>
      <Keywords>Human epidermis</Keywords>
      <Keywords>In vitro method</Keywords>
      <Keywords>Percutaneous absorption</Keywords>
      <Keywords>Reconstructed 3D human epidermis</Keywords>
      <Keywords>Skin protection</Keywords>
      <Keywords>Transepidermal water loss (TEWL)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Antonella Casiraghi</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Milan, Via G. Colombo 71, 20133 Milan, Italy. Electronic address: antonella.casiraghi@unimi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Francesco Ranzini</Name>
        <Affiliation>VitroScreen, In Vitro Research Laboratories, Via Mosè Bianchi 103, 20149 Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Umberto M. Musazzi</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Milan, Via G. Colombo 71, 20133 Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Franzè</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Milan, Via G. Colombo 71, 20133 Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Marisa Meloni</Name>
        <Affiliation>VitroScreen, In Vitro Research Laboratories, Via Mosè Bianchi 103, 20149 Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Paola Minghetti</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Milan, Via G. Colombo 71, 20133 Milan, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of tobacco heating product THP1.0. Part 8: Study to determine puffing topography, mouth level exposure and consumption among Japanese users.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28822877</pubmedLink>
    <Year>2018</Year>
    <DOI>S0273-2300(17)30247-7</DOI>
    <KeywordList>
      <Keywords>Actual use</Keywords>
      <Keywords>Consumer use</Keywords>
      <Keywords>Mouth insertion depth</Keywords>
      <Keywords>Mouth level exposure</Keywords>
      <Keywords>Next generation products</Keywords>
      <Keywords>Preclinical assessment</Keywords>
      <Keywords>Puffing topography</Keywords>
      <Keywords>Tobacco heating product</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jodie Gee</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Krishna Prasad</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton, SO15 8TL, UK. Electronic address: krishna_prasad@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra Slayford</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Adam Gray</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Kathryn Nother</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony Cunningham</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Eleni Mavropoulou</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Proctor</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of maternal feed restriction on prenatal development in rats and rabbits - A review of published data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28822876</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30251-9</DOI>
    <KeywordList>
      <Keywords>Classification</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Feed restriction</Keywords>
      <Keywords>Rabbit</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dana Nitzsche</Name>
        <Affiliation>Federal Institute for Occupational Safety and Health, Unit Toxicology, Friedrich-Henkel-Weg 1-25, 44149 Dortmund, Germany. Electronic address: nitzsche.dana@baua.bund.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28822875</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30250-7</DOI>
    <KeywordList>
      <Keywords>Expert review</Keywords>
      <Keywords>ICH M7</Keywords>
      <Keywords>Mirabilis</Keywords>
      <Keywords>Mutagenic impurity</Keywords>
      <Keywords>Purge</Keywords>
      <Keywords>Purge Ratio</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chris Barber</Name>
        <Affiliation>Lhasa Limited, Leeds, UK. Electronic address: chris.barber@lhasalimited.org.</Affiliation>
      </Author>
      <Author>
        <Name>Vincent Antonucci</Name>
        <Affiliation>Merck Sharp &amp; Dohme, Rahway, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jens Christoph Baumann</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Roland Brown</Name>
        <Affiliation>Pfizer, Sandwich, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth Covey-Crump</Name>
        <Affiliation>Lhasa Limited, Leeds, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Elder</Name>
        <Affiliation>Consultant, Hertford, Hertfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Elliott</Name>
        <Affiliation>Takeda Pharmaceuticals, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jared W. Fennell</Name>
        <Affiliation>Eli Lilly and Co., Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fabrice Gallou</Name>
        <Affiliation>Novartis, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Nathan D. Ide</Name>
        <Affiliation>AbbVie, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Guido Jordine</Name>
        <Affiliation>Novartis, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey M. Kallemeyn</Name>
        <Affiliation>AbbVie, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dirk Lauwers</Name>
        <Affiliation>Janssen Pharmaceutica NV, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Adam R. Looker</Name>
        <Affiliation>Vertex Pharmaceuticals, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lucie E. Lovelle</Name>
        <Affiliation>Novartis, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Mark McLaughlin</Name>
        <Affiliation>Merck Sharp &amp; Dohme, Rahway, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Molzahn</Name>
        <Affiliation>Excella GmbH &amp; Co. KG, Feucht, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Ott</Name>
        <Affiliation>Lhasa Limited, Leeds, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Didier Schils</Name>
        <Affiliation>Galapagos NV, Mechelen, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Rolf Schulte Oestrich</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Neil Stevenson</Name>
        <Affiliation>GlaxoSmithKline, Stevenage, Hertfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Pere Talavera</Name>
        <Affiliation>Esteve Química, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Teasdale</Name>
        <Affiliation>AstraZeneca, Macclesfield, Cheshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Michael W. Urquhart</Name>
        <Affiliation>GlaxoSmithKline, Stevenage, Hertfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David L. Varie</Name>
        <Affiliation>Eli Lilly and Co., Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dennie Welch</Name>
        <Affiliation>AbbVie, North Chicago, IL, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative assessment of HPHC yields in the Tobacco Heating System THS2.2 and commercial cigarettes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28818540</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30248-9</DOI>
    <KeywordList>
      <Keywords>Harmful and potentially harmful constituents</Keywords>
      <Keywords>Modified risk tobacco products</Keywords>
      <Keywords>THS 2.2</Keywords>
      <Keywords>Tobacco Heating System</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>G. Jaccard</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products SA, Rue des Usines 56, CH-2000 Neuchâtel, Switzerland. Electronic address: Guy.Jaccard@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>D. Tafin Djoko</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products SA, Rue des Usines 56, CH-2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>O. Moennikes</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products SA, Rue des Usines 56, CH-2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>C. Jeannet</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products SA, Rue des Usines 56, CH-2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>A. Kondylis</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products SA, Rue des Usines 56, CH-2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>M. Belushkin</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products SA, Rue des Usines 56, CH-2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Absence of subchronic oral toxicity and genotoxicity of rice koji with Aspergillus terreus.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28802559</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30246-5</DOI>
    <KeywordList>
      <Keywords>Aspergillus terreus</Keywords>
      <Keywords>Fermented food</Keywords>
      <Keywords>Functional food</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Koji</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Won Yun</Name>
        <Affiliation>Department of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyun Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Soon Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Ran You</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Young Cho</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Hee Yoon</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Euna Kwon</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Ju Lee</Name>
        <Affiliation>Daesang Co. Ltd., Icheon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seong Pil Kim</Name>
        <Affiliation>Daesang Co. Ltd., Icheon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Hoon Seo</Name>
        <Affiliation>Daesang Co. Ltd., Icheon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Pyung In</Name>
        <Affiliation>Daesang Co. Ltd., Icheon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Hun Ahn</Name>
        <Affiliation>Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ja June Jang</Name>
        <Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Sung Park</Name>
        <Affiliation>Department of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea; Department of Neurogenetics, Kolling Institute, Royal North Shore Hospital and University of Sydney, St. Leonards, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Hwan Che</Name>
        <Affiliation>Biomedical Center for Animal Resource and Development, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: casache@snu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Byeong Cheol Kang</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Biomedical Center for Animal Resource and Development, Seoul National University College of Medicine, Seoul, Republic of Korea; Designed Animal and Transplantation Research Institute, Institute of GreenBio Science Technology, Seoul National University, Pyeongchang-gun, Gangwon-do, Republic of Korea. Electronic address: bckang@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A quantitative framework to group nanoscale and microscale particles by hazard potency to derive occupational exposure limits: Proof of concept evaluation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28789940</pubmedLink>
    <GrantList>
      <Grant>R01 ES016189</Grant>
      <Grant>RC2 ES018772</Grant>
      <Grant>RC2 ES018741</Grant>
      <Grant>P30 ES007033</Grant>
      <Grant>RC2 ES018766</Grant>
      <Grant>R01 ES019311</Grant>
      <Grant>CC999999</Grant>
      <Grant>RC1 ES018232</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30245-3</DOI>
    <KeywordList>
      <Keywords>Benchmark dose modeling</Keywords>
      <Keywords>Hazard potency</Keywords>
      <Keywords>Hierarchical clustering</Keywords>
      <Keywords>Nanomaterial</Keywords>
      <Keywords>Occupational exposure limit</Keywords>
      <Keywords>Physicochemical properties</Keywords>
      <Keywords>Predictive modeling</Keywords>
      <Keywords>Pulmonary inflammation</Keywords>
      <Keywords>Random forest</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nathan M. Drew</Name>
        <Affiliation>National Institute for Occupational Safety and Health (NIOSH), Nanotechnology Research Center (NTRC), Cincinnati, OH 45226, USA. Electronic address: vom8@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Eileen D. Kuempel</Name>
        <Affiliation>National Institute for Occupational Safety and Health (NIOSH), Nanotechnology Research Center (NTRC), Cincinnati, OH 45226, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Pei</Name>
        <Affiliation>West Virginia University, Department of Industrial and Management System Engineering, Morgantown, WV 26506, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Yang</Name>
        <Affiliation>West Virginia University, Department of Industrial and Management System Engineering, Morgantown, WV 26506, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of neoagarooligosaccharides prepared by enzymatic hydrolysis of agar.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28782575</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30243-X</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Agar</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>NAOs (neoagarooligosaccharides)</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sun Joo Hong</Name>
        <Affiliation>Department of Biological Science and Bioinformatics, Myongji University, 116 Myongji-Ro, Cheoin-gu, Yongin, Gyeonggido 17058, Republic of Korea; Dynebio Inc., B-B205 Woolimlions Valley II, 45 Sagimagil-Ro, Jungwon-Gu, Seongnam-Si, Gyeonggi-Do 13209, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Je Hyeon Lee</Name>
        <Affiliation>Dynebio Inc., B-B205 Woolimlions Valley II, 45 Sagimagil-Ro, Jungwon-Gu, Seongnam-Si, Gyeonggi-Do 13209, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Joo Kim</Name>
        <Affiliation>Dynebio Inc., B-B205 Woolimlions Valley II, 45 Sagimagil-Ro, Jungwon-Gu, Seongnam-Si, Gyeonggi-Do 13209, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hea Jung Yang</Name>
        <Affiliation>Dynebio Inc., B-B205 Woolimlions Valley II, 45 Sagimagil-Ro, Jungwon-Gu, Seongnam-Si, Gyeonggi-Do 13209, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Seon Park</Name>
        <Affiliation>Department of Biological Science and Bioinformatics, Myongji University, 116 Myongji-Ro, Cheoin-gu, Yongin, Gyeonggido 17058, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soon Kwang Hong</Name>
        <Affiliation>Department of Biological Science and Bioinformatics, Myongji University, 116 Myongji-Ro, Cheoin-gu, Yongin, Gyeonggido 17058, Republic of Korea. Electronic address: skhong@mju.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Commentary on the safety of topical vitamin A in cosmetics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28782574</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30244-1</DOI>
    <KeywordList>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Human safety</Keywords>
      <Keywords>Oral exposure</Keywords>
      <Keywords>Skin penetration</Keywords>
      <Keywords>Topical exposure</Keywords>
      <Keywords>Vitamin A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gerhard J. Nohynek</Name>
        <Affiliation>Les Caillons, F-58460 Corvol l'Orgueilleux, France. Electronic address: nepomuk@noos.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comments on the safety assessment of decamethylcyclopentasiloxane (D5) published in regulatory toxicology and pharmacology, 2017, 83:117-118.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28780200</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30242-8</DOI>
    <KeywordList>
      <Keywords>Decamethylcyclopentasiloxane</Keywords>
      <Keywords>Inhalation toxicology</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Uterinetumors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James Bridges</Name>
        <Affiliation>University of Surrey, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>University of Würzburg, Germany. Electronic address: dekant@toxi.uni-wuerzburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Klaunig</Name>
        <Affiliation>Indiana University, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony R. Scialli</Name>
        <Affiliation>Reproductive Toxicology Center, George Washington University, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nicotine pharmacokinetic profiles of the Tobacco Heating System 2.2, cigarettes and nicotine gum in Japanese smokers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28760390</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30228-3</DOI>
    <KeywordList>
      <Keywords>Cigarette</Keywords>
      <Keywords>Menthol</Keywords>
      <Keywords>Nicotine gum</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Smoking</Keywords>
      <Keywords>Smoking urges</Keywords>
      <Keywords>THS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Patrick Brossard</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Rolf Weitkunat</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000 Neuchâtel, Switzerland. Electronic address: rolf.weitkunat@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Valerie Poux</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Nicola Lama</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Christelle Haziza</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Picavet</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Gizelle Baker</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Lüdicke</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, CH-2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative effect of ochratoxin A on inflammation and oxidative stress parameters in gut and kidney of piglets.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28760389</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30227-1</DOI>
    <KeywordList>
      <Keywords>Gut</Keywords>
      <Keywords>Immune response</Keywords>
      <Keywords>Kidney</Keywords>
      <Keywords>Ochratoxin A</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Piglets</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniela E. Marin</Name>
        <Affiliation>Laboratory of Animal Biology, National Institute for Research and Development for Biology and Animal Nutrition, Calea Bucuresti No. 1, Balotesti, Ilfov, 077015, Romania. Electronic address: daniela.marin@ibna.ro.</Affiliation>
      </Author>
      <Author>
        <Name>Gina C. Pistol</Name>
        <Affiliation>Laboratory of Animal Biology, National Institute for Research and Development for Biology and Animal Nutrition, Calea Bucuresti No. 1, Balotesti, Ilfov, 077015, Romania.</Affiliation>
      </Author>
      <Author>
        <Name>Mihai A. Gras</Name>
        <Affiliation>Laboratory of Animal Biology, National Institute for Research and Development for Biology and Animal Nutrition, Calea Bucuresti No. 1, Balotesti, Ilfov, 077015, Romania.</Affiliation>
      </Author>
      <Author>
        <Name>Mihai L. Palade</Name>
        <Affiliation>Laboratory of Animal Biology, National Institute for Research and Development for Biology and Animal Nutrition, Calea Bucuresti No. 1, Balotesti, Ilfov, 077015, Romania.</Affiliation>
      </Author>
      <Author>
        <Name>Ionelia Taranu</Name>
        <Affiliation>Laboratory of Animal Biology, National Institute for Research and Development for Biology and Animal Nutrition, Calea Bucuresti No. 1, Balotesti, Ilfov, 077015, Romania.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Baseline evaluation for natural radioactivity level and radiological hazardous parameters associated with processing of high grade monazite.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28760388</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30225-8</DOI>
    <KeywordList>
      <Keywords>Cancer and gonad risks</Keywords>
      <Keywords>Contamination</Keywords>
      <Keywords>Lanthanides</Keywords>
      <Keywords>Monazite</Keywords>
      <Keywords>Radiological hazards</Keywords>
      <Keywords>TENORM</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>E. M. El Afifi</Name>
        <Affiliation>Department of Analytical Chemistry and Environmental Control, Hot Laboratories and Waste Management Center (HLWMC), Egyptian Atomic Energy Authority, Post Office Code 13759, Cairo, Egypt. Electronic address: em_afifi1968@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Shahr El-Din</Name>
        <Affiliation>Department of Analytical Chemistry and Environmental Control, Hot Laboratories and Waste Management Center (HLWMC), Egyptian Atomic Energy Authority, Post Office Code 13759, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>R. F. Aglan</Name>
        <Affiliation>Department of Analytical Chemistry and Environmental Control, Hot Laboratories and Waste Management Center (HLWMC), Egyptian Atomic Energy Authority, Post Office Code 13759, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>E. H. Borai</Name>
        <Affiliation>Department of Analytical Chemistry and Environmental Control, Hot Laboratories and Waste Management Center (HLWMC), Egyptian Atomic Energy Authority, Post Office Code 13759, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>M. M. Abo-Aly</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exogenous administration of mitochondrial DNA promotes ischemia reperfusion injury via TLR9-p38 MAPK pathway.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28757323</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30224-6</DOI>
    <KeywordList>
      <Keywords>H9c2</Keywords>
      <Keywords>Mitochondrial DNA</Keywords>
      <Keywords>TLR9</Keywords>
      <Keywords>p38 MAPK</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liang Xie</Name>
        <Affiliation>Department of Cardiology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuyu Liu</Name>
        <Affiliation>Department of Cardiology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinghua Cheng</Name>
        <Affiliation>Department of Cardiology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lijun Wang</Name>
        <Affiliation>Department of Cardiology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Liu</Name>
        <Affiliation>Department of Cardiology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China. Electronic address: lygljhit@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jianbin Gong</Name>
        <Affiliation>Department of Cardiology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China. Electronic address: agong62@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Considerations on nonclinical approaches to modeling risk factors of suicidal ideation and behavior.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28757322</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30226-X</DOI>
    <KeywordList>
      <Keywords>Black box warning</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Suicidal ideation behavior</Keywords>
      <Keywords>Suicide</Keywords>
      <Keywords>Treatment-emergent</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. M. G. Goody</Name>
        <Affiliation>Pfizer Drug Safety Research &amp; Development, Groton, CT, USA. Electronic address: susan.goody@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>K. E. Cannon</Name>
        <Affiliation>Halozyme Inc, San Diego, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Liu</Name>
        <Affiliation>Drinker, Biddle and IQ Consortium, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. J. Kallman</Name>
        <Affiliation>Kallman Preclinical Consulting, Greenfield, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. P. Martinolle</Name>
        <Affiliation>Sanofi Research &amp; Development, Montpellier, France.</Affiliation>
      </Author>
      <Author>
        <Name>L. Mazelin-Winum</Name>
        <Affiliation>Sanofi Research &amp; Development, Montpellier, France.</Affiliation>
      </Author>
      <Author>
        <Name>A. Giarola</Name>
        <Affiliation>GlaxoSmithKline Safety Pharmacology Department, Ware, UK.</Affiliation>
      </Author>
      <Author>
        <Name>P. Ardayfio</Name>
        <Affiliation>Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. A. Moyer</Name>
        <Affiliation>Janssen Research &amp; Development, Titusville, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. Teuns</Name>
        <Affiliation>Janssen Research &amp; Development, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>T. J. Hudzik</Name>
        <Affiliation>ALA BioPharm Consulting, Gurnee, IL, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Caffeine and cardiovascular health.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28756014</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30221-0</DOI>
    <KeywordList>
      <Keywords>Caffeine</Keywords>
      <Keywords>Cardiovascular disease</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Duncan Turnbull</Name>
        <Affiliation>Ramboll Environ US Corporation, 4350 North Fairfax Drive, Arlington, VA 22203, United States. Electronic address: dturnbull@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph V. Rodricks</Name>
        <Affiliation>Ramboll Environ US Corporation, 4350 North Fairfax Drive, Arlington, VA 22203, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory F. Mariano</Name>
        <Affiliation>Ramboll Environ US Corporation, 4350 North Fairfax Drive, Arlington, VA 22203, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Farah Chowdhury</Name>
        <Affiliation>Ramboll Environ US Corporation, 4350 North Fairfax Drive, Arlington, VA 22203, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk assessment and Biomonitoring Equivalent for 2-ethylhexyl-2,3,4,5 tetrabromobenzoate (TBB) and tetrabromobenzoic acid (TBBA).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28751265</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30218-0</DOI>
    <KeywordList>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring Equivalent</Keywords>
      <Keywords>Brominated flame retardant</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sean M. Hays</Name>
        <Affiliation>Summit Toxicology, L.L.P., Bozeman, MT, United States. Electronic address: shays@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher R. Kirman</Name>
        <Affiliation>Summit Toxicology, L.L.P., Bozeman, MT, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Allergenic potential of novel proteins - What can we learn from animal production?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28751264</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30220-9</DOI>
    <KeywordList>
      <Keywords>Allergenicity</Keywords>
      <Keywords>Animal nutrition</Keywords>
      <Keywords>In vitro assays</Keywords>
      <Keywords>Novel proteins</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ricardo D. Ekmay</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, United States. Electronic address: rdekmay@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Craig N. Coon</Name>
        <Affiliation>University of Arkansas, Fayetteville, AR, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory S. Ladics</Name>
        <Affiliation>DuPont Co., Haskell Laboratory, Newark, DE, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Improving insect control protein activity for GM crops: A case study demonstrating that increased target insect potency can be achieved without impacting mammalian safety.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28751263</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30216-7</DOI>
    <KeywordList>
      <Keywords>Bt cotton</Keywords>
      <Keywords>Cry51Aa2</Keywords>
      <Keywords>Domain</Keywords>
      <Keywords>Lygus</Keywords>
      <Keywords>Pore-forming proteins</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Donna R. Farmer</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas C. Edrington</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Colton R. Kessenich</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Cunxi Wang</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jay S. Petrick</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, United States. Electronic address: jay.s.petrick@monsanto.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Do individuals with asthma experience airway hyper-responsiveness after exposure to nitrogen dioxide?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28751262</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30217-9</DOI>
    <KeywordList>
      <Keywords>Airway hyper-responsiveness</Keywords>
      <Keywords>Asthma</Keywords>
      <Keywords>Controlled exposure studies</Keywords>
      <Keywords>Criteria air pollutants</Keywords>
      <Keywords>National ambient air quality standards</Keywords>
      <Keywords>Nitrogen dioxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, 20 University Rd., Cambridge, MA 02138, USA. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Erin M. Kennedy</Name>
        <Affiliation>Gradient, 20 University Rd., Cambridge, MA 02138, USA. Electronic address: ekennedy@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mara Seeley</Name>
        <Affiliation>Gradient, 20 University Rd., Cambridge, MA 02138, USA. Electronic address: mseeley@gradientcorp.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Getting a molecule into the clinic: Nonclinical testing and starting dose considerations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28751261</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30223-4</DOI>
    <KeywordList>
      <Keywords>ADME</Keywords>
      <Keywords>Biopharmaceuticals</Keywords>
      <Keywords>Clinical starting dose</Keywords>
      <Keywords>Investigator Brochure</Keywords>
      <Keywords>Monoclonal antibodies</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Pharmacology</Keywords>
      <Keywords>Small molecules</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul Baldrick</Name>
        <Affiliation>Visiting Chair (Regulatory Toxicology) of the Lincoln School of Pharmacy, University of Lincoln, United Kingdom. Electronic address: paul.baldrick@covance.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification of appropriate QTc formula in beagle dogs for nonclinical safety assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28751260</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30222-2</DOI>
    <KeywordList>
      <Keywords>Beagle dogs</Keywords>
      <Keywords>Electrocardiogram</Keywords>
      <Keywords>Heart rate</Keywords>
      <Keywords>Preclinical assessment</Keywords>
      <Keywords>QT correction formula</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shitalkumar Patel</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Zydus Research Centre, Sarkhej-Bavla N.H. No. 8A, Moraiya, Ahmedabad, 382213 Gujarat, India.</Affiliation>
      </Author>
      <Author>
        <Name>Laxit Bhatt</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Zydus Research Centre, Sarkhej-Bavla N.H. No. 8A, Moraiya, Ahmedabad, 382213 Gujarat, India. Electronic address: bkltox@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rajesh Patel</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Zydus Research Centre, Sarkhej-Bavla N.H. No. 8A, Moraiya, Ahmedabad, 382213 Gujarat, India.</Affiliation>
      </Author>
      <Author>
        <Name>Chitrang Shah</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Zydus Research Centre, Sarkhej-Bavla N.H. No. 8A, Moraiya, Ahmedabad, 382213 Gujarat, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vipul Patel</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Zydus Research Centre, Sarkhej-Bavla N.H. No. 8A, Moraiya, Ahmedabad, 382213 Gujarat, India.</Affiliation>
      </Author>
      <Author>
        <Name>Jitendra Patel</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Zydus Research Centre, Sarkhej-Bavla N.H. No. 8A, Moraiya, Ahmedabad, 382213 Gujarat, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rajesh Sundar</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Zydus Research Centre, Sarkhej-Bavla N.H. No. 8A, Moraiya, Ahmedabad, 382213 Gujarat, India.</Affiliation>
      </Author>
      <Author>
        <Name>Upendra Bhatnagar</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Zydus Research Centre, Sarkhej-Bavla N.H. No. 8A, Moraiya, Ahmedabad, 382213 Gujarat, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mukul Jain</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Zydus Research Centre, Sarkhej-Bavla N.H. No. 8A, Moraiya, Ahmedabad, 382213 Gujarat, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation into the risk of ultra-low tar cigarettes and lung cancer.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28751259</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30219-2</DOI>
    <KeywordList>
      <Keywords>Case-control study</Keywords>
      <Keywords>Cigarettes</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Tar yield</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd., 17 Cedar Road, Sutton, Surrey SM2 5DA, United Kingdom. Electronic address: PeterLee@pnlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>John S. Fry</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd., 17 Cedar Road, Sutton, Surrey SM2 5DA, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Janette S. Hamling</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd., 17 Cedar Road, Sutton, Surrey SM2 5DA, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Novel approach for selective reduction of NNN in cigarette tobacco filler and mainstream smoke.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28736287</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30215-5</DOI>
    <KeywordList>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>HPHC</Keywords>
      <Keywords>Harmful and potentially harmful constituents</Keywords>
      <Keywords>N-nitrosonornicotine</Keywords>
      <Keywords>NNN</Keywords>
      <Keywords>Nicotine demethylase</Keywords>
      <Keywords>Nornicotine</Keywords>
      <Keywords>Selective smoke constituents' reduction</Keywords>
      <Keywords>TSNA</Keywords>
      <Keywords>Tobacco regulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Lusso</Name>
        <Affiliation>Altria Client Services LLC, Research Development &amp; Regulatory Affairs, 601 E. Jackson St., Richmond, VA 23219, USA. Electronic address: marcos.F.Lusso@altria.com.</Affiliation>
      </Author>
      <Author>
        <Name>I. Gunduz</Name>
        <Affiliation>Philip Morris International Management SA, Leaf Agricultural Programs, Avenue de Rhodanie 50, 1001 Lausanne, Switzerland. Electronic address: Irfan.gunduz@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>A. Kondylis</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>G. Jaccard</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>L. Ruffieux</Name>
        <Affiliation>Philip Morris International Management SA, Leaf Agricultural Programs, Avenue de Rhodanie 50, 1001 Lausanne, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>F. Gadani</Name>
        <Affiliation>Philip Morris Products SA, Product Development, Rue des Usines 56, 2000 Neuchatel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>K. Lion</Name>
        <Affiliation>Altria Client Services LLC, Research Development &amp; Regulatory Affairs, 601 E. Jackson St., Richmond, VA 23219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Adams</Name>
        <Affiliation>Altria Client Services LLC, Research Development &amp; Regulatory Affairs, 601 E. Jackson St., Richmond, VA 23219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>W. Morris</Name>
        <Affiliation>Altria Client Services LLC, Research Development &amp; Regulatory Affairs, 601 E. Jackson St., Richmond, VA 23219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>T. Danielson</Name>
        <Affiliation>Altria Client Services LLC, Research Development &amp; Regulatory Affairs, 601 E. Jackson St., Richmond, VA 23219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>U. Warek</Name>
        <Affiliation>Altria Client Services LLC, Research Development &amp; Regulatory Affairs, 601 E. Jackson St., Richmond, VA 23219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Strickland</Name>
        <Affiliation>Altria Client Services LLC, Research Development &amp; Regulatory Affairs, 601 E. Jackson St., Richmond, VA 23219, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lack of immunotoxic effects of repeated exposure to atrazine associated with the adaptation of adrenal gland activation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28736286</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30213-1</DOI>
    <KeywordList>
      <Keywords>Adrenal</Keywords>
      <Keywords>Atrazine</Keywords>
      <Keywords>Gonadal</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Pituitary hormones</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chad D. Foradori</Name>
        <Affiliation>Department of Anatomy, Physiology, and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Arthur D. Zimmerman</Name>
        <Affiliation>Department of Anatomy, Physiology, and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Pragati S. Coder</Name>
        <Affiliation>Charles River Laboratories Ashland LLC, Ashland, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Vanessa L. Peachee</Name>
        <Affiliation>Charles River Laboratories Ashland LLC, Ashland, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Robert J. Handa</Name>
        <Affiliation>College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Life Sciences, University of Manchester, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen B. Pruett</Name>
        <Affiliation>Department of Basic Sciences, College of Veterinary Medicine, Mississippi State University, MS, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Charles B. Breckenridge</Name>
        <Affiliation>Syngenta Crop Protection, LLC, Greensboro, NC, United States. Electronic address: charles.breckenridge@qualityscientificsolutions.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Azodicarbonamide (ADCA): A reconsideration of classification as a respiratory sensitiser.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28734852</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30214-3</DOI>
    <KeywordList>
      <Keywords>Occupational asthma</Keywords>
      <Keywords>Respiratory allergy</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Josje Arts</Name>
        <Affiliation>AkzoNobel NV, Velperweg 76, 6824 BM, Arnhem, The Netherlands. Electronic address: josje.arts@akzonobel.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory accepted but out of domain: In vitro skin irritation tests for agrochemical formulations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28734851</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30212-X</DOI>
    <KeywordList>
      <Keywords>Agrochemical formulation</Keywords>
      <Keywords>OECD TG 404</Keywords>
      <Keywords>OECD TG 431</Keywords>
      <Keywords>OECD TG 439</Keywords>
      <Keywords>Reconstructed human epidermis</Keywords>
      <Keywords>Skin corrosion</Keywords>
      <Keywords>Skin irritation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susanne N. Kolle</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany. Electronic address: susanne.kolle@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bennard van Ravenzwaay</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MeClas: An online tool for hazard identification and classification of complex inorganic metal-containing materials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28729132</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30211-8</DOI>
    <KeywordList>
      <Keywords>Alloys</Keywords>
      <Keywords>Bioavailability</Keywords>
      <Keywords>Classification</Keywords>
      <Keywords>GHS and CLP</Keywords>
      <Keywords>Labelling</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>OSHA</Keywords>
      <Keywords>Ores and concentrates</Keywords>
      <Keywords>UVCB</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Frederik Verdonck</Name>
        <Affiliation>Arche, Liefkensstraat 35d, 9032 Gent (Wondelgem), Belgium. Electronic address: frederik.verdonck@arche-consulting.be.</Affiliation>
      </Author>
      <Author>
        <Name>Hugo Waeterschoot</Name>
        <Affiliation>HW Consult, Groenstraat 59, 2540 Hove, Belgium; Eurometaux, Avenue de Broqueville 12, 1150 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Van Sprang</Name>
        <Affiliation>Arche, Liefkensstraat 35d, 9032 Gent (Wondelgem), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Isabelle Vercaigne</Name>
        <Affiliation>Arche, Liefkensstraat 35d, 9032 Gent (Wondelgem), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Katrien Delbeke</Name>
        <Affiliation>European Copper Institute (ECI), Avenue de Tervueren 168 b-10, 1150 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Chretien Simons</Name>
        <Affiliation>Glencore International Import BV, Blaak 31, 3011 GA Rotterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Violaine Verougstraete</Name>
        <Affiliation>Eurometaux, Avenue de Broqueville 12, 1150 Brussels, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of a novel muramidase for feed application.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28720348</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30210-6</DOI>
    <KeywordList>
      <Keywords>Chickens</Keywords>
      <Keywords>Feed</Keywords>
      <Keywords>Feed additive</Keywords>
      <Keywords>Lysozyme</Keywords>
      <Keywords>Muramidase</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Trichoderma reesei</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Lichtenberg</Name>
        <Affiliation>Novozymes A/S, Krogshoejvej 36, DK-2880 Bagsvaerd, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>E. Perez Calvo</Name>
        <Affiliation>DSM Nutritional Products France, Centre de Recherche en Nutrition et Santé Animale, F-68305 Saint Louis, France.</Affiliation>
      </Author>
      <Author>
        <Name>K. Madsen</Name>
        <Affiliation>Novozymes A/S, Krogshoejvej 36, DK-2880 Bagsvaerd, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>T. Østergaard Lund</Name>
        <Affiliation>Novozymes A/S, Krogshoejvej 36, DK-2880 Bagsvaerd, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>F. Kramer Birkved</Name>
        <Affiliation>Novozymes A/S, Krogshoejvej 36, DK-2880 Bagsvaerd, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>S. van Cauwenberghe</Name>
        <Affiliation>DSM Nutritional Products AG, P.O. Box 2676, 4002 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>M. Mourier</Name>
        <Affiliation>Novozymes A/S, Krogshoejvej 36, DK-2880 Bagsvaerd, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>L. Wulf-Andersen</Name>
        <Affiliation>Novozymes A/S, Krogshoejvej 36, DK-2880 Bagsvaerd, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>A. J. M. Jansman</Name>
        <Affiliation>Wageningen Livestock Research, P.O. Box 338, 6700 AH, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>R. Lopez-Ulibarri</Name>
        <Affiliation>DSM Nutritional Products AG, P.O. Box 2676, 4002 Basel, Switzerland. Electronic address: rual.lopez-ulibarri@dsm.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Transgenesis affects endogenous soybean allergen levels less than traditional breeding.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28720347</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30209-X</DOI>
    <KeywordList>
      <Keywords>Endogenous allergens</Keywords>
      <Keywords>Food safety</Keywords>
      <Keywords>Genetically engineered</Keywords>
      <Keywords>Glycine max</Keywords>
      <Keywords>LC-MS/MS</Keywords>
      <Keywords>Mass spectrometry</Keywords>
      <Keywords>Method validation</Keywords>
      <Keywords>Multiplexing method</Keywords>
      <Keywords>Soybean</Keywords>
      <Keywords>Surrogate peptide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ryan C. Hill</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN 46268, United States. Electronic address: rhill1@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Brandon J. Fast</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN 46268, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN 46268, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetic data reduce uncertainty in the acceptable daily intake for benzoic acid and its salts.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28720346</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30208-8</DOI>
    <KeywordList>
      <Keywords>Acceptable daily intake</Keywords>
      <Keywords>Benzoic acid</Keywords>
      <Keywords>Chemical-specific adjustment factor</Keywords>
      <Keywords>Data-derived exploration factor</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Potassium benzoate</Keywords>
      <Keywords>Sodium benzoate</Keywords>
      <Keywords>Uncertainty factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>K. Zu</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA, 02138, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. M. Pizzurro</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA, 02138, USA.</Affiliation>
      </Author>
      <Author>
        <Name>T. A. Lewandowski</Name>
        <Affiliation>Gradient, 600 Stewart Street, Suite 1900, Seattle, WA, 98101, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. E. Goodman</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA, 02138, USA. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Urinary NNAL in hookah smokers and non-smokers after attending a hookah social event in a hookah lounge or a private home.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28716579</pubmedLink>
    <GrantList>
      <Grant>P30 DA012393</Grant>
      <Grant>R01 CA138192</Grant>
      <Grant>R01 HL103684</Grant>
      <Grant>S10 RR026437</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30193-9</DOI>
    <KeywordList>
      <Keywords>Hookah</Keywords>
      <Keywords>NNAL</Keywords>
      <Keywords>NNK</Keywords>
      <Keywords>Secondhand smoke</Keywords>
      <Keywords>Waterpipe</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nada O. F. Kassem</Name>
        <Affiliation>Center for Behavioral Epidemiology and Community Health (CBEACH), Graduate School of Public Health, Division of Health Promotion, San Diego State University, San Diego, CA, 92123, United States. Electronic address: nadakassem@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Noura O. Kassem</Name>
        <Affiliation>Center for Behavioral Epidemiology and Community Health (CBEACH), Graduate School of Public Health, Division of Health Promotion, San Diego State University, San Diego, CA, 92123, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sandy Liles</Name>
        <Affiliation>Center for Behavioral Epidemiology and Community Health (CBEACH), Graduate School of Public Health, Division of Health Promotion, San Diego State University, San Diego, CA, 92123, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sheila R. Jackson</Name>
        <Affiliation>Center for Behavioral Epidemiology and Community Health (CBEACH), Graduate School of Public Health, Division of Health Promotion, San Diego State University, San Diego, CA, 92123, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dale A. Chatfield</Name>
        <Affiliation>San Diego State University Department of Chemistry, San Diego, CA 92182, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Peyton Jacob</Name>
        <Affiliation>School of Medicine, Departments of Psychiatry and Medicine, Division of Clinical Pharmacology and Experimental Therapeutics, San Francisco General Hospital Medical Center, University of California, San Francisco, CA 94110, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Neal L. Benowitz</Name>
        <Affiliation>Departments of Medicine and Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Melbourne F. Hovell</Name>
        <Affiliation>Center for Behavioral Epidemiology and Community Health (CBEACH), Graduate School of Public Health, Division of Health Promotion, San Diego State University, San Diego, CA, 92123, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Simulation to aid in interpreting biological relevance and setting of population-level protection goals for risk assessment of pesticides.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28716578</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30195-2</DOI>
    <KeywordList>
      <Keywords>ALMaSS</Keywords>
      <Keywords>Agent-based simulation</Keywords>
      <Keywords>Alauda arvensis</Keywords>
      <Keywords>Environmental risk assessment</Keywords>
      <Keywords>Skylarks</Keywords>
      <Keywords>Specific protection goals</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christopher John Topping</Name>
        <Affiliation>Department of Bioscience, Aarhus University, Kalø, Grenåvej 14, 8410, Rønde, Denmark. Electronic address: cjt@bios.au.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Luttik</Name>
        <Affiliation>Ulsevej 57, 2650 Hvidovre, Denmark.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Implementation of Good Laboratory Practices (GLP) in basic scientific research: Translating the concept beyond regulatory compliance.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28713068</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30194-0</DOI>
    <KeywordList>
      <Keywords>Good laboratory practices</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Reliability</Keywords>
      <Keywords>Reproducibility</Keywords>
      <Keywords>Research in basic science</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>G. B. Jena</Name>
        <Affiliation>Facility for Risk Assessment and Intervention Studies, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Sector-67, S.A.S. Nagar, Punjab 160062, India. Electronic address: gbjena@niper.ac.in.</Affiliation>
      </Author>
      <Author>
        <Name>Sapana Chavan</Name>
        <Affiliation>Facility for Risk Assessment and Intervention Studies, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Sector-67, S.A.S. Nagar, Punjab 160062, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicologic evaluations of recombinant liver-targeting interferon IFN-CSP: Genotoxicity and tegenicratoity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28709686</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30187-3</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Liver-targeting interferon</Keywords>
      <Keywords>Teratogenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wenting Zeng</Name>
        <Affiliation>School of Basic Courses, Guangdong Pharmaceutical University, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China; Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunxu Wu</Name>
        <Affiliation>School of Basic Courses, Guangdong Pharmaceutical University, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China; Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Wang</Name>
        <Affiliation>School of Basic Courses, Guangdong Pharmaceutical University, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China; Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingjie Cao</Name>
        <Affiliation>School of Basic Courses, Guangdong Pharmaceutical University, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China; Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaobao Jin</Name>
        <Affiliation>School of Basic Courses, Guangdong Pharmaceutical University, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China; Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiayong Zhu</Name>
        <Affiliation>School of Basic Courses, Guangdong Pharmaceutical University, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China; Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China. Electronic address: zhujiayong1020@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xuemei Lu</Name>
        <Affiliation>School of Basic Courses, Guangdong Pharmaceutical University, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China; Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou, People's Republic of China. Electronic address: luxuemei605@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biometrical evaluation of the performance of the revised OECD Test Guideline 402 for assessing acute dermal toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28709685</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30191-5</DOI>
    <KeywordList>
      <Keywords>Acute dermal toxicity</Keywords>
      <Keywords>Animal welfare</Keywords>
      <Keywords>Biometric evaluation</Keywords>
      <Keywords>Globally Harmonized System (GHS)</Keywords>
      <Keywords>Test guideline</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. Mielke</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, D-10589 Berlin, Germany. Electronic address: hans.mielke@bfr.bund.de.</Affiliation>
      </Author>
      <Author>
        <Name>J. Strickland</Name>
        <Affiliation>ILS, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. N. Jacobs</Name>
        <Affiliation>Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Chilton, Oxon, OX11 0RQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>J. M. Mehta</Name>
        <Affiliation>Dow AgroSciences Ltd, European Development Centre, 3B Park Square, Milton Park, Abingdon, Oxon, OX14 4RN, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of toxicity studies of flavonoid fraction of Lithocarpus polystachyus Rehd in rodents.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28697995</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30190-3</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Blood analysis</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Lithocarpus polystachyus Rehd</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jian Liang</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou Higher Education Mega Center, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Xian Chen</Name>
        <Affiliation>Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-sen University, No.600, Tianhe Road, Guangzhou 510630, China.</Affiliation>
      </Author>
      <Author>
        <Name>Song Huang</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou Higher Education Mega Center, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Yun Wu</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou Higher Education Mega Center, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cai Jie Zhou</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou Higher Education Mega Center, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Xu Jiang</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou Higher Education Mega Center, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chu Yan Liang</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou Higher Education Mega Center, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Qi Yuan</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou Higher Education Mega Center, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shao Zhen Hou</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou Higher Education Mega Center, Guangzhou 510006, China. Electronic address: hsz214@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Ping Lai</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou Higher Education Mega Center, Guangzhou 510006, China. Electronic address: lxp88@gzucm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Repeated dose 28-day oral toxicity study of DEAE-Dextran in mice: An advancement in safety chemotherapeutics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28694171</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30189-7</DOI>
    <KeywordList>
      <Keywords>DEAE-Dextran</Keywords>
      <Keywords>Gross histopathology</Keywords>
      <Keywords>Gross necropsy</Keywords>
      <Keywords>OECD 407</Keywords>
      <Keywords>Oral toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anita K. Bakrania</Name>
        <Affiliation>Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat 382 481, India.</Affiliation>
      </Author>
      <Author>
        <Name>Bhavesh C. Variya</Name>
        <Affiliation>Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat 382 481, India; Zydus Research Centre, Sarkhej-Bavla, Changodhar, Gujarat 382210, India.</Affiliation>
      </Author>
      <Author>
        <Name>Prem Madan</Name>
        <Affiliation>Sukoon Pathology Laboratory, Ahmedabad, Gujarat 380052, India.</Affiliation>
      </Author>
      <Author>
        <Name>Snehal S. Patel</Name>
        <Affiliation>Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat 382 481, India. Electronic address: snehalpharma53@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment and toxicological profiling of a novel combinational sunprotective dermal formulation containing melatonin and pumpkin seed oil.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28694170</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30188-5</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>Dermal</Keywords>
      <Keywords>Mammalian bone marrow chromosomal aberration</Keywords>
      <Keywords>Mammalian erythrocyte micronucleus test</Keywords>
      <Keywords>Preclinical</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Sunscreen</Keywords>
      <Keywords>Toxicological profiling</Keywords>
      <Keywords>UV radiation protection</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nilutpal Sharma Bora</Name>
        <Affiliation>Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur 784001, Assam, India; Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh 784001, Assam, India. Electronic address: nilutpalsharma3@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Manash Pratim Pathak</Name>
        <Affiliation>Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur 784001, Assam, India; Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh 784001, Assam, India.</Affiliation>
      </Author>
      <Author>
        <Name>Santa Mandal</Name>
        <Affiliation>Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur 784001, Assam, India; School of Pharmaceutical Sciences, IFTM University, Moradabad, Uttar Pradesh 244001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Bhaskar Mazumder</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh 784001, Assam, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rudragoud Policegoudra</Name>
        <Affiliation>Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur 784001, Assam, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pakalapati Srinivas Raju</Name>
        <Affiliation>Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur 784001, Assam, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pronobesh Chattopadhyay</Name>
        <Affiliation>Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur 784001, Assam, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Steps towards the international regulatory acceptance of non-animal methodology in safety assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28689746</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30185-X</DOI>
    <KeywordList>
      <Keywords>Global harmonisation</Keywords>
      <Keywords>New methodology</Keywords>
      <Keywords>Regulatory acceptance</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>in silico</Keywords>
      <Keywords>in vitro</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fiona Sewell</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3RS), Gibbs Building, 215 Euston Road, London, UK. Electronic address: fiona.sewell@nc3rs.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>John Doe</Name>
        <Affiliation>Parker Doe LLP, Stockport, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Nichola Gellatly</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3RS), Gibbs Building, 215 Euston Road, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Ragan</Name>
        <Affiliation>NC3Rs Board Member, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Natalie Burden</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3RS), Gibbs Building, 215 Euston Road, London, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Itching for change: Embracing modern flea and tick product development.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28689745</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30186-1</DOI>
    <KeywordList>
      <Keywords>Cats</Keywords>
      <Keywords>Dogs</Keywords>
      <Keywords>Ectoparasiticides</Keywords>
      <Keywords>Fleas</Keywords>
      <Keywords>In vitro feeding</Keywords>
      <Keywords>Product testing</Keywords>
      <Keywords>Ticks</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katherine Groff</Name>
        <Affiliation>People for the Ethical Treatment of Animals, 501 Front Street, Norfolk, VA, 23510, United States. Electronic address: KatherineG@peta.org.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Bishop</Name>
        <Affiliation>People for the Ethical Treatment of Animals, 501 Front Street, Norfolk, VA, 23510, United States. Electronic address: PatriciaB@peta.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lead substances selection using GHS approach for the classification of mixtures: Case study of painting in the work environment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28669715</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30184-8</DOI>
    <KeywordList>
      <Keywords>Acrylic urethane paint</Keywords>
      <Keywords>Chemical mixture</Keywords>
      <Keywords>ECETOC TRA</Keywords>
      <Keywords>GHS-based approach</Keywords>
      <Keywords>Global product strategy</Keywords>
      <Keywords>Lead substance</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kazuhiro Kaneko</Name>
        <Affiliation>Japan Chemical Industry Association, GPS/JIPS Promotion Committee, Evaluation Technology Working Group, Japan; Japan Chemical Industry Association, Sumitomo Rokko Bldg., 1-4-1, Shinkawa, Chuo-ku, Tokyo 104-0033, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Satoko Ishii</Name>
        <Affiliation>Japan Chemical Industry Association, GPS/JIPS Promotion Committee, Evaluation Technology Working Group, Japan; Chemicals Evaluation and Research Institute, Japan, 1-4-25, Kouraku, Bunkyo-ku, Tokyo 112-0004, Japan. Electronic address: ishii-satoko@ceri.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Sachio Hosohara</Name>
        <Affiliation>Japan Chemical Industry Association, GPS/JIPS Promotion Committee, Evaluation Technology Working Group, Japan; Toray Industries, Inc., Shiga Plant, 1-1-1, Sonoyama, Otsu, Shiga 520-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tsuyoshi Hirata</Name>
        <Affiliation>Japan Chemical Industry Association, GPS/JIPS Promotion Committee, Evaluation Technology Working Group, Japan; Mitsui Chemicals, Inc., 1144, Togo, Mobara, Chiba 297-0017, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Motoshi Masuda</Name>
        <Affiliation>Japan Chemical Industry Association, GPS/JIPS Promotion Committee, Evaluation Technology Working Group, Japan; LSI Medience Corporation, THE KAITEKI Bldg., 1-13-4, Uchikanda, Chiyoda-ku, Tokyo 101-8517, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kaori Murasawa</Name>
        <Affiliation>Japan Chemical Industry Association, GPS/JIPS Promotion Committee, Evaluation Technology Working Group, Japan; ERM Japan Ltd., The Landmark Tower Yokohama 19th Floor, 2-2-1, Minatomirai, Nishi-ku, Yokohama, Kanagawa 220-8119, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Airi Yamada</Name>
        <Affiliation>Japan Chemical Industry Association, GPS/JIPS Promotion Committee, Evaluation Technology Working Group, Japan; Sumitomo Chemical Co., Ltd., 2-27-1, Shinkawa, Chuo-ku, Tokyo 104-8260, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takaaki Tadokoro</Name>
        <Affiliation>Japan Chemical Industry Association, GPS/JIPS Promotion Committee, Evaluation Technology Working Group, Japan; Japan Chemical Industry Association, Sumitomo Rokko Bldg., 1-4-1, Shinkawa, Chuo-ku, Tokyo 104-0033, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masahiko Hanzawa</Name>
        <Affiliation>Japan Chemical Industry Association, GPS/JIPS Promotion Committee, Evaluation Technology Working Group, Japan; Japan Chemical Industry Association, Sumitomo Rokko Bldg., 1-4-1, Shinkawa, Chuo-ku, Tokyo 104-0033, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A retrospective analysis of in vivo eye irritation, skin irritation and skin sensitisation studies with agrochemical formulations: Setting the scene for development of alternative strategies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28668334</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30183-6</DOI>
    <KeywordList>
      <Keywords>Additivity formula</Keywords>
      <Keywords>Animal testing</Keywords>
      <Keywords>Delayed dermal sensitisation</Keywords>
      <Keywords>Eye irritation</Keywords>
      <Keywords>GHS</Keywords>
      <Keywords>Global policy change</Keywords>
      <Keywords>In vitro alternatives</Keywords>
      <Keywords>Skin irritation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Corvaro</Name>
        <Affiliation>Dow AgroSciences Ltd - European Development Centre, Milton Park, Abingdon, OX14 4RN, UK. Electronic address: mcorvaro@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>S. Gehen</Name>
        <Affiliation>Dow AgroSciences LLC - Headquarters, 9330 Zionsville Road, Indianapolis, IN 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Andrews</Name>
        <Affiliation>Dow AgroSciences Ltd - European Development Centre, Milton Park, Abingdon, OX14 4RN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>R. Chatfield</Name>
        <Affiliation>Dow AgroSciences Ltd - European Development Centre, Milton Park, Abingdon, OX14 4RN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>F. Macleod</Name>
        <Affiliation>Dow AgroSciences Ltd - European Development Centre, Milton Park, Abingdon, OX14 4RN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>J. Mehta</Name>
        <Affiliation>Dow AgroSciences Ltd - European Development Centre, Milton Park, Abingdon, OX14 4RN, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28666961</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30182-4</DOI>
    <KeywordList>
      <Keywords>Attitudes</Keywords>
      <Keywords>Awareness</Keywords>
      <Keywords>Biosimilar</Keywords>
      <Keywords>General practitioners</Keywords>
      <Keywords>Medical specialists</Keywords>
      <Keywords>Pharmacists</Keywords>
      <Keywords>Physicians</Keywords>
      <Keywords>Survey</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joan O'Callaghan</Name>
        <Affiliation>Regulatory Science Ireland, c/o School of Pharmacy, University College Cork, Cork, Ireland; School of Pharmacy, University College Cork, Cork, Ireland; Health Product Regulatory Authority, Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland. Electronic address: joan.ocallaghan@hpra.ie.</Affiliation>
      </Author>
      <Author>
        <Name>Margaret Bermingham</Name>
        <Affiliation>School of Pharmacy, University College Cork, Cork, Ireland. Electronic address: margaret.bermingham@ucc.ie.</Affiliation>
      </Author>
      <Author>
        <Name>Maurice Leonard</Name>
        <Affiliation>AbbVie Limited, 14 Riverwalk, Citywest Business Campus, Dublin 24, Ireland. Electronic address: maurice.leonard@abbvie.com.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Hallinan</Name>
        <Affiliation>Regulatory Science Ireland, c/o School of Pharmacy, University College Cork, Cork, Ireland; School of Pharmacy, University College Cork, Cork, Ireland; Jazz Pharmaceuticals, 1 Burlington Road, Dublin 4, Ireland. Electronic address: hallinaf@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Michael Morris</Name>
        <Affiliation>Regulatory Science Ireland, c/o School of Pharmacy, University College Cork, Cork, Ireland. Electronic address: mike.morris@ext.hpra.ie.</Affiliation>
      </Author>
      <Author>
        <Name>Una Moore</Name>
        <Affiliation>Health Product Regulatory Authority, Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland. Electronic address: una.moore@hpra.ie.</Affiliation>
      </Author>
      <Author>
        <Name>Brendan T. Griffin</Name>
        <Affiliation>Regulatory Science Ireland, c/o School of Pharmacy, University College Cork, Cork, Ireland; School of Pharmacy, University College Cork, Cork, Ireland. Electronic address: brendan.griffin@ucc.ie.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lessons learned from read-across case studies for repeated-dose toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28655656</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30180-0</DOI>
    <KeywordList>
      <Keywords>Case studies</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Regulatory acceptance</Keywords>
      <Keywords>Repeated-dose toxicity</Keywords>
      <Keywords>Similarity</Keywords>
      <Keywords>Uncertainty</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Terry W. Schultz</Name>
        <Affiliation>The University of Tennessee, College of Veterinary Medicine, 2407 River Drive, Knoxville, TN, 37996-4543, USA. Electronic address: tschultz@utk.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Mark T. D. Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, L3 3AF, Liverpool, England, UK. Electronic address: m.t.cronin@ljmu.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Relevance and reliability of experimental data in human health risk assessment of pesticides.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28655655</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30179-4</DOI>
    <KeywordList>
      <Keywords>Biocides</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Plant protection products</Keywords>
      <Keywords>Publication</Keywords>
      <Keywords>Relevance</Keywords>
      <Keywords>Reliability</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Test guidelines</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Uncertainty</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Johanna Kaltenhäuser</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589 Berlin, Germany. Electronic address: johanna.kaltenhaeuser@bfr.bund.de.</Affiliation>
      </Author>
      <Author>
        <Name>Carsten Kneuer</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Marx-Stoelting</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lars Niemann</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jens Schubert</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Bernd Stein</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Roland Solecki</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Azo dyes in clothing textiles can be cleaved into a series of mutagenic aromatic amines which are not regulated yet.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28655654</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30181-2</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>Aromatic amines</Keywords>
      <Keywords>Azo dyes</Keywords>
      <Keywords>In silico prediction</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Textile dyes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Beat J. Brüschweiler</Name>
        <Affiliation>Federal Food Safety and Veterinary Office (FSVO), Schwarzenburgstrasse 155, CH-3003 Bern, Switzerland. Electronic address: beat.brueschweiler@blv.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Cédric Merlot</Name>
        <Affiliation>LeadOp Computing Sarl, 89 rue du Domaine du Château, F-74580 Viry, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimating the effect of differing assumptions on the population health impact of introducing a Reduced Risk Tobacco Product in the USA.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28651854</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30178-2</DOI>
    <KeywordList>
      <Keywords>Attributable risk</Keywords>
      <Keywords>Harm reduction</Keywords>
      <Keywords>Modelling</Keywords>
      <Keywords>Reduced Risk Tobacco Product</Keywords>
      <Keywords>Smoking</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P N Lee Statistics and Computing Ltd, 17 Cedar Road, Sutton, Surrey, SM2 5DA, United Kingdom. Electronic address: PeterLee@pnlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>John S. Fry</Name>
        <Affiliation>P N Lee Statistics and Computing Ltd, 17 Cedar Road, Sutton, Surrey, SM2 5DA, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>John F. Hamling</Name>
        <Affiliation>P N Lee Statistics and Computing Ltd, 17 Cedar Road, Sutton, Surrey, SM2 5DA, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Sponsiello-Wang</Name>
        <Affiliation>Philip Morris International Research and Development, Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Gizelle Baker</Name>
        <Affiliation>Philip Morris International Research and Development, Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Rolf Weitkunat</Name>
        <Affiliation>Philip Morris International Research and Development, Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The Threshold of Toxicological Concern for prenatal developmental toxicity in rats and rabbits.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28645885</pubmedLink>
    <GrantList>
      <Grant>T32 ES007141</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30177-0</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Rabbit</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>TTC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>B. van Ravenzwaay</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Z 470, D-67056 Ludwigshafen, Germany. Electronic address: bennard.ravenzwaay@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>X. Jiang</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Z 470, D-67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>T. Luechtefeld</Name>
        <Affiliation>Johns Hopkins University, Bloomberg School of Public Health, Center for Alternatives to Animal Testing (CAAT), Baltimore, MD 21224, USA.</Affiliation>
      </Author>
      <Author>
        <Name>T. Hartung</Name>
        <Affiliation>Johns Hopkins University, Bloomberg School of Public Health, Center for Alternatives to Animal Testing (CAAT), Baltimore, MD 21224, USA; University of Konstanz, CAAT-Europe, 78464 Konstanz, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>CSAHi study-2: Validation of multi-electrode array systems (MEA60/2100) for prediction of drug-induced proarrhythmia using human iPS cell-derived cardiomyocytes: Assessment of reference compounds and comparison with non-clinical studies and clinical information.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28634147</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30175-7</DOI>
    <KeywordList>
      <Keywords>Arrest</Keywords>
      <Keywords>CSAHi</Keywords>
      <Keywords>CiPA</Keywords>
      <Keywords>EAD or TA</Keywords>
      <Keywords>FPD</Keywords>
      <Keywords>QT prolongation</Keywords>
      <Keywords>TdP</Keywords>
      <Keywords>hiPS-CMs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yumiko Nozaki</Name>
        <Affiliation>Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan. Electronic address: yumiko-nozaki@ds-pharma.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yayoi Honda</Name>
        <Affiliation>Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hitoshi Watanabe</Name>
        <Affiliation>Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shota Saiki</Name>
        <Affiliation>Research Laboratory for Development, Shionogi &amp; Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka 561-0825, Japan; Consortium for Safety Assessment using Human iPS Cells (CSAHi), Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kiyotaka Koyabu</Name>
        <Affiliation>Research Laboratory for Development, Shionogi &amp; Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka 561-0825, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tetsuji Itoh</Name>
        <Affiliation>Research Laboratory for Development, Shionogi &amp; Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka 561-0825, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Chiho Nagasawa</Name>
        <Affiliation>Drug Safety, Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Saitama-shi, Saitama 331-9530, Japan; Consortium for Safety Assessment using Human iPS Cells (CSAHi), Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Chiaki Nakamori</Name>
        <Affiliation>Drug Safety, Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Saitama-shi, Saitama 331-9530, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Chiaki Nakayama</Name>
        <Affiliation>Drug Safety, Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Saitama-shi, Saitama 331-9530, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Iwasaki</Name>
        <Affiliation>Drug Safety, Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Saitama-shi, Saitama 331-9530, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shinobu Suzuki</Name>
        <Affiliation>Nippon Boehringer Ingelheim Co., Ltd., 6-7-5, Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kohji Tanaka</Name>
        <Affiliation>Nippon Boehringer Ingelheim Co., Ltd., 6-7-5, Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Etsushi Takahashi</Name>
        <Affiliation>Research Laboratories, Toyama Chemical Co., Ltd., 4-1, Shimookui 2-chome, Toyama 930-8508, Japan; Consortium for Safety Assessment using Human iPS Cells (CSAHi), Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kaori Miyamoto</Name>
        <Affiliation>Research Laboratories, Toyama Chemical Co., Ltd., 4-1, Shimookui 2-chome, Toyama 930-8508, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kaoru Morimura</Name>
        <Affiliation>Research Laboratories, Toyama Chemical Co., Ltd., 4-1, Shimookui 2-chome, Toyama 930-8508, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Atsuhiro Yamanishi</Name>
        <Affiliation>Toxicology Research Laboratory, Kyorin Pharmaceutical Co., Ltd., 1848, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan; Consortium for Safety Assessment using Human iPS Cells (CSAHi), Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroko Endo</Name>
        <Affiliation>Toxicology Research Laboratory, Kyorin Pharmaceutical Co., Ltd., 1848, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Junko Shinozaki</Name>
        <Affiliation>Toxicology Research Laboratory, Kyorin Pharmaceutical Co., Ltd., 1848, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hisashi Nogawa</Name>
        <Affiliation>Toxicology Research Laboratory, Kyorin Pharmaceutical Co., Ltd., 1848, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tadahiro Shinozawa</Name>
        <Affiliation>Drug Safety Research Laboratories, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome Fujisawa, Kanagawa 251-8555, Japan; Consortium for Safety Assessment using Human iPS Cells (CSAHi), Japan; Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-Clinical Evaluation Expert Committee, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Fumiyo Saito</Name>
        <Affiliation>Chemicals Assessment and Research Center, Chemicals Evaluation and Research Institute, Japan (CERI), 1600, Shimotakano, Sugito-machi, Kitakatsushika-gun, Saitama 345-0043, Japan; Consortium for Safety Assessment using Human iPS Cells (CSAHi), Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeshi Kunimatsu</Name>
        <Affiliation>Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan; Consortium for Safety Assessment using Human iPS Cells (CSAHi), Japan; Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-Clinical Evaluation Expert Committee, Japan. Electronic address: takeshi-kunimatsu@ds-pharma.co.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sub-chronic oral toxicity of Cuminum cyminum L.'s essential oil in female Wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28634146</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30176-9</DOI>
    <KeywordList>
      <Keywords>C. cyminum'S essential oil</Keywords>
      <Keywords>Sub chronic toxicity</Keywords>
      <Keywords>Wistar rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohsen Taghizadeh</Name>
        <Affiliation>Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Seyed Naser Ostad</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Zatollah Asemi</Name>
        <Affiliation>Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mohaddese Mahboubi</Name>
        <Affiliation>Department of Microbiology, Medicinal Plant, Research Center of Barij Essence, Kashan, Islamic Republic of Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Sara Hejazi</Name>
        <Affiliation>Department of Microbiology, Medicinal Plant, Research Center of Barij Essence, Kashan, Islamic Republic of Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Reza Sharafati-Chaleshtori</Name>
        <Affiliation>Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Aliakbar Rashidi</Name>
        <Affiliation>Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Hosein Akbari</Name>
        <Affiliation>Department of Biostatistics, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Nasrin Sharifi</Name>
        <Affiliation>Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran. Electronic address: sharifi.nsr@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of rodent data for cancer risk assessment of smokeless tobacco in the regulatory context.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28625913</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30174-5</DOI>
    <KeywordList>
      <Keywords>Bioassay</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>DNA adducts</Keywords>
      <Keywords>Epidemiology</Keywords>
      <Keywords>Hemoglobin adducts</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Smokeless tobacco</Keywords>
      <Keywords>Snus</Keywords>
      <Keywords>TSNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Robert Nilsson</Name>
        <Affiliation>Vinča Institute of Nuclear Sciences, Laboratory for Physical Chemistry, University of Belgrade, Vinča, Serbia. Electronic address: robertn65@telia.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative assessment of immune complex-mediated hypersensitivity reactions with biotherapeutics in the non-human primate: Critical parameters, safety and lessons for future studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28624430</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30173-3</DOI>
    <KeywordList>
      <Keywords>Biopharmaceuticals</Keywords>
      <Keywords>Biotherapeutics</Keywords>
      <Keywords>Hypersensitivity</Keywords>
      <Keywords>Immune complex</Keywords>
      <Keywords>Immunogenicity</Keywords>
      <Keywords>Monoclonal antibodies</Keywords>
      <Keywords>Non-clinical safety</Keywords>
      <Keywords>Non-human primate</Keywords>
      <Keywords>Risk mitigation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sven Kronenberg</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4001 Basel, Switzerland. Electronic address: sven.kronenberg@roche.com.</Affiliation>
      </Author>
      <Author>
        <Name>Elisabeth Husar</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4001 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Christine Schubert</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4001 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Freichel</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4001 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Emrich</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4001 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Lechmann</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4001 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Maria Giusti</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4001 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Franziska Regenass</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4001 Basel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Air quality and acute deaths in California, 2000-2012.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28619682</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30153-8</DOI>
    <KeywordList>
      <Keywords>Acute deaths</Keywords>
      <Keywords>Air pollution</Keywords>
      <Keywords>Air quality</Keywords>
      <Keywords>Mortality</Keywords>
      <Keywords>Ozone</Keywords>
      <Keywords>PM(2.5)</Keywords>
      <Keywords>Time series regression</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Stanley Young</Name>
        <Affiliation>CGStat, 3401 Caldwell Drive, Raleigh, NC 27607, United States. Electronic address: genetree@bellsouth.net.</Affiliation>
      </Author>
      <Author>
        <Name>Richard L. Smith</Name>
        <Affiliation>University of North Carolina, Department of Statistics and Operations Research, University of North Carolina, Chapel Hill, NC 27599-3260, United States. Electronic address: rls@email.unc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Keneth K. Lopiano</Name>
        <Affiliation>Consultant, Winterville, NC 28590, United States. Electronic address: klopiano@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Binary test battery with KeratinoSens™ and h-CLAT as part of a bottom-up approach for skin sensitization hazard prediction.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28602621</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30152-6</DOI>
    <KeywordList>
      <Keywords>Bottom-up approach</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>KeratinoSens™</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>h-CLAT</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuki Otsubo</Name>
        <Affiliation>Safety Science Research Laboratories, Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Taku Nishijo</Name>
        <Affiliation>Safety Science Research Laboratories, Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masaaki Miyazawa</Name>
        <Affiliation>Safety Science Research Laboratories, Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi 321-3497, Japan. Electronic address: miyazawa.masaaki@kao.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kazutoshi Saito</Name>
        <Affiliation>Safety Science Research Laboratories, Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hideyuki Mizumachi</Name>
        <Affiliation>Safety Science Research Laboratories, Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi 321-3497, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hitoshi Sakaguchi</Name>
        <Affiliation>Safety Science Research Laboratories, Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi 321-3497, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Safety assessment and attenuation of cisplatin induced nephrotoxicity by tuberous roots of Boerhaavia diffusa" [Regul. Toxicol. and Pharmacol. 81 (2016) 341-352].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28592367</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30149-6</DOI>
    <AuthorList>
      <Author>
        <Name>Ritu Karwasra</Name>
        <Affiliation>Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.</Affiliation>
      </Author>
      <Author>
        <Name>Prerna Kalra</Name>
        <Affiliation>Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.</Affiliation>
      </Author>
      <Author>
        <Name>T. C. Nag</Name>
        <Affiliation>Department of Anatomy, All India Institute of Medical Sciences, New Delhi, 110029, India.</Affiliation>
      </Author>
      <Author>
        <Name>Y. K. Gupta</Name>
        <Affiliation>Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.</Affiliation>
      </Author>
      <Author>
        <Name>Surender Singh</Name>
        <Affiliation>Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India. Electronic address: surenderaiims@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anuj Panwar</Name>
        <Affiliation>Divison of Environmental Toxicology, AES Laboratories (P) Ltd., Noida, Uttar Pradesh, 201304, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dietary safety of a dual-enzyme preparation for animal feed: Acute and subchronic oral toxicity and genotoxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28583667</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30151-4</DOI>
    <KeywordList>
      <Keywords>Animal feed</Keywords>
      <Keywords>Aspergillus oryzae</Keywords>
      <Keywords>Enzyme</Keywords>
      <Keywords>Genotoxicity study</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Oral-toxicity study</Keywords>
      <Keywords>Protease</Keywords>
      <Keywords>Xylanase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>G. P. Dillon</Name>
        <Affiliation>Alltech Ireland, Sarney, Summerhill Road, Dunboyne, Co Meath, Ireland. Electronic address: gdillon@alltech.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. A. Gaffney</Name>
        <Affiliation>Alltech Ireland, Sarney, Summerhill Road, Dunboyne, Co Meath, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>C. M. Curran</Name>
        <Affiliation>Alltech Ireland, Sarney, Summerhill Road, Dunboyne, Co Meath, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>C. A. Moran</Name>
        <Affiliation>Alltech France SARL, Rue Charles Amand, 14500 Vire, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of water-soluble palm fruit bioactives.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28583666</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30150-2</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Oil palm</Keywords>
      <Keywords>Polyphenols</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Barry S. Lynch</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, Ontario, L5N 2X7, Canada. Electronic address: barry.lynch@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Spencer West</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, Ontario, L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ashley Roberts</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, Ontario, L5N 2X7, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integrating habits and practices data for soaps, cosmetics and air care products into an existing aggregate exposure model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28559157</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30146-0</DOI>
    <KeywordList>
      <Keywords>Aggregate exposure</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Database</Keywords>
      <Keywords>Fragrance ingredients</Keywords>
      <Keywords>Habits and practices</Keywords>
      <Keywords>Personal care</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>D. Comiskey</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Woodcliff Lake, NJ 07677, United States. Electronic address: amapi@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>C. Barrett</Name>
        <Affiliation>Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Beds MK44 1LQ, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>G. Ellis</Name>
        <Affiliation>Givaudan International S.A., 5 Chemin de la Parfumerie, CH1214, Vernier, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>C. McNamara</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>C. O'Mahony</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>S. H. Robison</Name>
        <Affiliation>SH Robison Consulting, LLC, P.O. Box 688, Milford, OH 45150, United States.</Affiliation>
      </Author>
      <Author>
        <Name>J. Rose</Name>
        <Affiliation>The Procter and Gamble Company, Mason Business Center, 8700 Mason Montgomery Rd, Mason, OH 45040, United States.</Affiliation>
      </Author>
      <Author>
        <Name>B. Safford</Name>
        <Affiliation>B-Safe Toxicology Consulting, 31 Hayway, Rushden, Northants, NN10 6AG, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>B. Smith</Name>
        <Affiliation>Firmenich Inc., Post Office Box 5880, Princeton, NJ 08543, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. Tozer</Name>
        <Affiliation>The Procter and Gamble Company, Central Product Safety, P&amp;G Technical Centres Ltd., Whitehall Lane, Egham, Surrey TW20 9NW, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dietary safety assessment of genetically modified rice EH rich in β-carotene.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28559156</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30148-4</DOI>
    <KeywordList>
      <Keywords>EH rice</Keywords>
      <Keywords>Food safety assessment</Keywords>
      <Keywords>Toxicity assessment</Keywords>
      <Keywords>Transgenic rice</Keywords>
      <Keywords>Β-carotene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yangyang Wu</Name>
        <Affiliation>College of Life and Environment Sciences, Shanghai Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Xu</Name>
        <Affiliation>College of Life and Environment Sciences, Shanghai Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanan Du</Name>
        <Affiliation>College of Life and Environment Sciences, Shanghai Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Zhao</Name>
        <Affiliation>College of Life Sciences, Ningxia University, Ningxia, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruili Hu</Name>
        <Affiliation>College of Life and Environment Sciences, Shanghai Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaorui Fan</Name>
        <Affiliation>College of Life and Environment Sciences, Shanghai Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fangfang Ren</Name>
        <Affiliation>College of Life and Environment Sciences, Shanghai Normal University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Quanhong Yao</Name>
        <Affiliation>Biotechnology Research Institute, Shanghai Academy of Agricultural Sciences, Shanghai, China; Key Laboratory of Agricultural Genetics and Breeding, Shanghai Academy of Agricultural Sciences, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rihe Peng</Name>
        <Affiliation>Biotechnology Research Institute, Shanghai Academy of Agricultural Sciences, Shanghai, China; Key Laboratory of Agricultural Genetics and Breeding, Shanghai Academy of Agricultural Sciences, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xueming Tang</Name>
        <Affiliation>Biotechnology Research Institute, Shanghai Academy of Agricultural Sciences, Shanghai, China; Key Laboratory of Agricultural Genetics and Breeding, Shanghai Academy of Agricultural Sciences, Shanghai, China. Electronic address: saas.xmtang@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Zhao</Name>
        <Affiliation>Biotechnology Research Institute, Shanghai Academy of Agricultural Sciences, Shanghai, China; Key Laboratory of Agricultural Genetics and Breeding, Shanghai Academy of Agricultural Sciences, Shanghai, China. Electronic address: kzhao118@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mercury contamination in facial skin lightening creams and its health risks to user.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28554823</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30147-2</DOI>
    <KeywordList>
      <Keywords>Cold vapor atomic absorption spectrometry (CV-AAS)</Keywords>
      <Keywords>Hazard quotient (HQ)</Keywords>
      <Keywords>Mercury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Bin Ho</Name>
        <Affiliation>Research Centre of Excellence for Environmental and Occupational Health, Department of Environmental and Occupational Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia. Electronic address: yubin@upm.edu.my.</Affiliation>
      </Author>
      <Author>
        <Name>Nor Hidayu Abdullah</Name>
        <Affiliation>Research Centre of Excellence for Environmental and Occupational Health, Department of Environmental and Occupational Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Hazwanee Hamsan</Name>
        <Affiliation>Research Centre of Excellence for Environmental and Occupational Health, Department of Environmental and Occupational Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Eugenie Sin Sing Tan</Name>
        <Affiliation>School of Healthy Aging, Medical Aesthetic and Regenerative Medicine, Faculty of Medicine and Health Sciences, UCSI University, No.1, Jalan Menara Gading, UCSI Heights, Cheras, 56000, Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Utility of published DNA reactivity alerts.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28549899</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30145-9</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>Derek Nexus</Keywords>
      <Keywords>Expert review</Keywords>
      <Keywords>ICH M7</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Sarah Nexus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alun Myden</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastien J. Guesne</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alex Cayley</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Richard V. Williams</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds LS11 5PS, UK. Electronic address: Richard.Williams@lhasalimited.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Probabilistic derivation of the interspecies assessment factor for skin sensitization.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28545776</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30130-7</DOI>
    <KeywordList>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Dose-response modeling</Keywords>
      <Keywords>HMT</Keywords>
      <Keywords>HRIPT</Keywords>
      <Keywords>Interspecies sensitization assessment factor</Keywords>
      <Keywords>LLNA</Keywords>
      <Keywords>Probability distribution</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>W. Bil</Name>
        <Affiliation>Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: w.bil@students.uu.nl.</Affiliation>
      </Author>
      <Author>
        <Name>A. G. Schuur</Name>
        <Affiliation>National Institute for Public Health and the Environment, Centre for Safety of Substances and Products, Bilthoven, The Netherlands. Electronic address: gerlienke.schuur@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>J. Ezendam</Name>
        <Affiliation>National Institute for Public Health and the Environment, Centre for Health Protection, Bilthoven, The Netherlands. Electronic address: janine.ezendam@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>B. G. H. Bokkers</Name>
        <Affiliation>National Institute for Public Health and the Environment, Centre for Safety of Substances and Products, Bilthoven, The Netherlands. Electronic address: bas.bokkers@rivm.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Framework for assessing causality of air pollution-related health effects for reviews of the National Ambient Air Quality Standards.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28526659</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30129-0</DOI>
    <KeywordList>
      <Keywords>Causal determination</Keywords>
      <Keywords>Criteria air pollutants</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>National Ambient Air Quality Standards</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elizabeth Oesterling Owens</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA. Electronic address: owens.beth@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Molini M. Patel</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen Kirrane</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas C. Long</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Brown</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ila Cote</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mary A. Ross</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Steven J. Dutton</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA. Electronic address: dutton.steven@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (BASAGLAR</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28526658</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30128-9</DOI>
    <KeywordList>
      <Keywords>Biosimilar insulin</Keywords>
      <Keywords>Glucodynamics</Keywords>
      <Keywords>Insulin glargine</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Pharmacology</Keywords>
      <Keywords>Preclinical</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard A. Byrd</Name>
        <Affiliation>Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA. Electronic address: byrd_richard_a@lilly.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca A. Owens</Name>
        <Affiliation>Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jamie L. Blackbourne</Name>
        <Affiliation>Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David E. Coutant</Name>
        <Affiliation>Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark W. Farmen</Name>
        <Affiliation>Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Dodson Michael</Name>
        <Affiliation>Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julie S. Moyers</Name>
        <Affiliation>Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Eric Schultze</Name>
        <Affiliation>Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael K. Sievert</Name>
        <Affiliation>Covance Laboratories, Inc., Madison, WI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Niraj K. Tripathi</Name>
        <Affiliation>Covance Laboratories, Inc., Madison, WI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John L. Vahle</Name>
        <Affiliation>Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 46285, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Proarrhythmic risk assessment using conventional and new in vitro assays.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28506844</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30127-7</DOI>
    <KeywordList>
      <Keywords>Action potential</Keywords>
      <Keywords>Arrhythmia</Keywords>
      <Keywords>Cardiac safety pharmacology</Keywords>
      <Keywords>Field potential</Keywords>
      <Keywords>Human-induced pluripotent stem cell-derived cardiomyocytes</Keywords>
      <Keywords>Multielectrode arrays</Keywords>
      <Keywords>Purkinje fiber</Keywords>
      <Keywords>hERG channel</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sonia Goineau</Name>
        <Affiliation>Porsolt, Z.A. de Glatigné, 53940 Le Genest-Saint-Isle, France. Electronic address: sgoineau-brissieux@porsolt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vincent Castagné</Name>
        <Affiliation>Porsolt, Z.A. de Glatigné, 53940 Le Genest-Saint-Isle, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Airborne Asbestos Exposures Associated with Gasket and Packing Replacement: A Simulation Study of Flange and Valve Repair Work and an Assessment of Exposure Variables" [Regul. Toxicol. Pharmacol. 71 (1) (2014) 35-51].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28506586</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30119-8</DOI>
    <AuthorList>
      <Author>
        <Name>Amy K. Madl</Name>
        <Affiliation>Cardno ChemRisk, LLC, 130 Vantis, Suite 170, Aliso Viejo, CA 92656, United States. Electronic address: amy.madl@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kathryn D. Devlin</Name>
        <Affiliation>Cardno ChemRisk, LLC, 4840 Pearl East Circle, Suite 300 West, Boulder, CO 80301, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Angela L. Perez</Name>
        <Affiliation>Cardno ChemRisk, LLC, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dana M. Hollins</Name>
        <Affiliation>Cardno ChemRisk, LLC, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dallas M. Cowan</Name>
        <Affiliation>Cardno ChemRisk, LLC, 130 Vantis, Suite 170, Aliso Viejo, CA 92656, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paul K. Scott</Name>
        <Affiliation>Cardno ChemRisk, LLC, 20 Stanwix Street, Suite 505, Pittsburgh, PA 15222, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Katherine White</Name>
        <Affiliation>Cardno ChemRisk, LLC, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Thales J. Cheng</Name>
        <Affiliation>Cardno ChemRisk, LLC, 130 Vantis, Suite 170, Aliso Viejo, CA 92656, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John L. Henshaw</Name>
        <Affiliation>Cardno ChemRisk, LLC, 1101 Periwinkle Way, Suite #101, Sanibel, FL 33957, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 12-week randomized clinical trial investigating the potential for sucralose to affect glucose homeostasis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28502831</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30126-5</DOI>
    <KeywordList>
      <Keywords>Glucose homeostasis</Keywords>
      <Keywords>Healthy volunteers</Keywords>
      <Keywords>OGTT</Keywords>
      <Keywords>Sucralose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>V. Lee Grotz</Name>
        <Affiliation>McNeil Nutritionals, Fort Washington, PA 19034, United States. Electronic address: lee.grotz@heartlandfpg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xavier Pi-Sunyer</Name>
        <Affiliation>Department of Medicine, Division of Endocrinology, Columbia University College of Physicians and Surgeons, New York, NY 10025, United States. Electronic address: fxp1@cumc.columbia.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Porte</Name>
        <Affiliation>Department of Medicine, Division of Endocrinology and Metabolism, University of California San Diego, San Diego, CA, United States; Department of Medicine, Endocrinology, Diabetes and Metabolism Section, VA San Diego Health Care System, San Diego, CA, United States. Electronic address: dporte@ucsd.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ashley Roberts</Name>
        <Affiliation>Food &amp; Nutrition Group, Intertek Scientific &amp; Regulatory Consultancy, Mississauga, Ontario, Canada. Electronic address: ashley.roberts@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Richard Trout</Name>
        <Affiliation>Rutgers University, New Brunswick, NJ, United States. Electronic address: rtrout@rci.rutgers.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxicity, acute and subchronic toxicity evaluation of savory food ingredients.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28487066</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30121-6</DOI>
    <KeywordList>
      <Keywords>Formic acid</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Glutamic acid</Keywords>
      <Keywords>Inosine 5′-monophosphate</Keywords>
      <Keywords>L-alanine</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>Succinic acid</Keywords>
      <Keywords>glycine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shahrzad Tafazoli</Name>
        <Affiliation>Intertek Scientific and Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga L5N 2X7, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Trung D. Vo</Name>
        <Affiliation>Intertek Scientific and Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga L5N 2X7, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Petersen</Name>
        <Affiliation>Nestlé Product Technology Centre Lebensmittelforschung GmbH, Lange Str.21, 78224 Singen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Constable</Name>
        <Affiliation>Nestec Ltd., P.O. Box 44, CH-1000 Lausanne 26, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Myriam Coulet</Name>
        <Affiliation>Nestec Ltd., P.O. Box 44, CH-1000 Lausanne 26, Switzerland. Electronic address: Myriam.Coulet@rdls.nestle.com.</Affiliation>
      </Author>
      <Author>
        <Name>Phoukham Phothirath</Name>
        <Affiliation>Nestlé Institute of Health Sciences SA, EPFL Innovation Park, Building H, CH-1015 Lausanne, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Johanna Lang</Name>
        <Affiliation>Aurigon GmbH, Machtlfinger Straße 13, 81379 München, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Nigel Baldwin</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, Room 1036, Building A8, Cody Technology Park, Ively Road, Farnborough, Hampshire, GU14 0LX, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comprehensive study on in vitro and in vivo toxicological evaluation of Artemisia capillaris.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28487065</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30125-3</DOI>
    <KeywordList>
      <Keywords>Artemisia capillaris</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Traditional medicine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Won Yun</Name>
        <Affiliation>Department of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyun Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Soon Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Ran You</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Young Cho</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Hee Yoon</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Euna Kwon</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Hun Ahn</Name>
        <Affiliation>Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ja June Jang</Name>
        <Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Hwan Che</Name>
        <Affiliation>Biomedical Center for Animal Resource and Development, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: casache@snu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Byeong Cheol Kang</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Biomedical Center for Animal Resource and Development, Seoul National University College of Medicine, Seoul, Republic of Korea; Designed Animal and Transplantation Research Institute, Institute of GreenBio Science Technology, Seoul National University, Pyeongchang-gun, Gangwon-do, Republic of Korea. Electronic address: bckang@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the scientific committee on consumer safety (SCCS) - Final version of the opinion on Ethylzingerone - 'Hydroxyethoxyphenyl Butanone' (HEPB) - Cosmetics Europe No P98 - in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28487064</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30115-0</DOI>
    <KeywordList>
      <Keywords>CAS 569646-79-3</Keywords>
      <Keywords>Cosmetics Europe No P98</Keywords>
      <Keywords>Ethylzingerone</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>‘Hydroxyethoxyphenyl Butanone’ (HEPB)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920 Luxembourg, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Ulrike Bernauer</Name>
        <Affiliation>Federal Institute for Risk Assessment (BfR), Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of astaxanthin derived from engineered Escherichia coli K-12 using a 13-week repeated dose oral toxicity study and a prenatal developmental toxicity study in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28483713</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30118-6</DOI>
    <KeywordList>
      <Keywords>Astaxanthin</Keywords>
      <Keywords>Metabolic engineering</Keywords>
      <Keywords>Prenatal developmental toxicity</Keywords>
      <Keywords>Recombinant Escherichia coli</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yin Ju Lin</Name>
        <Affiliation>Lemnaceae Fermentation Inc., No.53, Ln. 229, Sec. 3, Changxing Rd., Luzhu Township, Taoyuan County, 338, Taiwan. Electronic address: jessica@Lemnaceae.com.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Yu Lin</Name>
        <Affiliation>Level Biotechnology Inc., Preclinical Testing Center, No. 80, Lane 169, Kangning St., Hsi-Chih Dist., New Taipei City, 221, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Di Sheng Wang</Name>
        <Affiliation>Level Biotechnology Inc., Preclinical Testing Center, No. 80, Lane 169, Kangning St., Hsi-Chih Dist., New Taipei City, 221, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chien Hao Chen</Name>
        <Affiliation>Level Biotechnology Inc., Preclinical Testing Center, No. 80, Lane 169, Kangning St., Hsi-Chih Dist., New Taipei City, 221, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Hsi Chiou</Name>
        <Affiliation>Lemnaceae Fermentation Inc., No.53, Ln. 229, Sec. 3, Changxing Rd., Luzhu Township, Taoyuan County, 338, Taiwan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Margin of safety of pentylene glycol derived using measurements of cutaneous absorption and volatility.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28483712</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30122-8</DOI>
    <KeywordList>
      <Keywords>Margin of safety</Keywords>
      <Keywords>Pentylene glycol</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Skin penetration</Keywords>
      <Keywords>Sunscreen</Keywords>
      <Keywords>Volatile</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Steiner</Name>
        <Affiliation>Nestlé Skin Health R&amp;D, Froschackerstrasse 6, CH-4622 Egerkingen, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>K. Kugarajan</Name>
        <Affiliation>Nestlé Skin Health R&amp;D, Froschackerstrasse 6, CH-4622 Egerkingen, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>M. Wullimann</Name>
        <Affiliation>Nestlé Skin Health R&amp;D, Froschackerstrasse 6, CH-4622 Egerkingen, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>B. Ruty</Name>
        <Affiliation>Nestlé Skin Health R&amp;D, Froschackerstrasse 6, CH-4622 Egerkingen, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>G. Kunze</Name>
        <Affiliation>Nestlé Skin Health R&amp;D, Froschackerstrasse 6, CH-4622 Egerkingen, Switzerland. Electronic address: gernot.kunze@galderma.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the scientific committee on consumer safety (SCCS) - Final opinion on Polyaminopropyl Biguanide (PHMB) in cosmetic products - Submission III.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28483711</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30114-9</DOI>
    <KeywordList>
      <Keywords>CAS 32289-58-0 / 27083-27-8 / 28757-47-3 / 133029-32-0</Keywords>
      <Keywords>EC: 608-723-9 and 608-042-7</Keywords>
      <Keywords>Polyaminopropyl Biguanide (PHMB)</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920 Luxembourg, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Vera Rogiers</Name>
        <Affiliation>Vrije Universiteit Brussel, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Current nonclinical testing paradigms in support of safe clinical trials: An IQ Consortium DruSafe perspective.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28483710</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30124-1</DOI>
    <KeywordList>
      <Keywords>Attrition</Keywords>
      <Keywords>Bial</Keywords>
      <Keywords>Discovery toxicology</Keywords>
      <Keywords>DruSafe</Keywords>
      <Keywords>FIH</Keywords>
      <Keywords>IQ</Keywords>
      <Keywords>Nonclinical safety</Keywords>
      <Keywords>Phase 1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lynne D. Butler</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Eastern Point Rd, Groton, CT, 06340, USA. Electronic address: lynne.d.butler@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Peggy Guzzie-Peck</Name>
        <Affiliation>Janssen Research &amp; Development, LLC, 1400 McKean Road, Spring House, PA, 19477, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Hartke</Name>
        <Affiliation>Celgene Corporation, NonClinical Development, 10300 Campus Point Dr. Suite 100, San Diego, CA, 92121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew S. Bogdanffy</Name>
        <Affiliation>Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yvonne Will</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Eastern Point Rd, Groton, CT, 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dolores Diaz</Name>
        <Affiliation>Denali Therapeutics, 151 Oyster Point Blvd, South San Francisco, CA, 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elisabeth Mortimer-Cassen</Name>
        <Affiliation>Astra-Zeneca Innovation Medicines and Early Development, Melbourn Science Park, Melbourn, Hertfordshire, SG8 6EE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mazin Derzi</Name>
        <Affiliation>Pfizer Worldwide Research and Development, 1 Burtt Road, Andover, MA, 01810, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nigel Greene</Name>
        <Affiliation>Astra-Zeneca Innovation Medicines and Early Development, 35 Gatehouse Drive, Waltham, MA, 02451, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph J. DeGeorge</Name>
        <Affiliation>Merck &amp; Co., Inc. MRL, 770 Sumneytown Pike, WP 45-201, PO Box 4, West Point, PA, 19486, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure to DDT and its metabolites from khat (Catha edulis) chewing: Consumers risk assessment from southwestern Ethiopia.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28483709</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30123-X</DOI>
    <KeywordList>
      <Keywords>Chewers</Keywords>
      <Keywords>Consumption</Keywords>
      <Keywords>DDT residue</Keywords>
      <Keywords>Estimated daily intake</Keywords>
      <Keywords>Khat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Seblework Mekonen</Name>
        <Affiliation>Department of Environmental Health Sciences &amp; Technology, College of Health Sciences, Jimma University, Jimma, Ethiopia.</Affiliation>
      </Author>
      <Author>
        <Name>Argaw Ambelu</Name>
        <Affiliation>Department of Environmental Health Sciences &amp; Technology, College of Health Sciences, Jimma University, Jimma, Ethiopia. Electronic address: aambelu@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Belay Negassa</Name>
        <Affiliation>Department of Environmental Health Sciences &amp; Technology, College of Health Sciences, Jimma University, Jimma, Ethiopia.</Affiliation>
      </Author>
      <Author>
        <Name>Pieter Spanoghe</Name>
        <Affiliation>Department of Crop Protection, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetics of nicotine following the controlled use of a prototype novel tobacco vapor product.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28479294</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30120-4</DOI>
    <KeywordList>
      <Keywords>Clinical study</Keywords>
      <Keywords>Japanese healthy adult male smokers</Keywords>
      <Keywords>Mouth level exposure</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Prototype novel tobacco vapor product</Keywords>
      <Keywords>Relative bioavailability</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dai Yuki</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., Japan. Electronic address: dai.yuki@jti.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chikako Sakaguchi</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akira Kikuchi</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuyuki Futamura</Name>
        <Affiliation>Scientific Product Assessment Center, R&amp;D Group, Japan Tobacco Inc., Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of autophagy aggravated 4-nitrophenol-induced oxidative stress and apoptosis in NHPrE1 human normal prostate epithelial progenitor cells.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28476554</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30116-2</DOI>
    <KeywordList>
      <Keywords>4-Nitrophenol</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>NHPrE1</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>mTOR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yonghui Zhang</Name>
        <Affiliation>Laboratory of Nuclear Receptors and Cancer Research, Center for Basic Medical Research, Nantong University School of Medicine, Nantong 226000, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chong Zhang</Name>
        <Affiliation>Laboratory of Nuclear Receptors and Cancer Research, Center for Basic Medical Research, Nantong University School of Medicine, Nantong 226000, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fulu Dong</Name>
        <Affiliation>Laboratory of Nuclear Receptors and Cancer Research, Center for Basic Medical Research, Nantong University School of Medicine, Nantong 226000, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Miaomiao Chen</Name>
        <Affiliation>Laboratory of Nuclear Receptors and Cancer Research, Center for Basic Medical Research, Nantong University School of Medicine, Nantong 226000, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingchen Cao</Name>
        <Affiliation>Laboratory of Nuclear Receptors and Cancer Research, Center for Basic Medical Research, Nantong University School of Medicine, Nantong 226000, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyan Wang</Name>
        <Affiliation>Laboratory of Nuclear Receptors and Cancer Research, Center for Basic Medical Research, Nantong University School of Medicine, Nantong 226000, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Jiang</Name>
        <Affiliation>Laboratory of Nuclear Receptors and Cancer Research, Center for Basic Medical Research, Nantong University School of Medicine, Nantong 226000, Jiangsu, PR China; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: ming.jiang@ntu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Measurement of cardiovascular and pulmonary function endpoints and other physiological effects following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28476553</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30117-4</DOI>
    <KeywordList>
      <Keywords>Adverse effects</Keywords>
      <Keywords>Cardiovascular effects</Keywords>
      <Keywords>E-cigarette</Keywords>
      <Keywords>Exclusive and dual use</Keywords>
      <Keywords>Harm reduction</Keywords>
      <Keywords>Physiological effects</Keywords>
      <Keywords>Pulmonary effects</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carl D. D'Ruiz</Name>
        <Affiliation>Clinical Study Consultant, Fontem Ventures, Greensboro, NC, USA. Electronic address: carldruiz@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Grant O'Connell</Name>
        <Affiliation>Fontem Ventures, Scientific and Regulatory Affairs, Amsterdam, The Netherlands. Electronic address: grant.oconnell@fontemventures.com.</Affiliation>
      </Author>
      <Author>
        <Name>Donald W. Graff</Name>
        <Affiliation>Celerion, Lincoln, NE, USA. Electronic address: Donald.graff@celerion.com.</Affiliation>
      </Author>
      <Author>
        <Name>X. Sherwin Yan</Name>
        <Affiliation>Lorillard Tobacco Company (formerly), Greensboro, NC, USA. Electronic address: xyan1209@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human health assessment for long-term oral ingestion of diethylene glycol.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28465071</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30080-6</DOI>
    <KeywordList>
      <Keywords>Acute and long-term exposure toxic effects</Keywords>
      <Keywords>DEG</Keywords>
      <Keywords>Diethylene glycol</Keywords>
      <Keywords>Human-based oral RfD for chronic exposure</Keywords>
      <Keywords>Renal hydropic degeneration</Keywords>
      <Keywords>Renal toxicity mode of action</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>William M. Snellings</Name>
        <Affiliation>Snellings Toxicology Consulting, LLC, 23 Trails End Lane, Ridgefield, CT 06877, USA. Electronic address: toxdoc143@aol.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth E. McMartin</Name>
        <Affiliation>Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA. Electronic address: KMcmar@lsuhsc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Marcy I. Banton</Name>
        <Affiliation>LyondellBasell, Suite 300, 1221 McKinney Street, Houston, TX 77010, USA. Electronic address: marcy.banton@lyb.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fred Reitman</Name>
        <Affiliation>Shell Oil Company, 910 Louisiana St, #17004C, Houston, TX 77002, USA. Electronic address: fred.reitman@shell.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Klapacz</Name>
        <Affiliation>Toxicology and Environmental Research and Consulting, The Dow Chemical Company, Midland, MI 48640 USA. Electronic address: jklapacz@dow.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Calculation of a permitted daily exposure value for the solvent 2-methyltetrahydrofuran.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28461231</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30097-1</DOI>
    <KeywordList>
      <Keywords>3-Month toxicity study</Keywords>
      <Keywords>Permitted daily exposure</Keywords>
      <Keywords>Pharmaceuticals</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Solvent</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Patricia Parris</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety Research and Development, Sandwich, Kent, UK. Electronic address: patricia.parris@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Neil Duncan</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety Research and Development, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Fleetwood</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety Research and Development, Sandwich, Kent, UK.</Affiliation>
      </Author>
      <Author>
        <Name>William P. Beierschmitt</Name>
        <Affiliation>Pfizer Worldwide Research and Development, Drug Safety Research and Development, Groton, CT, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>"Simulated gastric hydrolysis and developmental toxicity of dioctyltin bis(2-Ethylhexylthioglycolate) [DOTE] in rabbits and mice".</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28456493</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30082-X</DOI>
    <KeywordList>
      <Keywords>CAS 15571-58-1</Keywords>
      <Keywords>Developmental</Keywords>
      <Keywords>Dioctyltin bis(2-ethylhexylthioglycolate)</Keywords>
      <Keywords>Gastric hydrolysis</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Rabbit</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Teratology</Keywords>
      <Keywords>gestation[al]</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard D. Costlow</Name>
        <Affiliation>Richard Costlow Consulting, LLC, Suite 2 East, 2080 Parkview Drive, Lansdale, PA, 19446, USA. Electronic address: Rich.Costlow@Verizon.net.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Nasshan</Name>
        <Affiliation>Galata Chemicals, GmbH, Chemiestraße 22, 68623 Lampertheim, Germany. Electronic address: Hans.Nasshan@galatachemicals.com.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Frenkel</Name>
        <Affiliation>Galata Chemicals, Inc., Suite A1, 464 Heritage Road, Southbury, CT, 06488, USA. Electronic address: Peter.Frenkel@galatachemicals.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A two-year dietary carcinogenicity study of cyadox in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28454720</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30096-X</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Cyadox</Keywords>
      <Keywords>Quinoxaline</Keywords>
      <Keywords>SD rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qianying Liu</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhixin Lei</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Luqing Cui</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianwu Zhang</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ihsan Awais</Name>
        <Affiliation>Department of Biosciences, COMSATS Institute of Information Technology, Sahiwal, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Menghong Dai</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Wang</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei 430070, China. Electronic address: wangxu@mail.hzau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zonghui Yuan</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei 430070, China; MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China. Electronic address: yuan5802@mail.hzau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetic and toxicology comparator testing of biosimilar drugs - Assessing need.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28433587</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30095-8</DOI>
    <KeywordList>
      <Keywords>Biosimilar</Keywords>
      <Keywords>Comparability exercise</Keywords>
      <Keywords>Innovator</Keywords>
      <Keywords>Pharmacokinetic testing</Keywords>
      <Keywords>Regulatory guidance</Keywords>
      <Keywords>Toxicology testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul Baldrick</Name>
        <Affiliation>Covance Laboratories Ltd., Otley Road, Harrogate, HG3 1PY, North Yorkshire, United Kingdom. Electronic address: paul.baldrick@covance.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics" [Regul. Toxicol. Pharmacol. (2017) 221-230].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28431771</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30091-0</DOI>
    <AuthorList>
      <Author>
        <Name>Christina L. Zuch de Zafra</Name>
        <Affiliation>Safety Assessment, Genentech, Inc., South San Francisco, CA, United States. Electronic address: cdezafra@amgen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vito G. Sasseville</Name>
        <Affiliation>Preclinical Safety, Novartis Institutes for BioMedical Research, Cambridge, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Steven Matsumoto</Name>
        <Affiliation>Nonclinical and Translational Sciences, Allergan, Irvine, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Freichel</Name>
        <Affiliation>Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Milton</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, Novartis Institutes for BioMedical Research, Cambridge, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy K. MacLachlan</Name>
        <Affiliation>Preclinical Safety, Novartis Institutes for BioMedical Research, Cambridge, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Cindy Farman</Name>
        <Affiliation>Safety Assessment, Genentech, Inc., South San Francisco, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Iona Raymond</Name>
        <Affiliation>Nonclinical and Translational Sciences, Allergan, Irvine, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Swati Gupta</Name>
        <Affiliation>Nonclinical and Translational Sciences, Allergan, Irvine, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald Newton</Name>
        <Affiliation>Preclinical Safety, Novartis Institutes for BioMedical Research, Cambridge, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Elke Astrid Atzpodien</Name>
        <Affiliation>Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Evan A. Thackaberry</Name>
        <Affiliation>Safety Assessment, Genentech, Inc., South San Francisco, CA, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Repeated sub-chronic oral toxicity study of xylooligosaccharides (XOS) in dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28428020</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30094-6</DOI>
    <KeywordList>
      <Keywords>Beagle dog</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>Xylooligosaccharide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Science, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunzhi Wang</Name>
        <Affiliation>School of Life Science, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanshen Li</Name>
        <Affiliation>School of Life Science, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Han</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Xiao</Name>
        <Affiliation>Shandong LongLive Bio-technology Co.,Ltd., Yucheng, 251200, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Cho</Name>
        <Affiliation>NutraSource, Inc., Clarksville, MD 21029, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yukui Ma</Name>
        <Affiliation>Shandong Institute of Pharmaceutical Industry, Jinan, 250100, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Fang</Name>
        <Affiliation>Shandong Institute of Pharmaceutical Industry, Jinan, 250100, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Albert W. Lee</Name>
        <Affiliation>NutraSource, Inc., Royal Oak, MI 48073, USA. Electronic address: icarus.descending@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and sub-acute toxicological evaluation of lyophilized Nymphaea x rubra Roxb. ex Andrews rhizome extract.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28414041</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30093-4</DOI>
    <KeywordList>
      <Keywords>Acute and sub-acute toxicity study</Keywords>
      <Keywords>Extraction</Keywords>
      <Keywords>Hematology</Keywords>
      <Keywords>Hippocratic screening</Keywords>
      <Keywords>Lyophillization</Keywords>
      <Keywords>N. rubra</Keywords>
      <Keywords>RP-HPLC analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kushal Kumar</Name>
        <Affiliation>Defence Institute of High Altitude Research, Defence Research and Development Organisation, C/o 56 APO, Leh-Ladakh, 901205, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sabeena Sharma</Name>
        <Affiliation>Defence Institute of High Altitude Research, Defence Research and Development Organisation, C/o 56 APO, Leh-Ladakh, 901205, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ashish Kumar</Name>
        <Affiliation>Defence Institute of High Altitude Research, Defence Research and Development Organisation, C/o 56 APO, Leh-Ladakh, 901205, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pushpender Bhardwaj</Name>
        <Affiliation>Defence Institute of High Altitude Research, Defence Research and Development Organisation, C/o 56 APO, Leh-Ladakh, 901205, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kalpana Barhwal</Name>
        <Affiliation>All India Institute of Medical Sciences, Sijua, Bhubaneswar, Odisha, 751019, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sunil Kumar Hota</Name>
        <Affiliation>Defence Institute of High Altitude Research, Defence Research and Development Organisation, C/o 56 APO, Leh-Ladakh, 901205, India. Electronic address: drsunilhota@yahoomail.co.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxicity testing of sodium formononetin-3'-sulphonate (Sul-F) by assessing bacterial reverse mutation, chromosomal aberrations and micronucleus tests.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28408196</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30090-9</DOI>
    <KeywordList>
      <Keywords>Bacterial reverse mutation</Keywords>
      <Keywords>Chromosomal aberration</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Micronucleus test</Keywords>
      <Keywords>Sodium formononetin-3′-sulphonate (Sul-F)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai 264005, PR China. Electronic address: gaoyongnlin@ytu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yunzhi Wang</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guisheng Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, PR China. Electronic address: liguisheng@luye.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaochen Fan</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanshen Li</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenghua Guo</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Tao</Name>
        <Affiliation>Hebei Gogin Pharmaceutical Co., LTD., Xingtai 054000, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lipid-soluble green tea extract: Genotoxicity and subchronic toxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28389326</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30086-7</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Lipid soluble green tea extract</Keywords>
      <Keywords>Lipid soluble tea polyphenol</Keywords>
      <Keywords>Mouse sperm abnormality assay</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zheng Liu</Name>
        <Affiliation>Institute of Health Food, Zhejiang Academy of Medical Sciences, 182 Tian Mu Shan Road, Hangzhou 310013 China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongying Liu</Name>
        <Affiliation>Institute of Health Food, Zhejiang Academy of Medical Sciences, 182 Tian Mu Shan Road, Hangzhou 310013 China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Cheng</Name>
        <Affiliation>Institute of Health Food, Zhejiang Academy of Medical Sciences, 182 Tian Mu Shan Road, Hangzhou 310013 China.</Affiliation>
      </Author>
      <Author>
        <Name>Song Mei</Name>
        <Affiliation>Institute of Health Food, Zhejiang Academy of Medical Sciences, 182 Tian Mu Shan Road, Hangzhou 310013 China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Fu</Name>
        <Affiliation>Institute of Health Food, Zhejiang Academy of Medical Sciences, 182 Tian Mu Shan Road, Hangzhou 310013 China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiqi Lai</Name>
        <Affiliation>Institute of Health Food, Zhejiang Academy of Medical Sciences, 182 Tian Mu Shan Road, Hangzhou 310013 China.</Affiliation>
      </Author>
      <Author>
        <Name>Yin Wang</Name>
        <Affiliation>Institute of Health Food, Zhejiang Academy of Medical Sciences, 182 Tian Mu Shan Road, Hangzhou 310013 China.</Affiliation>
      </Author>
      <Author>
        <Name>Yihong Xu</Name>
        <Affiliation>Zhejiang Provincial Center for Disease Control and Prevention, 3399 Binsheng Road, Hangzhou 310051, China.</Affiliation>
      </Author>
      <Author>
        <Name>Trung D. Vo</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON L5N 2X7 Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Barry S. Lynch</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON L5N 2X7 Canada. Electronic address: barry.lynch@intertek.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vivo toxicity evaluation of aqueous acetone extract of Terminalia bellirica (Gaertn.) Roxb. fruit.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28389325</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30087-9</DOI>
    <KeywordList>
      <Keywords>Acute toxicity study</Keywords>
      <Keywords>Aqueous acetone extract</Keywords>
      <Keywords>Lethal dose</Keywords>
      <Keywords>Terminalia bellirica</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kuriakose Jayesh</Name>
        <Affiliation>School of Biosciences, Mahatma Gandhi University, Priyadarshini Hills, Kottayam, Kerala, India.</Affiliation>
      </Author>
      <Author>
        <Name>Lal Raisa Helen</Name>
        <Affiliation>School of Biosciences, Mahatma Gandhi University, Priyadarshini Hills, Kottayam, Kerala, India.</Affiliation>
      </Author>
      <Author>
        <Name>A. Vysakh</Name>
        <Affiliation>School of Biosciences, Mahatma Gandhi University, Priyadarshini Hills, Kottayam, Kerala, India.</Affiliation>
      </Author>
      <Author>
        <Name>Eldhose Binil</Name>
        <Affiliation>School of Biosciences, Mahatma Gandhi University, Priyadarshini Hills, Kottayam, Kerala, India.</Affiliation>
      </Author>
      <Author>
        <Name>M. S. Latha</Name>
        <Affiliation>School of Biosciences, Mahatma Gandhi University, Priyadarshini Hills, Kottayam, Kerala, India. Electronic address: mslathasbs@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1-34).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28389324</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30088-0</DOI>
    <KeywordList>
      <Keywords>Abaloparatide</Keywords>
      <Keywords>Bone mineral content</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>F344 rat</Keywords>
      <Keywords>Osteoblastoma</Keywords>
      <Keywords>Osteosarcoma</Keywords>
      <Keywords>PTH1R</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jacquelin Jolette</Name>
        <Affiliation>Charles River Laboratories, Preclinical Services, Montreal, 22022 Transcanadienne, Senneville, Quebec H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Bassem Attalla</Name>
        <Affiliation>Charles River Laboratories, Preclinical Services, Montreal, 22022 Transcanadienne, Senneville, Quebec H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Aurore Varela</Name>
        <Affiliation>Charles River Laboratories, Preclinical Services, Montreal, 22022 Transcanadienne, Senneville, Quebec H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Gerald G. Long</Name>
        <Affiliation>Experimental Pathology Laboratories Inc., Sterling, VA 20166, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nacera Mellal</Name>
        <Affiliation>Charles River Laboratories, Preclinical Services, Montreal, 22022 Transcanadienne, Senneville, Quebec H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Sabile Trimm</Name>
        <Affiliation>Charles River Laboratories, Preclinical Services, Montreal, 22022 Transcanadienne, Senneville, Quebec H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Y. Smith</Name>
        <Affiliation>Charles River Laboratories, Preclinical Services, Montreal, 22022 Transcanadienne, Senneville, Quebec H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Michael S. Ominsky</Name>
        <Affiliation>Radius Health, Inc., 950 Winter Street, Waltham, MA 02451, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Hattersley</Name>
        <Affiliation>Radius Health, Inc., 950 Winter Street, Waltham, MA 02451, USA. Electronic address: ghattersley@radiuspharm.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An approach to allergy risk assessments for e-liquid ingredients.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28389323</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30089-2</DOI>
    <KeywordList>
      <Keywords>Contact sensitisation</Keywords>
      <Keywords>E-cigarette</Keywords>
      <Keywords>E-liquid</Keywords>
      <Keywords>ENDS</Keywords>
      <Keywords>Flavour</Keywords>
      <Keywords>Hypersensitivity</Keywords>
      <Keywords>Respiratory allergy</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sandra Costigan</Name>
        <Affiliation>Nicoventures R&amp;D, Regents Park, Southampton SO15 8TL, UK. Electronic address: sandra_costigan@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Lopez-Belmonte</Name>
        <Affiliation>BAT R&amp;D, Regents Park, Southampton SO15 8TL, UK. Electronic address: juan_lopez-belmonte@bat.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carbamates and ICH M7 classification: Making use of expert knowledge.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28385577</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30085-5</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Ames test</Keywords>
      <Keywords>Carbamates</Keywords>
      <Keywords>Derek Nexus</Keywords>
      <Keywords>Expert review</Keywords>
      <Keywords>ICH M7</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Sarah Nexus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rachel Hemingway</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Adrian Fowkes</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Richard V. Williams</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK. Electronic address: richard.williams@lhasalimited.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of an oral Maximum Allowable Dose Level for Bisphenol A.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28377091</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30084-3</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Maximum Allowable Dose Level</Keywords>
      <Keywords>Proposition 65</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael K. Peterson</Name>
        <Affiliation>Gradient, 600 Stewart Street, Seattle, WA 98101, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mary L. Hixon</Name>
        <Affiliation>Gradient, 100 Cambridge Park Drive, Cambridge, MA 02140, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sara Pacheco Shubin</Name>
        <Affiliation>Gradient, 600 Stewart Street, Seattle, WA 98101, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Kinetic modeling of the retention and fate of inhaled cerium oxide nanoparticles in rats: The cumulative displacement volume of agglomerates determines the outcome.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28373117</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30083-1</DOI>
    <KeywordList>
      <Keywords>Aggregates</Keywords>
      <Keywords>Disposition</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Repeated inhalation studies</Keywords>
      <Keywords>Volume displacement lung overload</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juergen Pauluhn</Name>
        <Affiliation>Hannover Medical School, Hannover, Germany; 4th Military Medical University, Xi'an, China. Electronic address: juergen.pauluhn@iCLOUD.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Update: Mode of action (MOA) for liver tumors induced by oral exposure to 1,4-dioxane.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28366800</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30042-9</DOI>
    <KeywordList>
      <Keywords>Dioxane</Keywords>
      <Keywords>Liver toxicity</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Regenerative hyperplasia</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael L. Dourson</Name>
        <Affiliation>University of Cincinnati, College of Medicine, Cincinnati, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jeri Higginbotham</Name>
        <Affiliation>Kentucky Department for Environmental Protection, Frankfort, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jeff Crum</Name>
        <Affiliation>Hamp, Mathews &amp; Associates, Inc., Bath, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Heather Burleigh-Flayer</Name>
        <Affiliation>PPG, Monroeville, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Nance</Name>
        <Affiliation>University of Cincinnati, College of Medicine, Cincinnati, OH, United States. Electronic address: patricia.nance@uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Norman D. Forsberg</Name>
        <Affiliation>Arcadis U.S., Inc., Chelmsford, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Lafranconi</Name>
        <Affiliation>Environmental Resources Management, Cincinnati, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John Reichard</Name>
        <Affiliation>University of Cincinnati, College of Medicine, Cincinnati, OH, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of biomonitoring equivalents for barium in urine and plasma for interpreting human biomonitoring data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28359824</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30081-8</DOI>
    <KeywordList>
      <Keywords>BE</Keywords>
      <Keywords>Barium</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring equivalent</Keywords>
      <Keywords>Exposure guidance values</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Devika Poddalgoda</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Macey</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Henry Assad</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Kannan Krishnan</Name>
        <Affiliation>Risk Sciences International, Ottawa, ON, Canada. Electronic address: KKrishnan@Risksciences.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of ethanolic extract from Stevia rebaudiana Bertoni leaves: Genotoxicity and subchronic oral toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28351677</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30079-X</DOI>
    <KeywordList>
      <Keywords>Ethanolic extract</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Safety evaluation</Keywords>
      <Keywords>Stevia rebaudiana Bertoni</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qiannan Zhang</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Yang</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongning Li</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haibo Liu</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xudong Jia</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing 100021, China. Electronic address: jiaxudong@cfsa.net.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk assessment for pyrrolizidine alkaloids detected in (herbal) teas and plant food supplements.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28347763</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30077-6</DOI>
    <KeywordList>
      <Keywords>(Herbal) teas</Keywords>
      <Keywords>BMDL(10)</Keywords>
      <Keywords>MOE</Keywords>
      <Keywords>Plant food supplements</Keywords>
      <Keywords>Pyrrolizidine alkaloids</Keywords>
      <Keywords>REP</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>T10</Keywords>
      <Keywords>T25</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lu Chen</Name>
        <Affiliation>Division of Toxicology, Wageningen University, PO Box 8000, 6700 EA, Wageningen, The Netherlands. Electronic address: Lu.Chen@wur.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick P. J. Mulder</Name>
        <Affiliation>RIKILT Wageningen University &amp; Research, PO Box 230, 6700 AE, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jochem Louisse</Name>
        <Affiliation>Division of Toxicology, Wageningen University, PO Box 8000, 6700 EA, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ad Peijnenburg</Name>
        <Affiliation>RIKILT Wageningen University &amp; Research, PO Box 230, 6700 AE, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Sebas Wesseling</Name>
        <Affiliation>Division of Toxicology, Wageningen University, PO Box 8000, 6700 EA, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ivonne M. C. M. Rietjens</Name>
        <Affiliation>Division of Toxicology, Wageningen University, PO Box 8000, 6700 EA, Wageningen, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An in vitro approach for comparative interspecies metabolism of agrochemicals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28347762</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30078-8</DOI>
    <KeywordList>
      <Keywords>Agrochemicals</Keywords>
      <Keywords>Comparative</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>Interspecies</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Pesticide</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul M. Whalley</Name>
        <Affiliation>Syngenta, Jealott's Hill International Research Centre, Bracknell, RG42 6EY, UK. Electronic address: paul.whalley@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Bartels</Name>
        <Affiliation>ToxMetrics.com, LLC, Midland, MI USA. Electronic address: mjbartels@toxmetrics.com.</Affiliation>
      </Author>
      <Author>
        <Name>Karin S. Bentley</Name>
        <Affiliation>DuPont Crop Protection, Stine-Haskell Research Center, Newark DE 19711, USA. Electronic address: karin.s.bentley-1@dupont.com.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Corvaro</Name>
        <Affiliation>Dow AgroSciences, 3B Park Square, Milton, Milton Park, Abingdon, Oxfordshire, OX14 4RN, UK. Electronic address: mcorvaro@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dorothee Funk</Name>
        <Affiliation>BASF SE Crop Protection, Global Consumer Safety, 67117 Limburgerhof, Germany. Electronic address: dorothee.funk@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew W. Himmelstein</Name>
        <Affiliation>DuPont Haskell Global Centers, USA. Electronic address: matthew.w.himmelstein@dupont.com.</Affiliation>
      </Author>
      <Author>
        <Name>Birgit Neumann</Name>
        <Affiliation>Bayer CropScience AG, 40789 Monheim Am Rhein, Germany. Electronic address: birgit.neumann2@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Strupp</Name>
        <Affiliation>ADAMA MAH BV Amsterdam NL Schaffhausen Branch, 8200 Schaffhausen, Switzerland. Electronic address: christian.strupp@adama.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fagen Zhang</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research and Consulting, Midland, MI 48674, USA. Electronic address: fzzhang@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jyotigna Mehta</Name>
        <Affiliation>Dow AgroSciences, 3B Park Square, Milton, Milton Park, Abingdon, Oxfordshire, OX14 4RN, UK. Electronic address: jmehta@dow.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>New studies on the in vitro genotoxicity of sodium molybdate and their impact on the overall assessment of the genotoxicity of molybdenum substances.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28342846</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30076-4</DOI>
    <KeywordList>
      <Keywords>Aneugenicity</Keywords>
      <Keywords>Clastogenicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Molybdate</Keywords>
      <Keywords>Molybdenum</Keywords>
      <Keywords>Mutation</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Arne Burzlaff</Name>
        <Affiliation>EBRC Consulting GmbH, Raffaelstr. 4, 30177 Hannover, Germany. Electronic address: a.burzlaff@ebrc.de.</Affiliation>
      </Author>
      <Author>
        <Name>Carol Beevers</Name>
        <Affiliation>Genetic Toxicology, Covance Laboratories Limited, Otley Road, Harrogate, North Yorkshire, HG3 1PY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Helen Pearce</Name>
        <Affiliation>Genetic Toxicology, Covance Laboratories Limited, Otley Road, Harrogate, North Yorkshire, HG3 1PY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Melvyn Lloyd</Name>
        <Affiliation>Genetic Toxicology, Covance Laboratories Limited, Otley Road, Harrogate, North Yorkshire, HG3 1PY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Klipsch</Name>
        <Affiliation>EBRC Consulting GmbH, Raffaelstr. 4, 30177 Hannover, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxic and cytotoxic evaluation of Jatropha dioica Sessé ex Cerv. by the micronucleus test in mouse peripheral blood.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28342845</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30075-2</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Erythrocytes</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Jatropha dioica Sessé ex Cerv.</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Micronuclei</Keywords>
      <Keywords>Peripheral blood</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Diana Isela Araujo-Espino</Name>
        <Affiliation>Maestría en Ciencias Biomédicas, Universidad Autónoma de Zacatecas, Zacatecas, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Lourdes Zamora-Perez</Name>
        <Affiliation>Instituto de Investigación en Odontología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Guillermo Moisés Zúñiga-González</Name>
        <Affiliation>Laboratorio de Mutagenesis, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Rosalinda Gutiérrez-Hernández</Name>
        <Affiliation>Doctorado en Farmacología Médica y Molecular, Unidad Académica de Medicina Humana, Universidad Autónoma de Zacatecas, Zacatecas, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriela Morales-Velazquez</Name>
        <Affiliation>Instituto de Investigación en Odontología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Doctorado en Farmacología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Blanca Patricia Lazalde-Ramos</Name>
        <Affiliation>Laboratorio de Etnofarmacología, Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas, Mexico. Electronic address: blancalazalde@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A system dynamics modelling approach to assess the impact of launching a new nicotine product on population health outcomes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28342844</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30070-3</DOI>
    <KeywordList>
      <Keywords>Cigarette</Keywords>
      <Keywords>Modelling</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Population modelling</Keywords>
      <Keywords>System dynamics</Keywords>
      <Keywords>Tobacco</Keywords>
      <Keywords>e-cigarette</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrew Hill</Name>
        <Affiliation>Ventana Systems UK Ltd., Alexandra House, St Johns Street, Salisbury, SP1 2SB, UK. Electronic address: andy@ventanasystems.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Oscar M. Camacho</Name>
        <Affiliation>British American Tobacco (Investments) Ltd., Group R&amp;D, Regents Park Road, Southampton, SO15 8TL, UK. Electronic address: Oscar_m_camacho@bat.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Report of Morinda citrifolia chronic toxicity not applicable to commercial noni juice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28341591</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30073-9</DOI>
    <AuthorList>
      <Author>
        <Name>Brett J. West</Name>
        <Affiliation>Research and Development, Morinda, Inc, 737 East 1180 South, American Fork, UT 84003, United States. Electronic address: brett_west@morinda.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28322894</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30072-7</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Anti-drug antibody</Keywords>
      <Keywords>Biologic</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Ocular</Keywords>
      <Keywords>Ophthalmic</Keywords>
      <Keywords>Rabbit</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christina L. Zuch de Zafra</Name>
        <Affiliation>Safety Assessment, Genentech, Inc., South San Francisco, CA, United States. Electronic address: cdezafra@amgen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vito G. Sasseville</Name>
        <Affiliation>Preclinical Safety, Novartis Institutes for BioMedical Research, Cambridge, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Steven Matsumoto</Name>
        <Affiliation>Nonclinical and Translational Sciences, Allergan, Irvine, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Freichel</Name>
        <Affiliation>Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Milton</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, Novartis Institutes for BioMedical Research, Cambridge, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy K. MacLachlan</Name>
        <Affiliation>Preclinical Safety, Novartis Institutes for BioMedical Research, Cambridge, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Cindy Farman</Name>
        <Affiliation>Safety Assessment, Genentech, Inc., South San Francisco, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Iona Raymond</Name>
        <Affiliation>Nonclinical and Translational Sciences, Allergan, Irvine, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Swati Gupta</Name>
        <Affiliation>Nonclinical and Translational Sciences, Allergan, Irvine, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald Newton</Name>
        <Affiliation>Preclinical Safety, Novartis Institutes for BioMedical Research, Cambridge, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Elke Astrid Atzpodien</Name>
        <Affiliation>Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Evan A. Thackaberry</Name>
        <Affiliation>Safety Assessment, Genentech, Inc., South San Francisco, CA, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro and in vivo safety evaluation of Nephure™.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28322893</pubmedLink>
    <GrantList>
      <Grant>R44 AT006065</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30074-0</DOI>
    <KeywordList>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Oxalate decarboxylase</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Helena Cowley</Name>
        <Affiliation>Captozyme Inc., 1622 NW 55th Place Gainesville FL 32653, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Yan</Name>
        <Affiliation>Captozyme Inc., 1622 NW 55th Place Gainesville FL 32653, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lee Koetzner</Name>
        <Affiliation>Product Safety Laboratories, 2394 Highway 130, Dayton, NJ 08810, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Laurie Dolan</Name>
        <Affiliation>Burdock Group, 859 Outer Road, Orlando FL 32801, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Erik Nordwald</Name>
        <Affiliation>Captozyme Inc., 1622 NW 55th Place Gainesville FL 32653, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Aaron B. Cowley</Name>
        <Affiliation>Captozyme Inc., 1622 NW 55th Place Gainesville FL 32653, United States. Electronic address: aaron.cowley@captozyme.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Knowing your whole noni (Morinda citrifolia L.) fruits eliminates confusion.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28322892</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30071-5</DOI>
    <KeywordList>
      <Keywords>Noni fruit purée</Keywords>
      <Keywords>Noni industry terminology</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Afa K. Palu</Name>
        <Affiliation>ZENNOA LLC. 1426 E. 750 N, 5th Floor, Orem, UT 84058, USA. Electronic address: afa@zennoa.com.</Affiliation>
      </Author>
      <Author>
        <Name>John R. Wadsworth</Name>
        <Affiliation>ZENNOA LLC. 1426 E. 750 N, 5th Floor, Orem, UT 84058, USA. Electronic address: john@zennoa.com.</Affiliation>
      </Author>
      <Author>
        <Name>David Kasteler</Name>
        <Affiliation>ZENNOA LLC. 1426 E. 750 N, 5th Floor, Orem, UT 84058, USA. Electronic address: david@zennoa.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jacob Smith</Name>
        <Affiliation>ZENNOA LLC. 1426 E. 750 N, 5th Floor, Orem, UT 84058, USA. Electronic address: jake@zennoa.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of an oral toxicity reference value for nickel.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28300623</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30069-7</DOI>
    <KeywordList>
      <Keywords>ADI</Keywords>
      <Keywords>Child</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Nickel</Keywords>
      <Keywords>Nickel sensitization</Keywords>
      <Keywords>RfD</Keywords>
      <Keywords>Toxicity reference value</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lynne T. Haber</Name>
        <Affiliation>Department of Environmental Health, University of Cincinnati, Cincinnati OH 45267, USA. Electronic address: Lynne.Haber@uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Hudson K. Bates</Name>
        <Affiliation>NiPERA Inc., 2525 Meridian Parkway, Suite 240, Durham, NC 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce C. Allen</Name>
        <Affiliation>Independent Consultant, 101 Corbin Hill Circle, Chapel Hill, NC 27514, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melissa J. Vincent</Name>
        <Affiliation>Department of Environmental Health, University of Cincinnati, Cincinnati OH 45267, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Adriana R. Oller</Name>
        <Affiliation>NiPERA Inc., 2525 Meridian Parkway, Suite 240, Durham, NC 27713, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Influence of measurement uncertainty on the world health organization recommended regulation for mainstream cigarette smoke constituents.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28300622</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30068-5</DOI>
    <KeywordList>
      <Keywords>Cigarette smoke constituents</Keywords>
      <Keywords>Compliance assessment</Keywords>
      <Keywords>Measurement uncertainty</Keywords>
      <Keywords>Tobacco regulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Huimin Deng</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, No.2 Fengyang Street, Zhengzhou High and New Technology Industries Development Zone, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhonghao Li</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, No.2 Fengyang Street, Zhengzhou High and New Technology Industries Development Zone, Zhengzhou 450001, China. Electronic address: lee_zhonghao@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhaoyang Bian</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, No.2 Fengyang Street, Zhengzhou High and New Technology Industries Development Zone, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Yang</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, No.2 Fengyang Street, Zhengzhou High and New Technology Industries Development Zone, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shanshan Liu</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, No.2 Fengyang Street, Zhengzhou High and New Technology Industries Development Zone, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ziyan Fan</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, No.2 Fengyang Street, Zhengzhou High and New Technology Industries Development Zone, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Wang</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, No.2 Fengyang Street, Zhengzhou High and New Technology Industries Development Zone, Zhengzhou 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gangling Tang</Name>
        <Affiliation>China National Tobacco Quality Supervision and Test Center, No.2 Fengyang Street, Zhengzhou High and New Technology Industries Development Zone, Zhengzhou 450001, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-neoplastic lesions found only in the two-year bioassays but not in shorter toxicity studies of rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28288808</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30066-1</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity study</Keywords>
      <Keywords>ICH</Keywords>
      <Keywords>Non-neoplastic lesion</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mizuho Nonaka</Name>
        <Affiliation>Pharmaceuticals and Medical Devices Agency, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kouhei Amakasu</Name>
        <Affiliation>Pharmaceuticals and Medical Devices Agency, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yukie Saegusa</Name>
        <Affiliation>Pharmaceuticals and Medical Devices Agency, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Misaki Naota</Name>
        <Affiliation>Pharmaceuticals and Medical Devices Agency, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takuya Nishimura</Name>
        <Affiliation>Pharmaceuticals and Medical Devices Agency, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kumiko Ogawa</Name>
        <Affiliation>Biological Safety Research Center, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akiyoshi Nishikawa</Name>
        <Affiliation>Biological Safety Research Center, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan. Electronic address: nishikaw@nihs.go.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety and tolerability of a dried aqueous spearmint extract.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28286189</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30063-6</DOI>
    <AuthorList>
      <Author>
        <Name>Joanne A. Lasrado</Name>
        <Affiliation>Kemin Foods, L.C., 2100 Maury St., Des Moines, IA 50317, USA. Electronic address: joanne.hollis@kemin.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin M. Nieman</Name>
        <Affiliation>Biofortis Clinical Research, 211 E. Lake St., Addison, IL 60101, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brenda A. Fonseca</Name>
        <Affiliation>Kemin Foods, L.C., 2100 Maury St., Des Moines, IA 50317, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kristen D. Sanoshy</Name>
        <Affiliation>Biofortis Clinical Research, 211 E. Lake St., Addison, IL 60101, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Arianne L. Schild</Name>
        <Affiliation>Biofortis Clinical Research, 211 E. Lake St., Addison, IL 60101, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kelli A. Herrlinger</Name>
        <Affiliation>Kemin Foods, L.C., 2100 Maury St., Des Moines, IA 50317, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Air quality environmental epidemiology studies are unreliable.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28284713</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30067-3</DOI>
    <KeywordList>
      <Keywords>Air quality</Keywords>
      <Keywords>Analysis search space</Keywords>
      <Keywords>Environmental epidemiology</Keywords>
      <Keywords>Mortality</Keywords>
      <Keywords>Multiple modeling</Keywords>
      <Keywords>Multiple testing</Keywords>
      <Keywords>Observational studies</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Stanley Young</Name>
        <Affiliation>CGStat, 3401 Caldwell Drive, Raleigh, NC 27607-3326, United States. Electronic address: genetree@bellsouth.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic toxicity and anti-HSV-1 activity in experimental animal of dolabelladienetriol from the seaweed, Dictyota pfaffii.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28284712</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30065-X</DOI>
    <KeywordList>
      <Keywords>Anti-HSV-1 activity</Keywords>
      <Keywords>BALB/c mice</Keywords>
      <Keywords>Dictyota pfaffii</Keywords>
      <Keywords>Dolabelladienetriol</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>Wistar rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Valéria Garrido</Name>
        <Affiliation>Department of Cellular and Molecular Biology, Laboratory of Molecular Virology Molecular - Biology Institute, Federal Fluminense University (UFF), Science and Biotechnology Postgraduate Program, Campos do Valonguinho, sn, Niterói, RJ, 24020-150, Brazil. Electronic address: valgarrido@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Caroline Barros</Name>
        <Affiliation>Department of Cellular and Molecular Biology, Laboratory of Molecular Virology Molecular - Biology Institute, Federal Fluminense University (UFF), Science and Biotechnology Postgraduate Program, Campos do Valonguinho, sn, Niterói, RJ, 24020-150, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Vanessa A. Melchiades</Name>
        <Affiliation>Department of Cellular and Molecular Biology, Laboratory of Molecular Virology Molecular - Biology Institute, Federal Fluminense University (UFF), Science and Biotechnology Postgraduate Program, Campos do Valonguinho, sn, Niterói, RJ, 24020-150, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rainomar Raimundo Fonseca</Name>
        <Affiliation>ALGAMAR-Laboratory Marine Biology Department, Institute of Biology of the UFF, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sergio Pinheiro</Name>
        <Affiliation>Department of Chemistry Organic, Institute of Chemistry of the UFF, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Patrícia Ocampo</Name>
        <Affiliation>General Pathology, Microbiology and Parasitology Department, Biomedical Institute, Federal University of Rio de Janeiro State/Laboratory of Innovations in Therapies, Essays and Bio Products. de, Oswaldo Cruz Institute/FIOCRUZ, Av. Brasil 4365, Manguinhos, Pavilhão Cardoso Fontes, 65, Rio de Janeiro, RJ, 21045-900, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Valéria L. Teixeira</Name>
        <Affiliation>ALGAMAR-Laboratory Marine Biology Department, Institute of Biology of the UFF, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Diana N. Cavalcanti</Name>
        <Affiliation>ALGAMAR-Laboratory Marine Biology Department, Institute of Biology of the UFF, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Viveca Giongo</Name>
        <Affiliation>Department of Cellular and Molecular Biology, Laboratory of Molecular Virology Molecular - Biology Institute, Federal Fluminense University (UFF), Science and Biotechnology Postgraduate Program, Campos do Valonguinho, sn, Niterói, RJ, 24020-150, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Norman A. Ratcliffe</Name>
        <Affiliation>Department of Biosciences, College of Science, Swansea University, Singleton Park, Swansea SA2 8PP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Gerlinde Teixeira</Name>
        <Affiliation>Department of Immunobiology, Biology Institute, Federal Fluminense University, Campus do Valonguinho, sn, Niterói, RJ, 24020-150, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Izabel Christina N. P. Paixão</Name>
        <Affiliation>Department of Cellular and Molecular Biology, Laboratory of Molecular Virology Molecular - Biology Institute, Federal Fluminense University (UFF), Science and Biotechnology Postgraduate Program, Campos do Valonguinho, sn, Niterói, RJ, 24020-150, Brazil. Electronic address: Izabeluff@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impact assessment of WHO TobReg proposals for mandated lowering of selected mainstream cigarette smoke toxicants.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28284711</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30053-3</DOI>
    <KeywordList>
      <Keywords>Ceilings</Keywords>
      <Keywords>Cigarette</Keywords>
      <Keywords>Emissions</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Smoke</Keywords>
      <Keywords>TobReg</Keywords>
      <Keywords>Toxicants</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alison C. Eldridge</Name>
        <Affiliation>British American Tobacco Investments Ltd, Group Research &amp; Development, Regents Park Road, SO158TL, Southampton, Hampshire, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin G. McAdam</Name>
        <Affiliation>British American Tobacco Investments Ltd, Group Research &amp; Development, Regents Park Road, SO158TL, Southampton, Hampshire, United Kingdom. Electronic address: Kevin_mcadam@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tatiana R. Betson</Name>
        <Affiliation>British American Tobacco Investments Ltd, Group Research &amp; Development, Regents Park Road, SO158TL, Southampton, Hampshire, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Marcos V. Gama</Name>
        <Affiliation>British American Tobacco Investments Ltd, Group Research &amp; Development, Regents Park Road, SO158TL, Southampton, Hampshire, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher J. Proctor</Name>
        <Affiliation>British American Tobacco Investments Ltd, Group Research &amp; Development, Regents Park Road, SO158TL, Southampton, Hampshire, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical assessment of the abuse potential of the orexin receptor antagonist, suvorexant.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28279667</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30064-8</DOI>
    <KeywordList>
      <Keywords>Abuse potential</Keywords>
      <Keywords>Drug dependence</Keywords>
      <Keywords>Drug discrimination</Keywords>
      <Keywords>MK-4305</Keywords>
      <Keywords>Methods</Keywords>
      <Keywords>Orexin receptor antagonist</Keywords>
      <Keywords>Preclinical drug development</Keywords>
      <Keywords>Self-administration</Keywords>
      <Keywords>Suvorexant</Keywords>
      <Keywords>Withdrawal</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stephanie Born</Name>
        <Affiliation>Merck &amp; Co., Inc., Kenilworth, NJ, USA. Electronic address: stephanie_born@merck.com.</Affiliation>
      </Author>
      <Author>
        <Name>David V. Gauvin</Name>
        <Affiliation>MPI Research, Inc., Mattawan, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suman Mukherjee</Name>
        <Affiliation>Merck &amp; Co., Inc., Kenilworth, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Briscoe</Name>
        <Affiliation>Merck &amp; Co., Inc., Kenilworth, NJ, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>IARC use of oxidative stress as key mode of action characteristic for facilitating cancer classification: Glyphosate case example illustrating a lack of robustness in interpretative implementation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28274811</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30062-4</DOI>
    <KeywordList>
      <Keywords>Cancer classification</Keywords>
      <Keywords>Glyphosate</Keywords>
      <Keywords>IARC</Keywords>
      <Keywords>Mechanism of action</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James S. Bus</Name>
        <Affiliation>Exponent, Inc., 1800 Diagonal Road, Suite 500, Alexandria, VA 22314, United States. Electronic address: jbus@exponent.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-clinical safety evaluation and risk assessment to human of aleglitazar, a dual PPAR α/γ agonist, and its major human metabolite.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28274810</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30061-2</DOI>
    <KeywordList>
      <Keywords>Dual PPAR alpha/gamma agonist</Keywords>
      <Keywords>Major human metabolite</Keywords>
      <Keywords>Pharmaceutical</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxicity profile</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Martin Bopst</Name>
        <Affiliation>Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland. Electronic address: martin.bopst@roche.com.</Affiliation>
      </Author>
      <Author>
        <Name>Elke Astrid Atzpodien</Name>
        <Affiliation>Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland. Electronic address: elke-astrid.atzpodien@roche.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Behaviour of chemical respiratory allergens in novel predictive methods for skin sensitisation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28274809</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30060-0</DOI>
    <KeywordList>
      <Keywords>Chemical respiratory allergens</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>Predictive tests</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, Bedfordshire, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Poole</Name>
        <Affiliation>European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), 2 Av E Van Nieuwenhuyse, 1160 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation of the mechanism of triclosan induced mouse liver tumors.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28267557</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30059-4</DOI>
    <KeywordList>
      <Keywords>Constitutive androstane receptor</Keywords>
      <Keywords>Mechanism of action</Keywords>
      <Keywords>Non-genotoxic carcinogens</Keywords>
      <Keywords>Peroxisome proliferator-activated receptor alpha</Keywords>
      <Keywords>Rodent liver</Keywords>
      <Keywords>Triclosan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zemin Wang</Name>
        <Affiliation>Laboratory of Investigative Toxicology and Pathology, Department of Environmental Health, Indiana University, Bloomington, IN 47408, United States. Electronic address: zemwang@indiana.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Xilin Li</Name>
        <Affiliation>Laboratory of Investigative Toxicology and Pathology, Department of Environmental Health, Indiana University, Bloomington, IN 47408, United States. Electronic address: lixil@indiana.edu.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Klaunig</Name>
        <Affiliation>Laboratory of Investigative Toxicology and Pathology, Department of Environmental Health, Indiana University, Bloomington, IN 47408, United States. Electronic address: jklauni@indiana.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of the expanded Creme RIFM consumer exposure model to fragrance ingredients in cosmetic, personal care and air care products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28257852</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30052-1</DOI>
    <KeywordList>
      <Keywords>Aggregate exposure</Keywords>
      <Keywords>Air care products</Keywords>
      <Keywords>Cosmetic products</Keywords>
      <Keywords>Fragrance ingredient</Keywords>
      <Keywords>Monte Carlo exposure model</Keywords>
      <Keywords>Personal care products</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>B. Safford</Name>
        <Affiliation>B-Safe Toxicology Consulting, 31 Hayway, Rushden, Northants, NN10 6AG, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, 50 Tice Boulevard, Woodcliff Lake, NJ 07677, United States of America. Electronic address: amapi@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>C. Barratt</Name>
        <Affiliation>Unilever, Safety and Environmental Assurance Centre, Colworth Park, Sharnbrook, Beds, MK44 1LQ, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>D. Comiskey</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>G. Ellis</Name>
        <Affiliation>Givaudan International S.A., 5 chemin de la parfumerie, CH1214, Vernier, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>C. McNamara</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>C. O'Mahony</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>S. Robison</Name>
        <Affiliation>SH Robison Consulting, LLC, P.O. Box 688, Milford, OH 45150, United States.</Affiliation>
      </Author>
      <Author>
        <Name>J. Rose</Name>
        <Affiliation>The Procter and Gamble Company, Sharon Woods Innovation Center, 11530 Reed Hartman Hwy, Cincinnati, OH 45241, United States.</Affiliation>
      </Author>
      <Author>
        <Name>B. Smith</Name>
        <Affiliation>Firmenich Inc., P.O. Box 5880, Princeton, NJ 08543, United States.</Affiliation>
      </Author>
      <Author>
        <Name>S. Tozer</Name>
        <Affiliation>Procter&amp;Gamble, Surrey, TW20 9NW, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>ALDH2-deficiency as genetic epidemiologic and biochemical model for the carcinogenicity of acetaldehyde.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28257851</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30055-7</DOI>
    <KeywordList>
      <Keywords>ALDH2</Keywords>
      <Keywords>Acetaldehyde</Keywords>
      <Keywords>Acetaldehyde (PubChem CID: 177)</Keywords>
      <Keywords>Alcohol</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Ethanol</Keywords>
      <Keywords>Ethanol (PubChem CID: 702)</Keywords>
      <Keywords>Genetic epidemiology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dirk W. Lachenmeier</Name>
        <Affiliation>Chemisches und Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weissenburger Strasse 3, 76187 Karlsruhe, Germany. Electronic address: Lachenmeier@web.de.</Affiliation>
      </Author>
      <Author>
        <Name>Mikko Salaspuro</Name>
        <Affiliation>Research Unit on Acetaldehyde and Cancer, University of Helsinki, Biomedicum Helsinki, PO Box 63, FIN-00014, Finland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hepatoprotective effect of Maytenus robusta Reiss extract on CCl</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28257850</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30054-5</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Hepatoprotective effect</Keywords>
      <Keywords>Maytenus robusta leaves</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liliani Carolini Thiesen</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Farmacêuticas, Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luisa Mota da Silva</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Farmacêuticas, Itajaí, SC, Brazil; Núcleo de Investigações Químico-Farmacêuticas (NQFAR), Universidade do Vale do Itajaí (UNIVALI), Itajaí, SC, Brazil. Electronic address: lu.isamota@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>José Roberto Santin</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Farmacêuticas, Itajaí, SC, Brazil; Núcleo de Investigações Químico-Farmacêuticas (NQFAR), Universidade do Vale do Itajaí (UNIVALI), Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Tania Mari Bellé Bresolin</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Farmacêuticas, Itajaí, SC, Brazil; Núcleo de Investigações Químico-Farmacêuticas (NQFAR), Universidade do Vale do Itajaí (UNIVALI), Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sérgio Faloni de Andrade</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Farmacêuticas, Itajaí, SC, Brazil; Núcleo de Investigações Químico-Farmacêuticas (NQFAR), Universidade do Vale do Itajaí (UNIVALI), Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Clarissa de Medeiros Amorim</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NQFAR), Universidade do Vale do Itajaí (UNIVALI), Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lidia Merlin</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NQFAR), Universidade do Vale do Itajaí (UNIVALI), Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rilton Alves de Freitas</Name>
        <Affiliation>Departamento de Química, Universidade Federal do Paraná, Curitiba, Paraná, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rivaldo Niero</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Farmacêuticas, Itajaí, SC, Brazil; Núcleo de Investigações Químico-Farmacêuticas (NQFAR), Universidade do Vale do Itajaí (UNIVALI), Itajaí, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daisy Janice Aguilar Netz</Name>
        <Affiliation>Núcleo de Investigações Químico-Farmacêuticas (NQFAR), Universidade do Vale do Itajaí (UNIVALI), Itajaí, SC, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Retrospective mining of toxicology data to discover multispecies and chemical class effects: Anemia as a case study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28242142</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30036-3</DOI>
    <KeywordList>
      <Keywords>Anemia</Keywords>
      <Keywords>Aniline</Keywords>
      <Keywords>Bioinformatics</Keywords>
      <Keywords>Database</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Pathology</Keywords>
      <Keywords>Uncertainty</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard S. Judson</Name>
        <Affiliation>U.S. Environmental Protection Agency, Research Triangle Park, NC, USA. Electronic address: judson.richard@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew T. Martin</Name>
        <Affiliation>U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Charles E. Wood</Name>
        <Affiliation>U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of a probabilistic PBPK/PD model to calculate Data Derived Extrapolation Factors for chlorpyrifos.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28238854</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30035-1</DOI>
    <KeywordList>
      <Keywords>Chlorpyrifos</Keywords>
      <Keywords>DDEF</Keywords>
      <Keywords>Monte Carlo</Keywords>
      <Keywords>PBPK/PD</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Torka S. Poet</Name>
        <Affiliation>Summit Toxicology, Richland, WA, 99352, USA. Electronic address: tspoet99@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Charles Timchalk</Name>
        <Affiliation>Battelle, Pacific Northwest Division, Richland, WA, 99354, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Bartels</Name>
        <Affiliation>ToxMetrics.com LLC, Midland, MI, 48642, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jordan N. Smith</Name>
        <Affiliation>Battelle, Pacific Northwest Division, Richland, WA, 99354, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robin McDougal</Name>
        <Affiliation>Dug Safety and Metabolism, AstraZeneca, Gatehouse Park, Waltham, Boston, 02451, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daland R. Juberg</Name>
        <Affiliation>Dow AgroSciences, Indianapolis, IA, 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul S. Price</Name>
        <Affiliation>ToxMetrics.com LLC, Midland, MI, 48642, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of vitacoxib: Acute and 90-day sub-chronic oral toxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28238853</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30041-7</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Coxibs</Keywords>
      <Keywords>NSAIDs</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>Vitacoxib</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jianzhong Wang</Name>
        <Affiliation>Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, People's Republic of China; Laboratory of Quality &amp; Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture, Beijing 100193, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Feifei Sun</Name>
        <Affiliation>Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, People's Republic of China; Laboratory of Quality &amp; Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture, Beijing 100193, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Shusheng Tang</Name>
        <Affiliation>Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, People's Republic of China; Laboratory of Quality &amp; Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture, Beijing 100193, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Suxia Zhang</Name>
        <Affiliation>Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, People's Republic of China; Laboratory of Quality &amp; Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture, Beijing 100193, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengyue Lv</Name>
        <Affiliation>Beijing Orbiepharm Co., Ltd, Beijing 100185, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Li</Name>
        <Affiliation>Beijing Orbiepharm Co., Ltd, Beijing 100185, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xingyuan Cao</Name>
        <Affiliation>Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, People's Republic of China; Laboratory of Quality &amp; Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture, Beijing 100193, People's Republic of China; Key Laboratory of Detection for Veterinary Drug Residue and Illegal Additive, Ministry of Agriculture, Beijing 100193, People's Republic of China. Electronic address: cxy@cau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The use of charcoal in modified cigarette filters for mainstream smoke carbonyl reduction.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28238852</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
      <Grant>FD999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30040-5</DOI>
    <KeywordList>
      <Keywords>Carbonyl</Keywords>
      <Keywords>Charcoal</Keywords>
      <Keywords>Cigarette</Keywords>
      <Keywords>Filtration</Keywords>
      <Keywords>HPHC</Keywords>
      <Keywords>Risk-reduction</Keywords>
      <Keywords>Smoke constituents</Keywords>
      <Keywords>Technology</Keywords>
      <Keywords>Tobacco</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julie A. Morabito</Name>
        <Affiliation>U.S. Food and Drug Administration, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew R. Holman</Name>
        <Affiliation>U.S. Food and Drug Administration, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yan S. Ding</Name>
        <Affiliation>Centers for Disease Control and Prevention, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Xizheng Yan</Name>
        <Affiliation>Centers for Disease Control and Prevention, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michele Chan</Name>
        <Affiliation>Centers for Disease Control and Prevention, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dana Chafin</Name>
        <Affiliation>Centers for Disease Control and Prevention, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jose Perez</Name>
        <Affiliation>Centers for Disease Control and Prevention, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Magaly I. Mendez</Name>
        <Affiliation>Centers for Disease Control and Prevention, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Roberto Bravo Cardenas</Name>
        <Affiliation>Centers for Disease Control and Prevention, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Clifford Watson</Name>
        <Affiliation>Centers for Disease Control and Prevention, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Towards toxicokinetic modelling of aluminium exposure from adjuvants in medicinal products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28237896</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30039-9</DOI>
    <KeywordList>
      <Keywords>Absorption kinetics</Keywords>
      <Keywords>Aluminium</Keywords>
      <Keywords>Aluminium adjuvants</Keywords>
      <Keywords>In vitro dissolution</Keywords>
      <Keywords>Toxicokinetic modelling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Karin Weisser</Name>
        <Affiliation>Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Paul-Ehrlich-Straße 7, 63225 Langen, Germany. Electronic address: karin.weisser@pei.de.</Affiliation>
      </Author>
      <Author>
        <Name>Sabine Stübler</Name>
        <Affiliation>Institute of Biochemistry and Biology, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476 Potsdam/Golm, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Walter Matheis</Name>
        <Affiliation>Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Paul-Ehrlich-Straße 7, 63225 Langen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Wilhelm Huisinga</Name>
        <Affiliation>Institute of Biochemistry and Biology, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476 Potsdam/Golm, Germany; Institute of Mathematics, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476 Potsdam/Golm, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quantitative weight of evidence to assess confidence in potential modes of action.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28232103</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30038-7</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Evidence integration</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard A. Becker</Name>
        <Affiliation>American Chemistry Council, 700 2nd St. NE, Washington, DC 20002, United States. Electronic address: rick_becker@americanchemistry.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vicki Dellarco</Name>
        <Affiliation>Independent Consultant, Silver Spring, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Seed</Name>
        <Affiliation>Independent Consultant, Alexandria, VA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joel M. Kronenberg</Name>
        <Affiliation>Monsanto Company, St. Louis, MO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bette Meek</Name>
        <Affiliation>University of Ottawa, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Foreman</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Annandale, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Christine Palermo</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Chris Kirman</Name>
        <Affiliation>Summit Toxicology, Orange Village, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Igor Linkov</Name>
        <Affiliation>US Army Engineer Research and Development Center, Concord, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rita Schoeny</Name>
        <Affiliation>Independent Consultant, Washington, DC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Dourson</Name>
        <Affiliation>University of Cincinnati, Cincinnati, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lynn H. Pottenger</Name>
        <Affiliation>Olin Corporation, Midland, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mary K. Manibusan</Name>
        <Affiliation>Exponent, Washington, DC, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Endocrine Disruptors: Data-based survey of in vivo tests, predictive models and the Adverse Outcome Pathway.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28232102</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30034-X</DOI>
    <KeywordList>
      <Keywords>Adverse Outcome Pathways</Keywords>
      <Keywords>Alternative methods</Keywords>
      <Keywords>Endocrine Disruptors</Keywords>
      <Keywords>High-throughput</Keywords>
      <Keywords>Human health</Keywords>
      <Keywords>Modelling</Keywords>
      <Keywords>Prediction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Romualdo Benigni</Name>
        <Affiliation>Environment and Health Department, Istituto Superiore di Sanita', Viale Regina Elena 299, 00161, Rome, Italy. Electronic address: romualdo.benigni@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chiara Laura Battistelli</Name>
        <Affiliation>Environment and Health Department, Istituto Superiore di Sanita', Viale Regina Elena 299, 00161, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Cecilia Bossa</Name>
        <Affiliation>Environment and Health Department, Istituto Superiore di Sanita', Viale Regina Elena 299, 00161, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Giuliani</Name>
        <Affiliation>Environment and Health Department, Istituto Superiore di Sanita', Viale Regina Elena 299, 00161, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Olga Tcheremenskaia</Name>
        <Affiliation>Environment and Health Department, Istituto Superiore di Sanita', Viale Regina Elena 299, 00161, Rome, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical safety evaluation of IQG-607 in rats: Acute and repeated dose toxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28232042</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30037-5</DOI>
    <KeywordList>
      <Keywords>Drug development</Keywords>
      <Keywords>IQG-607</Keywords>
      <Keywords>Preclinical toxicology</Keywords>
      <Keywords>Rodents</Keywords>
      <Keywords>Tuberculosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Valnês S. Rodrigues-Junior</Name>
        <Affiliation>Centro de Pesquisas em Biologia Molecular e Funcional (CPBMF), Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Av. Ipiranga 6681, Prédio 92A Tecnopuc, 90619-900, Porto Alegre, Brazil; Programa de Pós-Graduação em Medicina e Ciências da Saúde, PUCRS, Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Pablo Machado</Name>
        <Affiliation>Centro de Pesquisas em Biologia Molecular e Funcional (CPBMF), Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Av. Ipiranga 6681, Prédio 92A Tecnopuc, 90619-900, Porto Alegre, Brazil; Programa de Pós-Graduação em Biologia Celular e Molecular, PUCRS, Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>João B. Calixto</Name>
        <Affiliation>Departamento de Farmacologia, Universidade Federal de Santa Catarina, Florianópolis, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jarbas M. Siqueira</Name>
        <Affiliation>Departamento de Farmacologia, Universidade Federal de Santa Catarina, Florianópolis, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Edinéia L. Andrade</Name>
        <Affiliation>Departamento de Farmacologia, Universidade Federal de Santa Catarina, Florianópolis, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Allisson F. Bento</Name>
        <Affiliation>Departamento de Farmacologia, Universidade Federal de Santa Catarina, Florianópolis, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maria M. Campos</Name>
        <Affiliation>Programa de Pós-Graduação em Medicina e Ciências da Saúde, PUCRS, Porto Alegre, Brazil; Instituto de Toxicologia e Farmacologia, PUCRS, Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luiz A. Basso</Name>
        <Affiliation>Centro de Pesquisas em Biologia Molecular e Funcional (CPBMF), Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Av. Ipiranga 6681, Prédio 92A Tecnopuc, 90619-900, Porto Alegre, Brazil; Programa de Pós-Graduação em Medicina e Ciências da Saúde, PUCRS, Porto Alegre, Brazil; Programa de Pós-Graduação em Biologia Celular e Molecular, PUCRS, Porto Alegre, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Diógenes S. Santos</Name>
        <Affiliation>Centro de Pesquisas em Biologia Molecular e Funcional (CPBMF), Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Av. Ipiranga 6681, Prédio 92A Tecnopuc, 90619-900, Porto Alegre, Brazil; Programa de Pós-Graduação em Biologia Celular e Molecular, PUCRS, Porto Alegre, Brazil. Electronic address: diogenes@pucrs.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and subchronic toxicity studies of methanol extract of Polygonum minus leaves in Sprague Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28229903</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30026-0</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Methanol extract</Keywords>
      <Keywords>Polygonum minus</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Parayil Varghese Christapher</Name>
        <Affiliation>Unit of Pharmacology, Faculty of Pharmacy, AIMST University, Semeling, Bedong, 08100 Kedah, Malaysia; Discipline of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Subramani Parasuraman</Name>
        <Affiliation>Unit of Pharmacology, Faculty of Pharmacy, AIMST University, Semeling, Bedong, 08100 Kedah, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Mohd Zaini Asmawi</Name>
        <Affiliation>Discipline of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Vikneswaran Murugaiyah</Name>
        <Affiliation>Discipline of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia. Electronic address: vicky@usm.my.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of doxorubicin-induced ovarian toxicity on mouse ovarian granulosa cells.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28219713</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30033-8</DOI>
    <KeywordList>
      <Keywords>Bax, Bcl-2</Keywords>
      <Keywords>Chemotherapy</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Granulosa cells</Keywords>
      <Keywords>Oocyte</Keywords>
      <Keywords>Premature ovarian failure (POF)</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ting Zhang</Name>
        <Affiliation>National Population and Family Planning Key Laboratory of Contraceptives Drugs and Devices, Shanghai Engineering Research Center of Reproductive Health Drugs and Devices, Shanghai Institute of Planned Parenthood Research, Shanghai, PR China; Reproductive and Developmental Research Institute of Fudan University, Shanghai, PR China. Electronic address: fuzzyting@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wan Hong He</Name>
        <Affiliation>National Population and Family Planning Key Laboratory of Contraceptives Drugs and Devices, Shanghai Engineering Research Center of Reproductive Health Drugs and Devices, Shanghai Institute of Planned Parenthood Research, Shanghai, PR China; Reproductive and Developmental Research Institute of Fudan University, Shanghai, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Lin Feng</Name>
        <Affiliation>National Population and Family Planning Key Laboratory of Contraceptives Drugs and Devices, Shanghai Engineering Research Center of Reproductive Health Drugs and Devices, Shanghai Institute of Planned Parenthood Research, Shanghai, PR China; Reproductive and Developmental Research Institute of Fudan University, Shanghai, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Guang Huang</Name>
        <Affiliation>Hospital, Shanghai Institute of Planned Parenthood Research, Shanghai, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Classification schemes for carcinogenicity based on hazard identification serve science and society.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28216242</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30031-4</DOI>
    <AuthorList>
      <Author>
        <Name>Dana Loomis</Name>
        <Affiliation>IARC, Section of IARC Monographs, 150 Cours Albert Thomas, 69008 Lyon, France. Electronic address: loomisd@iarc.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Kathryn Z. Guyton</Name>
        <Affiliation>IARC, Section of IARC Monographs, 150 Cours Albert Thomas, 69008 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>Kurt Straif</Name>
        <Affiliation>IARC, Section of IARC Monographs, 150 Cours Albert Thomas, 69008 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher P. Wild</Name>
        <Affiliation>IARC, Section of IARC Monographs, 150 Cours Albert Thomas, 69008 Lyon, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Response to Loomis et al Comment on Boobis et al.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28212846</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30032-6</DOI>
    <AuthorList>
      <Author>
        <Name>Alan R. Boobis</Name>
        <Affiliation>Centre for Pharmacology &amp; Therapeutics, Toxicology Unit, Department of Medicine, Hammersmith Campus, Imperial College London, London, W12 0NN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel M. Cohen</Name>
        <Affiliation>Department of Pathology and Microbiology, Havlik-Wall Professor of Oncology, University of Nebraska Medical Center, Omaha, NE 68198-3135, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vicki L. Dellarco</Name>
        <Affiliation>Independent Consultant, Silver Spring, MD 20901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John E. Doe</Name>
        <Affiliation>Parker Doe LLP, Carpenter Court, Maple Road, Bramhall, Stockport, Cheshire, SK7 2DH, UK. Electronic address: john.doe@parkerdoe.com.</Affiliation>
      </Author>
      <Author>
        <Name>Penelope A. Fenner-Crisp</Name>
        <Affiliation>Independent Consultant, North Garden, VA 22959, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angelo Moretto</Name>
        <Affiliation>Dipartimento di Scienze Biochimiche e Cliniche (Department of Biomedical and Clinical Sciences), Università degli Studi di Milano, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy P. Pastoor</Name>
        <Affiliation>Pastoor Science Communication, LLC, Greensboro, NC, 27455, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rita S. Schoeny</Name>
        <Affiliation>Rita Schoeny LLC, Washington DC 20002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer G. Seed</Name>
        <Affiliation>Independent Consultant, Alexandria, VA 22301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas C. Wolf</Name>
        <Affiliation>Syngenta Crop Protection, LLC, Greensboro, NC 27419, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of medium- and long-chain triacylglycerols containing 30% (w/w) medium-chain fatty acids in mice and rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28212845</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30028-4</DOI>
    <KeywordList>
      <Keywords>90-Day feeding study</Keywords>
      <Keywords>Embryotoxicity study in pregnant rats</Keywords>
      <Keywords>Medium- and long-chain triacylglycerols</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Subacute oral toxicity study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shengmin Zhou</Name>
        <Affiliation>Institute of Food and Nutraceutical Science, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, 200240, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yueqiang Wang</Name>
        <Affiliation>Wilmar (Shanghai) Biotechnology Research &amp; Development Center Co., Ltd, Shanghai, 200137, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanrong Jiang</Name>
        <Affiliation>Wilmar (Shanghai) Biotechnology Research &amp; Development Center Co., Ltd, Shanghai, 200137, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liangli Lucy Yu</Name>
        <Affiliation>Department of Nutrition and Food Science, University of Maryland, College Park, MD 20742, United States. Electronic address: lyu5@umd.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of environmental risks to groundwater ecosystems related to use of veterinary medicinal products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28202348</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30030-2</DOI>
    <KeywordList>
      <Keywords>Groundwater ecosystem</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Stygofauna</Keywords>
      <Keywords>Veterinary medicines</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Boris Kolar</Name>
        <Affiliation>National Laboratory of Health, Environment and Food, Prvomajska 1, 2000 Maribor, Slovenia. Electronic address: boris.kolar@nlzoh.si.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio Finizio</Name>
        <Affiliation>Department of Earth and Environmental Sciences (DISAT), Università degli studi di Milano-Bicocca, piazza della Scienza, n. 1, 20126 Milano, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In silico design, chemical synthesis and toxicological evaluation of 1,3-thiazolidine-2,4-dione derivatives as PPARγ agonists.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28202347</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30029-6</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Chemical synthesis</Keywords>
      <Keywords>In silico studies</Keywords>
      <Keywords>PPARγ agonists</Keywords>
      <Keywords>Thiazolidinedione</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Diana Alemán-González-Duhart</Name>
        <Affiliation>Laboratorio de Biofísica y Biocatálisis, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Casco de Santo Tomas, Ciudad de México, 11340, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Feliciano Tamay-Cach</Name>
        <Affiliation>Laboratorio de Investigación en Bioquímica, Departamento de Formación Básica Disciplinaria y Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Casco de Santo Tomas, Ciudad de México, 11340, Mexico. Electronic address: dr.felicianotamay@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>José Correa-Basurto</Name>
        <Affiliation>Laboratorio de Modelado Molecular, Bioinformática y Diseño de Fármacos, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Ciudad de México, 11340, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Itzia Irene Padilla-Martínez</Name>
        <Affiliation>Laboratorio de Investigación Química, Departamento de Ciencias Básicas, Unidad Profesional Interdisciplinaria de Biotecnología, Instituto Politécnico Nacional, Av. Acueducto s/n, Barrio La Laguna Ticomán, Ciudad de México, 07340, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel Álvarez-Almazán</Name>
        <Affiliation>Laboratorio de Biofísica y Biocatálisis, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Casco de Santo Tomas, Ciudad de México, 11340, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica Elena Mendieta-Wejebe</Name>
        <Affiliation>Laboratorio de Biofísica y Biocatálisis, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Casco de Santo Tomas, Ciudad de México, 11340, Mexico. Electronic address: jesmenwej@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute toxicity, twenty-eight days repeated dose toxicity and genotoxicity of vanadyl trehalose in kunming mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28202346</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30022-3</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Kunming mice</Keywords>
      <Keywords>Twenty-eight days repeated dose toxicity</Keywords>
      <Keywords>Vanadium</Keywords>
      <Keywords>Vanadyl trehalose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pingzhe Jiang</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zaizhong Ni</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Wang</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Baicheng Ma</Name>
        <Affiliation>Tianjin Children's Hospital, 300074, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huikun Duan</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodan Li</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofeng Ma</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Wei</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangzhen Ji</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiqi Liu</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuguang Xing</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Minggang Li</Name>
        <Affiliation>Key Laboratory for Bioactive Materials of the Ministry of Education, Institute of Molecular Biology, College of Life Science, Nankai University, 300071, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology, Nankai University, 300071, Tianjin, China. Electronic address: mgl@nankai.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitizers compliant to UN GHS rev 4.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28193562</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30024-7</DOI>
    <KeywordList>
      <Keywords>Alternative to animal test</Keywords>
      <Keywords>GHS</Keywords>
      <Keywords>Local lymph node assay</Keywords>
      <Keywords>Non-radioisotopic LLNAs</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>UN Global Harmonization System</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Soojin Ha</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Il Young Ahn</Name>
        <Affiliation>National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Da Eun Kim</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Kwon Lee</Name>
        <Affiliation>National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soojung Sohn</Name>
        <Affiliation>National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Sook Jung</Name>
        <Affiliation>Pharmacology Efficacy Team, Biotoxtech Co., Ltd, O-Chang, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Heo</Name>
        <Affiliation>Department of Occupational Health, College of Natural Sciences, Catholic University of Daegu, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Takashi Omori</Name>
        <Affiliation>Division of Biostatistics, Department of Social/Community Medicine and Health Science, Kobe University School of Medicine, Kobe, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>SeungJin Bae</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea. Electronic address: sjbae@ewha.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Min Lim</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea. Electronic address: kmlim@ewha.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the sub-chronic toxicity of a standardized flavonoid extract of safflower in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28192173</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30027-2</DOI>
    <KeywordList>
      <Keywords>Flavonoid extract</Keywords>
      <Keywords>Safflower</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhilin Zhang</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China; Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Electronic address: zfc112233@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Runzhe Liu</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China; Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Electronic address: skpelm@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoping Pu</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China; Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Electronic address: puxiaopingbj@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Sun</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China; Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Electronic address: sunyi@bjmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Zhao</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China; Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Electronic address: zhaoxin2010@bjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The Isolated Chicken Eye test to replace the Draize test in rabbits.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28192172</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30009-0</DOI>
    <KeywordList>
      <Keywords>Alternative testing method</Keywords>
      <Keywords>CEET</Keywords>
      <Keywords>Chicken Enucleated Eye test</Keywords>
      <Keywords>Draize test</Keywords>
      <Keywords>Eye irritation in vitro</Keywords>
      <Keywords>ICE</Keywords>
      <Keywords>Isolated Chicken Eye test</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Menk K. Prinsen</Name>
        <Affiliation>Triskelion B.V., P.O. Box 844, 3700 AJ Zeist, The Netherlands. Electronic address: menk.prinsen@triskelion.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Coenraad F. M. Hendriksen</Name>
        <Affiliation>Utrecht University/Institute for Translational Vaccinology, P.O. Box 450, 3720 AL Bilthoven, The Netherlands. Electronic address: coenraad.hendriksen@intravacc.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Cyrille A. M. Krul</Name>
        <Affiliation>University of Applied Sciences Utrecht, Institute for Life Sciences &amp; Chemistry, P.O. Box 12011, 2501 AA Utrecht, The Netherlands; TNO Innovation for Life, P.O. Box 360, 3700 AJ Zeist, The Netherlands. Electronic address: cyrille.krul@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Ruud A. Woutersen</Name>
        <Affiliation>TNO Innovation for Life, P.O. Box 360, 3700 AJ Zeist, The Netherlands; Wageningen University Research Centre, Department Toxicology, Wageningen, The Netherlands. Electronic address: ruud.woutersen@tno.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Including non-dietary sources into an exposure assessment of the European Food Safety Authority: The challenge of multi-sector chemicals such as Bisphenol A.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28185845</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30025-9</DOI>
    <KeywordList>
      <Keywords>Aggregate</Keywords>
      <Keywords>Backward modeling</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Dietary</Keywords>
      <Keywords>EFSA</Keywords>
      <Keywords>European food safety authority</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Multi-route</Keywords>
      <Keywords>Source-to-dose modeling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>N. von Goetz</Name>
        <Affiliation>Swiss Federal Institute of Technology (ETH) Zurich, CH-8093 Zurich, Switzerland. Electronic address: Natalie.von.goetz@chem.ethz.ch.</Affiliation>
      </Author>
      <Author>
        <Name>R. Pirow</Name>
        <Affiliation>Federal Institute for Risk Assessment (BfR), D-10589 Berlin, Germany. Electronic address: Ralph.Pirow@bfr.bund.de.</Affiliation>
      </Author>
      <Author>
        <Name>A. Hart</Name>
        <Affiliation>Fera Science Ltd (FERA), York, YO41 1LZ, United Kingdom. Electronic address: Andy.Hart@fera.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>E. Bradley</Name>
        <Affiliation>Fera Science Ltd (FERA), York, YO41 1LZ, United Kingdom. Electronic address: Emma.Bradley@fera.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>F. Poças</Name>
        <Affiliation>Faculty of Biotechnology - Universidade Católica Portuguesa, P-Porto, Portugal. Electronic address: mpocas@porto.ucp.pt.</Affiliation>
      </Author>
      <Author>
        <Name>D. Arcella</Name>
        <Affiliation>European Food Safety Authority (EFSA), I-43126 Parma, Italy. Electronic address: Davide.Arcella@efsa.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>I. T. L. Lillegard</Name>
        <Affiliation>Norwegian Scientific Committee for Food Safety, N-0403 Oslo, Norway. Electronic address: inger.therese.laugsand.lillegaard@vkm.no.</Affiliation>
      </Author>
      <Author>
        <Name>C. Simoneau</Name>
        <Affiliation>European Commission Joint Research Centre, I-21020 Ispra, Italy. Electronic address: Catherine.simoneau@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>J. van Engelen</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), NL-3720 Bilthoven, The Netherlands. Electronic address: jacqueline.van.engelen@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>T. Husoy</Name>
        <Affiliation>Norwegian Institute of Public Health, N-0403 Oslo, Norway. Electronic address: Trine.Husoy@fhi.no.</Affiliation>
      </Author>
      <Author>
        <Name>A. Theobald</Name>
        <Affiliation>European Food Safety Authority (EFSA), I-43126 Parma, Italy. Electronic address: Anne.Theobald@efsa.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>C. Leclercq</Name>
        <Affiliation>Council for Agricultural Research and Analysis of Agricultural Economics Analysis, Center for Research on Food and Nutrition, I-00178 Rome, Italy. Electronic address: catherineleclercq63@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of various glyphosate concentrations on DNA damage in human Raji cells and its impact on cytotoxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28185844</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30023-5</DOI>
    <KeywordList>
      <Keywords>Cell viability assay</Keywords>
      <Keywords>Comet assay</Keywords>
      <Keywords>DNA damage</Keywords>
      <Keywords>Damage recovery</Keywords>
      <Keywords>Glyphosate</Keywords>
      <Keywords>Raji cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michelle Townsend</Name>
        <Affiliation>Department of Microbiology and Molecular Biology, Brigham Young University, Provo 84602, UT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Connor Peck</Name>
        <Affiliation>Department of Microbiology and Molecular Biology, Brigham Young University, Provo 84602, UT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Meng</Name>
        <Affiliation>Department of Microbiology and Molecular Biology, Brigham Young University, Provo 84602, UT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Heaton</Name>
        <Affiliation>Department of Statistics, Brigham Young University, Provo 84602, UT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Robison</Name>
        <Affiliation>Department of Microbiology and Molecular Biology, Brigham Young University, Provo 84602, UT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kim O'Neill</Name>
        <Affiliation>Department of Microbiology and Molecular Biology, Brigham Young University, Provo 84602, UT, USA. Electronic address: kim_oneill@byu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lacking applicability of in vitro eye irritation methods to identify seriously eye irritating agrochemical formulations: Results of bovine cornea opacity and permeability assay, isolated chicken eye test and the EpiOcular™ ET-50 method to classify according to UN GHS.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28163171</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30020-X</DOI>
    <KeywordList>
      <Keywords>(Modified) bovine corneal opacity and permeability test</Keywords>
      <Keywords>Agrochemical formulation</Keywords>
      <Keywords>Classification</Keywords>
      <Keywords>EpiOcular ET-50</Keywords>
      <Keywords>Isolated chicken eye test</Keywords>
      <Keywords>Serious eye damage</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susanne N. Kolle</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany. Electronic address: susanne.kolle@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Van Cott</Name>
        <Affiliation>BASF Corporation, Research Triangle Park, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bennard van Ravenzwaay</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Stroke risk among menthol versus non-menthol cigarette smokers in the United States: Analysis of the National Health and Nutrition Examination Survey (NHANES).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28163170</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30019-3</DOI>
    <KeywordList>
      <Keywords>Cross-model validation</Keywords>
      <Keywords>Menthol versus non-menthol</Keywords>
      <Keywords>NHANES</Keywords>
      <Keywords>Reanalysis</Keywords>
      <Keywords>Stroke</Keywords>
      <Keywords>Survey methods</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cynthia Van Landingham</Name>
        <Affiliation>Ramboll Environ, 3001 Armand St. Suite I, Monroe, LA 71201, USA. Electronic address: cvanlandingham@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>William Fuller</Name>
        <Affiliation>Ramboll Environ, 3001 Armand St. Suite I, Monroe, LA 71201, USA. Electronic address: wfuller@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Greg Mariano</Name>
        <Affiliation>Ramboll Environ US Corporation, 4350 North Fairfax Drive, Suite 300, Arlington, VA 22203, USA. Electronic address: gmariano@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Marano</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, USA. Electronic address: maranok@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Geoffrey Curtin</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, USA. Electronic address: curting@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra I. Sulsky</Name>
        <Affiliation>Ramboll Environ US Corporation, 28 Amity Street, Suite 2A, Amherst, MA 01002, USA. Electronic address: ssulsky@ramboll.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A review of toxicity studies on graphene-based nanomaterials in laboratory animals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28161457</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30011-9</DOI>
    <KeywordList>
      <Keywords>Biodistribution</Keywords>
      <Keywords>Graphene</Keywords>
      <Keywords>Graphene oxide</Keywords>
      <Keywords>Graphene quantum dots</Keywords>
      <Keywords>Graphene-based nanomaterials</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Reduced graphene oxide</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Makoto Ema</Name>
        <Affiliation>Research Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology (AIST) and Technology Research Association for Single Wall Carbon Nanotubes (TASC), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan. Electronic address: ema-makoto@aist.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Masashi Gamo</Name>
        <Affiliation>Research Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology (AIST) and Technology Research Association for Single Wall Carbon Nanotubes (TASC), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazumasa Honda</Name>
        <Affiliation>Research Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology (AIST) and Technology Research Association for Single Wall Carbon Nanotubes (TASC), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of skin sensitization under REACH: A case report on vehicle choice in the LLNA and its crucial role preventing false positive results.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28159477</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30010-7</DOI>
    <KeywordList>
      <Keywords>AOO</Keywords>
      <Keywords>Adverse Outcome Pathway</Keywords>
      <Keywords>BrdU-ELISA</Keywords>
      <Keywords>False positive results</Keywords>
      <Keywords>Local Lymph Node Assay</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>Test substance stability in the vehicle</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nico Watzek</Name>
        <Affiliation>Product Safety Department, BASF SE, 67056 Ludwigshafen am Rhein, Germany. Electronic address: nico.watzek@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Franz Berger</Name>
        <Affiliation>Product Safety Department, BASF SE, 67056 Ludwigshafen am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Noreen Kolle</Name>
        <Affiliation>Experimental Toxicology and Ecology, BASF SE, 67056 Ludwigshafen am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tanja Kaufmann</Name>
        <Affiliation>Experimental Toxicology and Ecology, BASF SE, 67056 Ludwigshafen am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Matthias Becker</Name>
        <Affiliation>Experimental Toxicology and Ecology, BASF SE, 67056 Ludwigshafen am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Bennard van Ravenzwaay</Name>
        <Affiliation>Experimental Toxicology and Ecology, BASF SE, 67056 Ludwigshafen am Rhein, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development/verification of methods for measurement of exhaled breath and environmental e-vapor product aerosol.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28153745</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30006-5</DOI>
    <KeywordList>
      <Keywords>Ambient air measurements</Keywords>
      <Keywords>E-vapor products</Keywords>
      <Keywords>Exhaled breath</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael J. Oldham</Name>
        <Affiliation>Regulatory Sciences, Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, USA. Electronic address: Michael.J.Oldham@altria.com.</Affiliation>
      </Author>
      <Author>
        <Name>Karl A. Wagner</Name>
        <Affiliation>Regulatory Sciences, Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>I. Gene Gilman</Name>
        <Affiliation>Enthalpy Analytical, Inc., 800 Capitola Drive, Durham, NC 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James B. Beach</Name>
        <Affiliation>Enthalpy Analytical, Inc., 800 Capitola Drive, Durham, NC 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jianmin Liu</Name>
        <Affiliation>Regulatory Affairs, Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ali A. Rostami</Name>
        <Affiliation>Research Development, Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamadi A. Sarkar</Name>
        <Affiliation>Regulatory Affairs, Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Deriving a provisional tolerable intake for intravenous exposure to silver nanoparticles released from medical devices.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28137642</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30007-7</DOI>
    <KeywordList>
      <Keywords>Annapolis accords</Keywords>
      <Keywords>Intravenous</Keywords>
      <Keywords>Medical devices</Keywords>
      <Keywords>Point of departure</Keywords>
      <Keywords>Provisional tolerable intake</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Silver nanoparticles</Keywords>
      <Keywords>ToxRTool</Keywords>
      <Keywords>Uncertainty factors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laura C. Savery</Name>
        <Affiliation>Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>René Viñas</Name>
        <Affiliation>Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amber M. Nagy</Name>
        <Affiliation>Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Prachi Pradeep</Name>
        <Affiliation>Department of Mathematics, Statistics, and Computer Science, Marquette University, P.O. Box 1881, Milwaukee, WI 53201, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen J. Merrill</Name>
        <Affiliation>Department of Mathematics, Statistics, and Computer Science, Marquette University, P.O. Box 1881, Milwaukee, WI 53201, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan M. Hood</Name>
        <Affiliation>Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Subhas G. Malghan</Name>
        <Affiliation>Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Peter L. Goering</Name>
        <Affiliation>Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: Peter.Goering@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald P. Brown</Name>
        <Affiliation>Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of xylan by a 90-day feeding study in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28137641</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30005-3</DOI>
    <KeywordList>
      <Keywords>Animal study</Keywords>
      <Keywords>Histopathological examination</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guangqiu Qin</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning 530028, China. Electronic address: qinguangqiu@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pingjing Wen</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning 530028, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanwu Wang</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning 530028, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lujuan Zhang</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning 530028, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huili Liang</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning 530028, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huiyan Qin</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning 530028, China.</Affiliation>
      </Author>
      <Author>
        <Name>Song Tang</Name>
        <Affiliation>School of Environment and Sustainability, University of Saskatchewan, Saskatoon, SK S7N5B3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Zhao</Name>
        <Affiliation>Institute of Toxicology, Guangxi Center for Disease Prevention and Control, Nanning 530028, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Barriers to the use of toxicogenomics data in human health risk assessment: A survey of Canadian risk assessors.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28137640</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30008-9</DOI>
    <KeywordList>
      <Keywords>21st century</Keywords>
      <Keywords>Genomics</Keywords>
      <Keywords>Knowledge application</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julien Vachon</Name>
        <Affiliation>Département de médecine sociale et préventive, Faculté de médecine, Université Laval, Québec, QC, Canada; Direction de la santé environnementale et de la toxicologie, Institut national de santé publique du Québec (INSPQ), Québec, QC, Canada; Axe Santé des populations et pratiques optimales en santé, Centre de recherche du Centre hospitalier universitaire de Québec, Québec, QC, Canada. Electronic address: julien.vachon.1@ulaval.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Céline Campagna</Name>
        <Affiliation>Département de médecine sociale et préventive, Faculté de médecine, Université Laval, Québec, QC, Canada; Direction de la santé environnementale et de la toxicologie, Institut national de santé publique du Québec (INSPQ), Québec, QC, Canada. Electronic address: celine.campagna@inspq.qc.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Manuel J. Rodriguez</Name>
        <Affiliation>École supérieure d'aménagement du territoire et de développement régional, Faculté d'aménagement, d'architecture, d'art et de design, Université Laval, Québec, QC, Canada; Chaire de recherche industrielle CRSNG, Gestion et surveillance de la qualité de l'eau potable, Université Laval, Québec, QC, Canada. Electronic address: manuel.rodriguez@esad.ulaval.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Marc André Sirard</Name>
        <Affiliation>Département des sciences animales, Faculté des sciences de l'agriculture et de l'alimentation, Université Laval, Québec, QC, Canada; Centre de recherche en reproduction, développement et santé intergénérationnelle, Centre de recherche du Centre hospitalier de Québec, Québec, QC, Canada. Electronic address: marc-andre.sirard@fsaa.ulaval.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Levallois</Name>
        <Affiliation>Département de médecine sociale et préventive, Faculté de médecine, Université Laval, Québec, QC, Canada; Direction de la santé environnementale et de la toxicologie, Institut national de santé publique du Québec (INSPQ), Québec, QC, Canada; Axe Santé des populations et pratiques optimales en santé, Centre de recherche du Centre hospitalier universitaire de Québec, Québec, QC, Canada. Electronic address: patrick.levallois@msp.ulaval.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 90-day toxicity study of GmTMT transgenic maize in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28132846</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30004-1</DOI>
    <KeywordList>
      <Keywords>Feeding study</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Transgenic maize</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jin Fang</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongquan Feng</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Zhi</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Zhang</Name>
        <Affiliation>Biotechnology Research Institute, National Key Facility of Crop Gene Resources and Genetic Improvement, Chinese Academy of Agricultural Sciences, Beijing 100081, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhou Yu</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing 100021, China. Electronic address: yuzhou310@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xudong Jia</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, National Center for Food Safety Risk Assessment, Beijing 100021, China. Electronic address: jiaxudong@cfsa.net.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Threshold and non-threshold chemical carcinogens: A survey of the present regulatory landscape.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28119000</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30003-X</DOI>
    <KeywordList>
      <Keywords>Carcinogen</Keywords>
      <Keywords>Classification</Keywords>
      <Keywords>Guideline values</Keywords>
      <Keywords>Non-threshold</Keywords>
      <Keywords>OELs</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Threshold</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ruth J. Bevan</Name>
        <Affiliation>IEH Consulting Ltd., No.4 The Lodge Business Centre, Rectory Farm, Marston Trussell, Market Harborough, Leicestershire LE16 9TU, UK. Electronic address: ruth@iehconsulting.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Paul T. C. Harrison</Name>
        <Affiliation>IEH Consulting Ltd., No.4 The Lodge Business Centre, Rectory Farm, Marston Trussell, Market Harborough, Leicestershire LE16 9TU, UK. Electronic address: paul@iehconsulting.co.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bioactive nutrients - Time for tolerable upper intake levels to address safety.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28110066</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30002-8</DOI>
    <KeywordList>
      <Keywords>Bioactives</Keywords>
      <Keywords>DRIs</Keywords>
      <Keywords>Dietary reference intakes</Keywords>
      <Keywords>EGCG</Keywords>
      <Keywords>Epigallocatechin gallate</Keywords>
      <Keywords>Green tea</Keywords>
      <Keywords>Lutein</Keywords>
      <Keywords>Nutrient reference values</Keywords>
      <Keywords>Nutrition</Keywords>
      <Keywords>Tolerable upper intake levels</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Allison A. Yates</Name>
        <Affiliation>Food and Nutrition Board, Institute of Medicine, National Research Council, Johnson City, TN 37615, United States. Electronic address: allisonayates@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>John W. Erdman</Name>
        <Affiliation>Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States. Electronic address: jwerdman@illinois.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Shao</Name>
        <Affiliation>Global Nutrition Policy, Herbalife Nutrition, Los Angeles, CA 90015, United States. Electronic address: andrewsh@herbalife.com.</Affiliation>
      </Author>
      <Author>
        <Name>Laurie C. Dolan</Name>
        <Affiliation>Burdock Group, Orlando, FL 32814, United States. Electronic address: ldolan@burdockgroup.com.</Affiliation>
      </Author>
      <Author>
        <Name>James C. Griffiths</Name>
        <Affiliation>Science &amp; International Affairs, Council for Responsible Nutrition, Washington, DC 20036, United States. Electronic address: jgriffiths@crnusa.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The lower alkyl methacrylates: Genotoxic profile of non-carcinogenic compounds.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28087335</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(17)30001-6</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Genotoxic intermediates</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Methacrylates</Keywords>
      <Keywords>Methyl methacrylate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard J. Albertini</Name>
        <Affiliation>The University of Vermont, Genetic Toxicology Laboratory, 665 Spear Street, Burlington, VT, USA. Electronic address: ralbert315@aol.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Distinguishing between expert and statistical systems for application under ICH M7.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28057482</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30394-4</DOI>
    <AuthorList>
      <Author>
        <Name>Chris Barber</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds LS11 5PY, UK. Electronic address: chris.barber@lhasalimited.org.</Affiliation>
      </Author>
      <Author>
        <Name>Thierry Hanser</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds LS11 5PY, UK. Electronic address: Thierry.Hanser@lhasalimited.org.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Judson</Name>
        <Affiliation>Heather Lea Cottage, Bland Hill, Norwood, Harrogate HG3 1TE, UK. Electronic address: Philip.Judson@blubberhouses.net.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Williams</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds LS11 5PY, UK. Electronic address: Richard.Williams@lhasalimited.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Management of organic impurities in small molecule medicinal products: Deriving safe limits for use in early development.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28038978</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30393-2</DOI>
    <KeywordList>
      <Keywords>1 mg/day</Keywords>
      <Keywords>Haber's law</Keywords>
      <Keywords>ICH M7</Keywords>
      <Keywords>ICH Q3A</Keywords>
      <Keywords>ICH Q3B</Keywords>
      <Keywords>ICH Q3C</Keywords>
      <Keywords>Impurity qualification</Keywords>
      <Keywords>Impurity safety</Keywords>
      <Keywords>Non-mutagenic impurities</Keywords>
      <Keywords>TTC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James Harvey</Name>
        <Affiliation>GlaxoSmithKline R&amp;D, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom. Electronic address: James.S.Harvey@GSK.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Fleetwood</Name>
        <Affiliation>Pfizer, Ramsgate Road Sandwich, Kent, CT13 9N, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Ron Ogilvie</Name>
        <Affiliation>Pfizer, Ramsgate Road Sandwich, Kent, CT13 9N, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Teasdale</Name>
        <Affiliation>AstraZeneca, Silk Road Business Park, Macclesfield, Cheshire, SK10 2NX, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Phil Wilcox</Name>
        <Affiliation>GlaxoSmithKline R&amp;D, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Steven Spanhaak</Name>
        <Affiliation>Janssen R&amp;D, Turnhoutseweg 30, 2340 Beerse, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Moderate doses of commercial preparations of Ginkgo biloba do not alter markers of liver function but moderate alcohol intake does: A new approach to identify and quantify biomarkers of 'adverse effects' of dietary supplements.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28025058</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30392-0</DOI>
    <KeywordList>
      <Keywords>Alanine aminotransferase</Keywords>
      <Keywords>Aspartate aminotransferase</Keywords>
      <Keywords>Bilirubin</Keywords>
      <Keywords>Gamma glutamyl transferase</Keywords>
      <Keywords>Lactate dehydrogenase</Keywords>
      <Keywords>NHANES</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Harris R. Lieberman</Name>
        <Affiliation>Military Nutrition Division, U.S. Army Research Institute of Environmental Medicine, Natick, MA 01760, USA. Electronic address: harris.r.lieberman.civ@mail.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Mark D. Kellogg</Name>
        <Affiliation>Department of Laboratory Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA. Electronic address: mark.kellogg@childrens.harvard.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Victor L. Fulgoni</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, Belcamp, MD 21017, USA; Henry M. Jackson Foundation, Bethesda, MD 20817, USA. Electronic address: vic3rd@aol.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sanjiv Agarwal</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, Belcamp, MD 21017, USA. Electronic address: agarwal47@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of in vitro assays for the assessment of the skin sensitization hazard of functional polysiloxanes and silanes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28017767</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30391-9</DOI>
    <KeywordList>
      <Keywords>DPRA</Keywords>
      <Keywords>GPMT</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>KeratinoSens™</Keywords>
      <Keywords>LLNA</Keywords>
      <Keywords>Polysiloxanes</Keywords>
      <Keywords>Sensitization</Keywords>
      <Keywords>Silanes</Keywords>
      <Keywords>h-CLAT</Keywords>
      <Keywords>mMUSST</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas Petry</Name>
        <Affiliation>ToxMinds BVBA, Product Safety &amp; Regulatory Affairs, B-1200 Brussels, Belgium. Electronic address: thomas.petry@toxminds.com.</Affiliation>
      </Author>
      <Author>
        <Name>Axel Bosch</Name>
        <Affiliation>Wacker Chemie AG, Corporate Product Safety, D-84489 Burghausen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Xavier Coste</Name>
        <Affiliation>Bluestar Silicones, F-69191 Saint Fons Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Dorothea Eigler</Name>
        <Affiliation>Evonik Nutrition &amp; Care, GmbH Goldschmidtstr.100, D-45127 Essen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Pierre Germain</Name>
        <Affiliation>Centre Européen des Silicones, CEFIC, B-1160 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Shawn Seidel</Name>
        <Affiliation>Dow Corning Corporation, Health and Environmental Sciences, 2200 West Salzburg Road, Auburn, MI 48611, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paul A. Jean</Name>
        <Affiliation>Dow Corning Corporation, Health and Environmental Sciences, 2200 West Salzburg Road, Auburn, MI 48611, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Child and adult exposure and health risk evaluation following the use of metal- and metalloid-containing costume cosmetics sold in the United States.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28007419</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30378-6</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Chromium</Keywords>
      <Keywords>Cosmetic</Keywords>
      <Keywords>Face paint</Keywords>
      <Keywords>Halloween</Keywords>
      <Keywords>Lead</Keywords>
      <Keywords>Makeup</Keywords>
      <Keywords>Metalloid</Keywords>
      <Keywords>Metals</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Angela L. Perez</Name>
        <Affiliation>Cardno ChemRisk, LLC, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States. Electronic address: Angela.perez@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Melanie Nembhard</Name>
        <Affiliation>Cardno ChemRisk, LLC, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Monnot</Name>
        <Affiliation>Cardno ChemRisk, LLC, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Bator</Name>
        <Affiliation>Dept. of Environmental Health Sciences, University of Michigan School of Public Health, 1415 Washington Heights Ann Arbor, MI 48109-2029, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth Madonick</Name>
        <Affiliation>Brooks Applied Labs, 18804 Northcreek Parkway, Bothell, WA 98011, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Shannon H. Gaffney</Name>
        <Affiliation>Cardno ChemRisk, LLC, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The changing face of nanomaterials: Risk assessment challenges along the value chain.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27998719</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30388-9</DOI>
    <KeywordList>
      <Keywords>Dose metric</Keywords>
      <Keywords>Grouping</Keywords>
      <Keywords>Life cycle</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Risk assessment approach</Keywords>
      <Keywords>Risk management</Keywords>
      <Keywords>Value chain</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mats Olof Mattsson</Name>
        <Affiliation>AIT Austrian Institute of Technology, Energy Department, Environmental Resources and Technologies, Konrad-Lorenz-Strasse 24, 3430 Tulln, Austria; SciProof International AB, Vaktpoststigen 4, 83132 Östersund, Sweden. Electronic address: mats-olof.mattsson@ait.ac.at.</Affiliation>
      </Author>
      <Author>
        <Name>Myrtill Simkó</Name>
        <Affiliation>AIT Austrian Institute of Technology, Energy Department, Environmental Resources and Technologies, Konrad-Lorenz-Strasse 24, 3430 Tulln, Austria; SciProof International AB, Vaktpoststigen 4, 83132 Östersund, Sweden.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro metabolism of [</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27993653</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30389-0</DOI>
    <KeywordList>
      <Keywords>Benalaxyl</Keywords>
      <Keywords>Comparative in vitro metabolism</Keywords>
      <Keywords>Cryopreserved</Keywords>
      <Keywords>Hepatocytes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gopinath C. Nallani</Name>
        <Affiliation>Global Regulatory Science, FMC Agricultural Solutions, 701 PrincetonSouth Corporate Center, Ewing, NJ, 08628, USA. Electronic address: Gopinath.Nallani@fmc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shaaban F. ElNaggar</Name>
        <Affiliation>Global Regulatory Science, FMC Agricultural Solutions, 701 PrincetonSouth Corporate Center, Ewing, NJ, 08628, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Li Shen</Name>
        <Affiliation>Frontage Laboratories, 700 Pennsylvania Drive, Exton, PA 19341, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Appavu Chandrasekaran</Name>
        <Affiliation>Global Regulatory Science, FMC Agricultural Solutions, 701 PrincetonSouth Corporate Center, Ewing, NJ, 08628, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of pre and post-treatments with dipyridamole in gentamicin-induced acute nephrotoxicity in the rat.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27993652</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30390-7</DOI>
    <KeywordList>
      <Keywords>Acute nephrotoxicity</Keywords>
      <Keywords>Dipyridamole</Keywords>
      <Keywords>Gentamicin</Keywords>
      <Keywords>Renal dysfunction</Keywords>
      <Keywords>Renal inflammation</Keywords>
      <Keywords>Renoprotection</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pitchai Balakumar</Name>
        <Affiliation>Faculty of Pharmacy, AIMST University, Semeling, 08100 Bedong, Malaysia. Electronic address: pbala2006@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Ern WitnessKoe</Name>
        <Affiliation>Faculty of Pharmacy, AIMST University, Semeling, 08100 Bedong, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Syen Gan</Name>
        <Affiliation>Faculty of Pharmacy, AIMST University, Semeling, 08100 Bedong, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Soo Mei JemayPuah</Name>
        <Affiliation>Faculty of Pharmacy, AIMST University, Semeling, 08100 Bedong, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Subramaniam Kuganesswari</Name>
        <Affiliation>Faculty of Pharmacy, AIMST University, Semeling, 08100 Bedong, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Sunil Kumar Prajapati</Name>
        <Affiliation>Faculty of Pharmacy, AIMST University, Semeling, 08100 Bedong, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Rajavel Varatharajan</Name>
        <Affiliation>Faculty of Pharmacy, AIMST University, Semeling, 08100 Bedong, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Sam Annie Jayachristy</Name>
        <Affiliation>Faculty of Medicine, AIMST University, Semeling, 08100 Bedong, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Karupiah Sundram</Name>
        <Affiliation>Faculty of Pharmacy, AIMST University, Semeling, 08100 Bedong, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Mohd Baidi Bahari</Name>
        <Affiliation>Faculty of Pharmacy, AIMST University, Semeling, 08100 Bedong, Malaysia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Delamanid is not metabolized by Salmonella or human nitroreductases: A possible mechanism for the lack of mutagenicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27988333</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30368-3</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>DT-Diaphorase (NQO1)</Keywords>
      <Keywords>Delamanid</Keywords>
      <Keywords>Metabolic rate</Keywords>
      <Keywords>Mutagen specific activity</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>NQO2</Keywords>
      <Keywords>Nitrofuran</Keywords>
      <Keywords>Nitroimidazole</Keywords>
      <Keywords>Nitroreductase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Erina Hanaki</Name>
        <Affiliation>Infectious Diseases Unit, Department of Medical Innovations, Otsuka Pharmaceutical, Tokushima, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mikayo Hayashi</Name>
        <Affiliation>Medical Chemistry Research Laboratories, Otsuka Pharmaceutical, Tokushima, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Matsumoto</Name>
        <Affiliation>Pharmaceutical Business Division, Otsuka Pharmaceutical, Tokushima, Japan. Electronic address: Matsumoto.Makoto@otsuka.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modeling emissions from CAFO poultry farms in Poland and evaluating potential risk to surrounding populations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27986593</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30327-0</DOI>
    <KeywordList>
      <Keywords>Air pollution</Keywords>
      <Keywords>Animal feeding operations</Keywords>
      <Keywords>Emissions modeling</Keywords>
      <Keywords>Mixtures evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. R. Pohl</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta, GA, USA. Electronic address: hpohl@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>M. Citra</Name>
        <Affiliation>SRC, Inc., North Syracuse, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>H. A. Abadin</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>I. Szadkowska-Stańczyk</Name>
        <Affiliation>Nofer Institute of Occupational Medicine, Łódź, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>A. Kozajda</Name>
        <Affiliation>Nofer Institute of Occupational Medicine, Łódź, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>L. Ingerman</Name>
        <Affiliation>SRC, Inc., North Syracuse, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Nguyen</Name>
        <Affiliation>SRC, Inc., North Syracuse, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>H. E. Murray</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta, GA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Approaches for grouping of pesticides into cumulative assessment groups for risk assessment of pesticide residues in food.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27965130</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30377-4</DOI>
    <KeywordList>
      <Keywords>Cumulative assessment groups (CAGs)</Keywords>
      <Keywords>Cumulative risk assessment</Keywords>
      <Keywords>Human relevance</Keywords>
      <Keywords>Margin of exposure</Keywords>
      <Keywords>Nervous system</Keywords>
      <Keywords>Organophosphates</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Thyroid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas Colnot</Name>
        <Affiliation>CiS Toxicology, Osorno, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>Department of Toxicology, University of Würzburg, Versbacher Strasse 9, 97078, Würzburg, Germany. Electronic address: dekant@toxi.uni-wuerzburg.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative subcutaneous repeated toxicity study of enoxaparin products in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27965129</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30376-2</DOI>
    <KeywordList>
      <Keywords>Biosimilars</Keywords>
      <Keywords>Enoxaparin</Keywords>
      <Keywords>Preclinical</Keywords>
      <Keywords>Repeated toxicity studies</Keywords>
      <Keywords>Wistar rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zina Kobbi</Name>
        <Affiliation>Faculty of Pharmacy of Monastir, Rue Ibn Sina, 5000, University of Monastir, Tunisia. Electronic address: kobbizina@yahoo.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Hazar Kraiem</Name>
        <Affiliation>Laboratory of Venoms and Therapeutic Molecules, Pasteur Institute of Tunis, 13 Place Pasteur, BP74, 1002, Tunis, University of Tunis El Manar, Tunisia. Electronic address: hazar.kraiem@yahoo.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Zakaria Benlasfar</Name>
        <Affiliation>Animal Unit, Pasteur Institute of Tunis, 13 Place Pasteur, BP74, 1002, Tunis, University of Tunis El Manar, Tunisia. Electronic address: zakaria.benlasfar@pasteur.rns.tn.</Affiliation>
      </Author>
      <Author>
        <Name>Ammar Marouani</Name>
        <Affiliation>Animal Unit, Pasteur Institute of Tunis, 13 Place Pasteur, BP74, 1002, Tunis, University of Tunis El Manar, Tunisia. Electronic address: ammar.marouani@pasteur.rns.tn.</Affiliation>
      </Author>
      <Author>
        <Name>Taieb Massoud</Name>
        <Affiliation>Laboratory of Biochemistry, Children's Hospital of Tunis/ Faculty of Pharmacy of Monastir, Rue Ibn Sina, 5000, University of Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Samir Boubaker</Name>
        <Affiliation>Laboratory of Human and Experimental Pathology, Pasteur Institute of Tunis, 13 Place Pasteur, BP74, 1002, Tunis, University of Tunis El Manar, Tunisia. Electronic address: samir.boubaker@pasteur.rns.tn.</Affiliation>
      </Author>
      <Author>
        <Name>Balkiss Bouhaouala-Zahar</Name>
        <Affiliation>Laboratory of Venoms and Therapeutic Molecules, Pasteur Institute of Tunis, 13 Place Pasteur, BP74, 1002, Tunis, University of Tunis El Manar, Tunisia. Electronic address: Balkiss.Bouhaouala@pasteur.rns.tn.</Affiliation>
      </Author>
      <Author>
        <Name>Nadia Fenina</Name>
        <Affiliation>Faculty of Pharmacy of Monastir, Rue Ibn Sina, 5000, University of Monastir, Tunisia. Electronic address: nadia.fenina@rns.tn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The chronic hepatotoxicity assessment of the herbal formula Zishen Yutai pill.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27916537</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30367-1</DOI>
    <KeywordList>
      <Keywords>Chronic hepatotoxicity</Keywords>
      <Keywords>Herbal formula</Keywords>
      <Keywords>No-observed-adverse-effect levels</Keywords>
      <Keywords>Polygoni multiflori Radix</Keywords>
      <Keywords>Zishen Yutai pill</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaoyan Xing</Name>
        <Affiliation>Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuehong Deng</Name>
        <Affiliation>Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinjin Shi</Name>
        <Affiliation>College of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meishuang Zhang</Name>
        <Affiliation>Changchun University of Chinese Medicine, Changchun, Jilin, 130117, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guibo Sun</Name>
        <Affiliation>Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shimin Tang</Name>
        <Affiliation>Changchun University of Chinese Medicine, Changchun, Jilin, 130117, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiuling Huang</Name>
        <Affiliation>Guangzhou Baiyunshan Zhongyi Pharmaceutical Co. Ltd, Guangzhou, Guangdong, 510530, China. Electronic address: 13826214009@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaobo Sun</Name>
        <Affiliation>Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100193, China. Electronic address: sun_xiaobo163@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carcinogenic risk of emerging persistent organic pollutant perfluorooctane sulfonate (PFOS): A proposal of classification.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27871870</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30365-8</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Carcinogenic risk</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>IARC</Keywords>
      <Keywords>PFCs</Keywords>
      <Keywords>PFOS</Keywords>
      <Keywords>Perfluorooctane sulfonate</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ricardo Arrieta-Cortes</Name>
        <Affiliation>Science, Technology and Society, Cinvestav-IPN, Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, C.P. 07360, Mexico City, Mexico. Electronic address: rarrieta@cinvestav.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Paulina Farias</Name>
        <Affiliation>Centro de Investigación en Salud Poblacional, INSP, Universidad No. 655, Colonia Santa María Ahuacatitlán, Cerrada Los Pinos y Caminera, Cuernavaca, Morelos, 62100, Mexico. Electronic address: paulina.farias@insp.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos Hoyo-Vadillo</Name>
        <Affiliation>Science, Technology and Society, Cinvestav-IPN, Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, C.P. 07360, Mexico City, Mexico; Pharmacology Department, Cinvestav-IPN, Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, C.P. 07360, Mexico City, Mexico. Electronic address: citocromo@cinvestav.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Mina Kleiche-Dray</Name>
        <Affiliation>Science, Technology and Society, Cinvestav-IPN, Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, C.P. 07360, Mexico City, Mexico; CEPED (IRD - Université Paris V Descartes), 19 rue Jacob, Paris, 75006, France. Electronic address: Mina.Kleiche@ird.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of read-across to simplify the toxicological assessment of a complex mixture of lysimeter leachate metabolites on the basis of chemical similarity and ADME behavior.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27871869</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30363-4</DOI>
    <KeywordList>
      <Keywords>ADME</Keywords>
      <Keywords>Lysimeter</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Relevance</Keywords>
      <Keywords>S-metolachlor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laurence H. Hand</Name>
        <Affiliation>Syngenta, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, United Kingdom. Electronic address: laurence.hand@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kevan Richardson</Name>
        <Affiliation>Syngenta, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen T. Hadfield</Name>
        <Affiliation>Syngenta, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Whalley</Name>
        <Affiliation>Syngenta, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Rawlinson</Name>
        <Affiliation>Syngenta, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Ewan D. Booth</Name>
        <Affiliation>Syngenta, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quantitative risk assessment for skin sensitization: Success or failure?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27871868</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30364-6</DOI>
    <KeywordList>
      <Keywords>Contact allergy</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>University of Manchester, Faculty of Life Sciences, Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK.</Affiliation>
      </Author>
      <Author>
        <Name>G. Frank Gerberick</Name>
        <Affiliation>The Procter &amp; Gamble Company, Central Product Safety, Mason Business Center, Mason, OH, 45040, USA. Electronic address: gerberick.gf@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>David A. Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, Bedfordshire, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic toxicity evaluation of Morinda citrifolia fruit and leaf in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27871867</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30366-X</DOI>
    <KeywordList>
      <Keywords>Fruit</Keywords>
      <Keywords>Leaf</Keywords>
      <Keywords>Liver toxicity</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Morinda citrifolia</Keywords>
      <Keywords>Noni</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nor Aijratul Asikin Mohamad Shalan</Name>
        <Affiliation>UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, University Putra Malaysia, 43400 Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Noordin M. Mustapha</Name>
        <Affiliation>Faculty of Veterinary Medicine, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Suhaila Mohamed</Name>
        <Affiliation>UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, University Putra Malaysia, 43400 Serdang, Selangor, Malaysia. Electronic address: mohamed.suhaila@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the Tobacco Heating System 2.2 (THS2.2). Part 5: microRNA expression from a 90-day rat inhalation study indicates that exposure to THS2.2 aerosol causes reduced effects on lung tissue compared with cigarette smoke.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27866933</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30362-2</DOI>
    <KeywordList>
      <Keywords>Heat-not-burn</Keywords>
      <Keywords>Inflammation-related microRNAs</Keywords>
      <Keywords>Inhalation toxicology study</Keywords>
      <Keywords>Modified risk tobacco product</Keywords>
      <Keywords>microRNA expression</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alain Sewer</Name>
        <Affiliation>Philip Morris International R&amp;D, Part of Philip Morris International Group of Companies, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland. Electronic address: alain.sewer@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ulrike Kogel</Name>
        <Affiliation>Philip Morris International R&amp;D, Part of Philip Morris International Group of Companies, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Marja Talikka</Name>
        <Affiliation>Philip Morris International R&amp;D, Part of Philip Morris International Group of Companies, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Ee Tsin Wong</Name>
        <Affiliation>Philip Morris International Research Laboratories Pte Ltd, Part of Philip Morris International Group of Companies, 50 Science Park Road, The Kendall #02-07, Science Park II, 117406, Singapore.</Affiliation>
      </Author>
      <Author>
        <Name>Florian Martin</Name>
        <Affiliation>Philip Morris International R&amp;D, Part of Philip Morris International Group of Companies, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Xiang</Name>
        <Affiliation>Philip Morris International R&amp;D, Part of Philip Morris International Group of Companies, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Emmanuel Guedj</Name>
        <Affiliation>Philip Morris International R&amp;D, Part of Philip Morris International Group of Companies, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Nikolai V. Ivanov</Name>
        <Affiliation>Philip Morris International R&amp;D, Part of Philip Morris International Group of Companies, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Julia Hoeng</Name>
        <Affiliation>Philip Morris International R&amp;D, Part of Philip Morris International Group of Companies, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Manuel C. Peitsch</Name>
        <Affiliation>Philip Morris International R&amp;D, Part of Philip Morris International Group of Companies, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer Safety (SCCS) - Final version of the Opinion on Vitamin A (retinol, retinyl acetate and retinyl palmitate) in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27856323</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30352-X</DOI>
    <KeywordList>
      <Keywords>CAS n. 11103-57-4 / 68-26-8 / 127-47-9 / 79-81-2</Keywords>
      <Keywords>EC 234-328-2 /200-683-7 / 204-844-2 / 201-228-5</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>Vitamin A (retinol, retinyl acetate, retinyl palmitate)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920 Luxembourg, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Christophe Rousselle</Name>
        <Affiliation>French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer Safety (SCCS) - Final version of the opinion on decamethylcyclopentasiloxane (cyclopentasiloxane, D5) in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27845160</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30351-8</DOI>
    <KeywordList>
      <Keywords>CAS n. 541-02-6</Keywords>
      <Keywords>Decamethylcyclopentasiloxane (cyclopentasiloxane, D5)</Keywords>
      <Keywords>EC number 208-764-9</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>Dr Christophe Rousselle</Name>
        <Affiliation>French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the tobacco heating system 2.2. Part 9: Application of systems pharmacology to identify exposure response markers in peripheral blood of smokers switching to THS2.2.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27845159</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30346-4</DOI>
    <KeywordList>
      <Keywords>Blood</Keywords>
      <Keywords>Exposure response</Keywords>
      <Keywords>Gene expression signature</Keywords>
      <Keywords>MRTP</Keywords>
      <Keywords>Novel tobacco heating system</Keywords>
      <Keywords>Smoking</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Florian Martin</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Neuchatel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Marja Talikka</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Neuchatel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Nikolai V. Ivanov</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Neuchatel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Christelle Haziza</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Neuchatel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Julia Hoeng</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Neuchatel, Switzerland(1). Electronic address: Hoeng@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Manuel C. Peitsch</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A., Neuchatel, Switzerland(1).</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Penetration of lycopsamine from a comfrey ointment through human epidermis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27840092</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30350-6</DOI>
    <KeywordList>
      <Keywords>Absorption</Keywords>
      <Keywords>Comfrey</Keywords>
      <Keywords>Epidermis</Keywords>
      <Keywords>Franz diffusion cell</Keywords>
      <Keywords>Lycopsamine</Keywords>
      <Keywords>Pyrrolizidine alkaloid</Keywords>
      <Keywords>Skin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nikoletta Jedlinszki</Name>
        <Affiliation>University of Szeged, Faculty of Pharmacy, Department of Pharmacognosy, H-6720, Szeged, Eötvös Street 6, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Boglárka Balázs</Name>
        <Affiliation>University of Szeged, Faculty of Pharmacy, Department of Pharmaceutical Technology, H-6720, Szeged, Eötvös Street 6, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Erzsébet Csányi</Name>
        <Affiliation>University of Szeged, Faculty of Pharmacy, Department of Pharmaceutical Technology, H-6720, Szeged, Eötvös Street 6, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Dezső Csupor</Name>
        <Affiliation>University of Szeged, Faculty of Pharmacy, Department of Pharmacognosy, H-6720, Szeged, Eötvös Street 6, Hungary; Interdisciplinary Centre of Natural Products, University of Szeged, Eötvös u. 6, H-6720, Szeged, Hungary. Electronic address: csupor.dezso@pharmacognosy.hu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Potential accumulation of protopanaxadiol-type ginsenosides in six-months toxicokinetic study of SHENMAI injection in dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27840091</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30347-6</DOI>
    <KeywordList>
      <Keywords>Dogs</Keywords>
      <Keywords>LC–MS/MS</Keywords>
      <Keywords>Protopanaxadiol-type ginsenosides</Keywords>
      <Keywords>Protopanaxatriol-type ginsenosides</Keywords>
      <Keywords>SHENMAI injection</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jian Yu</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Qiang Gu</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Fei Xin</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China. Electronic address: xinyanfei@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Sheng Bai</Name>
        <Affiliation>Beijing Space Odyssey Biotechnology Co., Ltd., Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sheng Zhang</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hai Yan Gao</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pan Sheng Xu</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhu Feng Ma</Name>
        <Affiliation>Chiatai QingChunbao Pharmaceutical Co., Ltd., Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Qiang You</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Wang</Name>
        <Affiliation>Chiatai QingChunbao Pharmaceutical Co., Ltd., Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yao Xian Xuan</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and subacute oral toxicity of periodate salts in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27838404</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30349-X</DOI>
    <KeywordList>
      <Keywords>Iodine</Keywords>
      <Keywords>Oxidizer</Keywords>
      <Keywords>Perchlorate</Keywords>
      <Keywords>Periodate</Keywords>
      <Keywords>Renal</Keywords>
      <Keywords>Thyroid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Emily May Lent</Name>
        <Affiliation>Toxicology Directorate, Army Public Health Center, Aberdeen Proving Ground, MD, USA. Electronic address: Emily.m.lent.civ@mail.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Lee C. B. Crouse</Name>
        <Affiliation>Toxicology Directorate, Army Public Health Center, Aberdeen Proving Ground, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William S. Eck</Name>
        <Affiliation>Toxicology Directorate, Army Public Health Center, Aberdeen Proving Ground, MD, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of human exposure to metals from some commonly used bathing soaps and shower gels in Nigeria.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27838403</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30348-8</DOI>
    <KeywordList>
      <Keywords>Bathing soaps and shower gels</Keywords>
      <Keywords>Margin of safety</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Nigeria</Keywords>
      <Keywords>Systemic exposure dosage</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chukwujindu M. A. Iwegbue</Name>
        <Affiliation>Department of Chemistry, Delta State University, P.M.B. 1, Abraka, Delta State, Nigeria. Electronic address: maxipriestley@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Omotekoro S. Emakunu</Name>
        <Affiliation>Department of Chemistry, Delta State University, P.M.B. 1, Abraka, Delta State, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Godwin E. Nwajei</Name>
        <Affiliation>Department of Chemistry, Delta State University, P.M.B. 1, Abraka, Delta State, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Francisca I. Bassey</Name>
        <Affiliation>Department of Chemistry, University of Calabar, P.M.B. 1115, Calabar, Cross-River State, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Bice S. Martincigh</Name>
        <Affiliation>School of Chemistry and Physics, University of KwaZulu-Natal, Westville Campus, Private Bag X54001, Durban, 4000, South Africa.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Response to Harper and Key-Schwartz.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27838402</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30308-7</DOI>
    <AuthorList>
      <Author>
        <Name>R. J. Lee</Name>
        <Affiliation>RJ Lee Group, Inc., 350 Hochberg Road, Monroeville, PA 15146, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. R. Van Orden</Name>
        <Affiliation>RJ Lee Group, Inc., 350 Hochberg Road, Monroeville, PA 15146, USA. Electronic address: drew@rjlg.com.</Affiliation>
      </Author>
      <Author>
        <Name>L. A. Cox</Name>
        <Affiliation>Cox Associates Inc, 503 Franklin Street, Denver, CO 80218, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. Arlauckas</Name>
        <Affiliation>RJ Lee Group, Inc., 350 Hochberg Road, Monroeville, PA 15146, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. J. Kautz</Name>
        <Affiliation>RJ Lee Group, Inc., 350 Hochberg Road, Monroeville, PA 15146, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Letter to the Editor: Preparation of respirable crystalline silica samples for subsequent analysis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27825988</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30307-5</DOI>
    <KeywordList>
      <Keywords>Quartz</Keywords>
      <Keywords>Respirable crystalline silica</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Martin Harper</Name>
        <Affiliation>Exposure Assessment Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health (NIOSH), 1095 Willowdale Rd., MS-3030, Morgantown, WV 26505, USA. Electronic address: mharper@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Rosa J. Key-Schwartz</Name>
        <Affiliation>Division of Applied Research and Technology, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS R-7, Cincinnati, OH 45226, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of Bacillus subtilis CU1 for use as a probiotic in humans.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27825987</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30345-2</DOI>
    <KeywordList>
      <Keywords>Bacillus subtilis</Keywords>
      <Keywords>Clinical study</Keywords>
      <Keywords>Food safety</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>probiotic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marie Lefevre</Name>
        <Affiliation>Lesaffre Human Care, Lesaffre Group, 137 Rue Gabriel Péri, F-59700, Marcq-en-Baroeul, France. Electronic address: mle@ennolys.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia M. Racedo</Name>
        <Affiliation>University of Bordeaux, UMR 5248, Bordeaux Sci Agro, Gradignan, France.</Affiliation>
      </Author>
      <Author>
        <Name>Muriel Denayrolles</Name>
        <Affiliation>University of Bordeaux, UMR 5248, Bordeaux Sci Agro, Gradignan, France.</Affiliation>
      </Author>
      <Author>
        <Name>Gabrielle Ripert</Name>
        <Affiliation>University of Bordeaux, UMR 5248, Bordeaux Sci Agro, Gradignan, France.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Desfougères</Name>
        <Affiliation>Lesaffre Human Care, Lesaffre Group, 137 Rue Gabriel Péri, F-59700, Marcq-en-Baroeul, France.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandra R. Lobach</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ryan Simon</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Fanny Pélerin</Name>
        <Affiliation>Lesaffre Human Care, Lesaffre Group, 137 Rue Gabriel Péri, F-59700, Marcq-en-Baroeul, France.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Jüsten</Name>
        <Affiliation>Lesaffre Human Care, Lesaffre Group, 137 Rue Gabriel Péri, F-59700, Marcq-en-Baroeul, France.</Affiliation>
      </Author>
      <Author>
        <Name>Maria C. Urdaci</Name>
        <Affiliation>University of Bordeaux, UMR 5248, Bordeaux Sci Agro, Gradignan, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer Safety (SCCS) - Final version of the opinion on Eco G+ in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27825836</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30329-4</DOI>
    <KeywordList>
      <Keywords>CAS 7440-22-4</Keywords>
      <Keywords>Directive 76/768/ECC</Keywords>
      <Keywords>EC 231-131-3</Keywords>
      <Keywords>EcoG+</Keywords>
      <Keywords>Preservative</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920 Luxembourg, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Gisela H. Degen</Name>
        <Affiliation>Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxic and anti-genotoxic effects of esculin and its oligomer fractions against mitomycin C-induced DNA damages in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27825835</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30330-0</DOI>
    <KeywordList>
      <Keywords>Antigenotoxicity</Keywords>
      <Keywords>Esculin</Keywords>
      <Keywords>Lipid peroxidation</Keywords>
      <Keywords>Mitomycin C</Keywords>
      <Keywords>Oligomer fractions</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Imen Mokdad Bzeouich</Name>
        <Affiliation>Laboratory of Cellular and Molecular Biology, Faculty of Dental Medicine, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia; Unit of Bioactive and Natural Substances and Biotechnology UR12ES12, Faculty of Pharmacy, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Nadia Mustapha</Name>
        <Affiliation>Laboratory of Cellular and Molecular Biology, Faculty of Dental Medicine, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia; Unit of Bioactive and Natural Substances and Biotechnology UR12ES12, Faculty of Pharmacy, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Mouna Maatouk</Name>
        <Affiliation>Laboratory of Cellular and Molecular Biology, Faculty of Dental Medicine, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia; Unit of Bioactive and Natural Substances and Biotechnology UR12ES12, Faculty of Pharmacy, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Kamel Ghedira</Name>
        <Affiliation>Laboratory of Cellular and Molecular Biology, Faculty of Dental Medicine, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed Ghoul</Name>
        <Affiliation>Laboratory of Biomolecular Engineering, National School of Agronomy and Food Industries, National Polytechnics Institute of Lorraine ENSAIA-INPL, 54505, Vandoeuvre les Nancy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Leila Chekir-Ghedira</Name>
        <Affiliation>Unit of Bioactive and Natural Substances and Biotechnology UR12ES12, Faculty of Pharmacy, University of Monastir, Avicenna Street, 5000, Monastir, Tunisia. Electronic address: leila.chekir@laposte.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment of Anionic Methacrylate Copolymer: I. Characterization, bioavailability and genotoxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27825834</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30344-0</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>Anionic Methacrylate Copolymer</Keywords>
      <Keywords>Chromosome aberration test</Keywords>
      <Keywords>Coating agent</Keywords>
      <Keywords>EUDRAGIT(®) FS</Keywords>
      <Keywords>EUDRAGUARD(®)</Keywords>
      <Keywords>Food additive</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Micronucleus assay</Keywords>
      <Keywords>Mouse lymphoma assay</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Johanna Eisele</Name>
        <Affiliation>Evonik Nutrition &amp; Care GmbH, Kirschenallee, 64293 Darmstadt, Federal Republic of Germany. Electronic address: Johanna.Eisele@evonik.com.</Affiliation>
      </Author>
      <Author>
        <Name>Geoff Haynes</Name>
        <Affiliation>Haynes Safety Services Ltd, Oakridge, Quarry Lane, Gorsley, Ross-on-Wye, Herefordshire HR9 7SJ, England, UK. Electronic address: geoff.haynes@breatheconnect.com.</Affiliation>
      </Author>
      <Author>
        <Name>Knut Kreuzer</Name>
        <Affiliation>Evonik Nutrition &amp; Care GmbH, Kirschenallee, 64293 Darmstadt, Federal Republic of Germany. Electronic address: Knut.Kreuzer@evonik.com.</Affiliation>
      </Author>
      <Author>
        <Name>Caroline Hall</Name>
        <Affiliation>Evonik Nutrition &amp; Care GmbH, Rodenbacher Chaussee 4, 63457 Hanau-Wolfgang, Federal Republic of Germany. Electronic address: Caroline.Hall@evonik.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer Safety (SCCS) - Final version of the opinion on Phenoxyethanol in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27825833</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30328-2</DOI>
    <KeywordList>
      <Keywords>CAS no. 122-99-6</Keywords>
      <Keywords>EC no. 204-589-7</Keywords>
      <Keywords>Phenoxyethanol</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Werner Lilienblum</Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the Tobacco Heating System 2.2. Part 6: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of a mentholated version compared with mentholated and non-mentholated cigarette smoke.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27818348</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30332-4</DOI>
    <KeywordList>
      <Keywords>Heat-not-burn</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Menthol</Keywords>
      <Keywords>Potential reduced risk product</Keywords>
      <Keywords>Pulmonary inflammation</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alberto Oviedo</Name>
        <Affiliation>Philip Morris International Research Laboratories Pte Ltd, 50 Science Park Road #02-07, The Kendall, Science Park II, Singapore 117406, Singapore(2).</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Lebrun</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Ulrike Kogel</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Jenny Ho</Name>
        <Affiliation>Philip Morris International Research Laboratories Pte Ltd, 50 Science Park Road #02-07, The Kendall, Science Park II, Singapore 117406, Singapore(2).</Affiliation>
      </Author>
      <Author>
        <Name>Wei Teck Tan</Name>
        <Affiliation>Philip Morris International Research Laboratories Pte Ltd, 50 Science Park Road #02-07, The Kendall, Science Park II, Singapore 117406, Singapore(2).</Affiliation>
      </Author>
      <Author>
        <Name>Bjoern Titz</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Patrice Leroy</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Gregory Vuillaume</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Monali Bera</Name>
        <Affiliation>Former employee of Philip Morris International R&amp;D, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Florian Martin</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Gregory Rodrigo</Name>
        <Affiliation>Former employee of Philip Morris International R&amp;D, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Esposito</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Dempsey</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Nikolai V. Ivanov</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Julia Hoeng</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Manuel C. Peitsch</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Vanscheeuwijck</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(2). Electronic address: Patrick.vanscheeuwijck@pmi.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the Tobacco Heating System 2.2. Part 7: Systems toxicological assessment of a mentholated version revealed reduced cellular and molecular exposure effects compared with mentholated and non-mentholated cigarette smoke.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27818347</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30333-6</DOI>
    <KeywordList>
      <Keywords>Lipidomics</Keywords>
      <Keywords>Modified risk tobacco product</Keywords>
      <Keywords>Proteomics</Keywords>
      <Keywords>Subchronic inhalation toxicity</Keywords>
      <Keywords>Systems toxicology</Keywords>
      <Keywords>Transcriptomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ulrike Kogel</Name>
        <Affiliation>Philip Morris International Research and Development, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Bjoern Titz</Name>
        <Affiliation>Philip Morris International Research and Development, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Walter K. Schlage</Name>
        <Affiliation>Biology consultant, Max-Baermann-Str. 21, 51429 Bergisch Gladbach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Nury</Name>
        <Affiliation>Philip Morris International Research and Development, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Florian Martin</Name>
        <Affiliation>Philip Morris International Research and Development, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Alberto Oviedo</Name>
        <Affiliation>Philip Morris International Research Laboratories, 50 Science Park Road, Singapore, Singapore(2).</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Lebrun</Name>
        <Affiliation>Philip Morris International Research and Development, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Ashraf Elamin</Name>
        <Affiliation>Philip Morris International Research and Development, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Emmanuel Guedj</Name>
        <Affiliation>Philip Morris International Research and Development, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Keyur Trivedi</Name>
        <Affiliation>Philip Morris International Research and Development, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Nikolai V. Ivanov</Name>
        <Affiliation>Philip Morris International Research and Development, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Vanscheeuwijck</Name>
        <Affiliation>Philip Morris International Research and Development, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Manuel C. Peitsch</Name>
        <Affiliation>Philip Morris International Research and Development, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland(2).</Affiliation>
      </Author>
      <Author>
        <Name>Julia Hoeng</Name>
        <Affiliation>Philip Morris International Research and Development, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchatel, Switzerland(2). Electronic address: julia.hoeng@pmi.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of BALB/c and CBA/J mice for the local lymph node assay using bromodeoxyuridine with flow cytometry (LLNA: BrdU-FCM).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27816673</pubmedLink>
    <Year>2017</Year>
    <DOI>S0273-2300(16)30326-9</DOI>
    <KeywordList>
      <Keywords>BALB/c</Keywords>
      <Keywords>BrdU-FCM</Keywords>
      <Keywords>CBA/J</Keywords>
      <Keywords>Flow cytometry</Keywords>
      <Keywords>LLNA</Keywords>
      <Keywords>Local lymph node assay</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yong Sun Lee</Name>
        <Affiliation>Toxicological Screening &amp; Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Sun Yi</Name>
        <Affiliation>Toxicological Screening &amp; Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Souk Jin Seo</Name>
        <Affiliation>Toxicological Screening &amp; Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Joo Hwan Kim</Name>
        <Affiliation>Toxicological Screening &amp; Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Sook Jung</Name>
        <Affiliation>Pharmacology Efficacy Team, Biotoxtech Co., Ltd., Ochang-eup, Cheongju-si, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Im Kwon Seo</Name>
        <Affiliation>Pharmacology Efficacy Team, Biotoxtech Co., Ltd., Ochang-eup, Cheongju-si, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ilyoung Ahn</Name>
        <Affiliation>Toxicological Screening &amp; Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyungyuk Ko</Name>
        <Affiliation>Toxicological Screening &amp; Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Sung Kim</Name>
        <Affiliation>Toxicological Screening &amp; Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Min Lim</Name>
        <Affiliation>College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soojung Sohn</Name>
        <Affiliation>Toxicological Screening &amp; Testing Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, Republic of Korea. Electronic address: sjsohn@korea.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the Tobacco Heating System 2.2. Part 8: 5-Day randomized reduced exposure clinical study in Poland.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27816672</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30331-2</DOI>
    <KeywordList>
      <Keywords>Biomarkers of exposure</Keywords>
      <Keywords>Conventional cigarettes</Keywords>
      <Keywords>Harmful and potentially harmful constituents</Keywords>
      <Keywords>Randomized study</Keywords>
      <Keywords>Smoking abstinence</Keywords>
      <Keywords>Tobacco heating system</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christelle Haziza</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland. Electronic address: Christelle.Haziza@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guillaume de La Bourdonnaye</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Dimitra Skiada</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jacek Ancerewicz</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Gizelle Baker</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Picavet</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Lüdicke</Name>
        <Affiliation>PMI R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of an in vitro human skin permeation assay to assess bioequivalence of two topical cream formulations containing butenafine hydrochloride (1%, w/w).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27816671</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30334-8</DOI>
    <KeywordList>
      <Keywords>Bioequivalence</Keywords>
      <Keywords>Butenafine</Keywords>
      <Keywords>Dermal</Keywords>
      <Keywords>Flux</Keywords>
      <Keywords>Skin permeation</Keywords>
      <Keywords>Topical</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amitava Mitra</Name>
        <Affiliation>Pharmaceutical Sciences and Clinical Supply, Merck &amp; Co., Inc., West Point, PA 19486, USA. Electronic address: mitraamitava11@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nanhye Kim</Name>
        <Affiliation>Bayer Consumer Care, Memphis, TN 38112, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Darren Spark</Name>
        <Affiliation>Charles River Laboratories, Tranent, East Lothian, EH33 2NE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Toner</Name>
        <Affiliation>Charles River Laboratories, Tranent, East Lothian, EH33 2NE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Craig</Name>
        <Affiliation>Charles River Laboratories, Tranent, East Lothian, EH33 2NE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Clive Roper</Name>
        <Affiliation>Charles River Laboratories, Tranent, East Lothian, EH33 2NE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas A. Meyer</Name>
        <Affiliation>Bayer Consumer Care, Memphis, TN 38112, USA. Electronic address: thomas.meyer3@bayer.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative biodistribution and safety profiling of olmesartan medoxomil oil-in-water oral nanoemulsion.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27815174</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30309-9</DOI>
    <KeywordList>
      <Keywords>Brain penetration</Keywords>
      <Keywords>Hematological parameters</Keywords>
      <Keywords>Histopathological characteristics</Keywords>
      <Keywords>Olmesartan nanoemulsion</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
      <Keywords>Tissue distribution</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bapi Gorain</Name>
        <Affiliation>Bioequivalence Study Centre, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India; Faculty of Pharmacy, Lincoln University College, Kuala Lumpur, Malaysia. Electronic address: bapi@lincoln.edu.my.</Affiliation>
      </Author>
      <Author>
        <Name>Hira Choudhury</Name>
        <Affiliation>Bioequivalence Study Centre, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Rakesh Kumar Tekade</Name>
        <Affiliation>National Institute of Pharmaceutical Education and Research (NIPER) - Ahmedabad, Department of Pharmaceutics, Opposite Air Force Station Palaj-Basan Road, Gandhinagar, Gujarat 382355, India.</Affiliation>
      </Author>
      <Author>
        <Name>Saumen Karan</Name>
        <Affiliation>Division of Pharmacology, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India.</Affiliation>
      </Author>
      <Author>
        <Name>P. Jaisankar</Name>
        <Affiliation>Department of Chemistry, Indian Institute of Chemical Biology, Jadavpur, Kolkata, India.</Affiliation>
      </Author>
      <Author>
        <Name>Tapan Kumar Pal</Name>
        <Affiliation>Bioequivalence Study Centre, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India. Electronic address: proftkpal@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of chronic toxicology studies in revealing new toxicities.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27769827</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30299-9</DOI>
    <KeywordList>
      <Keywords>Chronic</Keywords>
      <Keywords>Human safety risk</Keywords>
      <Keywords>Preclinical species</Keywords>
      <Keywords>Toxicology studies</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alema Galijatovic-Idrizbegovic</Name>
        <Affiliation>Merck and Co., Inc., West Point, PA, USA. Electronic address: alema_galijatovic@merck.com.</Affiliation>
      </Author>
      <Author>
        <Name>Judith E. Miller</Name>
        <Affiliation>Merck and Co., Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wendy D. Cornell</Name>
        <Affiliation>Merck and Co., Inc., Rahway, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James A. Butler</Name>
        <Affiliation>Linguamatics Solutions, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gordon K. Wollenberg</Name>
        <Affiliation>Merck and Co., Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Frank D. Sistare</Name>
        <Affiliation>Merck and Co., Inc., West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph J. DeGeorge</Name>
        <Affiliation>Merck and Co., Inc., West Point, PA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the Tobacco Heating System 2.2. Part 3: Influence of the tobacco blend on the formation of harmful and potentially harmful constituents of the Tobacco Heating System 2.2 aerosol.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27793747</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30305-1</DOI>
    <KeywordList>
      <Keywords>Aerosol chemistry</Keywords>
      <Keywords>Blend comparison</Keywords>
      <Keywords>HPHC</Keywords>
      <Keywords>Harmful and potentially harmful constituents</Keywords>
      <Keywords>Heat-not-burn</Keywords>
      <Keywords>Modified risk tobacco product</Keywords>
      <Keywords>THS2.2</Keywords>
      <Keywords>Tobacco heating system</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jean Pierre Schaller</Name>
        <Affiliation>Philip Morris International R&amp;D (part of Philip Morris International Group of Companies), Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland. Electronic address: jean-pierre.schaller@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Johannes P. M. Pijnenburg</Name>
        <Affiliation>Philip Morris International R&amp;D (part of Philip Morris International Group of Companies), Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Anu Ajithkumar</Name>
        <Affiliation>Philip Morris International R&amp;D (part of Philip Morris International Group of Companies), Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony R. Tricker</Name>
        <Affiliation>Philip Morris International R&amp;D (part of Philip Morris International Group of Companies), Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the Tobacco Heating System 2.2. Part 4: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects compared with cigarette smoke.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27793746</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30304-X</DOI>
    <KeywordList>
      <Keywords>Heat-not-burn</Keywords>
      <Keywords>Inhalation systems toxicology</Keywords>
      <Keywords>Inhalation toxicology study</Keywords>
      <Keywords>Modified risk tobacco product</Keywords>
      <Keywords>Pulmonary inflammation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ee Tsin Wong</Name>
        <Affiliation>Philip Morris International Research Laboratories Pte Ltd, 50 Science Park Road, The Kendall #02-07 Science Park II, 117406, Singapore(1).</Affiliation>
      </Author>
      <Author>
        <Name>Ulrike Kogel</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Emilija Veljkovic</Name>
        <Affiliation>Philip Morris International Research Laboratories Pte Ltd, 50 Science Park Road, The Kendall #02-07 Science Park II, 117406, Singapore(1).</Affiliation>
      </Author>
      <Author>
        <Name>Florian Martin</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Yang Xiang</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie Boue</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Gregory Vuillaume</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Patrice Leroy</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Emmanuel Guedj</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Gregory Rodrigo</Name>
        <Affiliation>Former employee of Philip Morris International R&amp;D, Philip Morris Products S.A., Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Nikolai V. Ivanov</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Julia Hoeng</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Manuel C. Peitsch</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Vanscheeuwijck</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland(1). Electronic address: Patrick.Vanscheeuwijck@pmi.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the toxicokinetics and apoptotic potential of ethanol extract from Echinodorus macrophyllus leaves in vivo.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27793745</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30306-3</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Comet assay</Keywords>
      <Keywords>Echinodorus macrophyllus</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>LD(50)</Keywords>
      <Keywords>Micronucleus test</Keywords>
      <Keywords>Mutagenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Márcia Soares Mattos Vaz</Name>
        <Affiliation>Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mário Sérgio Vaz da Silva</Name>
        <Affiliation>Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rodrigo Juliano Oliveira</Name>
        <Affiliation>Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jonas da Silva Mota</Name>
        <Affiliation>Centre for Research on Biodiversity (CPBIO), State University of Mato Grosso do Sul (UEMS), Dourados, Mato Grosso do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Débora Regina Hoff Brait</Name>
        <Affiliation>Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luciana Noia Borges de Carvalho</Name>
        <Affiliation>Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juliana Miron Vani</Name>
        <Affiliation>Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Rodrigues Berno</Name>
        <Affiliation>Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Flávio Henrique Souza Araújo</Name>
        <Affiliation>Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Márcio Eduardo de Barros</Name>
        <Affiliation>Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil; University Hospital of the Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil. Electronic address: marciobarros@ufgd.edu.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and repeated doses (28 days) oral toxicity study of Vicenin-1, a flavonoid glycoside isolated from fenugreek seeds in laboratory mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27773753</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30302-6</DOI>
    <KeywordList>
      <Keywords>Acute toxicity test</Keywords>
      <Keywords>Flavonol glycoside</Keywords>
      <Keywords>LD(50)</Keywords>
      <Keywords>Lowest adverse effect levels</Keywords>
      <Keywords>No-observed-adverse-effect levels</Keywords>
      <Keywords>Subacute toxicity tests</Keywords>
      <Keywords>Vicenin-1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amit D. Kandhare</Name>
        <Affiliation>Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Paud Road, Pune, 411 038, India.</Affiliation>
      </Author>
      <Author>
        <Name>Subhash L. Bodhankar</Name>
        <Affiliation>Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Paud Road, Pune, 411 038, India. Electronic address: drslbodh@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>V. Mohan</Name>
        <Affiliation>Indus Biotech Private Limited, 1, Rahul Residency, Off Salunke Vihar Road, Kondhwa, Pune, 411 048, India.</Affiliation>
      </Author>
      <Author>
        <Name>Prasad A. Thakurdesai</Name>
        <Affiliation>Indus Biotech Private Limited, 1, Rahul Residency, Off Salunke Vihar Road, Kondhwa, Pune, 411 048, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The need for transparency and reproducibility in documenting values for regulatory decision making and evaluating causality: The example of formaldehyde.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27771342</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30300-2</DOI>
    <KeywordList>
      <Keywords>Dose-response analysis</Keywords>
      <Keywords>Epidemiology</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Inhalation unit risk estimates</Keywords>
      <Keywords>Quantitative methods</Keywords>
      <Keywords>Reproducibility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cynthia Van Landingham</Name>
        <Affiliation>Ramboll Environ US Corporation, 3001 Armand St., Suite I, Monroe, LA 71201, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth A. Mundt</Name>
        <Affiliation>Ramboll Environ US Corporation, 28 Amity St., Suite 2A, Amherst, MA 01002, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce C. Allen</Name>
        <Affiliation>Independent Consultant, 101 Corbin Hill Circle, Chapel Hill, NC 27514, United States.</Affiliation>
      </Author>
      <Author>
        <Name>P. Robinan Gentry</Name>
        <Affiliation>Ramboll Environ US Corporation, 3001 Armand St., Suite I, Monroe, LA 71201, United States. Electronic address: rgentry@ramboll.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of in vivo immunomodulatory effects of 5-hydroxymethylfurfural and 5, 5'-oxydimethylenebis (2-furfural).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27765717</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30297-5</DOI>
    <KeywordList>
      <Keywords>5, 5′-Oxydimethylenebis (2-furfural)</Keywords>
      <Keywords>5-Hydroxymethylfurfural</Keywords>
      <Keywords>Immune-mediated hypersensitivity reaction</Keywords>
      <Keywords>Immunomudulation</Keywords>
      <Keywords>Immunosensitizing</Keywords>
      <Keywords>Popliteal lymph node assay</Keywords>
      <Keywords>Traditional Chinese medicine injection</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ni Lin</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Tiantian Liu</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Lin</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Sheng Lin</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingce Zang</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiuming He</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zeper Abliz</Name>
        <Affiliation>State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Li</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China; Beijing Union-Genius Pharmaceutical Technology Development Co., Ltd., Beijing 100050, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Aiping Wang</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China; Beijing Union-Genius Pharmaceutical Technology Development Co., Ltd., Beijing 100050, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongtao Jin</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China; Beijing Union-Genius Pharmaceutical Technology Development Co., Ltd., Beijing 100050, PR China. Electronic address: jinhongtao@imm.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Route-to-route extrapolation of 1,2-dichloroethane studies from the oral route to inhalation using physiologically based pharmacokinetic models.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27756559</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30292-6</DOI>
    <KeywordList>
      <Keywords>1,2-dichloroethane</Keywords>
      <Keywords>Ethylene dichloride</Keywords>
      <Keywords>Extended one-generation study</Keywords>
      <Keywords>PBPK modeling</Keywords>
      <Keywords>Route-to-route extrapolation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lisa M. Sweeney</Name>
        <Affiliation>Independent Consultants, Dayton, OH, USA. Electronic address: LMSweeney@aol.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael L. Gargas</Name>
        <Affiliation>Independent Consultants, Dayton, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of widely used fermented virgin coconut oil (Cocos nucifera) in Malaysia: Chronic toxicity studies and SAR analysis of the active components.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27756558</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30294-X</DOI>
    <KeywordList>
      <Keywords>Fermented virgin coconut oil</Keywords>
      <Keywords>SAR</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Southeast Asia</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ahmad H. Ibrahim</Name>
        <Affiliation>EMAN Testing &amp; Research Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia; Department of Biology, Faculty of Sciences, University of Zakho, Iraq.</Affiliation>
      </Author>
      <Author>
        <Name>Md Shamsuddin Sultan Khan</Name>
        <Affiliation>EMAN Testing &amp; Research Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Sawsan S. Al-Rawi</Name>
        <Affiliation>Department of Biology, Faculty of Sciences, University of Zakho, Iraq.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed B. Khadeer Ahamed</Name>
        <Affiliation>EMAN Biodiscoveries Sdn. Bhd., Suite 126, Level 1, EUREKA Complex, Universiti Sains Malaysia (USM), Minden, 11800, Penang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Aman Shah Bin Abdul Majid</Name>
        <Affiliation>Department of Pharmacology, QUEST International University, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Fouad Saleih R. Al-Suede</Name>
        <Affiliation>EMAN Testing &amp; Research Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Ji</Name>
        <Affiliation>The First People's Hospital of Changde City, Hunan Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Amin Malik Shah Abdul Majid</Name>
        <Affiliation>EMAN Testing &amp; Research Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia. Electronic address: aminmalikshah@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An FDA oncology analysis of immune activating products and first-in-human dose selection.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27743776</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30291-4</DOI>
    <KeywordList>
      <Keywords>First-in-human dose</Keywords>
      <Keywords>Immune oncology</Keywords>
      <Keywords>MABEL</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haleh Saber</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States. Electronic address: haleh.saber@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Ramadevi Gudi</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Manning</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Emily Wearne</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John K. Leighton</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tiered application of the neutral red release and EpiOcular™ assays for evaluating the eye irritation potential of agrochemical formulations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27693708</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30276-8</DOI>
    <KeywordList>
      <Keywords>Agrochemical formulations</Keywords>
      <Keywords>EpiOcular assay</Keywords>
      <Keywords>Eye irritation</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Neutral red release assay</Keywords>
      <Keywords>Ocular irritation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Raja S. Settivari</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA. Electronic address: rssettivari@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ricardo Acosta Amado</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Corvaro</Name>
        <Affiliation>Dow Chemical Services UK Ltd, Milton Park, Abingdon, Oxon, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Nicolo R. Visconti</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lynn Kan</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Edward W. Carney</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Darrell R. Boverhof</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sean C. Gehen</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of reproductive and developmental effects of DINP, DnHP and DCHP using quantitative weight of evidence.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27693707</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30280-X</DOI>
    <KeywordList>
      <Keywords>Classification and labeling</Keywords>
      <Keywords>Quantitative assessments</Keywords>
      <Keywords>Reproductive and developmental toxicity</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>Department of Toxicology, University of Würzburg, 97078 Würzburg, Germany. Electronic address: dekant@toxi.uni-wuerzburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>James Bridges</Name>
        <Affiliation>University of Surrey, Guildford, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human umbilical cord-derived mesenchymal stem cells in acute liver injury: Hepatoprotective efficacy, subchronic toxicity, tumorigenicity, and biodistribution.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27693706</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30277-X</DOI>
    <KeywordList>
      <Keywords>Biodistribution</Keywords>
      <Keywords>Liver injury</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Tumorigenicity</Keywords>
      <Keywords>Umbilical cord-derived mesenchymal stem cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Won Yun</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Hun Ahn</Name>
        <Affiliation>Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Euna Kwon</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyun Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hanna Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ja June Jang</Name>
        <Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Woo Ho Kim</Name>
        <Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Hyang Kim</Name>
        <Affiliation>Biotechnology Research Institute, Hurim BioCell Co. Ltd., Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Su Youne Han</Name>
        <Affiliation>Biotechnology Research Institute, Hurim BioCell Co. Ltd., Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Tac Kim</Name>
        <Affiliation>Biotechnology Research Institute, Hurim BioCell Co. Ltd., Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Hoon Kim</Name>
        <Affiliation>Laboratory of Stem Cell Biology, Division of Biotechnology, Department of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wookhwan Kim</Name>
        <Affiliation>Department of General Surgery, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Yup Ku</Name>
        <Affiliation>Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Rok Do</Name>
        <Affiliation>Biotechnology Research Institute, Hurim BioCell Co. Ltd., Seoul, Republic of Korea. Electronic address: brokdo@nuri.net.</Affiliation>
      </Author>
      <Author>
        <Name>Byeong Cheol Kang</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Biomedical Center for Animal Resource and Development, Seoul National University College of Medicine, Seoul, Republic of Korea; Designed Animal and Transplantation Research Institute, Institute of GreenBio Science Technology, Seoul National University, Pyeongchang-gun, Gangwon-do, Republic of Korea. Electronic address: bckang@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of biomonitoring equivalent for inorganic tin for interpreting population-level urinary biomonitoring data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27693705</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30278-1</DOI>
    <KeywordList>
      <Keywords>BE</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring-equivalents</Keywords>
      <Keywords>Inorganic tin</Keywords>
      <Keywords>Tin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Devika Poddalgoda</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Macey</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Innocent Jayawardene</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Kannan Krishnan</Name>
        <Affiliation>ESPUM, Université de Montréal, QC, Canada. Electronic address: KKrishnan@Risksciences.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Astaxanthin enhances pemetrexed-induced cytotoxicity by downregulation of thymidylate synthase expression in human lung cancer cells.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27693704</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30279-3</DOI>
    <KeywordList>
      <Keywords>Astaxanthin</Keywords>
      <Keywords>ERK1/2</Keywords>
      <Keywords>Non-small cell lung cancer</Keywords>
      <Keywords>Pemetrexed</Keywords>
      <Keywords>Thymidylate synthase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kai Sheng Liao</Name>
        <Affiliation>Department of Pathology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan; School of Nursing, Chung Jen Junior College of Nursing, Health Science and Management, Chiayi, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Li Wei</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Jyh Cheng Chen</Name>
        <Affiliation>Department of Food Science, National Chiayi University, Chiayi, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Yu Zheng</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Ching Chen</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Hung Wu</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Tai Jing Wang</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Shuan Peng</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Po Yuan Chang</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Wei Lin</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi, Taiwan. Electronic address: linyw@mail.ncyu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the reduction in levels of exposure to harmful and potentially harmful constituents in Japanese subjects using a novel tobacco heating system compared with conventional cigarettes and smoking abstinence: A randomized controlled study in confinement.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27693654</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30262-8</DOI>
    <KeywordList>
      <Keywords>Biomarkers of exposure</Keywords>
      <Keywords>Harmful and potentially harmful constituents</Keywords>
      <Keywords>Modified risk tobacco product</Keywords>
      <Keywords>Randomized study</Keywords>
      <Keywords>Reduced risk product</Keywords>
      <Keywords>Smoking</Keywords>
      <Keywords>Smoking abstinence</Keywords>
      <Keywords>Tobacco heating system</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christelle Haziza</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland. Electronic address: Christelle.haziza@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guillaume de La Bourdonnaye</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Merlet</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Muriel Benzimra</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jacek Ancerewicz</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Donelli</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Gizelle Baker</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Picavet</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Lüdicke</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A. (Part of Philip Morris International Group of Companies), Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Temporal kinetics of organ damage in copper toxicity: A histopathological correlation in rat model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27670080</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30273-2</DOI>
    <KeywordList>
      <Keywords>Brain</Keywords>
      <Keywords>Copper toxicity</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Kidney</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vijay Kumar</Name>
        <Affiliation>Department of Neurology, Sanjay Gandhi Post Graduate Medical Sciences, Lucknow, India.</Affiliation>
      </Author>
      <Author>
        <Name>Jayantee Kalita</Name>
        <Affiliation>Department of Neurology, Sanjay Gandhi Post Graduate Medical Sciences, Lucknow, India. Electronic address: jayanteek@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Himangsu K. Bora</Name>
        <Affiliation>National Laboratory Animal Centre, CSIR-Central Drug Research Institute, Lucknow, India.</Affiliation>
      </Author>
      <Author>
        <Name>Usha K. Misra</Name>
        <Affiliation>Department of Neurology, Sanjay Gandhi Post Graduate Medical Sciences, Lucknow, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The JRC Nanomaterials Repository: A unique facility providing representative test materials for nanoEHS research.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27670079</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30229-X</DOI>
    <KeywordList>
      <Keywords>Harmonisation of test guidelines</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>OECD WPMN testing programme</Keywords>
      <Keywords>Repository</Keywords>
      <Keywords>Representative nanomaterials</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sara Totaro</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate F - Consumer Product Safety - Via E. Fermi 2749, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Giulio Cotogno</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate F - Consumer Product Safety - Via E. Fermi 2749, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Kirsten Rasmussen</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate F - Consumer Product Safety - Via E. Fermi 2749, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Francesca Pianella</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate F - Consumer Product Safety - Via E. Fermi 2749, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Roncaglia</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate F - Consumer Product Safety - Via E. Fermi 2749, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Heidi Olsson</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate F - Consumer Product Safety - Via E. Fermi 2749, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Juan M. Riego Sintes</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate F - Consumer Product Safety - Via E. Fermi 2749, Ispra, VA, Italy. Electronic address: juan.riego-sintes@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Hugues P. Crutzen</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate F - Consumer Product Safety - Via E. Fermi 2749, Ispra, VA, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment and attenuation of cisplatin induced nephrotoxicity by tuberous roots of Boerhaavia diffusa.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27667768</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30268-9</DOI>
    <KeywordList>
      <Keywords>Acute toxicity study</Keywords>
      <Keywords>Boerhaavia diffusa</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Nephrotoxicity</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ritu Karwasra</Name>
        <Affiliation>Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.</Affiliation>
      </Author>
      <Author>
        <Name>Prerna Kalra</Name>
        <Affiliation>Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.</Affiliation>
      </Author>
      <Author>
        <Name>T. C. Nag</Name>
        <Affiliation>Department of Anatomy, All India Institute of Medical Sciences, New Delhi, 110029, India.</Affiliation>
      </Author>
      <Author>
        <Name>Y. K. Gupta</Name>
        <Affiliation>Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.</Affiliation>
      </Author>
      <Author>
        <Name>Surender Singh</Name>
        <Affiliation>Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India. Electronic address: surenderaiims@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anuj Panwar</Name>
        <Affiliation>Division of Environmental Toxicology, AES Laboratories (P) Ltd., Noida, Uttar Pradesh, 201304, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Critical elements for human health risk assessment of less than lifetime exposures.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27664324</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30274-4</DOI>
    <KeywordList>
      <Keywords>Fluctuating exposure</Keywords>
      <Keywords>Intermittent exposure</Keywords>
      <Keywords>Less than lifetime exposure</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liesbeth Geraets</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Monique M. Nijkamp</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Wouter Ter Burg</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: wouter.ter.burg@rivm.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subacute toxicity evaluation of KR-33493, FAF1 inhibitor for a new anti-parkinson's disease agent, after oral administration in rats and dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27664323</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30270-7</DOI>
    <KeywordList>
      <Keywords>FAF1 inhibitor</Keywords>
      <Keywords>KR33493</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Parkinson's disease</Keywords>
      <Keywords>Phase 1 clinical trial</Keywords>
      <Keywords>Subacute toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jong Woo Jeong</Name>
        <Affiliation>Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Changsun Yu</Name>
        <Affiliation>College of Biological Sciences and Biotechnology, Chungnam National University, Daejeon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Hwa Lee</Name>
        <Affiliation>Research Center for General and Applied Toxicology, Korea Institute Toxicology, Daejeon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyoung Sik Moon</Name>
        <Affiliation>Research Center for General and Applied Toxicology, Korea Institute Toxicology, Daejeon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eunhee Kim</Name>
        <Affiliation>Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, South Korea; College of Biological Sciences and Biotechnology, Chungnam National University, Daejeon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Eun Yoo</Name>
        <Affiliation>Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, South Korea. Electronic address: seyoo@cnu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Sung Koo</Name>
        <Affiliation>Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, South Korea. Electronic address: kootae@cnu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Testing in artificial sweat - Is less more? Comparison of metal release in two different artificial sweat solutions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27664322</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30269-0</DOI>
    <KeywordList>
      <Keywords>Artificial sweat</Keywords>
      <Keywords>Bio-elution test</Keywords>
      <Keywords>Bioaccessibility</Keywords>
      <Keywords>Cobalt</Keywords>
      <Keywords>Contact allergy</Keywords>
      <Keywords>Hard metal</Keywords>
      <Keywords>Nickel</Keywords>
      <Keywords>Sensitizing metals</Keywords>
      <Keywords>White gold</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Klara Midander</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE 171 77, Stockholm, Sweden. Electronic address: klara.midander@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>Anneli Julander</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE 171 77, Stockholm, Sweden. Electronic address: anneli.julander@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>Jolinde Kettelarij</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE 171 77, Stockholm, Sweden. Electronic address: jolinde.kettelarij@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>Carola Lidén</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE 171 77, Stockholm, Sweden. Electronic address: carola.liden@ki.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Polymeric nanocapsules as a technological alternative to reduce the toxicity caused by meloxicam in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27664321</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30271-9</DOI>
    <KeywordList>
      <Keywords>Lipid peroxidation</Keywords>
      <Keywords>Meloxicam</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Nanotoxicology</Keywords>
      <Keywords>Ulcerogenic potential</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Benonio T. Villalba</Name>
        <Affiliation>Programa de Pós-graduação em Nanociências, Centro de Ciências Tecnológicas, Centro Universitário Franciscano, Santa Maria, CEP 97010-032, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Francine R. Ianiski</Name>
        <Affiliation>Programa de Pós-graduação em Nanociências, Centro de Ciências Tecnológicas, Centro Universitário Franciscano, Santa Maria, CEP 97010-032, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ane G. Vogt</Name>
        <Affiliation>Grupo de Pesquisa em Neurobiotecnologia, Universidade Federal de Pelotas, Capão do Leão, CEP: 96010-900, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mikaela P. Pinz</Name>
        <Affiliation>Grupo de Pesquisa em Neurobiotecnologia, Universidade Federal de Pelotas, Capão do Leão, CEP: 96010-900, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Angélica S. Reis</Name>
        <Affiliation>Grupo de Pesquisa em Neurobiotecnologia, Universidade Federal de Pelotas, Capão do Leão, CEP: 96010-900, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rodrigo A. Vaucher</Name>
        <Affiliation>Programa de Pós-graduação em Nanociências, Centro de Ciências Tecnológicas, Centro Universitário Franciscano, Santa Maria, CEP 97010-032, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mauro P. Soares</Name>
        <Affiliation>Laboratório Regional de Diagnóstico Faculdade de Veterinária, Universidade Federal de Pelotas, Capão do Leão, CEP: 96010-900, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ethel A. Wilhelm</Name>
        <Affiliation>Grupo de Pesquisa em Neurobiotecnologia, Universidade Federal de Pelotas, Capão do Leão, CEP: 96010-900, RS, Brazil. Electronic address: ethelwilhelm@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Cristiane Luchese</Name>
        <Affiliation>Grupo de Pesquisa em Neurobiotecnologia, Universidade Federal de Pelotas, Capão do Leão, CEP: 96010-900, RS, Brazil. Electronic address: cristiane_luchese@yahoo.com.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effect of time changes in diagnosing lung cancer type on its recorded distribution, with particular reference to adenocarcinoma.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27664320</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30267-7</DOI>
    <KeywordList>
      <Keywords>Diagnostic accuracy</Keywords>
      <Keywords>Histological type</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Time trends</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd., Sutton, Surrey, UK. Electronic address: PeterLee@peterlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>John R. Gosney</Name>
        <Affiliation>Department of Pathology, Royal Liverpool Hospital, Liverpool, UK. Electronic address: J.Gosney@rlbuht.nhs.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic trioxide mediates HAPI microglia inflammatory response and the secretion of inflammatory cytokine IL-6 via Akt/NF-κB signaling pathway.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27664319</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30275-6</DOI>
    <KeywordList>
      <Keywords>Akt/NF-кB/IL-6</Keywords>
      <Keywords>Arsenic trioxide</Keywords>
      <Keywords>Microglia</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gang Chen</Name>
        <Affiliation>Department of Labor and Environmental Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiamin Mao</Name>
        <Affiliation>Department of Labor and Environmental Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianmei Zhao</Name>
        <Affiliation>Department of Pediatrics, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhang</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Li</Name>
        <Affiliation>Department of Labor and Environmental Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Wang</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingfei Xu</Name>
        <Affiliation>Department of Labor and Environmental Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiaoyun Hu</Name>
        <Affiliation>Department of Labor and Environmental Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoke Wang</Name>
        <Affiliation>Department of Labor and Environmental Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengyang Jiang</Name>
        <Affiliation>Department of Labor and Environmental Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoke Nie</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiyun Wu</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China. Electronic address: wqy@ntu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Methyl isobutyl ketone-induced hepatocellular carcinogenesis in B6C3F</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27664318</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30272-0</DOI>
    <KeywordList>
      <Keywords>BrdU labeling</Keywords>
      <Keywords>CAR/PXR</Keywords>
      <Keywords>Knockout mice</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Rodent liver</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>B. J. Hughes</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA. Electronic address: bhughes2@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Thomas</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Lynch</Name>
        <Affiliation>American Chemistry Council, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. J. Borghoff</Name>
        <Affiliation>ToxStrategies, Cary, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. Green</Name>
        <Affiliation>Eastman Chemical, Kingsport, TN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>T. Mensing</Name>
        <Affiliation>Sasol Solvents, Moers, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>S. S. Sarang</Name>
        <Affiliation>Shell International, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. J. LeBaron</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Residue behavior and dietary intake risk assessment of three fungicides in tomatoes (Lycopersicon esculentum Mill.) under greenhouse conditions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27647629</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30263-X</DOI>
    <KeywordList>
      <Keywords>Dissipation</Keywords>
      <Keywords>Fungicide</Keywords>
      <Keywords>Greenhouse</Keywords>
      <Keywords>Residue</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Tomato</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaodan Zhu</Name>
        <Affiliation>Institute of Plant and Environment Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing, 100097, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunhong Jia</Name>
        <Affiliation>Institute of Plant and Environment Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing, 100097, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lifang Duan</Name>
        <Affiliation>Institute for the Control of Agrochemicals, Ministry of Agriculture, Beijing, 100125, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhang</Name>
        <Affiliation>Institute for the Control of Agrochemicals, Ministry of Agriculture, Beijing, 100125, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pingzhong Yu</Name>
        <Affiliation>Institute of Plant and Environment Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing, 100097, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min He</Name>
        <Affiliation>Institute of Plant and Environment Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing, 100097, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Chen</Name>
        <Affiliation>Institute of Plant and Environment Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing, 100097, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ercheng Zhao</Name>
        <Affiliation>Institute of Plant and Environment Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing, 100097, China. Electronic address: eczhao@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Results from oral gavage carcinogenicity studies of ruxolitinib in Tg.rasH2 mice and Sprague-Dawley (Crl:CD) rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27647628</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30264-1</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>JAK</Keywords>
      <Keywords>Jakafi</Keywords>
      <Keywords>Jakavi</Keywords>
      <Keywords>Janus kinase</Keywords>
      <Keywords>Ruxolitinib</Keywords>
      <Keywords>Tg.rasH2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dana L. Shuey</Name>
        <Affiliation>Incyte Corporation, USA. Electronic address: dshuey@incyte.com.</Affiliation>
      </Author>
      <Author>
        <Name>Julian Oliver</Name>
        <Affiliation>Incyte Corporation, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gongfu Zhou</Name>
        <Affiliation>Incyte Corporation, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Roberts</Name>
        <Affiliation>Incyte Corporation, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metabolomics as read-across tool: A case study with phenoxy herbicides.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27637788</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30261-6</DOI>
    <KeywordList>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Prediction</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Read across</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>B. van Ravenzwaay</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany. Electronic address: bennard.ravenzwaay@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>S. Sperber</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>O. Lemke</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>E. Fabian</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>F. Faulhammer</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>H. Kamp</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>W. Mellert</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>V. Strauss</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>A. Strigun</Name>
        <Affiliation>Metanomics GmbH, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>E. Peter</Name>
        <Affiliation>Metanomics GmbH, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>M. Spitzer</Name>
        <Affiliation>Metanomics GmbH, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>T. Walk</Name>
        <Affiliation>Metanomics GmbH, Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Monitoring and exposure assessment of pesticide residues in cowpea (Vigna unguiculata L. Walp) from five provinces of southern China.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27637787</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30260-4</DOI>
    <KeywordList>
      <Keywords>Deterministic assessment</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Monitoring</Keywords>
      <Keywords>Probabilistic assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhibo Huan</Name>
        <Affiliation>Hainan Provincial Key Laboratory of Quality and Safety for Tropical Fruits and Vegetables, Analysis and Testing Center, Chinese Academy of Tropical Agricultural Sciences, Haikou 571101, China. Electronic address: huanzhibo@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Xu</Name>
        <Affiliation>Hainan Provincial Key Laboratory of Quality and Safety for Tropical Fruits and Vegetables, Analysis and Testing Center, Chinese Academy of Tropical Agricultural Sciences, Haikou 571101, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinhui Luo</Name>
        <Affiliation>Hainan Provincial Key Laboratory of Quality and Safety for Tropical Fruits and Vegetables, Analysis and Testing Center, Chinese Academy of Tropical Agricultural Sciences, Haikou 571101, China.</Affiliation>
      </Author>
      <Author>
        <Name>Defang Xie</Name>
        <Affiliation>Hainan Provincial Key Laboratory of Quality and Safety for Tropical Fruits and Vegetables, Analysis and Testing Center, Chinese Academy of Tropical Agricultural Sciences, Haikou 571101, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>4-Week repeated dose oral toxicity study of N-ethyl-2-pyrrolidone in Sprague Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27634062</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30259-8</DOI>
    <KeywordList>
      <Keywords>28-Day study</Keywords>
      <Keywords>N-ethyl-2-pyrrolidone</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. M. Saillenfait</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Vandoeuvre, France. Electronic address: anne-marie.saillenfait@inrs.fr.</Affiliation>
      </Author>
      <Author>
        <Name>F. Marquet</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Vandoeuvre, France.</Affiliation>
      </Author>
      <Author>
        <Name>J. P. Sabaté</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Vandoeuvre, France.</Affiliation>
      </Author>
      <Author>
        <Name>D. Ndiaye</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Vandoeuvre, France.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Lambert-Xolin</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Vandoeuvre, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>How accurately and consistently do laboratories measure workplace concentrations of respirable crystalline silica?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27620965</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30255-0</DOI>
    <KeywordList>
      <Keywords>Accuracy</Keywords>
      <Keywords>Estimation error</Keywords>
      <Keywords>Laboratory error</Keywords>
      <Keywords>Performance statistics</Keywords>
      <Keywords>Reliability</Keywords>
      <Keywords>Respirable crystalline silica (RCS)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Louis Anthony Tony Cox</Name>
        <Affiliation>Cox Associates, 503 Franklin St., Denver, CO 80218, United States. Electronic address: tcoxdenver@aol.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prediction of carcinogenic potential of chemicals using repeated-dose (13-week) toxicity data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27614137</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30251-3</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Non-genotoxic carcinogens</Keywords>
      <Keywords>Predictivity</Keywords>
      <Keywords>Preneoplastic lesions</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
      <Keywords>Tumours</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ruud A. Woutersen</Name>
        <Affiliation>TNO Innovation for Life, P.O. Box 360, 3700 AJ, Zeist, The Netherlands; Division of Toxicology, Wageningen University and Research Centre, P.O. Box 8000, 6700 EA, Wageningen, The Netherlands. Electronic address: ruud.woutersen@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Ans E. M. F. Soffers</Name>
        <Affiliation>Division of Toxicology, Wageningen University and Research Centre, P.O. Box 8000, 6700 EA, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>E. Dinant Kroese</Name>
        <Affiliation>TNO Innovation for Life, P.O. Box 360, 3700 AJ, Zeist, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Cyrille A. M. Krul</Name>
        <Affiliation>TNO Innovation for Life, P.O. Box 360, 3700 AJ, Zeist, The Netherlands; University of Applied Sciences Utrecht, Institute for Life Sciences &amp; Chemistry, P.O. Box 12011, 3501 AA, Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Willem van der Laan</Name>
        <Affiliation>Medicines Evaluation Board, Section on Pharmacological, Toxicological and Biotechnological Assessment, P.O. Box 8275, 3503 RG, Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jan van Benthem</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Health Protection, P.O. Box 1, 3720 BA, Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Mirjam Luijten</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Health Protection, P.O. Box 1, 3720 BA, Bilthoven, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quantifying the benefits of using read-across and in silico techniques to fulfill hazard data requirements for chemical categories.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27612993</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30252-5</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Animal alternatives</Keywords>
      <Keywords>Category approach</Keywords>
      <Keywords>HPV</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Trend analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kathleen Stanton</Name>
        <Affiliation>Technical Department, American Cleaning Institute, 1331 L Street, NW, Suite 650, Washington, DC, USA. Electronic address: kstanton@cleaninginstitute.org.</Affiliation>
      </Author>
      <Author>
        <Name>Francis H. Kruszewski</Name>
        <Affiliation>Technical Department, American Cleaning Institute, 1331 L Street, NW, Suite 650, Washington, DC, USA. Electronic address: fkruszewski@cleaninginstitute.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The comparison of animal models for premature ovarian failure established by several different source of inducers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27612992</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30250-1</DOI>
    <KeywordList>
      <Keywords>4-Vinylcyclohexene diepoxide</Keywords>
      <Keywords>Busulfan</Keywords>
      <Keywords>Chemotherapy</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Cyclophosphamide</Keywords>
      <Keywords>Galactose</Keywords>
      <Keywords>Premature ovarian failure</Keywords>
      <Keywords>Tripterygium glycosides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ting Zhang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China; Reproductive and Developmental Research Institute of Fudan University, China; National Population and Family Planning Key Laboratory of Contraceptives Drugs and Devices, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dawei Yan</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China; Reproductive and Developmental Research Institute of Fudan University, China; National Population and Family Planning Key Laboratory of Contraceptives Drugs and Devices, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China; Reproductive and Developmental Research Institute of Fudan University, China; National Population and Family Planning Key Laboratory of Contraceptives Drugs and Devices, China.</Affiliation>
      </Author>
      <Author>
        <Name>Aicui Ma</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China; Reproductive and Developmental Research Institute of Fudan University, China; National Population and Family Planning Key Laboratory of Contraceptives Drugs and Devices, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Li</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China; Reproductive and Developmental Research Institute of Fudan University, China; National Population and Family Planning Key Laboratory of Contraceptives Drugs and Devices, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhonghui Wang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China; Reproductive and Developmental Research Institute of Fudan University, China; National Population and Family Planning Key Laboratory of Contraceptives Drugs and Devices, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Pan</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China; Reproductive and Developmental Research Institute of Fudan University, China; National Population and Family Planning Key Laboratory of Contraceptives Drugs and Devices, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zuyue Sun</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China; Reproductive and Developmental Research Institute of Fudan University, China; National Population and Family Planning Key Laboratory of Contraceptives Drugs and Devices, China. Electronic address: sunzy64@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of dose volume and delivery device on bronchoalveolar lavage parameters of intratracheally administered nano-sized TiO</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27586790</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30248-3</DOI>
    <KeywordList>
      <Keywords>Delivery device</Keywords>
      <Keywords>Dose volume</Keywords>
      <Keywords>Intratracheal administration</Keywords>
      <Keywords>Nanomaterial</Keywords>
      <Keywords>Titanium dioxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Toshio Kobayashi</Name>
        <Affiliation>CERI Hita, Chemicals Evaluation and Research Institute, Japan, 3-822, Ishii-machi, Hita-shi, Oita, 877-0061, Japan. Electronic address: kobayashi-toshio@ceri.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yutaka Oshima</Name>
        <Affiliation>CERI Hita, Chemicals Evaluation and Research Institute, Japan, 3-822, Ishii-machi, Hita-shi, Oita, 877-0061, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuhiro Tsubokura</Name>
        <Affiliation>CERI Hita, Chemicals Evaluation and Research Institute, Japan, 3-822, Ishii-machi, Hita-shi, Oita, 877-0061, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Naoki Hashizume</Name>
        <Affiliation>CERI Kurume, Chemicals Evaluation and Research Institute, Japan, 3-2-7, Miyanojin, Kurume-shi, Fukuoka, 839-0801, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shozo Ajimi</Name>
        <Affiliation>CERI Hita, Chemicals Evaluation and Research Institute, Japan, 3-822, Ishii-machi, Hita-shi, Oita, 877-0061, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takakazu Kayashima</Name>
        <Affiliation>Chemical Biotesting Center, Chemicals Evaluation and Research Institute, Japan, 1-4-25, Kouraku, Bunkyo-ku, Tokyo, 112-0004, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Nakai</Name>
        <Affiliation>Chemicals Assessment and Research Center, Chemicals Evaluation and Research Institute, Japan, 1-4-25, Kouraku, Bunkyo-ku, Tokyo, 112-0004, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeshi Sasaki</Name>
        <Affiliation>National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kenji Kawaguchi</Name>
        <Affiliation>National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nobuya Imatanaka</Name>
        <Affiliation>Chemicals Assessment and Research Center, Chemicals Evaluation and Research Institute, Japan, 1-4-25, Kouraku, Bunkyo-ku, Tokyo, 112-0004, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure Factor considerations for safety evaluation of modern disposable diapers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27580878</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30247-1</DOI>
    <KeywordList>
      <Keywords>Baby</Keywords>
      <Keywords>Children</Keywords>
      <Keywords>Diaper safety</Keywords>
      <Keywords>Disposable baby diapers</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Exposure based safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Swatee Dey</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, USA. Electronic address: dey.s.3@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mike Purdon</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Taryn Kirsch</Name>
        <Affiliation>Procter &amp; Gamble Service GmDH, Schwalbach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>HansMartin Helbich</Name>
        <Affiliation>Procter &amp; Gamble Service GmDH, Schwalbach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Kenny Kerr</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lijuan Li</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shaoying Zhou</Name>
        <Affiliation>The Procter &amp; Gamble Company, Cincinnati, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of dicamba mono-oxygenases that confer dicamba tolerance to various crops.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27575686</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30244-6</DOI>
    <KeywordList>
      <Keywords>Dicamba</Keywords>
      <Keywords>Dicamba mono-oxygenase</Keywords>
      <Keywords>Domain structure</Keywords>
      <Keywords>Functionality</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cunxi Wang</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, USA. Electronic address: cunxi.wang@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin C. Glenn</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Colton Kessenich</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Erin Bell</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Luis A. Burzio</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael S. Koch</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Li</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andre Silvanovich</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Surface passivity largely governs the bioaccessibility of nickel-based powder particles at human exposure conditions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27575685</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30243-4</DOI>
    <KeywordList>
      <Keywords>Alloy</Keywords>
      <Keywords>Bioaccessibility</Keywords>
      <Keywords>Inconel</Keywords>
      <Keywords>Nickel</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yolanda S. Hedberg</Name>
        <Affiliation>KTH Royal Institute of Technology, School of Chemical Science and Engineering, Department of Chemistry, Division of Surface and Corrosion Science, Drottning Kristinas v. 51, SE-10044, Stockholm, Sweden; Unit of Work Environment Toxicology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77, Stockholm, Sweden. Electronic address: yolanda@kth.se.</Affiliation>
      </Author>
      <Author>
        <Name>Gunilla Herting</Name>
        <Affiliation>KTH Royal Institute of Technology, School of Chemical Science and Engineering, Department of Chemistry, Division of Surface and Corrosion Science, Drottning Kristinas v. 51, SE-10044, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Siiri Latvala</Name>
        <Affiliation>Department of Environmental Science and Analytical Chemistry, Stockholm University, Svante Arrhenius v.8, SE-106 91, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Karine Elihn</Name>
        <Affiliation>Department of Environmental Science and Analytical Chemistry, Stockholm University, Svante Arrhenius v.8, SE-106 91, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Hanna L. Karlsson</Name>
        <Affiliation>Unit of Biochemical Toxicology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Inger Odnevall Wallinder</Name>
        <Affiliation>KTH Royal Institute of Technology, School of Chemical Science and Engineering, Department of Chemistry, Division of Surface and Corrosion Science, Drottning Kristinas v. 51, SE-10044, Stockholm, Sweden.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27569204</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30231-8</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Chronic toxicity</Keywords>
      <Keywords>Null antibody</Keywords>
      <Keywords>Romosozumab</Keywords>
      <Keywords>Sclerostin antibody</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Luc Chouinard</Name>
        <Affiliation>Charles River Laboratories, Montreal ULC, 22022 Transcanadienne, Senneville, Quebec, H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Melanie Felx</Name>
        <Affiliation>Charles River Laboratories, Montreal ULC, 22022 Transcanadienne, Senneville, Quebec, H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Nacera Mellal</Name>
        <Affiliation>Charles River Laboratories, Montreal ULC, 22022 Transcanadienne, Senneville, Quebec, H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Aurora Varela</Name>
        <Affiliation>Charles River Laboratories, Montreal ULC, 22022 Transcanadienne, Senneville, Quebec, H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Mann</Name>
        <Affiliation>EPL NorthWest, 600 North 36th Street, Suite 220, Seattle, WA, 98103, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jacquelin Jolette</Name>
        <Affiliation>Charles River Laboratories, Montreal ULC, 22022 Transcanadienne, Senneville, Quebec, H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Rana Samadfam</Name>
        <Affiliation>Charles River Laboratories, Montreal ULC, 22022 Transcanadienne, Senneville, Quebec, H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Y. Smith</Name>
        <Affiliation>Charles River Laboratories, Montreal ULC, 22022 Transcanadienne, Senneville, Quebec, H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Kathrin Locher</Name>
        <Affiliation>One Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sabina Buntich</Name>
        <Affiliation>One Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael S. Ominsky</Name>
        <Affiliation>One Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Pyrah</Name>
        <Affiliation>One Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rogely Waite Boyce</Name>
        <Affiliation>One Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA. Electronic address: rboyce@amgen.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing safety of extractables from materials and leachables in pharmaceuticals and biologics - Current challenges and approaches.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27569203</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30232-X</DOI>
    <KeywordList>
      <Keywords>Extractables</Keywords>
      <Keywords>Leachables</Keywords>
      <Keywords>Permitted daily exposure</Keywords>
      <Keywords>Safety evaluation</Keywords>
      <Keywords>Safety threshold</Keywords>
      <Keywords>Structure activity relationship</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas H. Broschard</Name>
        <Affiliation>Merck KGaA, Darmstadt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Uma S. Bruen</Name>
        <Affiliation>Merck &amp; Co, Whitehouse Station, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lee M. Nagao</Name>
        <Affiliation>Drinker Biddle &amp; Reath, LLP, Washington, DC, USA. Electronic address: lee.nagao@dbr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Teasdale</Name>
        <Affiliation>AstraZeneca, Macclesfield, Cheshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Cheryl L. M. Stults</Name>
        <Affiliation>C&amp;M Technical Consulting, LLC, San Mateo, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kim L. Li</Name>
        <Affiliation>Amgen, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laurie A. Iciek</Name>
        <Affiliation>MedImmune, Gaithersburg, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Greg Erexson</Name>
        <Affiliation>Abbvie, North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth A. Martin</Name>
        <Affiliation>AstraZeneca, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas J. Ball</Name>
        <Affiliation>Pfizer, Inc, Groton, CT, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety profiling of pioglitazone and telmisartan combination by sub-chronic toxicity study in rat.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27569202</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30230-6</DOI>
    <KeywordList>
      <Keywords>Combination</Keywords>
      <Keywords>Pioglitazone</Keywords>
      <Keywords>Safety profile</Keywords>
      <Keywords>Telmisartan</Keywords>
      <Keywords>Toxicity study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pinaki Sengupta</Name>
        <Affiliation>Kulliyyah of Pharmacy, International Islamic University Malaysia, Malaysia. Electronic address: psg725@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Arindam Das</Name>
        <Affiliation>Faculty of Pharmacy, Lincoln University College, Malaysia. Electronic address: pikuarin@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fuzianna Ibrahim</Name>
        <Affiliation>Faculty of Pharmacy, Lincoln University College, Malaysia. Electronic address: myfuzianna@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Uttam Kumar Mandal</Name>
        <Affiliation>Kulliyyah of Pharmacy, International Islamic University Malaysia, Malaysia. Electronic address: mandalju2007@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bappaditya Chatterjee</Name>
        <Affiliation>Kulliyyah of Pharmacy, International Islamic University Malaysia, Malaysia. Electronic address: bdpharmaju@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Syed Mahmood</Name>
        <Affiliation>Kulliyyah of Pharmacy, International Islamic University Malaysia, Malaysia. Electronic address: syed872011@yahoo.co.in.</Affiliation>
      </Author>
      <Author>
        <Name>Sreemoy Kanti Das</Name>
        <Affiliation>Faculty of Pharmacy, Lincoln University College, Malaysia. Electronic address: zecods@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Muhammad Kifayatullah</Name>
        <Affiliation>Faculty of Pharmacy, Lincoln University College, Malaysia. Electronic address: kifayatpharma86@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 28-day oral toxicity study of echimidine and lasiocarpine in Wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27546169</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30227-6</DOI>
    <KeywordList>
      <Keywords>Echimidine</Keywords>
      <Keywords>Lasiocarpine</Keywords>
      <Keywords>Pyrrolizidine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rosalind R. Dalefield</Name>
        <Affiliation>Food Standards Australia New Zealand, Level 3, 154 Featherston Street, Wellington 6011, 6143, New Zealand. Electronic address: rosalind.dalefield@foodstandards.govt.nz.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle A. Gosse</Name>
        <Affiliation>Food Standards Australia New Zealand, Level 3, 154 Featherston Street, Wellington 6011, 6143, New Zealand. Electronic address: michelle.gosse@foodstandards.govt.nz.</Affiliation>
      </Author>
      <Author>
        <Name>Utz Mueller</Name>
        <Affiliation>Food Standards Australia New Zealand, 55 Blackall Street, Barton, ACT 2600, Australia. Electronic address: utz.mueller@foodstandards.gov.au.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk assessment of skin lightening cosmetics containing hydroquinone.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27521610</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30226-4</DOI>
    <KeywordList>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Dermal absorption</Keywords>
      <Keywords>Hydroquinone</Keywords>
      <Keywords>Margin of exposure</Keywords>
      <Keywords>Permeation coefficients</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mariko Matsumoto</Name>
        <Affiliation>Division of Risk Assessment, National Institute of Health Sciences, Tokyo, Japan; Department of Epidemiology and Environmental Health, Juntendo University, Faculty of Medicine, Tokyo, Japan. Electronic address: mariko@nihs.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroaki Todo</Name>
        <Affiliation>Josai University, Faculty of Pharmaceutical Sciences, Saitama, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takumi Akiyama</Name>
        <Affiliation>Division of Environmental Chemistry, National Institute of Health Sciences, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mutsuko Hirata-Koizumi</Name>
        <Affiliation>Division of Risk Assessment, National Institute of Health Sciences, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kenji Sugibayashi</Name>
        <Affiliation>Josai University, Faculty of Pharmaceutical Sciences, Saitama, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshiaki Ikarashi</Name>
        <Affiliation>Division of Environmental Chemistry, National Institute of Health Sciences, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Atsushi Ono</Name>
        <Affiliation>Division of Risk Assessment, National Institute of Health Sciences, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akihiko Hirose</Name>
        <Affiliation>Division of Risk Assessment, National Institute of Health Sciences, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuhito Yokoyama</Name>
        <Affiliation>Department of Epidemiology and Environmental Health, Juntendo University, Faculty of Medicine, Tokyo, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetics and biodistribution of squalene-containing emulsion adjuvant following intramuscular injection of H5N1 influenza vaccine in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27498239</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30215-X</DOI>
    <KeywordList>
      <Keywords>AS03</Keywords>
      <Keywords>Lymphatic delivery</Keywords>
      <Keywords>MF59</Keywords>
      <Keywords>NONMEM</Keywords>
      <Keywords>Pre-pandemic</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Million A. Tegenge</Name>
        <Affiliation>Office of Biostatistics &amp; Epidemiology, Center for Biologics Evaluation and Research, FDA, USA. Electronic address: million.tegenge@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Linda S. Von Tungeln</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, FDA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert J. Mitkus</Name>
        <Affiliation>Office of Biostatistics &amp; Epidemiology, Center for Biologics Evaluation and Research, FDA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Steven A. Anderson</Name>
        <Affiliation>Office of Biostatistics &amp; Epidemiology, Center for Biologics Evaluation and Research, FDA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle M. Vanlandingham</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, FDA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Forshee</Name>
        <Affiliation>Office of Biostatistics &amp; Epidemiology, Center for Biologics Evaluation and Research, FDA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Frederick A. Beland</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, FDA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rapid simulated gastric fluid digestion of in-seed/grain proteins expressed in genetically engineered crops.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27497625</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30216-1</DOI>
    <KeywordList>
      <Keywords>Allergenicity</Keywords>
      <Keywords>Digestion</Keywords>
      <Keywords>Genetically engineered</Keywords>
      <Keywords>Genetically modified</Keywords>
      <Keywords>In-matrix</Keywords>
      <Keywords>Purified proteins</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Simulated gastric fluid</Keywords>
      <Keywords>Transgenic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Barry W. Schafer</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shawna K. Embrey</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, 46268, USA. Electronic address: raherman@dow.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Slow infusion rate of doxorubicin induces higher pro-inflammatory cytokine production.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27494949</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30214-8</DOI>
    <KeywordList>
      <Keywords>Acute inflammation</Keywords>
      <Keywords>Cytokine</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Infusion rate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chin Chieh Tien</Name>
        <Affiliation>Institute of Medical Sciences, Tzu Chi University, Hualien 97004, Taiwan, ROC; Department of Nursing, Hsin Sheng College of Medical Care and Management, Taoyuan 32544, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Chi Peng</Name>
        <Affiliation>Institute of Medical Sciences, Tzu Chi University, Hualien 97004, Taiwan, ROC; Department of Nursing, National Taichung University of Science and Technology, Taichung 40343, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Fwu Lin Yang</Name>
        <Affiliation>Intensive Care Unit, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan, ROC; School of Medicine, Tzu Chi University, Hualien 97004, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Maun Subeq</Name>
        <Affiliation>Department of Nursing, Tzu Chi University, Hualien 97004, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Ru Ping Lee</Name>
        <Affiliation>Institute of Medical Sciences, Tzu Chi University, Hualien 97004, Taiwan, ROC. Electronic address: fish@mail.tcu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ecological risk assessment for DvSnf7 RNA: A plant-incorporated protectant with targeted activity against western corn rootworm.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27494948</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30213-6</DOI>
    <KeywordList>
      <Keywords>DvSnf7</Keywords>
      <Keywords>Ecological risk assessment</Keywords>
      <Keywords>GE crop</Keywords>
      <Keywords>MON 87411</Keywords>
      <Keywords>Non-target organism</Keywords>
      <Keywords>RNAi</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pamela M. Bachman</Name>
        <Affiliation>Global Regulatory Sciences, Monsanto Company, 800 North Lindbergh Boulevard Creve Coeur, MO, 63167, USA. Electronic address: pamela.m.bachman@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin M. Huizinga</Name>
        <Affiliation>Global Regulatory Sciences, Monsanto Company, 800 North Lindbergh Boulevard Creve Coeur, MO, 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Peter D. Jensen</Name>
        <Affiliation>Global Regulatory Sciences, Monsanto Company, 800 North Lindbergh Boulevard Creve Coeur, MO, 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Geoffrey Mueller</Name>
        <Affiliation>Global Regulatory Sciences, Monsanto Company, 800 North Lindbergh Boulevard Creve Coeur, MO, 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Tan</Name>
        <Affiliation>Global Regulatory Sciences, Monsanto Company, 800 North Lindbergh Boulevard Creve Coeur, MO, 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua P. Uffman</Name>
        <Affiliation>Global Regulatory Sciences, Monsanto Company, 800 North Lindbergh Boulevard Creve Coeur, MO, 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Steven L. Levine</Name>
        <Affiliation>Global Regulatory Sciences, Monsanto Company, 800 North Lindbergh Boulevard Creve Coeur, MO, 63167, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comparison of the results from intra-pleural and intra-peritoneal studies with those from inhalation and intratracheal tests for the assessment of pulmonary responses to inhalable dusts and fibres.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27480961</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30211-2</DOI>
    <KeywordList>
      <Keywords>Carcinogenic response</Keywords>
      <Keywords>Dusts</Keywords>
      <Keywords>Fibres</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Intra-peritoneal</Keywords>
      <Keywords>Intra-pleural</Keywords>
      <Keywords>Intra-tracheal</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Pathological response</Keywords>
      <Keywords>Pulmonary toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gail Drummond</Name>
        <Affiliation>University of Hertfordshire, College Lane, Hatfield, Hertfordshire, AL10 9AB, UK. Electronic address: g.drummond@herts.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Bevan</Name>
        <Affiliation>IEH Consulting, No.4 The Lodge Business Centre, Rectory Farm, Marston Trussell, Market Harborough, Leicestershire, LE16 9TU, UK. Electronic address: ruth@iehconsulting.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Harrison</Name>
        <Affiliation>IEH Consulting, No.4 The Lodge Business Centre, Rectory Farm, Marston Trussell, Market Harborough, Leicestershire, LE16 9TU, UK. Electronic address: paul@iehconsulting.co.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A subchronic toxicity study of Radix Dipsaci water extract by oral administration in F344 rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27477088</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30207-0</DOI>
    <KeywordList>
      <Keywords>Radix Dipsaci</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>Traditional medicines</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ji Seok Han</Name>
        <Affiliation>Research Center for Toxicologic Pathology, Korea Institute of Toxicology (KIT), 141 Gajeong-ro, Yuseong-gu, Daejeon, 305-343, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byoung Seok Lee</Name>
        <Affiliation>Research Center for Toxicologic Pathology, Korea Institute of Toxicology (KIT), 141 Gajeong-ro, Yuseong-gu, Daejeon, 305-343, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>So Ri Han</Name>
        <Affiliation>Research Center for General and Applied Toxicology, Korea Institute of Toxicology (KIT), 141 Gajeong-ro, Yuseong-gu, Daejeon, 305-343, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyoung Yun Han</Name>
        <Affiliation>Research Center for General and Applied Toxicology, Korea Institute of Toxicology (KIT), 141 Gajeong-ro, Yuseong-gu, Daejeon, 305-343, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Moon Koo Chung</Name>
        <Affiliation>Research Center for General and Applied Toxicology, Korea Institute of Toxicology (KIT), 141 Gajeong-ro, Yuseong-gu, Daejeon, 305-343, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Sun Min</Name>
        <Affiliation>College of Pharmacy, Catholic University of Daegu, 13-13 Hayang-ro, Hayang-eup, Gyeongsan-si, Gyeongsangbuk-do, 712-702, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Hyeon Seok</Name>
        <Affiliation>Toxicological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Osong Health Technology Administration Complex, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, 363-951, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Bum Kim</Name>
        <Affiliation>Research Center for Toxicologic Pathology, Korea Institute of Toxicology (KIT), 141 Gajeong-ro, Yuseong-gu, Daejeon, 305-343, Republic of Korea. Electronic address: ybkim@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reproductive toxicity of ZishenYutai pill in rats: Perinatal and postnatal development study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27470441</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30198-2</DOI>
    <KeywordList>
      <Keywords>Chinese patent medicines</Keywords>
      <Keywords>Development</Keywords>
      <Keywords>Miscarriage</Keywords>
      <Keywords>Perinatal toxicity</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Reproductive ability</Keywords>
      <Keywords>ZishenYutai pill</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Li Zhou</Name>
        <Affiliation>National Evaluation Centre for the Toxicology of Fertility Regulating Drug, Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, PR China; Key Laboratory of Reproduction Regulation of NPFPC, Shanghai 200032, PR China; Reproductive and Developmental Research Institute of Fudan University, Shanghai, Shanghai 200032, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Zhou</Name>
        <Affiliation>Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Jiang</Name>
        <Affiliation>National Evaluation Centre for the Toxicology of Fertility Regulating Drug, Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, PR China; Key Laboratory of Reproduction Regulation of NPFPC, Shanghai 200032, PR China; Reproductive and Developmental Research Institute of Fudan University, Shanghai, Shanghai 200032, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yang</Name>
        <Affiliation>National Evaluation Centre for the Toxicology of Fertility Regulating Drug, Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, PR China; Key Laboratory of Reproduction Regulation of NPFPC, Shanghai 200032, PR China; Reproductive and Developmental Research Institute of Fudan University, Shanghai, Shanghai 200032, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiuling Huang</Name>
        <Affiliation>Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Dawei Yan</Name>
        <Affiliation>National Evaluation Centre for the Toxicology of Fertility Regulating Drug, Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, PR China; Key Laboratory of Reproduction Regulation of NPFPC, Shanghai 200032, PR China; Reproductive and Developmental Research Institute of Fudan University, Shanghai, Shanghai 200032, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Xu</Name>
        <Affiliation>National Evaluation Centre for the Toxicology of Fertility Regulating Drug, Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, PR China; Key Laboratory of Reproduction Regulation of NPFPC, Shanghai 200032, PR China; Reproductive and Developmental Research Institute of Fudan University, Shanghai, Shanghai 200032, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yushuang Chai</Name>
        <Affiliation>Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liming Chong</Name>
        <Affiliation>National Evaluation Centre for the Toxicology of Fertility Regulating Drug, Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, PR China; Key Laboratory of Reproduction Regulation of NPFPC, Shanghai 200032, PR China; Reproductive and Developmental Research Institute of Fudan University, Shanghai, Shanghai 200032, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zuyue Sun</Name>
        <Affiliation>National Evaluation Centre for the Toxicology of Fertility Regulating Drug, Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, PR China; Key Laboratory of Reproduction Regulation of NPFPC, Shanghai 200032, PR China; Reproductive and Developmental Research Institute of Fudan University, Shanghai, Shanghai 200032, PR China. Electronic address: sunzy64@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Optimizing the design of a reproduction toxicity test with the pond snail Lymnaea stagnalis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27461040</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30195-7</DOI>
    <KeywordList>
      <Keywords>Count data</Keywords>
      <Keywords>ECx</Keywords>
      <Keywords>Fecundity</Keywords>
      <Keywords>Mollusc</Keywords>
      <Keywords>Test design optimization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sandrine Charles</Name>
        <Affiliation>Univ Lyon, Université Lyon 1, UMR CNRS 5558, Laboratoire de Biométrie et Biologie Évolutive, F-69100 Villeurbanne, France. Electronic address: sandrine.charles@univ-lyon1.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Virginie Ducrot</Name>
        <Affiliation>Institut National de la Recherche Agronomique (INRA), Centre de Recherche de Rennes, 65 rue de Saint-Brieuc, F-35042 Rennes, France; Bayer Aktiengesellschaft, Crop Science Division, BCS AG-R&amp;D-D-EnSa-ETX-AQ, Alfred-Nobel Straße 50, D-40789 Monheim am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Didier Azam</Name>
        <Affiliation>Institut National de la Recherche Agronomique (INRA), Centre de Recherche de Rennes, 65 rue de Saint-Brieuc, F-35042 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel Benstead</Name>
        <Affiliation>The Food and Environment Research Agency (now Fera Science Ltd), Sand Hutton, York, YO41 1LZ, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Denise Brettschneider</Name>
        <Affiliation>Goethe University Frankfurt am Main, Department Aquatic Ecotoxicology, Max-von-Laue-Straße 13, D-60438 Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Karel De Schamphelaere</Name>
        <Affiliation>Laboratory of Environmental Toxicology and Aquatic Ecology, Faculty of Bioscience Engineering, Ghent University, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra Filipe Goncalves</Name>
        <Affiliation>Department of Biology &amp; CESAM, Centre for Environmental and Marine Studies, University of Aveiro, 3810-193 Aveiro, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>John W. Green</Name>
        <Affiliation>DuPont, PO Box 60, 1090 Elkton Road, DuPont Stine-Haskell Research Center, S315/1369 Newark, Delaware, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Henrik Holbech</Name>
        <Affiliation>Department of Biology, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas H. Hutchinson</Name>
        <Affiliation>School of Biological Sciences, University of Plymouth, Plymouth, PL4 8AA, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Faber</Name>
        <Affiliation>Bayer Aktiengesellschaft, Crop Science Division, BCS AG-R&amp;D-D-EnSa-ETX-AQ, Alfred-Nobel Straße 50, D-40789 Monheim am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Filipe Laranjeiro</Name>
        <Affiliation>Departamento de Biologia, Universidade de Aveiro, 3810-193 Aveiro, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Matthiessen</Name>
        <Affiliation>Old School House, Brow Edge, Backbarrow, Ulverston, Cumbria LA128QX, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Leif Norrgren</Name>
        <Affiliation>Department of Pathology, Faculty of Veterinary Science, Swedish University of Agricultural Sciences, P.O. Box 7028, Uppsala, S-750 07, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Jörg Oehlmann</Name>
        <Affiliation>Goethe University Frankfurt am Main, Department Aquatic Ecotoxicology, Max-von-Laue-Straße 13, D-60438 Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Evelyn Reategui-Zirena</Name>
        <Affiliation>Department of Environmental Toxicology, Texas Tech University, Lubbock, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Seeland-Fremer</Name>
        <Affiliation>Ibacon GmbH, Arheilger Weg 17, 64380 Rossdorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Matthias Teigeler</Name>
        <Affiliation>Fraunhofer Institute for Molecular Biology and Applied Ecology, Department of Ecotoxicology, Auf dem Aberg 1, 57392 Schmallenberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Pierre Thome</Name>
        <Affiliation>University of Liège, Laboratory of Animal Ecology and Ecotoxicity (LEAE-CART), Allée du 6 Août, 11, Sart-Tilman, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Marysia Tobor Kaplon</Name>
        <Affiliation>WIL Research, Department of In vitro and Environmental Toxicology, Ashland, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lennart Weltje</Name>
        <Affiliation>BASF SE, Crop Protection - Ecotoxicology, Speyerer Straße 2, D-67117 Limburgerhof, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Laurent Lagadic</Name>
        <Affiliation>Institut National de la Recherche Agronomique (INRA), Centre de Recherche de Rennes, 65 rue de Saint-Brieuc, F-35042 Rennes, France; Bayer Aktiengesellschaft, Crop Science Division, BCS AG-R&amp;D-D-EnSa-ETX-AQ, Alfred-Nobel Straße 50, D-40789 Monheim am Rhein, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Apneic events - A proposed new target for respiratory safety pharmacology.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27449231</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30184-2</DOI>
    <KeywordList>
      <Keywords>Apnea</Keywords>
      <Keywords>Apneic event</Keywords>
      <Keywords>Drug safety</Keywords>
      <Keywords>ICHS7A</Keywords>
      <Keywords>Intermittent hypoxia</Keywords>
      <Keywords>Respiratory</Keywords>
      <Keywords>Safety pharmacology</Keywords>
      <Keywords>Sleep apnea</Keywords>
      <Keywords>Ventilatory instability</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dennis J. Murphy</Name>
        <Affiliation>Department of Safety Pharmacology, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA, USA. Electronic address: murphyphddabt@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antioxidant effects of alfalfa can improve iron oxide nanoparticle damage: Invivo and invitro studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27445214</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30193-3</DOI>
    <KeywordList>
      <Keywords>Alfalfa extract</Keywords>
      <Keywords>Apoptosis inhibitor</Keywords>
      <Keywords>Bio incompatible nanoparticle</Keywords>
      <Keywords>Iron oxide nanoparticle</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Leila Sadeghi</Name>
        <Affiliation>Department of Biochemistry, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran. Electronic address: l.sadeghi@modares.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Farzeen Tanwir</Name>
        <Affiliation>Department of Odontology, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Vahid Yousefi Babadi</Name>
        <Affiliation>Department of Physiology, Payam Noor University of Iran, Iran. Electronic address: v.yoosefi@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corn rootworm-active RNA DvSnf7: Repeat dose oral toxicology assessment in support of human and mammalian safety.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27436086</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30192-1</DOI>
    <KeywordList>
      <Keywords>Biotech crop</Keywords>
      <Keywords>GM crop</Keywords>
      <Keywords>Gene suppression</Keywords>
      <Keywords>Genetically modified crop</Keywords>
      <Keywords>Plant incorporated protectant</Keywords>
      <Keywords>RNAi</Keywords>
      <Keywords>dsRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jay S. Petrick</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA. Electronic address: jay.s.petrick@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory E. Frierdich</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie M. Carleton</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Colton R. Kessenich</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andre Silvanovich</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanji Zhang</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael S. Koch</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Printed paper and board food contact materials as a potential source of food contamination.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27389280</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30183-0</DOI>
    <KeywordList>
      <Keywords>Food contact materials</Keywords>
      <Keywords>Food contamination</Keywords>
      <Keywords>Paper and board</Keywords>
      <Keywords>Printing inks</Keywords>
      <Keywords>Prioritisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melissa Van Bossuyt</Name>
        <Affiliation>Department of Food, Medicines and Consumer Safety, Scientific Institute of Public Health, Juliette Wytsmanstraat 14, Brussels, Belgium; Department of In Vitro Toxicology and Dermato-cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, Belgium. Electronic address: Melissa.VanBossuyt@wiv-isp.be.</Affiliation>
      </Author>
      <Author>
        <Name>Els Van Hoeck</Name>
        <Affiliation>Department of Food, Medicines and Consumer Safety, Scientific Institute of Public Health, Juliette Wytsmanstraat 14, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Tamara Vanhaecke</Name>
        <Affiliation>Department of In Vitro Toxicology and Dermato-cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Vera Rogiers</Name>
        <Affiliation>Department of In Vitro Toxicology and Dermato-cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Birgit Mertens</Name>
        <Affiliation>Department of Food, Medicines and Consumer Safety, Scientific Institute of Public Health, Juliette Wytsmanstraat 14, Brussels, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective effect of two essential oils isolated from Rosa damascena Mill. and Lavandula angustifolia Mill, and two classic antioxidants against L-dopa oxidative toxicity induced in healthy mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27381452</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30182-9</DOI>
    <KeywordList>
      <Keywords>Antioxidant</Keywords>
      <Keywords>DNA damage</Keywords>
      <Keywords>L-dopa</Keywords>
      <Keywords>Lipids</Keywords>
      <Keywords>Protein carbonyl content</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Galina Nikolova</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Medical Faculty, Trakia University, 11 Armeiska Str., 6000 Stara Zagora, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Yanka Karamalakova</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Medical Faculty, Trakia University, 11 Armeiska Str., 6000 Stara Zagora, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Natasha Kovacheva</Name>
        <Affiliation>Agricultural Academy, Institute of Roses and Aromatic Plants, Kazanluk, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Stanko Stanev</Name>
        <Affiliation>Agricultural Academy, Institute of Roses and Aromatic Plants, Kazanluk, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Antoaneta Zheleva</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Medical Faculty, Trakia University, 11 Armeiska Str., 6000 Stara Zagora, Bulgaria. Electronic address: zhelleva.a@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Veselina Gadjeva</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Medical Faculty, Trakia University, 11 Armeiska Str., 6000 Stara Zagora, Bulgaria.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An assessment of formaldehyde emissions from laminate flooring manufactured in China.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27377234</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30180-5</DOI>
    <KeywordList>
      <Keywords>CARB compliance</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Laminate flooring</Keywords>
      <Keywords>Small chamber testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jennifer S. Pierce</Name>
        <Affiliation>Cardno ChemRisk, 30 North LaSalle Street Suite 3910, Chicago, IL 60602, USA. Electronic address: jennifer.pierce@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anders Abelmann</Name>
        <Affiliation>Cardno ChemRisk, 30 North LaSalle Street Suite 3910, Chicago, IL 60602, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jason T. Lotter</Name>
        <Affiliation>Cardno ChemRisk, 30 North LaSalle Street Suite 3910, Chicago, IL 60602, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Peter S. Ruestow</Name>
        <Affiliation>Cardno ChemRisk, 30 North LaSalle Street Suite 3910, Chicago, IL 60602, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth M. Unice</Name>
        <Affiliation>Cardno ChemRisk, 20 Stanwix Street Suite 505, Pittsburgh, PA 15222, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Evan M. Beckett</Name>
        <Affiliation>Cardno ChemRisk, 30 North LaSalle Street Suite 3910, Chicago, IL 60602, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Heidi A. Fritz</Name>
        <Affiliation>Cardno ChemRisk, 30 North LaSalle Street Suite 3910, Chicago, IL 60602, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer L. Bare</Name>
        <Affiliation>Cardno ChemRisk, 20 Stanwix Street Suite 505, Pittsburgh, PA 15222, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brent L. Finley</Name>
        <Affiliation>Cardno ChemRisk, 231 Front Street Suite 202, Brooklyn, NY 11201, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An approach for the development of emergency response levels for halogenated hydrocarbons.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27370942</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30179-9</DOI>
    <KeywordList>
      <Keywords>Default guideline levels</Keywords>
      <Keywords>Emergency guideline levels</Keywords>
      <Keywords>Emergency response</Keywords>
      <Keywords>Guideline levels</Keywords>
      <Keywords>Halogenated hydrocarbons</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>George M. Rusch</Name>
        <Affiliation>Risk Assessment and Toxicology Services, 6900 Corral Gate Lane, Sarasota, FL 34241, USA. Electronic address: George.rusch9@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Deepening uncertainty on how the EU may regulate supposable endocrine disruptors.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27350054</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30178-7</DOI>
    <AuthorList>
      <Author>
        <Name>Gio Batta Gori</Name>
        <Affiliation>Regulatory Toxicology and Pharmacology, Bethesda, MD, USA. Electronic address: gorigb@msn.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>University of Würzburg, Würzburg, Germany. Electronic address: dekant@toxi.uni-wuerzburg.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27769828</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30293-8</DOI>
    <KeywordList>
      <Keywords>Adverse events</Keywords>
      <Keywords>Biomarkers of biological effect</Keywords>
      <Keywords>Biomarkers of exposure</Keywords>
      <Keywords>Cigarette</Keywords>
      <Keywords>Clinical study</Keywords>
      <Keywords>Electronic cigarette</Keywords>
      <Keywords>Electronic vapour product</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Smoking urges</Keywords>
      <Keywords>Withdrawal symptoms</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ana S. Cravo</Name>
        <Affiliation>Fontem Ventures, Barbara Strozzilaan 101, 1083 HN, Amsterdam, Netherlands. Electronic address: AnaMaria.Cravo@fontemventures.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jim Bush</Name>
        <Affiliation>Covance Clinical Research Unit, Hyde Street, Leeds, LS2 9LH, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Girish Sharma</Name>
        <Affiliation>Simbec Research, Merthyr Tydfil, CF48 4DR, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca Savioz</Name>
        <Affiliation>Clinopsis S.A., Jardins 6, 1426, Concise, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Martin</Name>
        <Affiliation>Clinopsis S.A., Jardins 6, 1426, Concise, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Craige</Name>
        <Affiliation>Fontem Ventures, Barbara Strozzilaan 101, 1083 HN, Amsterdam, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Tanvir Walele</Name>
        <Affiliation>Fontem Ventures, Barbara Strozzilaan 101, 1083 HN, Amsterdam, Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Classification schemes for carcinogenicity based on hazard-identification have become outmoded and serve neither science nor society.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27780763</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30303-8</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Classification</Keywords>
      <Keywords>GHS</Keywords>
      <Keywords>Hazard characterization</Keywords>
      <Keywords>IARC</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alan R. Boobis</Name>
        <Affiliation>Centre for Pharmacology &amp; Therapeutics, Toxicology Unit, Department of Medicine, Hammersmith Campus, Imperial College London, London, W12 0NN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel M. Cohen</Name>
        <Affiliation>Department of Pathology and Microbiology, Havlik-Wall Professor of Oncology, University of Nebraska Medical Center, Omaha, NE 68198-3135, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vicki L. Dellarco</Name>
        <Affiliation>Independent Consultant, Silver Spring, MD 20901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John E. Doe</Name>
        <Affiliation>Parker Doe LLP, Carpenter Court, Maple Road, Bramhall, Stockport, Cheshire SK7 2DH, UK. Electronic address: john.doe@parkerdoe.com.</Affiliation>
      </Author>
      <Author>
        <Name>Penelope A. Fenner-Crisp</Name>
        <Affiliation>Independent Consultant, North Garden, VA 22959, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angelo Moretto</Name>
        <Affiliation>Dipartimento di Scienze Biochimiche e Cliniche (Department of Biomedical and Clinical Sciences), Università degli Studi di Milano, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy P. Pastoor</Name>
        <Affiliation>Pastoor Science Communication, LLC, Greensboro, NC 27455, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rita S. Schoeny</Name>
        <Affiliation>Rita Schoeny LLC, Washington DC, 20002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer G. Seed</Name>
        <Affiliation>Independent Consultant, Alexandria, VA 22301, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas C. Wolf</Name>
        <Affiliation>Syngenta Crop Protection, LLC, Greensboro, NC 27419, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Peripheral neuropathy with microtubule inhibitor containing antibody drug conjugates: Challenges and perspectives in translatability from nonclinical toxicology studies to the clinic.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27773754</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30301-4</DOI>
    <KeywordList>
      <Keywords>Antibody drug conjugate (ADC)</Keywords>
      <Keywords>Chemotherapy</Keywords>
      <Keywords>Clinical</Keywords>
      <Keywords>Microtubules</Keywords>
      <Keywords>Monomethyl auristatin E (MMAE)</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Peripheral neuropathy (PN)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicola J. Stagg</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address: Staggn@gene.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ben Quan Shen</Name>
        <Affiliation>Department of Preclinical &amp; Translational Pharmacokinetics &amp; Pharmacodynamics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Flavia Brunstein</Name>
        <Affiliation>Drug Safety, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chunze Li</Name>
        <Affiliation>Clinical Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amrita V. Kamath</Name>
        <Affiliation>Department of Preclinical &amp; Translational Pharmacokinetics &amp; Pharmacodynamics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fiona Zhong</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melissa Schutten</Name>
        <Affiliation>Safety Assessment, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bernard M. Fine</Name>
        <Affiliation>Clinical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Graphical display of histopathology data from toxicology studies for drug discovery and development: An industry perspective.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27769829</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30298-7</DOI>
    <KeywordList>
      <Keywords>Graphics</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Informatics</Keywords>
      <Keywords>SEND</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alan P. Brown</Name>
        <Affiliation>Novartis Institutes for Biomedical Research, 100 Technology Square, Cambridge, MA 02139, USA. Electronic address: alan_p.brown@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Drew</Name>
        <Affiliation>PDS Consultants, Innovation Centre, 49 Oxford Street, Leicester, LE1 5XY England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Knight</Name>
        <Affiliation>Boehringer-Ingelheim, 900 Ridgebury Road, Ridgefield, CT 06877, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Philippe Marc</Name>
        <Affiliation>Novartis Institutes for Biomedical Research, Basel CH-4200, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Sean Troth</Name>
        <Affiliation>Merck &amp; Co., Inc., WP81-404, Sumneytown Pike, West Point, PA 19486, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kuno Wuersch</Name>
        <Affiliation>Novartis Institutes for Biomedical Research, Basel CH-4200, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Joyce Zandee</Name>
        <Affiliation>Integrated Nonclinical Development Solutions (INDS) Incorporated, 6111 Jackson Road, Suite 100, Ann Arbor, MI 48103, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27720919</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30290-2</DOI>
    <KeywordList>
      <Keywords>Aerosol chemistry</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>HPHC</Keywords>
      <Keywords>Harmful and potentially harmful constituents</Keywords>
      <Keywords>Heat-not-burn</Keywords>
      <Keywords>Modified risk tobacco product</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>THS2.2</Keywords>
      <Keywords>Tobacco heating system</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jean Pierre Schaller</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland. Electronic address: jean-pierre.schaller@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela Keller</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Laurent Poget</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Pascal Pratte</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Etienne Kaelin</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Damian McHugh</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Gianluca Cudazzo</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Smart</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony R. Tricker</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Lydia Gautier</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Michel Yerly</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Roger Reis Pires</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Soazig Le Bouhellec</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>David Ghosh</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Iris Hofer</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Eva Garcia</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Vanscheeuwijck</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Serge Maeder</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A.(Part of Philip Morris International Group of Companies), Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Weight-of-evidence evaluation of associations between particulate matter exposure and biomarkers of lung cancer.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27765718</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30295-1</DOI>
    <KeywordList>
      <Keywords>Cancer biomarkers</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Mechanism of action</Keywords>
      <Keywords>Particulate matter</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. N. Lynch</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA.</Affiliation>
      </Author>
      <Author>
        <Name>C. T. Loftus</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, 4225 Roosevelt Way NE, Suite 301 Seattle WA 98105, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. M. Cohen</Name>
        <Affiliation>Gradient, 600 Stewart Street, Suite 1900, Seattle, WA 98101, USA.</Affiliation>
      </Author>
      <Author>
        <Name>L. E. Kerper</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA.</Affiliation>
      </Author>
      <Author>
        <Name>E. M. Kennedy</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. E. Goodman</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>GHS additivity formula: A true replacement method for acute systemic toxicity testing of agrochemical formulations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27765716</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30296-3</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>GHS</Keywords>
      <Keywords>Global policy change</Keywords>
      <Keywords>Replacement</Keywords>
      <Keywords>Theory of additivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Corvaro</Name>
        <Affiliation>Dow AgroSciences Ltd, European Development Centre, Milton Park, Abingdon, OX14 4RN, UK. Electronic address: mcorvaro@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>S. Gehen</Name>
        <Affiliation>Dow AgroSciences LLC, Headquarters, 9330 Zionsville Road, Indianapolis, IN 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Andrews</Name>
        <Affiliation>Dow AgroSciences Ltd, European Development Centre, Milton Park, Abingdon, OX14 4RN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>R. Chatfield</Name>
        <Affiliation>Dow AgroSciences Ltd, European Development Centre, Milton Park, Abingdon, OX14 4RN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>C. Arasti</Name>
        <Affiliation>Dow AgroSciences Ltd, European Development Centre, Milton Park, Abingdon, OX14 4RN, UK.</Affiliation>
      </Author>
      <Author>
        <Name>J. Mehta</Name>
        <Affiliation>Dow AgroSciences Ltd, European Development Centre, Milton Park, Abingdon, OX14 4RN, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Skin sensitization risk assessment: Considering available data for weight of evidence assessments.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27681532</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30254-9</DOI>
    <KeywordList>
      <Keywords>GPMT</Keywords>
      <Keywords>LLNA</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas A. Lewandowski</Name>
        <Affiliation>Gradient, 600 Stewart Street, Suite No. 1900, Seattle, WA 98101, USA. Electronic address: tlewandowski@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joel M. Cohen</Name>
        <Affiliation>Gradient, 20 University Road, Floor 5, Cambridge, MA 02138, USA. Electronic address: jcohen@gradientcorp.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Advancing the use of noncoding RNA in regulatory toxicology: Report of an ECETOC workshop.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27663666</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30266-5</DOI>
    <KeywordList>
      <Keywords>Adverse-outcome-pathway</Keywords>
      <Keywords>Biomarker</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Noncoding RNA (ncRNA)</Keywords>
      <Keywords>Phenotypic consequence</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Achim Aigner</Name>
        <Affiliation>Rudolf-Boehm-Institute for Pharmacology and Toxicology, Clinical Pharmacology, Leipzig University, 04107 Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Roland Buesen</Name>
        <Affiliation>BASF SE, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tim Gant</Name>
        <Affiliation>Centre for Radiation, Chemical and Environmental Hazards, Public Health England (PHE), Harwell Campus, Chilton, Oxfordshire, OX11 0RQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Nigel Gooderham</Name>
        <Affiliation>Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Helmut Greim</Name>
        <Affiliation>Technical University Munich, 85354 Freising-Weihenstephan, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jörg Hackermüller</Name>
        <Affiliation>Young Investigators Group Bioinformatics and Transcriptomics, Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research - UFZ, 04318 Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Hubesch</Name>
        <Affiliation>European Chemicals Council (Cefic) Long-Range Research Initiative, 1160 Brussels, Belgium; Hubesch Consult BVBA, 1600 Sint-Pieters-Leeuw, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Madeleine Laffont</Name>
        <Affiliation>European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), 1160 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Emma Marczylo</Name>
        <Affiliation>Centre for Radiation, Chemical and Environmental Hazards, Public Health England (PHE), Harwell Campus, Chilton, Oxfordshire, OX11 0RQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Gunter Meister</Name>
        <Affiliation>Biochemistry Centre Regensburg, University of Regensburg, 93053 Regensburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jay S. Petrick</Name>
        <Affiliation>Monsanto Company, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Reza J. Rasoulpour</Name>
        <Affiliation>Dow AgroSciences, Indianapolis, IN 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, 85579 Neubiberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Kerstin Schmidt</Name>
        <Affiliation>BioMath GmbH, 18055 Rostock, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Hervé Seitz</Name>
        <Affiliation>Institut de Génétique Humain (IGH), Centre National de la Recherche Scientifique - National Centre of Scientific Research (CNRS), 34396 Montpellier Cedex 5, France.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Slack</Name>
        <Affiliation>Department of Pathology, Institute for RNA Medicine, Beth Israel Deaconess Medical Center - BIDMC Cancer Center Harvard Medical School, Boston, MA 02215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tokuo Sukata</Name>
        <Affiliation>Sumitomo Chemical Europe, 1830 Machelen, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Saskia M. van der Vies</Name>
        <Affiliation>Neuroscience Amsterdam, VU University Medical Centre, 1081HV 1117, Amsterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Verhaert</Name>
        <Affiliation>Monsanto Company, 1150 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth W. Witwer</Name>
        <Affiliation>The John Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Poole</Name>
        <Affiliation>European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), 1160 Brussels, Belgium. Electronic address: alan.poole@ecetoc.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A practice analysis of toxicology.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27647630</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30265-3</DOI>
    <KeywordList>
      <Keywords>Delineation</Keywords>
      <Keywords>Examination specifications</Keywords>
      <Keywords>Practice analysis</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carol S. Wood</Name>
        <Affiliation>PO Box 2008, Bldg 1507, MS 6407, Oak Ridge National Laboratory, Oak Ridge, TN 38501, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher P. Weis</Name>
        <Affiliation>National Institute of Environmental Health Sciences, 31 Center Drive, Building 31, Room B1C02, Bethesda, MD 20892-2256, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carla M. Caro</Name>
        <Affiliation>Professional Exam Services, 475 Riverside Drive, 6th Floor, New York, NY 10115, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amy Roe</Name>
        <Affiliation>The Procter &amp; Gamble Company, 8700 Mason-Montgomery Rd, Cincinnati, OH 45040, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Influence of cigarette circumference on smoke chemistry, biological activity, and smoking behaviour.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27634061</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30258-6</DOI>
    <KeywordList>
      <Keywords>Bioactivity</Keywords>
      <Keywords>Cigarette</Keywords>
      <Keywords>Circumference</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Slim</Keywords>
      <Keywords>Smoke yields</Keywords>
      <Keywords>Smoulder</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kevin McAdam</Name>
        <Affiliation>Group Research &amp; Development, British American Tobacco (BAT), Regents Park Road, Southampton, SO15 8TL, UK. Electronic address: Kevin_McAdam@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alison Eldridge</Name>
        <Affiliation>Group Research &amp; Development, British American Tobacco (BAT), Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ian M. Fearon</Name>
        <Affiliation>Group Research &amp; Development, British American Tobacco (BAT), Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Chuan Liu</Name>
        <Affiliation>Group Research &amp; Development, British American Tobacco (BAT), Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Manson</Name>
        <Affiliation>Group Research &amp; Development, British American Tobacco (BAT), Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James Murphy</Name>
        <Affiliation>Group Research &amp; Development, British American Tobacco (BAT), Regents Park Road, Southampton, SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Porter</Name>
        <Affiliation>3810 Saint Antoine West, Montreal, QC, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A quantitative weight of evidence methodology for the assessment of reproductive and developmental toxicity and its application for classification and labeling of chemicals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27620966</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30257-4</DOI>
    <KeywordList>
      <Keywords>Classification and labeling</Keywords>
      <Keywords>Reproductive and developmental toxicity</Keywords>
      <Keywords>Systematic review</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>Department of Toxicology, University of Würzburg, 97078 Würzburg, Germany. Electronic address: dekant@toxi.uni-wuerzburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>James Bridges</Name>
        <Affiliation>University of Surrey, Guildford, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Whither the impending european regulation of presumed endocrine disruptors?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27615676</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30256-2</DOI>
    <AuthorList>
      <Author>
        <Name>Herman N. Autrup</Name>
        <Affiliation>Institute of Public Health, University of Aarhus, Aarhus, Denmark. Electronic address: ha@ph.au.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Sir Colin L. Berry</Name>
        <Affiliation>Queen Mary, London, UK. Electronic address: colin@sircolinberry.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel M. Cohen</Name>
        <Affiliation>Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA. Electronic address: scohen@unmc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>E. Edmond Creppy</Name>
        <Affiliation>Department of Toxicology and Applied Hygiene, University of Bordeaux, Bordeaux, France. Electronic address: eecreppyprof@yahoo.fr.</Affiliation>
      </Author>
      <Author>
        <Name>João L. de Camargo</Name>
        <Affiliation>UNESP Medical School, Botucatu 18600 SP, Brazil. Electronic address: decam@fmb.unesp.br.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>University of Wuerzburg, Wuerzburg, Germany. Electronic address: dekant@toxi.uni-wuerzburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Dietrich</Name>
        <Affiliation>Human and Environmental Toxicology, University of Konstanz, Konstanz, Germany. Electronic address: Daniel.Dietrich@uni-konstanz.de.</Affiliation>
      </Author>
      <Author>
        <Name>Corrado L. Galli</Name>
        <Affiliation>Section of Toxicology and Risk Assessment, Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy. Electronic address: corrado.galli@unimi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Jay I. Goodman</Name>
        <Affiliation>Michigan State University, East Lansing, MI, USA. Electronic address: goodman3@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Gio B. Gori</Name>
        <Affiliation>Regulatory Toxicology and Pharmacology, Bethesda, MD, USA. Electronic address: gorigb@msn.com.</Affiliation>
      </Author>
      <Author>
        <Name>Helmut A. Greim</Name>
        <Affiliation>Toxicology, Technical University of Munich, Munich, Germany. Electronic address: helmut.greim@lrz.tum.de.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Klaunig</Name>
        <Affiliation>Department of Environmental Health, Indiana University, Bloomington, IN 47405, USA. Electronic address: jklauni@indiana.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Marcello Lotti</Name>
        <Affiliation>Department of Cardiology, Thoracic and Vascular Sciences, School of Medicine, University of Padua, Padua, Italy. Electronic address: marcello.lotti@unipd.it.</Affiliation>
      </Author>
      <Author>
        <Name>Hans W. Marquardt</Name>
        <Affiliation>Experimental and Clinical Toxicology, University of Hamburg Medical School. Hamburg, Germany. Electronic address: marquardt@uke.uni-hamburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>Kendall B. Wallace</Name>
        <Affiliation>University of Minnesota Medical School, Duluth, MN, USA. Electronic address: kwallace@d.umn.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Yamazaki</Name>
        <Affiliation>Showa Pharmaceutical University, Machida, Tokyo, Japan. Electronic address: hyamazak@ac.shoyaku.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Authors' response to Lewandowski and Cohen.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27614136</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30253-7</DOI>
    <AuthorList>
      <Author>
        <Name>David Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, Bedfordshire, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bob Safford</Name>
        <Affiliation>B-Safe Toxicology Consulting, Rushden, Northamptonshire, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Corn rootworm-active RNA DvSnf7: Repeat dose oral toxicology assessment in support of human and mammalian safety" [Regul. Toxicol. Pharmacol. 81 (2016) 57-68].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27614135</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30249-5</DOI>
    <AuthorList>
      <Author>
        <Name>J. S. Petrick</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA. Electronic address: jay.s.petrick@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>G. E. Frierdich</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. M. Carleton</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>C. R. Kessenich</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Silvanovich</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Y. Zhang</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. S. Koch</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Probabilistic Monte Carlo estimation for quantitative exposure assessment of lotion transfer via baby wipes usage" [Regul. Toxicol. Pharmacol. 79 (2016) 54-63].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27590994</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30187-8</DOI>
    <AuthorList>
      <Author>
        <Name>Swatee Dey</Name>
        <Affiliation>The Procter &amp; Gamble Company, WHBC, 6280 Center Hill Road, Cincinnati, OH 45224, USA. Electronic address: dey.s.3@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory J. Carr</Name>
        <Affiliation>The Procter &amp; Gamble Company, WHBC, 6280 Center Hill Road, Cincinnati, OH 45224, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lijuan Li</Name>
        <Affiliation>The Procter &amp; Gamble Company, WHBC, 6280 Center Hill Road, Cincinnati, OH 45224, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susanna Brink</Name>
        <Affiliation>The Procter &amp; Gamble Company, GmbH, Schwalbach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Shaoying Zhou</Name>
        <Affiliation>The Procter &amp; Gamble Company, WHBC, 6280 Center Hill Road, Cincinnati, OH 45224, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Response to the letter to the editor.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27586789</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30246-X</DOI>
    <AuthorList />
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Letter to the Editor: Qualitative and quantitative composition of essential oils.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27578451</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30245-8</DOI>
    <AuthorList>
      <Author>
        <Name>Anton C. de Groot</Name>
        <Affiliation>Acdegroot Publishing, Schipslootweg 5, 8351 HV Wapserveen, The Netherlands. Electronic address: mail@patchtesting.info.</Affiliation>
      </Author>
      <Author>
        <Name>Erich Schmidt</Name>
        <Affiliation>Gottfried Kellerstrasse 8, 86720 Nördlingen, Germany. Electronic address: info@artandfragrance.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-clinical Safety Evaluation of Biotherapeutics - Challenges, Opportunities and new Insights.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27578450</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30242-2</DOI>
    <KeywordList>
      <Keywords>Antibody-drug conjugate</Keywords>
      <Keywords>Biotherapeutics</Keywords>
      <Keywords>Cross-reactive species</Keywords>
      <Keywords>Gene and cell therapy</Keywords>
      <Keywords>Immunogenicity</Keywords>
      <Keywords>Nonclinical safety</Keywords>
      <Keywords>PEGylated biologics</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guenter Blaich</Name>
        <Affiliation>AbbVie GmbH, Ludwigshafen, Germany. Electronic address: guenter.blaich@abbvie.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Baumann</Name>
        <Affiliation>Bayer Pharma AG, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sven Kronenberg</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Lolke de Haan</Name>
        <Affiliation>MedImmune, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Ulrich</Name>
        <Affiliation>Novartis Pharma, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang F. Richter</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jay Tibbitts</Name>
        <Affiliation>UCB Celltech, Slough, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Chivers</Name>
        <Affiliation>ADC Therapeutics, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Edit Tarcsa</Name>
        <Affiliation>AbbVie BioResearch, Worcester, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Caldwell</Name>
        <Affiliation>AbbVie Inc., North Chicago, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Flavio Crameri</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Can currently available non-animal methods detect pre and pro-haptens relevant for skin sensitization?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27569201</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30228-8</DOI>
    <KeywordList>
      <Keywords>Adverse Outcome Pathway</Keywords>
      <Keywords>DPRA</Keywords>
      <Keywords>KeratinoSens™</Keywords>
      <Keywords>Pre-hapten</Keywords>
      <Keywords>Pro-hapten</Keywords>
      <Keywords>Reaction mechanistic domain</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>h-CLAT</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>US Environmental Protection Agency, National Center for Computational Toxicology, Research Triangle Park, NC, USA. Electronic address: patlewicz.grace@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Casati</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate F - Health, Consumers and Reference Materials, Chemical Safety and Alternative Methods Unit, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>David A. Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, Bedfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Asturiol</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate F - Health, Consumers and Reference Materials, Chemical Safety and Alternative Methods Unit, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>David W. Roberts</Name>
        <Affiliation>Liverpool John Moores University, School of Pharmacy and Biomolecular Sciences, Liverpool, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Pierre Lepoittevin</Name>
        <Affiliation>Institute of Chemistry, CNRS UMR 7177 and University of Strasbourg, Strasbourg, France.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew P. Worth</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate F - Health, Consumers and Reference Materials, Chemical Safety and Alternative Methods Unit, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Aschberger</Name>
        <Affiliation>European Commission, Joint Research Centre, Directorate F - Health, Consumers and Reference Materials, Chemical Safety and Alternative Methods Unit, Ispra, VA, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Harmonization efforts for deriving health-based exposure limits in the pharmaceutical industry - Advancing the current science and practice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27531049</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.07.016</DOI>
    <AuthorList>
      <Author>
        <Name>Patricia A. Weideman</Name>
        <Affiliation>Genentech Inc, United States; Sakari Consultants LLC, United States. Electronic address: patricia.weideman@sakariconsultants.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alison M. Pecquet</Name>
        <Affiliation>University of Cincinnati, Toxicology Excellence for Risk Assessment (TERA) Center, United States.</Affiliation>
      </Author>
      <Author>
        <Name>M. Andrew Maier</Name>
        <Affiliation>University of Cincinnati, Toxicology Excellence for Risk Assessment (TERA) Center, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigating a toxic risk (self-inflicted) the example of conventional and advanced studies of a novel Tobacco Heating System.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27483981</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30212-4</DOI>
    <KeywordList>
      <Keywords>'Omics technologies</Keywords>
      <Keywords>Bioinformatics</Keywords>
      <Keywords>Modified risk tobacco product</Keywords>
      <Keywords>Novel toxicity testing</Keywords>
      <Keywords>Risk prediction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anthony D. Dayan</Name>
        <Affiliation>11 St Andrews Pl, London NW1 4LE, UK. Electronic address: anthony.dayan@rcplondon.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 3. Apparent discrepancies between LLNA and GPMT sensitisation potential: False positives or differences in sensitivity?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27477089</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.07.018</DOI>
    <KeywordList>
      <Keywords>Autoxidation</Keywords>
      <Keywords>Surfactants</Keywords>
      <Keywords>Unsaturated fatty acids</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David W. Roberts</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, L3 3AF, United Kingdom. Electronic address: D.W.Roberts@ljmu.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Terry W. Schultz</Name>
        <Affiliation>The University of Tennessee, College of Veterinary, 2407 River Drive, Knoxville, TN, 37996, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Marie Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ, 07677, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Migration limits for children's toys are nothing to play with.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27470440</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.07.014</DOI>
    <KeywordList>
      <Keywords>Children</Keywords>
      <Keywords>Ingestion</Keywords>
      <Keywords>Liquid</Keywords>
      <Keywords>Pliable</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Scraped-off toy material</Keywords>
      <Keywords>Sticky</Keywords>
      <Keywords>Toys</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>European Commission, Directorate General for Health and Food Safety, L-2920 Luxembourg, Luxembourg. Electronic address: SANTE-C2-SCHEER@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Renate Krätke</Name>
        <Affiliation>European Commission, Directorate General for Health and Food Safety, L-2920 Luxembourg, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Beausoleil</Name>
        <Affiliation>European Commission, Directorate General for Health and Food Safety, L-2920 Luxembourg, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Maria José Carroquino</Name>
        <Affiliation>European Commission, Directorate General for Health and Food Safety, L-2920 Luxembourg, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Raquel Duarte-Davidson</Name>
        <Affiliation>European Commission, Directorate General for Health and Food Safety, L-2920 Luxembourg, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Teresa Fernandes</Name>
        <Affiliation>European Commission, Directorate General for Health and Food Safety, L-2920 Luxembourg, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Greet Schoeters</Name>
        <Affiliation>European Commission, Directorate General for Health and Food Safety, L-2920 Luxembourg, Luxembourg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27470439</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.07.013</DOI>
    <KeywordList>
      <Keywords>Biological variability</Keywords>
      <Keywords>LLNA</Keywords>
      <Keywords>Non-animal prediction</Keywords>
      <Keywords>QMM</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David W. Roberts</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, L3 3AF, United Kingdom. Electronic address: D.W.Roberts@ljmu.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Marie Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Aynur O. Aptula</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedford, MK44 1LQ, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The acute lethal dose 50 (LD50) of caffeine in albino rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27461039</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.07.011</DOI>
    <KeywordList>
      <Keywords>Albino rats</Keywords>
      <Keywords>Caffeine</Keywords>
      <Keywords>Lethal dose 50</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard H. Adamson</Name>
        <Affiliation>TPN Associates LLC, 13625 Esworthy Road, Germantown, MD 20874, United States; 7Haynes Street, Walpole, MA 02081, United States. Electronic address: radamson.tpn@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the system and the scientific assessment program.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27450400</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30189-1</DOI>
    <KeywordList>
      <Keywords>Heat-not-burn</Keywords>
      <Keywords>Modified risk tobacco product</Keywords>
      <Keywords>Scientific assessment approach</Keywords>
      <Keywords>Tobacco harm reduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maurice R. Smith</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(1). Electronic address: Maurice.Smith@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce Clark</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Frank Lüdicke</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Jean Pierre Schaller</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Patrick Vanscheeuwijck</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Julia Hoeng</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
      <Author>
        <Name>Manuel C. Peitsch</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland(1).</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Advances in assessing ingredient safety.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27427210</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.07.008</DOI>
    <KeywordList>
      <Keywords>Acceptable daily intake</Keywords>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Critical effect</Keywords>
      <Keywords>Ingredient safety</Keywords>
      <Keywords>Reference dose</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Uncertainty factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael L. Dourson</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA), 2300 Montana Avenue, Suite 409, Cincinnati, OH 45211, USA. Electronic address: doursoml@uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond G. York</Name>
        <Affiliation>R G York &amp; Associates LLC, Cincinnati, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitization potency. Part 1. Underlying physical organic chemistry principles and the extent to which they are represented in the LLNA validation dataset.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27424000</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.07.007</DOI>
    <KeywordList>
      <Keywords>Electrophilicity</Keywords>
      <Keywords>Hydrophobicity</Keywords>
      <Keywords>Reactivity</Keywords>
      <Keywords>Relative Alkylation Index (RAI)</Keywords>
      <Keywords>Skin penetration</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>D. W. Roberts</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, United Kingdom. Electronic address: D.W.Roberts@ljmu.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. Patlewicz</Name>
        <Affiliation>DuPont Haskell Global Centers, 1090 Elkton Road, Newark, DE 19711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>T. W. Schultz</Name>
        <Affiliation>The University of Tennessee, College of Veterinary, 2407 River Drive, Knoxville, TN 37996, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gastric mucosal irritation following oral exposure to sodium metabisulphite: A reproducible effect?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27401986</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.07.005</DOI>
    <KeywordList>
      <Keywords>Sodium metabisulphite</Keywords>
      <Keywords>Sulphite</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rosalind R. Dalefield</Name>
        <Affiliation>Food Standards Australia New Zealand, Level 3, 154 Featherston Street, Wellington, 6011, New Zealand. Electronic address: rosalind.dalefield@foodstandards.govt.nz.</Affiliation>
      </Author>
      <Author>
        <Name>Utz Mueller</Name>
        <Affiliation>Food Standards Australia New Zealand, Boeing House, 55 Blackall St., Barton, ACT, 2600, Australia. Electronic address: utz.mueller@apvma.gov.au.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developing a framework for assessing chemical respiratory sensitization: A workshop report.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27396307</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.006</DOI>
    <KeywordList>
      <Keywords>Framework</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Respiratory sensitization</Keywords>
      <Keywords>Sensitization</Keywords>
      <Keywords>Skin</Keywords>
      <Keywords>Tiered approach</Keywords>
      <Keywords>Workshop report</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Colin M. North</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., Annandale, NJ, USA. Electronic address: colin.m.north@exxonmobil.com.</Affiliation>
      </Author>
      <Author>
        <Name>Janine Ezendam</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jon A. Hotchkiss</Name>
        <Affiliation>Dow Chemical Company - Toxicology and Environmental Research and Consulting, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Curtis Maier</Name>
        <Affiliation>GlaxoSmithKline Pharmaceuticals, King of Prussia, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kohji Aoyama</Name>
        <Affiliation>Kagoshima University, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Steve Enoch</Name>
        <Affiliation>Liverpool John Moores University, Liverpool, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Amber Goetz</Name>
        <Affiliation>Syngenta, Greensboro, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cynthia Graham</Name>
        <Affiliation>Hunstman LLC, The Woodlands, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Life Sciences, University of Manchester, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Antti Karjalainen</Name>
        <Affiliation>European Chemicals Agency, Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Juergen Pauluhn</Name>
        <Affiliation>Bayer Pharma, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Erwin L. Roggen</Name>
        <Affiliation>3Rs Management and Consulting ApS, Lyngby, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>MaryJane Selgrade</Name>
        <Affiliation>ICF International, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susan M. Tarlo</Name>
        <Affiliation>University of Toronto, Toronto, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Connie L. Chen</Name>
        <Affiliation>ILSI - Health and Environmental Sciences Institute, Washington, DC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Overview of the ISRTP October 2014 workshop on GRAS determinations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27392697</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.07.002</DOI>
    <KeywordList>
      <Keywords>Executive summary</Keywords>
      <Keywords>Workshop on GRAS determinations</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Diane B. McColl</Name>
        <Affiliation>Hyman, Phelps &amp; McNamara, P.C., 700 13th Street, NW, Suite 1200, Washington, DC, 20005, USA. Electronic address: dmccoll@hpm.com.</Affiliation>
      </Author>
      <Author>
        <Name>Erik R. Janus</Name>
        <Affiliation>M³ Technical &amp; Regulatory Services, LLC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemistry, manufacturing and exposure assessments to support generally recognized as safe (GRAS) determinations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27389281</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.07.003</DOI>
    <KeywordList>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>GRAS determination methods</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Leila Barraj</Name>
        <Affiliation>Exponent, Inc., 1150 Connecticut Avenue, NW, Suite 1100, Washington, DC 20036, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Murphy</Name>
        <Affiliation>Exponent, Inc., 1150 Connecticut Avenue, NW, Suite 1100, Washington, DC 20036, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nga Tran</Name>
        <Affiliation>Exponent, Inc., 1150 Connecticut Avenue, NW, Suite 1100, Washington, DC 20036, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Petersen</Name>
        <Affiliation>Exponent, Inc., 1150 Connecticut Avenue, NW, Suite 1100, Washington, DC 20036, USA. Electronic address: bpetersen@exponent.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Qualitative and quantitative composition of essential oils: A literature-based database on contact allergens used for safety assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27375057</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.016</DOI>
    <KeywordList>
      <Keywords>Aromatherapy</Keywords>
      <Keywords>Contact sensitization</Keywords>
      <Keywords>Database</Keywords>
      <Keywords>Dermal exposure</Keywords>
      <Keywords>Exposure assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>N. Dornic</Name>
        <Affiliation>Laboratoire d'Evaluation du Risque Chimique pour le Consommateur (LERCCo), Université Européenne de Bretagne, Université de Bretagne Occidentale (UEB-UBO), UFR Sciences et Techniques, 6 Av. Victor Le Gorgeu, CS93837 29238, Brest Cedex 3, France. Electronic address: nicolas.dornic@univ-brest.fr.</Affiliation>
      </Author>
      <Author>
        <Name>A. S. Ficheux</Name>
        <Affiliation>Laboratoire d'Evaluation du Risque Chimique pour le Consommateur (LERCCo), Université Européenne de Bretagne, Université de Bretagne Occidentale (UEB-UBO), UFR Sciences et Techniques, 6 Av. Victor Le Gorgeu, CS93837 29238, Brest Cedex 3, France.</Affiliation>
      </Author>
      <Author>
        <Name>A. C. Roudot</Name>
        <Affiliation>Laboratoire d'Evaluation du Risque Chimique pour le Consommateur (LERCCo), Université Européenne de Bretagne, Université de Bretagne Occidentale (UEB-UBO), UFR Sciences et Techniques, 6 Av. Victor Le Gorgeu, CS93837 29238, Brest Cedex 3, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute toxicity evaluation of a thiazolo arene ruthenium (II) complex in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27375008</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.018</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Arene ruthenium complexes</Keywords>
      <Keywords>Thiazole</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Adriana Grozav</Name>
        <Affiliation>Department of Organic Chemistry, Faculty of Pharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy, 41 Victor Babes, RO-400012 Cluj-Napoca, Romania. Electronic address: adriana.ignat@umfcluj.ro.</Affiliation>
      </Author>
      <Author>
        <Name>Viorel Miclaus</Name>
        <Affiliation>Department of Cell Biology, Histology and Embryology, Faculty of Veterinary Medicine, 3-5 Calea Mănăstur, RO-400372 Cluj-Napoca, Romania. Electronic address: vmiclaus@usamvcluj.ro.</Affiliation>
      </Author>
      <Author>
        <Name>Oliviu Vostinaru</Name>
        <Affiliation>Department of Pharmacology, Physiology and Physiopathology, Faculty of Pharmacy, "Iuliu Haţieganu" University of Medicine and Pharmacy, 6A, L Pasteur, 400012 Cluj-Napoca, Romania. Electronic address: oliviu.vostinaru@umfcluj.ro.</Affiliation>
      </Author>
      <Author>
        <Name>Steliana Ghibu</Name>
        <Affiliation>Department of Pharmacology, Physiology and Physiopathology, Faculty of Pharmacy, "Iuliu Haţieganu" University of Medicine and Pharmacy, 6A, L Pasteur, 400012 Cluj-Napoca, Romania. Electronic address: stelianaghibu@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cristian Berce</Name>
        <Affiliation>Practical Skills and Experimental Medicine Centre, "Iuliu Haţieganu" University of Medicine and Pharmacy, 8 Victor Babeş, 400012 Cluj-Napoca, Romania. Electronic address: cristi.berce@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ioana Rotar</Name>
        <Affiliation>Clinic of Obstetrics and Gynecology, Department Mother and Baby, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania. Electronic address: cristina.rotar@umfcluj.ro.</Affiliation>
      </Author>
      <Author>
        <Name>Cristina Mogosan</Name>
        <Affiliation>Department of Pharmacology, Physiology and Physiopathology, Faculty of Pharmacy, "Iuliu Haţieganu" University of Medicine and Pharmacy, 6A, L Pasteur, 400012 Cluj-Napoca, Romania. Electronic address: cmogosan@umfcluj.ro.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Therrien</Name>
        <Affiliation>Institut de Chimie, Université de Neuchâtel, 51 Avenue de Bellevaux, CH-2000 Neuchâtel, Switzerland. Electronic address: bruno.therrien@unine.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Felicia Loghin</Name>
        <Affiliation>Department of Toxicology, Faculty of Pharmacy, "Iuliu Haţieganu" University of Medicine and Pharmacy, 8 Victor Babeş, 400012 Cluj-Napoca, Romania. Electronic address: floghin@umfcluj.ro.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela Saveta Popa</Name>
        <Affiliation>Department of Toxicology, Faculty of Pharmacy, "Iuliu Haţieganu" University of Medicine and Pharmacy, 8 Victor Babeş, 400012 Cluj-Napoca, Romania. Electronic address: dpopa@umfcluj.ro.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27350053</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.019</DOI>
    <KeywordList>
      <Keywords>6-Propylthiouracil (PTU)</Keywords>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Methimazole (MMI)</Keywords>
      <Keywords>Resorcinol</Keywords>
      <Keywords>Thyroid peroxidase (TPO)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kozo Motonaga</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., 3-1-98, Kasugadenaka, Konohana-ku, Osaka, 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mika Ota</Name>
        <Affiliation>Sumika Technoservice Co., 4-2-1, Takatsukasa, Takarazuka, Hyogo, 665-0051, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kyoko Odawara</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., 3-1-98, Kasugadenaka, Konohana-ku, Osaka, 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shoji Saito</Name>
        <Affiliation>Sumika Chemical Analysis Service, Ltd., 3-22-5, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Welsch</Name>
        <Affiliation>Orbitox, International Toxicology Consultants, 7 Avenida Vista Grande #274, Santa Fe, NM, 87508, USA. Electronic address: orbitox@comcast.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute inhalation toxicity of carbon monoxide and hydrogen cyanide revisited: Comparison of models to disentangle the concentration × time conundrum of lethality and incapacitation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27346845</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.017</DOI>
    <KeywordList>
      <Keywords>Asphyxiant gases</Keywords>
      <Keywords>Biomarkers of exposure and effect</Keywords>
      <Keywords>Carboxyhemoglobin</Keywords>
      <Keywords>Combustion toxicology</Keywords>
      <Keywords>Haber’s rule</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juergen Pauluhn</Name>
        <Affiliation>Hannover Medical School, Hannover, Germany. Electronic address: juergen.pauluhn@iCLOUD.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Managing risks of noncancer health effects at hazardous waste sites: A case study using the Reference Concentration (RfC) of trichloroethylene (TCE).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27346665</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.013</DOI>
    <KeywordList>
      <Keywords>Indoor air</Keywords>
      <Keywords>Non-cancer hazard</Keywords>
      <Keywords>Reference dose/concentration</Keywords>
      <Keywords>Risk management</Keywords>
      <Keywords>Safety range</Keywords>
      <Keywords>Sensitive subpopulation</Keywords>
      <Keywords>Short-term exposure</Keywords>
      <Keywords>Trichloroethylene</Keywords>
      <Keywords>Uncertainty factor</Keywords>
      <Keywords>Vapor intrusion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael L. Dourson</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA) Center, University of Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bernard K. Gadagbui</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA) Center, University of Cincinnati, OH, USA. Electronic address: gadagbbd@ucmail.uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Rod B. Thompson</Name>
        <Affiliation>Risk Options, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Edward J. Pfau</Name>
        <Affiliation>Hull &amp; Associates, Inc., Dublin, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Lowe</Name>
        <Affiliation>CH2M, Spokane, WA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Potential pitfalls associated with testing of enzyme preparations in the Salmonella/microsome assay.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27330008</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.008</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>Food enzymes</Keywords>
      <Keywords>Mutagenicity testing</Keywords>
      <Keywords>Positive controls</Keywords>
      <Keywords>S9 activation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Luigi Conti</Name>
        <Affiliation>Department of Environment and Primary Prevention, Istituto Superiore di Sanità, 00161 Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Riccardo Crebelli</Name>
        <Affiliation>Department of Environment and Primary Prevention, Istituto Superiore di Sanità, 00161 Rome, Italy. Electronic address: riccardo.crebelli@iss.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>GRAS determination scientific procedures and possible alternatives.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27328372</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.015</DOI>
    <KeywordList>
      <Keywords>Accelerated carcinogenicity bioassay(ACB)</Keywords>
      <Keywords>Alternatives</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>GRAS determination scientific procedures</Keywords>
      <Keywords>Generally Recognized as Safe (GRAS)</Keywords>
      <Keywords>In Ovo assay</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Scientific procedures</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gary M. Williams</Name>
        <Affiliation>Department of Pathology, New York Medical College, 40Sunshine Cottage Road, BSB # 413, Valhalla, NY, 10595, USA. Electronic address: gary_williams@nymc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Tetyana Kobets</Name>
        <Affiliation>Department of Pathology, New York Medical College, 40Sunshine Cottage Road, BSB # 413, Valhalla, NY, 10595, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Iatropoulos</Name>
        <Affiliation>Department of Pathology, New York Medical College, 40Sunshine Cottage Road, BSB # 413, Valhalla, NY, 10595, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Dong Duan</Name>
        <Affiliation>Department of Pathology, New York Medical College, 40Sunshine Cottage Road, BSB # 413, Valhalla, NY, 10595, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus D. Brunnemann</Name>
        <Affiliation>Department of Pathology, New York Medical College, 40Sunshine Cottage Road, BSB # 413, Valhalla, NY, 10595, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute toxicity when concentration varies with time: A case study with carbon monoxide inhalation by rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27321061</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.014</DOI>
    <KeywordList>
      <Keywords>Acute inhalation toxicity</Keywords>
      <Keywords>Carbon monoxide</Keywords>
      <Keywords>Dose-response models</Keywords>
      <Keywords>Fluctuation</Keywords>
      <Keywords>Toxic load model</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lisa M. Sweeney</Name>
        <Affiliation>Naval Medical Research Unit Dayton (NAMRU-D), 2728 Q Street, Area B, Building 837, Wright-Patterson Air Force Base, OH 45433, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA. Electronic address: lisa.sweeney.3.ctr@us.af.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas R. Sommerville</Name>
        <Affiliation>Edgewood Chemical Biological Center, Aberdeen Proving Ground, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle R. Goodwin</Name>
        <Affiliation>Naval Medical Research Unit Dayton (NAMRU-D), 2728 Q Street, Area B, Building 837, Wright-Patterson Air Force Base, OH 45433, USA; CAMRIS, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. Arden James</Name>
        <Affiliation>Naval Medical Research Unit Dayton (NAMRU-D), 2728 Q Street, Area B, Building 837, Wright-Patterson Air Force Base, OH 45433, USA; CAMRIS, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen R. Channel</Name>
        <Affiliation>Leidos, Linton, IN 47441, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impact of muffle furnace preparation on the results of crystalline silica analysis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27321060</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.002</DOI>
    <KeywordList>
      <Keywords>Crucible</Keywords>
      <Keywords>Crystalline silica</Keywords>
      <Keywords>Muffle furnace</Keywords>
      <Keywords>NIOSH 7500</Keywords>
      <Keywords>Plasma ash</Keywords>
      <Keywords>X-ray diffraction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>R. J. Lee</Name>
        <Affiliation>RJ Lee Group, Inc., 350 Hochberg Road, Monroeville, PA, 15146, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. R. Van Orden</Name>
        <Affiliation>RJ Lee Group, Inc., 350 Hochberg Road, Monroeville, PA, 15146, USA. Electronic address: drew@rjlg.com.</Affiliation>
      </Author>
      <Author>
        <Name>L. A. Cox</Name>
        <Affiliation>Cox Associates Inc., 503 Franklin Street, Denver, CO, 80218, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. Arlauckas</Name>
        <Affiliation>RJ Lee Group, Inc., 350 Hochberg Road, Monroeville, PA, 15146, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. J. Kautz</Name>
        <Affiliation>RJ Lee Group, Inc., 350 Hochberg Road, Monroeville, PA, 15146, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Epidemiological evidence on environmental tobacco smoke and cancers other than lung or breast.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27321059</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.012</DOI>
    <KeywordList>
      <Keywords>Environmental tobacco smoke</Keywords>
      <Keywords>Meta-analysis</Keywords>
      <Keywords>Neoplasms</Keywords>
      <Keywords>Nonsmoker</Keywords>
      <Keywords>Review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd., 17 Cedar Road, Sutton, Surrey, SM2 5DA, UK. Electronic address: PeterLee@pnlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Alison J. Thornton</Name>
        <Affiliation>Independent Consultant, Oak Cottage, Beer Farm, Okehampton, Devon, EX20 1SG, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Janette S. Hamling</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd., 17 Cedar Road, Sutton, Surrey, SM2 5DA, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Performance standard-based validation study for local lymph node assay: 5-bromo-2-deoxyuridine-flow cytometry method.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27318101</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.009</DOI>
    <KeywordList>
      <Keywords>Flow cytometry</Keywords>
      <Keywords>LLNA: BrdU-FCM</Keywords>
      <Keywords>Local lymph node assay</Keywords>
      <Keywords>Performance standards</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>Validation study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ilyoung Ahn</Name>
        <Affiliation>Korean Center for the Validation of Alternative Methods, National Institute of Food and Drug Safety Evaluation, MFDS, Chungbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Sung Kim</Name>
        <Affiliation>Korean Center for the Validation of Alternative Methods, National Institute of Food and Drug Safety Evaluation, MFDS, Chungbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Sun Jung</Name>
        <Affiliation>National Institute of Food and Drug Safety Evaluation, Toxicological Evaluation and Research Dept., Toxicological Screening &amp; Testing Division, MFDS, Chungbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Sun Yi</Name>
        <Affiliation>National Institute of Food and Drug Safety Evaluation, Toxicological Evaluation and Research Dept., Toxicological Screening &amp; Testing Division, MFDS, Chungbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Won Hee Jang</Name>
        <Affiliation>Medical Beauty Research Division, AmorePacific Corp., R&amp;D Center, Yongin, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyoung Mi Jung</Name>
        <Affiliation>Medical Beauty Research Division, AmorePacific Corp., R&amp;D Center, Yongin, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Miyoung Park</Name>
        <Affiliation>Medical Beauty Research Division, AmorePacific Corp., R&amp;D Center, Yongin, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Sook Jung</Name>
        <Affiliation>Biotoxtech Co., Ltd., Pharmacology Efficacy Team, Chungbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Young Jeon</Name>
        <Affiliation>Biotoxtech Co., Ltd., Pharmacology Efficacy Team, Chungbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyeong Uk Yeo</Name>
        <Affiliation>Catholic University of Daegu, College of Medical and Public Health Sciences, Dept. Occupational Health and GLP Center, Gyeongbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Hoon Jo</Name>
        <Affiliation>Catholic University of Daegu, College of Medical and Public Health Sciences, Dept. Occupational Health and GLP Center, Gyeongbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Eun Park</Name>
        <Affiliation>Catholic University of Daegu, College of Medical and Public Health Sciences, Dept. Occupational Health and GLP Center, Gyeongbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Yul Kim</Name>
        <Affiliation>Catholic University of Daegu, College of Medical and Public Health Sciences, Dept. Occupational Health and GLP Center, Gyeongbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yeong Chul Park</Name>
        <Affiliation>Catholic University of Daegu, College of Medical and Public Health Sciences, Dept. Occupational Health and GLP Center, Gyeongbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Won Keun Seong</Name>
        <Affiliation>Korean Center for the Validation of Alternative Methods, National Institute of Food and Drug Safety Evaluation, MFDS, Chungbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ai Young Lee</Name>
        <Affiliation>Dongguk University, Ilsan Hospital, Gyeonggi-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Jin Chun</Name>
        <Affiliation>Chung-Ang University, College of Pharmacy, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Cheon Jeong</Name>
        <Affiliation>Yeungnam University, College of Pharmacy, Gyeongbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eui Bae Jeung</Name>
        <Affiliation>Chungbuk National University, College of Veterinary Medicine, Chungbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Min Lim</Name>
        <Affiliation>Ewha Womans University, College of Pharmacy, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>SeungJin Bae</Name>
        <Affiliation>Ewha Womans University, College of Pharmacy, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soojung Sohn</Name>
        <Affiliation>Korean Center for the Validation of Alternative Methods, National Institute of Food and Drug Safety Evaluation, MFDS, Chungbuk, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Heo</Name>
        <Affiliation>Catholic University of Daegu, College of Medical and Public Health Sciences, Dept. Occupational Health and GLP Center, Gyeongbuk, Republic of Korea. Electronic address: yheo@cu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The relevance of international assessments to GRAS determinations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27318100</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.010</DOI>
    <KeywordList>
      <Keywords>GRAS determinations</Keywords>
      <Keywords>International assessments relevance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Claire Kruger</Name>
        <Affiliation>Spherix Consulting, Inc., 11821 Parklawn Drive, Suite 310, Rockville, MD, 20852, USA. Electronic address: clairek@chromadex.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A hard look at FDA's review of GRAS notices.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27318099</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.011</DOI>
    <KeywordList>
      <Keywords>Critical review</Keywords>
      <Keywords>FDA</Keywords>
      <Keywords>Food ingredients</Keywords>
      <Keywords>GRAS</Keywords>
      <Keywords>Notices</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ashley Roberts</Name>
        <Affiliation>Intertek Scientific and Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, ON, L5N 2X7, Canada. Electronic address: ashley.roberts@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lois A. Haighton</Name>
        <Affiliation>Intertek Scientific and Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, ON, L5N 2X7, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human health risk assessment of chloroxylenol in liquid hand soap and dishwashing soap used by consumers and health-care professionals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27316554</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.003</DOI>
    <KeywordList>
      <Keywords>Chloroxylenol</Keywords>
      <Keywords>Personal care products</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lisa J. Yost</Name>
        <Affiliation>Ramboll Environ, 333 W. Wacker Dr., Suite 2700, Chicago, IL 60606, USA. Electronic address: lyost@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph D. Rodricks</Name>
        <Affiliation>Ramboll Environ, 4350 North Fairfax Drive Suite 300, Arlington, VA 22203, USA. Electronic address: jrodricks@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Duncan Turnbull</Name>
        <Affiliation>Ramboll Environ, 4350 North Fairfax Drive Suite 300, Arlington, VA 22203, USA. Electronic address: dturnbull@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paul C. DeLeo</Name>
        <Affiliation>American Cleaning Institute, 1331 L Street, N.W., Sui te 650, Washington, D.C. 20005, USA. Electronic address: PDeLeo@CleaningInstitute.org.</Affiliation>
      </Author>
      <Author>
        <Name>J. Frank Nash</Name>
        <Affiliation>The Proctor and Gamble Company, 11530 Reed Hartman Hwy., Cincinnati, OH 45241, USA. Electronic address: Nash.jf@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio Quiñones-Rivera</Name>
        <Affiliation>GOJO Industries, One GOJO Plaza, Suite 500, Akron, Ohio, 44311, USA. Electronic address: QuinonesA@gojo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pete A. Carlson</Name>
        <Affiliation>Ecolab, 370 Wabasha Street North, Saint Paul, MN 55102, USA. Electronic address: pete.carlson@ecolab.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low dose X-irradiation mitigates diazepam induced depression in rat brain.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27316553</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.004</DOI>
    <KeywordList>
      <Keywords>Antioxidants</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Behavior</Keywords>
      <Keywords>Brain</Keywords>
      <Keywords>Depression</Keywords>
      <Keywords>Diazepam</Keywords>
      <Keywords>Low dose radiation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amandeep Kaur</Name>
        <Affiliation>Department of Biophysics, Panjab University, Chandigarh, 160014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Neha Singla</Name>
        <Affiliation>Department of Biophysics, Panjab University, Chandigarh, 160014, India. Electronic address: nehasbph@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>D. K. Dhawan</Name>
        <Affiliation>Department of Biophysics, Panjab University, Chandigarh, 160014, India. Electronic address: dhawan@pu.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxicity and subchronic toxicity evaluation of dried Euglena gracilis ATCC PTA-123017.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27311684</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.007</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ryan R. Simon</Name>
        <Affiliation>Intertek Scientific and Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, ON L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Trung D. Vo</Name>
        <Affiliation>Intertek Scientific and Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, ON L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Levine</Name>
        <Affiliation>Algal Scientific Corporation, 14925 Galleon Court, Plymouth, MI 48170, USA. Electronic address: robert.levine@algalscientific.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of the impact of the Tobacco Heating System 2.2 and a cigarette on indoor air quality.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27311683</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.005</DOI>
    <KeywordList>
      <Keywords>Carbonyls</Keywords>
      <Keywords>Environmental aerosol</Keywords>
      <Keywords>Environmental tobacco smoke</Keywords>
      <Keywords>Harmful and potentially harmful constituent</Keywords>
      <Keywords>Heat-not-Burn</Keywords>
      <Keywords>Indoor air quality</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>THS 2.2</Keywords>
      <Keywords>Tobacco heating system</Keywords>
      <Keywords>Volatile organic compounds</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maya I. Mitova</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland (part of Philip Morris International group of companies). Electronic address: maya.mitova@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pedro B. Campelos</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland (part of Philip Morris International group of companies).</Affiliation>
      </Author>
      <Author>
        <Name>Catherine G. Goujon-Ginglinger</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland (part of Philip Morris International group of companies).</Affiliation>
      </Author>
      <Author>
        <Name>Serge Maeder</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland (part of Philip Morris International group of companies).</Affiliation>
      </Author>
      <Author>
        <Name>Nicolas Mottier</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland (part of Philip Morris International group of companies).</Affiliation>
      </Author>
      <Author>
        <Name>Emmanuel G. R. Rouget</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland (part of Philip Morris International group of companies).</Affiliation>
      </Author>
      <Author>
        <Name>Manuel Tharin</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland (part of Philip Morris International group of companies).</Affiliation>
      </Author>
      <Author>
        <Name>Anthony R. Tricker</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland (part of Philip Morris International group of companies).</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing - Operational considerations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27267172</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.06.001</DOI>
    <KeywordList>
      <Keywords>Acceptable Daily Exposure (ADE)</Keywords>
      <Keywords>Active Pharmaceutical Ingredient (API)</Keywords>
      <Keywords>Cross-contamination</Keywords>
      <Keywords>Dedicated/segregated facilities</Keywords>
      <Keywords>International Society of Pharmaceutical Engineers (ISPE)</Keywords>
      <Keywords>Maximum Daily Dose (MDD)</Keywords>
      <Keywords>Maximum allowable carryover (MAC) or maximum safe carryover (MSC)</Keywords>
      <Keywords>Permitted Daily Exposure (PDE)</Keywords>
      <Keywords>Process intermediates (PI)</Keywords>
      <Keywords>Starting materials (SM)</Keywords>
      <Keywords>Threshold of Toxicological Concern (TTC)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eileen P. Hayes</Name>
        <Affiliation>EPHayes Toxicology Services, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert A. Jolly</Name>
        <Affiliation>Eli Lilly and Company, USA. Electronic address: jolly_robert_a@lilly.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen C. Faria</Name>
        <Affiliation>Johnson &amp; Johnson, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ester Lovsin Barle</Name>
        <Affiliation>Novartis, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Joel P. Bercu</Name>
        <Affiliation>Gilead Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lance R. Molnar</Name>
        <Affiliation>Mylan, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce D. Naumann</Name>
        <Affiliation>Merck &amp; Co., Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Olson</Name>
        <Affiliation>SafeBridge Consultants, Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alison M. Pecquet</Name>
        <Affiliation>University of Cincinnati, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Reena Sandhu</Name>
        <Affiliation>Safedose Ltd., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan K. Shipp</Name>
        <Affiliation>Pfizer Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert G. Sussman</Name>
        <Affiliation>SafeBridge Consultants, Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia A. Weideman</Name>
        <Affiliation>Genentech, Inc., USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identifying and assessing highly hazardous drugs within quality risk management programs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27267171</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.025</DOI>
    <KeywordList>
      <Keywords>Anti-cancer</Keywords>
      <Keywords>Cross-contamination</Keywords>
      <Keywords>Cytotoxic</Keywords>
      <Keywords>Hormone</Keywords>
      <Keywords>Pharmaceutical manufacturing</Keywords>
      <Keywords>Quality assurance</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Steroid</Keywords>
      <Keywords>cGMP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Robert G. Sussman</Name>
        <Affiliation>SafeBridge Consultants, Inc., USA. Electronic address: robert.sussman@safebridge.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony R. Schatz</Name>
        <Affiliation>Merck &amp; Co., Inc., USA; Ashland, Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tracy A. Kimmel</Name>
        <Affiliation>SafeBridge Consultants, Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Allan Ader</Name>
        <Affiliation>SafeBridge Consultants, Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce D. Naumann</Name>
        <Affiliation>Merck &amp; Co., Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia A. Weideman</Name>
        <Affiliation>Genentech, Inc., USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Towards a nanospecific approach for risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27255696</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.037</DOI>
    <KeywordList>
      <Keywords>(Q)SARs</Keywords>
      <Keywords>Grouping</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Prioritisation</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Risk assessment approach</Keywords>
      <Keywords>Testing strategy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susan Dekkers</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Electronic address: susan.dekkers@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Agnes G. Oomen</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Eric A. J. Bleeker</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Rob J. Vandebriel</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Micheletti</Name>
        <Affiliation>ECAMRICERT, Vicenza, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Joan Cabellos</Name>
        <Affiliation>LEITAT, Technological Center, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Gemma Janer</Name>
        <Affiliation>LEITAT, Technological Center, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Natalia Fuentes</Name>
        <Affiliation>LEITAT, Technological Center, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Socorro Vázquez-Campos</Name>
        <Affiliation>LEITAT, Technological Center, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Teresa Borges</Name>
        <Affiliation>Directorate-General of Health (DGS) and PToNANO, Lisbon, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Maria João Silva</Name>
        <Affiliation>National Institute of Health Doutor Ricardo Jorge (INSA) and PToNANO, Lisbon, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Adriele Prina-Mello</Name>
        <Affiliation>Trinity College Dublin (TCD), Dublin, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>Dania Movia</Name>
        <Affiliation>Trinity College Dublin (TCD), Dublin, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>Fabrice Nesslany</Name>
        <Affiliation>Institute Pasteur de Lille (IPL), Lille Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Ana R. Ribeiro</Name>
        <Affiliation>National Institute of Metrology Quality and Technology (INMETRO), Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Paulo Emílio Leite</Name>
        <Affiliation>National Institute of Metrology Quality and Technology (INMETRO), Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Monique Groenewold</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Flemming R. Cassee</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Adrienne J. A. M. Sips</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aart Dijkzeul</Name>
        <Affiliation>Ministry of Infrastructure and the Environment (Min I&amp;M), The Hague, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Tom van Teunenbroek</Name>
        <Affiliation>Ministry of Infrastructure and the Environment (Min I&amp;M), The Hague, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Susan W. P. Wijnhoven</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Guidance on the selection of cohorts for the extended one-generation reproduction toxicity study (OECD test guideline 443).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27245879</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.036</DOI>
    <KeywordList>
      <Keywords>Cohorts</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>EOGRTS</Keywords>
      <Keywords>Extended one-generation reproductive toxicity study</Keywords>
      <Keywords>Fertility</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Reproduction</Keywords>
      <Keywords>Triggers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nigel P. Moore</Name>
        <Affiliation>Ubrs GmbH, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Manon Beekhuijzen</Name>
        <Affiliation>WIL Research Europe BV, s'-Hertogenbosch, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Peter J. Boogaard</Name>
        <Affiliation>Shell International BV, The Hague, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer E. Foreman</Name>
        <Affiliation>ExxonMobil Biomedical Sciences Inc., Annandale, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Colin M. North</Name>
        <Affiliation>ExxonMobil Biomedical Sciences Inc., Annandale, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christine Palermo</Name>
        <Affiliation>ExxonMobil Petroleum and Chemical, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Steffen Schneider</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Volker Strauss</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Bennard van Ravenzwaay</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Poole</Name>
        <Affiliation>European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), Brussels, Belgium. Electronic address: alan.poole@ecetoc.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Monitoring and probabilistic risk assessment of chlorothalonil residues in vegetables from Shandong province (China).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27240750</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.035</DOI>
    <KeywordList>
      <Keywords>Chlorothalonil</Keywords>
      <Keywords>Non-parameter probabilistic model</Keywords>
      <Keywords>Residues</Keywords>
      <Keywords>Vegetables</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hong Zhang</Name>
        <Affiliation>Institution of Quality Standard and Testing Technology for Agro-product, Shandong Academy of Agricultural Science Shandong Key Laboratory of Testing Technology for Food Quality and Security, No. 202 Gongye North Road, Jinan 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Nie</Name>
        <Affiliation>Institution of Quality Standard and Testing Technology for Agro-product, Shandong Academy of Agricultural Science Shandong Key Laboratory of Testing Technology for Food Quality and Security, No. 202 Gongye North Road, Jinan 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuqiu Zhang</Name>
        <Affiliation>Institution of Quality Standard and Testing Technology for Agro-product, Shandong Academy of Agricultural Science Shandong Key Laboratory of Testing Technology for Food Quality and Security, No. 202 Gongye North Road, Jinan 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Zheng Wang</Name>
        <Affiliation>Institution of Quality Standard and Testing Technology for Agro-product, Shandong Academy of Agricultural Science Shandong Key Laboratory of Testing Technology for Food Quality and Security, No. 202 Gongye North Road, Jinan 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huidong Li</Name>
        <Affiliation>Institution of Quality Standard and Testing Technology for Agro-product, Shandong Academy of Agricultural Science Shandong Key Laboratory of Testing Technology for Food Quality and Security, No. 202 Gongye North Road, Jinan 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengen Wang</Name>
        <Affiliation>Institution of Quality Standard and Testing Technology for Agro-product, Shandong Academy of Agricultural Science Shandong Key Laboratory of Testing Technology for Food Quality and Security, No. 202 Gongye North Road, Jinan 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Lv</Name>
        <Affiliation>Institution of Quality Standard and Testing Technology for Agro-product, Shandong Academy of Agricultural Science Shandong Key Laboratory of Testing Technology for Food Quality and Security, No. 202 Gongye North Road, Jinan 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zilei Chen</Name>
        <Affiliation>Institution of Quality Standard and Testing Technology for Agro-product, Shandong Academy of Agricultural Science Shandong Key Laboratory of Testing Technology for Food Quality and Security, No. 202 Gongye North Road, Jinan 250100, China. Electronic address: CZL7274@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Advantages of using an abbreviated dossier for drug master file applications in Taiwan.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27237380</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.034</DOI>
    <KeywordList>
      <Keywords>Abbreviated dossier</Keywords>
      <Keywords>Active pharmaceutical ingredient</Keywords>
      <Keywords>Dossier type</Keywords>
      <Keywords>Drug master file</Keywords>
      <Keywords>Full dossier</Keywords>
      <Keywords>Review outcome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>I. Chen Sun</Name>
        <Affiliation>Division of Pharmaceutical Science, Center for Drug Evaluation, Taipei, Taiwan, ROC; School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, ROC. Electronic address: icsun@cde.org.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>New trends and challenges in the European regulation of innovative medicines.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27237379</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.033</DOI>
    <KeywordList>
      <Keywords>Health technology assessment</Keywords>
      <Keywords>Marketing authorization</Keywords>
      <Keywords>Regulatory affairs</Keywords>
      <Keywords>Reimbursement</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Harald Enzmann</Name>
        <Affiliation>Bundesinstitut für Arzneimittel und Medizinprodukte, Kurt Georg Kiesinger Allee 3, 53175, Bonn, Germany. Electronic address: Harald.enzmann@bfarm.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comment on "Exposure-response modeling of non-cancer effects in humans exposed to Libby Amphibole Asbestos; update" by Benson et al. (2015).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27235558</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.014</DOI>
    <AuthorList>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Zu</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA. Electronic address: kzu@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ge Tao</Name>
        <Affiliation>Infinity Pharmaceuticals, 780 Memorial Drive, Cambridge, MA 02139, USA. Electronic address: getao@buffalo.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Laura E. Kerper</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA. Electronic address: lkerper@gradientcorp.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The utility of QSARs in predicting acute fish toxicity of pesticide metabolites: A retrospective validation approach.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27235557</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.032</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Fish toxicity</Keywords>
      <Keywords>Metabolites</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>QSARs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Natalie Burden</Name>
        <Affiliation>NC3Rs, Gibbs Building, 215 Euston Road, London, NW1 2BE, UK. Electronic address: natalie.burden@nc3rs.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel K. Maynard</Name>
        <Affiliation>Syngenta Environmental Safety, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Lennart Weltje</Name>
        <Affiliation>BASF SE, Crop Protection - Ecotoxicology, Speyerer Strasse 2, D-67117, Limburgerhof, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>James R. Wheeler</Name>
        <Affiliation>Dow AgroSciences, 3B Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Using default methodologies to derive an acceptable daily exposure (ADE).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27233926</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.026</DOI>
    <KeywordList>
      <Keywords>Acceptable daily exposure (ADE)</Keywords>
      <Keywords>Cleaning</Keywords>
      <Keywords>Cross-contamination</Keywords>
      <Keywords>Default</Keywords>
      <Keywords>Median lethal dose (LD(50))</Keywords>
      <Keywords>Occupational exposure band (OEB)</Keywords>
      <Keywords>Permitted daily exposure (PDE)</Keywords>
      <Keywords>Therapeutic dose (TD)</Keywords>
      <Keywords>Threshold of toxicological concern (TTC)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ellen C. Faria</Name>
        <Affiliation>Janssen Pharmaceutical Company, an Affiliate of Johnson &amp; Johnson, United States. Electronic address: efaria1@its.jnj.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joel P. Bercu</Name>
        <Affiliation>Gilead Sciences, Inc., United States.</Affiliation>
      </Author>
      <Author>
        <Name>David G. Dolan</Name>
        <Affiliation>Amgen Inc., United States.</Affiliation>
      </Author>
      <Author>
        <Name>Eric J. Morinello</Name>
        <Affiliation>Genentech, Inc., United States.</Affiliation>
      </Author>
      <Author>
        <Name>Alison M. Pecquet</Name>
        <Affiliation>University of Cincinnati, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Seaman</Name>
        <Affiliation>GlaxoSmithKline, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Sehner</Name>
        <Affiliation>Boehringer Ingelheim Pharma GmbH &amp; Co. KG, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia A. Weideman</Name>
        <Affiliation>Genentech, Inc., United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Point of departure (PoD) selection for the derivation of acceptable daily exposures (ADEs) for active pharmaceutical ingredients (APIs).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27233925</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.028</DOI>
    <KeywordList>
      <Keywords>Acceptable Daily Exposure (ADE)</Keywords>
      <Keywords>Cleaning validation</Keywords>
      <Keywords>Cross-contamination</Keywords>
      <Keywords>Lowest-observed-adverse-effect-level (LOAEL)</Keywords>
      <Keywords>No-observed-adverse-effect-level (NOAEL)</Keywords>
      <Keywords>Permitted Daily Exposure (PDE)</Keywords>
      <Keywords>Pharmacodynamics (PD)</Keywords>
      <Keywords>Pharmacokinetics (PK)</Keywords>
      <Keywords>Point of departure (PoD)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joel P. Bercu</Name>
        <Affiliation>Gilead Sciences, Inc., United States. Electronic address: joel.bercu@gilead.com.</Affiliation>
      </Author>
      <Author>
        <Name>Eric J. Morinello</Name>
        <Affiliation>Genentech, Inc., United States.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Sehner</Name>
        <Affiliation>Boehringer Ingelheim Pharma GmbH &amp; Co. KG, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan K. Shipp</Name>
        <Affiliation>Pfizer, Inc., United States.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia A. Weideman</Name>
        <Affiliation>Genentech, Inc., United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Special endpoint and product specific considerations in pharmaceutical acceptable daily exposure derivation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27233924</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.022</DOI>
    <KeywordList>
      <Keywords>Acceptable Daily Exposure (ADE)</Keywords>
      <Keywords>Cross-contamination</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Hypersensitivity</Keywords>
      <Keywords>Immune response</Keywords>
      <Keywords>Permitted Daily Exposure (PDE)</Keywords>
      <Keywords>Protein therapeutics</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Janet Gould</Name>
        <Affiliation>Bristol-Myers Squibb, USA. Electronic address: janet.gould@bms.com.</Affiliation>
      </Author>
      <Author>
        <Name>Courtney M. Callis</Name>
        <Affiliation>Eli Lilly and Company, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David G. Dolan</Name>
        <Affiliation>Amgen Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brad Stanard</Name>
        <Affiliation>MedImmune, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia A. Weideman</Name>
        <Affiliation>Genentech, Inc., USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Issues and approaches for ensuring effective communication on acceptable daily exposure (ADE) values applied to pharmaceutical cleaning.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27233923</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.024</DOI>
    <KeywordList>
      <Keywords>Acceptable Daily Exposure (ADE)</Keywords>
      <Keywords>Communication</Keywords>
      <Keywords>Contract manufacturer</Keywords>
      <Keywords>Monograph</Keywords>
      <Keywords>Permitted Daily Exposure (PDE)</Keywords>
      <Keywords>Pharmaceutical manufacturing</Keywords>
      <Keywords>Regulatory agencies</Keywords>
      <Keywords>Stakeholder</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael J. Olson</Name>
        <Affiliation>SafeBridge Consultants, Inc., USA. Electronic address: michael.olson@safebridge.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen C. Faria</Name>
        <Affiliation>Janssen Pharmaceutical Company, An Affiliate of Johnson &amp; Johnson, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eileen P. Hayes</Name>
        <Affiliation>EPHayes Toxicology Services, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert A. Jolly</Name>
        <Affiliation>Eli Lilly and Company, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ester Lovsin Barle</Name>
        <Affiliation>Novartis, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Lance R. Molnar</Name>
        <Affiliation>Mylan, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce D. Naumann</Name>
        <Affiliation>Merck &amp; Co., Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alison M. Pecquet</Name>
        <Affiliation>University of Cincinnati, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan K. Shipp</Name>
        <Affiliation>Pfizer Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert G. Sussman</Name>
        <Affiliation>SafeBridge Consultants, Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia A. Weideman</Name>
        <Affiliation>Genentech, Inc., USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of linear and threshold no significant risk levels for inhalation exposure to titanium dioxide using systematic review and mode of action considerations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27233922</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.031</DOI>
    <KeywordList>
      <Keywords>No significant risk level (NSRL)</Keywords>
      <Keywords>Risk of bias</Keywords>
      <Keywords>Systematic review</Keywords>
      <Keywords>Titanium dioxide (TiO(2))</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chad M. Thompson</Name>
        <Affiliation>ToxStrategies, Katy, TX 77494, USA. Electronic address: cthompson@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mina Suh</Name>
        <Affiliation>ToxStrategies, Mission Viejo, CA 92692, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Liz Mittal</Name>
        <Affiliation>ToxStrategies, Katy, TX 77494, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniele S. Wikoff</Name>
        <Affiliation>ToxStrategies, Austin, TX 78759, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Welsh</Name>
        <Affiliation>ToxStrategies, Austin, TX 78759, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Deborah M. Proctor</Name>
        <Affiliation>ToxStrategies, Mission Viejo, CA 92692, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Clinical safety evaluation of marine oil derived from Calanus finmarchicus.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27233921</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.030</DOI>
    <KeywordList>
      <Keywords>Calanus oil</Keywords>
      <Keywords>Clinical trial</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kurt S. Tande</Name>
        <Affiliation>Calanus AS, Stakkevollveien 65, N-9010, Tromsø, Norway. Electronic address: kurt.tande@calanus.no.</Affiliation>
      </Author>
      <Author>
        <Name>Trung D. Vo</Name>
        <Affiliation>Intertek Scientific and Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, Ontario, L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Barry S. Lynch</Name>
        <Affiliation>Intertek Scientific and Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, Ontario, L5N 2X7, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The regulatory framework for preventing cross-contamination of pharmaceutical products: History and considerations for the future.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27230736</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.029</DOI>
    <KeywordList>
      <Keywords>Acceptable daily exposure</Keywords>
      <Keywords>Cleaning validation</Keywords>
      <Keywords>Cross-contamination</Keywords>
      <Keywords>GMP</Keywords>
      <Keywords>Maximum allowable carryover</Keywords>
      <Keywords>Maximum safe carryover</Keywords>
      <Keywords>Permitted daily exposure</Keywords>
      <Keywords>Pharmaceutical manufacturing</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Edward V. Sargent</Name>
        <Affiliation>Rutgers University, United States. Electronic address: evsargent@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Flueckiger</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Ester Lovsin Barle</Name>
        <Affiliation>Novartis, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Wendy Luo</Name>
        <Affiliation>Bristol-Myers Squibb, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lance R. Molnar</Name>
        <Affiliation>Mylan, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Reena Sandhu</Name>
        <Affiliation>SafeDose, Ltd, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia A. Weideman</Name>
        <Affiliation>Genentech, Inc., United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27224509</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.027</DOI>
    <KeywordList>
      <Keywords>Area under the curve (AUC)</Keywords>
      <Keywords>Bioaccumulation</Keywords>
      <Keywords>Bioavailability</Keywords>
      <Keywords>C(max)</Keywords>
      <Keywords>Chemical specific adjustment factor (CSAF)</Keywords>
      <Keywords>Human health risk assessment</Keywords>
      <Keywords>Pharmacodynamic</Keywords>
      <Keywords>Pharmacokinetic</Keywords>
      <Keywords>Toxicodynamic</Keywords>
      <Keywords>Toxicokinetic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John F. Reichard</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA) at the University of Cincinnati, USA. Electronic address: reichajf@ucmail.uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>M. Andrew Maier</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA) at the University of Cincinnati, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce D. Naumann</Name>
        <Affiliation>Merck &amp; Co., Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alison M. Pecquet</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA) at the University of Cincinnati, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Pfister</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Reena Sandhu</Name>
        <Affiliation>SafeDose Ltd, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Edward V. Sargent</Name>
        <Affiliation>Rutgers University, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony J. Streeter</Name>
        <Affiliation>Johnson &amp; Johnson, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia A. Weideman</Name>
        <Affiliation>Genentech, Inc., USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A harmonization effort for acceptable daily exposure derivation - Considerations for application of adjustment factors.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27221789</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.023</DOI>
    <KeywordList>
      <Keywords>Acceptable daily exposure (ADE)</Keywords>
      <Keywords>Adjustment factor (AF)</Keywords>
      <Keywords>Extrapolation</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Interindividual variability</Keywords>
      <Keywords>Interspecies extrapolation</Keywords>
      <Keywords>Permitted daily exposure (PDE)</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
      <Keywords>Safety factors (SF)</Keywords>
      <Keywords>Uncertainty factors (UF)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Robert G. Sussman</Name>
        <Affiliation>SafeBridge Consultants, Inc., USA. Electronic address: robert.sussman@safebridge.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce D. Naumann</Name>
        <Affiliation>Merck &amp; Co., Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Pfister</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Sehner</Name>
        <Affiliation>Boehringer Ingelheim Pharma GmbH &amp; Co. KG, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Seaman</Name>
        <Affiliation>GlaxoSmithKline, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia A. Weideman</Name>
        <Affiliation>Genentech, Inc., USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bayesian methods for uncertainty factor application for derivation of reference values.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27211295</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.018</DOI>
    <KeywordList>
      <Keywords>Bayesian methods</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Reference concentration</Keywords>
      <Keywords>Reference dose</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Uncertainty factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ted W. Simon</Name>
        <Affiliation>Ted Simon LLC, 4184 Johnston Road, Winston, GA 30187, United States. Electronic address: ted@tedsimon-toxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yiliang Zhu</Name>
        <Affiliation>Department of Epidemiology and Biostatistics, University of South Florida, 13201 Bruce B. Downs, MDC56, Tampa, FL 33612, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael L. Dourson</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA) Center, University of Cincinnati, College of Medicine, 160 Panzeca Way, Cincinnati, OH 45267-0056, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Nancy B. Beck</Name>
        <Affiliation>Regulatory Science Policy, Regulatory and Technical Affairs, American Chemistry Council, 700 2nd Street NE, Washington, DC 20002, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory assessment of chemical mixtures: Requirements, current approaches and future perspectives.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27211294</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.020</DOI>
    <KeywordList>
      <Keywords>Combined effect</Keywords>
      <Keywords>Mixture</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aude Kienzler</Name>
        <Affiliation>European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Systems Toxicology Unit and EURL ECVAM, Via Enrico Fermi 2749, 21027, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie K. Bopp</Name>
        <Affiliation>European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Systems Toxicology Unit and EURL ECVAM, Via Enrico Fermi 2749, 21027, Ispra, VA, Italy. Electronic address: Stephanie.BOPP@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Sander van der Linden</Name>
        <Affiliation>European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Systems Toxicology Unit and EURL ECVAM, Via Enrico Fermi 2749, 21027, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Elisabet Berggren</Name>
        <Affiliation>European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Systems Toxicology Unit and EURL ECVAM, Via Enrico Fermi 2749, 21027, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Worth</Name>
        <Affiliation>European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Systems Toxicology Unit and EURL ECVAM, Via Enrico Fermi 2749, 21027, Ispra, VA, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory bioinformatics for food and drug safety.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27208439</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.021</DOI>
    <KeywordList>
      <Keywords>Bioinformatics</Keywords>
      <Keywords>Drug safety</Keywords>
      <Keywords>Food safety</Keywords>
      <Keywords>GCRSR</Keywords>
      <Keywords>GSRS</Keywords>
      <Keywords>Genomics</Keywords>
      <Keywords>Microbiome</Keywords>
      <Keywords>Next-generation sequencing</Keywords>
      <Keywords>Regulatory bioinformatics</Keywords>
      <Keywords>Regulatory science</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marion J. Healy</Name>
        <Affiliation>Food Standards Australia New Zealand, Barton, Australian Capital Territory, 2905, Australia. Electronic address: marion.healy@foodstandards.gov.au.</Affiliation>
      </Author>
      <Author>
        <Name>Weida Tong</Name>
        <Affiliation>National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079-9502, USA. Electronic address: weida.tong@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Ostroff</Name>
        <Affiliation>US Food and Drug Administration, Silver Spring, MD, 20993-0002, USA. Electronic address: stephen.ostroff@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Georg Eichler</Name>
        <Affiliation>European Medicines Agency, London, E14 5EU, United Kingdom. Electronic address: hans-georg.eichler@ema.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Alex Patak</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Varese, 21027, Italy. Electronic address: alex.patak@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Margaret Neuspiel</Name>
        <Affiliation>Canadian Food Inspection Agency, Ottawa, Ontario, Canada. Electronic address: margaret.neuspiel@inspection.gc.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Hubert Deluyker</Name>
        <Affiliation>European Food Safety Authority, Parma, 43126, Italy. Electronic address: Hubert.deluyker@efsa.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>William Slikker</Name>
        <Affiliation>National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079-9502, USA. Electronic address: william.slikker@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A biokinetic model for nickel released from cardiovascular devices.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27208438</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.019</DOI>
    <KeywordList>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Compartment model</Keywords>
      <Keywords>Diffusion</Keywords>
      <Keywords>Nickel release</Keywords>
      <Keywords>Nitinol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David M. Saylor</Name>
        <Affiliation>Center for Devices and Radiological Health, FDA, Silver Spring, MD 20993, USA. Electronic address: david.saylor@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Lingga Adidharma</Name>
        <Affiliation>Center for Devices and Radiological Health, FDA, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey W. Fisher</Name>
        <Affiliation>National Center for Toxicological Research, FDA, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald P. Brown</Name>
        <Affiliation>Center for Devices and Radiological Health, FDA, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Response to comment on "Exposure-response modeling of non-cancer effects in humans exposed to Libby Amphibole Asbestos; update" by Benson et al. (2015) submitted by Goodman et al. (2016).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27191601</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.015</DOI>
    <AuthorList>
      <Author>
        <Name>Robert Benson</Name>
        <Affiliation>Environmental Protection Agency, 1595 Wynkoop St, Denver, CO 80202, United States. Electronic address: benson.bob@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>David Berry</Name>
        <Affiliation>Environmental Protection Agency, 1595 Wynkoop St, Denver, CO 80202, United States. Electronic address: berry.david@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>James Lockey</Name>
        <Affiliation>University of Cincinnati, Department of Environmental Health, 160 Panzeca Way, Cincinnati, OH 45267, United States; University of Cincinnati, Department of Internal Medicine, Pulmonary Division, 160 Panzeca Way, Cincinnati, OH 45267, United States. Electronic address: lockeyje@ucmail.uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>William Brattin</Name>
        <Affiliation>SRC Inc., Suite 1380, 999 18th St, Denver, CO 80202, United States. Electronic address: brattin@srcinc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy Hilbert</Name>
        <Affiliation>University of Cincinnati, Department of Environmental Health, 160 Panzeca Way, Cincinnati, OH 45267, United States. Electronic address: hilberttj@ucmail.uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Grace LeMasters</Name>
        <Affiliation>University of Cincinnati, Department of Environmental Health, 160 Panzeca Way, Cincinnati, OH 45267, United States. Electronic address: lemastgj@ucmail.uc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Determination of lead, cadmium and nickel in hennas and other hair dyes sold in Turkey.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27184940</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30127-1</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>HR-CS GFAAS</Keywords>
      <Keywords>Hair dye</Keywords>
      <Keywords>Henna</Keywords>
      <Keywords>Lead</Keywords>
      <Keywords>Nickel</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nil Ozbek</Name>
        <Affiliation>Istanbul Technical University, Faculty of Arts and Sciences, Department of Chemistry, 34469, Maslak, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Suleyman Akman</Name>
        <Affiliation>Istanbul Technical University, Faculty of Arts and Sciences, Department of Chemistry, 34469, Maslak, Istanbul, Turkey. Electronic address: akmans@itu.edu.tr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Probabilistic Monte Carlo estimation for quantitative exposure assessment of lotion transfer via baby wipes usage.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27184939</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30109-X</DOI>
    <KeywordList>
      <Keywords>Baby wipes</Keywords>
      <Keywords>Children</Keywords>
      <Keywords>Consumer products</Keywords>
      <Keywords>Exposure based risk assessment</Keywords>
      <Keywords>Habits and practices</Keywords>
      <Keywords>Lotion transfer</Keywords>
      <Keywords>Monte Carlo simulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Swatee Dey</Name>
        <Affiliation>The Procter &amp; Gamble Company, WHBC, 6280 Center Hill Road, Cincinnati, OH 45224, USA. Electronic address: dey.s.3@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory J. Carr</Name>
        <Affiliation>The Procter &amp; Gamble Company, WHBC, 6280 Center Hill Road, Cincinnati, OH 45224, USA. Electronic address: Carr.g@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lijuan Li</Name>
        <Affiliation>The Procter &amp; Gamble Company, WHBC, 6280 Center Hill Road, Cincinnati, OH 45224, USA. Electronic address: Li.l@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Susanna Brink</Name>
        <Affiliation>The Procter &amp; Gamble Company, GmbH, Schwalbach, Germany. Electronic address: brink.s@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shaoying Zhou</Name>
        <Affiliation>The Procter &amp; Gamble Company, WHBC, 6280 Center Hill Road, Cincinnati, OH 45224, USA. Electronic address: zhou.s@pg.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical-specific adjustment factors (inter-species toxicokinetics) to establish the ADI for steviol glycosides.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27181453</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30125-8</DOI>
    <KeywordList>
      <Keywords>ADI</Keywords>
      <Keywords>Humans</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Steviol glycosides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ashley Roberts</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada. Electronic address: ashley.roberts@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Lynch</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca Rogerson</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Renwick</Name>
        <Affiliation>Faculty of Medicine, Highfield, University of Southampton, Southampton, SO17 1BJ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Kern</Name>
        <Affiliation>Biofortis Clinical Research, 211 East Lake Street, Addison, IL, 60101, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Coffee</Name>
        <Affiliation>WIL Research, 1407 George Road, Ashland, OH, 44805-8946, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Cuellar-Kingston</Name>
        <Affiliation>Cargill, Incorporated, 15407 McGinty Rd W., Wayzata, MN, 55391, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alex Eapen</Name>
        <Affiliation>Cargill, Incorporated, 15407 McGinty Rd W., Wayzata, MN, 55391, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christine Crincoli</Name>
        <Affiliation>Cargill, Incorporated, 15407 McGinty Rd W., Wayzata, MN, 55391, USA.</Affiliation>
      </Author>
      <Author>
        <Name>George Pugh</Name>
        <Affiliation>The Coca-Cola Company, One Coca-Cola Plaza, Atlanta, GA, 30126, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sachin Bhusari</Name>
        <Affiliation>The Coca-Cola Company, One Coca-Cola Plaza, Atlanta, GA, 30126, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sidd Purkayastha</Name>
        <Affiliation>PureCircle Limited, 915 Harger Road, Suite 250, Oak Brook, IL, 60523, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Carakostas</Name>
        <Affiliation>ToxStrategies, Inc., 2 Reeve Crt #200, St. Helena Island, SC, 29920, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemical, physical, and in vitro characterization of research cigarettes containing denicotinized tobacco.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27181452</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30130-1</DOI>
    <KeywordList>
      <Keywords>Denic</Keywords>
      <Keywords>Denicotinized tobacco</Keywords>
      <Keywords>Reduced nicotine content cigarettes</Keywords>
      <Keywords>Tobacco constituents</Keywords>
      <Keywords>Very low nicotine tobacco</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bonnie G. Coffa</Name>
        <Affiliation>Altria Client Services LLC, Richmond, VA, USA. Electronic address: bonnie.g.coffa@altria.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher R. E. Coggins</Name>
        <Affiliation>Carson Watts Consulting, King, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael S. Werley</Name>
        <Affiliation>Altria Client Services LLC, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Oldham</Name>
        <Affiliation>Altria Client Services LLC, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marc W. Fariss</Name>
        <Affiliation>Altria Client Services LLC, Richmond, VA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of an occupational exposure limit for an inhalation analgesic methoxyflurane (Penthrox(®)).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27181451</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.012</DOI>
    <KeywordList>
      <Keywords>Benchmark concentration</Keywords>
      <Keywords>Methoxyflurane</Keywords>
      <Keywords>Occupational exposure limit</Keywords>
      <Keywords>Penthrox</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John Frangos</Name>
        <Affiliation>Golder Associates, 570 - 588 Swan Street, Richmond, Victoria, 3121, Australia. Electronic address: jfrangos@golder.com.au.</Affiliation>
      </Author>
      <Author>
        <Name>Antti Mikkonen</Name>
        <Affiliation>Golder Associates, 570 - 588 Swan Street, Richmond, Victoria, 3121, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Christin Down</Name>
        <Affiliation>Golder Associates, 570 - 588 Swan Street, Richmond, Victoria, 3121, Australia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhalation cancer risk assessment of cobalt metal.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27177823</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30112-X</DOI>
    <KeywordList>
      <Keywords>Benchmark dose (BMD) modeling</Keywords>
      <Keywords>Cobalt metal</Keywords>
      <Keywords>Inhalation unit risk (IUR)</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mina Suh</Name>
        <Affiliation>ToxStrategies, Inc., Mission Viejo, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Chad M. Thompson</Name>
        <Affiliation>ToxStrategies, Inc., Katy, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory P. Brorby</Name>
        <Affiliation>ToxStrategies, Inc., Richmond, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Liz Mittal</Name>
        <Affiliation>ToxStrategies, Inc., Katy, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Deborah M. Proctor</Name>
        <Affiliation>ToxStrategies, Inc., Mission Viejo, CA, United States. Electronic address: dproctor@toxstrategies.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and subacute toxicity studies of CMICE-013, a novel iodinated rotenone-based myocardial perfusion tracer, in Sprague Dawley rats and Gottingen minipigs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27177822</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.011</DOI>
    <KeywordList>
      <Keywords>CMICE-013</Keywords>
      <Keywords>Iodinated rotenone</Keywords>
      <Keywords>Myocardial perfusion tracer</Keywords>
      <Keywords>Preclinical toxicity study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yin Duan</Name>
        <Affiliation>Nordion Inc., 447 March Road, Ottawa, ON K2K 1X8, Canada; Canadian Molecular Imaging Center of Excellence (CMICE), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON K1Y 4W7, Canada. Electronic address: dyduan81@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xuxu Yan</Name>
        <Affiliation>Nordion Inc., 447 March Road, Ottawa, ON K2K 1X8, Canada; Canadian Molecular Imaging Center of Excellence (CMICE), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON K1Y 4W7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Lihui Wei</Name>
        <Affiliation>Nordion Inc., 447 March Road, Ottawa, ON K2K 1X8, Canada; Canadian Molecular Imaging Center of Excellence (CMICE), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON K1Y 4W7, Canada; Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON K1Y 4W7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Corinne Bensimon</Name>
        <Affiliation>Nordion Inc., 447 March Road, Ottawa, ON K2K 1X8, Canada; Canadian Molecular Imaging Center of Excellence (CMICE), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON K1Y 4W7, Canada; Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON K1Y 4W7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Pasan Fernando</Name>
        <Affiliation>Nordion Inc., 447 March Road, Ottawa, ON K2K 1X8, Canada; Canadian Molecular Imaging Center of Excellence (CMICE), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON K1Y 4W7, Canada; Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON K1Y 4W7, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Terrence D. Ruddy</Name>
        <Affiliation>Canadian Molecular Imaging Center of Excellence (CMICE), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON K1Y 4W7, Canada; Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON K1Y 4W7, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute oral toxicity of chemicals in terrestrial life stages of amphibians: Comparisons to birds and mammals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27177821</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.004</DOI>
    <KeywordList>
      <Keywords>Amphibians</Keywords>
      <Keywords>Oral exposure</Keywords>
      <Keywords>Terrestrial toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark Crane</Name>
        <Affiliation>AG-HERA, 23 London Street, Faringdon, Oxfordshire, SN7 7AG, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Meaghean Finnegan</Name>
        <Affiliation>Syngenta, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EX, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Lennart Weltje</Name>
        <Affiliation>BASF SE, Crop Protection - Ecotoxicology, Speyerer-Strasse 2, D-67117, Limburgerhof, Germany. Electronic address: Lennart.weltje@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sylwia Kosmala-Grzechnik</Name>
        <Affiliation>WCA Environment, Brunel House, Volunteer Way, Faringdon, Oxfordshire, SN7 7YR, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Melanie Gross</Name>
        <Affiliation>WCA Environment, Brunel House, Volunteer Way, Faringdon, Oxfordshire, SN7 7YR, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James R. Wheeler</Name>
        <Affiliation>Dow AgroSciences, 3B Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Aqueous extract of Senecio candicans DC induce liver and kidney damage in a sub-chronic oral toxicity study in Wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27177820</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30113-1</DOI>
    <KeywordList>
      <Keywords>Albino rats</Keywords>
      <Keywords>Aqueous extract</Keywords>
      <Keywords>Pyrrolizidine alkaloids</Keywords>
      <Keywords>Safety evaluation</Keywords>
      <Keywords>Senecio candicans</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hariprasath Lakshmanan</Name>
        <Affiliation>Centre for Advanced Studies in Botany, University of Madras, Guindy Campus, Chennai, 600 025, Tamil Nadu, India; Mushroom Research Centre (MRC), Faculty of Science, University of Malaya, 50603, Kuala Lumpur, Malaysia. Electronic address: hariprasath80@um.edu.my.</Affiliation>
      </Author>
      <Author>
        <Name>Jegadeesh Raman</Name>
        <Affiliation>Centre for Advanced Studies in Botany, University of Madras, Guindy Campus, Chennai, 600 025, Tamil Nadu, India; Mushroom Research Centre (MRC), Faculty of Science, University of Malaya, 50603, Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Arjun Pandian</Name>
        <Affiliation>Centre for Advanced Studies in Botany, University of Madras, Guindy Campus, Chennai, 600 025, Tamil Nadu, India; Department of Crop Science, Tshwane University of Technology, Pretoria Campus (West), Pretoria, 0001, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Kumaresan Kuppamuthu</Name>
        <Affiliation>Department of Biotechnology, Kumaraguru College of Technology, Coimbatore, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Raaman Nanjian</Name>
        <Affiliation>Centre for Advanced Studies in Botany, University of Madras, Guindy Campus, Chennai, 600 025, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vikineswary Sabaratam</Name>
        <Affiliation>Mushroom Research Centre (MRC), Faculty of Science, University of Malaya, 50603, Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Murali Naidu</Name>
        <Affiliation>Mushroom Research Centre (MRC), Faculty of Science, University of Malaya, 50603, Kuala Lumpur, Malaysia; Department of Anatomy, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Systematically evaluating read-across prediction and performance using a local validity approach characterized by chemical structure and bioactivity information.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27174420</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30111-8</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Bioactivity</Keywords>
      <Keywords>KNN</Keywords>
      <Keywords>Local validity domains</Keywords>
      <Keywords>Nearest neighbors</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>ToxCast</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Imran Shah</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: shah.imran@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Liu</Name>
        <Affiliation>Department of Information Science, University of Arkansas at Little Rock, AR 72204, USA; Oak Ridge Institute for Science Education Fellow, National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard S. Judson</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Russell S. Thomas</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Trichloroethylene exposure aggravates behavioral abnormalities in mice that are deficient in superoxide dismutase.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27166294</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30110-6</DOI>
    <KeywordList>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Parkinson’s disease</Keywords>
      <Keywords>Superoxide dismutase</Keywords>
      <Keywords>Trichloroethylene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Noriyuki Otsuki</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Yamagata University, 2-2-2 Iidanishi, Yamagata 990-9585, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takujiro Homma</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Yamagata University, 2-2-2 Iidanishi, Yamagata 990-9585, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroki Fujiwara</Name>
        <Affiliation>Department of Physiology, Yamagata University School of Medicine, 2-2-2 Iidanishi, Yamagata 990-9585, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kenya Kaneko</Name>
        <Affiliation>Department of Physiology, Yamagata University School of Medicine, 2-2-2 Iidanishi, Yamagata 990-9585, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasukazu Hozumi</Name>
        <Affiliation>Department of Anatomy and Cell Biology, Yamagata University School of Medicine, Iidanishi 2-2-2, Yamagata 990-9585, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mototada Shichiri</Name>
        <Affiliation>Health Research Institute (HRI), National Institute of Advanced Industrial Science and Technology (AIST), 1-8-31 Midorigaoka, Ikeda, Osaka 563-8577, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mizuki Takashima</Name>
        <Affiliation>Health Research Institute (HRI), National Institute of Advanced Industrial Science and Technology (AIST), 1-8-31 Midorigaoka, Ikeda, Osaka 563-8577, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Junitsu Ito</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Yamagata University, 2-2-2 Iidanishi, Yamagata 990-9585, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tasuku Konno</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Yamagata University, 2-2-2 Iidanishi, Yamagata 990-9585, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshihiro Kurahashi</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Yamagata University, 2-2-2 Iidanishi, Yamagata 990-9585, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasukazu Yoshida</Name>
        <Affiliation>Health Research Institute (HRI), National Institute of Advanced Industrial Science and Technology (AIST), 2217-14 Hayashi-cho, Takamatsu, Kagawa 761-0395, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kaoru Goto</Name>
        <Affiliation>Department of Anatomy and Cell Biology, Yamagata University School of Medicine, Iidanishi 2-2-2, Yamagata 990-9585, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Satoshi Fujii</Name>
        <Affiliation>Department of Physiology, Yamagata University School of Medicine, 2-2-2 Iidanishi, Yamagata 990-9585, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Junichi Fujii</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Yamagata University, 2-2-2 Iidanishi, Yamagata 990-9585, Japan. Electronic address: jfujii@med.id.yamagata-u.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sub-chronic safety evaluation of the ethanol extract of Aralia elata leaves in Beagle dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27156779</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30108-8</DOI>
    <KeywordList>
      <Keywords>Aralia elata Seem.</Keywords>
      <Keywords>Beagle dogs</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fengjin Li</Name>
        <Affiliation>Department of Basic Medicine, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China; Research Center for Pharmacology and Toxicology, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoli He</Name>
        <Affiliation>Research Center for Pharmacology and Toxicology, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenying Niu</Name>
        <Affiliation>Department of Basic Medicine, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuenan Feng</Name>
        <Affiliation>Department of Basic Medicine, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingqi Bian</Name>
        <Affiliation>Department of Basic Medicine, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haixue Kuang</Name>
        <Affiliation>Department of Basic Medicine, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China. Electronic address: hxkuang@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hongbin Xiao</Name>
        <Affiliation>Department of Basic Medicine, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China. Electronic address: hrbxiaohongbin@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing the predictive value of the rodent neurofunctional assessment for commonly reported adverse events in phase I clinical trials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27155597</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.05.002</DOI>
    <KeywordList>
      <Keywords>Adverse events</Keywords>
      <Keywords>Central nervous system</Keywords>
      <Keywords>First-in-human</Keywords>
      <Keywords>Functional observational battery</Keywords>
      <Keywords>Methods</Keywords>
      <Keywords>Neurobehavioural assessment</Keywords>
      <Keywords>Predictive value</Keywords>
      <Keywords>Translation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andy N. Mead</Name>
        <Affiliation>Pfizer Inc., Eastern Point Road, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hamid R. Amouzadeh</Name>
        <Affiliation>Amgen Inc., Global Patient Safety &amp; Labeling, Thousand Oaks CA 91320, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kathryn Chapman</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Lorna Ewart</Name>
        <Affiliation>AstraZeneca R&amp;D, da Vinci Building, Melbourn Science Park, Cambridge Road, Melbourn, Royston, Hertfordshire, SG8 6HB, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandra Giarola</Name>
        <Affiliation>GlaxoSmithKline, Safety Assessment Department, Park Road, Ware, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel J. Jackson</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, UK. Electronic address: sam.jackson@nc3rs.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Jarvis</Name>
        <Affiliation>Novartis DS&amp;E and Oncology OGD, Postfach, CH-4002, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Pierre Jordaan</Name>
        <Affiliation>Novartis DS&amp;E and Oncology OGD, Postfach, CH-4002, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Will Redfern</Name>
        <Affiliation>AstraZeneca R&amp;D, Drug Safety &amp; Metabolism, Cambridge, CB22 3AT, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Traebert</Name>
        <Affiliation>Novartis Institutes of Biomedical Research, Safety Pharmacology, CH-4057, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Pierre Valentin</Name>
        <Affiliation>AstraZeneca R&amp;D, Drug Safety &amp; Metabolism, Alderley Park, SK10-4TG, Macclesfield, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Hugo M. Vargas</Name>
        <Affiliation>Amgen Inc., Global Patient Safety &amp; Labeling, Thousand Oaks CA 91320, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing the potential for interaction between the insecticidal activity of two genetically engineered cotton events combined by conventional breeding: An example with COT102 × MON 15985.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27155596</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30106-4</DOI>
    <KeywordList>
      <Keywords>Additivity</Keywords>
      <Keywords>Bt protein</Keywords>
      <Keywords>Concentration addition</Keywords>
      <Keywords>Cotton</Keywords>
      <Keywords>Cry1Ac</Keywords>
      <Keywords>Cry2Ab2</Keywords>
      <Keywords>Plant incorporated protectants</Keywords>
      <Keywords>Vip3Aa19</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Steven L. Levine</Name>
        <Affiliation>Global Regulatory Sciences, Monsanto Company, St. Louis, MO, 63167, United States. Electronic address: steven.l.levine@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Geoffrey M. Mueller</Name>
        <Affiliation>Global Regulatory Sciences, Monsanto Company, St. Louis, MO, 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua P. Uffman</Name>
        <Affiliation>Global Regulatory Sciences, Monsanto Company, St. Louis, MO, 63167, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Determination of parabens in serum by liquid chromatography-tandem mass spectrometry: Correlation with lipstick use.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27154569</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30104-0</DOI>
    <KeywordList>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Lipstick use</Keywords>
      <Keywords>Liquid chromatography-tandem mass spectrometry</Keywords>
      <Keywords>Parabens in serum</Keywords>
      <Keywords>Toxicology of cosmetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gabriella Padovani Tahan</Name>
        <Affiliation>Laboratory of Toxicants and Drugs Analysis, Faculty of Pharmaceutical Sciences, Federal University of Alfenas - Unifal-MG, Gabriel Monteiro da Silva Street, 700, CEP 37130-000, Alfenas, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Nayara de Kássia Souza Santos</Name>
        <Affiliation>Laboratory of Toxicants and Drugs Analysis, Faculty of Pharmaceutical Sciences, Federal University of Alfenas - Unifal-MG, Gabriel Monteiro da Silva Street, 700, CEP 37130-000, Alfenas, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Carolina Albuquerque</Name>
        <Affiliation>Laboratory of Toxicants and Drugs Analysis, Faculty of Pharmaceutical Sciences, Federal University of Alfenas - Unifal-MG, Gabriel Monteiro da Silva Street, 700, CEP 37130-000, Alfenas, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Isarita Martins</Name>
        <Affiliation>Laboratory of Toxicants and Drugs Analysis, Faculty of Pharmaceutical Sciences, Federal University of Alfenas - Unifal-MG, Gabriel Monteiro da Silva Street, 700, CEP 37130-000, Alfenas, MG, Brazil. Electronic address: isarita.sakakibara@unifal-mg.edu.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>26-week repeated oral dose toxicity study of UP446, a combination of defined extracts of Scutellaria baicalensis and Acacia catechu, in beagle dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27125835</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.04.007</DOI>
    <KeywordList>
      <Keywords>Acacia catechu</Keywords>
      <Keywords>Scutellaria baicalensis</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
      <Keywords>UP446</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mesfin Yimam</Name>
        <Affiliation>Unigen Inc., 3005 1st Ave., Seattle, WA 98121, USA. Electronic address: myimam@unigen.net.</Affiliation>
      </Author>
      <Author>
        <Name>Young Chul Lee</Name>
        <Affiliation>Unigen Inc., #450-86, Maebong-Ro, Dongnam-Gu, Cheonan-Si, Chungnam 330-863, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Jia</Name>
        <Affiliation>Unigen Inc., 3005 1st Ave., Seattle, WA 98121, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cereboost™, an American ginseng extract, improves cognitive function via up-regulation of choline acetyltransferase expression and neuroprotection.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27112419</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.04.006</DOI>
    <KeywordList>
      <Keywords>American ginseng (Panax quinquefolius)</Keywords>
      <Keywords>Amyloid-beta peptide</Keywords>
      <Keywords>Cereboost™</Keywords>
      <Keywords>Choline acetyltransferase</Keywords>
      <Keywords>Cognitive function</Keywords>
      <Keywords>Neuroprotection</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kyungha Shin</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyu Guo</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yeseul Cha</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Hwan Ban</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Da Woom Seo</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Youngjin Choi</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Su Kim</Name>
        <Affiliation>Anydoctor Healthcare Co., Ltd., Cheonan, Chungnam 31066, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Pyo Lee</Name>
        <Affiliation>Anydoctor Healthcare Co., Ltd., Cheonan, Chungnam 31066, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Choon Kim</Name>
        <Affiliation>College of Veterinary Medicine, Chonnam National University, Gwangju 61186, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ehn Kyoung Choi</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Min Yon</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, South Korea. Electronic address: yjm0000@hanmail.net.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Bae Kim</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, South Korea. Electronic address: solar93@cbu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of potential adjuvanticity of Cry proteins.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27105772</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30094-0</DOI>
    <KeywordList>
      <Keywords>Adjuvant</Keywords>
      <Keywords>Bacillus thuringiensis</Keywords>
      <Keywords>Cry proteins</Keywords>
      <Keywords>Food/feed safety</Keywords>
      <Keywords>GM crops</Keywords>
      <Keywords>Genetic modification</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Saurabh S. Joshi</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd., St. Louis, MO 63167, USA. Electronic address: saurabh.joshi@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Barnett</Name>
        <Affiliation>BASF Plant Science, 26 Davis Drive, Research Triangle Park, NC 27709, USA. Electronic address: brian.barnett@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nancy G. Doerrer</Name>
        <Affiliation>ILSI Health and Environmental Sciences Institute, 1156 Fifteenth St., NW, Suite 200, Washington, DC 20005, USA. Electronic address: ndoerrer@hesiglobal.org.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Glenn</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd., St. Louis, MO 63167, USA. Electronic address: kevin.c.glenn@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Dow AgroSciences, 9330 Zionsville Rd, Indianapolis, IN 46268, USA. Electronic address: raherman@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Corinne Herouet-Guicheney</Name>
        <Affiliation>Bayer SAS, Bayer CropScience, 355 Rue Dostoïevski, 06903 Sophia Antipolis Cedex, France. Electronic address: corinne.herouet-guicheney@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Penny Hunst</Name>
        <Affiliation>Bayer CropScience, 2 T.W. Alexander Dr., Research Triangle Park, NC 27709, USA. Electronic address: penny.hunst@bayercropscience.com.</Affiliation>
      </Author>
      <Author>
        <Name>John Kough</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Pesticide Programs, Ariel Rios Building, MC 7511P, 1200 Pennsylvania Avenue, NW, Washington, DC 20460, USA. Electronic address: kough.john@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory S. Ladics</Name>
        <Affiliation>DuPont Haskell Global Centers for Health and Environmental Sciences, 1090 Elkton Road, Newark, DE 19711, USA. Electronic address: gregory.s.ladics@dupont.com.</Affiliation>
      </Author>
      <Author>
        <Name>Scott McClain</Name>
        <Affiliation>Syngenta Crop Protection, LLC, 3054 E. Cornwallis Road, Research Triangle Park, NC 27709, USA. Electronic address: scott.mcclain@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sabitha Papineni</Name>
        <Affiliation>Dow AgroSciences, 9330 Zionsville Rd, Indianapolis, IN 46268, USA. Electronic address: spapineni@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lars K. Poulsen</Name>
        <Affiliation>Allergy Clinic, Copenhagen University Hospital at Gentofte, Niels Andersens Vej 65, Dept. 22, 1st Floor, DK-2900 Hellerup, Denmark. Electronic address: lkpallgy@mail.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Baptiste Rascle</Name>
        <Affiliation>Bayer SAS, Bayer CropScience, 355 Rue Dostoïevski, 06903 Sophia Antipolis Cedex, France. Electronic address: jean-baptiste.rascle@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ai Lin Tao</Name>
        <Affiliation>Guangzhou Medical University, 250 Changgang Road East, Guangzhou 510260, People's Republic of China. Electronic address: AerobiologiaTao@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald van Ree</Name>
        <Affiliation>Departments of Experimental Immunology and Otorhinolaryngology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Room K0-130, 1105 AZ Amsterdam, The Netherlands. Electronic address: r.vanree@amc.uva.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Ward</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd., St. Louis, MO 63167, USA. Electronic address: jason.m.ward@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christal C. Bowman</Name>
        <Affiliation>Bayer CropScience, 2 T.W. Alexander Dr., Research Triangle Park, NC 27709, USA. Electronic address: christal.bowman@bayer.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the integrated testing strategy for PNEC derivation under REACH.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27103318</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.04.004</DOI>
    <KeywordList>
      <Keywords>Aquatic ecotoxicology</Keywords>
      <Keywords>Chronic fish toxicity</Keywords>
      <Keywords>Environmental hazard assessment</Keywords>
      <Keywords>Integrated testing strategy</Keywords>
      <Keywords>Relative species sensitivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Martin May</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine, Chemical Risk Assessment, Nikolai-Fuchs-Strasse 1, 30625 Hannover, Germany. Electronic address: martin.may@item.fraunhofer.de.</Affiliation>
      </Author>
      <Author>
        <Name>Wiebke Drost</Name>
        <Affiliation>German Environment Agency, Wörlitzer Platz 1, 06844 Dessau-Rosslau, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sabine Germer</Name>
        <Affiliation>German Environment Agency, Wörlitzer Platz 1, 06844 Dessau-Rosslau, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tanja Juffernholz</Name>
        <Affiliation>German Environment Agency, Wörlitzer Platz 1, 06844 Dessau-Rosslau, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Hahn</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine, Chemical Risk Assessment, Nikolai-Fuchs-Strasse 1, 30625 Hannover, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A data-based exploration of the adverse outcome pathway for skin sensitization points to the necessary requirements for its prediction with alternative methods.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27090483</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.04.003</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathways</Keywords>
      <Keywords>Alternative</Keywords>
      <Keywords>Human health</Keywords>
      <Keywords>Modeling</Keywords>
      <Keywords>Prediction</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>Structure-activity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Romualdo Benigni</Name>
        <Affiliation>Environment and Health Department, Istituto Superiore di Sanita', Viale Regina Elena 299, 00161, Rome, Italy. Electronic address: Romualdo.benigni@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cecilia Bossa</Name>
        <Affiliation>Environment and Health Department, Istituto Superiore di Sanita', Viale Regina Elena 299, 00161, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Olga Tcheremenskaia</Name>
        <Affiliation>Environment and Health Department, Istituto Superiore di Sanita', Viale Regina Elena 299, 00161, Rome, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Two new nontoxic, non-pathogenic strains of Sphingomonas elodea for gellan gum production.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27079414</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.04.002</DOI>
    <KeywordList>
      <Keywords>Gellan gum</Keywords>
      <Keywords>Pathogenicity</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Sphingomonas elodea</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laurie C. Dolan</Name>
        <Affiliation>Burdock Group, 859 Outer Road, Orlando, FL 32814, USA. Electronic address: ldolan@burdockgroup.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ray A. Matulka</Name>
        <Affiliation>Burdock Group, 859 Outer Road, Orlando, FL 32814, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alex L. LeBeau</Name>
        <Affiliation>Burdock Group, 859 Outer Road, Orlando, FL 32814, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jamie M. Boulet</Name>
        <Affiliation>Product Safety Laboratories, 2394 Highway 130, Dayton, NJ 08810, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reproductive and developmental toxicity testing: Examination of the extended one-generation reproductive toxicity study guideline.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27074386</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30067-8</DOI>
    <KeywordList>
      <Keywords>EOGRT</Keywords>
      <Keywords>Extended one-generation reproductive toxicity study design</Keywords>
      <Keywords>KMD</Keywords>
      <Keywords>Kinetically-derived maximum dose</Keywords>
      <Keywords>Systemic dose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shakil A. Saghir</Name>
        <Affiliation>Smithers Avanza Toxicology Services, LLC, 11B Firstfield Road, Gaithersburg, MD 20878, USA. Electronic address: shakil.saghir@smithers.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael A. Dorato</Name>
        <Affiliation>Smithers Avanza Toxicology Services, LLC, 11B Firstfield Road, Gaithersburg, MD 20878, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification of urinary microRNA biomarkers for detection of gentamicin-induced acute kidney injury in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27074385</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.04.001</DOI>
    <KeywordList>
      <Keywords>Gentamicin</Keywords>
      <Keywords>Nephrotoxicity</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Urinary biomarkers</Keywords>
      <Keywords>microRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaobing Zhou</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes of Food and Drug Control, Hongda Middle Street A8, Beijing Economic and Technological Development Area, Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Qu</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes of Food and Drug Control, Hongda Middle Street A8, Beijing Economic and Technological Development Area, Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cong Zhu</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes of Food and Drug Control, Hongda Middle Street A8, Beijing Economic and Technological Development Area, Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Lin</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes of Food and Drug Control, Hongda Middle Street A8, Beijing Economic and Technological Development Area, Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Huo</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes of Food and Drug Control, Hongda Middle Street A8, Beijing Economic and Technological Development Area, Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Wang</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes of Food and Drug Control, Hongda Middle Street A8, Beijing Economic and Technological Development Area, Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jufeng Wang</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes of Food and Drug Control, Hongda Middle Street A8, Beijing Economic and Technological Development Area, Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Li</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes of Food and Drug Control, Hongda Middle Street A8, Beijing Economic and Technological Development Area, Beijing, 100176, China. Electronic address: libo@nifdc.org.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Trace elements in e-liquids - Development and validation of an ICP-MS method for the analysis of electronic cigarette refills.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27058761</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30068-X</DOI>
    <KeywordList>
      <Keywords>E-liquids</Keywords>
      <Keywords>Electronic cigarettes</Keywords>
      <Keywords>ICP-MS</Keywords>
      <Keywords>Method validation</Keywords>
      <Keywords>Trace elements</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>N. Beauval</Name>
        <Affiliation>Univ. Lille, CHU Lille, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact de l'Environnement Chimique sur la Santé humaine, F-59000 Lille, France.</Affiliation>
      </Author>
      <Author>
        <Name>M. Howsam</Name>
        <Affiliation>Centre Universitaire de Mesures et d'Analyses, Université de Lille 2, Faculté des Sciences Pharmaceutiques et Biologiques de Lille, 59006 Lille, France.</Affiliation>
      </Author>
      <Author>
        <Name>S. Antherieu</Name>
        <Affiliation>Univ. Lille, CHU Lille, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact de l'Environnement Chimique sur la Santé humaine, F-59000 Lille, France.</Affiliation>
      </Author>
      <Author>
        <Name>D. Allorge</Name>
        <Affiliation>Univ. Lille, CHU Lille, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact de l'Environnement Chimique sur la Santé humaine, F-59000 Lille, France.</Affiliation>
      </Author>
      <Author>
        <Name>M. Soyez</Name>
        <Affiliation>Univ. Lille, CHU Lille, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact de l'Environnement Chimique sur la Santé humaine, F-59000 Lille, France.</Affiliation>
      </Author>
      <Author>
        <Name>G. Garçon</Name>
        <Affiliation>Univ. Lille, CHU Lille, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact de l'Environnement Chimique sur la Santé humaine, F-59000 Lille, France.</Affiliation>
      </Author>
      <Author>
        <Name>J. F. Goossens</Name>
        <Affiliation>Centre Universitaire de Mesures et d'Analyses, Université de Lille 2, Faculté des Sciences Pharmaceutiques et Biologiques de Lille, 59006 Lille, France.</Affiliation>
      </Author>
      <Author>
        <Name>J. M. Lo-Guidice</Name>
        <Affiliation>Univ. Lille, CHU Lille, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact de l'Environnement Chimique sur la Santé humaine, F-59000 Lille, France.</Affiliation>
      </Author>
      <Author>
        <Name>A. Garat</Name>
        <Affiliation>Univ. Lille, CHU Lille, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact de l'Environnement Chimique sur la Santé humaine, F-59000 Lille, France. Electronic address: anne.garat-2@univ-lille2.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Physicians prefer greater detail in the biosimilar label (SmPC) - Results of a survey across seven European countries.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27041395</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.021</DOI>
    <KeywordList>
      <Keywords>Biosimilars</Keywords>
      <Keywords>Labelling survey</Keywords>
      <Keywords>Physician preference</Keywords>
      <Keywords>Regulatory requirements</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anna Hallersten</Name>
        <Affiliation>SFL Regulatory Affairs &amp; Scientific Communication Ltd, Basel, Switzerland. Electronic address: a.hallersten@sfl-services.com.</Affiliation>
      </Author>
      <Author>
        <Name>Walter Fürst</Name>
        <Affiliation>SFL Regulatory Affairs &amp; Scientific Communication Ltd, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Riccardo Mezzasalma</Name>
        <Affiliation>EuropaBio, Brussels, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Best-practices approach to determination of blood alcohol concentration (BAC) at specific time points: Combination of ante-mortem alcohol pharmacokinetic modeling and post-mortem alcohol generation and transport considerations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27041394</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.020</DOI>
    <KeywordList>
      <Keywords>Alcohol</Keywords>
      <Keywords>Blood alcohol concentration (BAC)</Keywords>
      <Keywords>Ethanol</Keywords>
      <Keywords>Forensic toxicology</Keywords>
      <Keywords>Pharmacokinetic model</Keywords>
      <Keywords>Post-mortem neoformation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dallas M. Cowan</Name>
        <Affiliation>Cardno ChemRisk, LLC, Aliso Viejo, CA, United States. Electronic address: dallas.cowan@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua R. Maskrey</Name>
        <Affiliation>Cardno ChemRisk, LLC, Pittsburgh, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ernest S. Fung</Name>
        <Affiliation>Cardno ChemRisk, LLC, Aliso Viejo, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tyler A. Woods</Name>
        <Affiliation>Cardno ChemRisk, LLC, Aliso Viejo, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa M. Stabryla</Name>
        <Affiliation>Cardno ChemRisk, LLC, Pittsburgh, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paul K. Scott</Name>
        <Affiliation>Cardno ChemRisk, LLC, Pittsburgh, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Brent L. Finley</Name>
        <Affiliation>Cardno ChemRisk, LLC, Brooklyn, NY, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhalation TTC values: A new integrative grouping approach considering structural, toxicological and mechanistic features.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27041393</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.022</DOI>
    <KeywordList>
      <Keywords>Grouping</Keywords>
      <Keywords>Inhalation exposure</Keywords>
      <Keywords>Local effects</Keywords>
      <Keywords>Repeated dose</Keywords>
      <Keywords>TTC</Keywords>
      <Keywords>Threshold of toxicological concern</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>I. Tluczkiewicz</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Nikolai-Fuchs-Str. 1, 30625 Hannover, Germany; Institute for Organic Chemistry, Technical University Bergakademie Freiberg, Leipziger Str. 29, 09596 Freiberg, Germany. Electronic address: inga.tluczkiewicz@item.fraunhofer.de.</Affiliation>
      </Author>
      <Author>
        <Name>R. Kühne</Name>
        <Affiliation>Helmholtz Centre for Environmental Research - UFZ, Permoserstr. 15, 04318 Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>R. U. Ebert</Name>
        <Affiliation>Helmholtz Centre for Environmental Research - UFZ, Permoserstr. 15, 04318 Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>M. Batke</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Nikolai-Fuchs-Str. 1, 30625 Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>G. Schüürmann</Name>
        <Affiliation>Helmholtz Centre for Environmental Research - UFZ, Permoserstr. 15, 04318 Leipzig, Germany; Institute for Organic Chemistry, Technical University Bergakademie Freiberg, Leipziger Str. 29, 09596 Freiberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>I. Mangelsdorf</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Nikolai-Fuchs-Str. 1, 30625 Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>S. E. Escher</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Nikolai-Fuchs-Str. 1, 30625 Hannover, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The Tibetan medicine Zuotai differs from HgCl2 and MeHg in producing liver injury in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27032305</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.017</DOI>
    <KeywordList>
      <Keywords>Cinnabar</Keywords>
      <Keywords>Electronmicrospy</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Mercury chloride</Keywords>
      <Keywords>MethylMercury</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Zuotai</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qin Wu</Name>
        <Affiliation>Key Laboratory for Basic Pharmacology of Ministry of Health, Zunyi Medical College, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Kai Li</Name>
        <Affiliation>Key Laboratory for Basic Pharmacology of Ministry of Health, Zunyi Medical College, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Ping Zhou</Name>
        <Affiliation>Medical Research Center, Zunyi Medical College, Zunyi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Ying Li</Name>
        <Affiliation>Key Laboratory for Basic Pharmacology of Ministry of Health, Zunyi Medical College, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Wan Xiong</Name>
        <Affiliation>Key Laboratory for Basic Pharmacology of Ministry of Health, Zunyi Medical College, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Zhi Du</Name>
        <Affiliation>Northwest Plateau Institute of Biology of Chinese Academy of Sciences, Xining, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Xin Wei</Name>
        <Affiliation>Northwest Plateau Institute of Biology of Chinese Academy of Sciences, Xining, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Liu</Name>
        <Affiliation>Key Laboratory for Basic Pharmacology of Ministry of Health, Zunyi Medical College, China. Electronic address: JieLiu@zmc.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27025923</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.019</DOI>
    <KeywordList>
      <Keywords>Alanine aminotransferase</Keywords>
      <Keywords>Bilirubin</Keywords>
      <Keywords>Clinical trial</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Liver enzyme</Keywords>
      <Keywords>Liver injury</Keywords>
      <Keywords>Metastasis</Keywords>
      <Keywords>Oncology</Keywords>
      <Keywords>Truncated robust multivariate outlier detection</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sumitra Shantakumar</Name>
        <Affiliation>Worldwide Epidemiology, GlaxoSmithKline, Gateway West, Singapore. Electronic address: sumitra.y.shantakumar@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Landis</Name>
        <Affiliation>Worldwide Epidemiology, GlaxoSmithKline, Stockley Park, United Kingdom. Electronic address: sarah.h.landis@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andy Lawton</Name>
        <Affiliation>Worldwide Epidemiology, GlaxoSmithKline, Stockley Park, United Kingdom. Electronic address: andy.m.lawton@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christine M. Hunt</Name>
        <Affiliation>Department of Veterans Affairs, Durham VA Medical Center, North Carolina, USA. Electronic address: christine.hunt@va.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A three-tier QSAR modeling strategy for estimating eye irritation potential of diverse chemicals in rabbit for regulatory purposes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27018829</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.014</DOI>
    <KeywordList>
      <Keywords>Eye irritation potential</Keywords>
      <Keywords>Qualitative and semi-quantitative QSAR</Keywords>
      <Keywords>Regression QSAR</Keywords>
      <Keywords>Structural diversity</Keywords>
      <Keywords>Structural features</Keywords>
      <Keywords>Three-tier strategy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nikita Basant</Name>
        <Affiliation>ETRC, Gomtinagar, Lucknow 226010, India.</Affiliation>
      </Author>
      <Author>
        <Name>Shikha Gupta</Name>
        <Affiliation>Environmental Chemistry Division, CSIR-Indian Institute of Toxicology Research, Post Box 80, Mahatma Gandhi Marg, Lucknow 226001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kunwar P. Singh</Name>
        <Affiliation>Environmental Chemistry Division, CSIR-Indian Institute of Toxicology Research, Post Box 80, Mahatma Gandhi Marg, Lucknow 226001, India. Electronic address: kpsingh_52@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of the risk-based, phased-in approach for the international harmonization of the regulation of container closure systems for drugs in Taiwan.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27016398</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.018</DOI>
    <KeywordList>
      <Keywords>Packaging material</Keywords>
      <Keywords>Quality</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lin Chau Chang</Name>
        <Affiliation>Center for Drug Evaluation, 3F, No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. Electronic address: chaemily@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jaw Jou Kang</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, No.1, Sec.1, Jen Ai Rd., Taipei 10051, Taiwan. Electronic address: jjkang@ntu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Churn Shiouh Gau</Name>
        <Affiliation>Center for Drug Evaluation, 3F, No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. Electronic address: csgau206@cde.org.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Examining the differences in current regulatory processes for sunscreens and proposed safety assessment paradigm.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27016397</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30053-8</DOI>
    <KeywordList>
      <Keywords>Human</Keywords>
      <Keywords>Non-clinical</Keywords>
      <Keywords>Safety testing</Keywords>
      <Keywords>Skin cancer</Keywords>
      <Keywords>Sunscreens</Keywords>
      <Keywords>UV filters</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Edward V. Sargent</Name>
        <Affiliation>Rutgers University, School of Public Health, Piscataway, NJ, USA. Electronic address: evsargent@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey B. Travers</Name>
        <Affiliation>Wright State University, Dayton, OH, USA; Dayton Veterans Administration Medical Center, Dayton, OH, USA. Electronic address: Jeffrey.travers@wright.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Allergenicity assessment strategy for novel food proteins and protein sources.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27012375</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30060-5</DOI>
    <KeywordList>
      <Keywords>Allergenicity assessment</Keywords>
      <Keywords>Cross-reactivity</Keywords>
      <Keywords>De novo sensitisation</Keywords>
      <Keywords>Novel food protein</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kitty Verhoeckx</Name>
        <Affiliation>TNO, Utrechtseweg 48, 3704 HE Zeist, The Netherlands; Dep. Dermatology/Allergology, University Medical Centre Utrecht (UMCU), P.O. Box 85500, Internal mail no G02.124, 3508 GA, Utrecht, The Netherlands. Electronic address: Kitty.verhoeckx@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Henrike Broekman</Name>
        <Affiliation>Dep. Dermatology/Allergology, University Medical Centre Utrecht (UMCU), P.O. Box 85500, Internal mail no G02.124, 3508 GA, Utrecht, The Netherlands. Electronic address: h.c.h.broekman-4@umcutrecht.nl.</Affiliation>
      </Author>
      <Author>
        <Name>André Knulst</Name>
        <Affiliation>Dep. Dermatology/Allergology, University Medical Centre Utrecht (UMCU), P.O. Box 85500, Internal mail no G02.124, 3508 GA, Utrecht, The Netherlands. Electronic address: A.C.Knulst@UmcUtrecht.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Geert Houben</Name>
        <Affiliation>TNO, Utrechtseweg 48, 3704 HE Zeist, The Netherlands; Dep. Dermatology/Allergology, University Medical Centre Utrecht (UMCU), P.O. Box 85500, Internal mail no G02.124, 3508 GA, Utrecht, The Netherlands. Electronic address: Geert.houben@tno.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of a botanical composition, UP446, on respiratory, cardiovascular and central nervous systems in beagle dogs and rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27012374</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.015</DOI>
    <KeywordList>
      <Keywords>Acacia catechu</Keywords>
      <Keywords>Cardiovascular system</Keywords>
      <Keywords>Central nervous system</Keywords>
      <Keywords>Respiratory system</Keywords>
      <Keywords>Scutellaria baicalensis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mesfin Yimam</Name>
        <Affiliation>Unigen Inc., 3005 1st Ave., Seattle, WA 98121, USA. Electronic address: myimam@unigen.net.</Affiliation>
      </Author>
      <Author>
        <Name>Young Chul Lee</Name>
        <Affiliation>Unigen Inc., #450-86, Maebong-Ro, Dongnam-Gu, Cheonan-Si, Chungnam 330-863, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Jia</Name>
        <Affiliation>Unigen Inc., 3005 1st Ave., Seattle, WA 98121, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oral subchronic toxicity evaluation of a novel antitumor agent 25-methoxydammarane-3, 12, 20-triol from Panax notoginseng in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27002186</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.013</DOI>
    <KeywordList>
      <Keywords>25-methoxydammarane-3, 12, 20-triol</Keywords>
      <Keywords>Panax notoginseng</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Li</Name>
        <Affiliation>The College of Pharmacy, Jilin University, Jilin, 130021, China; Department of Traditional Chinese Material Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangrong Zhang</Name>
        <Affiliation>Department of Traditional Chinese Material Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanfei Xin</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou 310013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaoxian Xuan</Name>
        <Affiliation>Center of Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou 310013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinping Liu</Name>
        <Affiliation>The College of Pharmacy, Jilin University, Jilin, 130021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pingya Li</Name>
        <Affiliation>The College of Pharmacy, Jilin University, Jilin, 130021, China. Electronic address: lipy@jlu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yuqing Zhao</Name>
        <Affiliation>Department of Traditional Chinese Material Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China. Electronic address: zyq4885@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk assessment of human health from exposure to the discharged ballast water after full-scale electrolysis treatment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26997144</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.011</DOI>
    <KeywordList>
      <Keywords>Ballast water treatment</Keywords>
      <Keywords>Derived no effect levels (DNELs)</Keywords>
      <Keywords>Disinfection by-products (DBPs)</Keywords>
      <Keywords>Full-scale</Keywords>
      <Keywords>Human health risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nahui Zhang</Name>
        <Affiliation>Ballast Water Detecting Lab, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China; Ministry of Education Key Laboratory of Exploration and Utilization of Aquatic Resource, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yidan Wang</Name>
        <Affiliation>Ballast Water Detecting Lab, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China; Ministry of Education Key Laboratory of Exploration and Utilization of Aquatic Resource, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junzeng Xue</Name>
        <Affiliation>Ballast Water Detecting Lab, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China; Ministry of Education Key Laboratory of Exploration and Utilization of Aquatic Resource, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Yuan</Name>
        <Affiliation>Ballast Water Detecting Lab, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China; Ministry of Education Key Laboratory of Exploration and Utilization of Aquatic Resource, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiong Wang</Name>
        <Affiliation>Ballast Water Detecting Lab, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China; Ministry of Education Key Laboratory of Exploration and Utilization of Aquatic Resource, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Liu</Name>
        <Affiliation>Ballast Water Detecting Lab, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China; Ministry of Education Key Laboratory of Exploration and Utilization of Aquatic Resource, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huixian Wu</Name>
        <Affiliation>Ballast Water Detecting Lab, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China; Ministry of Education Key Laboratory of Exploration and Utilization of Aquatic Resource, Shanghai Ocean University, No. 999 Huchenghuan Rd, Pudong New District, Shanghai 201306, China. Electronic address: hxwu@shou.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Kefeng Hu</Name>
        <Affiliation>China Classification Society, 9 Dongzhimen Nan Da Jie, Beijing 100007, China. Electronic address: hukf@ccs.org.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Residues and dissipation kinetics of carbendazim and diethofencarb in tomato (Lycopersicon esculentum Mill.) and intake risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26995029</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.012</DOI>
    <KeywordList>
      <Keywords>Carbendazim</Keywords>
      <Keywords>Diethofencarb</Keywords>
      <Keywords>Dissipation</Keywords>
      <Keywords>Residue</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Huidong Li</Name>
        <Affiliation>Institute of Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China; Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China. Electronic address: lihuidong8066@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hongxia du</Name>
        <Affiliation>Institute of Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China; Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liping Fang</Name>
        <Affiliation>Institute of Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China; Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhan Dong</Name>
        <Affiliation>Institute of Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China; Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuai Guan</Name>
        <Affiliation>Institute of Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China; Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjing Fan</Name>
        <Affiliation>Institute of Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China; Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zilei Chen</Name>
        <Affiliation>Institute of Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China; Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China. Electronic address: czl7274@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of gender on ketamine-induced conditioned placed preference and urine metabonomics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26995028</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.007</DOI>
    <KeywordList>
      <Keywords>(1)H NMR</Keywords>
      <Keywords>Addicted rat</Keywords>
      <Keywords>CPP</Keywords>
      <Keywords>Gender</Keywords>
      <Keywords>Ketamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Run Guo</Name>
        <Affiliation>College of Basic Science and Forensic Medicine, Sichuan University, Chengdu, 610041, Sichuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qunxing Tang</Name>
        <Affiliation>College of Pharmacy, Sichuan University, Chengdu, 610041, Sichuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Ye</Name>
        <Affiliation>College of Basic Science and Forensic Medicine, Sichuan University, Chengdu, 610041, Sichuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiang Lu</Name>
        <Affiliation>College of Pharmacy, Sichuan University, Chengdu, 610041, Sichuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Chen</Name>
        <Affiliation>College of Basic Science and Forensic Medicine, Sichuan University, Chengdu, 610041, Sichuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinhua Dai</Name>
        <Affiliation>College of Basic Science and Forensic Medicine, Sichuan University, Chengdu, 610041, Sichuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Youyi Yan</Name>
        <Affiliation>College of Basic Science and Forensic Medicine, Sichuan University, Chengdu, 610041, Sichuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Linchuan Liao</Name>
        <Affiliation>College of Basic Science and Forensic Medicine, Sichuan University, Chengdu, 610041, Sichuan, China. Electronic address: linchuanliao@scu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of freeze-dried powdered Tenebrio molitor larvae (yellow mealworm) as novel food source: Evaluation of 90-day toxicity in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26993751</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.006</DOI>
    <KeywordList>
      <Keywords>Edible insects</Keywords>
      <Keywords>Food allergy</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>Tenebrio molitor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>So Ri Han</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byoung Seok Lee</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Jin Jung</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hee Jin Yu</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Young Yun</Name>
        <Affiliation>Department of Agricultural Biology Applied Entomology Division, National Institute of Agricultural Science, 166, Nongsaengmyong-ro, Iseo-myeon, Wanju-gun, Jeollabuk-do 55365, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Sam Hwang</Name>
        <Affiliation>Department of Agricultural Biology Applied Entomology Division, National Institute of Agricultural Science, 166, Nongsaengmyong-ro, Iseo-myeon, Wanju-gun, Jeollabuk-do 55365, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyoung Sik Moon</Name>
        <Affiliation>Department of Toxicological Evaluation and Research, Korea Institute Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea. Electronic address: ksmoon@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation of developmental toxicity and teratogenicity of cyclosporine A, tacrolimus and their combinations with prednisolone.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26993750</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.010</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cyclosporine A</Keywords>
      <Keywords>In vitro embryo culture</Keywords>
      <Keywords>Prednisolone</Keywords>
      <Keywords>Tacrolimus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nadire Unver Dogan</Name>
        <Affiliation>Department of Anatomy, Medical Faculty, Selcuk University, Konya, Turkey. Electronic address: nunver2003@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ismihan Ilknur Uysal</Name>
        <Affiliation>Department of Anatomy, Medical Faculty, Selcuk University, Konya, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Zeliha Fazliogullari</Name>
        <Affiliation>Department of Anatomy, Medical Faculty, Selcuk University, Konya, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmet Kagan Karabulut</Name>
        <Affiliation>Department of Anatomy, Medical Faculty, Selcuk University, Konya, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Hasan Acar</Name>
        <Affiliation>Department of Medical Genetics, Medical Faculty, Selcuk University, Konya, Turkey.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Influence of the uncertainty in the validation of PBPK models: A case-study for PFOS and PFOA.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26993749</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.009</DOI>
    <KeywordList>
      <Keywords>Model validation</Keywords>
      <Keywords>Perfluorooctane sulfonic acid (PFOS)</Keywords>
      <Keywords>Perfluorooctanoic acid (PFOA)</Keywords>
      <Keywords>Physiologically based pharmacokinetic (PBPK) model</Keywords>
      <Keywords>Uncertainty analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Francesc Fàbrega</Name>
        <Affiliation>Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Universitat Rovira i Virgili, Reus, Catalonia, Spain; Environmental Engineering Laboratory, Departament d'Enginyeria Química, Universitat Rovira i Virgili, Tarragona, Catalonia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Martí Nadal</Name>
        <Affiliation>Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Universitat Rovira i Virgili, Reus, Catalonia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Marta Schuhmacher</Name>
        <Affiliation>Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Universitat Rovira i Virgili, Reus, Catalonia, Spain; Environmental Engineering Laboratory, Departament d'Enginyeria Química, Universitat Rovira i Virgili, Tarragona, Catalonia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>José L. Domingo</Name>
        <Affiliation>Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Universitat Rovira i Virgili, Reus, Catalonia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Vikas Kumar</Name>
        <Affiliation>Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Universitat Rovira i Virgili, Reus, Catalonia, Spain; Environmental Engineering Laboratory, Departament d'Enginyeria Química, Universitat Rovira i Virgili, Tarragona, Catalonia, Spain. Electronic address: vikas.kumar@urv.cat.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Animal models of myocardial infarction: Mainstay in clinical translation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26988997</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.005</DOI>
    <KeywordList>
      <Keywords>Animal model</Keywords>
      <Keywords>Infarction</Keywords>
      <Keywords>Ischemia</Keywords>
      <Keywords>Reperfusion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mukesh Kumar</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati 781032, Assam, India. Electronic address: budhanimukesh1991@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Eshvendar Reddy Kasala</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati 781032, Assam, India. Electronic address: ishreddy4@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lakshmi Narendra Bodduluru</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati 781032, Assam, India. Electronic address: laxmi.naren21@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vicky Dahiya</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati 781032, Assam, India. Electronic address: dahiya.vicky681@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dinesh Sharma</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati 781032, Assam, India. Electronic address: sharma231088@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vikas Kumar</Name>
        <Affiliation>Department of Pharmaceutics, Indian Institute of Technology (BHU), Varanasi 221005, Uttar Pradesh, India. Electronic address: vikas.phe@iitbhu.ac.in.</Affiliation>
      </Author>
      <Author>
        <Name>Mangala Lahkar</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati 781032, Assam, India; Department of Pharmacology, Gauhati Medical College, Guwahati 781032, Assam, India. Electronic address: dr_mlahkar@rediffmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comment on Amchova et al., 2015 review of food color safety.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26976383</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30048-4</DOI>
    <KeywordList>
      <Keywords>EFSA</Keywords>
      <Keywords>Food additive</Keywords>
      <Keywords>Food color</Keywords>
      <Keywords>Food safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maria Bastaki</Name>
        <Affiliation>International Association of Color Manufacturers (IACM), Science, 1101 17th Street, Washington, DC, 20036, United States. Electronic address: mbastaki@vertosolutions.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biomonitoring Equivalents for molybdenum.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26972837</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.004</DOI>
    <KeywordList>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring Equivalents</Keywords>
      <Keywords>Molybdenum</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sean M. Hays</Name>
        <Affiliation>Summit Toxicology, LLP, Lyons, CO 90540, USA. Electronic address: shays@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Macey</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Devika Poddalgoda</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Lu</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Andy Nong</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Lesa L. Aylward</Name>
        <Affiliation>Summit Toxicology, LLP, Falls Church, VA 22044, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of an inhalation unit risk factor for cadmium.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26970597</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.03.003</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Tumorigenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Haney</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), Austin, TX, United States. Electronic address: joseph.haney@tceq.texas.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An FDA oncology view of juvenile animal studies in support of initial pediatric trials for anticancer drugs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26952647</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30045-9</DOI>
    <KeywordList>
      <Keywords>First in pediatric trials</Keywords>
      <Keywords>Juvenile animal studies</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John K. Leighton</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States. Electronic address: john.leighton@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Haleh Saber</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory Reaman</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Pazdur</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer Safety (SCCS) - Revision of the opinion on o-Phenylphenol, Sodium o-phenylphenate and Potassium o-phenylphenate (OPP), in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26946408</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30043-5</DOI>
    <KeywordList>
      <Keywords>132-27-4</Keywords>
      <Keywords>13707-65-8</Keywords>
      <Keywords>205-055-6</Keywords>
      <Keywords>237-243-9</Keywords>
      <Keywords>CAS 90-43-7</Keywords>
      <Keywords>EC 201-993-5</Keywords>
      <Keywords>Potassium ophenylphenate</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>Sodium o-phenylphenate</Keywords>
      <Keywords>o-Phenylphenol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920 Luxembourg, Luxembourg. Electronic address: SANTE-C2-SCCS@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Ulrike Bernauer</Name>
        <Affiliation>Federal Institute for Risk Assessment (BfR), Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer safety (SCCS) - Second revision of the opinion on carbon black, nano-form, in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26946407</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30044-7</DOI>
    <KeywordList>
      <Keywords>CAS 1333-86-4</Keywords>
      <Keywords>CI 77266</Keywords>
      <Keywords>Carbon black</Keywords>
      <Keywords>EC 215-609-9</Keywords>
      <Keywords>Nano-form</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920 Luxembourg, Luxembourg. Electronic address: SANTE-C2-SCCS@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Qasim Chaudhry</Name>
        <Affiliation>Institute of Food Science &amp; Innovation, University of Chester, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment in vitro of the genotoxicity, antigenotoxicity and antioxidant of Ceratonia siliqua L. extracts in murine leukaemia cells L1210 by comet assay.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26946406</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.009</DOI>
    <KeywordList>
      <Keywords>Antigenotoxicity</Keywords>
      <Keywords>Cellular antioxidant activity</Keywords>
      <Keywords>Ceratonia siliqua</Keywords>
      <Keywords>Comet assay</Keywords>
      <Keywords>Lipid peroxidation</Keywords>
      <Keywords>Polyphenols</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aïcha Sassi</Name>
        <Affiliation>Laboratoire de biologie cellulaire et moléculaire. Faculté de médecine dentaire. Université de Monastir, Rue Avicenne 5000 Monastir, Tunisie; Unité de Substances Naturelles Bioactives et Biotechnologie « UR12ES12 ». Faculté de pharmacie de Monastir, Université de Monastir, Rue Avicenne 5000 Monastir, Tunisie.</Affiliation>
      </Author>
      <Author>
        <Name>Ines Bouhlel</Name>
        <Affiliation>Laboratoire de biologie cellulaire et moléculaire. Faculté de médecine dentaire. Université de Monastir, Rue Avicenne 5000 Monastir, Tunisie; Unité de Substances Naturelles Bioactives et Biotechnologie « UR12ES12 ». Faculté de pharmacie de Monastir, Université de Monastir, Rue Avicenne 5000 Monastir, Tunisie.</Affiliation>
      </Author>
      <Author>
        <Name>Nadia Mustapha</Name>
        <Affiliation>Laboratoire de biologie cellulaire et moléculaire. Faculté de médecine dentaire. Université de Monastir, Rue Avicenne 5000 Monastir, Tunisie; Unité de Substances Naturelles Bioactives et Biotechnologie « UR12ES12 ». Faculté de pharmacie de Monastir, Université de Monastir, Rue Avicenne 5000 Monastir, Tunisie.</Affiliation>
      </Author>
      <Author>
        <Name>Imen Mokdad-Bzeouich</Name>
        <Affiliation>Laboratoire de biologie cellulaire et moléculaire. Faculté de médecine dentaire. Université de Monastir, Rue Avicenne 5000 Monastir, Tunisie; Unité de Substances Naturelles Bioactives et Biotechnologie « UR12ES12 ». Faculté de pharmacie de Monastir, Université de Monastir, Rue Avicenne 5000 Monastir, Tunisie.</Affiliation>
      </Author>
      <Author>
        <Name>Fadwa Chaabane</Name>
        <Affiliation>Laboratoire de biologie cellulaire et moléculaire. Faculté de médecine dentaire. Université de Monastir, Rue Avicenne 5000 Monastir, Tunisie; Unité de Substances Naturelles Bioactives et Biotechnologie « UR12ES12 ». Faculté de pharmacie de Monastir, Université de Monastir, Rue Avicenne 5000 Monastir, Tunisie.</Affiliation>
      </Author>
      <Author>
        <Name>Kamel Ghedira</Name>
        <Affiliation>Unité de Substances Naturelles Bioactives et Biotechnologie « UR12ES12 ». Faculté de pharmacie de Monastir, Université de Monastir, Rue Avicenne 5000 Monastir, Tunisie.</Affiliation>
      </Author>
      <Author>
        <Name>Leila Chekir-Ghedira</Name>
        <Affiliation>Laboratoire de biologie cellulaire et moléculaire. Faculté de médecine dentaire. Université de Monastir, Rue Avicenne 5000 Monastir, Tunisie; Unité de Substances Naturelles Bioactives et Biotechnologie « UR12ES12 ». Faculté de pharmacie de Monastir, Université de Monastir, Rue Avicenne 5000 Monastir, Tunisie. Electronic address: leila.chekir@laposte.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Letter: Clarifying doubt about endocrine-related science.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26930636</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.019</DOI>
    <AuthorList>
      <Author>
        <Name>Howard Minigh</Name>
        <Affiliation>CropLife International, 326 Avenue Louise, Box 35, 1050 Brussels, Belgium. Electronic address: howard.minigh@croplife.org.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Charles Bocquet</Name>
        <Affiliation>European Crop Protection Association, 6 Avenue E. Van Nieuwenhuyse, 1160 Brussels, Belgium. Electronic address: jean-charles.bocquet@ecpa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Jay Vroom</Name>
        <Affiliation>CropLife America, 1156 15th St., NW, Washington, DC 20005, USA. Electronic address: jvroom@croplifeamerica.org.</Affiliation>
      </Author>
      <Author>
        <Name>Ted Menzies</Name>
        <Affiliation>CropLife Canada, 202-350 Sparks St., Ottawa, ON K1R 7S8, Canada. Electronic address: menziest@croplife.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Micro-CT imaging: Developing criteria for examining fetal skeletons in regulatory developmental toxicology studies - A workshop report.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26930635</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.018</DOI>
    <KeywordList>
      <Keywords>Concordance criteria</Keywords>
      <Keywords>Developmental toxicology</Keywords>
      <Keywords>GLP validation</Keywords>
      <Keywords>Imaging</Keywords>
      <Keywords>Micro-CT</Keywords>
      <Keywords>Skeletal evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Howard M. Solomon</Name>
        <Affiliation>GlaxoSmithKline, King of Prussia, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Susan L. Makris</Name>
        <Affiliation>U.S. Environmental Protection Agency, National Center for Environmental Assessment, Washington, DC, United States. Electronic address: makris.susan@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Hasan Alsaid</Name>
        <Affiliation>GlaxoSmithKline, King of Prussia, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Oscar Bermudez</Name>
        <Affiliation>ILSI Health and Environmental Sciences Institute, Washington, DC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce K. Beyer</Name>
        <Affiliation>Sanofi U.S. Inc., Bridgewater, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Antong Chen</Name>
        <Affiliation>Merck Research Laboratories, Kenilworth, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Connie L. Chen</Name>
        <Affiliation>ILSI Health and Environmental Sciences Institute, Washington, DC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Zhou Chen</Name>
        <Affiliation>U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Silver Spring, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Chmielewski</Name>
        <Affiliation>Covance Laboratories, Greenfield, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony M. DeLise</Name>
        <Affiliation>Novartis Pharmaceutical Corporation, East Hanover, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Luc de Schaepdrijver</Name>
        <Affiliation>Janssen R&amp;D, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Belma Dogdas</Name>
        <Affiliation>Merck Research Laboratories, Kenilworth, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Julian French</Name>
        <Affiliation>Morphology Consulting Ltd., Staffordshire, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Wafa Harrouk</Name>
        <Affiliation>U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Silver Spring, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Helfgott</Name>
        <Affiliation>Stage 2 Innovations, Framingham, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>R. Mark Henkelman</Name>
        <Affiliation>The Hospital for Sick Children, University of Toronto, Toronto, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jacob Hesterman</Name>
        <Affiliation>InviCRO, Boston, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kok Wah Hew</Name>
        <Affiliation>Takeda Pharmaceutical Company, Deerfield, IL, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Hoberman</Name>
        <Affiliation>Charles River Laboratories, Preclinical Services, Horsham, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Cecilia W. Lo</Name>
        <Affiliation>University of Pittsburgh, Pittsburgh, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew McDougal</Name>
        <Affiliation>U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Silver Spring, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel R. Minck</Name>
        <Affiliation>U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Silver Spring, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lelia Scott</Name>
        <Affiliation>Charles River Laboratories, Preclinical Services, Horsham, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Stewart</Name>
        <Affiliation>ApconiX, Macclesfield, Cheshire, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Vicki Sutherland</Name>
        <Affiliation>National Toxicology Program/NIEHS, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Arun K. Tatiparthi</Name>
        <Affiliation>Covance Laboratories, Greenfield, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher T. Winkelmann</Name>
        <Affiliation>Pfizer Worldwide Research &amp; Development, La Jolla, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>L. David Wise</Name>
        <Affiliation>Independent Teratologist, Philadelphia, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra L. Wood</Name>
        <Affiliation>Merck Research Laboratories, Upper Gwynedd, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyou Ying</Name>
        <Affiliation>Sanofi U.S. Inc., Cambridge, MA, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impact of e-cigarette refill liquid exposure on rat kidney.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26925498</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.012</DOI>
    <KeywordList>
      <Keywords>Histopathology</Keywords>
      <Keywords>Kidney injury</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>e-liquid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Narges El Golli</Name>
        <Affiliation>LMBA, Department of Biology, Faculty of Sciences, University of Tunis El Manar, Tunis, Tunisia. Electronic address: nelgolli@yahoo.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Aicha Jrad-Lamine</Name>
        <Affiliation>LMBA, Department of Biology, Faculty of Sciences, University of Tunis El Manar, Tunis, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Hajira Neffati</Name>
        <Affiliation>LMBA, Department of Biology, Faculty of Sciences, University of Tunis El Manar, Tunis, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Houssem Dkhili</Name>
        <Affiliation>LMBA, Department of Biology, Faculty of Sciences, University of Tunis El Manar, Tunis, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Dalila Rahali</Name>
        <Affiliation>LMBA, Department of Biology, Faculty of Sciences, University of Tunis El Manar, Tunis, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Yosra Dallagi</Name>
        <Affiliation>LMBA, Department of Biology, Faculty of Sciences, University of Tunis El Manar, Tunis, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Michele V. El May</Name>
        <Affiliation>Laboratory of Histology-Embryology and Cell Biology, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Saloua El Fazaa</Name>
        <Affiliation>LMBA, Department of Biology, Faculty of Sciences, University of Tunis El Manar, Tunis, Tunisia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and subchronic (13-week) toxicity of fermented Acanthopanax koreanum extracts in Sprague Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26925497</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.017</DOI>
    <KeywordList>
      <Keywords>13-week toxicity</Keywords>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Blood biochemistry</Keywords>
      <Keywords>Fermented Acanthopanax koreanum</Keywords>
      <Keywords>NOAEL</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>MyoungLae Cho</Name>
        <Affiliation>Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gi Hae Shin</Name>
        <Affiliation>Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Min Kim</Name>
        <Affiliation>Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Ha Lee</Name>
        <Affiliation>Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Ok Park</Name>
        <Affiliation>STR Biotech Co., LTD, Chuncheon 24234, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Jong Lee</Name>
        <Affiliation>STR Biotech Co., LTD, Chuncheon 24234, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>HyunMu Shin</Name>
        <Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Boo Yong Lee</Name>
        <Affiliation>Department of Food Science and Biotechnology, CHA University, Kyonggi 13488, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Il Jun Kang</Name>
        <Affiliation>Department of Food Science and Nutrition, Hallym University, Chuncheon 24252, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ok Hwan Lee</Name>
        <Affiliation>Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea. Electronic address: loh99@kangwon.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 90-day subchronic toxicity study with sodium formononetin-3'-sulphonate (Sul-F) delivered to dogs via intravenous administration.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26924788</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.016</DOI>
    <KeywordList>
      <Keywords>Dogs</Keywords>
      <Keywords>Intravenous administration</Keywords>
      <Keywords>Sodium formononetin-3′-sulphonate (Sul-F)</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guisheng Li</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai, 264005, PR China. Electronic address: gylbill@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chengfeng Sun</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyan Wang</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai, 264005, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Steviol glycosides in purified stevia leaf extract sharing the same metabolic fate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26924787</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.015</DOI>
    <KeywordList>
      <Keywords>Anaerobic</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>In vitro metabolism</Keywords>
      <Keywords>Rebaudiosides</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Stevia leaf extract</Keywords>
      <Keywords>Steviol glycosides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sidd Purkayastha</Name>
        <Affiliation>PureCircle Limited, 915 Harger Road, Suite 250, Oak Brook, IL 60523, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Avetik Markosyan</Name>
        <Affiliation>PureCircle Limited, 915 Harger Road, Suite 250, Oak Brook, IL 60523, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Indra Prakash</Name>
        <Affiliation>The Coca-Cola Company, One Coca-Cola Plaza, Atlanta, GA 30126, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sachin Bhusari</Name>
        <Affiliation>The Coca-Cola Company, One Coca-Cola Plaza, Atlanta, GA 30126, USA.</Affiliation>
      </Author>
      <Author>
        <Name>George Pugh</Name>
        <Affiliation>The Coca-Cola Company, One Coca-Cola Plaza, Atlanta, GA 30126, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Lynch</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ashley Roberts</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON, L5N 2X7, Canada. Electronic address: ashley.roberts@intertek.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Linear No-Threshold model and standards for protection against radiation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26924276</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.011</DOI>
    <KeywordList>
      <Keywords>ALARA</Keywords>
      <Keywords>Adaptive response</Keywords>
      <Keywords>Guidelines</Keywords>
      <Keywords>LNT</Keywords>
      <Keywords>Model uncertainty</Keywords>
      <Keywords>Preconditioning</Keywords>
      <Keywords>Radiation hormesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dima Yazji Shamoun</Name>
        <Affiliation>Mercatus Center at George Mason University, USA. Electronic address: dshamoun@mercatus.gmu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Is sunitinib a Narrow Therapeutic Index Drug? - A systematic review and in vitro toxicology-analysis of Sunitinib vs. Imatinib in cells from different tissues.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26924275</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.010</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cell viability</Keywords>
      <Keywords>Drug safety</Keywords>
      <Keywords>Imatinib</Keywords>
      <Keywords>Narrow Therapeutic Index Drug (NTID)</Keywords>
      <Keywords>Receptor tyrosine kinase (RTK)</Keywords>
      <Keywords>Sunitinib</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Tyrosine kinase inhibitor (TKI)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bodo Haas</Name>
        <Affiliation>Federal Institute of Drugs and Medical Devices, Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany. Electronic address: bodo.haas@bfarm.de.</Affiliation>
      </Author>
      <Author>
        <Name>Konstantin Weber-Lassalle</Name>
        <Affiliation>Federal Institute of Drugs and Medical Devices, Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Roland Frötschl</Name>
        <Affiliation>Federal Institute of Drugs and Medical Devices, Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Niels Eckstein</Name>
        <Affiliation>Federal Institute of Drugs and Medical Devices, Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany; Applied Pharmacy, University of Applied Sciences Kaiserslautern, Campus Pirmasens, Carl-Schurz-Str. 10-16, 66953 Pirmasens, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of advanced glycation end product Nε-(carboxymethyl)lysine: Acute and subacute oral toxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26921796</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.013</DOI>
    <KeywordList>
      <Keywords>Mice</Keywords>
      <Keywords>Nε-(carboxymethyl)lysine</Keywords>
      <Keywords>Oral acute toxicity</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Subacute toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xin Liu</Name>
        <Affiliation>Institute of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430023, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liangqing Zheng</Name>
        <Affiliation>Institute of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430023, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Zhang</Name>
        <Affiliation>Institute of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430023, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gang Liu</Name>
        <Affiliation>Institute of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430023, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shensheng Xiao</Name>
        <Affiliation>Institute of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430023, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoting Qiao</Name>
        <Affiliation>Institute of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430023, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongning Wu</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, China National Centre for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiyong Gong</Name>
        <Affiliation>Institute of Food Science and Engineering, Wuhan Polytechnic University, Wuhan 430023, Hubei, China. Electronic address: gongwhqg@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Relevance of bioaccumulating substances in the TTC concept.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26921795</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.014</DOI>
    <KeywordList>
      <Keywords>Accumulation</Keywords>
      <Keywords>Bioaccumulation</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>TTC</Keywords>
      <Keywords>Thresholds</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Winfried R. Leeman</Name>
        <Affiliation>TNO, Utrechtseweg 48, PO Box 360, NL-3700 AJ Zeist, The Netherlands. Electronic address: winfried.leeman@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Tanja Rouhani-Rankouhi</Name>
        <Affiliation>TNO, Utrechtseweg 48, PO Box 360, NL-3700 AJ Zeist, The Netherlands. Electronic address: tanja.rouhanirankouhi@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Jack Vogels</Name>
        <Affiliation>TNO, Utrechtseweg 48, PO Box 360, NL-3700 AJ Zeist, The Netherlands. Electronic address: jack.vogels@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Lisette Krul</Name>
        <Affiliation>TNO, Utrechtseweg 48, PO Box 360, NL-3700 AJ Zeist, The Netherlands. Electronic address: lisette.krul@tno.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity evaluation of hydroalcoholic extract of Ferula gummosa root.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26893240</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.008</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Ferula gummosa</Keywords>
      <Keywords>Medicinal plant</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ahmad Ghorbani</Name>
        <Affiliation>Pharmacological Research Center of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: ghorbania@mums.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Reza Mohebbati</Name>
        <Affiliation>Neurogenic Inflammation Research Center, Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: Mohebbatir911@mums.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Amir Hossein Jafarian</Name>
        <Affiliation>Cancer Molecular Pathology Research Center, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: Jafarianah@mums.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Mahdi Vahedi</Name>
        <Affiliation>Department of Pharmacology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: vahedimm901@mums.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Seyed Mahmoud Hosseini</Name>
        <Affiliation>Neurocognitive Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: hosseinim@mums.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Soukhtanloo</Name>
        <Affiliation>Department of Medical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: soukhtanloom@mums.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Hamid Reza Sadeghnia</Name>
        <Affiliation>Pharmacological Research Center of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmacology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Neurocognitive Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: sadeghniahr@mums.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name> Azar Hosseini</Name>
        <Affiliation>Pharmacological Research Center of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: hoseiniaz@mums.ac.ir.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>CSAHi study: Validation of multi-electrode array systems (MEA60/2100) for prediction of drug-induced proarrhythmia using human iPS cell-derived cardiomyocytes -assessment of inter-facility and cells lot-to-lot-variability.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26884090</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.007</DOI>
    <KeywordList>
      <Keywords>Comprehensive in vitro Proarrthythmia assay (CiPA)</Keywords>
      <Keywords>Consortium for drug safety assessment using human iPS cells (CSAHi)</Keywords>
      <Keywords>Early after depolarization (EAD) or triggered activity (TA)</Keywords>
      <Keywords>Human iPS cells-derived cardiomyocytes (hiPS-CMs)</Keywords>
      <Keywords>Inter-facility variability</Keywords>
      <Keywords>Multi electrode array (MEA)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yumiko Nozaki</Name>
        <Affiliation>Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yayoi Honda</Name>
        <Affiliation>Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hitoshi Watanabe</Name>
        <Affiliation>Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shota Saiki</Name>
        <Affiliation>Research Laboratory for Development, Shionogi &amp; Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka 561-0825, Japan; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kiyotaka Koyabu</Name>
        <Affiliation>Research Laboratory for Development, Shionogi &amp; Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka 561-0825, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tetsuji Itoh</Name>
        <Affiliation>Research Laboratory for Development, Shionogi &amp; Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka 561-0825, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Chiho Nagasawa</Name>
        <Affiliation>Research Center, Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Saitama-shi, Saitama 331-9530, Japan; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Chiaki Nakamori</Name>
        <Affiliation>Research Center, Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Saitama-shi, Saitama 331-9530, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Chiaki Nakayama</Name>
        <Affiliation>Research Center, Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Saitama-shi, Saitama 331-9530, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Iwasaki</Name>
        <Affiliation>Research Center, Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Saitama-shi, Saitama 331-9530, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shinobu Suzuki</Name>
        <Affiliation>Nippon Boehringer Ingelheim Co., Ltd., 6-7-5, Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ikumi Washio</Name>
        <Affiliation>Nippon Boehringer Ingelheim Co., Ltd., 6-7-5, Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Etsushi Takahashi</Name>
        <Affiliation>Research Laboratories, Toyama Chemical Co., Ltd., 4-1, Shimookui 2-chome, Toyama 930-8508, Japan; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kaori Miyamoto</Name>
        <Affiliation>Research Laboratories, Toyama Chemical Co., Ltd., 4-1, Shimookui 2-chome, Toyama 930-8508, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Atsuhiro Yamanishi</Name>
        <Affiliation>Toxicology Research Laboratory, Kyorin Pharmaceutical Co., Ltd., 1848, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi, 329-0114, Japan; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroko Endo</Name>
        <Affiliation>Toxicology Research Laboratory, Kyorin Pharmaceutical Co., Ltd., 1848, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi, 329-0114, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Junko Shinozaki</Name>
        <Affiliation>Toxicology Research Laboratory, Kyorin Pharmaceutical Co., Ltd., 1848, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi, 329-0114, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hisashi Nogawa</Name>
        <Affiliation>Toxicology Research Laboratory, Kyorin Pharmaceutical Co., Ltd., 1848, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi, 329-0114, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeshi Kunimatsu</Name>
        <Affiliation>Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-0023, Japan. Electronic address: takeshi-kunimatsu@ds-pharma.co.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26879463</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.003</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Aromatic amines</Keywords>
      <Keywords>ICH M7</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Pharmaceutical impurities</Keywords>
      <Keywords>SAR fingerprint</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ernst Ahlberg</Name>
        <Affiliation>AstraZeneca, Mölndal, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander Amberg</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa D. Beilke</Name>
        <Affiliation>Toxicology Solutions, San Diego, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Bower</Name>
        <Affiliation>Leadscope, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin P. Cross</Name>
        <Affiliation>Leadscope, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Custer</Name>
        <Affiliation>Bristol-Myers Squibb Co., New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin A. Ford</Name>
        <Affiliation>Genentech, South San Francisco, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jacky Van Gompel</Name>
        <Affiliation>Janssen Research and Development, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>James Harvey</Name>
        <Affiliation>GlaxoSmithKline, Ware, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Masamitsu Honma</Name>
        <Affiliation>National Institute of Health Sciences, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Jolly</Name>
        <Affiliation>Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elisabeth Joossens</Name>
        <Affiliation>European Commission Joint Research Centre, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond A. Kemper</Name>
        <Affiliation>Vertex, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Kenyon</Name>
        <Affiliation>Pfizer, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naomi Kruhlak</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lara Kuhnke</Name>
        <Affiliation>Bayer HealthCare, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Penny Leavitt</Name>
        <Affiliation>Bristol-Myers Squibb Co., New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Russell Naven</Name>
        <Affiliation>Pfizer, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Neilan</Name>
        <Affiliation>Incyte Corporation, Wilmington, DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donald P. Quigley</Name>
        <Affiliation>Leadscope, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dana Shuey</Name>
        <Affiliation>Incyte Corporation, Wilmington, DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Peter Spirkl</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lidiya Stavitskaya</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Teasdale</Name>
        <Affiliation>AstraZeneca, Cheshire, England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Angela White</Name>
        <Affiliation>GlaxoSmithKline, Ware, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Joerg Wichard</Name>
        <Affiliation>Bayer HealthCare, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Craig Zwickl</Name>
        <Affiliation>Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Glenn J. Myatt</Name>
        <Affiliation>Leadscope, Columbus, OH, USA. Electronic address: gmyatt@leadscope.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>How well can in vitro data predict in vivo effects of chemicals? Rodent carcinogenicity as a case study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26879462</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.005</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>High throughput screening</Keywords>
      <Keywords>Prediction modeling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Louis Anthony Tony Cox</Name>
        <Affiliation>Cox Associates, 503 Franklin St., Denver, CO, 80218, USA. Electronic address: tcoxdenver@aol.com.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas A. Popken</Name>
        <Affiliation>Cox Associates, 503 Franklin St., Denver, CO, 80218, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Michael Kaplan</Name>
        <Affiliation>A. Michael Kaplan &amp; Associates, LLC, 23 Wilkinson Drive, Landenberg, PA, 19350, USA. Electronic address: amkaplan1@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Laura M. Plunkett</Name>
        <Affiliation>Integrative Biostrategies LLC, 1127 Eldridge Parkway, Suite 300-335, Houston, TX, 77077, USA. Electronic address: lmplunkett@inbiostrat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Becker</Name>
        <Affiliation>American Chemistry Council, 700 Second Street NE, Washington, D.C. 20002, USA. Electronic address: Rick_Becker@americanchemistry.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26877192</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.004</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Ames test</Keywords>
      <Keywords>Expert review</Keywords>
      <Keywords>ICH M7</Keywords>
      <Keywords>Impurities</Keywords>
      <Keywords>Mutagenic impurities</Keywords>
      <Keywords>Toxicity databases</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alexander Amberg</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Beilke</Name>
        <Affiliation>Toxicology Solutions, San Diego, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joel Bercu</Name>
        <Affiliation>Gilead, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dave Bower</Name>
        <Affiliation>Leadscope, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Brigo</Name>
        <Affiliation>Roche Pharmaceutical Research &amp; Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin P. Cross</Name>
        <Affiliation>Leadscope, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Custer</Name>
        <Affiliation>Bristol-Myers Squibb, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Krista Dobo</Name>
        <Affiliation>Pfizer, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Dowdy</Name>
        <Affiliation>Gilead, Foster City, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin A. Ford</Name>
        <Affiliation>Genentech, South San Francisco, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis Institutes for Biomedical Research, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jacky Van Gompel</Name>
        <Affiliation>Janssen, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>James Harvey</Name>
        <Affiliation>GlaxoSmithKline, Ware, Herts, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Catrin Hasselgren</Name>
        <Affiliation>Leadscope, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Masamitsu Honma</Name>
        <Affiliation>National Institute of Health Sciences, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Jolly</Name>
        <Affiliation>Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond Kemper</Name>
        <Affiliation>Vertex, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Kenyon</Name>
        <Affiliation>Pfizer, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naomi Kruhlak</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Penny Leavitt</Name>
        <Affiliation>Bristol-Myers Squibb, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Miller</Name>
        <Affiliation>Leadscope, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Muster</Name>
        <Affiliation>Roche Pharmaceutical Research &amp; Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>John Nicolette</Name>
        <Affiliation>AbbVie Inc., North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andreja Plaper</Name>
        <Affiliation>KRKA, Novo Mesto, Slovenia.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Powley</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donald P. Quigley</Name>
        <Affiliation>Leadscope, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Vijayaraj Reddy</Name>
        <Affiliation>Merck Research Laboratories, West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Peter Spirkl</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lidiya Stavitskaya</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Teasdale</Name>
        <Affiliation>AstraZeneca, Macclesfield, Cheshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sandy Weiner</Name>
        <Affiliation>Janssen, Spring House, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dennie S. Welch</Name>
        <Affiliation>AbbVie Inc., North Chicago, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angela White</Name>
        <Affiliation>GlaxoSmithKline, Ware, Herts, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Joerg Wichard</Name>
        <Affiliation>Bayer HealthCare, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Glenn J. Myatt</Name>
        <Affiliation>Leadscope, Columbus, OH, USA. Electronic address: gmyatt@leadscope.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Promoting the 3Rs to enhance the OECD fish toxicity testing framework.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26873775</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.006</DOI>
    <KeywordList>
      <Keywords>Aquatic</Keywords>
      <Keywords>Chemicals</Keywords>
      <Keywords>Effluent</Keywords>
      <Keywords>Hazard</Keywords>
      <Keywords>Risk</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas H. Hutchinson</Name>
        <Affiliation>School of Biological Sciences, University of Plymouth, Drake Circus, Plymouth, PL4 8AA, United Kingdom. Electronic address: tom.hutchinson@plymouth.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>James R. Wheeler</Name>
        <Affiliation>Dow AgroSciences, 3B Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom. Electronic address: jrwheeler@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Gourmelon</Name>
        <Affiliation>Organization for Economic Co-operation and Development (OECD), 2 rue André-Pascal, F-75775, Paris Cedex 16, France. Electronic address: anne.gourmelon@oecd.org.</Affiliation>
      </Author>
      <Author>
        <Name>Natalie Burden</Name>
        <Affiliation>NC3Rs, Gibbs Building, 215 Euston Road, London, NW1 2BE, United Kingdom. Electronic address: natalie.burden@nc3rs.org.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Spontaneously occurring fundus findings observed using confocal scanning laser ophthalmoscopy in wild type Sprague Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26873774</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.002</DOI>
    <KeywordList>
      <Keywords>Baseline abnormality</Keywords>
      <Keywords>In vivo optical imaging</Keywords>
      <Keywords>Retinal toxicity</Keywords>
      <Keywords>Spontaneous lesion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rahul Joshi</Name>
        <Affiliation>Keenan Research Centre for Biomedical Science, St Michael's Hospital, 209 Victoria Street, Toronto, ON, Canada, M5B 1W8.</Affiliation>
      </Author>
      <Author>
        <Name>Natalie Pankova</Name>
        <Affiliation>University of Toronto, Department of Laboratory Medicine and Pathobiology, 1 King's College Circle, Toronto, ON, Canada, M5S 1A8; University of Toronto, Department of Ophthalmology and Vision Sciences, 340 College Street, Toronto, ON, Canada, M5T 3A9; Keenan Research Centre for Biomedical Science, St Michael's Hospital, 209 Victoria Street, Toronto, ON, Canada, M5B 1W8.</Affiliation>
      </Author>
      <Author>
        <Name>Hai Wang</Name>
        <Affiliation>Keenan Research Centre for Biomedical Science, St Michael's Hospital, 209 Victoria Street, Toronto, ON, Canada, M5B 1W8.</Affiliation>
      </Author>
      <Author>
        <Name>David Sung Hyeon Baek</Name>
        <Affiliation>University of Toronto, Department of Laboratory Medicine and Pathobiology, 1 King's College Circle, Toronto, ON, Canada, M5S 1A8; Keenan Research Centre for Biomedical Science, St Michael's Hospital, 209 Victoria Street, Toronto, ON, Canada, M5B 1W8.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Zhao</Name>
        <Affiliation>Keenan Research Centre for Biomedical Science, St Michael's Hospital, 209 Victoria Street, Toronto, ON, Canada, M5B 1W8.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Reyad</Name>
        <Affiliation>Keenan Research Centre for Biomedical Science, St Michael's Hospital, 209 Victoria Street, Toronto, ON, Canada, M5B 1W8.</Affiliation>
      </Author>
      <Author>
        <Name>Shelley R. Boyd</Name>
        <Affiliation>University of Toronto, Department of Laboratory Medicine and Pathobiology, 1 King's College Circle, Toronto, ON, Canada, M5S 1A8; University of Toronto, Department of Ophthalmology and Vision Sciences, 340 College Street, Toronto, ON, Canada, M5T 3A9; Keenan Research Centre for Biomedical Science, St Michael's Hospital, 209 Victoria Street, Toronto, ON, Canada, M5B 1W8; Department of Ophthalmology, St. Michael's Hospital, 30 Bond Street, Toronto, ON, Canada, M5B 1W8; Biomedical Engineering, McMaster University, 1280 Main Street West, Hamilton, ON, Canada, L8S 4K1. Electronic address: boyds@smh.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The safety of medical devices containing DEHP plasticized PVC or other plasticizers on neonates and other groups possibly at risk (2015 update).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26854686</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.013</DOI>
    <KeywordList>
      <Keywords>Alternative plasticizers</Keywords>
      <Keywords>DEHP</Keywords>
      <Keywords>Health risks</Keywords>
      <Keywords>Medical devices</Keywords>
      <Keywords>Neonates</Keywords>
      <Keywords>Phthalates</Keywords>
      <Keywords>SCENIHR</Keywords>
      <Keywords>Scientific opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Emanuela Testai</Name>
        <Affiliation>Member of the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name>Philippe Hartemann</Name>
        <Affiliation>Member of the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Suresh Chandra Rastogi</Name>
        <Affiliation>Member of the Scientific Committee on Consumer Safety (SCCS), Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Ulrike Bernauer</Name>
        <Affiliation>Member of the Scientific Committee on Consumer Safety (SCCS), Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Aldert Piersma</Name>
        <Affiliation>Member of the SCENIHR Working Group on DEHP, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Wim De Jong</Name>
        <Affiliation>Member of the SCENIHR Working Group on DEHP, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Gulliksson</Name>
        <Affiliation>Member of the SCENIHR Working Group on DEHP, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Sharpe</Name>
        <Affiliation>Member of the SCENIHR Working Group on DEHP, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Dirk Schubert</Name>
        <Affiliation>Member of the SCENIHR Working Group on DEHP, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo Rodríguez-Farre</Name>
        <Affiliation>Member of the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A TTC threshold for acute oral exposure to non-genotoxic substances.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26853733</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.022</DOI>
    <KeywordList>
      <Keywords>ADI</Keywords>
      <Keywords>ARfD</Keywords>
      <Keywords>Acute TTC</Keywords>
      <Keywords>Chronic TTC</Keywords>
      <Keywords>Cramer class</Keywords>
      <Keywords>Munro dataset</Keywords>
      <Keywords>Pesticides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Harrie E. Buist</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, The Netherlands. Electronic address: harrie.buist@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Lisette Krul</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Winfried R. Leeman</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The bottom-up approach to bounding potential low-dose cancer risks from formaldehyde: An update.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26851508</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.021</DOI>
    <KeywordList>
      <Keywords>Bottom-up approach</Keywords>
      <Keywords>Carcinogenic risk assessment</Keywords>
      <Keywords>Endogenous formaldehyde</Keywords>
      <Keywords>Exogenous formaldehyde</Keywords>
      <Keywords>Formaldehyde-DNA adducts</Keywords>
      <Keywords>Upper 95% confidence bound</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas B. Starr</Name>
        <Affiliation>TBS Associates, 7500 Rainwater Road, Raleigh, NC 27615, USA; Department of Environmental Sciences and Engineering, University of North Carolina, Chapel Hill, 166 Rosenau Hall, CB #7431, Chapel Hill, NC 27599-7431, USA. Electronic address: tbstarr@mindspring.com.</Affiliation>
      </Author>
      <Author>
        <Name>James A. Swenberg</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, University of North Carolina, Chapel Hill, 166 Rosenau Hall, CB #7431, Chapel Hill, NC 27599-7431, USA. Electronic address: jswenber@email.unc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The safety of the use of bisphenol A in medical devices.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26851507</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(16)30014-9</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Medical devices</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>SCENIHR</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Emanuela Testai</Name>
        <Affiliation>Member of the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name>Philippe Hartemann</Name>
        <Affiliation>Member of the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo Rodríguez-Farre</Name>
        <Affiliation>Member of the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Suresh Chandra Rastogi</Name>
        <Affiliation>Member of the Scientific Committee on Consumer Safety (SCCS), Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Juana Bustos</Name>
        <Affiliation>Member of the SCENIHR Working Group on BPA, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula Gundert-Remy</Name>
        <Affiliation>Member of the SCENIHR Working Group on BPA, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Arne Hensten</Name>
        <Affiliation>Member of the SCENIHR Working Group on BPA, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Hilde Molvig Kopperud</Name>
        <Affiliation>Member of the SCENIHR Working Group on BPA, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Nicolás Olea</Name>
        <Affiliation>Member of the SCENIHR Working Group on BPA, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Aldert Piersma</Name>
        <Affiliation>Member of the SCENIHR Working Group on BPA, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Wim De Jong</Name>
        <Affiliation>Member of the SCENIHR Working Group on BPA, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name> </Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Differential analyses of major allergen proteins in wild-type rice and rice producing a fragment of anti-rotavirus antibody.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26851506</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.023</DOI>
    <KeywordList>
      <Keywords>2D-DIGE</Keywords>
      <Keywords>Immunoelectron microscopy</Keywords>
      <Keywords>Rice allergens</Keywords>
      <Keywords>Rice-based antibody</Keywords>
      <Keywords>Shotgun MS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yoshikazu Yuki</Name>
        <Affiliation>Division of Mucosal Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, 108-8639, Tokyo, Japan; International Research and Development Center for Mucosal Vaccine, The Institute of Medical Science, The University of Tokyo, 108-8639, Tokyo, Japan. Electronic address: yukiy@ims.u-tokyo.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Shiho Kurokawa</Name>
        <Affiliation>Division of Mucosal Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, 108-8639, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroko Kozuka-Hata</Name>
        <Affiliation>Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, 108-8639, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Daisuke Tokuhara</Name>
        <Affiliation>Department of Pediatrics, Osaka City University Graduate School of Medicine, 545-8585, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mio Mejima</Name>
        <Affiliation>Division of Mucosal Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, 108-8639, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masaharu Kuroda</Name>
        <Affiliation>Crop Development Division, NARO Agriculture Research Center, 943-0193, Niigata, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masaaki Oyama</Name>
        <Affiliation>Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, 108-8639, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoko Nishimaki-Mogami</Name>
        <Affiliation>Division of Biochemistry, National Institute of Health Sciences, 158-8501, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Reiko Teshima</Name>
        <Affiliation>Division of Foods, National Institute of Health Sciences, 158-8501, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Kiyono</Name>
        <Affiliation>Division of Mucosal Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, 108-8639, Tokyo, Japan; International Research and Development Center for Mucosal Vaccine, The Institute of Medical Science, The University of Tokyo, 108-8639, Tokyo, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of a No-significant-risk-level (NSRL) for dermal exposures to diethanolamine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26850685</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.020</DOI>
    <KeywordList>
      <Keywords>Dose-response assessment</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Species differences</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. R. Kirman</Name>
        <Affiliation>Summit Toxicology, Orange Village, OH 44022, USA. Electronic address: ckirman@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>B. Hughes</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. A. Becker</Name>
        <Affiliation>American Chemistry Council, Washington, DC 20002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. M. Hays</Name>
        <Affiliation>Summit Toxicology, Lyons, CO 80540, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A subchronic feeding study of dicamba-tolerant soybean with the dmo gene in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26850684</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.02.001</DOI>
    <KeywordList>
      <Keywords>Food safety</Keywords>
      <Keywords>Subchronic feeding study</Keywords>
      <Keywords>Trangenic soybean</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaoyun Wang</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyun He</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China; The Supervision, Inspection and Testing Center of Genetically Modified Organisms, Ministry of Agriculture, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shiyin Zou</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China; The Supervision, Inspection and Testing Center of Genetically Modified Organisms, Ministry of Agriculture, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wentao Xu</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China; The Supervision, Inspection and Testing Center of Genetically Modified Organisms, Ministry of Agriculture, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Jia</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Zhao</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changhui Zhao</Name>
        <Affiliation>Department of Nutrition and Food Science, University of Maryland, College Park, MD, 20742, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kunlun Huang</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China; The Supervision, Inspection and Testing Center of Genetically Modified Organisms, Ministry of Agriculture, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihong Liang</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China; The Supervision, Inspection and Testing Center of Genetically Modified Organisms, Ministry of Agriculture, Beijing, China. Electronic address: liangzhihong@cau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization and safety evaluation of a Deinococcus member as feed additive for hens.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26845483</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.019</DOI>
    <KeywordList>
      <Keywords>Biotechnology</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Fermentation</Keywords>
      <Keywords>Fermented food</Keywords>
      <Keywords>Food safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Szu Yin Wu</Name>
        <Affiliation>Grape King Bio Ltd, Taoyuan City 320, Taiwan. Electronic address: sy.wu@grapeking.com.tw.</Affiliation>
      </Author>
      <Author>
        <Name>I. Chen Li</Name>
        <Affiliation>Grape King Bio Ltd, Taoyuan City 320, Taiwan. Electronic address: ichen.li@grapeking.com.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Chin Lin</Name>
        <Affiliation>Grape King Bio Ltd, Taoyuan City 320, Taiwan. Electronic address: yi.lin@grapeking.com.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chin Chu Chen</Name>
        <Affiliation>Grape King Bio Ltd, Taoyuan City 320, Taiwan; Institute of Food Science and Technology, National Taiwan University, Taipei City, Taiwan; Department of Food Science, Nutrition, and Nutraceutical Biotechnology, Shin Chien University, Taipei City, Taiwan; Department of Applied Science, National Hsin-Chu University of Education, Hsinchu City, Taiwan. Electronic address: gkbioeng@grapeking.com.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A high dose mode of action for tetrabromobisphenol A-induced uterine adenocarcinomas in Wistar Han rats: A critical evaluation of key events in an adverse outcome pathway framework.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26828025</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.018</DOI>
    <KeywordList>
      <Keywords>AOP</Keywords>
      <Keywords>Estrogen</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Sulfotransferase</Keywords>
      <Keywords>TBBPA</Keywords>
      <Keywords>Uterine tumor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>D. S. Wikoff</Name>
        <Affiliation>ToxStrategies, Austin, TX, United States. Electronic address: dwikoff@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. E. Rager</Name>
        <Affiliation>ToxStrategies, Austin, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>L. C. Haws</Name>
        <Affiliation>ToxStrategies, Austin, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>S. J. Borghoff</Name>
        <Affiliation>ToxStrategies, Cary, NC, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition by blueberries (bilberries) and extract from milk thistle of rat forestomach hyperplasia induced by oral smokeless tobacco (Swedish snus).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26828024</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.017</DOI>
    <KeywordList>
      <Keywords>Blueberries</Keywords>
      <Keywords>Bromodeoxyuridine</Keywords>
      <Keywords>Forestomach</Keywords>
      <Keywords>Hyperplasia</Keywords>
      <Keywords>Milk thistle</Keywords>
      <Keywords>Phytoprotection</Keywords>
      <Keywords>Silymarin</Keywords>
      <Keywords>Smokeless tobacco</Keywords>
      <Keywords>Snus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Robert Nilsson</Name>
        <Affiliation>Vinča Institute of Nuclear Sciences, Laboratory for Physical Chemistry, University of Belgrade, Vinča, Belgrade, Serbia. Electronic address: robertn65@telia.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mileva Mićić</Name>
        <Affiliation>Institute for Medical Investigation, University of Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Jelena Filipović</Name>
        <Affiliation>Vinča Institute of Nuclear Sciences, Laboratory for Physical Chemistry, University of Belgrade, Vinča, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Valenta Šobot</Name>
        <Affiliation>Vinča Institute of Nuclear Sciences, Laboratory for Physical Chemistry, University of Belgrade, Vinča, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Dunja Drakulić</Name>
        <Affiliation>Vinča Institute of Nuclear Sciences, Laboratory for Physical Chemistry, University of Belgrade, Vinča, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Miloš Stanojlović</Name>
        <Affiliation>Vinča Institute of Nuclear Sciences, Laboratory for Physical Chemistry, University of Belgrade, Vinča, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Gordana Joksiċ</Name>
        <Affiliation>Vinča Institute of Nuclear Sciences, Laboratory for Physical Chemistry, University of Belgrade, Vinča, Belgrade, Serbia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Usage patterns of aromatherapy among the French general population: A descriptive study focusing on dermal exposure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26826550</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.016</DOI>
    <KeywordList>
      <Keywords>Aromatherapy</Keywords>
      <Keywords>Consumption</Keywords>
      <Keywords>Dermal exposure</Keywords>
      <Keywords>French population</Keywords>
      <Keywords>Lack of regulation</Keywords>
      <Keywords>Sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>N. Dornic</Name>
        <Affiliation>Laboratoire d'Evaluation du Risque Chimique pour le Consommateur (LERCCo), Université Européenne de Bretagne - Université de Bretagne Occidentale (UEB-UBO), UFR Sciences et Techniques, 6 Av. Victor Le Gorgeu, CS93837, 29238 Brest Cedex 3, France. Electronic address: nicolas.dornic@univ-brest.fr.</Affiliation>
      </Author>
      <Author>
        <Name>A. S. Ficheux</Name>
        <Affiliation>Laboratoire d'Evaluation du Risque Chimique pour le Consommateur (LERCCo), Université Européenne de Bretagne - Université de Bretagne Occidentale (UEB-UBO), UFR Sciences et Techniques, 6 Av. Victor Le Gorgeu, CS93837, 29238 Brest Cedex 3, France.</Affiliation>
      </Author>
      <Author>
        <Name>A. C. Roudot</Name>
        <Affiliation>Laboratoire d'Evaluation du Risque Chimique pour le Consommateur (LERCCo), Université Européenne de Bretagne - Université de Bretagne Occidentale (UEB-UBO), UFR Sciences et Techniques, 6 Av. Victor Le Gorgeu, CS93837, 29238 Brest Cedex 3, France.</Affiliation>
      </Author>
      <Author>
        <Name>D. Saboureau</Name>
        <Affiliation>Independent Toxicologist Expert (Eurotox List) 33610 Cestas, France.</Affiliation>
      </Author>
      <Author>
        <Name>K. Ezzedine</Name>
        <Affiliation>Service de Dermatologie, Hôpital Henri Mondor, 94010 Créteil, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing the safety of cosmetic chemicals: Consideration of a flux decision tree to predict dermally delivered systemic dose for comparison with oral TTC (Threshold of Toxicological Concern).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26825378</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.005</DOI>
    <KeywordList>
      <Keywords>Cosmetic chemical</Keywords>
      <Keywords>Decision tree</Keywords>
      <Keywords>Dermal</Keywords>
      <Keywords>Flux</Keywords>
      <Keywords>Prediction</Keywords>
      <Keywords>Systemic bioavailability</Keywords>
      <Keywords>Threshold of Toxicological Concern (TTC)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Faith M. Williams</Name>
        <Affiliation>Newcastle University, Newcastle upon Tyne, UK. Electronic address: publications@ilsieurope.be.</Affiliation>
      </Author>
      <Author>
        <Name>Helga Rothe</Name>
        <Affiliation>Procter &amp; Gamble Service GmbH, Schwalbach, DE, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gordon Barrett</Name>
        <Affiliation>Health Canada, Ottawa, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Chiodini</Name>
        <Affiliation>ILSI Europe, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Jacqueline Whyte</Name>
        <Affiliation>ILSI Europe, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Mark T. D. Cronin</Name>
        <Affiliation>Liverpool John Moore University, Liverpool, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Nancy A. Monteiro-Riviere</Name>
        <Affiliation>Kansas State University, Manhattan, KS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Plautz</Name>
        <Affiliation>DSM Nutritional Products, Basel, CH, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Clive Roper</Name>
        <Affiliation>Charles River Laboratories, Edinburgh, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Joost Westerhout</Name>
        <Affiliation>TNO, Zeist, NL, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Chihae Yang</Name>
        <Affiliation>Altamira LLC, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard H. Guy</Name>
        <Affiliation>University of Bath, Bath, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Linking existing in vitro dermal absorption data to physicochemical properties: Contribution to the design of a weight-of-evidence approach for the safety evaluation of cosmetic ingredients with low dermal bioavailability.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26807814</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.015</DOI>
    <KeywordList>
      <Keywords>Bioavailability</Keywords>
      <Keywords>Cosmetic ingredient</Keywords>
      <Keywords>Dermal absorption</Keywords>
      <Keywords>In silico prediction</Keywords>
      <Keywords>Modelling</Keywords>
      <Keywords>Physicochemical properties</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Safety evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gamze Ates</Name>
        <Affiliation>Department of In Vitro Toxicology and Dermato-cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. Electronic address: Gamze.Ates@vub.ac.be.</Affiliation>
      </Author>
      <Author>
        <Name>Fabian P. Steinmetz</Name>
        <Affiliation>QSAR and Modelling Group, School of Pharmacy and Biomolecular Sciences Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, England, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Tatyana Yordanova Doktorova</Name>
        <Affiliation>Unit of Toxicology, Scientific Institute of Public Health (IPH), Juliette Wytsmanstraat 14, B-1050, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Judith C. Madden</Name>
        <Affiliation>QSAR and Modelling Group, School of Pharmacy and Biomolecular Sciences Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, England, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Vera Rogiers</Name>
        <Affiliation>Department of In Vitro Toxicology and Dermato-cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tobacco-specific N-nitrosamines NNN and NNK levels in cigarette brands between 2000 and 2014.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26806560</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.012</DOI>
    <KeywordList>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>NNK</Keywords>
      <Keywords>NNN</Keywords>
      <Keywords>Smoke transfer</Keywords>
      <Keywords>TSNA</Keywords>
      <Keywords>Tobacco</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>I. Gunduz</Name>
        <Affiliation>Philip Morris Products SA, Product Development, Rue des Usines 56, 2000 Neuchâtel, Switzerland. Electronic address: irfan.gunduz@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>A. Kondylis</Name>
        <Affiliation>Philip Morris Products SA, Product Development, Rue des Usines 56, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>G. Jaccard</Name>
        <Affiliation>Philip Morris International Management SA, Product and Process Quality, Quai Jeanrenaud 56, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>J. M. Renaud</Name>
        <Affiliation>Philip Morris Products SA, Product Development, Rue des Usines 56, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>R. Hofer</Name>
        <Affiliation>Philip Morris Products SA, Product Development, Rue des Usines 56, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>L. Ruffieux</Name>
        <Affiliation>Philip Morris International Management SA, Leaf Agricultural Programs, Avenue de Rhodanie 50, 1001 Lausanne, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>F. Gadani</Name>
        <Affiliation>Philip Morris Products SA, Product Development, Rue des Usines 56, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bioavailability study of arsenic and mercury in traditional Chinese medicines (TCM) using an animal model after a single dose exposure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26804582</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.010</DOI>
    <KeywordList>
      <Keywords>Chinese medicines</Keywords>
      <Keywords>Rat study</Keywords>
      <Keywords>Relative bioavailability</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ujang Tinggi</Name>
        <Affiliation>Queensland Health Forensic and Scientific Services, Australia. Electronic address: ujang.tinggi@health.qld.gov.au.</Affiliation>
      </Author>
      <Author>
        <Name>Ross Sadler</Name>
        <Affiliation>Centre for Environment and Population Health, Griffith University, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Jack Ng</Name>
        <Affiliation>National Research Centre for Environmental Toxicology (EnTox), The University of Queensland, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Noller</Name>
        <Affiliation>Centre for Mined Land Rehabilitation, The University of Queensland, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Seawright</Name>
        <Affiliation>National Research Centre for Environmental Toxicology (EnTox), The University of Queensland, Australia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antimicrobial activities of ethanol and butanol fractions of white rose petal extract.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26802535</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.011</DOI>
    <KeywordList>
      <Keywords>Antimicrobial activity</Keywords>
      <Keywords>Butanol fraction</Keywords>
      <Keywords>Ethanol fraction</Keywords>
      <Keywords>Helicobacter pylori</Keywords>
      <Keywords>Propionibacterium acnes</Keywords>
      <Keywords>White rose petal extract</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dongsun Park</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyungha Shin</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Youngjin Choi</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyu Guo</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yeseul Cha</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sa Hyun Kim</Name>
        <Affiliation>Department of Biomedical Laboratory Sciences, Semyung University, Jecheon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Nam Soo Han</Name>
        <Affiliation>Department of Food Science and Technology, Chungbuk National University, Cheongju, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seong Soo Joo</Name>
        <Affiliation>Department of Marine Molecular Biotechnology, Gangneung-Wonju National University, Gangneung, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Kwon Choi</Name>
        <Affiliation>Central Research Institute, Dr. Chung's Food Co. Ltd., Cheongju, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yoon Bok Lee</Name>
        <Affiliation>Central Research Institute, Dr. Chung's Food Co. Ltd., Cheongju, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ehn Kyoung Choi</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Bae Kim</Name>
        <Affiliation>Department of Biomedical Laboratory Sciences, Yonsei University, Wonju, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Bae Kim</Name>
        <Affiliation>College of Veterinary Medicine, Chungbuk National University, Cheongju, South Korea. Electronic address: solar93@cbu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The safety of dental amalgam and alternative dental restoration materials for patients and users.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26796567</pubmedLink>
    <Year>2016</Year>
    <DOI>S0273-2300(15)30150-1</DOI>
    <KeywordList>
      <Keywords>Allergy</Keywords>
      <Keywords>Dental amalgam</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Glass ionomer cements</Keywords>
      <Keywords>Mercury</Keywords>
      <Keywords>Resin-based composites</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>SCENIHR</Keywords>
      <Keywords>Systemic health effects</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eduardo Rodríguez-Farre</Name>
        <Affiliation>Member of the SCENIHR, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Emanuela Testai</Name>
        <Affiliation>Member of the SCENIHR, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen Bruzell</Name>
        <Affiliation>Member of the SCENIHR Working Group on Dental Amalgam, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Wim De Jong</Name>
        <Affiliation>Member of the SCENIHR Working Group on Dental Amalgam, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Gottfried Schmalz</Name>
        <Affiliation>Member of the SCENIHR Working Group on Dental Amalgam, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Mogens Thomsen</Name>
        <Affiliation>Member of the SCENIHR Working Group on Dental Amalgam, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Arne Hensten</Name>
        <Affiliation>Member of the SCENIHR Working Group on Dental Amalgam, Luxembourg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Predicting skin sensitisation using a decision tree integrated testing strategy with an in silico model and in chemico/in vitro assays.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26796566</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.009</DOI>
    <KeywordList>
      <Keywords>DPRA</Keywords>
      <Keywords>Derek Nexus</Keywords>
      <Keywords>In silico assessment</Keywords>
      <Keywords>Integrated testing strategy</Keywords>
      <Keywords>KeratinoSens</Keywords>
      <Keywords>LuSens</Keywords>
      <Keywords>Skin sensitisation</Keywords>
      <Keywords>U-SENS</Keywords>
      <Keywords>h-CLAT</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Donna S. Macmillan</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK. Electronic address: donna.macmillan@lhasalimited.org.</Affiliation>
      </Author>
      <Author>
        <Name>Steven J. Canipa</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Martyn L. Chilton</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Richard V. Williams</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher G. Barber</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on the safety of the use of Methylisothiazolinone (MI) (P94), in cosmetic products (sensitisation only).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26790577</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.001</DOI>
    <KeywordList>
      <Keywords>CAS 2682-20-4</Keywords>
      <Keywords>EC 220-239-6</Keywords>
      <Keywords>Methylisothiazolinone (MI) (P94)</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>Sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920 Luxembourg, Luxembourg. Electronic address: SANTE-C2-SCCS@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Giménez-Arnau</Name>
        <Affiliation>Department of Dermatology, Hospital del Mar. Parc de Salut Mar. Universitat Autònoma, Barcelona, Spain.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>It's difficult, but important, to make negative predictions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26785392</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.008</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Expert assessment</Keywords>
      <Keywords>Expert system</Keywords>
      <Keywords>ICH M7</Keywords>
      <Keywords>In silico toxicology</Keywords>
      <Keywords>Negative predictions</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard V. Williams</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK. Electronic address: richard.williams@lhasalimited.org.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander Amberg</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, R&amp;D DSAR/Preclinical Safety FF, Industriepark Hoechst, Bldg. H823, D-65926 Frankfurt am Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Brigo</Name>
        <Affiliation>Roche Pharmaceutical Research &amp; Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Grenzacherstrasse 124, CH-4070 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Laurence Coquin</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda Giddings</Name>
        <Affiliation>GlaxoSmithKline Pre-Clinical Development, Park Road, Ware, Hertfordshire SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis Pharma AG, Pre-clinical Safety, Werk Klybeck, CH-4057 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Nigel Greene</Name>
        <Affiliation>Compound Safety Prediction, Pfizer Global Research &amp; Development, 558 Eastern Point Road, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Jolly</Name>
        <Affiliation>Health/Safety/Environmental, Lilly Research Laboratories, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ray Kemper</Name>
        <Affiliation>Vertex Pharmaceuticals Incorporated, 50 Northern Ave, Boston MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine O'Leary-Steele</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alexis Parenty</Name>
        <Affiliation>Novartis Pharma AG, Pre-clinical Safety, Werk Klybeck, CH-4057 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Peter Spirkl</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, R&amp;D DSAR/Preclinical Safety FF, Industriepark Hoechst, Bldg. H823, D-65926 Frankfurt am Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne A. Stalford</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sandy K. Weiner</Name>
        <Affiliation>Janssen Research &amp; Development, 1400 McKean Road, Spring House, PA 19477, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joerg Wichard</Name>
        <Affiliation>Bayer Pharma AG, Investigational Toxicology, Muellerstr. 178, S 116, D-13353, Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Using physiologically based pharmacokinetic modeling and benchmark dose methods to derive an occupational exposure limit for N-methylpyrrolidone.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26776754</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.020</DOI>
    <KeywordList>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Occupational exposure limit</Keywords>
      <Keywords>PBPK modeling</Keywords>
      <Keywords>Window of susceptibility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>T. S. Poet</Name>
        <Affiliation>Summit Toxicology, Richland, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. M. Schlosser</Name>
        <Affiliation>USEPA, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>C. E. Rodriguez</Name>
        <Affiliation>USEPA, Washington DC, USA; The Coca Cola Company, Atlanta, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. J. Parod</Name>
        <Affiliation>BASF Corporation, Wyandotte, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. E. Rodwell</Name>
        <Affiliation>Rodwell and Associates, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>C. R. Kirman</Name>
        <Affiliation>Summit Toxicology, Orange Village, OH, USA. Electronic address: ckirman@summittoxicology.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on consumer safety (SCCS) - Opinion on the use of 2,2'-methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) (nano) - S79 - In cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26776753</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.002</DOI>
    <KeywordList>
      <Keywords>2,2′-methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) nano</Keywords>
      <Keywords>CAS 103597-45-1</Keywords>
      <Keywords>EC 403-800-1</Keywords>
      <Keywords>MBBT</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>S79</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>UV-Filter</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name>Shareen H. Doak</Name>
        <Affiliation>Swansea University Medical School, Singleton Park, Swansea SA2 8PP, Wales, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing Natural Product-Drug Interactions: An End-to-End Safety Framework.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26776752</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.004</DOI>
    <KeywordList>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Dietary supplements</Keywords>
      <Keywords>Drug interactions</Keywords>
      <Keywords>Herbal medicines</Keywords>
      <Keywords>Metabolic enzymes</Keywords>
      <Keywords>Natural products</Keywords>
      <Keywords>Transporters</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amy L. Roe</Name>
        <Affiliation>Product Safety &amp; Regulatory Affairs, The Procter &amp; Gamble Company, Cincinnati, OH 45040, United States. Electronic address: roe.al@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mary F. Paine</Name>
        <Affiliation>Experimental and Systems Pharmacology, College of Pharmacy, Washington State University, Spokane, WA 99210, United States. Electronic address: mary.paine@wsu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Bill J. Gurley</Name>
        <Affiliation>College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States. Electronic address: GurleyBilyJ@uams.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth R. Brouwer</Name>
        <Affiliation>Qualyst Transporter Solutions, Durham, NC 27713, United States. Electronic address: kennethbrouwer@qualyst.com.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Jordan</Name>
        <Affiliation>Marketed Biologicals, Biotechnology and Natural Health Products Bureau, Marketed Health Products Directorate, Health Canada, Ottawa, Ontario, Canada. Electronic address: ScottJordan@hc-sc.gc.ca.</Affiliation>
      </Author>
      <Author>
        <Name>James C. Griffiths</Name>
        <Affiliation>Council for Responsible Nutrition, Washington, DC 20036, United States. Electronic address: JGriffiths@crnusa.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carcinogenicity and chronic toxicity of hydrazine monohydrate in rats and mice by two-year drinking water treatment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26774757</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.006</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Chronic toxicity</Keywords>
      <Keywords>Hydrazine monohydrate</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michiharu Matsumoto</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Industrial Safety and Health Association, 2445 Hirasawa, Hadano, Kanagawa, 257-0015, Japan. Electronic address: m-matsumoto@jisha.or.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hirokazu Kano</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Industrial Safety and Health Association, 2445 Hirasawa, Hadano, Kanagawa, 257-0015, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masaaki Suzuki</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Industrial Safety and Health Association, 2445 Hirasawa, Hadano, Kanagawa, 257-0015, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Taku Katagiri</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Industrial Safety and Health Association, 2445 Hirasawa, Hadano, Kanagawa, 257-0015, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yumi Umeda</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Industrial Safety and Health Association, 2445 Hirasawa, Hadano, Kanagawa, 257-0015, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shoji Fukushima</Name>
        <Affiliation>Japan Bioassay Research Center, Japan Industrial Safety and Health Association, 2445 Hirasawa, Hadano, Kanagawa, 257-0015, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Adverse outcome pathways: From research to regulation scientific workshop report.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26774756</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.007</DOI>
    <KeywordList>
      <Keywords>AOP</Keywords>
      <Keywords>Acceptance</Keywords>
      <Keywords>Application</Keywords>
      <Keywords>Computational</Keywords>
      <Keywords>Criteria</Keywords>
      <Keywords>Pathway</Keywords>
      <Keywords>Quantitative</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Workshop</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicole C. Kleinstreuer</Name>
        <Affiliation>National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA. Electronic address: Nicole.kleinstreuer@nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Kristie Sullivan</Name>
        <Affiliation>Physicians Committee for Responsible Medicine, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Allen</Name>
        <Affiliation>Integrated Laboratory Systems, Inc., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Edwards</Name>
        <Affiliation>National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donna L. Mendrick</Name>
        <Affiliation>National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Embry</Name>
        <Affiliation>ILSI Health and Environmental Sciences Institute, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Matheson</Name>
        <Affiliation>U.S. Consumer Product Safety Commission, Rockville, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Craig Rowlands</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sharon Munn</Name>
        <Affiliation>Joint Research Centre, European Commission, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth Maull</Name>
        <Affiliation>National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Warren Casey</Name>
        <Affiliation>National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetic-pharmacodynamic analyses of antihypertensive drugs, nifedipine and propranolol, in spontaneously hypertensive rats to investigate characteristics of effect and side effects.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26773344</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2016.01.003</DOI>
    <KeywordList>
      <Keywords>Antihypertensive drug</Keywords>
      <Keywords>Blood pressure</Keywords>
      <Keywords>Heart rate</Keywords>
      <Keywords>Nifedipine</Keywords>
      <Keywords>Pharmacokinetic-pharmacodynamic (PK-PD) modeling</Keywords>
      <Keywords>Propranolol</Keywords>
      <Keywords>QT interval</Keywords>
      <Keywords>Spontaneously hypertensive rat (SHR)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Akiko Kiriyama</Name>
        <Affiliation>Department of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kodo, Kyotanabe, Kyoto, 610-0395, Japan. Electronic address: akiriyam@dwc.doshisha.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Akino Honbo</Name>
        <Affiliation>Department of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kodo, Kyotanabe, Kyoto, 610-0395, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Asako Nishimura</Name>
        <Affiliation>Department of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kodo, Kyotanabe, Kyoto, 610-0395, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nobuhito Shibata</Name>
        <Affiliation>Department of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kodo, Kyotanabe, Kyoto, 610-0395, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Katsumi Iga</Name>
        <Affiliation>Department of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kodo, Kyotanabe, Kyoto, 610-0395, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Statistical considerations for a chronic bioassay study: Exposure to Decamethylcyclopentasiloxane (D5) and incidence of uterine endometrial adenocarcinomas in a 2-year inhalation study with Fischer rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26772617</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.005</DOI>
    <KeywordList>
      <Keywords>Adenocarcinoma</Keywords>
      <Keywords>Decamethylcyclopentasiloxane D5</Keywords>
      <Keywords>Exact logistic regression</Keywords>
      <Keywords>Fisher exact test</Keywords>
      <Keywords>Max poly-k trend test</Keywords>
      <Keywords>Probit model</Keywords>
      <Keywords>Rat experiment</Keywords>
      <Keywords>Statistical analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Linda J. Young</Name>
        <Affiliation>Department of Statistics, Institute of Food and Agricultural Sciences, University of Florida, Gainesville, USA. Electronic address: LJYoung@ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Morfeld</Name>
        <Affiliation>Institute for Occupational Epidemiology and Risk Assessment of Evonik Industries, Essen, Germany; Institute and Policlinic for Occupational Medicine, Environmental Medicine and Preventive Research, University of Cologne, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26743742</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.018</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Immunomodulation</Keywords>
      <Keywords>Immunosuppression</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Immunotoxicology</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. Lebrec</Name>
        <Affiliation>Amgen Inc, 1120 Veterans Blvd, South San Francisco, CA 94080, USA. Electronic address: hlebrec@amgen.com.</Affiliation>
      </Author>
      <Author>
        <Name>F. R. Brennan</Name>
        <Affiliation>UCB-Celltech, 208 Bath Road, Slough SL1 3WE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>H. Haggerty</Name>
        <Affiliation>Bristol-Myers Squibb Company, 1 Squibb Dr., New Brunswick, NJ 08903, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. Herzyk</Name>
        <Affiliation>Merck &amp; Co Inc, 770 Sumneytown Pike, PO Box 4, MS WP45-233, West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>C. Kamperschroer</Name>
        <Affiliation>Pfizer Inc, Eastern Point Rd, Groton, CT 063340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>C. C. Maier</Name>
        <Affiliation>GlaxoSmithKline, 709 Swedeland Rd, King of Prussia, PA 19406, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. Ponce</Name>
        <Affiliation>Amgen Inc, 1120 Veterans Blvd, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>B. D. Preston</Name>
        <Affiliation>Amgen Inc, 1120 Veterans Blvd, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. Weinstock</Name>
        <Affiliation>Janssen Research &amp; Development, LLC, Welsh &amp; McKean Roads, Spring House, PA 19477, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. D. Mellon</Name>
        <Affiliation>Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Systematic comparison of study quality criteria.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26743741</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.017</DOI>
    <KeywordList>
      <Keywords>Evidence integration</Keywords>
      <Keywords>Study quality</Keywords>
      <Keywords>Systematic review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heather N. Lynch</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jade A. Tabony</Name>
        <Affiliation>Gradient, 600 Stewart Street, Suite 1900, Seattle, WA 98101, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lorenz R. Rhomberg</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA. Electronic address: lrhomberg@gradientcorp.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of variable power levels on the yield of total aerosol mass and formation of aldehydes in e-cigarette aerosols.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26743740</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.019</DOI>
    <KeywordList>
      <Keywords>2,4-DNPH derivatives of aldehydes</Keywords>
      <Keywords>Acetaldehyde</Keywords>
      <Keywords>Acrolein</Keywords>
      <Keywords>Chemical composition</Keywords>
      <Keywords>Electronic nicotine delivery systems</Keywords>
      <Keywords>Electronic-cigarettes</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Liquid chromatography</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>I. G. Gillman</Name>
        <Affiliation>Enthalpy Analytical Inc., Durham, NC 27713, USA. Electronic address: gene.gillman@enthalpy.com.</Affiliation>
      </Author>
      <Author>
        <Name>K. A. Kistler</Name>
        <Affiliation>Department of Chemistry, The Pennsylvania State University, Brandywine Campus, Media, PA 19063, USA.</Affiliation>
      </Author>
      <Author>
        <Name>E. W. Stewart</Name>
        <Affiliation>Enthalpy Analytical Inc., Durham, NC 27713, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. R. Paolantonio</Name>
        <Affiliation>Enthalpy Analytical Inc., Durham, NC 27713, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tobacco alkaloids reduction by casings added/enzymatic hydrolysis treatments assessed through PLSR analysis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26739812</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.016</DOI>
    <KeywordList>
      <Keywords>Cigarette mainstream smoke</Keywords>
      <Keywords>Enzymatic hydrolysis</Keywords>
      <Keywords>Glucose</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Partial least squares regression (PLSR)</Keywords>
      <Keywords>Risk</Keywords>
      <Keywords>Sensory attributes</Keywords>
      <Keywords>Tobacco alkaloids</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shunshun Lin</Name>
        <Affiliation>State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi 214122, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoming Zhang</Name>
        <Affiliation>State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi 214122, Jiangsu, PR China. Electronic address: xmzhang@jiangnan.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shiqing Song</Name>
        <Affiliation>Department of Biology and Food Engineering, Shanghai Institute of Technology, 200235 Shanghai, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Khizar Hayat</Name>
        <Affiliation>Department of Food Science and Nutrition, College of Food and Agricultural Sciences, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Karangwa Eric</Name>
        <Affiliation>State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi 214122, Jiangsu, PR China; Research and Development, AAFUD Industry (Zhuhai) Co. Ltd, Zhuhai 519085, Guangdong, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hamid Majeed</Name>
        <Affiliation>State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi 214122, Jiangsu, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biosimilars: A consideration of the regulations in the United States and European union.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26732800</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.013</DOI>
    <KeywordList>
      <Keywords>Biosimilar</Keywords>
      <Keywords>Extrapolation</Keywords>
      <Keywords>Interchangeability</Keywords>
      <Keywords>Pharmacovigilance</Keywords>
      <Keywords>Regulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Justin Daller</Name>
        <Affiliation>Medical Products, Preclinical Safety and Efficacy, Baxter Healthcare Corporation, Round Lake, IL 60073, USA. Electronic address: justin_daller@baxter.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A tiered assessment strategy for more effective evaluation of bioaccumulation of chemicals in fish.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26724733</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.012</DOI>
    <KeywordList>
      <Keywords>Bioaccumulation</Keywords>
      <Keywords>Bioconcentration</Keywords>
      <Keywords>Integrated test strategy</Keywords>
      <Keywords>PBT</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Tiered assessment strategy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Adam Lillicrap</Name>
        <Affiliation>Norwegian Institute for Water Research (NIVA), Oslo, NO-0349, Norway. Electronic address: ali@niva.no.</Affiliation>
      </Author>
      <Author>
        <Name>Tim Springer</Name>
        <Affiliation>Wildlife International, 8598 Commerce Drive, Easton, MD 21601, USA. Electronic address: tspringer@eag.com.</Affiliation>
      </Author>
      <Author>
        <Name>Charles R. Tyler</Name>
        <Affiliation>Biosciences, College of Life and Environmental Sciences, University of Exeter, Stocker Road, Exeter, EX4 4QD, UK. Electronic address: c.r.tyler@exeter.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of an integrated multi-species and multi-dose route PBPK model for volatile methyl siloxanes - D4 and D5.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26724268</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.010</DOI>
    <KeywordList>
      <Keywords>Cyclic volatile methyl siloxane</Keywords>
      <Keywords>D4</Keywords>
      <Keywords>D5</Keywords>
      <Keywords>Decamethylcyclopentasiloxane</Keywords>
      <Keywords>Kinetics</Keywords>
      <Keywords>Octamethylcyclotetrasiloxane</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Physiologically based pharmacokinetic model</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Siloxane</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tami S. McMullin</Name>
        <Affiliation>Dow Corning Corporation, Health and Environmental Sciences, 2200 West Salzburg Road, Auburn, MI 48611, USA. Electronic address: tami.mcmullin@state.co.us.</Affiliation>
      </Author>
      <Author>
        <Name>Yuching Yang</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, 6 Davis Drive, P.O. Box 12137, Research Triangle Park, NC 27709-2137, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jerry Campbell</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, 6 Davis Drive, P.O. Box 12137, Research Triangle Park, NC 27709-2137, USA. Electronic address: jcampbell@thehamner.org.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, 6 Davis Drive, P.O. Box 12137, Research Triangle Park, NC 27709-2137, USA. Electronic address: hclewell@thehamner.org.</Affiliation>
      </Author>
      <Author>
        <Name>Kathy Plotzke</Name>
        <Affiliation>Dow Corning Corporation, Health and Environmental Sciences, 2200 West Salzburg Road, Auburn, MI 48611, USA. Electronic address: kathy.plotzke@dowcorning.com.</Affiliation>
      </Author>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, 6 Davis Drive, P.O. Box 12137, Research Triangle Park, NC 27709-2137, USA. Electronic address: mandersen@thehamner.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A weight of evidence assessment approach for adverse outcome pathways.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26724267</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.014</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Bradford Hill criteria</Keywords>
      <Keywords>Key event relationships</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Molecular initiating event</Keywords>
      <Keywords>Quantitative AOP</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zachary A. Collier</Name>
        <Affiliation>Environmental Laboratory, US Army Engineer Research &amp; Development Center, Vicksburg, MS, USA. Electronic address: zac4nf@virginia.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Kurt A. Gust</Name>
        <Affiliation>Environmental Laboratory, US Army Engineer Research &amp; Development Center, Vicksburg, MS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Benette Gonzalez-Morales</Name>
        <Affiliation>University of Puerto Rico at Mayagüez, Mayagüez, Puerto Rico.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Gong</Name>
        <Affiliation>Environmental Laboratory, US Army Engineer Research &amp; Development Center, Vicksburg, MS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mitchell S. Wilbanks</Name>
        <Affiliation>Environmental Laboratory, US Army Engineer Research &amp; Development Center, Vicksburg, MS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Igor Linkov</Name>
        <Affiliation>Environmental Laboratory, US Army Engineer Research &amp; Development Center, Vicksburg, MS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Edward J. Perkins</Name>
        <Affiliation>Environmental Laboratory, US Army Engineer Research &amp; Development Center, Vicksburg, MS, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A randomized clinical study to assess ingestion of dentifrice by children.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26721340</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.008</DOI>
    <KeywordList>
      <Keywords>Chloride-supplemented marker dentifrice</Keywords>
      <Keywords>Dentifrice usage and ingestion in children</Keywords>
      <Keywords>Flavored dentifrices</Keywords>
      <Keywords>Fluoride dentifrices</Keywords>
      <Keywords>Lithium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. A. Strittholt</Name>
        <Affiliation>Global Product Stewardship, Procter &amp; Gamble, 8700 Mason Montgomery Rd. Mason, OH, USA. Electronic address: strittholt.ca@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>D. A. McMillan</Name>
        <Affiliation>Global Product Stewardship, Procter &amp; Gamble, 8700 Mason Montgomery Rd. Mason, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>T. He</Name>
        <Affiliation>Global Clinical Trials, Procter &amp; Gamble, 8700 Mason Montgomery Rd. Mason, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. A. Baker</Name>
        <Affiliation>Quantitative Sciences, Biostatistics, Procter &amp; Gamble, 8700 Mason Montgomery Rd. Mason, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. L. Barker</Name>
        <Affiliation>Quantitative Sciences, Biostatistics, Procter &amp; Gamble, 8700 Mason Montgomery Rd. Mason, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer Safety (SCCS) - Opinion on the fragrance ingredients Tagetes minuta and Tagetes patula extracts and essential oils (phototoxicity only) in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26721339</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.006</DOI>
    <KeywordList>
      <Keywords>294-862-7</Keywords>
      <Keywords>91770-75-1</Keywords>
      <Keywords>CAS 91722-29-1</Keywords>
      <Keywords>EC 294-431-3</Keywords>
      <Keywords>Fragrance ingredients</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>Tagetes minuta</Keywords>
      <Keywords>Tagetes patula</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920, Luxembourg. Electronic address: sante-c2-scientific-committees@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Pieter Jan Coenraads</Name>
        <Affiliation>University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Trends in prescription of pregnancy-contraindicated drugs in Korea, 2007-2011.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26721338</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.011</DOI>
    <KeywordList>
      <Keywords>Drug utilization review</Keywords>
      <Keywords>Inappropriate drug use</Keywords>
      <Keywords>Pregnancy-contraindicated drugs</Keywords>
      <Keywords>Regulatory action</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Inmyung Song</Name>
        <Affiliation>Korea Health Industry Development Institute, Department of R&amp;D Planning, Chongju, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>So Hyun Choi</Name>
        <Affiliation>Seoul National University College of Medicine and Seoul National University Hospital, Medical Research Collaborating Center, Seoul, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ju Young Shin</Name>
        <Affiliation>McGill University, Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, Canada. Electronic address: ju-young.shin@mail.mcgill.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carcinogenicity and mode of action evaluation for alpha-hexachlorocyclohexane: Implications for human health risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26713892</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.007</DOI>
    <KeywordList>
      <Keywords>Alpha-hexachlorocyclohexane</Keywords>
      <Keywords>Dose-response</Keywords>
      <Keywords>Hexachlorocyclohexane</Keywords>
      <Keywords>Human relevance</Keywords>
      <Keywords>Liver carcinogenesis</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Nonlinear</Keywords>
      <Keywords>Reference dose</Keywords>
      <Keywords>Threshold</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ann E. Bradley</Name>
        <Affiliation>Integral Consulting Inc., USA. Electronic address: abradley@integral-corp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna L. Shoenfelt</Name>
        <Affiliation>Integral Consulting Inc., USA.</Affiliation>
      </Author>
      <Author>
        <Name>Judi L. Durda</Name>
        <Affiliation>Integral Consulting Inc., USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Review of genotoxicity and rat carcinogenicity investigations with astaxanthin.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26713891</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.009</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>Astaxanthin</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Clastogenicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Hepatocellular adenoma</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Micronucleus test</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James A. Edwards</Name>
        <Affiliation>NIC-RD/HN Toxicology and Kinetics, DSM Nutritional Products Ltd., Wurmisweg 576, 4303 Kaiseraugst, Switzerland. Electronic address: james-a.edwards@dsm.com.</Affiliation>
      </Author>
      <Author>
        <Name>Phillip Bellion</Name>
        <Affiliation>NIC-RD/HN Toxicology and Kinetics, DSM Nutritional Products Ltd., Wurmisweg 576, 4303 Kaiseraugst, Switzerland. Electronic address: phillip.bellion@dsm.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Beilstein</Name>
        <Affiliation>NIC-RD/HN Toxicology and Kinetics, DSM Nutritional Products Ltd., Wurmisweg 576, 4303 Kaiseraugst, Switzerland. Electronic address: paul.beilstein@dsm.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Rümbeli</Name>
        <Affiliation>NIC-RD/HN Toxicology and Kinetics, DSM Nutritional Products Ltd., Wurmisweg 576, 4303 Kaiseraugst, Switzerland. Electronic address: robert.ruembeli@dsm.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph Schierle</Name>
        <Affiliation>Analytical Research Centre, DSM Nutritional Products Ltd., Wurmisweg 576, 4303 Kaiseraugst, Switzerland. Electronic address: joseph.schierle@dsm.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of a statistics-based Ames mutagenicity QSAR model and interpretation of the results obtained.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26708083</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.006</DOI>
    <KeywordList>
      <Keywords>ICH M7</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Sarah nexus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chris Barber</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alex Cayley</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK. Electronic address: alex.cayley@lhasalimited.org.</Affiliation>
      </Author>
      <Author>
        <Name>Thierry Hanser</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alex Harding</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Crina Heghes</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan D. Vessey</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Stephane Werner</Name>
        <Affiliation>Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sandy K. Weiner</Name>
        <Affiliation>Janssen Research &amp; Development, 1400 McKean Road, Spring House, PA, 19477, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joerg Wichard</Name>
        <Affiliation>Bayer Pharma AG, Investigational Toxicology, Muellerstr. 178, S 116, D-13353, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda Giddings</Name>
        <Affiliation>GlaxoSmithKline Pre-Clinical Development, Park Road, Ware, Hertfordshire, SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH-4057, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Alexis Parenty</Name>
        <Affiliation>Novartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH-4057, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Brigo</Name>
        <Affiliation>Roche Pharmaceutical Research &amp; Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Peter Spirkl</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, R&amp;D DSAR/Preclinical Safety FF, Industriepark Hoechst, Bldg. H823, Room 116, D-65926, Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander Amberg</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, R&amp;D DSAR/Preclinical Safety FF, Industriepark Hoechst, Bldg. H823, Room 116, D-65926, Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ray Kemper</Name>
        <Affiliation>Vertex Pharmaceuticals, Discovery and Investigative Toxicology, 50 Northern Ave, Boston, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Nigel Greene</Name>
        <Affiliation>Compound Safety Prediction, Pfizer Global Research &amp; Development, 558 Eastern Point Road, Groton, CT, 06340, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neurobehavioral hazard identification and characterization for caffeine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26702789</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.002</DOI>
    <KeywordList>
      <Keywords>Anxiety</Keywords>
      <Keywords>Caffeine</Keywords>
      <Keywords>Risk-taking</Keywords>
      <Keywords>Sleep disturbance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Duncan Turnbull</Name>
        <Affiliation>Ramboll Environ US Corporation, 4350 North Fairfax Drive, Arlington, VA 22203, USA. Electronic address: dturnbull@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph V. Rodricks</Name>
        <Affiliation>Ramboll Environ US Corporation, 4350 North Fairfax Drive, Arlington, VA 22203, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory F. Mariano</Name>
        <Affiliation>Ramboll Environ US Corporation, 4350 North Fairfax Drive, Arlington, VA 22203, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: Safety and subjective effects.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26702788</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.004</DOI>
    <KeywordList>
      <Keywords>Adverse events</Keywords>
      <Keywords>Cigarette</Keywords>
      <Keywords>Clinical study</Keywords>
      <Keywords>Electronic cigarette</Keywords>
      <Keywords>Electronic vapour product</Keywords>
      <Keywords>Nicotine inhalator</Keywords>
      <Keywords>Smoking urges</Keywords>
      <Keywords>Withdrawal symptoms</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tanvir Walele</Name>
        <Affiliation>Fontem Ventures, Barbara Strozzilaan 101, 1083 HN Amsterdam, Netherlands. Electronic address: tanvir.walele@fontemventures.com.</Affiliation>
      </Author>
      <Author>
        <Name>Girish Sharma</Name>
        <Affiliation>Simbec Research, Merthyr Tydfil, CF48 4DR, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca Savioz</Name>
        <Affiliation>Clinopsis S.A., Jardins 6, Concise 1426, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Martin</Name>
        <Affiliation>Clinopsis S.A., Jardins 6, Concise 1426, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Josie Williams</Name>
        <Affiliation>Imperial Tobacco, Product Science, 121 Winterstoke Road, Bristol, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A: Pharmacokinetics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26696273</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.003</DOI>
    <KeywordList>
      <Keywords>Cigarette</Keywords>
      <Keywords>Clinical study</Keywords>
      <Keywords>Electronic cigarette</Keywords>
      <Keywords>Electronic vapour product</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Nicotine inhalator</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tanvir Walele</Name>
        <Affiliation>Fontem Ventures, Barbara Strozzilaan 101, 1083 HN Amsterdam, Netherlands. Electronic address: tanvir.walele@fontemventures.com.</Affiliation>
      </Author>
      <Author>
        <Name>Girish Sharma</Name>
        <Affiliation>Simbec Research, Merthyr Tydfil CF48 4DR, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca Savioz</Name>
        <Affiliation>Clinopsis S.A., Jardins 6, 1426 Concise, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Martin</Name>
        <Affiliation>Clinopsis S.A., Jardins 6, 1426 Concise, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Josie Williams</Name>
        <Affiliation>Imperial Tobacco, Product Science, 121 Winterstoke Road, Bristol, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26687418</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.020</DOI>
    <KeywordList>
      <Keywords>Amorphous silica nanomaterials</Keywords>
      <Keywords>Apical toxic effects</Keywords>
      <Keywords>Biopersistence and biodistribution</Keywords>
      <Keywords>Carbonaceous nanomaterials</Keywords>
      <Keywords>Cellular effects</Keywords>
      <Keywords>Grouping</Keywords>
      <Keywords>Intrinsic material and system-dependent properties</Keywords>
      <Keywords>Metal oxide and metal sulphate nanomaterials</Keywords>
      <Keywords>Organic pigments</Keywords>
      <Keywords>Read-across</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Josje H. E. Arts</Name>
        <Affiliation>AkzoNobel NV, Arnhem, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Muhammad Adeel Irfan</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Athena M. Keene</Name>
        <Affiliation>Afton Chemical, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Reinhard Kreiling</Name>
        <Affiliation>Clariant Produkte GmbH, Sulzbach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Delina Lyon</Name>
        <Affiliation>Shell Health, Shell Oil Company, Houston TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Monika Maier</Name>
        <Affiliation>Evonik Resource Efficiency GmbH, Hanau, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Michel</Name>
        <Affiliation>Henkel AG &amp; Co. KGaA, Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Neubauer</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Petry</Name>
        <Affiliation>Toxminds BVBA, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Neubiberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>David Warheit</Name>
        <Affiliation>The Chemours Company, Wilmington DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Wiench</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Wendel Wohlleben</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany. Electronic address: robert.landsiedel@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Windows of sensitivity to toxic chemicals in the motor effects development.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26686904</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.018</DOI>
    <KeywordList>
      <Keywords>Chemical exposures</Keywords>
      <Keywords>Laboratory animals</Keywords>
      <Keywords>Motor development</Keywords>
      <Keywords>Windows of sensitivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susan Z. Ingber</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hana R. Pohl</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta, GA, USA. Electronic address: hpohl@cdc.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dietary administration of diquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26683030</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.12.001</DOI>
    <KeywordList>
      <Keywords>C57BL/6J mice</Keywords>
      <Keywords>Diquat</Keywords>
      <Keywords>Dopamine</Keywords>
      <Keywords>MPTP</Keywords>
      <Keywords>Substantia nigra</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniel J. Minnema</Name>
        <Affiliation>Syngenta Crop Protection, LLC, P.O. Box 18300, Greensboro, NC, 27419-8300, USA. Electronic address: daniel.minnema@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kim Z. Travis</Name>
        <Affiliation>Syngenta Limited, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK. Electronic address: kim.travis@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Charles B. Breckenridge</Name>
        <Affiliation>Syngenta Crop Protection, LLC, P.O. Box 18300, Greensboro, NC, 27419-8300, USA. Electronic address: charles.breckenridge@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nicholas C. Sturgess</Name>
        <Affiliation>Syngenta Limited, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK. Electronic address: nick.sturgess@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Butt</Name>
        <Affiliation>Tox Path Specialists, LLC, 8420 Gas House Pike, Frederick, MD, 21701-2607, USA. Electronic address: mbutt@toxpath.net.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey C. Wolf</Name>
        <Affiliation>Experimental Pathology Laboratories, Inc., 45600 Terminal Drive, Sterling, VA, 20166, USA. Electronic address: jwolf@epl-Inc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Zadory</Name>
        <Affiliation>Experimental Pathology Laboratories, Inc., 45600 Terminal Drive, Sterling, VA, 20166, USA. Electronic address: dzadory@epl-Inc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mark T. Herberth</Name>
        <Affiliation>WIL Research, Ashland, OH, 44805, USA. Electronic address: mark.herberth@wilresearch.com.</Affiliation>
      </Author>
      <Author>
        <Name>Scott L. Watson</Name>
        <Affiliation>RTI International, 3040 Cornwallis Road, Research Triangle Park, NC, 27709-2194, USA. Electronic address: slwatson@rti.org.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew R. Cook</Name>
        <Affiliation>Syngenta Limited, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK. Electronic address: andy.cook@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Philip A. Botham</Name>
        <Affiliation>Syngenta Limited, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK. Electronic address: phil.botham@syngenta.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer Safety (SCCS) - Revision of the opinion on the safety of the use of Silica, Hydrated Silica, and Silica Surface Modified with Alkyl Silylates (nano form) in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26654931</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.005</DOI>
    <KeywordList>
      <Keywords>CAS 7631-86-9 and 112926-00-8, 7631-86-9 and 112945-52-5, 68611-44-9 and 68909-20-6, 7631-86-9 and 112926-00-8</Keywords>
      <Keywords>EC: 231-545-4, 271-893-4, and 272-697-1, 231-545-4</Keywords>
      <Keywords>Hydrated Silica, and Silica Surface Modified with Alkyl Silylates (nano form)</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>Silica</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> Sccs</Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920 Luxembourg, Luxembourg. Electronic address: SANTE-C2-SCCS@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>P. H. M. Hoet</Name>
        <Affiliation>Department of Public Health K.U. Leuven, Faculty of Medicine, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An integrated exposure assessment of phthalates for the general population in China based on both exposure scenario and biomonitoring estimation approaches.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26654930</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.019</DOI>
    <KeywordList>
      <Keywords>Biomonitoring estimation approach</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Exposure scenario approach</Keywords>
      <Keywords>Phthalate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Cao</Name>
        <Affiliation>State Key Joint Laboratory of Environmental Simulation and Pollution Control, College of Environmental Sciences and Engineering, Peking University, Beijing, 100871, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Liu</Name>
        <Affiliation>State Key Joint Laboratory of Environmental Simulation and Pollution Control, College of Environmental Sciences and Engineering, Peking University, Beijing, 100871, China. Electronic address: jgliu@pku.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Liu</Name>
        <Affiliation>Food Science Department, College of Applied Arts and Sciences of Beijing Union University, Beijing, 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Wang</Name>
        <Affiliation>State Key Joint Laboratory of Environmental Simulation and Pollution Control, College of Environmental Sciences and Engineering, Peking University, Beijing, 100871, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuewen Hao</Name>
        <Affiliation>State Key Joint Laboratory of Environmental Simulation and Pollution Control, College of Environmental Sciences and Engineering, Peking University, Beijing, 100871, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer safety (SCCS)--Opinion on the safety of the use of α-arbutin in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26646661</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.008</DOI>
    <KeywordList>
      <Keywords>CAS 84380-01-8</Keywords>
      <Keywords>EC 440-470-8</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>α-Arbutin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> Sccs</Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920, Luxembourg, Luxembourg. Electronic address: SANTE-C2-SCCS@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Gisela H. Degen</Name>
        <Affiliation>Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on the safety of the use of deoxyarbutin in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26646660</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.007</DOI>
    <KeywordList>
      <Keywords>CAS 53936-56-4</Keywords>
      <Keywords>Deoxyarbutin</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>Tetrahydropyranyloxy phenol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> Sccs</Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920, Luxembourg, Luxembourg. Electronic address: SANTE-C2-SCCS@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Gisela H. Degen</Name>
        <Affiliation>Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Multiple exposures to indoor contaminants: Derivation of benchmark doses and relative potency factors based on male reprotoxic effects.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26644063</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.017</DOI>
    <KeywordList>
      <Keywords>Benchmark doses</Keywords>
      <Keywords>Cumulative risk assessment</Keywords>
      <Keywords>Mixture</Keywords>
      <Keywords>Reproduction</Keywords>
      <Keywords>Semi-volatile organic compounds</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>K. Fournier</Name>
        <Affiliation>EHESP School of Public Health, Sorbonne Paris Cité, Avenue du Professeur Léon Bernard, 35043 Rennes Cedex, France; INSERM UMR1085 IRSET (Research Institute in Environmental and Occupational Health), Rennes, France. Electronic address: kevin.fournier@ehesp.fr.</Affiliation>
      </Author>
      <Author>
        <Name>C. Tebby</Name>
        <Affiliation>INERIS, Unité Modèles pour l'Ecotoxicologie et la Toxicologie (METO), Verneuil-en-Halatte, France. Electronic address: cleo.tebby@ineris.fr.</Affiliation>
      </Author>
      <Author>
        <Name>F. Zeman</Name>
        <Affiliation>INERIS, Unité Modèles pour l'Ecotoxicologie et la Toxicologie (METO), Verneuil-en-Halatte, France. Electronic address: florence.zeman@ineris.fr.</Affiliation>
      </Author>
      <Author>
        <Name>P. Glorennec</Name>
        <Affiliation>EHESP School of Public Health, Sorbonne Paris Cité, Avenue du Professeur Léon Bernard, 35043 Rennes Cedex, France; INSERM UMR1085 IRSET (Research Institute in Environmental and Occupational Health), Rennes, France. Electronic address: Philippe.glorennec@ehesp.fr.</Affiliation>
      </Author>
      <Author>
        <Name>D. Zmirou-Navier</Name>
        <Affiliation>EHESP School of Public Health, Sorbonne Paris Cité, Avenue du Professeur Léon Bernard, 35043 Rennes Cedex, France; INSERM UMR1085 IRSET (Research Institute in Environmental and Occupational Health), Rennes, France; Lorraine University Medical School, Nancy, France. Electronic address: denis.zmirou@ehesp.fr.</Affiliation>
      </Author>
      <Author>
        <Name>N. Bonvallot</Name>
        <Affiliation>EHESP School of Public Health, Sorbonne Paris Cité, Avenue du Professeur Léon Bernard, 35043 Rennes Cedex, France; INSERM UMR1085 IRSET (Research Institute in Environmental and Occupational Health), Rennes, France. Electronic address: nathalie.bonvallot@ehesp.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Time trends in never smokers in the relative frequency of the different histological types of lung cancer, in particular adenocarcinoma.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26640118</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.016</DOI>
    <KeywordList>
      <Keywords>Histological type</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Smoking</Keywords>
      <Keywords>Time trends</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P N Lee Statistics and Computing Ltd, Sutton, Surrey, United Kingdom. Electronic address: PeterLee@pnlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara A. Forey</Name>
        <Affiliation>P N Lee Statistics and Computing Ltd, Sutton, Surrey, United Kingdom. Electronic address: BarbaraForey@pnlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Katharine J. Coombs</Name>
        <Affiliation>P N Lee Statistics and Computing Ltd, Sutton, Surrey, United Kingdom. Electronic address: Katharine@thecoombses.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Peter J. Lipowicz</Name>
        <Affiliation>Altria Client Services, Richmond, VA, USA. Electronic address: Peter.J.Lipowicz@altria.com.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Appleton</Name>
        <Affiliation>Altria Client Services, Richmond, VA, USA. Electronic address: Scott.Appleton@altria.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety study of Ciprofloxacin in newborn mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26627140</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.002</DOI>
    <KeywordList>
      <Keywords>Arthrotoxicity</Keywords>
      <Keywords>Fluoroquinolone</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Neonate</Keywords>
      <Keywords>Nephrotoxicity</Keywords>
      <Keywords>Neurodevelopment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas Bourgeois</Name>
        <Affiliation>Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Lise Delezoide</Name>
        <Affiliation>Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France; Department of Developmental Biology, Robert Debré Hospital, APHP, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhao</Name>
        <Affiliation>Inserm, Clinical Investigation Center CIC 1426, Robert Debré Hospital, APHP, Paris, France; Department of Pediatric Pharmacology and Pharmacogenetics, Robert Debré Hospital, APHP, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Fabien Guimiot</Name>
        <Affiliation>Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France; Department of Developmental Biology, Robert Debré Hospital, APHP, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Homa Adle-Biassette</Name>
        <Affiliation>Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France; Department of Pathology, Lariboisière Hospital, APHP, 75010, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Estelle Durand</Name>
        <Affiliation>Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France; PhenoPups SAS, Evry, France.</Affiliation>
      </Author>
      <Author>
        <Name>Maud Ringot</Name>
        <Affiliation>Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Gallego</Name>
        <Affiliation>Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Storme</Name>
        <Affiliation>Department of Pharmacy, Robert Debré Hospital, APHP, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Chantal Le Guellec</Name>
        <Affiliation>EA4245, Faculté de Médecine, Université François Rabelais, Tours, France.</Affiliation>
      </Author>
      <Author>
        <Name>Behrouz Kassaï</Name>
        <Affiliation>Department of Clinical Pharmacology and Clinical Trials, Louis Pradel Hospital, EPICIME, Lyon, France; CNRS, UMR, 5558, Lyon, France; Lyon-1 University, Lyon, France; Inserm, Clinical Investigation Center CIC1407, Louis Pradel Hospital, Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>Mark A. Turner</Name>
        <Affiliation>Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Evelyne Jacqz-Aigrain</Name>
        <Affiliation>Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France; Inserm, Clinical Investigation Center CIC 1426, Robert Debré Hospital, APHP, Paris, France; Department of Pediatric Pharmacology and Pharmacogenetics, Robert Debré Hospital, APHP, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Boris Matrot</Name>
        <Affiliation>Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France. Electronic address: boris.matrot@inserm.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Transdermal nicotine absorption handling e-cigarette refill liquids.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26619784</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.014</DOI>
    <KeywordList>
      <Keywords>Percutaneous absorption</Keywords>
      <Keywords>Skin contamination</Keywords>
      <Keywords>e-cigarette</Keywords>
      <Keywords>e-liquid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Giovanni Maina</Name>
        <Affiliation>Department of Clinical and Biological Science, University of Torino, Via Zuretti 29, 10126 Torino, Italy. Electronic address: giovanni.maina@unito.it.</Affiliation>
      </Author>
      <Author>
        <Name>Carlotta Castagnoli</Name>
        <Affiliation>City of Health and Science Hospital, Corso Bramante 80, 10126 Torino, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Valter Passini</Name>
        <Affiliation>City of Health and Science Hospital, Corso Bramante 80, 10126 Torino, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Matteo Crosera</Name>
        <Affiliation>Department of Chemical and Pharmaceutical Sciences, University of Trieste, Via Giorgeri 1, 34127 Trieste, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Gianpiero Adami</Name>
        <Affiliation>Department of Chemical and Pharmaceutical Sciences, University of Trieste, Via Giorgeri 1, 34127 Trieste, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Marcella Mauro</Name>
        <Affiliation>Clinical Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Via della Pietà 19, 34129 Trieste, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Francesca Larese Filon</Name>
        <Affiliation>Clinical Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Via della Pietà 19, 34129 Trieste, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A review of toxicity studies of single-walled carbon nanotubes in laboratory animals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26619783</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.015</DOI>
    <KeywordList>
      <Keywords>Carbon nanotubes</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Intratracheal instillation</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Nanotoxicology</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Pharyngeal aspiration</Keywords>
      <Keywords>Pulmonary toxicology</Keywords>
      <Keywords>Single-walled carbon nanotubes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Makoto Ema</Name>
        <Affiliation>Research Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan. Electronic address: ema-makoto@aist.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Masashi Gamo</Name>
        <Affiliation>Research Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazumasa Honda</Name>
        <Affiliation>Research Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Embryo-fetal development toxicity of honokiol microemulsion intravenously administered to pregnant rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26619782</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.012</DOI>
    <KeywordList>
      <Keywords>Cerebral ischemia protection</Keywords>
      <Keywords>Embryo-fetal development toxicity</Keywords>
      <Keywords>Honokiol microemulsion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qianqian Zhang</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangfeng Ye</Name>
        <Affiliation>Beijing Union-Genious Pharmaceutical Technology Ltd., Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingzhi Wang</Name>
        <Affiliation>Beijing Union-Genious Pharmaceutical Technology Ltd., Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bangjie Peng</Name>
        <Affiliation>Beijing Union-Genious Pharmaceutical Technology Ltd., Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingxue Zhang</Name>
        <Affiliation>Beijing Union-Genious Pharmaceutical Technology Ltd., Beijing, 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Bao</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanfang Li</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinfeng Wei</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Aiping Wang</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongtao Jin</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, 100050, China. Electronic address: jinhongtao@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shizhong Chen</Name>
        <Affiliation>School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. Electronic address: chenshizhong66@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Skin sensitization quantitative risk assessment: A review of underlying assumptions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26619781</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.013</DOI>
    <KeywordList>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
      <Keywords>Safety factors</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, Bedfordshire, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bob Safford</Name>
        <Affiliation>B-Safe Toxicology Consulting, Rushden, Northamptonshire, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of potential impurities and degradation products in electronic cigarette formulations and aerosols.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26617410</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.009</DOI>
    <KeywordList>
      <Keywords>Aerosol</Keywords>
      <Keywords>E-cigarettes</Keywords>
      <Keywords>E-vapor</Keywords>
      <Keywords>Formulation</Keywords>
      <Keywords>Harmful and potentially harmful constituents (HPHC)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jason W. Flora</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, United States. Electronic address: Jason.W.Flora@altria.com.</Affiliation>
      </Author>
      <Author>
        <Name>Naren Meruva</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Chorng B. Huang</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Celeste T. Wilkinson</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Regina Ballentine</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Donna C. Smith</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael S. Werley</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Willie J. McKinney</Name>
        <Affiliation>Altria Client Services LLC, 601 East Jackson Street, Richmond, VA 23219, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the safety of primary metabolites of cyadox: Acute and sub-chronic toxicology studies and genotoxicity assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26617409</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.011</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Cyadox</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Metabolites</Keywords>
      <Keywords>Quinoxaline</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qin Huang</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Awais Ihsan</Name>
        <Affiliation>Department of Biosciences, COMSATS Institute of Information Technology, Sahiwal, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Pu Guo</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xun Luo</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guyue Cheng</Name>
        <Affiliation>Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haihong Hao</Name>
        <Affiliation>Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongmei Chen</Name>
        <Affiliation>Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Farrukh Jamil</Name>
        <Affiliation>Department of Biosciences, COMSATS Institute of Information Technology, Sahiwal, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Yanfei Tao</Name>
        <Affiliation>Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Wang</Name>
        <Affiliation>Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China. Electronic address: wangxu@mail.hzau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zonghui Yuan</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei 430070, China; MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China. Electronic address: yuan5802@mail.hzau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vivo micronucleus studies with 6 titanium dioxide materials (3 pigment-grade &amp; 3 nanoscale) in orally-exposed rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26617408</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.003</DOI>
    <KeywordList>
      <Keywords>In vivo genotoxicity</Keywords>
      <Keywords>In vivo micronucleus toxicity</Keywords>
      <Keywords>Nanoparticle</Keywords>
      <Keywords>Nanoscale TiO(2) particles</Keywords>
      <Keywords>OECD 474 test guidelines</Keywords>
      <Keywords>Particle characterization</Keywords>
      <Keywords>Particle size distribution</Keywords>
      <Keywords>Particles</Keywords>
      <Keywords>Pigment-grade TiO(2) particles</Keywords>
      <Keywords>Titanium dioxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>E. M. Donner</Name>
        <Affiliation>DuPont Haskell, Newark, DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. Myhre</Name>
        <Affiliation>DuPont Haskell, Newark, DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. C. Brown</Name>
        <Affiliation>Chemours Company, Wilmington, DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. Boatman</Name>
        <Affiliation>Boatman Toxicology Consulting LLC, Rochester, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. B. Warheit</Name>
        <Affiliation>Chemours Company, Wilmington, DE, USA. Electronic address: WARHEIT@chemours.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of genotoxic and apoptotic potential of Hypericum adenotrichum Spach. in vitro.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26617407</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.010</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Hypericum adenotrichum</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mehmet Sarimahmut</Name>
        <Affiliation>Uludag University, Faculty of Science and Arts, Department of Biology, 16059 Bursa, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Necmiye Balikci</Name>
        <Affiliation>Uludag University, Faculty of Science and Arts, Department of Biology, 16059 Bursa, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Serap Celikler</Name>
        <Affiliation>Uludag University, Faculty of Science and Arts, Department of Biology, 16059 Bursa, Turkey. Electronic address: scelikler@uludag.edu.tr.</Affiliation>
      </Author>
      <Author>
        <Name>Ferda Ari</Name>
        <Affiliation>Uludag University, Faculty of Science and Arts, Department of Biology, 16059 Bursa, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Engin Ulukaya</Name>
        <Affiliation>Uludag University, Faculty of Medicine, Department of Medical Biochemistry, 16059 Bursa, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Gurcan Guleryuz</Name>
        <Affiliation>Uludag University, Faculty of Science and Arts, Department of Biology, 16059 Bursa, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Mustafa Zafer Ozel</Name>
        <Affiliation>University of York, Department of Chemistry, Heslington, York YO10 5DD, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Review of achievements of the OECD Working Party on Manufactured Nanomaterials' Testing and Assessment Programme. From exploratory testing to test guidelines.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26603783</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.11.004</DOI>
    <KeywordList>
      <Keywords>Manufactured nanomaterials</Keywords>
      <Keywords>OECD WPMN testing programme</Keywords>
      <Keywords>OECD test guidelines</Keywords>
      <Keywords>Regulatory testing</Keywords>
      <Keywords>Working Party on Manufactured Nanomaterials</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kirsten Rasmussen</Name>
        <Affiliation>European Commission, Joint Research Centre, Institute for Health and Consumer Protection, via E. Fermi 2749, 21027, Ispra, VA, Italy. Electronic address: kirsten.rasmussen@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Mar González</Name>
        <Affiliation>Organisation for Economic Co-operation and Development (OECD), Environment Directorate, 75775, Paris Cedex 16, France.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Kearns</Name>
        <Affiliation>Organisation for Economic Co-operation and Development (OECD), Environment Directorate, 75775, Paris Cedex 16, France.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Riego Sintes</Name>
        <Affiliation>European Commission, Joint Research Centre, Institute for Health and Consumer Protection, via E. Fermi 2749, 21027, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>François Rossi</Name>
        <Affiliation>European Commission, Joint Research Centre, Institute for Health and Consumer Protection, via E. Fermi 2749, 21027, Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Phil Sayre</Name>
        <Affiliation>U.S. Environmental Protection Agency, formerly with Office of Pollution Prevention and Toxics, Washington DC, 20460, USA. Electronic address: phil.sayre@verizon.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A global human health risk assessment for Decamethylcyclopentasiloxane (D5).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26577197</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.10.023</DOI>
    <KeywordList>
      <Keywords>D(5)</Keywords>
      <Keywords>Decamethylcyclopentasiloxane</Keywords>
      <Keywords>Global risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Allison Franzen</Name>
        <Affiliation>Ramboll Environ US Corporation, 1900 N. 18th St. Suite 804, Monroe, LA 71201, United States. Electronic address: afranzen@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cynthia Van Landingham</Name>
        <Affiliation>Ramboll Environ US Corporation, 1900 N. 18th St. Suite 804, Monroe, LA 71201, United States. Electronic address: cvanlandingham@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tracy Greene</Name>
        <Affiliation>Ramboll Environ US Corporation, 1900 N. 18th St. Suite 804, Monroe, LA 71201, United States. Electronic address: tgreen@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kathy Plotzke</Name>
        <Affiliation>Dow Corning Corporation Health and Environmental Sciences, 22000 West Salzburg Road, Auburn, MI 48611, United States. Electronic address: kathy.plotzke@dowcorning.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robinan Gentry</Name>
        <Affiliation>Ramboll Environ US Corporation, 1900 N. 18th St. Suite 804, Monroe, LA 71201, United States. Electronic address: rgentry@environcorp.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Interpreting biomonitoring data for 2,4-dichlorophenoxyacetic acid: Update to Biomonitoring Equivalents and population biomonitoring data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26577196</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.11.001</DOI>
    <KeywordList>
      <Keywords>2,4-Dichlorophenoxyacetic acid</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>L. L. Aylward</Name>
        <Affiliation>Summit Toxicology, LLP, Falls Church, VA, USA. Electronic address: laylward@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>S. M. Hays</Name>
        <Affiliation>Summit Toxicology, LLP, Lyons, CO, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comments on the opinions published by Bergman et al. (2015) on Critical Comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals (Lamb et al., 2014).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26550933</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.029</DOI>
    <KeywordList>
      <Keywords>Endocrine disrupting chemicals (EDC)</Keywords>
      <Keywords>Endocrine mode-of-action</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Risk characterization</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James C. Lamb</Name>
        <Affiliation>Exponent, 1800 Diagonal Road, Suite #500, Alexandria, VA 22314, USA. Electronic address: jlamb@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paolo Boffetta</Name>
        <Affiliation>The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, 17 East 102 Street Floor West Tower, 5th Floor Room 5-142, New York, NY 10029, USA. Electronic address: paolo.boffetta@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Warren G. Foster</Name>
        <Affiliation>Department of Obstetrics &amp; Gynecology, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada. Electronic address: foster@mcmaster.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Karyn L. Hentz</Name>
        <Affiliation>Exponent, 1800 Diagonal Road, Suite #500, Alexandria, VA 22314, USA. Electronic address: khentz@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lorenz R. Rhomberg</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA. Electronic address: lrhomberg@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Staveley</Name>
        <Affiliation>Exponent, 1800 Diagonal Road, Suite #500, Alexandria, VA 22314, USA. Electronic address: jstaveley@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gerard Swaen</Name>
        <Affiliation>Maastrich University, Netherlands. Electronic address: g.swaen@maastrichtuniversity.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Glen Van Der Kraak</Name>
        <Affiliation>Department of Integrative Biology, University of Guelph, Guelph ON N1G 2W1, Canada. Electronic address: gvanderk@uoguelph.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Amy L. Williams</Name>
        <Affiliation>Exponent, 1800 Diagonal Road, Suite #500, Alexandria, VA 22314, USA. Electronic address: awilliams@exponent.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of an inhalation unit risk factor for isoprene.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26545327</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.030</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Isoprene</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Tumorigenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joseph T. Haney</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), Toxicology Division, MC-168, P.O. Box 13087, Austin, TX 78711, United States. Electronic address: Joseph.Haney@tceq.texas.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Tracie Phillips</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), Toxicology Division, MC-168, P.O. Box 13087, Austin, TX 78711, United States. Electronic address: Tracie.Phillips@tceq.texas.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Robert L. Sielken</Name>
        <Affiliation>Sielken &amp; Associates Consulting, Inc., 3833 Texas Avenue, Bryan, TX 77802, United States. Electronic address: SielkenAssoc@aol.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ciriaco Valdez-Flores</Name>
        <Affiliation>Texas A&amp;M University, 4073 Emerging Technologies Building, 3131 TAMU, College Station, TX 77843, United States. Electronic address: Ciriacov@tamu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological analysis and anti-inflammatory effects of essential oil from Piper vicosanum leaves.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26545326</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.028</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Essential oil</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Piper vicosanum</Keywords>
      <Keywords>Piperaceae</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Débora Regina Hoff Brait</Name>
        <Affiliation>School of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Márcia Soares Mattos Vaz</Name>
        <Affiliation>School of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jucicléia da Silva Arrigo</Name>
        <Affiliation>School of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luciana Noia Borges de Carvalho</Name>
        <Affiliation>School of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Flávio Henrique Souza de Araújo</Name>
        <Affiliation>Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juliana Miron Vani</Name>
        <Affiliation>Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jonas da Silva Mota</Name>
        <Affiliation>Mato Grosso do Sul State University (UEMS), Dourados, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Andrea Lima Cardoso</Name>
        <Affiliation>Mato Grosso do Sul State University (UEMS), Dourados, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rodrigo Juliano Oliveira</Name>
        <Affiliation>Federal University of Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Fábio Juliano Negrão</Name>
        <Affiliation>School of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cândida Aparecida Leite Kassuya</Name>
        <Affiliation>School of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Arielle Cristina Arena</Name>
        <Affiliation>School of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil; Department of Morphology, Institute of Biosciences of Botucatu, UNESP - Univ. Estadual Paulista, Botucatu, SP, Brazil. Electronic address: ariellearena@ibb.unesp.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reconstructing exposures from biomarkers using exposure-pharmacokinetic modeling--A case study with carbaryl.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26545325</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.031</DOI>
    <KeywordList>
      <Keywords>Biomarker interpretation</Keywords>
      <Keywords>CARES</Keywords>
      <Keywords>Carbaryl</Keywords>
      <Keywords>Discretized Bayesian</Keywords>
      <Keywords>Exposure conversion factor</Keywords>
      <Keywords>Exposure reconstruction</Keywords>
      <Keywords>Markov Chain Monte Carlo</Keywords>
      <Keywords>Pharmacokinetic modeling</Keywords>
      <Keywords>Physiologically based pharmacokinetic model</Keywords>
      <Keywords>Population-based biomonitoring</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kathleen Brown</Name>
        <Affiliation>U.S. Environmental Protection Agency, National Exposure Research Laboratory, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Phillips</Name>
        <Affiliation>Minnesota Department of Health, St. Paul, MN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Grulke</Name>
        <Affiliation>Lockheed Martin, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Miyoung Yoon</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, Durham NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce Young</Name>
        <Affiliation>Bayer CropScience, Durham NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robin McDougall</Name>
        <Affiliation>Astra Zeneca, Boston MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeremy Leonard</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, Oak Ridge, TN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jingtao Lu</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, Oak Ridge, TN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William Lefew</Name>
        <Affiliation>Meemir Consulting, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Mei Tan</Name>
        <Affiliation>U.S. Environmental Protection Agency, National Exposure Research Laboratory, Durham, NC, USA. Electronic address: tan.cecilia@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mechanical-chemical analyses and sub-chronic systemic toxicity of chemical treated organic bovine bone.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26529390</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.027</DOI>
    <KeywordList>
      <Keywords>Bending strength</Keywords>
      <Keywords>Bone graft</Keywords>
      <Keywords>Bovine bone</Keywords>
      <Keywords>Sub-chronic</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Xenograft</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kwang il Lee</Name>
        <Affiliation>The Institute of Biomaterial and Medical Engineering, Cellumed Co., Ltd., Seoul, Republic of Korea. Electronic address: jasonklee77@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jung soo Lee</Name>
        <Affiliation>The Institute of Biomaterial and Medical Engineering, Cellumed Co., Ltd., Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Keun soo Lee</Name>
        <Affiliation>The Institute of Biomaterial and Medical Engineering, Cellumed Co., Ltd., Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hong hee Jung</Name>
        <Affiliation>The Institute of Biomaterial and Medical Engineering, Cellumed Co., Ltd., Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Chan min Ahn</Name>
        <Affiliation>The Institute of Biomaterial and Medical Engineering, Cellumed Co., Ltd., Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young sik Kim</Name>
        <Affiliation>The Institute of Biomaterial and Medical Engineering, Cellumed Co., Ltd., Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young bock Shim</Name>
        <Affiliation>The Institute of Biomaterial and Medical Engineering, Cellumed Co., Ltd., Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ju woong Jang</Name>
        <Affiliation>The Institute of Biomaterial and Medical Engineering, Cellumed Co., Ltd., Seoul, Republic of Korea. Electronic address: orienta@empal.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure-response modeling of non-cancer effects in humans exposed to Libby Amphibole Asbestos; update.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26524929</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.019</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>DPT</Keywords>
      <Keywords>LAA</Keywords>
      <Keywords>LPT</Keywords>
      <Keywords>Libby amphibole</Keywords>
      <Keywords>Pleural thickening</Keywords>
      <Keywords>SIO</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Robert Benson</Name>
        <Affiliation>Environmental Protection Agency, 1595 Wynkoop St, Denver, CO, 80202, United States. Electronic address: Benson.Bob@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>David Berry</Name>
        <Affiliation>Environmental Protection Agency, 1595 Wynkoop St, Denver, CO, 80202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>James Lockey</Name>
        <Affiliation>University of Cincinnati, Department of Environmental Health, 160 Panzeca Way, Cincinnati, OH, 45267, United States; University of Cincinnati, Department of Internal Medicine, Pulmonary Division, 160 Panzeca Way, Cincinnati, OH 45267, United States.</Affiliation>
      </Author>
      <Author>
        <Name>William Brattin</Name>
        <Affiliation>SRC Inc., Suite 1380, 999 18th St, Denver, CO, 80202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy Hilbert</Name>
        <Affiliation>University of Cincinnati, Department of Environmental Health, 160 Panzeca Way, Cincinnati, OH, 45267, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Grace LeMasters</Name>
        <Affiliation>University of Cincinnati, Department of Environmental Health, 160 Panzeca Way, Cincinnati, OH, 45267, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dissipation kinetics and residue of LH-2010A in cucumber and soil under greenhouse condition.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26522813</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.026</DOI>
    <KeywordList>
      <Keywords>Cucumber</Keywords>
      <Keywords>Dissipation</Keywords>
      <Keywords>Fungicide</Keywords>
      <Keywords>LH-2010A</Keywords>
      <Keywords>QuEChERS</Keywords>
      <Keywords>Residue</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ruijuan Li</Name>
        <Affiliation>Institute of Plant Protection, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tongjin Liu</Name>
        <Affiliation>Institute of Plant Protection, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guochun Song</Name>
        <Affiliation>Institute of Plant Protection, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rumei Li</Name>
        <Affiliation>Institute of Plant Protection, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianlei Yu</Name>
        <Affiliation>Institute of Plant Protection, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China. Electronic address: jlyu2010@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and sub-chronic (28 days) oral toxicity evaluation of tincture Baccharis trimera (Less) Backer in male and female rodent animals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26522812</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.10.024</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Baccharis trimera</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
      <Keywords>Tincture</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andreia R. H. da Silva</Name>
        <Affiliation>Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil. Electronic address: andreiaregina_silva@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Fernanda Z. Reginato</Name>
        <Affiliation>Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Camille G. Guex</Name>
        <Affiliation>Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Kássia C. Figueredo</Name>
        <Affiliation>Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Isabel C. da C Araldi</Name>
        <Affiliation>Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Robson B. de Freitas</Name>
        <Affiliation>Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Aline A. Boligon</Name>
        <Affiliation>Departamento de Farmácia Industrial, Laboratório de Pesquisa Fitoquímica, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Margareth L. Athayde</Name>
        <Affiliation>Departamento de Farmácia Industrial, Laboratório de Pesquisa Fitoquímica, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cinthia Melazzo de Andrade Mazzanti</Name>
        <Affiliation>Departamento de Clínica de Pequenos Animais, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gilberti H. Hübscher</Name>
        <Affiliation>Departamento de Tecnologia e Ciência dos Alimentos, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Liliane de F Bauermann</Name>
        <Affiliation>Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Orally administered glycidol and its fatty acid esters as well as 3-MCPD fatty acid esters are metabolized to 3-MCPD in the F344 rat.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26520183</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.020</DOI>
    <KeywordList>
      <Keywords>3-MCPD</Keywords>
      <Keywords>Fatty acid esters</Keywords>
      <Keywords>Glycidol</Keywords>
      <Keywords>Linoleate</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Palmitate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Saeko Onami</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo, 158-8501, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1, Yanagido, Gifu, 501-1193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Young Man Cho</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo, 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeshi Toyoda</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo, 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jun ichi Akagi</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo, 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Satoshi Fujiwara</Name>
        <Affiliation>Division of Pharmaceutical and Life Sciences, Shimadzu Techno-Research Inc., 1, Nishinokyo-Shimoaicho, Nakagyo-ku, Kyoto, 604-8436, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ryosuke Ochiai</Name>
        <Affiliation>Division of Pharmaceutical and Life Sciences, Shimadzu Techno-Research Inc., 1, Nishinokyo-Shimoaicho, Nakagyo-ku, Kyoto, 604-8436, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazushige Tsujino</Name>
        <Affiliation>Division of Pharmaceutical and Life Sciences, Shimadzu Techno-Research Inc., 1, Nishinokyo-Shimoaicho, Nakagyo-ku, Kyoto, 604-8436, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akiyoshi Nishikawa</Name>
        <Affiliation>Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1, Yanagido, Gifu, 501-1193, Japan; Biological Safety Research Center, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo, 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kumiko Ogawa</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo, 158-8501, Japan. Electronic address: ogawa93@nihs.go.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human health risk characterization of petroleum coke calcining facility emissions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26520182</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.025</DOI>
    <KeywordList>
      <Keywords>Black carbon</Keywords>
      <Keywords>Calcined coke</Keywords>
      <Keywords>Calciner facility</Keywords>
      <Keywords>Particulate matter</Keywords>
      <Keywords>Petrochemical industry</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Davinderjit Singh</Name>
        <Affiliation>Center for Environmental and Occupational Risk Analysis and Management, University of South Florida, Tampa, FL, 33612, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Giffe T. Johnson</Name>
        <Affiliation>Center for Environmental and Occupational Risk Analysis and Management, University of South Florida, Tampa, FL, 33612, USA. Electronic address: gjohnson@health.usf.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond D. Harbison</Name>
        <Affiliation>Center for Environmental and Occupational Risk Analysis and Management, University of South Florida, Tampa, FL, 33612, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Analysis of Moms Across America report suggesting bioaccumulation of glyphosate in U.S. mother's breast milk: Implausibility based on inconsistency with available body of glyphosate animal toxicokinetic, human biomonitoring, and physico-chemical data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26520181</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.022</DOI>
    <KeywordList>
      <Keywords>Bioaccumulation</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Breast milk</Keywords>
      <Keywords>Glyphosate</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James S. Bus</Name>
        <Affiliation>Exponent, Inc., 1800 Diagonal Road, Suite 500, Alexandria, VA, 22314, USA. Electronic address: jbus@exponent.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Target organ profiles in toxicity studies supporting human dosing: Does severity progress with longer duration of exposure?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26517939</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.021</DOI>
    <KeywordList>
      <Keywords>Dose duration</Keywords>
      <Keywords>Nonclinical studies</Keywords>
      <Keywords>Target organs</Keywords>
      <Keywords>Toxicities</Keywords>
      <Keywords>Toxicity profile</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ruth Roberts</Name>
        <Affiliation>ApconiX Ltd, UK. Electronic address: ruth.roberts@apconix.com.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Callander</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Duffy</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Matt Jacobsen</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Knight</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Boobis</Name>
        <Affiliation>Imperial College London, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A global initiative to refine acute inhalation studies through the use of 'evident toxicity' as an endpoint: Towards adoption of the fixed concentration procedure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26505531</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.018</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Acute inhalation studies</Keywords>
      <Keywords>Evident toxicity</Keywords>
      <Keywords>Fixed concentration procedure (FCP)</Keywords>
      <Keywords>Refinement</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>TG4303</Keywords>
      <Keywords>TG433</Keywords>
      <Keywords>TG436</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fiona Sewell</Name>
        <Affiliation>NC3Rs, UK. Electronic address: fiona.sewell@nc3rs.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Ragan</Name>
        <Affiliation>Board Member, NC3Rs, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Tim Marczylo</Name>
        <Affiliation>Public Health England, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Anderson</Name>
        <Affiliation>Harlan Laboratories, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Braun</Name>
        <Affiliation>INERIS, France.</Affiliation>
      </Author>
      <Author>
        <Name>Warren Casey</Name>
        <Affiliation>NICEATM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ngaire Dennison</Name>
        <Affiliation>Home Office, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Griffiths</Name>
        <Affiliation>Harlan Laboratories, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Guest</Name>
        <Affiliation>Harlan Laboratories, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Tom Holmes</Name>
        <Affiliation>Exponent International Limited, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ton van Huygevoort</Name>
        <Affiliation>WIL Research, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Indans</Name>
        <Affiliation>Health and Safety Executive, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Terry Kenny</Name>
        <Affiliation>Huntingdon Life Sciences, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Hajime Kojima</Name>
        <Affiliation>JaCVAM (Japanese Center for the Validation of Alternative Methods), NIHS (National Institute of Health Sciences), Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kyuhong Lee</Name>
        <Affiliation>Korea Institute of Toxicology, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Pilar Prieto</Name>
        <Affiliation>EURL ECVAM, Systems Toxicology Unit, Institute for Health and Consumer Protection, European Commission, Joint Research Centre, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Smith</Name>
        <Affiliation>Charles River Laboratories, Edinburgh, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Smedley</Name>
        <Affiliation>Charles River Laboratories, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William S. Stokes</Name>
        <Affiliation>U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Animal Care, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Wnorowski</Name>
        <Affiliation>Product Safety Laboratories, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Graham Horgan</Name>
        <Affiliation>BioSS, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Recreational nitrous oxide use: Prevalence and risks.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26496821</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.017</DOI>
    <KeywordList>
      <Keywords>Anesthetic</Keywords>
      <Keywords>Bulbs</Keywords>
      <Keywords>Dependence</Keywords>
      <Keywords>Laughing gas</Keywords>
      <Keywords>Megaloblastoma</Keywords>
      <Keywords>Nitrous oxide</Keywords>
      <Keywords>Peripheral neuropathy</Keywords>
      <Keywords>Recreational use</Keywords>
      <Keywords>Whippits</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jan van Amsterdam</Name>
        <Affiliation>Department of Psychiatry, Academic Medical Center, University of Amsterdam, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands. Electronic address: jan.van.amsterdam@amc.uva.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Ton Nabben</Name>
        <Affiliation>Bonger Institute for Criminology, University of Amsterdam, P.O. Box 1030, 1000 BA Amsterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Wim van den Brink</Name>
        <Affiliation>Department of Psychiatry, Academic Medical Center, University of Amsterdam, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands; Amsterdam Institute for Addiction Research, Academic Medical Center, P.O. Box 75867, 1070 AW Amsterdam, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Drinking water toxicity study of the environmental contaminant--Bromate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26496820</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.015</DOI>
    <KeywordList>
      <Keywords>Bromate</Keywords>
      <Keywords>Contamination</Keywords>
      <Keywords>Drinking water</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liu Dongmei</Name>
        <Affiliation>State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin 150090, PR China. Electronic address: mei18@hit.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Wang Zhiwei</Name>
        <Affiliation>State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin 150090, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhu Qi</Name>
        <Affiliation>Key Laboratory of Chemical Engineering Process &amp; Technology for High-efficiency Conversion, School of Chemistry and Material Sciences, Heilongjiang University, Harbin 150080, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Cui Fuyi</Name>
        <Affiliation>State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin 150090, PR China. Electronic address: hit_cuifuyi@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shan Yujuan</Name>
        <Affiliation>School of Food Science and Engineering, Harbin Institute of Technology, Harbin 150090, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liu Xiaodong</Name>
        <Affiliation>Shenzhen Water (Group) Co., Ltd., Shenzhen 518031, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of traces of nickel and chrome in cosmetics: The case of Dead Sea mud.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26496819</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.016</DOI>
    <KeywordList>
      <Keywords>1223/2009/EC</Keywords>
      <Keywords>CMR impurity</Keywords>
      <Keywords>Chrome</Keywords>
      <Keywords>Cosmetic regulation</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Dead Sea mud</Keywords>
      <Keywords>Metal traces</Keywords>
      <Keywords>Nickel</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Safety evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ze'evi Ma'or</Name>
        <Affiliation>AHAVA - Dead Sea Laboratories, Airport City Lod, 7015002, Israel; Dead Sea and Arava Science Center, The Laboratory for Skin Biochemistry and Biotechnology, Ein-Gedi 8698000, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Ludwik Halicz</Name>
        <Affiliation>Geological Survey of Israel, Jerusalem 9550166, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Meital Portugal-Cohen</Name>
        <Affiliation>AHAVA - Dead Sea Laboratories, Airport City Lod, 7015002, Israel; Dead Sea and Arava Science Center, The Laboratory for Skin Biochemistry and Biotechnology, Ein-Gedi 8698000, Israel. Electronic address: meital.p@ahava.com.</Affiliation>
      </Author>
      <Author>
        <Name>Matteo Zanotti Russo</Name>
        <Affiliation>Angel Consulting SAS, Via San Senatore 14, Milano 20122, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Federica Robino</Name>
        <Affiliation>Angel Consulting SAS, Via San Senatore 14, Milano 20122, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Tamara Vanhaecke</Name>
        <Affiliation>In vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Vera Rogiers</Name>
        <Affiliation>In vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Consideration of non-linear, non-threshold and threshold approaches for assessing the carcinogenicity of oral exposure to hexavalent chromium.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26493004</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.011</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Chromium</Keywords>
      <Keywords>Hexavalent</Keywords>
      <Keywords>Oral exposure</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Haney</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), Austin, TX, United States. Electronic address: joseph.haney@tceq.texas.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Transgenic proteins in agricultural biotechnology: The toxicology forum 40th annual summer meeting.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26493003</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.014</DOI>
    <KeywordList>
      <Keywords>Biotechnology</Keywords>
      <Keywords>GMO</Keywords>
      <Keywords>Golden rice</Keywords>
      <Keywords>Peer-review</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Transgenic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James H. Sherman</Name>
        <Affiliation>Monsanto Company, Toxicology and Nutrition Center, 800 N. Lindbergh Blvd, St. Louis, MO 63167, USA. Electronic address: james.sherman@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Supratim Choudhuri</Name>
        <Affiliation>US FDA-CFSAN, Office of Food Additive Safety, 5100 Paint Branch Parkway, College Park, MD 20740, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John L. Vicini</Name>
        <Affiliation>Monsanto Company, Regulatory Policy and Scientific Affairs, 800 N. Lindbergh Blvd, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Contrasting directions and directives on hazard identification for formaldehyde carcinogenicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26493002</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.012</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>National Research Council</Keywords>
      <Keywords>Report on Carcinogens</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lorenz R. Rhomberg</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA. Electronic address: lrhomberg@gradientcorp.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic (13-week) toxicity and prenatal developmental toxicity studies of dietary astaxanthin in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26493001</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.013</DOI>
    <KeywordList>
      <Keywords>Astaxanthin</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Diet</Keywords>
      <Keywords>Oral toxicity</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Reproduction</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katherine Vega</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 100 Davidson Ave., Somerset, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Edwards</Name>
        <Affiliation>NIC-RD/HN Toxicology and Kinetics, DSM Nutritional Products Ltd, Wurmisweg 576, 4303 Kaiseraugst, Switzerland. Electronic address: james-a.edwards@dsm.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Beilstein</Name>
        <Affiliation>NIC-RD/HN Toxicology and Kinetics, DSM Nutritional Products Ltd, Wurmisweg 576, 4303 Kaiseraugst, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of dimethoate in male mice reproductive parameters.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26482405</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.010</DOI>
    <KeywordList>
      <Keywords>Dimethoate</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Reprotoxicity</Keywords>
      <Keywords>Testis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Manel Jallouli</Name>
        <Affiliation>Laboratory of Aggression Physiology and Endocrine Metabolic Studies, Department of Biology, Faculty of Sciences, El Manar University Tunis, 2092, Tunisia. Electronic address: Jallouli-manel@hotmail.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Ines El Bini Dhouib</Name>
        <Affiliation>Laboratory of Aggression Physiology and Endocrine Metabolic Studies, Department of Biology, Faculty of Sciences, El Manar University Tunis, 2092, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Hanène Dhouib</Name>
        <Affiliation>Laboratory of Aggression Physiology and Endocrine Metabolic Studies, Department of Biology, Faculty of Sciences, El Manar University Tunis, 2092, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Najoua Gharbi</Name>
        <Affiliation>Laboratory of Aggression Physiology and Endocrine Metabolic Studies, Department of Biology, Faculty of Sciences, El Manar University Tunis, 2092, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Saloua El Fazaa</Name>
        <Affiliation>Laboratory of Aggression Physiology and Endocrine Metabolic Studies, Department of Biology, Faculty of Sciences, El Manar University Tunis, 2092, Tunisia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Adverse food-drug interactions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26482404</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.009</DOI>
    <KeywordList>
      <Keywords>Adverse interactions</Keywords>
      <Keywords>Bioactives</Keywords>
      <Keywords>European legislation</Keywords>
      <Keywords>Food law</Keywords>
      <Keywords>Food supplements</Keywords>
      <Keywords>Health enhancing products</Keywords>
      <Keywords>Medicinal products</Keywords>
      <Keywords>Wellness</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alie de Boer</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands. Electronic address: a.deboer@maastrichtuniversity.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Florence van Hunsel</Name>
        <Affiliation>Netherlands Pharmacovigilance Centre Lareb, Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 's-Hertogenbosch, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aalt Bast</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer Safety (SCCS)--Opinion on the safety of the use of β-arbutin in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26482403</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.008</DOI>
    <KeywordList>
      <Keywords>CAS: 497-76-7</Keywords>
      <Keywords>EC: 207-850-3</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>β-arbutin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920 Luxembourg, Luxembourg. Electronic address: SANTE-C2-SCCS@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Gisela H. Degen</Name>
        <Affiliation>Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of atherosclerosis as a potential mode of action for cardiovascular effects of particulate matter.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26474868</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.034</DOI>
    <KeywordList>
      <Keywords>Atherosclerosis</Keywords>
      <Keywords>Cardiovascular disease</Keywords>
      <Keywords>Coagulation</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Particulate matter</Keywords>
      <Keywords>Thrombosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Robyn L. Prueitt</Name>
        <Affiliation>Gradient, 600 Stewart Street, Suite 1900, Seattle, WA, 98101, USA. Electronic address: rprueitt@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joel M. Cohen</Name>
        <Affiliation>Gradient, 600 Stewart Street, Suite 1900, Seattle, WA, 98101, USA. Electronic address: jcohen@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, 20 University Road, Suite 5, Cambridge, MA, 02138, USA. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Implementing a framework for integrating toxicokinetics into human health risk assessment for agrochemicals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26472101</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.10.003</DOI>
    <KeywordList>
      <Keywords>Agrochemicals</Keywords>
      <Keywords>Biomonitoring equivalents</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Claire Terry</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, USA. Electronic address: cterry@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sean Hays</Name>
        <Affiliation>Summit Toxicology, CO, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alene T. McCoy</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa G. McFadden</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Manoj Aggarwal</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Reza J. Rasoulpour</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daland R. Juberg</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The potential protective effect of green, black, red and white tea infusions against adverse effect of cadmium and lead during chronic exposure - A rat model study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26472100</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.007</DOI>
    <KeywordList>
      <Keywords>Adult rats</Keywords>
      <Keywords>Antioxidant activity</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Lead</Keywords>
      <Keywords>Protective effect</Keywords>
      <Keywords>Tea</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anna Winiarska-Mieczan</Name>
        <Affiliation>Department of Bromatology and Food Physiology, University of Life Sciences in Lublin, Akademicka 13, 20-950 Lublin, Poland. Electronic address: anna.mieczan@up.lublin.pl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the scientific committee on consumer safety (SCCS)--2nd Revision of the safety of the use of poly(hexamethylene) biguanide hydrochloride or polyaminopropyl biguanide (PHMB) in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26456666</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.035</DOI>
    <KeywordList>
      <Keywords>CAS no. 32289-58-0 or 27083-27-8)</Keywords>
      <Keywords>Poly(hexamethylene) biguanide hydrochloride</Keywords>
      <Keywords>Polyaminopropyl biguanide (PHMB)</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name>Ulrike Bernauer</Name>
        <Affiliation>Federal Institute for Risk Assessment (BfR), Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the toxicity of α-(phenylselanyl) acetophenone in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26456665</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.004</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Organoselenium</Keywords>
      <Keywords>Selenium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Angela M. Casaril</Name>
        <Affiliation>Centro de Desenvolvimento Tecnológico, Unidade Biotecnologia, Grupo de pesquisa em Neurobiotecnologia, Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Débora Martins Martinez</Name>
        <Affiliation>Centro de Desenvolvimento Tecnológico, Unidade Biotecnologia, Grupo de pesquisa em Neurobiotecnologia, Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil; Laboratório de Síntese Orgânica Limpa, Universidade Federal de Pelotas, UFPel Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Vanesssa Gentil Ricordi</Name>
        <Affiliation>Laboratório de Síntese Orgânica Limpa, Universidade Federal de Pelotas, UFPel Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Diego Alves</Name>
        <Affiliation>Laboratório de Síntese Orgânica Limpa, Universidade Federal de Pelotas, UFPel Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Eder João Lenardão</Name>
        <Affiliation>Laboratório de Síntese Orgânica Limpa, Universidade Federal de Pelotas, UFPel Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Eduarda Schultze</Name>
        <Affiliation>Programa de Pós-Graduação em Biotecnologia (PPGB), Grupo de Pesquisa em Oncologia Celular e Molecular, Laboratório de Genômica Funcional, Biotecnologia/Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Tiago Collares</Name>
        <Affiliation>Programa de Pós-Graduação em Biotecnologia (PPGB), Grupo de Pesquisa em Oncologia Celular e Molecular, Laboratório de Genômica Funcional, Biotecnologia/Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Fabiana Kömmling Seixas</Name>
        <Affiliation>Programa de Pós-Graduação em Biotecnologia (PPGB), Grupo de Pesquisa em Oncologia Celular e Molecular, Laboratório de Genômica Funcional, Biotecnologia/Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lucielli Savegnago</Name>
        <Affiliation>Centro de Desenvolvimento Tecnológico, Unidade Biotecnologia, Grupo de pesquisa em Neurobiotecnologia, Universidade Federal de Pelotas, UFPel, Pelotas, RS, Brazil. Electronic address: luciellisavegnago@yahoo.com.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the mode of action of mouse lung tumors induced by 4-methylimidazole.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26456664</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.006</DOI>
    <KeywordList>
      <Keywords>4-Methylimidazole</Keywords>
      <Keywords>CYP2F2</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Mechanism</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Styrene</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>George Cruzan</Name>
        <Affiliation>ToxWorks, 1153 Roadstone Rd., Bridgeton, NJ 08302, USA. Electronic address: toxworks@aol.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jack R. Harkema</Name>
        <Affiliation>Michigan State University, 1129 Farm Ln., Rm. 212, East Lansing, MI 48824, USA. Electronic address: harkemaj@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Hiromi Hosako</Name>
        <Affiliation>WIL Research Laboratories LLC, 1407 George Rd., Ashland, OH 44805, USA. Electronic address: hiromi.hosako@wilresearch.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer M. Wasil</Name>
        <Affiliation>WIL Research Laboratories LLC, 1407 George Rd., Ashland, OH 44805, USA.</Affiliation>
      </Author>
      <Author>
        <Name>F. Jay Murray</Name>
        <Affiliation>Murray &amp; Associates, 5529 Perugia Cir., San Jose, CA 95138, USA. Electronic address: jmurray2@sbcglobal.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Alternatives for skin sensitisation: Hazard identification and potency categorisation: Report from an EPAA/CEFIC LRI/Cosmetics Europe cross sector workshop, ECHA Helsinki, April 23rd and 24th 2015.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26456663</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.005</DOI>
    <KeywordList>
      <Keywords>Integrated approaches to testing and assessment</Keywords>
      <Keywords>Integrated testing strategies</Keywords>
      <Keywords>In vitro alternatives</Keywords>
      <Keywords>Skin sensitisation</Keywords>
      <Keywords>hazard classification</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, MK44 1PR, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>Takao Ashikaga</Name>
        <Affiliation>Shiseido, Yokohama, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Casati</Name>
        <Affiliation>EURL ECVAM, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Hubesch</Name>
        <Affiliation>CEFIC, Brussels, Belgium; Hubesch Consult BVBA, Sint-Pieters-Leeuw, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Jaworska</Name>
        <Affiliation>Procter &amp; Gamble, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Joop de Knecht</Name>
        <Affiliation>OECD, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Irene Manou</Name>
        <Affiliation>EPAA, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Annette Mehling</Name>
        <Affiliation>BASF Personal Care and Nutrition GmbH, Duesseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Dirk Petersohn</Name>
        <Affiliation>Henkel AG &amp; Co. KGaA, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Emiel Rorije</Name>
        <Affiliation>RIVM, Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Laura H. Rossi</Name>
        <Affiliation>ECHA, Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Winfried Steiling</Name>
        <Affiliation>VCI, (Verband der Chemischen Industrie e.V.), Frankfurt/Main, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Teissier</Name>
        <Affiliation>L'Oreal, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Worth</Name>
        <Affiliation>EURL ECVAM, Ispra, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26454093</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.001</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Ames test</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Occupational exposure</Keywords>
      <Keywords>Pharmaceutical intermediates</Keywords>
      <Keywords>Structural alert</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Selene Araya</Name>
        <Affiliation>Novartis Pharma AG, TechOps, HSE, CH-4057 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Ester Lovsin-Barle</Name>
        <Affiliation>Novartis Pharma AG, TechOps, HSE, CH-4057 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis Pharma AG, NIBR, PCS, CH-4057 Basel, Switzerland. Electronic address: susanne.glowienke@novartis.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Potential confounding effects of benzyl alcohol as a formulation excipient support the elimination of the abnormal toxicity test from pharmacopoeias.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26449397</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.033</DOI>
    <KeywordList>
      <Keywords>Abnormal toxicity test</Keywords>
      <Keywords>Benzyl alcohol</Keywords>
      <Keywords>Guinea pigs</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Pharmacopeia</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jianxun Xie</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Roche Innovation Center, Shanghai 201023, China. Electronic address: jianxun.xie@roche.com.</Affiliation>
      </Author>
      <Author>
        <Name>Giorgio Ottaviani</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Roche Innovation Center, Shanghai 201023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Sun</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Roche Innovation Center, Shanghai 201023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingqiu Lu</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Roche Innovation Center, Shanghai 201023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqin Wu</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Roche Innovation Center, Shanghai 201023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sunfeng Huang</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Roche Innovation Center, Shanghai 201023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Bopst</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Roche Pharma and Early Development, Roche Innovation Center, Basel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>California biomonitoring data: Comparison to NHANES and interpretation in a risk assessment context.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26449396</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.10.002</DOI>
    <KeywordList>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring equivalents</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lesa L. Aylward</Name>
        <Affiliation>Summit Toxicology, LLP, Falls Church, VA 22044, USA; National Centre for Environmental Toxicology, University of Queensland, Brisbane, QLD, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>James N. Seiber</Name>
        <Affiliation>Department of Environmental Toxicology, University of California, Davis, CA 95616, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sean M. Hays</Name>
        <Affiliation>Summit Toxicology, LLP, Allenspark, CO 80510, USA. Electronic address: shays@summittoxicology.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developmental toxicity studies with 6 forms of titanium dioxide test materials (3 pigment-different grade &amp; 3 nanoscale) demonstrate an absence of effects in orally-exposed rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26434710</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.032</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Nanoparticle</Keywords>
      <Keywords>Nanoscale TiO(2) particles</Keywords>
      <Keywords>OECD 414 test guidelines</Keywords>
      <Keywords>Particle</Keywords>
      <Keywords>Particle characterization</Keywords>
      <Keywords>Particle size distribution</Keywords>
      <Keywords>Pigment-grade TiO(2) particles</Keywords>
      <Keywords>Prenatal developmental toxicity study</Keywords>
      <Keywords>Titanium dioxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>D. B. Warheit</Name>
        <Affiliation>Chemours Company, Wilmington, DE, USA. Electronic address: david.b.warheit@chemours.com.</Affiliation>
      </Author>
      <Author>
        <Name>R. Boatman</Name>
        <Affiliation>Boatman Toxicology Consulting LLC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. C. Brown</Name>
        <Affiliation>Chemours Company, Wilmington, DE, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fragrance sensitisers: Is inhalation an allergy risk?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26433121</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.031</DOI>
    <KeywordList>
      <Keywords>Airborne contact dermatitis</Keywords>
      <Keywords>Fragrance</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Respiratory allergy</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of Guibi-tang: Subchronic toxicity study in Crl:CD SD rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26432010</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.030</DOI>
    <KeywordList>
      <Keywords>Guibi-tang</Keywords>
      <Keywords>Kihi-To</Keywords>
      <Keywords>NOAE</Keywords>
      <Keywords>Qui-Pi-Tang</Keywords>
      <Keywords>Subchronic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mee Young Lee</Name>
        <Affiliation>Herbal Medicine Formulation Research Group, Korea Institute of Oriental Medicine, 483 Expo-ro, Yuseong-gu, Daejeon 305-811, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Seob Seo</Name>
        <Affiliation>Herbal Medicine Formulation Research Group, Korea Institute of Oriental Medicine, 483 Expo-ro, Yuseong-gu, Daejeon 305-811, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Bum Kim</Name>
        <Affiliation>Division of Non-clinical Studies, Korea Institute of Toxicology, P.O.Box 123, 100 Jangdong, Yuseong-gu, Daejeon 305-343, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyeun Kyoo Shin</Name>
        <Affiliation>Herbal Medicine Formulation Research Group, Korea Institute of Oriental Medicine, 483 Expo-ro, Yuseong-gu, Daejeon 305-811, Republic of Korea. Electronic address: hkshin@kiom.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Does the EU migration level of chromium VI in toys need to be lowered?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26429545</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.029</DOI>
    <KeywordList>
      <Keywords>Chromium VI</Keywords>
      <Keywords>Migration limits</Keywords>
      <Keywords>NTP</Keywords>
      <Keywords>OEHHA</Keywords>
      <Keywords>SCHER</Keywords>
      <Keywords>Toy Safety Directive</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name>Renate Krätke</Name>
        <Affiliation>Federal Institute for Risk Assessment (BfR), Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A tiered asthma hazard characterization and exposure assessment approach for evaluation of consumer product ingredients.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26416168</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.028</DOI>
    <KeywordList>
      <Keywords>Acetic acid</Keywords>
      <Keywords>Asthma</Keywords>
      <Keywords>Consumer products</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Hazard characterization</Keywords>
      <Keywords>Irritation</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Sensitization</Keywords>
      <Keywords>Tiered assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrew Maier</Name>
        <Affiliation>Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Electronic address: maierma@ucmail.uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Melissa J. Vincent</Name>
        <Affiliation>Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ann Parker</Name>
        <Affiliation>Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bernard K. Gadagbui</Name>
        <Affiliation>Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Jayjock</Name>
        <Affiliation>The LifeLine Group, 4610 Quarter Charge Dr, Annandale, VA, 22003, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>What do animal experiments tell us that in vitro systems cannot? The Human Toxome Project.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26409932</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.09.027</DOI>
    <KeywordList>
      <Keywords>Cell culture studies</Keywords>
      <Keywords>Human Toxome Project</Keywords>
      <Keywords>Human vs mouse PPARA</Keywords>
      <Keywords>Intact animal studies</Keywords>
      <Keywords>In vitro studies</Keywords>
      <Keywords>Mouse genetics</Keywords>
      <Keywords>Toxicity and cancer by fibrate drugs</Keywords>
      <Keywords>Toxicity and cancer by oral benzo[a]pyrene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniel W. Nebert</Name>
        <Affiliation>Department of Environmental Health &amp; Center for Environmental Genetics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA; Department of Pediatrics &amp; Molecular Developmental Biology, Division of Human Genetics, Cincinnati Children's Hospital, Cincinnati, OH 45229, USA. Electronic address: dan.nebert@uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Magnus Ingelman-Sundberg</Name>
        <Affiliation>Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, 171 77 Stockholm, Sweden. Electronic address: magnus.ingelman-sundberg@ki.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oral toxicity of Miglyol 812(®) in the Göttingen(®) minipig.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26408152</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.022</DOI>
    <KeywordList>
      <Keywords>Medium-chain triglycerides</Keywords>
      <Keywords>Miglyol 812(®)</Keywords>
      <Keywords>Minipig</Keywords>
      <Keywords>Oral</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Vehicle</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>G. Le Bars</Name>
        <Affiliation>Preclinical Development, Galderma R&amp;D, Biot, France. Electronic address: gwenaelle.lebars@galderma.com.</Affiliation>
      </Author>
      <Author>
        <Name>S. Dion</Name>
        <Affiliation>Preclinical Development, Galderma R&amp;D, Biot, France.</Affiliation>
      </Author>
      <Author>
        <Name>B. Gauthier</Name>
        <Affiliation>Preclinical Development, Galderma R&amp;D, Biot, France.</Affiliation>
      </Author>
      <Author>
        <Name>S. Mhedhbi</Name>
        <Affiliation>Preclinical Development, Galderma R&amp;D, Biot, France.</Affiliation>
      </Author>
      <Author>
        <Name>G. Pohlmeyer-Esch</Name>
        <Affiliation>KALEIDIS, Consultancy in Histopathology, St Louis, France.</Affiliation>
      </Author>
      <Author>
        <Name>P. Comby</Name>
        <Affiliation>Preclinical Development, Galderma R&amp;D, Biot, France.</Affiliation>
      </Author>
      <Author>
        <Name>N. Vivan</Name>
        <Affiliation>Preclinical Development, Galderma R&amp;D, Biot, France.</Affiliation>
      </Author>
      <Author>
        <Name>B. Ruty</Name>
        <Affiliation>Preclinical Development, Galderma R&amp;D, Biot, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of thirteen-week subchronic oral toxicity of cyadox in Beagle dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26408151</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.023</DOI>
    <KeywordList>
      <Keywords>Beagle dogs</Keywords>
      <Keywords>Cyadox</Keywords>
      <Keywords>Quinoxaline</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xu Wang</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MOA Key Laboratory for Detection of Veterinary Drug Residues, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Zhou</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Awais Ihsan</Name>
        <Affiliation>Department of Biosciences, COMSATS Institute of Information Technology, Sahiwal, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Dongmei Chen</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guyue Cheng</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haihong Hao</Name>
        <Affiliation>Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenli Liu</Name>
        <Affiliation>Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yulian Wang</Name>
        <Affiliation>Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China. Electronic address: wangyulian@mail.hzau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zonghui Yuan</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MOA Key Laboratory for Detection of Veterinary Drug Residues, China; MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China. Electronic address: yuan5802@mail.hzau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health safety issues of synthetic food colorants.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26404013</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.026</DOI>
    <KeywordList>
      <Keywords>Children's behaviour</Keywords>
      <Keywords>Colorant</Keywords>
      <Keywords>Food dye</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Petra Amchova</Name>
        <Affiliation>Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Experimental and Applied Neuropsychopharmacology Research Group, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Hana Kotolova</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Jana Ruda-Kucerova</Name>
        <Affiliation>Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Experimental and Applied Neuropsychopharmacology Research Group, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic. Electronic address: jkucer@med.muni.cz.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antigenotoxic activity of lactic acid bacteria, prebiotics, and products of their fermentation against selected mutagens.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26404012</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.021</DOI>
    <KeywordList>
      <Keywords>DNA repair</Keywords>
      <Keywords>Faecal water</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Mutagens</Keywords>
      <Keywords>Prebiotics</Keywords>
      <Keywords>Probiotics</Keywords>
      <Keywords>SCFA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Adriana Nowak</Name>
        <Affiliation>Institute of Fermentation Technology and Microbiology, Lodz University of Technology, Wolczanska 171/173, 90-924 Lodz, Poland. Electronic address: adriana.nowak@p.lodz.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Katarzyna Śliżewska</Name>
        <Affiliation>Institute of Fermentation Technology and Microbiology, Lodz University of Technology, Wolczanska 171/173, 90-924 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Otlewska</Name>
        <Affiliation>Institute of Fermentation Technology and Microbiology, Lodz University of Technology, Wolczanska 171/173, 90-924 Lodz, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity and antioxidant capacity of Frangula alnus Mill. bark and its active component emodin.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26399165</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.025</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Human peripheral blood lymphocytes</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Polyphenol content</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sandra Radić Brkanac</Name>
        <Affiliation>Department of Biology, Faculty of Science, University of Zagreb, Rooseveltov Trg 6, 10000 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Marko Gerić</Name>
        <Affiliation>Mutagenesis Unit, Institute for Medical Research and Occupational Health, Ksaverska c. 2, 10000 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Goran Gajski</Name>
        <Affiliation>Mutagenesis Unit, Institute for Medical Research and Occupational Health, Ksaverska c. 2, 10000 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Valerija Vujčić</Name>
        <Affiliation>Department of Biology, Faculty of Science, University of Zagreb, Rooseveltov Trg 6, 10000 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Vera Garaj-Vrhovac</Name>
        <Affiliation>Mutagenesis Unit, Institute for Medical Research and Occupational Health, Ksaverska c. 2, 10000 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Dario Kremer</Name>
        <Affiliation>Department of Pharmaceutical Botany, Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10000 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Marija Domijan</Name>
        <Affiliation>Department of Pharmaceutical Botany, Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10000 Zagreb, Croatia. Electronic address: adomijan@pharma.hr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk assessment on the use of herbal medicinal products containing pyrrolizidine alkaloids.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26399164</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.024</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Herbal medicinal products</Keywords>
      <Keywords>Herbals</Keywords>
      <Keywords>Margin of exposure</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Pyrrolizidine alkaloids</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Clemens Allgaier</Name>
        <Affiliation>ACA-pharma Concept GmbH, Deutscher Platz 5, 04103, Leipzig, Germany; Rudolf-Boehm-Institute of Pharmacology and Toxicology and PGS Toxikologie und Umweltschutz, University of Leipzig, Leipzig, Germany. Electronic address: aca24@aca-pharma.de.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie Franz</Name>
        <Affiliation>ACA-pharma Concept GmbH, Deutscher Platz 5, 04103, Leipzig, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Performance characteristics of the AmpliSeq Cancer Hotspot panel v2 in combination with the Ion Torrent Next Generation Sequencing Personal Genome Machine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26387931</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.09.011</DOI>
    <KeywordList>
      <Keywords>Cancer Hotspot panel</Keywords>
      <Keywords>Ion Torrent Personal Genome Machine</Keywords>
      <Keywords>Mutation detection</Keywords>
      <Keywords>Next generation sequencing</Keywords>
      <Keywords>Performance analysis</Keywords>
      <Keywords>Systematic error analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kimberly S. Butler</Name>
        <Affiliation>U.S. Food and Drug Administration, Office of Medical Products and Tobacco, Center for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biology, Chemistry and Materials Science, 10903 New Hampshire Ave, Silver Spring, MD 20993, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Megan Y. L. Young</Name>
        <Affiliation>U.S. Food and Drug Administration, Office of Medical Products and Tobacco, Center for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biology, Chemistry and Materials Science, 10903 New Hampshire Ave, Silver Spring, MD 20993, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihua Li</Name>
        <Affiliation>U.S. Food and Drug Administration, Office of Medical Products and Tobacco, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Clinical Pharmacology, Division of Applied Regulatory Science, 10903 New Hampshire Ave, Silver Spring, MD 20993, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rosalie K. Elespuru</Name>
        <Affiliation>U.S. Food and Drug Administration, Office of Medical Products and Tobacco, Center for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biology, Chemistry and Materials Science, 10903 New Hampshire Ave, Silver Spring, MD 20993, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Steven C. Wood</Name>
        <Affiliation>U.S. Food and Drug Administration, Office of Medical Products and Tobacco, Center for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biology, Chemistry and Materials Science, 10903 New Hampshire Ave, Silver Spring, MD 20993, United States. Electronic address: steven.wood@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26387930</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.020</DOI>
    <KeywordList>
      <Keywords>Excipient</Keywords>
      <Keywords>Quality</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lin Chau Chang</Name>
        <Affiliation>Center for Drug Evaluation, 3F, No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. Electronic address: chaemily@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jaw Jou Kang</Name>
        <Affiliation>Institute of Toxicology, College of Medicine, National Taiwan University, No.1, Sec.1, Jen Ai Rd., Taipei 10051, Taiwan. Electronic address: jjkang@ntu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Churn Shiouh Gau</Name>
        <Affiliation>Center for Drug Evaluation, 3F, No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. Electronic address: csgau206@cde.org.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ranking the harm of non-medically used prescription opioids in the UK.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26382614</pubmedLink>
    <GrantList>
      <Grant>MR/J013269/1</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.014</DOI>
    <KeywordList>
      <Keywords>Harm</Keywords>
      <Keywords>MCDA</Keywords>
      <Keywords>Opioids</Keywords>
      <Keywords>Prescription drugs</Keywords>
      <Keywords>Ranking</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Street heroin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jan van Amsterdam</Name>
        <Affiliation>Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: jan.van.amsterdam@amc.uva.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Lawrence Phillips</Name>
        <Affiliation>Department of Management, London School of Economics and Political Science, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Graeme Henderson</Name>
        <Affiliation>School of Physiology &amp; Pharmacology, University of Bristol, Bristol, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James Bell</Name>
        <Affiliation>Kings College London, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Owen Bowden-Jones</Name>
        <Affiliation>Faculty of Medicine, Department of Medicine, Imperial College London, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Hammersley</Name>
        <Affiliation>Department of Psychology, University of Hull, Hull, UK.</Affiliation>
      </Author>
      <Author>
        <Name>John Ramsey</Name>
        <Affiliation>TICTAC Communications Ltd, St George's University of London, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Polly Taylor</Name>
        <Affiliation>Taylor Monroe, Ely, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Annette Dale-Perera</Name>
        <Affiliation>NHS, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Melichar</Name>
        <Affiliation>School of Clinical Sciences, University of Bristol, Bristol, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Wim van den Brink</Name>
        <Affiliation>Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>David Nutt</Name>
        <Affiliation>Centre for Neuropychopharmacology, Imperial College London, London, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-clinical safety assessment of gadoterate meglumine (Dotarem(®)) in neonatal and juvenile rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26382613</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.018</DOI>
    <KeywordList>
      <Keywords>Contrast agents</Keywords>
      <Keywords>Gadolinium</Keywords>
      <Keywords>Gadolinium-based contrast agent</Keywords>
      <Keywords>Juvenile toxicity</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hervé Giorgi</Name>
        <Affiliation>WIL Research Europe, 329 Impasse du Domaine Rozier, Les Oncins, 69210 Saint-Germain-Nuelles, France. Electronic address: herve.giorgi@wilresearch.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Ammerman</Name>
        <Affiliation>MPI Research, 54943 N. Main Street, Mattawan, MI 49071, USA. Electronic address: Jennifer.Ammerman@mpiresearch.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Paul Briffaux</Name>
        <Affiliation>WIL Research Europe, 329 Impasse du Domaine Rozier, Les Oncins, 69210 Saint-Germain-Nuelles, France. Electronic address: jean-paul.briffaux@wilresearch.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalie Fretellier</Name>
        <Affiliation>Guerbet-Group, BP 57400, 95943 Roissy CDG Cedex, France. Electronic address: nathalie.fretellier@guerbet-group.com.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Corot</Name>
        <Affiliation>Guerbet-Group, BP 57400, 95943 Roissy CDG Cedex, France. Electronic address: claire.corot@guerbet-group.com.</Affiliation>
      </Author>
      <Author>
        <Name>Philippe Bourrinet</Name>
        <Affiliation>Guerbet-Group, BP 57400, 95943 Roissy CDG Cedex, France. Electronic address: philippe.bourrinet@guerbet-group.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The use of human adipose-derived stem cells based cytotoxicity assay for acute toxicity test.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26382612</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.015</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Stem cells</Keywords>
      <Keywords>Toxicity prediction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ana Paula Ressetti Abud</Name>
        <Affiliation>Laboratório de Biologia Básica de Células-tronco, Instituto Carlos Chagas, Fiocruz, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jaiesa Zych</Name>
        <Affiliation>Laboratório de Biologia Básica de Células-tronco, Instituto Carlos Chagas, Fiocruz, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Thamile Luciane Reus</Name>
        <Affiliation>Laboratório de Biologia Básica de Células-tronco, Instituto Carlos Chagas, Fiocruz, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Crisciele Kuligovski</Name>
        <Affiliation>Laboratório de Biologia Básica de Células-tronco, Instituto Carlos Chagas, Fiocruz, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth de Moraes</Name>
        <Affiliation>Laboratório de Biologia Básica de Células-tronco, Instituto Carlos Chagas, Fiocruz, Curitiba, PR, Brazil; Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Dallagiovanna</Name>
        <Affiliation>Laboratório de Biologia Básica de Células-tronco, Instituto Carlos Chagas, Fiocruz, Curitiba, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandra Melo de Aguiar</Name>
        <Affiliation>Laboratório de Biologia Básica de Células-tronco, Instituto Carlos Chagas, Fiocruz, Curitiba, PR, Brazil. Electronic address: alessandra_aguiar@fiocruz.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A practical guidance for Cramer class determination.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26382611</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.017</DOI>
    <AuthorList>
      <Author>
        <Name>David W. Roberts</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, L3 3AF, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Aynur Aptula</Name>
        <Affiliation>Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedford, MK44 1LQ, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Terry W. Schultz</Name>
        <Affiliation>The University of Tennessee, College of Veterinary, 2407 River Drive, Knoxville, TN 37996, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Shen</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA. Electronic address: jshen@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Marie Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sneha Bhatia</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lambros Kromidas</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Five-year yield variation in N-nitrosonornicotine and (4-methylnitrosoamino)-1-(3-pyridyl)-1-butanone from the smoke of commercial cigarette brands on the Japanese market.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26382610</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.019</DOI>
    <KeywordList>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>Japan</Keywords>
      <Keywords>NNK</Keywords>
      <Keywords>NNN</Keywords>
      <Keywords>Variation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>T. Hyodo</Name>
        <Affiliation>Japan Tobacco Inc., 2-1-1 Toranomon, Minato-ku, Tokyo 105-8422, Japan. Electronic address: takatsugu.hyodo@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>K. Minagawa</Name>
        <Affiliation>Japan Tobacco Inc., 2-1-1 Toranomon, Minato-ku, Tokyo 105-8422, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>A. Mikita</Name>
        <Affiliation>Japan Tobacco Inc., 2-1-1 Toranomon, Minato-ku, Tokyo 105-8422, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Decreased maternal and fetal cholesterol following maternal bococizumab (anti-PCSK9 monoclonal antibody) administration does not affect rat embryo-fetal development.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26382609</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.08.007</DOI>
    <KeywordList>
      <Keywords>Bococizumab</Keywords>
      <Keywords>Cholesterol</Keywords>
      <Keywords>Embryo-fetal development</Keywords>
      <Keywords>Monoclonal antibody</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sarah N. Campion</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Worldwide Research &amp; Development, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bora Han</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Worldwide Research &amp; Development, La Jolla, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gregg D. Cappon</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Worldwide Research &amp; Development, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elise M. Lewis</Name>
        <Affiliation>Charles River Laboratories, Preclinical Services Pennsylvania, Horsham, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eugenia Kraynov</Name>
        <Affiliation>Pharmacokinetics Dynamics and Metabolism, Pfizer Worldwide Research &amp; Development, La Jolla, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Liang</Name>
        <Affiliation>Rinat, Pfizer Worldwide Research &amp; Development, South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher J. Bowman</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Worldwide Research &amp; Development, Groton, CT, USA. Electronic address: christopher.j.bowman@pfizer.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hazard index, a tool for a long term risk assessment of pesticide residues in some commodities, a pilot study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26382608</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.016</DOI>
    <KeywordList>
      <Keywords>Exposure</Keywords>
      <Keywords>Pesticide residues</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sohair A. Gad Alla</Name>
        <Affiliation>Central Laboratory of Residue Analysis of Pesticides and Heavy Metals in Food (QCAP), Agricultural Research Center, Giza, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Naglaa M. Loutfy</Name>
        <Affiliation>Faculty of Agriculture, Suez Canal University, Ismailia 41522, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Amr H. Shendy</Name>
        <Affiliation>Central Laboratory of Residue Analysis of Pesticides and Heavy Metals in Food (QCAP), Agricultural Research Center, Giza, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed Tawfic Ahmed</Name>
        <Affiliation>Faculty of Agriculture, Suez Canal University, Ismailia 41522, Egypt. Electronic address: motawfic@tedata.net.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of residents' pesticide exposure with predictions obtained using the UK regulatory exposure assessment approach.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26364754</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.012</DOI>
    <KeywordList>
      <Keywords>Agriculture</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Regulatory exposure assessment</Keywords>
      <Keywords>Residents</Keywords>
      <Keywords>Urinary biomarkers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Karen S. Galea</Name>
        <Affiliation>Centre for Human Exposure Science, Institute of Occupational Medicine (IOM), Edinburgh, UK. Electronic address: karen.galea@iom-world.org.</Affiliation>
      </Author>
      <Author>
        <Name>Laura MacCalman</Name>
        <Affiliation>Centre for Human Exposure Science, Institute of Occupational Medicine (IOM), Edinburgh, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Kate Jones</Name>
        <Affiliation>Health and Safety Laboratory (HSL), Buxton, UK.</Affiliation>
      </Author>
      <Author>
        <Name>John Cocker</Name>
        <Affiliation>Health and Safety Laboratory (HSL), Buxton, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Teedon</Name>
        <Affiliation>School of Engineering and the Built Environment, Glasgow Caledonian University, Glasgow, UK.</Affiliation>
      </Author>
      <Author>
        <Name>John W. Cherrie</Name>
        <Affiliation>Centre for Human Exposure Science, Institute of Occupational Medicine (IOM), Edinburgh, UK; School of Life Sciences, Heriot Watt University, Edinburgh, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Martie van Tongeren</Name>
        <Affiliation>Centre for Human Exposure Science, Institute of Occupational Medicine (IOM), Edinburgh, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of ferrous N-carbamylglycinate chelate: Acute, Sub-acute toxicity and mutagenicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26364753</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.013</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Ferrous N-carbamylglycinate</Keywords>
      <Keywords>Iron amino acid chelates</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Sub-acute toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dan Wan</Name>
        <Affiliation>Hunan Provincial Engineering Research Center for Healthy Livestock and Poultry Production, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, 410125, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xihong Zhou</Name>
        <Affiliation>Hunan Provincial Engineering Research Center for Healthy Livestock and Poultry Production, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, 410125, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunyan Xie</Name>
        <Affiliation>Hunan Provincial Engineering Research Center for Healthy Livestock and Poultry Production, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, 410125, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xugang Shu</Name>
        <Affiliation>College of Chemistry and Chemical Engineering, Zhongkai University of Agriculture and Engineering, Guangzhou, 510225, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Wu</Name>
        <Affiliation>Hunan Provincial Engineering Research Center for Healthy Livestock and Poultry Production, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, 410125, China. Electronic address: wu-xin@foxmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yulong Yin</Name>
        <Affiliation>Hunan Provincial Engineering Research Center for Healthy Livestock and Poultry Production, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, 410125, China. Electronic address: yinyulong@isa.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 90-day subchronic study of rats fed lean pork from genetically modified pigs with muscle-specific expression of recombinant follistatin.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26363208</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.009</DOI>
    <KeywordList>
      <Keywords>90-Day feeding study</Keywords>
      <Keywords>Genetically modified pig</Keywords>
      <Keywords>Pork</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shiying Zou</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Tang</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyun He</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China; The Supervision, Inspection and Testing Center of Genetically Modified Organisms, Ministry of Agriculture, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Cao</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Zhao</Name>
        <Affiliation>College of Biological Science, China Agricultural University, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wentao Xu</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China; The Supervision, Inspection and Testing Center of Genetically Modified Organisms, Ministry of Agriculture, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihong Liang</Name>
        <Affiliation>The Supervision, Inspection and Testing Center of Genetically Modified Organisms, Ministry of Agriculture, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kunlun Huang</Name>
        <Affiliation>College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China; The Supervision, Inspection and Testing Center of Genetically Modified Organisms, Ministry of Agriculture, Beijing, 100083, China. Electronic address: hkl009@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute toxicity of sodium formononetin-3'-sulphonate (Sul-F) in Sprague-Dawley rats and Beagle dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26363207</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.010</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Beagle dogs</Keywords>
      <Keywords>Sodium formononetin-3′-sulphonate (Sul-F)</Keywords>
      <Keywords>Sprague-Dawley rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guisheng Li</Name>
        <Affiliation>School of Pharmacy, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Menglin Yang</Name>
        <Affiliation>School of Pharmacy, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinmiao Hao</Name>
        <Affiliation>School of Pharmacy, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Yantai University, Yantai 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Science, Yantai University, Yantai 264005, PR China. Electronic address: gylbill@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Tao</Name>
        <Affiliation>Hebei Gogin Pharmaceutical Co., LTD., Xingtai 054000, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer safety (SCCS) - Revision of the opinion on the safety of the use of titanium dioxide, nano form, in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26363206</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.005</DOI>
    <KeywordList>
      <Keywords>53 directive 76/768/ECC</Keywords>
      <Keywords>CAS number: 13463-67-7</Keywords>
      <Keywords>EC: 236-675-5</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>SCCS/1516/13</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>Titanium dioxide (nano form)</Keywords>
      <Keywords>UV filter</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920 Luxembourg, Luxembourg. Electronic address: SANTE-C2-SCCS@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Qasim Chaudhry</Name>
        <Affiliation>University of Chester, Parkgate Road, Chester CH14BJ, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer Safety (SCCS)--Revision of the opinion on the safety of aluminium in cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26363205</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.006</DOI>
    <KeywordList>
      <Keywords>1223/2009</Keywords>
      <Keywords>Aluminium</Keywords>
      <Keywords>CAS 68-11-1</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>SCCS Secretariat at the European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920 Luxembourg, Luxembourg. Electronic address: SANTE-C2-SCCS@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Christophe Rousselle</Name>
        <Affiliation>French Agency for Food, Environmental and Occupational Health &amp; Safety - ANSES, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>RNAi technologies in agricultural biotechnology: The Toxicology Forum 40th Annual Summer Meeting.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26361858</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.001</DOI>
    <KeywordList>
      <Keywords>Agriculture</Keywords>
      <Keywords>Biotechnology</Keywords>
      <Keywords>GMO</Keywords>
      <Keywords>RNAi</Keywords>
      <Keywords>Toxicology Forum</Keywords>
      <Keywords>dsRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James H. Sherman</Name>
        <Affiliation>Monsanto Company, 800 N. Lindbergh Blvd, St. Louis, MO 63167, United States. Electronic address: james.sherman@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tichafa Munyikwa</Name>
        <Affiliation>Syngenta Crop Protection, Inc., 5106 Bearberry Pt., Greensboro, NC 27419, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Y. Chan</Name>
        <Affiliation>Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jay S. Petrick</Name>
        <Affiliation>Monsanto Company, 800 N. Lindbergh Blvd, St. Louis, MO 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth W. Witwer</Name>
        <Affiliation>The Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD 21205, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Supratim Choudhuri</Name>
        <Affiliation>US FDA-CFSAN, 5100 Paint Branch Parkway, College Park, MD 20740, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Feasibility of repeated testing for learning ability in juvenile primates for pediatric safety assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26361857</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.08.008</DOI>
    <KeywordList>
      <Keywords>Cynomolgus monkey</Keywords>
      <Keywords>Juvenile toxicity studies</Keywords>
      <Keywords>Learning ability</Keywords>
      <Keywords>Memory</Keywords>
      <Keywords>Wisconsin General Testing Apparatus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. Rose</Name>
        <Affiliation>Covance Preclinical Services GmbH, Kesselfeld 29, 48163 Muenster, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>C. M. Luetjens</Name>
        <Affiliation>Covance Preclinical Services GmbH, Kesselfeld 29, 48163 Muenster, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>S. Grote-Wessels</Name>
        <Affiliation>Covance Preclinical Services GmbH, Kesselfeld 29, 48163 Muenster, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>G. F. Weinbauer</Name>
        <Affiliation>Covance Preclinical Services GmbH, Kesselfeld 29, 48163 Muenster, Germany. Electronic address: gerhard.weinbauer@covance.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of exposure routes on the relationships of lethal toxicity to rats from oral, intravenous, intraperitoneal and intramuscular routes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26361856</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.008</DOI>
    <KeywordList>
      <Keywords>Absorption rate</Keywords>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Correlation</Keywords>
      <Keywords>Exposure route</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Toxic kinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhong H. Ning</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuang Long</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Y. Zhou</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zi Y. Peng</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi N. Sun</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Si W. Chen</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Li M. Su</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan H. Zhao</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China. Electronic address: zhaoyh@nenu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Roles of ROS mediated oxidative stress and DNA damage in 3-methyl-2-quinoxalin benzenevinylketo-1, 4-dioxide-induced immunotoxicity of Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26361855</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.002</DOI>
    <KeywordList>
      <Keywords>3-methyl-2-quinoxalin benzenevinylketo-1</Keywords>
      <Keywords>4-dioxide</Keywords>
      <Keywords>DNA damage</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hui Gao</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China; MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Di Wang</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China; MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shun Zhang</Name>
        <Affiliation>MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengjing Xu</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China; MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Yang</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China; MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Peipei Yan</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China; MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Liu</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China; MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Luo</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China; MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hailei Wu</Name>
        <Affiliation>Nanjing Entry-Exit Inspection and Quarantine Bureau, Najing, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Yao</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China; MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Yan</Name>
        <Affiliation>MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China. Electronic address: yanhong@mails.tjmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Liegang Liu</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China; MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science &amp; Technology, 13 Hangkong Road, Wuhan, 430030, PR China. Electronic address: lgliu@mails.tjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hexavalent and trivalent chromium in leather: What should be done?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26361854</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.007</DOI>
    <KeywordList>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Chromium</Keywords>
      <Keywords>Content</Keywords>
      <Keywords>Hexavalent</Keywords>
      <Keywords>Leather</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Release</Keywords>
      <Keywords>Risk</Keywords>
      <Keywords>Trivalent</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Angelo Moretto</Name>
        <Affiliation>Dipartimento di Scienze Biomediche e Cliniche (Department of Biomedical and Clinical Sciences), Università degli Studi di Milano, Italy. Electronic address: angelo.moretto@unimi.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Proof of concept for a banding scheme to support risk assessments related to multi-product biologics manufacturing.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26361853</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.003</DOI>
    <KeywordList>
      <Keywords>Biologics</Keywords>
      <Keywords>Cleaning validation</Keywords>
      <Keywords>Cross-contamination</Keywords>
      <Keywords>Impurities</Keywords>
      <Keywords>Manufacturing</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeffrey W. Card</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, Mississauga, ON, Canada. Electronic address: jeffrey.card@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hana Fikree</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, Mississauga, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Lois A. Haighton</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, Mississauga, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>James Blackwell</Name>
        <Affiliation>The Quantic Group, Livingston, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Felice</Name>
        <Affiliation>Shire, Lexington, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Teresa L. Wright</Name>
        <Affiliation>Dimension Therapeutics, Inc., Cambridge, MA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel method of demonstrating the molecular and functional equivalence between in vitro and plant-produced double-stranded RNA.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26361852</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.09.004</DOI>
    <KeywordList>
      <Keywords>Double stranded RNA</Keywords>
      <Keywords>DvSnf7</Keywords>
      <Keywords>Functional equivalence</Keywords>
      <Keywords>MON 87411</Keywords>
      <Keywords>Molecular equivalence</Keywords>
      <Keywords>Prediction interval</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>dsRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>William Urquhart</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, Missouri 63167, United States. Electronic address: william.urquhart@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Geoffrey M. Mueller</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, Missouri 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie Carleton</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, Missouri 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Zihong Song</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, Missouri 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tim Perez</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, Missouri 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua P. Uffman</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, Missouri 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Peter D. Jensen</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, Missouri 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Steven L. Levine</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, Missouri 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Ward</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, Missouri 63167, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of isopropylparaben and isobutylparaben mixture in Sprague-Dawley rats following 28 days of dermal exposure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26359141</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.08.005</DOI>
    <KeywordList>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Isobutylparaben</Keywords>
      <Keywords>Isopropylparaben</Keywords>
      <Keywords>Mixture toxicity</Keywords>
      <Keywords>NOAEL</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Min Ji Kim</Name>
        <Affiliation>Division of Toxicology, School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, 440-746, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Jun Kwack</Name>
        <Affiliation>Department of Biochemistry and Health Science, College of Natural Sciences, Changwon National University, 92 Toechonro, Uichang-gu, Changwon, Gyeongnam 641-773, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seong Kwang Lim</Name>
        <Affiliation>Division of Toxicology, School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, 440-746, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yeon Joo Kim</Name>
        <Affiliation>Division of Toxicology, School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, 440-746, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Hyun Roh</Name>
        <Affiliation>Division of Toxicology, School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, 440-746, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seul Min Choi</Name>
        <Affiliation>Division of Toxicology, School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, 440-746, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Sik Kim</Name>
        <Affiliation>Division of Toxicology, School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, 440-746, South Korea. Electronic address: hkims@skku.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Mu Lee</Name>
        <Affiliation>Division of Toxicology, School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, 440-746, South Korea. Electronic address: bmlee@skku.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk assessment of pesticide residues in dietary intake of celery in China.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26344481</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.08.009</DOI>
    <KeywordList>
      <Keywords>Celery</Keywords>
      <Keywords>Dietary intake</Keywords>
      <Keywords>Pesticide</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Risk ranking</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liping Fang</Name>
        <Affiliation>Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China; Institute of Agricultural Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuqiu Zhang</Name>
        <Affiliation>Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China; Institute of Agricultural Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zilei Chen</Name>
        <Affiliation>Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China; Institute of Agricultural Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongxia Du</Name>
        <Affiliation>Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China; Institute of Agricultural Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Zhu</Name>
        <Affiliation>Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China; Institute of Agricultural Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhan Dong</Name>
        <Affiliation>Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China; Institute of Agricultural Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huidong Li</Name>
        <Affiliation>Shandong Provincial Key Laboratory of Test Technology on Food Quality and Safety, Jinan, Shandong, 250100, China; Institute of Agricultural Quality Standard and Test Technology for Agro-products, Shandong Academy of Agricultural Sciences, Jinan, Shandong, 250100, China. Electronic address: lihuidong8066@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Data quality and relevance in ecotoxicity: The undocumented influences of model assumptions and modifying factors on aquatic toxicity dose metrics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26343167</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.08.006</DOI>
    <KeywordList>
      <Keywords>Data quality</Keywords>
      <Keywords>Dose–response</Keywords>
      <Keywords>LC50</Keywords>
      <Keywords>LR50</Keywords>
      <Keywords>Model</Keywords>
      <Keywords>Modifying factors</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>L. S. McCarty</Name>
        <Affiliation>L.S. McCarty Scientific Research &amp; Consulting, 1115 Quaker Trail, Newmarket, ON L3X 3E2, Canada. Electronic address: lsmccarty@rogers.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Physiologically based pharmacokinetic modeling of ethyl acetate and ethanol in rodents and humans.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26297692</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.021</DOI>
    <KeywordList>
      <Keywords>Ethanol</Keywords>
      <Keywords>Ethyl acetate</Keywords>
      <Keywords>Extrapolation</Keywords>
      <Keywords>Metabolic series approach</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Physiologically based pharmacokinetic modeling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. R. Crowell</Name>
        <Affiliation>Pacific Northwest National Laboratory, Richland, WA, United States. Electronic address: crowell.susan@gene.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. N. Smith</Name>
        <Affiliation>Pacific Northwest National Laboratory, Richland, WA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>J. A. Creim</Name>
        <Affiliation>Pacific Northwest National Laboratory, Richland, WA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>W. Faber</Name>
        <Affiliation>Willem Faber Toxicology Consulting, LLC, Victor, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>J. G. Teeguarden</Name>
        <Affiliation>Pacific Northwest National Laboratory, Richland, WA, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Revision of the opinion on hydrolysed wheat proteins - Sensitisation only.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26279001</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.08.004</DOI>
    <KeywordList>
      <Keywords>100209-50-5</Keywords>
      <Keywords>222400-28-4</Keywords>
      <Keywords>70084-87-6</Keywords>
      <Keywords>CAS 94350-06-8</Keywords>
      <Keywords>Cosmetic ingredients</Keywords>
      <Keywords>EC 305-225-0</Keywords>
      <Keywords>Hydrolysed wheat proteins</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>European Commission, Directorate General for Health and Food Safety, 11, rue E. Ruppert, L-2920 Luxembourg, Luxembourg. Electronic address: SANTE-C2-SCCS@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Pieter Jan Coenraads</Name>
        <Affiliation>University Medical Center Groningen, Groningen, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Revision of the opinion on peanut oil - Sensitisation only.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26275710</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.031</DOI>
    <KeywordList>
      <Keywords>CAS 75980-60-8</Keywords>
      <Keywords>Cosmetic ingredients</Keywords>
      <Keywords>EC 232-296-4</Keywords>
      <Keywords>Peanut oil</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name>Pieter Jan Coenraads</Name>
        <Affiliation>University Medical Center Groningen, Groningen, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Broccoli seed extract: Genotoxicity and subchronic toxicity studies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26271574</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.08.003</DOI>
    <KeywordList>
      <Keywords>Broccoli seed extract</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Mouse sperm abnormality assay</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Zhou</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of National Health and Family Planning Commission, China National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Yang</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of National Health and Family Planning Commission, China National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongning Li</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of National Health and Family Planning Commission, China National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>B. Lynch</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Rd., Suite 201, Mississauga, ON L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Xudong Jia</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of National Health and Family Planning Commission, China National Center for Food Safety Risk Assessment, Beijing 100021, China. Electronic address: jiaxudong@cfsa.net.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health Canada's use of priority review status for drugs for unmet needs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26260656</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.08.002</DOI>
    <KeywordList>
      <Keywords>Canada</Keywords>
      <Keywords>Drug regulation</Keywords>
      <Keywords>Drugs for unmet needs</Keywords>
      <Keywords>Health policy</Keywords>
      <Keywords>Priority review status</Keywords>
      <Keywords>United States</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nigel S. B. Rawson</Name>
        <Affiliation>Eastlake Research Group, Oakville, Ontario, Canada; Canadian Health Policy Institute, Toronto, Ontario, Canada. Electronic address: EastlakeRG@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Levels and potential health risks of mercury in prescription, non-prescription medicines and dietary supplements in Poland.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26260655</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.08.001</DOI>
    <KeywordList>
      <Keywords>CV-AFS</Keywords>
      <Keywords>Dietary supplements</Keywords>
      <Keywords>Drugs</Keywords>
      <Keywords>Mercury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Artur Kowalski</Name>
        <Affiliation>Department of Water and Soil Analysis, Faculty of Chemistry, Adam Mickiewicz University in Poznań, Umultowska 89b, 61-614 Poznań, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Marcin Frankowski</Name>
        <Affiliation>Department of Water and Soil Analysis, Faculty of Chemistry, Adam Mickiewicz University in Poznań, Umultowska 89b, 61-614 Poznań, Poland. Electronic address: Marcin.Frankowski@amu.edu.pl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impact of a modification of food regulation on cadmium exposure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26255107</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.027</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Dietary exposure</Keywords>
      <Keywords>Maximum limits</Keywords>
      <Keywords>Regulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julien Jean</Name>
        <Affiliation>Risk Assessment Directorate - French Agency for Food Environmental and Occupational Health and Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>Véronique Sirot</Name>
        <Affiliation>Risk Assessment Directorate - French Agency for Food Environmental and Occupational Health and Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>Paule Vasseur</Name>
        <Affiliation>CNRS Université Paul Verlaine, 57050 Metz, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jean François Narbonne</Name>
        <Affiliation>Laboratoire de Physico-Toxico Chimie des Systèmes Naturels, Université Bordeaux 1, Talence, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Charles Leblanc</Name>
        <Affiliation>Risk Assessment Directorate - French Agency for Food Environmental and Occupational Health and Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Luc Volatier</Name>
        <Affiliation>Risk Assessment Directorate - French Agency for Food Environmental and Occupational Health and Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>Gilles Rivière</Name>
        <Affiliation>Risk Assessment Directorate - French Agency for Food Environmental and Occupational Health and Safety (ANSES), Maisons-Alfort, France. Electronic address: gilles.riviere@anses.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tolerance of rising dietary concentrations of esterified propoxylated glycerol (EPG) among human volunteers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26255106</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.030</DOI>
    <KeywordList>
      <Keywords>Clinical study</Keywords>
      <Keywords>EPG</Keywords>
      <Keywords>Esterified propoxylated glycerol</Keywords>
      <Keywords>Fat substitute</Keywords>
      <Keywords>Humans</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David H. Bechtel</Name>
        <Affiliation>Best Foods, Division of CPC International, 150 Pierce St., Somerset, NJ 08873, USA. Electronic address: david.bechtel@intertek.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of sanitary pads with a polymeric foam absorbent core.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26255105</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.028</DOI>
    <KeywordList>
      <Keywords>Emollient</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Menstrual hygiene</Keywords>
      <Keywords>Menstrual pad</Keywords>
      <Keywords>Polyacrylate</Keywords>
      <Keywords>Polymeric foam</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Sanitary pad</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kara E. Woeller</Name>
        <Affiliation>Global Product Stewardship, Feminine Care Business Unit, The Procter &amp; Gamble Company, Cincinnati, OH, USA. Electronic address: Woeller.ke@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anne E. Hochwalt</Name>
        <Affiliation>Global Product Stewardship, Feminine Care Business Unit, The Procter &amp; Gamble Company, Cincinnati, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory risk assessment approaches for synthetic mineral fibres.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26253001</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.029</DOI>
    <KeywordList>
      <Keywords>ASW</Keywords>
      <Keywords>Assessment</Keywords>
      <Keywords>Harmonisation</Keywords>
      <Keywords>Management</Keywords>
      <Keywords>OEL</Keywords>
      <Keywords>RCF</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Risk</Keywords>
      <Keywords>SMF</Keywords>
      <Keywords>SVF</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul Harrison</Name>
        <Affiliation>IEH Consulting, No.4 The Lodge Business Centre, Rectory Farm, Marston Trussell, Market Harborough, Leicestershire LE16 9TU, UK. Electronic address: paul@iehconsulting.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Philip Holmes</Name>
        <Affiliation>IEH Consulting, No.4 The Lodge Business Centre, Rectory Farm, Marston Trussell, Market Harborough, Leicestershire LE16 9TU, UK. Electronic address: phil@iehconsulting.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Bevan</Name>
        <Affiliation>IEH Consulting, No.4 The Lodge Business Centre, Rectory Farm, Marston Trussell, Market Harborough, Leicestershire LE16 9TU, UK. Electronic address: ruth@iehconsulting.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus Kamps</Name>
        <Affiliation>ECFIA, 3, rue du Colonel Moll, 75017 Paris, France. Electronic address: kkamps@unifrax.com.</Affiliation>
      </Author>
      <Author>
        <Name>Leonard Levy</Name>
        <Affiliation>Cranfield University, College Road, Cranfield, Bedfordshire MK43 0AL, UK. Electronic address: len.levy@cranfield.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Helmut Greim</Name>
        <Affiliation>Technical University, Arcisstraße 21, D-80333 Munich, Germany. Electronic address: helmut.greim@lrz.tu-muenchen.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Establishing best practise in the application of expert review of mutagenicity under ICH M7.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26248005</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.018</DOI>
    <KeywordList>
      <Keywords>Ames</Keywords>
      <Keywords>Expert rule-based</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>ICH M7</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Statistical</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chris Barber</Name>
        <Affiliation>Lhasa Limited, Leeds, UK. Electronic address: chris.barber@lhasalimited.org.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander Amberg</Name>
        <Affiliation>Sanofi-Aventis Deutschland GmbH, DSAR Preclinical Safety, Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Custer</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, New Brunswick, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Krista L. Dobo</Name>
        <Affiliation>Pfizer, Drug Safety Research and Development, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Glowienke</Name>
        <Affiliation>Novartis Institutes for Biomedical Research, Department of Preclinical Safety, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Jacky Van Gompel</Name>
        <Affiliation>Janssen, Drug Safety Sciences, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Steve Gutsell</Name>
        <Affiliation>Unilever, Safety and Environmental Assurance Centre, Colworth, Beds, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jim Harvey</Name>
        <Affiliation>GlaxoSmithkline, Computational Toxicology, Ware, Herts, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Masamitsu Honma</Name>
        <Affiliation>National Institute of Health Sciences, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle O. Kenyon</Name>
        <Affiliation>Pfizer, Drug Safety Research and Development, Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naomi Kruhlak</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Muster</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Lidiya Stavitskaya</Name>
        <Affiliation>FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Teasdale</Name>
        <Affiliation>AstraZeneca, Macclesfield, Cheshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Vessey</Name>
        <Affiliation>Lhasa Limited, Leeds, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Joerg Wichard</Name>
        <Affiliation>Bayer, HealthCare, Genetic Toxicology, Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Manufacturing doubt about endocrine disrupter science--A rebuttal of industry-sponsored critical comments on the UNEP/WHO report "State of the Science of Endocrine Disrupting Chemicals 2012".</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26239693</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.026</DOI>
    <KeywordList>
      <Keywords>EDCs</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Endocrine disruptors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Åke Bergman</Name>
        <Affiliation>Swedish Toxicology Sciences Research Center (Swetox), Södertälje, Sweden. Electronic address: ake.bergman@swetox.se.</Affiliation>
      </Author>
      <Author>
        <Name>Georg Becher</Name>
        <Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce Blumberg</Name>
        <Affiliation>University of California, Irvine, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Poul Bjerregaard</Name>
        <Affiliation>University of Southern Denmark, Odense, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Riana Bornman</Name>
        <Affiliation>School of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Ingvar Brandt</Name>
        <Affiliation>Uppsala University, Uppsala, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie C. Casey</Name>
        <Affiliation>University of California, Irvine, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Heloise Frouin</Name>
        <Affiliation>Vancouver Aquarium Marine Science Center, Vancouver, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Linda C. Giudice</Name>
        <Affiliation>University of California, San Francisco, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jerrold J. Heindel</Name>
        <Affiliation>National Institute of Environmental Health Sciences, Research Triangle Park, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Taisen Iguchi</Name>
        <Affiliation>National Institute for Basic Biology, Okazaki, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Jobling</Name>
        <Affiliation>Brunel University London, Uxbridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Karen A. Kidd</Name>
        <Affiliation>University of New Brunswick, Saint John, New Brunswick, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Kortenkamp</Name>
        <Affiliation>Brunel University London, Uxbridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>P. Monica Lind</Name>
        <Affiliation>Uppsala University, Uppsala, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Derek Muir</Name>
        <Affiliation>Environment Canada, Burlington, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Roseline Ochieng</Name>
        <Affiliation>Aga Khan University Hospital, Nairobi, Kenya.</Affiliation>
      </Author>
      <Author>
        <Name>Erik Ropstad</Name>
        <Affiliation>Norwegian University of Life Sciences, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Peter S. Ross</Name>
        <Affiliation>Vancouver Aquarium Marine Science Center, Vancouver, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Niels Erik Skakkebaek</Name>
        <Affiliation>Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Jorma Toppari</Name>
        <Affiliation>University of Turku, Turku, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Laura N. Vandenberg</Name>
        <Affiliation>University of Massachusetts Amherst, Amherst, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tracey J. Woodruff</Name>
        <Affiliation>University of California, San Francisco, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. Thomas Zoeller</Name>
        <Affiliation>University of Massachusetts Amherst, Amherst, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In utero arsenic exposure in mice and early life susceptibility to cancer.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26239692</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.023</DOI>
    <KeywordList>
      <Keywords>Adrenal</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>In utero</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>Prenatal</Keywords>
      <Keywords>Transplacental carcinogenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael R. Garry</Name>
        <Affiliation>Exponent, 15375 SE 30th Place, Suite 250, Bellevue, WA, 98007, USA. Electronic address: mgarry@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Annette B. Santamaria</Name>
        <Affiliation>Rimkus Consulting Group, 8 Greenway Plaza, Suite 500, Houston, TX, 77046, USA. Electronic address: asantamaria@rimkus.com.</Affiliation>
      </Author>
      <Author>
        <Name>Amy L. Williams</Name>
        <Affiliation>Exponent, 1800 Diagonal Road, Suite 500, Alexandria, VA, 22314, USA. Electronic address: awilliams@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>John M. DeSesso</Name>
        <Affiliation>Exponent, 1800 Diagonal Road, Suite 500, Alexandria, VA, 22314, USA. Electronic address: Jdesesso@exponent.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impact analysis of ICH S9 on non-clinical development of anticancer drugs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26232707</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.022</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Animal welfare</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Centralised procedure</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>EMA</Keywords>
      <Keywords>ICH S9</Keywords>
      <Keywords>International Conference for Harmonisation</Keywords>
      <Keywords>Oncology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Milton Bonelli</Name>
        <Affiliation>European Medicines Agency (EMA), 30 Churchill Place, E3 2PY, London, UK. Electronic address: Milton.Bonelli@ema.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Francesca Di Giuseppe</Name>
        <Affiliation>Government Affairs &amp; Strategic Health Initiatives Analyst, AbbVie, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Sonja Beken</Name>
        <Affiliation>Belgian Federal Agency for Medicines and Health Products, also Chair of EMA Joint Expert Group on 3Rs, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of pyrogenic response of lipoteichoic acid by the monocyte activation test and the rabbit pyrogen test.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26232706</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.025</DOI>
    <KeywordList>
      <Keywords>Alternative methods</Keywords>
      <Keywords>Gram-positive bacteria</Keywords>
      <Keywords>Human cryopreserved whole blood</Keywords>
      <Keywords>Lipoteichoic acid</Keywords>
      <Keywords>Monocyte activation test</Keywords>
      <Keywords>Rabbit pyrogen test</Keywords>
      <Keywords>Sanitary surveillance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Izabela Gimenes</Name>
        <Affiliation>National Institute for Quality Control in Health, Oswaldo Cruz Foundation, Avenida Brasil 4365, 21040-900, Rio de Janeiro, Brazil. Electronic address: izabela.gimenes@incqs.fiocruz.br.</Affiliation>
      </Author>
      <Author>
        <Name>Cristiane Caldeira</Name>
        <Affiliation>National Institute for Quality Control in Health, Oswaldo Cruz Foundation, Avenida Brasil 4365, 21040-900, Rio de Janeiro, Brazil. Electronic address: cristiane.caldeira@incqs.fiocruz.br.</Affiliation>
      </Author>
      <Author>
        <Name>Octavio Augusto França Presgrave</Name>
        <Affiliation>National Institute for Quality Control in Health, Oswaldo Cruz Foundation, Avenida Brasil 4365, 21040-900, Rio de Janeiro, Brazil. Electronic address: octavio.presgrave@incqs.fiocruz.br.</Affiliation>
      </Author>
      <Author>
        <Name>Wlamir Correa de Moura</Name>
        <Affiliation>National Institute for Quality Control in Health, Oswaldo Cruz Foundation, Avenida Brasil 4365, 21040-900, Rio de Janeiro, Brazil. Electronic address: wlamir.moura@incqs.fiocruz.br.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Helena Simões Villas Boas</Name>
        <Affiliation>National Institute for Quality Control in Health, Oswaldo Cruz Foundation, Avenida Brasil 4365, 21040-900, Rio de Janeiro, Brazil. Electronic address: maria.villas@incqs.fiocruz.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carcinogenicity testing of eliglustat in mice and rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26232705</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.024</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Cerdelga</Keywords>
      <Keywords>Eliglustat</Keywords>
      <Keywords>Gaucher disease</Keywords>
      <Keywords>Glucosylceramide synthase inhibitor</Keywords>
      <Keywords>Lysosomal storage disease</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rafif Dagher</Name>
        <Affiliation>Genzyme, Waltham, MA 02451, USA. Electronic address: rdagher@catabasis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Malene Watzinger</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux, France. Electronic address: malene.watzinger@glpg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guillaume Chevalier</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux, France. Electronic address: guillaume.chevalier@fr.citoxlab.com.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Thirion-Delalande</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux, France. Electronic address: catherine.thirion-delalande@fr.citoxlab.com.</Affiliation>
      </Author>
      <Author>
        <Name>Frederic Gervais</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux, France. Electronic address: frederic.gervais@fr.citoxlab.com.</Affiliation>
      </Author>
      <Author>
        <Name>Roy Forster</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux, France. Electronic address: roy.forster@fr.citoxlab.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical safety testing of biopharmaceuticals--Addressing current challenges of these novel and emerging therapies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26219199</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.019</DOI>
    <KeywordList>
      <Keywords>Biopharmaceuticals</Keywords>
      <Keywords>Gene and cell therapies</Keywords>
      <Keywords>Immunomodulation</Keywords>
      <Keywords>Monoclonal antibodies</Keywords>
      <Keywords>Non-clinical safety</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Pharmcodynamics</Keywords>
      <Keywords>Recombinant proteins</Keywords>
      <Keywords>Vaccines</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Frank R. Brennan</Name>
        <Affiliation>UCB Pharma, Slough, UK. Electronic address: frank.brennan@ucb.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Baumann</Name>
        <Affiliation>Bayer Pharma AG, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Guenter Blaich</Name>
        <Affiliation>Abbvie GmbH, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lolke de Haan</Name>
        <Affiliation>Medimmune LLC, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Rajni Fagg</Name>
        <Affiliation>Glaxo Smithkline Pharma, Stevenage, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Kiessling</Name>
        <Affiliation>Novartis Pharma, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Sven Kronenberg</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Mathias Locher</Name>
        <Affiliation>Covagen, Zurich, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Milton</Name>
        <Affiliation>Novartis Pharma, Boston, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jay Tibbitts</Name>
        <Affiliation>UCB Pharma, Slough, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Ulrich</Name>
        <Affiliation>Novartis Pharma, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Lucinda Weir</Name>
        <Affiliation>Glaxo Smithkline Pharma, Stevenage, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment for ethanol-based topical antiseptic use by health care workers: Evaluation of developmental toxicity potential.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26212636</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.015</DOI>
    <KeywordList>
      <Keywords>Blood alcohol concentration</Keywords>
      <Keywords>Dermal exposure</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Dose–response</Keywords>
      <Keywords>Ethanol</Keywords>
      <Keywords>Hand sanitizers</Keywords>
      <Keywords>Healthcare workers</Keywords>
      <Keywords>Margin of exposure</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrew Maier</Name>
        <Affiliation>Department Environmental Health, University Cincinnati College of Medicine, Cincinnati, OH, USA. Electronic address: maierma@ucmail.uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jerald L. Ovesen</Name>
        <Affiliation>Department Environmental Health, University Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Casey L. Allen</Name>
        <Affiliation>Department Environmental Health, University Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond G. York</Name>
        <Affiliation>RG York and Associates LLC, Manlius, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bernard K. Gadagbui</Name>
        <Affiliation>Toxicology Excellence For Risk Assessment, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher R. Kirman</Name>
        <Affiliation>Summit Toxicology LLP, Cleveland, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Torka Poet</Name>
        <Affiliation>Summit Toxicology, LLP, Richland, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio Quiñones-Rivera</Name>
        <Affiliation>GOJO Industries, Inc., Akron, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Using gene expression profiling to evaluate cellular responses in mouse lungs exposed to V2O5 and a group of other mouse lung tumorigens and non-tumorigens.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26210822</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.017</DOI>
    <KeywordList>
      <Keywords>Functional ontology</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Mouse lung</Keywords>
      <Keywords>Vanadium pentoxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael B. Black</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, Six Davis Drive, PO Box 12137, Research Triangle Park, NC 27709, USA. Electronic address: mblack@thehamner.org.</Affiliation>
      </Author>
      <Author>
        <Name>Darol E. Dodd</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, Six Davis Drive, PO Box 12137, Research Triangle Park, NC 27709, USA. Electronic address: Darol.Dodd@crl.com.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick D. McMullen</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, Six Davis Drive, PO Box 12137, Research Triangle Park, NC 27709, USA. Electronic address: pmcmullen@thehamner.org.</Affiliation>
      </Author>
      <Author>
        <Name>Salil Pendse</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, Six Davis Drive, PO Box 12137, Research Triangle Park, NC 27709, USA. Electronic address: spendse@thehamner.org.</Affiliation>
      </Author>
      <Author>
        <Name>Judith A. MacGregor</Name>
        <Affiliation>Toxicology Consulting Services, 26881 Wedgewood Dr., Bonita Springs, FL 34134, USA. Electronic address: jamacgregor101@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>B. Bhaskar Gollapudi</Name>
        <Affiliation>Exponent Inc., 1910 St. Andrews St., Midland, MI 48640, USA. Electronic address: bgollapudi@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, Six Davis Drive, PO Box 12137, Research Triangle Park, NC 27709, USA. Electronic address: mandersen@thehamner.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>New investigations into the genotoxicity of cobalt compounds and their impact on overall assessment of genotoxic risk.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26210821</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.016</DOI>
    <KeywordList>
      <Keywords>Cobalt compounds</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Overall assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David Kirkland</Name>
        <Affiliation>Kirkland Consulting, PO Box 79, Tadcaster LS24 0AS, United Kingdom. Electronic address: dkirkland@genetoxconsulting.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Tom Brock</Name>
        <Affiliation>Division of Occupational and Environmental Medicine, Department of Community &amp; Family Medicine, Box 3400, Duke University Medical Center, Durham, NC 27705, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hasnaà Haddouk</Name>
        <Affiliation>CitoxLab, BP 563, 27005 Evreux, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Victoria Hargeaves</Name>
        <Affiliation>Genetic Toxicology, Covance Laboratories Limited, Otley Road, Harrogate HG3 1PY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Melvyn Lloyd</Name>
        <Affiliation>Genetic Toxicology, Covance Laboratories Limited, Otley Road, Harrogate HG3 1PY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Mc Garry</Name>
        <Affiliation>Genetic Toxicology, Covance Laboratories Limited, Otley Road, Harrogate HG3 1PY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond Proudlock</Name>
        <Affiliation>Charles River Laboratories Preclinical Services, Montreal, 22022 Transcanadienne, Senneville, Quebec H9X 3R3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Séverine Sarlang</Name>
        <Affiliation>CitoxLab, BP 563, 27005 Evreux, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Katherina Sewald</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine, Nikolai-Fuchs-Str. 1, 30625 Hannover, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Guillaume Sire</Name>
        <Affiliation>CitoxLab, BP 563, 27005 Evreux, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Sokolowski</Name>
        <Affiliation>Harlan Cytotest Cell Research, In den Leppsteinswiesen 19, 64380 Roßdorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christina Ziemann</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine, Nikolai-Fuchs-Str. 1, 30625 Hannover, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and sub-chronic toxicity study of diaveridine in Wistar rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26209270</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.010</DOI>
    <KeywordList>
      <Keywords>Acute study</Keywords>
      <Keywords>Diaminopyrimidines</Keywords>
      <Keywords>Diaveridine</Keywords>
      <Keywords>Sub-chronic study</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xu Wang</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shijia Su</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Awais Ihsan</Name>
        <Affiliation>Department of Biosciences, COMSATS Institute of Information Technology, Sahiwal, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Huang</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongmei Chen</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guyue Cheng</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenli Liu</Name>
        <Affiliation>Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yulian Wang</Name>
        <Affiliation>Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China. Electronic address: wangyulian@mail.hzau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zonghui Yuan</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China; MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China; Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Wuhan, Hubei, China. Electronic address: yuan5802@mail.hzau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hazard banding in compliance with the new Globally Harmonised System (GHS) for use in control banding tools.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26206396</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.014</DOI>
    <KeywordList>
      <Keywords>COSHH essentials</Keywords>
      <Keywords>Control banding tools</Keywords>
      <Keywords>Globally Harmonised System (GHS)</Keywords>
      <Keywords>H statements</Keywords>
      <Keywords>Hazard banding</Keywords>
      <Keywords>Hazardous substances</Keywords>
      <Keywords>Principle of substitution</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Stoffenmanager(®)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mario Arnone</Name>
        <Affiliation>Institute for Occupational Safety and Health of the German Social Accident Insurance (IFA), Alte Heerstr. 111, 53757 Sankt Augustin, Germany. Electronic address: mario.arnone@dguv.de.</Affiliation>
      </Author>
      <Author>
        <Name>Dorothea Koppisch</Name>
        <Affiliation>Institute for Occupational Safety and Health of the German Social Accident Insurance (IFA), Alte Heerstr. 111, 53757 Sankt Augustin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Smola</Name>
        <Affiliation>Institute for Occupational Safety and Health of the German Social Accident Insurance (IFA), Alte Heerstr. 111, 53757 Sankt Augustin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Gabriel</Name>
        <Affiliation>Institute for Occupational Safety and Health of the German Social Accident Insurance (IFA), Alte Heerstr. 111, 53757 Sankt Augustin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Koen Verbist</Name>
        <Affiliation>Cosanta B.V., Laan van Kronenburg 14, 1183 AS Amstelveen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Remco Visser</Name>
        <Affiliation>TNO, Post Box 155, 2600 AD Delft, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulation of non-relevant metabolites of plant protection products in drinking and groundwater in the EU: Current status and way forward.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26192637</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.023</DOI>
    <KeywordList>
      <Keywords>Drinking water</Keywords>
      <Keywords>Groundwater</Keywords>
      <Keywords>Non-relevant metabolite</Keywords>
      <Keywords>Pesticide</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>TTC</Keywords>
      <Keywords>Threshold of toxicological concern</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>V. Laabs</Name>
        <Affiliation>BASF SE, APD/S, 67117 Limburgerhof, Germany. Electronic address: volker.laabs@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>C. Leake</Name>
        <Affiliation>Bayer CropScience, Alfred Nobel Str. 50, 40789 Monheim am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>P. Botham</Name>
        <Affiliation>Syngenta, Jealott's Hill, Bracknell, Berkshire RG42 6EY, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>S. Melching-Kollmuß</Name>
        <Affiliation>BASF SE, GUP/PP, Z470, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Concerning statements made in "Development of a category approach to predict the testicular toxicity of chemical substances structurally related to ethylene glycol methyl ether" [Regul. Toxicol. Pharmacol. 70 (3) (2014) 711-719].</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26190305</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.004</DOI>
    <KeywordList>
      <Keywords>2-(2-ethoxyethoxy)ethanol</Keywords>
      <Keywords>Category approach</Keywords>
      <Keywords>Diethylene glycol ethyl ether</Keywords>
      <Keywords>Methoxyethanol</Keywords>
      <Keywords>Repeated-dose toxicity</Keywords>
      <Keywords>Testicular toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. R. Kelsey</Name>
        <Affiliation>Chemsage Ltd, Product Stewardship, PO Box 431, Fleet, Hampshire GU51 9BP, United Kingdom. Electronic address: kelseyjr@chemsage.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>K. Smet</Name>
        <Affiliation>INEOS nv, Nieuwe Weg 1, Haven 1053, 2070 Zwijndrecht, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Heavy metals contamination in lipsticks and their associated health risks to lipstick consumers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26190304</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.005</DOI>
    <KeywordList>
      <Keywords>Health risk assessment</Keywords>
      <Keywords>Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES)</Keywords>
      <Keywords>Lipstick</Keywords>
      <Keywords>Microwave digestion</Keywords>
      <Keywords>Price</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Airin Zakaria</Name>
        <Affiliation>Department of Environmental and Occupational Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Bin Ho</Name>
        <Affiliation>Department of Environmental and Occupational Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia. Electronic address: yubin@upm.edu.my.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Microbiological toxicity of tilmicosin on human colonic microflora in chemostats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26190303</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.008</DOI>
    <KeywordList>
      <Keywords>Chemostat</Keywords>
      <Keywords>Human intestinal flora</Keywords>
      <Keywords>Microbiological toxicity</Keywords>
      <Keywords>Resistance</Keywords>
      <Keywords>Tilmicosin</Keywords>
      <Keywords>Virulence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haihong Hao</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junping Yao</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qinghua Wu</Name>
        <Affiliation>College of Life Science, Yangtze University, Jingzhou, Hubei, China; Faculty of Informatics and Management, Center for Basic and Applied Research, University of Hradec Kralove, Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Yajing Wei</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Menghong Dai</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zahid Iqbal</Name>
        <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Wang</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yulian Wang</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingli Huang</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongmei Chen</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanfei Tao</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenli Liu</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zonghui Yuan</Name>
        <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China; MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei 430070, China. Electronic address: yuan5802@mail.hzau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Children's liver chemistries vary with age and gender and require customized pediatric reference ranges.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26190302</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.013</DOI>
    <KeywordList>
      <Keywords>Alanine aminotransferase</Keywords>
      <Keywords>Alkaline phosphatase</Keywords>
      <Keywords>Laboratory reference ranges</Keywords>
      <Keywords>Liver chemistries</Keywords>
      <Keywords>Pediatric clinical trials</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heide A. Stirnadel-Farrant</Name>
        <Affiliation>Worldwide Epidemiology, GlaxoSmithKline, Stockley Park, UK. Electronic address: heide.a.stirnadel@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nicholas Galwey</Name>
        <Affiliation>Worldwide Epidemiology, GlaxoSmithKline, Stockley Park, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Chanchal Bains</Name>
        <Affiliation>Worldwide Epidemiology, GlaxoSmithKline, Stockley Park, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Caroline Yancey</Name>
        <Affiliation>Department of Epidemiology, University of North Carolina, Gillings School of Global Public Health, Chapel Hill, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christine M. Hunt</Name>
        <Affiliation>Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA; Durham Veterans Administration Medical Center, Durham, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of in vitro and in vivo safety profile of the Indian traditional medicinal plant Grewia tiliaefolia.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26188119</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.011</DOI>
    <KeywordList>
      <Keywords>Ames assay</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Haematology</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>PBMC</Keywords>
      <Keywords>Salmonella typhimurium</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>Wistar rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sheeja Malar Dicson</Name>
        <Affiliation>Department of Biotechnology, Alagappa University, Karaikudi 630 004, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Muniasamy Samuthirapandi</Name>
        <Affiliation>Centre for Pheromone Technology, Department of Animal Science, Bharathidasan University, Tiruchirappalli 620 024, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Archunan Govindaraju</Name>
        <Affiliation>Centre for Pheromone Technology, Department of Animal Science, Bharathidasan University, Tiruchirappalli 620 024, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pandima Devi Kasi</Name>
        <Affiliation>Department of Biotechnology, Alagappa University, Karaikudi 630 004, Tamil Nadu, India. Electronic address: devikasi@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pre-clinical in vitro and in vivo safety evaluation of Cimicifuga heracleifolia.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26188118</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.006</DOI>
    <KeywordList>
      <Keywords>Cimicifuga heracleifolia</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>Traditional medicine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Won Yun</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Ran You</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Soon Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Young Cho</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyun Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Hee Yoon</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Euna Kwon</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Doo Hyun Chung</Name>
        <Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Tae Kim</Name>
        <Affiliation>Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ja June Jang</Name>
        <Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Hwan Che</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Biomedical Center for Animal Resource and Development, N-BIO, Seoul National University, Seoul, Republic of Korea. Electronic address: casache@snu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Byeong Cheol Kang</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Biomedical Center for Animal Resource and Development, N-BIO, Seoul National University, Seoul, Republic of Korea; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Designed Animal and Transplantation Research Institute, Institute of GreenBio Science Technology, Seoul National University, Pyeongchang-gun, Gangwon-do, Republic of Korea. Electronic address: bckang@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and sub-acute oral toxicological evaluations and mutagenicity of N-carbamylglutamate (NCG).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26188117</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.009</DOI>
    <KeywordList>
      <Keywords>Acute/subacute toxicity</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>N-carbamylglutamate</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xin Wu</Name>
        <Affiliation>Observation and Experiment Station of Animal Nutrition and Feed Science in South-Central China, Ministry of Agriculture, Hunan Provincial Engineering Research Center for Healthy Livestock and Poultry Production, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha 410125, China; State Key Laboratory of Food Science and Technology and College of Life Science and Food Engineering, Nanchang University, Nanchang 330031, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Wan</Name>
        <Affiliation>Observation and Experiment Station of Animal Nutrition and Feed Science in South-Central China, Ministry of Agriculture, Hunan Provincial Engineering Research Center for Healthy Livestock and Poultry Production, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha 410125, China. Electronic address: w.dan@isa.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Chunyan Xie</Name>
        <Affiliation>Observation and Experiment Station of Animal Nutrition and Feed Science in South-Central China, Ministry of Agriculture, Hunan Provincial Engineering Research Center for Healthy Livestock and Poultry Production, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha 410125, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tiejun Li</Name>
        <Affiliation>Observation and Experiment Station of Animal Nutrition and Feed Science in South-Central China, Ministry of Agriculture, Hunan Provincial Engineering Research Center for Healthy Livestock and Poultry Production, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha 410125, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruilin Huang</Name>
        <Affiliation>Observation and Experiment Station of Animal Nutrition and Feed Science in South-Central China, Ministry of Agriculture, Hunan Provincial Engineering Research Center for Healthy Livestock and Poultry Production, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha 410125, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xugang Shu</Name>
        <Affiliation>State Key Laboratory of Food Science and Technology and College of Life Science and Food Engineering, Nanchang University, Nanchang 330031, China; Guangzhou Tanke BIO-TECH Co. Ltd., Guangzhou 510800, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Ruan</Name>
        <Affiliation>State Key Laboratory of Food Science and Technology and College of Life Science and Food Engineering, Nanchang University, Nanchang 330031, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zeyuan Deng</Name>
        <Affiliation>State Key Laboratory of Food Science and Technology and College of Life Science and Food Engineering, Nanchang University, Nanchang 330031, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yulong Yin</Name>
        <Affiliation>Observation and Experiment Station of Animal Nutrition and Feed Science in South-Central China, Ministry of Agriculture, Hunan Provincial Engineering Research Center for Healthy Livestock and Poultry Production, Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha 410125, China; State Key Laboratory of Food Science and Technology and College of Life Science and Food Engineering, Nanchang University, Nanchang 330031, China. Electronic address: yinyulong@isa.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshop.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26188116</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.007</DOI>
    <KeywordList>
      <Keywords>3Rs principle (replace, reduce, refine animal testing)</Keywords>
      <Keywords>Alternatives to animal testing</Keywords>
      <Keywords>Cross-sector collaboration</Keywords>
      <Keywords>Data sharing</Keywords>
      <Keywords>International harmonization</Keywords>
      <Keywords>Regulatory acceptance</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Research framework programmes</Keywords>
      <Keywords>Test method validation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tzutzuy Ramirez</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany. Electronic address: tzutzuy.ramirez-hernandez@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sonja Beken</Name>
        <Affiliation>Federal Agency for Medicines and Health Products, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Magda Chlebus</Name>
        <Affiliation>European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Graham Ellis</Name>
        <Affiliation>Givaudan International SA, Vernier, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Claudius Griesinger</Name>
        <Affiliation>European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra De Jonghe</Name>
        <Affiliation>Preclinical Development and Safety, Janssen Research &amp; Development, Janssen Pharmaceutica NV, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Irene Manou</Name>
        <Affiliation>European Partnership for Alternative Approaches to Animal Testing (EPAA), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Annette Mehling</Name>
        <Affiliation>BASF Personal Care and Nutrition GmbH, Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Kerstin Reisinger</Name>
        <Affiliation>Henkel AG &amp; Co KGaA, Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Laura H. Rossi</Name>
        <Affiliation>European Chemicals Agency, Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Jan van Benthem</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Willem van der Laan</Name>
        <Affiliation>Medicines Evaluation Board, Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Renate Weissenhorn</Name>
        <Affiliation>European Commission, Directorate General Enterprise and Industry, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Neubiberg, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26188115</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.012</DOI>
    <KeywordList>
      <Keywords>Dosimetry</Keywords>
      <Keywords>Ethylene glycol phenyl ether</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Toxicokinetics</Keywords>
      <Keywords>Uncertainty factors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John A. Troutman</Name>
        <Affiliation>Central Product Safety, The Procter &amp; Gamble Company, Cincinnati, OH, USA. Electronic address: troutman.ja@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>David L. Rick</Name>
        <Affiliation>Toxicology &amp; Environmental Research &amp; Consulting, The Dow Chemical Company, Midland, MI, USA. Electronic address: LRick@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sharon B. Stuard</Name>
        <Affiliation>Central Product Safety, The Procter &amp; Gamble Company, Cincinnati, OH, USA. Electronic address: stuard.sb@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Fisher</Name>
        <Affiliation>National Center for Toxicological Research, Food &amp; Drug Administration, Jefferson, AR, USA. Electronic address: jeffrey.fisher@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Bartels</Name>
        <Affiliation>Toxicology &amp; Environmental Research &amp; Consulting, The Dow Chemical Company, Midland, MI, USA. Electronic address: MJBartels@dow.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic toxicity and oncogenicity of decamethylcyclopentasiloxane in the Fischer 344 Rat.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26184430</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.06.014</DOI>
    <KeywordList>
      <Keywords>Adenocarcinoma</Keywords>
      <Keywords>Bioassay</Keywords>
      <Keywords>Decamethylcyclopentasiloxane</Keywords>
      <Keywords>Oncogenicity</Keywords>
      <Keywords>Reproductive</Keywords>
      <Keywords>Siloxane</Keywords>
      <Keywords>Uterine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul A. Jean</Name>
        <Affiliation>Dow Corning Corporation, 2200 West Salzburg Road, Midland, MI, 48686-0994, USA. Electronic address: paul.a.jean@dowcorning.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen P. Plotzke</Name>
        <Affiliation>Dow Corning Corporation, 2200 West Salzburg Road, Midland, MI, 48686-0994, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony R. Scialli</Name>
        <Affiliation>Scialli Consulting, 3033 Wilson Blvd, Arlington, VA, 22201, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory aspects of nanotechnology in the agri/feed/food sector in EU and non-EU countries.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26169479</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.016</DOI>
    <KeywordList>
      <Keywords>Agriculture</Keywords>
      <Keywords>Feed</Keywords>
      <Keywords>Food</Keywords>
      <Keywords>Hazard</Keywords>
      <Keywords>Legislation</Keywords>
      <Keywords>Nano</Keywords>
      <Keywords>Nanomaterial</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Risk</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Valeria Amenta</Name>
        <Affiliation>JRC, Nanobiosciences Unit, Institute for Health and Consumer Protection, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Aschberger</Name>
        <Affiliation>JRC, Nanobiosciences Unit, Institute for Health and Consumer Protection, Ispra, Italy. Electronic address: karin.aschberger@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Arena</Name>
        <Affiliation>JRC, Nanobiosciences Unit, Institute for Health and Consumer Protection, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Bouwmeester</Name>
        <Affiliation>RIKILT, Wageningen UR, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Filipa Botelho Moniz</Name>
        <Affiliation>JRC, Nanobiosciences Unit, Institute for Health and Consumer Protection, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Puck Brandhoff</Name>
        <Affiliation>RIKILT, Wageningen UR, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Stefania Gottardo</Name>
        <Affiliation>JRC, Nanobiosciences Unit, Institute for Health and Consumer Protection, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Hans J. P. Marvin</Name>
        <Affiliation>RIKILT, Wageningen UR, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Agnieszka Mech</Name>
        <Affiliation>JRC, Nanobiosciences Unit, Institute for Health and Consumer Protection, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Laia Quiros Pesudo</Name>
        <Affiliation>JRC, Nanobiosciences Unit, Institute for Health and Consumer Protection, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Hubert Rauscher</Name>
        <Affiliation>JRC, Nanobiosciences Unit, Institute for Health and Consumer Protection, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Reinhilde Schoonjans</Name>
        <Affiliation>EFSA, Scientific Committee and FEED Additives Unit, Parma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Vittoria Vettori</Name>
        <Affiliation>EFSA, Scientific Committee and FEED Additives Unit, Parma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Weigel</Name>
        <Affiliation>RIKILT, Wageningen UR, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ruud J. Peters</Name>
        <Affiliation>RIKILT, Wageningen UR, Wageningen, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Determining the safety of microbial cultures for consumption by humans and animals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26165564</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.003</DOI>
    <KeywordList>
      <Keywords>Fermented feed</Keywords>
      <Keywords>Fermented food</Keywords>
      <Keywords>Food safety</Keywords>
      <Keywords>Microbial culture safety</Keywords>
      <Keywords>Probiotic safety</Keywords>
      <Keywords>Safety decision tree</Keywords>
      <Keywords>Safety evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael W. Pariza</Name>
        <Affiliation>Department of Food Science, University of Wisconsin-Madison, Madison, WI, USA. Electronic address: mwpariza@wisc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin O. Gillies</Name>
        <Affiliation>Kevin O. Gillies Consulting Services, LLC, Denver, Co, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah F. Kraak-Ripple</Name>
        <Affiliation>DuPont Nutrition and Health, Madison, WI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory Leyer</Name>
        <Affiliation>UAS Labs, Madison, WI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amy B. Smith</Name>
        <Affiliation>DuPont Nutrition and Health, Madison, WI, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Authors' response to Letter to the Editor by Jeff Kelsey et al. "Response to 'Development of a category approach to predict the testicular toxicity of chemical substances structurally related to ethylene glycol methyl ether.'" 2015.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26165563</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.002</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Category approach</Keywords>
      <Keywords>Methoxyacetic acid</Keywords>
      <Keywords>Repeated-dose toxicity</Keywords>
      <Keywords>Testicular toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Takashi Yamada</Name>
        <Affiliation>National Institute of Technology and Evaluation, Japan. Electronic address: yamada-takashi@nite.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yushiro Tanaka</Name>
        <Affiliation>National Institute of Technology and Evaluation, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ryuichi Hasegawa</Name>
        <Affiliation>National Institute of Technology and Evaluation, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuki Sakuratani</Name>
        <Affiliation>National Institute of Technology and Evaluation, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasushi Yamazoe</Name>
        <Affiliation>Food Safety Commission, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Atsushi Ono</Name>
        <Affiliation>National Institute of Health Sciences, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akihiko Hirose</Name>
        <Affiliation>National Institute of Health Sciences, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Hayashi</Name>
        <Affiliation>BioSafety Research Center, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Net gain analysis, an addition to responder analysis--The case of antipsychotic treatment of acute mania.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26164267</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.020</DOI>
    <KeywordList>
      <Keywords>Bipolar mania</Keywords>
      <Keywords>Efficacy</Keywords>
      <Keywords>Pharmacotherapy</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Responder analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. C. M. Welten</Name>
        <Affiliation>Dept. of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Medicines Evaluation Board, Utrecht, The Netherlands. Electronic address: c.c.welten@amc.uva.nl.</Affiliation>
      </Author>
      <Author>
        <Name>M. W. J. Koeter</Name>
        <Affiliation>Dept. of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>T. D. Wohlfarth</Name>
        <Affiliation>Medicines Evaluation Board, Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>J. G. Storosum</Name>
        <Affiliation>Dept. of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>W. van den Brink</Name>
        <Affiliation>Dept. of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>C. C. Gispen-de Wied</Name>
        <Affiliation>Medicines Evaluation Board, Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>H. G. M. Leufkens</Name>
        <Affiliation>Medicines Evaluation Board, Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>D. A. J. P. Denys</Name>
        <Affiliation>Dept. of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>How reliable are crystalline silica dust concentration measurements?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26160597</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.07.001</DOI>
    <KeywordList>
      <Keywords>Crystalline silica</Keywords>
      <Keywords>Interlaboratory testing</Keywords>
      <Keywords>Intralaboratory testing</Keywords>
      <Keywords>Precision</Keywords>
      <Keywords>Variability</Keywords>
      <Keywords>X-ray diffraction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>L. A. Cox</Name>
        <Affiliation>Cox Associates and University of Colorado, 503 Franklin St, Denver, CO 80218, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. R. Van Orden</Name>
        <Affiliation>RJ Lee Group, Inc., 350 Hochberg Road, Monroeville, PA 15146, USA. Electronic address: drew@rjlg.com.</Affiliation>
      </Author>
      <Author>
        <Name>R. J. Lee</Name>
        <Affiliation>RJ Lee Group, Inc., 350 Hochberg Road, Monroeville, PA 15146, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. M. Arlauckas</Name>
        <Affiliation>RJ Lee Group, Inc., 350 Hochberg Road, Monroeville, PA 15146, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. A. Kautz</Name>
        <Affiliation>RJ Lee Group, Inc., 350 Hochberg Road, Monroeville, PA 15146, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. L. Warzel</Name>
        <Affiliation>RJ Lee Group, Inc., 350 Hochberg Road, Monroeville, PA 15146, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. F. Bailey</Name>
        <Affiliation>Vulcan Materials Company, 1200 Urban Center Drive, Birmingham, AL 35242, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. K. Ranpuria</Name>
        <Affiliation>Sandler Occupational Medicine Associates, Inc., 12700 Sunrise Valley Dr, Suite 405, Reston, VA 20191, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Raspberry ketone in food supplements--High intake, few toxicity data--A cause for safety concern?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26160596</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.022</DOI>
    <KeywordList>
      <Keywords>4-(4-hydroxyphenyl)-2-butanone</Keywords>
      <Keywords>Flavouring</Keywords>
      <Keywords>Food supplement</Keywords>
      <Keywords>Margin of safety</Keywords>
      <Keywords>Natural</Keywords>
      <Keywords>Novel food</Keywords>
      <Keywords>Raspberry ketone</Keywords>
      <Keywords>Threshold of toxicological concern</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Weight loss</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lea Bredsdorff</Name>
        <Affiliation>Technical University of Denmark, National Food Institute, Mørkhøj Bygade 19, DK-2860 Søborg, Denmark. Electronic address: leab@food.dtu.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Eva Bay Wedebye</Name>
        <Affiliation>Technical University of Denmark, National Food Institute, Mørkhøj Bygade 19, DK-2860 Søborg, Denmark. Electronic address: ebawe@food.dtu.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Nikolai Georgiev Nikolov</Name>
        <Affiliation>Technical University of Denmark, National Food Institute, Mørkhøj Bygade 19, DK-2860 Søborg, Denmark. Electronic address: nign@food.dtu.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Torben Hallas-Møller</Name>
        <Affiliation>Technical University of Denmark, National Food Institute, Mørkhøj Bygade 19, DK-2860 Søborg, Denmark. Electronic address: tohal@food.dtu.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Kirsten Pilegaard</Name>
        <Affiliation>Technical University of Denmark, National Food Institute, Mørkhøj Bygade 19, DK-2860 Søborg, Denmark. Electronic address: kpil@food.dtu.dk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biological relevance of decamethylcyclopentasiloxane (D5) induced rat uterine endometrial adenocarcinoma tumorigenesis: Mode of action and relevance to humans.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26148665</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.06.021</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Enzyme induction</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Silicones</Keywords>
      <Keywords>Uterine tumors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James E. Klaunig</Name>
        <Affiliation>Indiana University, USA. Electronic address: jklauni@indiana.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>University of Würzburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Kathy Plotzke</Name>
        <Affiliation>Dow Corning, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony R. Scialli</Name>
        <Affiliation>Scialli Consulting LLC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bayesian evaluation of a physiologically-based pharmacokinetic (PBPK) model of long-term kinetics of metal nanoparticles in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26145831</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
      <Grant>13FED1313358</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.019</DOI>
    <KeywordList>
      <Keywords>Bayesian analysis</Keywords>
      <Keywords>Markov chain Monte Carlo</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Physiologically-based pharmacokinetic model</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lisa M. Sweeney</Name>
        <Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Naval Medical Research Unit Dayton (NAMRU Dayton), 2729 R Street, Building 837, Wright Patterson Air Force Base, OH 45433, USA; Toxicology Excellence for Risk Assessment (TERA), 2300 Montana Avenue, Cincinnati, OH 45211, USA. Electronic address: LMS29@cwru.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Laura MacCalman</Name>
        <Affiliation>Institute of Occupational Medicine, Research Avenue North, Riccarton, Edinburgh EH14 4AP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Lynne T. Haber</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment (TERA), 2300 Montana Avenue, Cincinnati, OH 45211, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eileen D. Kuempel</Name>
        <Affiliation>National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, M.S. C-15, Cincinnati, OH 45226-1998, USA.</Affiliation>
      </Author>
      <Author>
        <Name>C. Lang Tran</Name>
        <Affiliation>Institute of Occupational Medicine, Research Avenue North, Riccarton, Edinburgh EH14 4AP, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26145830</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.015</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Liver tumor promotion</Keywords>
      <Keywords>Mode of action</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard A. Becker</Name>
        <Affiliation>Regulatory and Technical Affairs Department, American Chemistry Council (ACC), Washington, DC 20002, USA. Electronic address: rick_becker@americanchemistry.com.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>DuPont Haskell Global Centers for Health and Environmental Sciences, Newark, DE 19711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ted W. Simon</Name>
        <Affiliation>Ted Simon LLC, 4184 Johnston Road, Winston, GA 30187, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Craig Rowlands</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research &amp; Consulting, 1803 Building Washington Street, Midland, MI 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert A. Budinsky</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research &amp; Consulting, 1803 Building Washington Street, Midland, MI 48674, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Implementation of toxicokinetics in toxicity studies--Toxicokinetics of 4-methylanisole and its metabolites in juvenile and adult rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26140820</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.018</DOI>
    <KeywordList>
      <Keywords>3R principle</Keywords>
      <Keywords>Internal exposure</Keywords>
      <Keywords>Kinetics</Keywords>
      <Keywords>p-cresol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Esther F. A. Brandon</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Petra C. E. van Kesteren</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jan C. H. van Eijkeren</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Marc Tienstra</Name>
        <Affiliation>RIKILT Wageningen UR, P.O. Box 230, 6700 AE Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Lopez Sanchez</Name>
        <Affiliation>RIKILT Wageningen UR, P.O. Box 230, 6700 AE Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Elisa C. M. Tonk</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aldert H. Piersma</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: aldert.piersma@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Peter M. J. Bos</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Considerations for comparative tobacco product assessments based on smoke constituent yields.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26140819</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.017</DOI>
    <KeywordList>
      <Keywords>Cigarette smoke constituent</Keywords>
      <Keywords>Quantitative comparisons</Keywords>
      <Keywords>Tobacco regulations</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Belushkin</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Rue des Usines 90, 2000 Neuchâtel, Switzerland. Electronic address: Maxim.Belushkin@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>G. Jaccard</Name>
        <Affiliation>Philip Morris International Management SA, Product &amp; Process Quality, Quai Jeanrenaud 56, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>A. Kondylis</Name>
        <Affiliation>Philip Morrris Products SA, Product Development, Rue des Usines 56, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation of the amount of transdermal exposure of newborn babies to phthalates in paper diapers and certification of the safety of paper diapers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26123074</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.010</DOI>
    <KeywordList>
      <Keywords>Diaper</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Nonwoven fabric</Keywords>
      <Keywords>Phthalates</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Satoko Ishii</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Tokyo, Japan. Electronic address: ishii-satoko@ceri.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Ritsuko Katagiri</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasushi Minobe</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Isamu Kuribara</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeharu Wada</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mitsuhiro Wada</Name>
        <Affiliation>Unicharm Corporation, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shigeo Imai</Name>
        <Affiliation>Unicharm Corporation, Tokyo, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative assessment of nanomaterial definitions and safety evaluation considerations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26111608</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.001</DOI>
    <KeywordList>
      <Keywords>Definitions</Keywords>
      <Keywords>Nanomaterial</Keywords>
      <Keywords>Risk evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Darrell R. Boverhof</Name>
        <Affiliation>The Dow Chemical Company, 200 Larkin, E-157, Midland, MI 48674, USA. Electronic address: rboverhof@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christina M. Bramante</Name>
        <Affiliation>Cabot Corporation, 157 Concord Road, Billerica, MA 01821, USA. Electronic address: christina.bramante@cabotcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>John H. Butala</Name>
        <Affiliation>Toxicology Consultants, Inc., 7 Glasgow Road, Gibsonia, 15044 PA, USA. Electronic address: butala@jhbutala.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shaun F. Clancy</Name>
        <Affiliation>Evonik Corporation, 299 Jefferson Road, Parsippany, NJ 07054, USA. Electronic address: shaun.clancy@evonik.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Lafranconi</Name>
        <Affiliation>Tox Horizons, LLC, 7569 Kings Mills Rd, Maineville, OH 45039, USA. Electronic address: toxhorizons@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jay West</Name>
        <Affiliation>American Chemistry Council, 700 2nd Street NE, Washington, DC 20002, USA. Electronic address: jay_west@americanchemistry.com.</Affiliation>
      </Author>
      <Author>
        <Name>Steve C. Gordon</Name>
        <Affiliation>3M Company, 3M Center, Building 220-6E-03, St. Paul, MN 55144, USA. Electronic address: scgordon@mmm.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicology of decamethylcyclopentasiloxane (D5).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26111607</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.yrtph.2015.06.011</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Enzyme induction</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Silicones</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>Department of Toxicology, University of Würzburg, Germany. Electronic address: dekant@toxi.uni-wuerzburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Klaunig</Name>
        <Affiliation>Department of Environmental Health, School of Public Health, Indiana University, Bloomington, USA. Electronic address: jklauni@indiana.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Differences in tissue distribution of iron from various clinically used intravenous iron complexes in fetal avian heart and liver.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26111606</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.005</DOI>
    <KeywordList>
      <Keywords>Bioequivalence</Keywords>
      <Keywords>Essential similarity</Keywords>
      <Keywords>Generic medicine</Keywords>
      <Keywords>Iron</Keywords>
      <Keywords>Nanomedicine</Keywords>
      <Keywords>Non-biological complex drugs</Keywords>
      <Keywords>Organotropy</Keywords>
      <Keywords>Tissue distribution</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Karsten Spicher</Name>
        <Affiliation>Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Brendler-Schwaab</Name>
        <Affiliation>Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christoph Schlösser</Name>
        <Affiliation>Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Catarinolo</Name>
        <Affiliation>Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sören Fütterer</Name>
        <Affiliation>Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Langguth</Name>
        <Affiliation>Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Harald Enzmann</Name>
        <Affiliation>Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany. Electronic address: Harald.enzmann@bfarm.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of physiologic and pharmacologic parameters in Asian and mauritius cynomolgus macaques.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26111605</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.008</DOI>
    <KeywordList>
      <Keywords>Asian macaque</Keywords>
      <Keywords>Background parameters</Keywords>
      <Keywords>Cynomolgus macaque</Keywords>
      <Keywords>Mauritius macaque</Keywords>
      <Keywords>Pharmacologic comparison</Keywords>
      <Keywords>Physiologic comparison</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John C. Kozlosky</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, Research and Development, New Brunswick, NJ, USA. Electronic address: john.kozlosky@bms.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jagannatha Mysore</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, Research and Development, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shawn P. Clark</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, Research and Development, Mount Vernon, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Holly N. Burr</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, Research and Development, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jinze Li</Name>
        <Affiliation>Genentech, Inc., Safety Assessment Development Sciences, South San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nelly Aranibar</Name>
        <Affiliation>Bristol-Myers Squibb, Discovery Toxicology, Research and Development, Princeton, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ragini Vuppugalla</Name>
        <Affiliation>Bristol-Myers Squibb, Metabolism and Pharmacokinetics, Research and Development, Princeton, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald C. West</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, Research and Development, Princeton, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Raja S. Mangipudy</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, Research and Development, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Graziano</Name>
        <Affiliation>Bristol-Myers Squibb, Drug Safety Evaluation, Research and Development, Princeton, NJ, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Incorporation of capillary microsampling into whole body plethysmography and modified Irwin safety pharmacology studies in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26111604</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.002</DOI>
    <KeywordList>
      <Keywords>Capillary microsampling</Keywords>
      <Keywords>Modified Irwin screen</Keywords>
      <Keywords>PK-PD</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Refining animal welfare</Keywords>
      <Keywords>Whole body plethysmography</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Helen Prior</Name>
        <Affiliation>AstraZeneca, Innovative Medicines, Drug Safety &amp; Metabolism, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK. Electronic address: HelenPrior.pharmacology@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Louise Marks</Name>
        <Affiliation>AstraZeneca, Innovative Medicines, Drug Safety &amp; Metabolism, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Grant</Name>
        <Affiliation>AstraZeneca, Innovative Medicines, Drug Safety &amp; Metabolism, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Marie South</Name>
        <Affiliation>AstraZeneca, Innovative Medicines, Discovery Sciences, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dietary supplements: International legal framework and adulteration profiles, and characteristics of products on the Brazilian clandestine market.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26107294</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.013</DOI>
    <KeywordList>
      <Keywords>Adulteration</Keywords>
      <Keywords>Brazil</Keywords>
      <Keywords>Dietary supplements</Keywords>
      <Keywords>European Union</Keywords>
      <Keywords>Fat-burners</Keywords>
      <Keywords>Hormones</Keywords>
      <Keywords>Irregular products</Keywords>
      <Keywords>Legislation</Keywords>
      <Keywords>United States</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Diana Brito da Justa Neves</Name>
        <Affiliation>National Institute of Criminalistics, Federal Police Department, 70610-200 Brasilia, DF, Brazil. Electronic address: diana.dbjn@dpf.gov.br.</Affiliation>
      </Author>
      <Author>
        <Name>Eloisa Dutra Caldas</Name>
        <Affiliation>Laboratory of Toxicology, Faculty of Health Sciences, University of Brasília, 70910-900 Brasilia, DF, Brazil. Electronic address: eloisa@unb.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The toxicological evaluation of repetitive 2- and 4-week intravenous injection of Activin A/BMP-2 chimera (AB204) into rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26107293</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.007</DOI>
    <KeywordList>
      <Keywords>Activin A</Keywords>
      <Keywords>BMP-2</Keywords>
      <Keywords>Intravenous administration</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Repetitive administration</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Byung Hak Yoon</Name>
        <Affiliation>Protein Engineering Laboratory, Joint Center for Biosciences at Songdo Smart Valley, Incheon 406-840, Republic of Korea; Department of Basic Science, Hongik Univesity, 94 Wausan-ro, Mapo-Gu, Seoul 121-791, Repulic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Hyup Lee</Name>
        <Affiliation>Department of Orthopedic Surgery, College of Medicine, Seoul National University, SMG-SNU Boramae Medical Center, Seoul 156-707, Republic of Korea. Electronic address: spinelee@snu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Kyuheum Na</Name>
        <Affiliation>Dong-A Socio Holdings Research Institute. Giheung-gu, Yongin, Gyeonggi 446-905, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jongho Cho</Name>
        <Affiliation>Dong-A Socio Holdings Research Institute. Giheung-gu, Yongin, Gyeonggi 446-905, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Senyon Choe</Name>
        <Affiliation>Protein Engineering Laboratory, Joint Center for Biosciences at Songdo Smart Valley, Incheon 406-840, Republic of Korea; Structural Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical assessment of abuse liability of biologics: In defense of current regulatory control policies.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26107292</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.009</DOI>
    <KeywordList>
      <Keywords>Abuse liability</Keywords>
      <Keywords>Biologics</Keywords>
      <Keywords>Drug control</Keywords>
      <Keywords>Drug safety</Keywords>
      <Keywords>Large molecule</Keywords>
      <Keywords>Small molecule</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David V. Gauvin</Name>
        <Affiliation>MPI Research, 54943 North Main Street, Mattawan, MI 49071, USA. Electronic address: david.gauvin@mpiresearch.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zachary J. Zimmermann</Name>
        <Affiliation>MPI Research, 54943 North Main Street, Mattawan, MI 49071, USA. Electronic address: zachary.zimmermann@mpiresearch.com.</Affiliation>
      </Author>
      <Author>
        <Name>Theodore J. Baird</Name>
        <Affiliation>MPI Research, 54943 North Main Street, Mattawan, MI 49071, USA. Electronic address: theodore.baird@mpiresearch.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quantitative risk assessment of the aggregate dermal exposure to the sensitizing fragrance geraniol in personal care products and household cleaning agents.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26107291</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.004</DOI>
    <KeywordList>
      <Keywords>Aggregate exposure assessment</Keywords>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Consumer products</Keywords>
      <Keywords>Fragrance</Keywords>
      <Keywords>Geraniol</Keywords>
      <Keywords>Household cleaning agents</Keywords>
      <Keywords>Personal care products</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
      <Keywords>Sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. M. Nijkamp</Name>
        <Affiliation>National Institute of Public Health and the Environment, Centre for Safety of Substances and Products, Bilthoven, The Netherlands. Electronic address: Monique.Nijkamp@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>B. G. H. Bokkers</Name>
        <Affiliation>National Institute of Public Health and the Environment, Centre for Safety of Substances and Products, Bilthoven, The Netherlands. Electronic address: Bas.Bokkers@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>M. I. Bakker</Name>
        <Affiliation>National Institute of Public Health and the Environment, Centre for Safety of Substances and Products, Bilthoven, The Netherlands. Electronic address: Martine.Bakker@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>J. Ezendam</Name>
        <Affiliation>National Institute of Public Health and the Environment, Centre for Health Protection, Bilthoven, The Netherlands. Electronic address: Janine.Ezendam@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>J. E. Delmaar</Name>
        <Affiliation>National Institute of Public Health and the Environment, Centre for Safety of Substances and Products, Bilthoven, The Netherlands. Electronic address: Christiaan.Delmaar@rivm.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Using in vitro/in silico data for consumer safety assessment of feed flavoring additives--A feasibility study using piperine.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26107290</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.006</DOI>
    <KeywordList>
      <Keywords>Metabolism</Keywords>
      <Keywords>Piperine</Keywords>
      <Keywords>Residue estimation</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Transfer database</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Thiel</Name>
        <Affiliation>DSM Nutritional Products AG, Wurmisweg 576, 4303 Kaiseraugst, Switzerland. Electronic address: anette.thiel@dsm.com.</Affiliation>
      </Author>
      <Author>
        <Name>S. Etheve</Name>
        <Affiliation>DSM Nutritional Products AG, Wurmisweg 576, 4303 Kaiseraugst, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>E. Fabian</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>W. R. Leeman</Name>
        <Affiliation>TNO, Utrechtseweg 48, 3704 HE Zeist, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>J. R. Plautz</Name>
        <Affiliation>DSM Nutritional Products AG, Wurmisweg 576, 4303 Kaiseraugst, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of Adjuvant Systems on the cardiovascular and respiratory functions in telemetered conscious dogs and anaesthetised rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26103602</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.06.003</DOI>
    <KeywordList>
      <Keywords>AS01</Keywords>
      <Keywords>AS03</Keywords>
      <Keywords>AS04</Keywords>
      <Keywords>AS15</Keywords>
      <Keywords>Adjuvant System</Keywords>
      <Keywords>Cardiovascular</Keywords>
      <Keywords>Dog</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Respiratory</Keywords>
      <Keywords>Telemetry</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lawrence Segal</Name>
        <Affiliation>GSK Vaccines, Rue Fleming 20, 1300 Wavre, Belgium. Electronic address: lawrence.m.segal@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Virginie Roger</Name>
        <Affiliation>WIL Research Europe-Lyon, 329 impasse du Domaine Rozier, 69210 Saint-Germain-Nuelles, France.</Affiliation>
      </Author>
      <Author>
        <Name>Colin Williams</Name>
        <Affiliation>Huntingdon Life Sciences Ltd, Woolley Road Alconbury, Huntingdon, Cambridgeshire PE28 4HS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Destexhe</Name>
        <Affiliation>GSK Vaccines, Rue de l'Institut 89, 1330 Rixensart, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalie Garçon</Name>
        <Affiliation>GSK Vaccines, Rue de l'Institut 89, 1330 Rixensart, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of an aggregate exposure model to estimate consumer exposure to fragrance ingredients in personal care and cosmetic products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26071898</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.017</DOI>
    <KeywordList>
      <Keywords>Aggregate exposure</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Fragrance ingredients</Keywords>
      <Keywords>Personal care products</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>B. Safford</Name>
        <Affiliation>B-Safe Toxicology Consulting, 31 Hayway, Rushden, Northants NN10 6AG, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, 50 Tice Boulevard, Woodcliff Lake, NJ 07677, United States. Electronic address: amapi@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>C. Barratt</Name>
        <Affiliation>Unilever, Safety and Environmental Assurance Centre, Colworth Park, Sharnbrook, Beds MK44 1LQ, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>D. Comiskey</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>E. J. Daly</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>G. Ellis</Name>
        <Affiliation>Givaudan International S.A., 5 chemin de la parfumerie, CH1214 Vernier, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>C. McNamara</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>C. O'Mahony</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>S. Robison</Name>
        <Affiliation>The Procter and Gamble Company, Mason Business Center, 8700 Mason Montgomery Rd, Mason, OH 45040, United States.</Affiliation>
      </Author>
      <Author>
        <Name>B. Smith</Name>
        <Affiliation>Firmenich Inc., P.O. Box 5880, Princeton, NJ 08543, United States.</Affiliation>
      </Author>
      <Author>
        <Name>R. Thomas</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>S. Tozer</Name>
        <Affiliation>Procter&amp;Gamble, Surrey TW20 9NW, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Adverse drug reactions for medicine newly approved in Japan from 1999 to 2013: Syncope/loss of consciousness and seizures/convulsions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26056066</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.030</DOI>
    <KeywordList>
      <Keywords>Adverse drug reaction</Keywords>
      <Keywords>Animal toxicity</Keywords>
      <Keywords>Medicine</Keywords>
      <Keywords>Seizure</Keywords>
      <Keywords>Syncope</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Takashi Nagayama</Name>
        <Affiliation>Non-Clinical Development, Science, Services &amp; Planning, UCB Japan Co., Ltd., Shinjuku Grand Tower, 8-17-1 Nishi-shinjuku, Shinjuku-ku, Tokyo 160-0023 Japan. Electronic address: Takashi.Nagayama@ucb.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sameness: The regulatory crux with nanomaterial identity and grouping schemes for hazard assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26049104</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.031</DOI>
    <KeywordList>
      <Keywords>Entity of nanomaterials</Keywords>
      <Keywords>Grouping</Keywords>
      <Keywords>Hazard assessment of nanomaterials</Keywords>
      <Keywords>Identity of nanomaterials</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Sameness</Keywords>
      <Keywords>Testing strategy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tobias Walser</Name>
        <Affiliation>Federal Office of Public Health, 3003 Bern, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Christoph Studer</Name>
        <Affiliation>Federal Office of Public Health, 3003 Bern, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-animal photosafety screening for complex cosmetic ingredients with photochemical and photobiochemical assessment tools.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26048216</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.029</DOI>
    <KeywordList>
      <Keywords>Complex cosmetic ingredients</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Photosafety assessment</Keywords>
      <Keywords>Phototoxicity</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hayato Nishida</Name>
        <Affiliation>Shiseido Research Center, Shiseido Co. Ltd., 2-2-1 Hayabuchi, Tsuzuki-ku, Yokohama-shi, Kanagawa 224-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Morihiko Hirota</Name>
        <Affiliation>Shiseido Research Center, Shiseido Co. Ltd., 2-2-1 Hayabuchi, Tsuzuki-ku, Yokohama-shi, Kanagawa 224-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshiki Seto</Name>
        <Affiliation>Department of Pharmacokinetics and Pharmacodynamics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Gen Suzuki</Name>
        <Affiliation>Department of Pharmacokinetics and Pharmacodynamics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masashi Kato</Name>
        <Affiliation>Department of Pharmacokinetics and Pharmacodynamics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masato Kitagaki</Name>
        <Affiliation>Shiseido Research Center, Shiseido Co. Ltd., 2-2-1 Hayabuchi, Tsuzuki-ku, Yokohama-shi, Kanagawa 224-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mariko Sugiyama</Name>
        <Affiliation>Shiseido Research Center, Shiseido Co. Ltd., 2-2-1 Hayabuchi, Tsuzuki-ku, Yokohama-shi, Kanagawa 224-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hirokazu Kouzuki</Name>
        <Affiliation>Shiseido Research Center, Shiseido Co. Ltd., 2-2-1 Hayabuchi, Tsuzuki-ku, Yokohama-shi, Kanagawa 224-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Satomi Onoue</Name>
        <Affiliation>Department of Pharmacokinetics and Pharmacodynamics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan. Electronic address: onoue@u-shizuoka-ken.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Analysis of EPA's endocrine screening battery and recommendations for further review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26044367</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.028</DOI>
    <KeywordList>
      <Keywords>Assay</Keywords>
      <Keywords>Endocrine Disruptor Screening Program</Keywords>
      <Keywords>Hormone system</Keywords>
      <Keywords>Tier 1 Endocrine Screening Battery</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Adam W. Schapaugh</Name>
        <Affiliation>Monsanto Company, St. Louis, MO, USA. Electronic address: adam.schapaugh@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa G. McFadden</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Leah M. Zorrilla</Name>
        <Affiliation>Bayer CropScience, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David R. Geter</Name>
        <Affiliation>Bayer CropScience, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Leah D. Stuchal</Name>
        <Affiliation>Center for Environmental and Human Toxicology, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Neha Sunger</Name>
        <Affiliation>Department of Health, West Chester University, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher J. Borgert</Name>
        <Affiliation>Center for Environmental and Human Toxicology, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA; Applied Pharmacology and Toxicology, Inc., Gainesville, FL, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bioaccessibility of micron-sized powder particles of molybdenum metal, iron metal, molybdenum oxides and ferromolybdenum--Importance of surface oxides.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26032492</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.027</DOI>
    <KeywordList>
      <Keywords>Alloy</Keywords>
      <Keywords>Bioaccessibility</Keywords>
      <Keywords>Ferromolybdenum</Keywords>
      <Keywords>Molybdenum</Keywords>
      <Keywords>Surface oxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alexander Mörsdorf</Name>
        <Affiliation>KTH Royal Institute of Technology, School of Chemical Science and Engineering, Department of Chemistry, Division of Surface and Corrosion Science, Drottning Kristinas väg 51, SE-10044 Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Inger Odnevall Wallinder</Name>
        <Affiliation>KTH Royal Institute of Technology, School of Chemical Science and Engineering, Department of Chemistry, Division of Surface and Corrosion Science, Drottning Kristinas väg 51, SE-10044 Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Yolanda Hedberg</Name>
        <Affiliation>KTH Royal Institute of Technology, School of Chemical Science and Engineering, Department of Chemistry, Division of Surface and Corrosion Science, Drottning Kristinas väg 51, SE-10044 Stockholm, Sweden. Electronic address: yolanda@kth.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of Angelica gigas: Genotoxicity and 13-weeks oral subchronic toxicity in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26032491</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.025</DOI>
    <KeywordList>
      <Keywords>Angelica gigas</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Traditional medicine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Won Yun</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Hwan Che</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Biomedical Center for Animal Resource and Development, N-BIO, Seoul National University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Euna Kwon</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Soon Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyun Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Ran You</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Woo Ho Kim</Name>
        <Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyeon Hoe Kim</Name>
        <Affiliation>Department of Urology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byeong Cheol Kang</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Biomedical Center for Animal Resource and Development, N-BIO, Seoul National University, Seoul, Republic of Korea; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Designed Animal and Transplantation Research Institute, Institute of GreenBio Science Technology, Seoul National University, Pyeongchang-gun, Gangwon-do, Republic of Korea. Electronic address: bckang@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Clinical and anatomic pathology effects of serial blood sampling in rat toxicology studies, using conventional or microsampling methods.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26028367</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.022</DOI>
    <KeywordList>
      <Keywords>Anatomic pathology</Keywords>
      <Keywords>Clinical pathology</Keywords>
      <Keywords>Rodent</Keywords>
      <Keywords>Serial blood sampling</Keywords>
      <Keywords>Toxicokinetic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alexis Caron</Name>
        <Affiliation>Sanofi-Aventis Recherche &amp; Développement, Disposition, Safety &amp; Animal Research, Paris, France. Electronic address: alexis.caron@sanofi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christine Lelong</Name>
        <Affiliation>Sanofi-Aventis Recherche &amp; Développement, Disposition, Safety &amp; Animal Research, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>T. Bartels</Name>
        <Affiliation>Sanofi-Aventis Recherche &amp; Développement, Disposition, Safety &amp; Animal Research, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>O. Dorchies</Name>
        <Affiliation>Sanofi-Aventis Recherche &amp; Développement, Disposition, Safety &amp; Animal Research, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>T. Gury</Name>
        <Affiliation>Sanofi-Aventis Recherche &amp; Développement, Disposition, Safety &amp; Animal Research, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Chalier</Name>
        <Affiliation>Sanofi-Aventis Recherche &amp; Développement, Disposition, Safety &amp; Animal Research, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Véronique Benning</Name>
        <Affiliation>Sanofi-Aventis Recherche &amp; Développement, Disposition, Safety &amp; Animal Research, Paris, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Classification of dermal sensitizers in pharmaceutical manufacturing.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26028366</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.026</DOI>
    <KeywordList>
      <Keywords>Classification</Keywords>
      <Keywords>Contact sensitizer</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>Drug research</Keywords>
      <Keywords>Occupational contact dermatitis</Keywords>
      <Keywords>Occupational health</Keywords>
      <Keywords>Pharmaceutical manufacturing</Keywords>
      <Keywords>Quantitative risk assessment</Keywords>
      <Keywords>Worker safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gian C. Winkler</Name>
        <Affiliation>Novartis Pharma AG NIBR, Postfach, CH-4002 Basel, Switzerland. Electronic address: gian_christian.winkler@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Perino</Name>
        <Affiliation>Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936-1080, USA. Electronic address: christopher.perino@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Selene H. Araya</Name>
        <Affiliation>University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland. Electronic address: selene.araya@unibas.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Rudolf Bechter</Name>
        <Affiliation>Bechter Consulting GmbH, Stadtweg 37, CH-4310 Rheinfelden, Switzerland. Electronic address: rudolf@bechter.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Kuster</Name>
        <Affiliation>Novartis International AG, Postfach, CH-4002 Basel, Switzerland. Electronic address: martin.kuster@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ester Lovsin Barle</Name>
        <Affiliation>Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland. Electronic address: ester.lovsin_barle@novartis.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An approach to ingredient screening and toxicological risk assessment of flavours in e-liquids.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26026505</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.018</DOI>
    <KeywordList>
      <Keywords>Contaminants</Keywords>
      <Keywords>E-cigarettes</Keywords>
      <Keywords>E-liquid</Keywords>
      <Keywords>Electronic cigarettes</Keywords>
      <Keywords>Flavour ingredients</Keywords>
      <Keywords>Ingredient screening</Keywords>
      <Keywords>TTCs</Keywords>
      <Keywords>Toxicological risk assessment</Keywords>
      <Keywords>Toxicological thresholds of concern</Keywords>
      <Keywords>Vaping</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Costigan</Name>
        <Affiliation>Nicoventures, Research &amp; Development, Regents Park Road, Southampton, Hampshire SO15 8TL, United Kingdom. Electronic address: Sandra_Costigan@nicoventures.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>C. Meredith</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton, Hampshire SO15 8TL, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Threshold of toxicological concern (TTC) for developmental and reproductive toxicity of anticancer compounds.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26025210</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.024</DOI>
    <KeywordList>
      <Keywords>Acceptable Daily Exposure (ADE)</Keywords>
      <Keywords>Anticancer</Keywords>
      <Keywords>Antineoplastic</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Direct-acting</Keywords>
      <Keywords>Indirect-acting</Keywords>
      <Keywords>Permitted Daily Exposure (PDE)</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Threshold of toxicological concern (TTC)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brad Stanard</Name>
        <Affiliation>MedImmune, One MedImmune Way, Gaithersburg, MD 20878, USA; Colorado State University, Department of Environmental and Radiological Health Sciences, College of Veterinary Medicine and Biomedical Sciences, Ft. Collins, CO 80523, USA. Electronic address: stanardb@medimmune.com.</Affiliation>
      </Author>
      <Author>
        <Name>David G. Dolan</Name>
        <Affiliation>Amgen, Inc., One Amgen Center Drive, MS 28-1A, Thousand Oaks, CA 91360, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William Hanneman</Name>
        <Affiliation>Colorado State University, Department of Environmental and Radiological Health Sciences, College of Veterinary Medicine and Biomedical Sciences, Ft. Collins, CO 80523, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Legare</Name>
        <Affiliation>Colorado State University, Department of Environmental and Radiological Health Sciences, College of Veterinary Medicine and Biomedical Sciences, Ft. Collins, CO 80523, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joel P. Bercu</Name>
        <Affiliation>Amgen, Inc., One Amgen Center Drive, MS 28-1A, Thousand Oaks, CA 91360, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Empirical characterisation of ranges of mainstream smoke toxicant yields from contemporary cigarette products using quantile regression methodology.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26021184</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.023</DOI>
    <KeywordList>
      <Keywords>Acetone</Keywords>
      <Keywords>Cigarette smoke toxicants</Keywords>
      <Keywords>N′-nitrosoanatabine</Keywords>
      <Keywords>Percentiles</Keywords>
      <Keywords>Phenol</Keywords>
      <Keywords>Pyridine</Keywords>
      <Keywords>Quantile regression</Keywords>
      <Keywords>Tobacco regulation</Keywords>
      <Keywords>Toxicant yields</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Oscar M. Camacho</Name>
        <Affiliation>Group Research and Development, British American Tobacco (Investments) Ltd, Southampton, UK. Electronic address: Oscar_M_Camacho@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alison Eldridge</Name>
        <Affiliation>Group Research and Development, British American Tobacco (Investments) Ltd, Southampton, UK. Electronic address: Alison_Eldridge@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher J. Proctor</Name>
        <Affiliation>Group Research and Development, British American Tobacco (Investments) Ltd, Southampton, UK. Electronic address: Christopher_Proctor@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin McAdam</Name>
        <Affiliation>Group Research and Development, British American Tobacco (Investments) Ltd, Southampton, UK. Electronic address: Kevin_McAdam@bat.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The molecular mechanisms of sodium metabisulfite on the expression of K ATP and L-Ca2+ channels in rat hearts.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26015265</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.021</DOI>
    <KeywordList>
      <Keywords>Cardiovascular disease</Keywords>
      <Keywords>Food additives</Keywords>
      <Keywords>Heart</Keywords>
      <Keywords>K(ATP) channels</Keywords>
      <Keywords>L-Ca(2+) channels</Keywords>
      <Keywords>Molecular mechanism</Keywords>
      <Keywords>Negative inotropic effects</Keywords>
      <Keywords>Preservative</Keywords>
      <Keywords>Sodium metabisulfite</Keywords>
      <Keywords>Ventricular cardiomyocytes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Quanxi Zhang</Name>
        <Affiliation>Institute of Environmental Medicine and Toxicology, Institute of Environmental Science, Shanxi University, Taiyuan 030006, China. Electronic address: qxzhang@sxu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yunlong Bai</Name>
        <Affiliation>Institute of Environmental Medicine and Toxicology, Institute of Environmental Science, Shanxi University, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenhua Yang</Name>
        <Affiliation>Institute of Environmental Medicine and Toxicology, Institute of Environmental Science, Shanxi University, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingjing Tian</Name>
        <Affiliation>Institute of Environmental Medicine and Toxicology, Institute of Environmental Science, Shanxi University, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ziqiang Meng</Name>
        <Affiliation>Institute of Environmental Medicine and Toxicology, Institute of Environmental Science, Shanxi University, Taiyuan 030006, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of Human Exposure to metals from some popular brands of underarm cosmetics in Nigeria.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26009314</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.020</DOI>
    <KeywordList>
      <Keywords>Antiperspirants/deodorants</Keywords>
      <Keywords>Human exposure</Keywords>
      <Keywords>Margin of safety</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Nigeria</Keywords>
      <Keywords>Systemic exposure dosage</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chukwujindu M. A. Iwegbue</Name>
        <Affiliation>Department of Chemistry, Delta State University, P.M.B. 1, Abraka, Nigeria. Electronic address: maxipriestley@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developmental toxicity assessment of the new turf herbicide, methiozolin ([5-(2,6-difluorobenzyl)oxymethyl-5-methyl-3,3(3-methylthiophen-2-yl)-1,2-isoxazoline]), in rabbits.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26003517</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.007</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Methiozolin</Keywords>
      <Keywords>Rabbit</Keywords>
      <Keywords>Safety evaluation</Keywords>
      <Keywords>Turf herbicide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jinsoo Lee</Name>
        <Affiliation>Division of Toxicological Research and Evaluation, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeongah Song</Name>
        <Affiliation>Division of Toxicological Research and Evaluation, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Ju Jeong</Name>
        <Affiliation>Division of Toxicological Research and Evaluation, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Moon Koo Chung</Name>
        <Affiliation>Division of Toxicological Research and Evaluation, Korea Institute of Toxicology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ki Hwan Hwang</Name>
        <Affiliation>Moghu Research Center Ltd., Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Suk Jin Koo</Name>
        <Affiliation>Moghu Research Center Ltd., Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wook Joon Yu</Name>
        <Affiliation>Division of Toxicological Research and Evaluation, Korea Institute of Toxicology, Daejeon, Republic of Korea. Electronic address: yuwj@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Challenges in using the ToxRefDB as a resource for toxicity prediction modeling.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26003516</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.013</DOI>
    <KeywordList>
      <Keywords>Prediction models</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>ToxRefDB</Keywords>
      <Keywords>Validation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laura M. Plunkett</Name>
        <Affiliation>Integrative Biostrategies, LLC, 1127 Eldridge Parkway, Suite 300-335, Houston, TX 77077, United States. Electronic address: lmplunkett@inbiostrat.com.</Affiliation>
      </Author>
      <Author>
        <Name>A. Michael Kaplan</Name>
        <Affiliation>A. Michael Kaplan &amp; Associates, LLC, 23 Wilkinson Drive, Landenberg, PA 19350, United States. Electronic address: amkaplan1@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Becker</Name>
        <Affiliation>American Chemistry Council, 700 Second Street NE, Washington, DC 20002, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Novel database for exposure to fragrance ingredients in cosmetics and personal care products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26003515</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.012</DOI>
    <KeywordList>
      <Keywords>Aggregate exposure</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Database</Keywords>
      <Keywords>Fragrance ingredients</Keywords>
      <Keywords>Habits and practices</Keywords>
      <Keywords>Monte Carlo simulations</Keywords>
      <Keywords>Personal care</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>D. Comiskey</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Api</Name>
        <Affiliation>Unilever, Safety and Environmental Assurance Centre, Colworth Park, Sharnbrook, Beds MK44 1LQ, United Kingdom. Electronic address: amapi@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>C. Barratt</Name>
        <Affiliation>Research Institute for Fragrance Materials, Woodcliff Lake, NJ 07677, United States.</Affiliation>
      </Author>
      <Author>
        <Name>E. J. Daly</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>G. Ellis</Name>
        <Affiliation>Givaudan International S.A., 5 chemin de la parfumerie, CH1214, Vernier, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>C. McNamara</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>C. O'Mahony</Name>
        <Affiliation>Creme Global Ltd, The Tower, Trinity Enterprise Centre, Grand Canal Quay, Dublin 2, Ireland.</Affiliation>
      </Author>
      <Author>
        <Name>S. H. Robison</Name>
        <Affiliation>The Procter and Gamble Company, Mason Business Center, 8700 Mason Montgomery Rd, Mason, OH 45040, United States.</Affiliation>
      </Author>
      <Author>
        <Name>B. Safford</Name>
        <Affiliation>B-Safe Toxicology Consulting, 31 Hayway, Rushden, Northants NN10 6AG, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>B. Smith</Name>
        <Affiliation>Firmenich Inc., Post Office Box 5880, Princeton, NJ 08543, USA(2).</Affiliation>
      </Author>
      <Author>
        <Name>S. Tozer</Name>
        <Affiliation>The Procter and Gamble Company, Central Product Safety, P&amp;G Technical Centres Ltd., Whitehall Lane, Egham, Surrey TW20 9NW, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro metabolism of rebaudioside E under anaerobic conditions: Comparison with rebaudioside A.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26003514</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.019</DOI>
    <KeywordList>
      <Keywords>Human</Keywords>
      <Keywords>In vitro metabolism</Keywords>
      <Keywords>Purified stevia leaf extract</Keywords>
      <Keywords>Rebaudiosides</Keywords>
      <Keywords>Stevia extract</Keywords>
      <Keywords>Stevia leaf extract</Keywords>
      <Keywords>Steviol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sidd Purkayastha</Name>
        <Affiliation>PureCircle Limited, 915 Harger Road, Suite 250, Oak Brook, IL 60523, USA. Electronic address: sidd.purkayastha@purecircle.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sachin Bhusari</Name>
        <Affiliation>The Coca-Cola Company, One Coca-Cola Plaza, Atlanta, GA 30126, USA.</Affiliation>
      </Author>
      <Author>
        <Name>George Pugh</Name>
        <Affiliation>The Coca-Cola Company, One Coca-Cola Plaza, Atlanta, GA 30126, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowei Teng</Name>
        <Affiliation>BRI Biopharmaceutical Research Inc., 101-8898 Heather St., Vancouver, BC V6P 3S8, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>David Kwok</Name>
        <Affiliation>BRI Biopharmaceutical Research Inc., 101-8898 Heather St., Vancouver, BC V6P 3S8, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Stanley M. Tarka</Name>
        <Affiliation>The Tarka Group, Inc., 210 N. Old Stonehouse Road, Carlisle, PA 17015, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A strategy for structuring and reporting a read-across prediction of toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26003513</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.016</DOI>
    <KeywordList>
      <Keywords>Chemical analogue identification</Keywords>
      <Keywords>OECD</Keywords>
      <Keywords>Prediction</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Regulatory acceptance</Keywords>
      <Keywords>Similarity</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Uncertainty</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>T. W. Schultz</Name>
        <Affiliation>The University of Tennessee, College of Veterinary Medicine, Knoxville, TN 37996-4500, USA. Electronic address: tschultz@utk.edu.</Affiliation>
      </Author>
      <Author>
        <Name>P. Amcoff</Name>
        <Affiliation>Cosmetics Europe, Avenue Herrmann Debroux 40, 1160 Brussels, Belgium. Electronic address: pamcoff@cosmeticseurope.eu.</Affiliation>
      </Author>
      <Author>
        <Name>E. Berggren</Name>
        <Affiliation>Joint Research Centre, European Commission, 21021 Ispra, Italy. Electronic address: elisabet.berggren@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>F. Gautier</Name>
        <Affiliation>L'Oréal, 25-29 Quai Aulagnier, 92600 Asnières-sur-Seine, France. Electronic address: fgautier@rd.loreal.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Klaric</Name>
        <Affiliation>Cosmetics Europe, Avenue Herrmann Debroux 40, 1160 Brussels, Belgium. Electronic address: mklaric@cosmeticseurope.eu.</Affiliation>
      </Author>
      <Author>
        <Name>D. J. Knight</Name>
        <Affiliation>ECHA, Annankatu 18, P.O. Box 400, Helsinki, Finland. Electronic address: Derek.Knight@echa.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>C. Mahony</Name>
        <Affiliation>Procter &amp; Gamble, Technical Centres Ltd, Whitehall Lane, Egham, Surrey, England, United Kingdom. Electronic address: mahony.c@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Schwarz</Name>
        <Affiliation>Eberhard Karls University of Tübingen, Institute of Experimental and Clinical Pharmacology and Toxicology, Department of Toxicology, Wilhelmstr. 56, 72074 Tübingen, Germany. Electronic address: Michael.schwarz@uni-tuebingen.de.</Affiliation>
      </Author>
      <Author>
        <Name>A. White</Name>
        <Affiliation>Unilever PLC, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, England, United Kingdom. Electronic address: Andrew.white@unilever.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. T. D. Cronin</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool L3 3AF, England, United Kingdom. Electronic address: m.t.cronin@ljmu.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Novel analytical method to measure formaldehyde release from heated hair straightening cosmetic products: Impact on risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26003512</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.010</DOI>
    <KeywordList>
      <Keywords>Analytical method</Keywords>
      <Keywords>Cosmetic safety</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Fraud control</Keywords>
      <Keywords>Hair smoothing products</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Corrado Lodovico Galli</Name>
        <Affiliation>Section of Risk Assessment, Dipartimento di Scienze Farmacologiche e Biomolecolari, University of Milan, via Balzaretti 9, 20133 Milan, Italy. Electronic address: corrado.galli@unimi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Federico Bettin</Name>
        <Affiliation>R&amp;D Department Chelab-Silliker a Mérieux Nutriscience Company, via Fratta 25, 31023 Resana, Italy. Electronic address: federico.bettin@mxns.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pierre Metra</Name>
        <Affiliation>R&amp;D Department Chelab-Silliker a Mérieux Nutriscience Company, via Fratta 25, 31023 Resana, Italy. Electronic address: pierre.metra@mxns.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paola Fidente</Name>
        <Affiliation>Section of Risk Assessment, Dipartimento di Scienze Farmacologiche e Biomolecolari, University of Milan, via Balzaretti 9, 20133 Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Emiliano De Dominicis</Name>
        <Affiliation>R&amp;D Department Chelab-Silliker a Mérieux Nutriscience Company, via Fratta 25, 31023 Resana, Italy. Electronic address: emiliano.de.dominicis@mxns.com.</Affiliation>
      </Author>
      <Author>
        <Name>Marina Marinovich</Name>
        <Affiliation>Section of Risk Assessment, Dipartimento di Scienze Farmacologiche e Biomolecolari, University of Milan, via Balzaretti 9, 20133 Milan, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mutagenicity and chemopreventive activities of Astronium species assessed by Ames test.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26002624</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.014</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>Antimutagenicity</Keywords>
      <Keywords>Astronium spp.</Keywords>
      <Keywords>Mutagenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Flávia Aparecida Resende</Name>
        <Affiliation>Department of Biological Sciences and Health, Centro Universitário de Araraquara, UNIARA, CEP 14801-340 Araraquara, São Paulo, Brazil; Department of Biological Sciences, Faculty of Pharmaceutical Sciences of Araraquara, UNESP-São Paulo State University, CEP 14801-902 Araraquara, São Paulo, Brazil. Electronic address: flaviabiomed@yahoo.com.br.</Affiliation>
      </Author>
      <Author>
        <Name>Debora Leite Campos</Name>
        <Affiliation>Department of Biological Sciences, Faculty of Pharmaceutical Sciences of Araraquara, UNESP-São Paulo State University, CEP 14801-902 Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Viviane Cândida da Silva</Name>
        <Affiliation>Department of Organic Chemistry, Chemistry Institute of Araraquara, UNESP-São Paulo State University, CEP 14801-970 Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rone Aparecido De Grandis</Name>
        <Affiliation>Department of Biological Sciences, Faculty of Pharmaceutical Sciences of Araraquara, UNESP-São Paulo State University, CEP 14801-902 Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Leonardo Perez Souza</Name>
        <Affiliation>Department of Organic Chemistry, Chemistry Institute of Araraquara, UNESP-São Paulo State University, CEP 14801-970 Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos Sérgio Leonardo Junior</Name>
        <Affiliation>Department of Organic Chemistry, Chemistry Institute of Araraquara, UNESP-São Paulo State University, CEP 14801-970 Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cláudia Quintino da Rocha</Name>
        <Affiliation>UNESP-São Paulo State University, Experimental Campus of the Paulista Coast, CEP 11330-900 São Vicente, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lourdes Campaner dos Santos</Name>
        <Affiliation>Department of Organic Chemistry, Chemistry Institute of Araraquara, UNESP-São Paulo State University, CEP 14801-970 Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Wagner Vilegas</Name>
        <Affiliation>UNESP-São Paulo State University, Experimental Campus of the Paulista Coast, CEP 11330-900 São Vicente, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Eliana Aparecida Varanda</Name>
        <Affiliation>Department of Biological Sciences, Faculty of Pharmaceutical Sciences of Araraquara, UNESP-São Paulo State University, CEP 14801-902 Araraquara, São Paulo, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impact of study design and database parameters on NOAEL distributions used for toxicological concern (TTC) values.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26001586</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.015</DOI>
    <KeywordList>
      <Keywords>LOAEL</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>NOAEL distribution</Keywords>
      <Keywords>TTC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jürg A. Zarn</Name>
        <Affiliation>Federal Food Safety and Veterinary Office FSVO, Risk Assessment Division, Stauffacherstrasse 101, 8004 Zürich, Switzerland. Electronic address: juerg.zarn@blv.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Emanuel Hänggi</Name>
        <Affiliation>Federal Food Safety and Veterinary Office FSVO, Risk Assessment Division, Stauffacherstrasse 101, 8004 Zürich, Switzerland. Electronic address: emanuel.haenggi@blv.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara E. Engeli</Name>
        <Affiliation>Federal Food Safety and Veterinary Office FSVO, Risk Assessment Division, Stauffacherstrasse 101, 8004 Zürich, Switzerland. Electronic address: barbara.engeli@blv.admin.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25988394</pubmedLink>
    <GrantList>
      <Grant>UL1 RR024128</Grant>
      <Grant>UL1RR024128</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.004</DOI>
    <KeywordList>
      <Keywords>Concomitant medications</Keywords>
      <Keywords>Drug-induced liver injury</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Quantitative signal detection methods</Keywords>
      <Keywords>Spontaneous adverse event reporting system</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ayako Suzuki</Name>
        <Affiliation>Gastroenterology, Central Arkansas Veterans Healthcare System and Gastroenterology and Hepatology, Univ. of Arkansas for Med. Sciences, Little Rock, AR, United States. Electronic address: asuzuki@uams.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Nancy A. Yuen</Name>
        <Affiliation>Clinical Safety, GlaxoSmithKline, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Katarina Ilic</Name>
        <Affiliation>Pharmacovigilance and Risk Management, Raptor Pharmaceuticals, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Richard T. Miller</Name>
        <Affiliation>Safety Assessment, GlaxoSmithKline, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Melinda J. Reese</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>H. Roger Brown</Name>
        <Affiliation>Safety Assessment, GlaxoSmithKline, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey I. Ambroso</Name>
        <Affiliation>Safety Assessment, GlaxoSmithKline, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>J. Gregory Falls</Name>
        <Affiliation>Safety Assessment, GlaxoSmithKline, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Christine M. Hunt</Name>
        <Affiliation>Gastroenterology, Duke University Medical Center and Durham Veterans Administration Medical Center, Durham, NC, United States. Electronic address: Christine.Hunt@va.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hepatotoxicity induced by acute and chronic paracetamol overdose in adults. Where do we stand?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25985715</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.011</DOI>
    <KeywordList>
      <Keywords>Acute liver failure</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Overdose</Keywords>
      <Keywords>Paracetamol</Keywords>
      <Keywords>Pharmacovigilance</Keywords>
      <Keywords>Poisoning</Keywords>
      <Keywords>Safety pharmacology</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hoi Y. Tong</Name>
        <Affiliation>Department of Clinical Pharmacology, Hospital Universitario La Paz, IdiPAZ, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Nicolás Medrano</Name>
        <Affiliation>Department of Clinical Pharmacology, Hospital Universitario La Paz, IdiPAZ, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Alberto M. Borobia</Name>
        <Affiliation>Department of Clinical Pharmacology, Hospital Universitario La Paz, IdiPAZ, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain; General Emergency Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ana M. Martínez</Name>
        <Affiliation>General Emergency Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Julia Martín</Name>
        <Affiliation>Paediatric Emergency Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>José A. Ruiz</Name>
        <Affiliation>Paediatric Emergency Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Santos García</Name>
        <Affiliation>Paediatric Emergency Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Manuel Quintana</Name>
        <Affiliation>General Emergency Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio J. Carcas</Name>
        <Affiliation>Department of Clinical Pharmacology, Hospital Universitario La Paz, IdiPAZ, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Jesús Frías</Name>
        <Affiliation>Department of Clinical Pharmacology, Hospital Universitario La Paz, IdiPAZ, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Elena Ramírez</Name>
        <Affiliation>Department of Clinical Pharmacology, Hospital Universitario La Paz, IdiPAZ, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain. Electronic address: elena.ramirez@inv.uam.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Analysis of workplace compliance measurements of asbestos by the U.S. Occupational Safety and Health Administration (1984-2011).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25985714</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.002</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>CEHD</Keywords>
      <Keywords>Compliance sampling</Keywords>
      <Keywords>IMIS</Keywords>
      <Keywords>Industry</Keywords>
      <Keywords>OSHA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dallas M. Cowan</Name>
        <Affiliation>Cardno ChemRisk, LLC, Aliso Viejo, CA, United States. Electronic address: dallas.cowan@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thales J. Cheng</Name>
        <Affiliation>Cardno ChemRisk, LLC, Aliso Viejo, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Ground</Name>
        <Affiliation>Cardno ChemRisk, LLC, Boulder, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Sahmel</Name>
        <Affiliation>Cardno ChemRisk, LLC, Boulder, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Allysha Varughese</Name>
        <Affiliation>Cardno ChemRisk, LLC, Aliso Viejo, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Amy K. Madl</Name>
        <Affiliation>Cardno ChemRisk, LLC, Aliso Viejo, CA, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of the KeratinoSens™ assay for assessing the skin sensitization potential of agrochemical active ingredients and formulations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25981449</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.006</DOI>
    <KeywordList>
      <Keywords>Agrochemical formulations</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>KeratinoSens test</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Raja S. Settivari</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, United States. Electronic address: rssettivari@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sean C. Gehen</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ricardo Acosta Amado</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Nicolo R. Visconti</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Darrell R. Boverhof</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Edward W. Carney</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A practical application of two in silico systems for identification of potentially mutagenic impurities.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25980641</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.008</DOI>
    <KeywordList>
      <Keywords>Computational toxicology</Keywords>
      <Keywords>Genotoxic impurities</Keywords>
      <Keywords>ICH M7</Keywords>
      <Keywords>Structure–activity relationships</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nigel Greene</Name>
        <Affiliation>Computational Sciences CoE, Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Krista L. Dobo</Name>
        <Affiliation>Genetic Toxicology, Drug Safety Research and Development, Pfizer Worldwide Research and Development, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle O. Kenyon</Name>
        <Affiliation>Genetic Toxicology, Drug Safety Research and Development, Pfizer Worldwide Research and Development, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Cheung</Name>
        <Affiliation>Genetic Toxicology, Drug Safety Research and Development, Pfizer Worldwide Research and Development, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Munzner</Name>
        <Affiliation>Genetic Toxicology, Drug Safety Research and Development, Pfizer Worldwide Research and Development, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhanna Sobol</Name>
        <Affiliation>Genetic Toxicology, Drug Safety Research and Development, Pfizer Worldwide Research and Development, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory Sluggett</Name>
        <Affiliation>Analytical R&amp;D, Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Todd Zelesky</Name>
        <Affiliation>Analytical R&amp;D, Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Sutter</Name>
        <Affiliation>Bayer Health Care, Investigational Toxicology, Müllerstr. 178, 13353 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Joerg Wichard</Name>
        <Affiliation>Bayer Health Care, Investigational Toxicology, Müllerstr. 178, 13353 Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rethinking guideline toxicity testing.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25980640</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.009</DOI>
    <KeywordList>
      <Keywords>Agrochemical</Keywords>
      <Keywords>Environmental chemical</Keywords>
      <Keywords>Industrial chemicals</Keywords>
      <Keywords>KMD</Keywords>
      <Keywords>Kinetically-derived maximum dose</Keywords>
      <Keywords>Non-pharmaceuticals</Keywords>
      <Keywords>Plant protection products</Keywords>
      <Keywords>Systemic dose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shakil Ahmed Saghir</Name>
        <Affiliation>Smithers Avanza Toxicology Services, 11B Firstfield Road, Gaithersburg, MD 20878, United States. Electronic address: shakil.saghir@smithers.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nanoparticles skin absorption: New aspects for a safety profile evaluation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25979643</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.005</DOI>
    <KeywordList>
      <Keywords>Nanoparticles interaction in physiological media</Keywords>
      <Keywords>Nanoparticles size</Keywords>
      <Keywords>Nanoparticles skin absorption</Keywords>
      <Keywords>Review</Keywords>
      <Keywords>Shape</Keywords>
      <Keywords>Surface properties</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Francesca Larese Filon</Name>
        <Affiliation>Clinical Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, via della Pietà 19, 1-34100 Trieste, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Marcella Mauro</Name>
        <Affiliation>Clinical Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, via della Pietà 19, 1-34100 Trieste, Italy. Electronic address: marcella.mauro82@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gianpiero Adami</Name>
        <Affiliation>Department of Chemical and Pharmaceutical Sciences, University of Trieste, via Giorgieri, 1-34127 Trieste, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Massimo Bovenzi</Name>
        <Affiliation>Clinical Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, via della Pietà 19, 1-34100 Trieste, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Matteo Crosera</Name>
        <Affiliation>Department of Chemical and Pharmaceutical Sciences, University of Trieste, via Giorgieri, 1-34127 Trieste, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and repeated doses (28 days) oral toxicity study of glycosides based standardized fenugreek seed extract in laboratory mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25979642</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.05.003</DOI>
    <KeywordList>
      <Keywords>Acute toxicity test</Keywords>
      <Keywords>Fenugreek seed extract</Keywords>
      <Keywords>Glycosides</Keywords>
      <Keywords>LD(50)</Keywords>
      <Keywords>No observed adverse effect levels</Keywords>
      <Keywords>Subacute toxicity tests</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amit D. Kandhare</Name>
        <Affiliation>Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Paud Road, Pune 411 038, India.</Affiliation>
      </Author>
      <Author>
        <Name>Subhash L. Bodhankar</Name>
        <Affiliation>Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Paud Road, Pune 411 038, India. Electronic address: sbodhindus@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>V. Mohan</Name>
        <Affiliation>Indus Biotech Private Limited, 1, Rahul Residency, Off SalunkeVihar Road, Kondhwa, Pune 411 048, India.</Affiliation>
      </Author>
      <Author>
        <Name>Prasad A. Thakurdesai</Name>
        <Affiliation>Indus Biotech Private Limited, 1, Rahul Residency, Off SalunkeVihar Road, Kondhwa, Pune 411 048, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory action and moderate decrease in methylphenidate use among ADHD diagnosed patients aged five and under in Korea.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25957571</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.022</DOI>
    <KeywordList>
      <Keywords>ADHD</Keywords>
      <Keywords>Children</Keywords>
      <Keywords>Methylphenidate</Keywords>
      <Keywords>Population-based study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ju Young Shin</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management (KIDS), Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Shin Haeng Lee</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management (KIDS), Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Mi Shin</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management (KIDS), Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Han Na Shin</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management (KIDS), Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Joo Park</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management (KIDS), Seoul, Republic of Korea; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: bjpark@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Changes in levels of biomarkers of exposure and biological effect in a controlled study of smokers switched from conventional cigarettes to reduced-toxicant-prototype cigarettes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25957570</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.016</DOI>
    <KeywordList>
      <Keywords>Biomarker of biological effect</Keywords>
      <Keywords>Biomarker of effective dose</Keywords>
      <Keywords>Biomarker of exposure</Keywords>
      <Keywords>MRTP</Keywords>
      <Keywords>Modified risk tobacco product</Keywords>
      <Keywords>PREP</Keywords>
      <Keywords>Potential reduced-exposure product</Keywords>
      <Keywords>Reduced toxicant prototype cigarettes</Keywords>
      <Keywords>Smoking</Keywords>
      <Keywords>Tobacco smoke toxicants</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christopher J. Shepperd</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Nik Newland</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alison Eldridge</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton SO15 8TL, UK. Electronic address: alison_eldridge@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Linsey Haswell</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Frazer Lowe</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ermioni Papadopoulou</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Oscar Camacho</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher J. Proctor</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Don Graff</Name>
        <Affiliation>Celerion, 621 Rose Street, Lincoln, NE 68502, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ingo Meyer</Name>
        <Affiliation>MPS Hamburg GmbH, Kieler Strasse 99-105, Hamburg 22769, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Allergenicity characteristics of germinated soybean proteins in a BALB/c mouse model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25956662</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.021</DOI>
    <KeywordList>
      <Keywords>Germination</Keywords>
      <Keywords>Mouse model</Keywords>
      <Keywords>Oral sensitization</Keywords>
      <Keywords>Soybean proteins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hui Yang</Name>
        <Affiliation>State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China; School of Life Sciences and Food Engineering, Nanchang University, Nanchang 330047, China; Sino-German Joint Research Institute, Nanchang University, Nanchang 330047, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinyan Gao</Name>
        <Affiliation>School of Life Sciences and Food Engineering, Nanchang University, Nanchang 330047, China.</Affiliation>
      </Author>
      <Author>
        <Name>Anshu Yang</Name>
        <Affiliation>Sino-German Joint Research Institute, Nanchang University, Nanchang 330047, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Lu</Name>
        <Affiliation>State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China; School of Life Sciences and Food Engineering, Nanchang University, Nanchang 330047, China; Sino-German Joint Research Institute, Nanchang University, Nanchang 330047, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongbing Chen</Name>
        <Affiliation>State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China; Sino-German Joint Research Institute, Nanchang University, Nanchang 330047, China. Electronic address: chenhongbing@ncu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Technical guide for applications of gene expression profiling in human health risk assessment of environmental chemicals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25944780</pubmedLink>
    <GrantList>
      <Grant>ZIA ES102345</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.010</DOI>
    <KeywordList>
      <Keywords>Chemical mode of action</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Human health risk assessment</Keywords>
      <Keywords>Risk characterization</Keywords>
      <Keywords>Toxicogenomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julie A. Bourdon-Lacombe</Name>
        <Affiliation>Water and Air Quality Bureau, Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ivy D. Moffat</Name>
        <Affiliation>Water and Air Quality Bureau, Health Canada, Ottawa, ON, Canada. Electronic address: Ivy.Moffat@hc-sc.gc.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Deveau</Name>
        <Affiliation>Water and Air Quality Bureau, Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Mainul Husain</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Auerbach</Name>
        <Affiliation>Biomolecular Screening Branch, Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Krewski</Name>
        <Affiliation>McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Russell S. Thomas</Name>
        <Affiliation>National Centre for Computational Toxicology, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Pierre R. Bushel</Name>
        <Affiliation>Biostatistics and Computational Biology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Williams</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Carole L. Yauk</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Method for the determination of ammonium in cigarette tobacco using ion chromatography.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25934256</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.019</DOI>
    <KeywordList>
      <Keywords>Ammonia</Keywords>
      <Keywords>Cigarettes</Keywords>
      <Keywords>Ion chromatography</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christina Vaughan Watson</Name>
        <Affiliation>Centers for Disease Control and Prevention, National Center for Environmental Health, Division of Laborartory Sciences, Tobacco and Volatiles Branch, Mailstop F-47, 4770 Buford Highway, N.E., Atlanta, GA 31314, United States. Electronic address: cvaughan@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Liza Valentin-Blasini</Name>
        <Affiliation>Centers for Disease Control and Prevention, National Center for Environmental Health, Division of Laborartory Sciences, Tobacco and Volatiles Branch, Mailstop F-47, 4770 Buford Highway, N.E., Atlanta, GA 31314, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Damian</Name>
        <Affiliation>Centers for Disease Control and Prevention, National Center for Environmental Health, Division of Laborartory Sciences, Tobacco and Volatiles Branch, Mailstop F-47, 4770 Buford Highway, N.E., Atlanta, GA 31314, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Clifford H. Watson</Name>
        <Affiliation>Centers for Disease Control and Prevention, National Center for Environmental Health, Division of Laborartory Sciences, Tobacco and Volatiles Branch, Mailstop F-47, 4770 Buford Highway, N.E., Atlanta, GA 31314, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Extension of the Dermal Sensitisation Threshold (DST) approach to incorporate chemicals classified as reactive.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25934255</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.020</DOI>
    <KeywordList>
      <Keywords>Dermal Sensitisation Threshold (DST)</Keywords>
      <Keywords>Local Lymph Node Assay (LLNA)</Keywords>
      <Keywords>Non-animal methods</Keywords>
      <Keywords>Sensitisation risk assessment</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Robert J. Safford</Name>
        <Affiliation>B-Safe Toxicology Consulting, 31 Hayway, Rushden, Northants NN10 6AG, United Kingdom. Electronic address: bob.safford@bstoxconsult.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Marie Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, United States. Electronic address: amapi@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>David W. Roberts</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool L3 3AF, United Kingdom. Electronic address: d.w.roberts@ljmu.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Jon F. Lalko</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, United States. Electronic address: jlalko@rifm.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modernizing problem formulation for risk assessment necessitates articulation of mode of action.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25929618</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.018</DOI>
    <KeywordList>
      <Keywords>Cancer classification</Keywords>
      <Keywords>Carbon tetrachloride</Keywords>
      <Keywords>Chloroform</Keywords>
      <Keywords>Dose response</Keywords>
      <Keywords>Hazard identification</Keywords>
      <Keywords>Human health risk assessment</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Problem formulation</Keywords>
      <Keywords>Threshold</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christopher J. Borgert</Name>
        <Affiliation>Applied Pharmacology &amp; Toxicology, Inc., 2250 NW 24th Ave, Gainesville, FL 32605, USA; C.E.H.T., University of Florida, Dept. of Physiological Sciences, Gainesville, FL 32610, USA. Electronic address: cjborgert@apt-pharmatox.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kimberly Wise</Name>
        <Affiliation>American Chemistry Council, 700 Second Street, NE, Washington, DC 20002, USA. Electronic address: kimberly_wise@americanchemistry.com.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Becker</Name>
        <Affiliation>American Chemistry Council, 700 Second Street, NE, Washington, DC 20002, USA. Electronic address: rick_becker@americanchemistry.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological risk assessment of elemental gold following oral exposure to sheets and nanoparticles - A review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25929617</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.017</DOI>
    <KeywordList>
      <Keywords>Au</Keywords>
      <Keywords>Colloidal</Keywords>
      <Keywords>Elemental</Keywords>
      <Keywords>Gold</Keywords>
      <Keywords>Metallic</Keywords>
      <Keywords>Nanoparticle</Keywords>
      <Keywords>Oral</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Niels Hadrup</Name>
        <Affiliation>Division of Food Production, National Food Institute, Technical University of Denmark, Mørkhøj Bygade 19, DK 2860 Søborg, Denmark. Electronic address: nilha@food.dtu.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Anoop K. Sharma</Name>
        <Affiliation>Division of Food Health and Environment, National Food Institute, Technical University of Denmark, Mørkhøj Bygade 19, DK 2860 Søborg, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Morten Poulsen</Name>
        <Affiliation>Division of Food Health and Environment, National Food Institute, Technical University of Denmark, Mørkhøj Bygade 19, DK 2860 Søborg, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Elsa Nielsen</Name>
        <Affiliation>Divison of Risk Assessment and Nutrition, National Food Institute, Technical University of Denmark, Mørkhøj Bygade 19, DK 2860 Søborg, Denmark.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A strategy for safety assessment of chemicals with data gaps for developmental and/or reproductive toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25910676</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.006</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Uncertainty factors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Karen Blackburn</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Road, Cincinnati, OH 45040, United States. Electronic address: blackburn.kl@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>George Daston</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Road, Cincinnati, OH 45040, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joan Fisher</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Road, Cincinnati, OH 45040, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Cathy Lester</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Road, Cincinnati, OH 45040, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge M. Naciff</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Road, Cincinnati, OH 45040, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Echoleah S. Rufer</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, Sharon Woods Innovation Center, 11530 Reed Hartman Highway, Cincinnati, OH 45241, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sharon B. Stuard</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Road, Cincinnati, OH 45040, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kara Woeller</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, Winton Hill Business Center, 6110 Center Hill Avenue, Cincinnati, OH 45224, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Implications of dose-dependent target tissue absorption for linear and non-linear/threshold approaches in development of a cancer-based oral toxicity factor for hexavalent chromium.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25910675</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.015</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Chromium</Keywords>
      <Keywords>Hexavalent</Keywords>
      <Keywords>Oral exposure</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Haney</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), Austin, TX, United States. Electronic address: joseph.haney@tceq.texas.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of a risk management tool for prioritizing chemical hazard-food pairs and demonstration for selected mycotoxins.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25908512</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.014</DOI>
    <KeywordList>
      <Keywords>Food safety</Keywords>
      <Keywords>Hazard</Keywords>
      <Keywords>Mycotoxin</Keywords>
      <Keywords>Prioritization</Keywords>
      <Keywords>Ranking</Keywords>
      <Keywords>Risk management</Keywords>
      <Keywords>Tool</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alessia Stornetta</Name>
        <Affiliation>ETH Zürich, Department of Health Sciences and Technology, Schmelzbergstrasse 9, 8092 Zürich, Switzerland. Electronic address: alessia.stornetta@hest.ethz.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara E. Engeli</Name>
        <Affiliation>Federal Food Safety and Veterinary Office FSVO, 8004 Zürich, Switzerland. Electronic address: barbara.engeli@blv.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Jürg A. Zarn</Name>
        <Affiliation>Federal Food Safety and Veterinary Office FSVO, 8004 Zürich, Switzerland. Electronic address: juerg.zarn@blv.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Gérard Gremaud</Name>
        <Affiliation>Federal Food Safety and Veterinary Office FSVO, 3097 Liebefeld, Switzerland. Electronic address: gerard.gremaud@blv.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Shana J. Sturla</Name>
        <Affiliation>ETH Zürich, Department of Health Sciences and Technology, Schmelzbergstrasse 9, 8092 Zürich, Switzerland. Electronic address: sturlas@ethz.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Consumer exposure modelling under REACH: Assessing the defaults.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25908511</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.013</DOI>
    <KeywordList>
      <Keywords>Consumers</Keywords>
      <Keywords>Defaults</Keywords>
      <Keywords>Exposure estimation</Keywords>
      <Keywords>Exposure factors</Keywords>
      <Keywords>Exposure modelling</Keywords>
      <Keywords>Operational conditions</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Software</Keywords>
      <Keywords>Tools</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Oltmanns</Name>
        <Affiliation>Forschungs- und Beratungsinstitut Gefahrstoffe GmbH (FoBiG), Klarastr. 63, 79106 Freiburg, Germany. Electronic address: jan.oltmanns@fobig.de.</Affiliation>
      </Author>
      <Author>
        <Name>F. Neisel</Name>
        <Affiliation>Bundesinstitut für Risikobewertung, Max-Dohrn-Straße 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>G. Heinemeyer</Name>
        <Affiliation>Bundesinstitut für Risikobewertung, Max-Dohrn-Straße 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>E. Kaiser</Name>
        <Affiliation>Forschungs- und Beratungsinstitut Gefahrstoffe GmbH (FoBiG), Klarastr. 63, 79106 Freiburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>K. Schneider</Name>
        <Affiliation>Forschungs- und Beratungsinstitut Gefahrstoffe GmbH (FoBiG), Klarastr. 63, 79106 Freiburg, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Improving the power of long term rodent carcinogenicity bioassays by adjusting the experimental design.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25908510</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.011</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Experimental design</Keywords>
      <Keywords>Power</Keywords>
      <Keywords>Rodents</Keywords>
      <Keywords>Type 1 error</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Matthew T. Jackson</Name>
        <Affiliation>Amgen Inc, 1120 Veterans Blvd, South San Francisco, CA 94080, USA. Electronic address: majackso@amgen.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative endpoint sensitivity of in vitro estrogen agonist assays.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25896097</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.009</DOI>
    <KeywordList>
      <Keywords>Chemical toxicity distributions</Keywords>
      <Keywords>Comparative toxicology</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Estrogen agonist</Keywords>
      <Keywords>High throughput</Keywords>
      <Keywords>Probabilistic hazard assessment</Keywords>
      <Keywords>Tox21</Keywords>
      <Keywords>ToxCast</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David A. Dreier</Name>
        <Affiliation>Environmental Health Science Program, Department of Environmental Science, Baylor University, Waco, TX 76798, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin A. Connors</Name>
        <Affiliation>Environmental Health Science Program, Department of Environmental Science, Baylor University, Waco, TX 76798, USA; Institute of Biomedical Studies, Baylor University, Waco, TX 76798, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan W. Brooks</Name>
        <Affiliation>Environmental Health Science Program, Department of Environmental Science, Baylor University, Waco, TX 76798, USA; Institute of Biomedical Studies, Baylor University, Waco, TX 76798, USA. Electronic address: Bryan_Brooks@baylor.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carcinogenicity assessment of the pan-caspase inhibitor, emricasan, in Tg.rasH2 mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25896096</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.007</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Caspase inhibitor</Keywords>
      <Keywords>Emricasan</Keywords>
      <Keywords>IDN-6556</Keywords>
      <Keywords>Tg.rasH2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>R. H. Elbekai</Name>
        <Affiliation>BioReliance by SAFC, Rockville, MD, United States. Electronic address: reem.elbekai@bioreliance.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. G. Paranjpe</Name>
        <Affiliation>BioReliance by SAFC, Rockville, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>P. C. Contreras</Name>
        <Affiliation>Conatus Pharmaceuticals, San Diego, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>A. Spada</Name>
        <Affiliation>Conatus Pharmaceuticals, San Diego, CA, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety and compliance of a complex homeopathic drug (Contramutan N Saft) in the treatment of acute respiratory tract infections: A large observational (non-interventional) study in children and adults focussing on homeopathy specific adverse reactions versus adverse drug reactions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25882307</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.002</DOI>
    <KeywordList>
      <Keywords>Acute respiratory tract infection</Keywords>
      <Keywords>Adverse events</Keywords>
      <Keywords>Dosage</Keywords>
      <Keywords>Echinacea angustifolia</Keywords>
      <Keywords>Eupatorium perfoliatum</Keywords>
      <Keywords>Homeopathic aggravation</Keywords>
      <Keywords>Mother tincture</Keywords>
      <Keywords>Non-interventional study</Keywords>
      <Keywords>Proving symptoms</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andreas Michalsen</Name>
        <Affiliation>Immanuel Krankenhaus Berlin, Königstraße 63, 14109 Berlin, Germany. Electronic address: a.michalsen@immanuel.de.</Affiliation>
      </Author>
      <Author>
        <Name>Bernhard Uehleke</Name>
        <Affiliation>Immanuel Krankenhaus Berlin, Königstraße 63, 14109 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Rainer Stange</Name>
        <Affiliation>Immanuel Krankenhaus Berlin, Königstraße 63, 14109 Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developmental immunotoxicity testing of 4-methyl anisole.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25882306</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.003</DOI>
    <KeywordList>
      <Keywords>4-Methyl anisole</Keywords>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Developmental immunotoxicity</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Prenatal exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elisa C. M. Tonk</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), Leeuwenhoeklaan 9, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aart Verhoef</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), Leeuwenhoeklaan 9, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Eric R. Gremmer</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), Leeuwenhoeklaan 9, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Henk van Loveren</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), Leeuwenhoeklaan 9, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aldert H. Piersma</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), Leeuwenhoeklaan 9, 3720 BA Bilthoven, The Netherlands; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: aldert.piersma@rivm.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of subchronic (13week) toxicity and genotoxicity potential of vinegar-processed Genkwa Flos.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25882305</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.008</DOI>
    <KeywordList>
      <Keywords>Ames</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Processed Genkwa Flos</Keywords>
      <Keywords>Subchronic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Won Yun</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyun Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Soon Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Ran You</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Euna Kwon</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ja June Jang</Name>
        <Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>In Ae Park</Name>
        <Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hee Chan Kim</Name>
        <Affiliation>Department of Biomedical Engineering, College of Medicine and Institute of Medical and Biological Engineering, Medical Research Center, Seoul National University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyeon Hoe Kim</Name>
        <Affiliation>Department of Urology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Hwan Che</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Biomedical Center for Animal Resource and Development, N-BIO, Seoul National University, Seoul, Republic of Korea. Electronic address: casache@snu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Byeong Cheol Kang</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Biomedical Center for Animal Resource and Development, N-BIO, Seoul National University, Seoul, Republic of Korea; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Designed Animal and Transplantation Research Institute, Institute of GreenBio Science Technology, Seoul National University, Pyeongchang-gun, Gangwon-do, Republic of Korea. Electronic address: bckang@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25863193</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.004</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Bradford-Hill considerations</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard A. Becker</Name>
        <Affiliation>American Chemistry Council, Washington, DC, USA. Electronic address: rick_becker@americanchemistry.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gerald T. Ankley</Name>
        <Affiliation>US Environmental Protection Agency, Office of Research and Development, Mid-Continent Ecology Division, Duluth, MN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen W. Edwards</Name>
        <Affiliation>US Environmental Protection Agency, Office of Research and Development, Integrated Systems Toxicology Division, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sean W. Kennedy</Name>
        <Affiliation>Environment Canada, National Wildlife Research Centre, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Igor Linkov</Name>
        <Affiliation>Environmental Laboratory, Engineer Research and Development Center, US Army Corps of Engineers, Concord, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bette Meek</Name>
        <Affiliation>University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Magdalini Sachana</Name>
        <Affiliation>European Commission, Joint Research Centre, Via E. Fermi 2749, 21027, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Helmut Segner</Name>
        <Affiliation>Centre for Fish and Wildlife Health, University of Bern, Bern, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Bart Van Der Burg</Name>
        <Affiliation>BioDetection Systems BV, Amsterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel L. Villeneuve</Name>
        <Affiliation>US Environmental Protection Agency, Office of Research and Development, Mid-Continent Ecology Division, Duluth, MN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Haruna Watanabe</Name>
        <Affiliation>Center for Environmental Risk Research, National Institute for Environmental Studies, Tsukuba, Ibaraki, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tara S. Barton-Maclaren</Name>
        <Affiliation>Existing Substances Risk Assessment Bureau, Health Canada, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biomonitoring Equivalents for interpretation of urinary fluoride.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25863192</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.005</DOI>
    <KeywordList>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring Equivalents</Keywords>
      <Keywords>Fluoride</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>L. L. Aylward</Name>
        <Affiliation>Summit Toxicology, LLP, Falls Church, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. M. Hays</Name>
        <Affiliation>Summit Toxicology, LLP, Lyons, CO, USA. Electronic address: shays@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>A. Vezina</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>M. Deveau</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>A. St-Amand</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>A. Nong</Name>
        <Affiliation>Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Building scientific confidence in the development and evaluation of read-across.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25857293</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.015</DOI>
    <KeywordList>
      <Keywords>(Quantitative) Structure Activity Relationship (Q)SAR</Keywords>
      <Keywords>Adverse Outcome Pathway (AOP)</Keywords>
      <Keywords>Analogue approach</Keywords>
      <Keywords>Chemical categories</Keywords>
      <Keywords>Quantitative Mechanistic Models (QMM)</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Scientific confidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>G. Patlewicz</Name>
        <Affiliation>DuPont Haskell Global Centers, 1090 Elkton Road, Newark, DE 19711, USA. Electronic address: patlewig@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>N. Ball</Name>
        <Affiliation>Toxicology &amp; Environmental Research and Consulting (TERC), The Dow Chemical Company, Midland, MI 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. J. Boogaard</Name>
        <Affiliation>Shell Health, Shell International b.v., PO Box 162, 2501 AN The Hague, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>R. A. Becker</Name>
        <Affiliation>Regulatory and Technical Affairs Department, American Chemistry Council (ACC), Washington, DC 20002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>B. Hubesch</Name>
        <Affiliation>CEFIC - The European Chemical Industry Council, 4 Avenue E. Van Nieuwenhuyse, B-1160 Brussels, Belgium; Hubesch Consult BVBA, Madeliefjeslaan 10, B-1600 Sint-Pieters-Leeuw, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Are the elements of the proposed ozone National Ambient Air Quality Standards informed by the best available science?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25857292</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.04.001</DOI>
    <KeywordList>
      <Keywords>Controlled exposure studies</Keywords>
      <Keywords>Epidemiology studies</Keywords>
      <Keywords>National Ambient Air Quality Standards</Keywords>
      <Keywords>Ozone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, United States. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sonja N. Sax</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sabine Lange</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), 12100 Park 35 Circle, Austin, TX 78753, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lorenz R. Rhomberg</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Relevance of the mouse skin initiation-promotion model for the classification of carcinogenic substances encountered at the workplace.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25846367</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.014</DOI>
    <KeywordList>
      <Keywords>Carcinoma</Keywords>
      <Keywords>Mouse skin</Keywords>
      <Keywords>Papilloma</Keywords>
      <Keywords>Tumor promotion</Keywords>
      <Keywords>Workspace</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael Schwarz</Name>
        <Affiliation>Eberhard Karls University of Tübingen, Institute of Experimental and Clinical Pharmacology and Toxicology, Department of Toxicology, Wilhelmstr. 56, 72074 Tübingen, Germany. Electronic address: michael.schwarz@uni-tuebingen.de.</Affiliation>
      </Author>
      <Author>
        <Name>Heinz W. Thielmann</Name>
        <Affiliation>German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Veronika Meischner</Name>
        <Affiliation>Scientific Secretariat of the Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission), Hohenbachernstr. 15-17, D-85354 Freising-Weihenstephan, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Manigé Fartasch</Name>
        <Affiliation>Ruhr University Bochum, Institute for Prevention and Occupational Medicine of the DGUV, Department for Clinical and Experimental Occupational Dermatology, Bürkle-de-la-Camp-Platz 1, D-44789 Bochum, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pronamide: Weight of evidence for potential estrogen, androgen or thyroid effects.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25846366</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.016</DOI>
    <KeywordList>
      <Keywords>Androgen</Keywords>
      <Keywords>Endocrine</Keywords>
      <Keywords>Endocrine Disruptor Screening Program (EDSP)</Keywords>
      <Keywords>Enzyme induction</Keywords>
      <Keywords>Estrogen</Keywords>
      <Keywords>Pronamide</Keywords>
      <Keywords>Testosterone metabolism</Keywords>
      <Keywords>Thyroid</Keywords>
      <Keywords>Thyroxine metabolism</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mary Sue Marty</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA. Electronic address: mmarty@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sabitha Papineni</Name>
        <Affiliation>Dow AgroSciences, LLC, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katherine K. Coady</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Reza J. Rasoulpour</Name>
        <Affiliation>Dow AgroSciences, LLC, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lynn H. Pottenger</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David L. Eisenbrandt</Name>
        <Affiliation>Dow AgroSciences, LLC, Indianapolis, IN, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An improved method for the isolation of rat alveolar type II lung cells: Use in the Comet assay to determine DNA damage induced by cigarette smoke.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25846365</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.013</DOI>
    <KeywordList>
      <Keywords>3R4F reference cigarette</Keywords>
      <Keywords>Alveolar type II cells (AEC II)</Keywords>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>Comet assay</Keywords>
      <Keywords>DNA damage</Keywords>
      <Keywords>Genotoxicity endpoint</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Annette Dalrymple</Name>
        <Affiliation>British American Tobacco, Group R&amp;D, Southampton, Hampshire SO15 8TL, UK. Electronic address: Annette_Dalrymple@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Ordoñez</Name>
        <Affiliation>Vivotecnia Research S.L., Parque Científico de Madrid, C/Santiago Grisolía, 2 (PTM), 28760 Tres Cantos, Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>David Thorne</Name>
        <Affiliation>British American Tobacco, Group R&amp;D, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Debbie Dillon</Name>
        <Affiliation>British American Tobacco, Group R&amp;D, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Clive Meredith</Name>
        <Affiliation>British American Tobacco, Group R&amp;D, Southampton, Hampshire SO15 8TL, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pronamide: Human relevance of liver-mediated rat leydig cell tumors.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25846364</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.012</DOI>
    <KeywordList>
      <Keywords>Leydig cell tumor</Keywords>
      <Keywords>Liver enzyme induction</Keywords>
      <Keywords>Mechanisms</Keywords>
      <Keywords>Pronamide</Keywords>
      <Keywords>Testosterone metabolism</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Reza J. Rasoulpour</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda K. Andrus</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA. Electronic address: akandrus@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Sue Marty</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fagen Zhang</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Johnson Thomas</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew J. LeBaron</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sabitha Papineni</Name>
        <Affiliation>Dow AgroSciences, LLC, Indianapolis, IN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lynn H. Pottenger</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David L. Eisenbrandt</Name>
        <Affiliation>Dow AgroSciences, LLC, Indianapolis, IN, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel approach to assess the population health impact of introducing a Modified Risk Tobacco Product.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25819932</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.011</DOI>
    <KeywordList>
      <Keywords>Attributable risk</Keywords>
      <Keywords>Harm reduction</Keywords>
      <Keywords>Modeling</Keywords>
      <Keywords>Modified Risk Tobacco Product</Keywords>
      <Keywords>Smoking</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rolf Weitkunat</Name>
        <Affiliation>Philip Morris International Research &amp; Development, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland. Electronic address: rolf.weitkunat@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P N Lee Statistics and Computing Ltd, 17 Cedar Road, Sutton, Surrey SM2 5DA, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Gizelle Baker</Name>
        <Affiliation>Philip Morris International Research &amp; Development, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Sponsiello-Wang</Name>
        <Affiliation>Philip Morris International Research &amp; Development, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Angela M. González-Zuloeta Ladd</Name>
        <Affiliation>Philip Morris International Research &amp; Development, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Lüdicke</Name>
        <Affiliation>Philip Morris International Research &amp; Development, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion of the Scientific Committee on Consumer Safety (SCCS)--The safety of the use of formaldehyde in nail hardeners.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25819931</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.019</DOI>
    <KeywordList>
      <Keywords>CAS Number 50-00-0</Keywords>
      <Keywords>EC Number 200-001-8</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Regulation 1223/2009</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
      </Author>
      <Author>
        <Name>Ulrike Bernauer</Name>
      </Author>
      <Author>
        <Name>Pieter Jan Coenraads</Name>
      </Author>
      <Author>
        <Name>Gisela H. Degen</Name>
      </Author>
      <Author>
        <Name>Maria Dusinska</Name>
      </Author>
      <Author>
        <Name>Werner Lilienblum</Name>
      </Author>
      <Author>
        <Name>Andreas Luch</Name>
      </Author>
      <Author>
        <Name>Elsa Nielsen</Name>
      </Author>
      <Author>
        <Name>Thomas Platzek</Name>
      </Author>
      <Author>
        <Name>Suresh Rastogi</Name>
      </Author>
      <Author>
        <Name>Christophe Rousselle</Name>
      </Author>
      <Author>
        <Name>Jan van Benthem</Name>
      </Author>
      <Author>
        <Name>Alfred Bernard</Name>
      </Author>
      <Author>
        <Name>Ana M. Giménez-Arnau</Name>
      </Author>
      <Author>
        <Name>Tamara Vanhaecke</Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25818068</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.007</DOI>
    <KeywordList>
      <Keywords>Apical toxic effects</Keywords>
      <Keywords>Biodistribution</Keywords>
      <Keywords>Biopersistence</Keywords>
      <Keywords>Cellular effects</Keywords>
      <Keywords>Grouping</Keywords>
      <Keywords>Intrinsic material properties</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>System-dependent properties</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Josje H. E. Arts</Name>
        <Affiliation>AkzoNobel, Technology and Engineering, Arnhem, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Mackenzie Hadi</Name>
        <Affiliation>Shell Health, Shell International B.V., The Hague, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Muhammad Adeel Irfan</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Athena M. Keene</Name>
        <Affiliation>Afton Chemical, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Reinhard Kreiling</Name>
        <Affiliation>Clariant Produkte GmbH, Sulzbach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Delina Lyon</Name>
        <Affiliation>Shell Health, Shell Oil Company, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Monika Maier</Name>
        <Affiliation>Evonik Degussa GmbH, Hanau, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Michel</Name>
        <Affiliation>Henkel AG &amp; Co. KGaA, Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Petry</Name>
        <Affiliation>Toxminds BVBA, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Neubiberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>David Warheit</Name>
        <Affiliation>DuPont Haskell Global Centers for HES, Newark, DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Wiench</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Wendel Wohlleben</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany. Electronic address: robert.landsiedel@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Providing perspective for interpreting cardiovascular mortality risks associated with ozone exposures.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25817736</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.009</DOI>
    <KeywordList>
      <Keywords>Air pollution</Keywords>
      <Keywords>Cardiovascular mortality</Keywords>
      <Keywords>Environmental health policy</Keywords>
      <Keywords>NAAQS (National Ambient Air Quality Standards)</Keywords>
      <Keywords>Ozone exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Catherine Petito Boyce</Name>
        <Affiliation>Gradient, 600 Stewart Street, Ste 1900, Seattle, WA 98101, USA. Electronic address: cpetitoboyce@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, 20 University Road, Ste 5, Cambridge, MA 02138, USA. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sonja N. Sax</Name>
        <Affiliation>Gradient, 20 University Road, Ste 5, Cambridge, MA 02138, USA. Electronic address: ssax@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christine T. Loftus</Name>
        <Affiliation>Gradient, 600 Stewart Street, Ste 1900, Seattle, WA 98101, USA. Electronic address: cloftus@gradientcorp.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Opinion on environmental risks and indirect health effects of mercury from dental amalgam.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25817735</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.006</DOI>
    <KeywordList>
      <Keywords>Dental amalgam</Keywords>
      <Keywords>Mercury</Keywords>
      <Keywords>Methylation</Keywords>
      <Keywords>SCHER</Keywords>
      <Keywords>Scientific opinion</Keywords>
      <Keywords>Secondary poisoning</Keywords>
      <Keywords>Surface water</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name> </Name>
        <Affiliation>European Commission, Directorate General Health and Food Safety, L-2920 Luxembourg, Luxembourg.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Linders</Name>
        <Affiliation>RIVM, The Netherlands(2).</Affiliation>
      </Author>
      <Author>
        <Name>Colin Janssen</Name>
        <Affiliation>Ghent University, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Emanuela Testai</Name>
        <Affiliation>Istituto Superiore di Sanità, Environment and Primary Prevention, Dept., Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Vighi</Name>
        <Affiliation>University of Milano, Bicocca, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Dekant</Name>
        <Affiliation>Universität Würzburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>John Munth</Name>
        <Affiliation>IVL Swedish Environmental Research Institute Ltd, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Nicola Pirrone</Name>
        <Affiliation>CNR - Istituto sull' Inquinamento Atmosferico (CNR-IIA), Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Richardson</Name>
        <Affiliation>Stantec Consulting Ltd., 200 - 2781 Lancaster Road, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human urine and plasma concentrations of bisphenol A extrapolated from pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and semi-physiological pharmacokinetic modeling.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25805149</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.010</DOI>
    <KeywordList>
      <Keywords>Allometric scaling</Keywords>
      <Keywords>Bisphenol A glucuronide</Keywords>
      <Keywords>Humanized-liver mouse</Keywords>
      <Keywords>PK modeling</Keywords>
      <Keywords>Semi-physiologicalpharmacokinetic modeling</Keywords>
      <Keywords>Species difference</Keywords>
      <Keywords>Urinary excretion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Takamori Miyaguchi</Name>
        <Affiliation>Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Suemizu</Name>
        <Affiliation>Central Institute for Experimental Animals, Kawasaki-ku, Kawasaki 210-0821, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makiko Shimizu</Name>
        <Affiliation>Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Satomi Shida</Name>
        <Affiliation>Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Sayako Nishiyama</Name>
        <Affiliation>Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ryohji Takano</Name>
        <Affiliation>Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan; Fujitsu Kyusyu Systems, Fukuoka 814-8589, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Norie Murayama</Name>
        <Affiliation>Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Yamazaki</Name>
        <Affiliation>Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan. Electronic address: hyamazak@ac.shoyaku.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Re the article "Incorporating potency into the EU classification for carcinogenicity and reproductive toxicity" by Hennes C et al. (Regulatory toxicology and Pharmacology, 70 (1024), 457-67).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25797335</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.008</DOI>
    <AuthorList>
      <Author>
        <Name>J. R. Kelsey</Name>
        <Affiliation>Chemsage Ltd, PO Box 431, Fleet, Hampshire GU51 3DB, United Kingdom. Electronic address: kelsey@chemsage.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>P. Davison</Name>
        <Affiliation>Davison Consultants Ltd, Locke Cottage, Hook Road, North Warnborough, Hampshire RG29 1EU, United Kingdom. Electronic address: phillip.davison@davisonconsultants.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genomics in the land of regulatory science.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25796433</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.008</DOI>
    <KeywordList>
      <Keywords>Genomics</Keywords>
      <Keywords>Next generation sequencing</Keywords>
      <Keywords>Regulatory science</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Weida Tong</Name>
        <Affiliation>National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA. Electronic address: Weida.tong@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Ostroff</Name>
        <Affiliation>Office of the Chief Scientist, US Food and Drug Administration, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Burton Blais</Name>
        <Affiliation>Canadian Food Inspection Agency, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Primal Silva</Name>
        <Affiliation>Canadian Food Inspection Agency, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Martine Dubuc</Name>
        <Affiliation>Canadian Food Inspection Agency, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Marion Healy</Name>
        <Affiliation>Foods Standards Australia New Zealand, Canberra, ACT, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>William Slikker</Name>
        <Affiliation>National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA. Electronic address: William.slikker@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25792138</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.003</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Adverse Outcome Pathway (AOP)</Keywords>
      <Keywords>Carcinogenicity classification</Keywords>
      <Keywords>Integrated Approaches to Testing and Assessment (IATA)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Petko I. Petkov</Name>
        <Affiliation>Laboratory of Mathematical Chemistry (LMC), As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>DuPont Haskell Global Centers for Health and Environmental Sciences, Newark, DE 19711, USA. Electronic address: patlewig@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Terry W. Schultz</Name>
        <Affiliation>College of Veterinary Medicine, The University of Tennessee, Knoxville, TN 37996-4500, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Masamitsu Honma</Name>
        <Affiliation>Division of Genetics and Mutagenesis, National Institute of Health Sciences, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Milen Todorov</Name>
        <Affiliation>Laboratory of Mathematical Chemistry (LMC), As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Kotov</Name>
        <Affiliation>Laboratory of Mathematical Chemistry (LMC), As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Sabcho D. Dimitrov</Name>
        <Affiliation>Laboratory of Mathematical Chemistry (LMC), As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>E. Maria Donner</Name>
        <Affiliation>DuPont Haskell Global Centers for Health and Environmental Sciences, Newark, DE 19711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ovanes G. Mekenyan</Name>
        <Affiliation>Laboratory of Mathematical Chemistry (LMC), As. Zlatarov University, Bourgas, Bulgaria.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MRL calculations based on both intra- and inter-trial residue variability.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25784487</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.002</DOI>
    <KeywordList>
      <Keywords>JMPR</Keywords>
      <Keywords>POSP equation</Keywords>
      <Keywords>Pesticide MRL</Keywords>
      <Keywords>Supervised residue trial</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Denis J. Hamilton</Name>
        <Affiliation>Queensland Department of Primary Industries, Brisbane, Australia. Electronic address: denisjhamilton@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A longitudinal study of smokers' exposure to cigarette smoke and the effects of spontaneous product switching.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25777840</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.004</DOI>
    <KeywordList>
      <Keywords>Biomarkers of exposure</Keywords>
      <Keywords>Cigarette consumption</Keywords>
      <Keywords>Compensatory smoking behaviour</Keywords>
      <Keywords>Longitudinal</Keywords>
      <Keywords>Mouth level exposure</Keywords>
      <Keywords>Tobacco smoke</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anthony Cunningham</Name>
        <Affiliation>Group Research and Development, British American Tobacco (Investments) Ltd., Southampton SO15 8TL, United Kingdom. Electronic address: Anthony_Cunningham@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Johan Sommarström</Name>
        <Affiliation>Group Research and Development, British American Tobacco (Investments) Ltd., Southampton SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Oscar M. Camacho</Name>
        <Affiliation>Group Research and Development, British American Tobacco (Investments) Ltd., Southampton SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Ajit S. Sisodiya</Name>
        <Affiliation>Group Research and Development, British American Tobacco (Investments) Ltd., Southampton SO15 8TL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Krishna Prasad</Name>
        <Affiliation>Group Research and Development, British American Tobacco (Investments) Ltd., Southampton SO15 8TL, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the ToxRTool's ability to rate the reliability of toxicological data for human health hazard assessments.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25777839</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.005</DOI>
    <KeywordList>
      <Keywords>Data quality</Keywords>
      <Keywords>Human health risk assessment</Keywords>
      <Keywords>Risk of bias</Keywords>
      <Keywords>Systematic review</Keywords>
      <Keywords>ToxRTool</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>D. Segal</Name>
        <Affiliation>EPA Office of Research and Development (ORD), National Center for Environmental Assessment, United States. Electronic address: segal.deborah@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>S. L. Makris</Name>
        <Affiliation>EPA Office of Research and Development (ORD), National Center for Environmental Assessment, United States.</Affiliation>
      </Author>
      <Author>
        <Name>A. D. Kraft</Name>
        <Affiliation>EPA Office of Research and Development (ORD), National Center for Environmental Assessment, United States.</Affiliation>
      </Author>
      <Author>
        <Name>A. S. Bale</Name>
        <Affiliation>EPA Office of Research and Development (ORD), National Center for Environmental Assessment, United States.</Affiliation>
      </Author>
      <Author>
        <Name>J. Fox</Name>
        <Affiliation>EPA Office of Research and Development (ORD), National Center for Environmental Assessment, United States.</Affiliation>
      </Author>
      <Author>
        <Name>M. Gilbert</Name>
        <Affiliation>EPA ORD National Health and Environmental Effects Research Laboratory, United States.</Affiliation>
      </Author>
      <Author>
        <Name>D. R. Bergfelt</Name>
        <Affiliation>Dept. of Biomedical Sciences, Ross University School of Veterinary Medicine, St. Kitts, St. Kitts and Nevis.</Affiliation>
      </Author>
      <Author>
        <Name>K. C. Raffaele</Name>
        <Affiliation>EPA Office of Solid Waste and Emergency Response, United States.</Affiliation>
      </Author>
      <Author>
        <Name>R. B. Blain</Name>
        <Affiliation>ICF International Environment and Social Sustainability Division, United States.</Affiliation>
      </Author>
      <Author>
        <Name>K. M. Fedak</Name>
        <Affiliation>ICF International Environment and Social Sustainability Division, United States.</Affiliation>
      </Author>
      <Author>
        <Name>M. K. Selgrade</Name>
        <Affiliation>ICF International Environment and Social Sustainability Division, United States.</Affiliation>
      </Author>
      <Author>
        <Name>K. M. Crofton</Name>
        <Affiliation>EPA ORD National Center for Computational Toxicology, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Principles for identification of High Potency Category Chemicals for which the Dermal Sensitisation Threshold (DST) approach should not be applied.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25765509</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.03.001</DOI>
    <KeywordList>
      <Keywords>Dermal Sensitisation Threshold (DST)</Keywords>
      <Keywords>High Potency Category Chemicals (HPC)</Keywords>
      <Keywords>Local Lymph Node Assay (LLNA)</Keywords>
      <Keywords>Non-animal methods</Keywords>
      <Keywords>Sensitisation risk assessment</Keywords>
      <Keywords>Skin sensitisation</Keywords>
      <Keywords>Structure alerts</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David W. Roberts</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool L3 3AF, United Kingdom. Electronic address: d.w.roberts@ljmu.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Marie Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, United States. Electronic address: amapi@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>Robert J. Safford</Name>
        <Affiliation>B-Safe Toxicology Consulting, 31 Hayway, Rushden, Northants NN10 6AG, United Kingdom. Electronic address: bob.safford@bstoxconsult.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Jon F. Lalko</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, United States. Electronic address: jlalko@rifm.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of an extended dataset of in vitro human dermal absorption studies on pesticides to determine default values, opportunities for read-across and influence of dilution on absorption.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25765508</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.017</DOI>
    <KeywordList>
      <Keywords>Agrochemicals</Keywords>
      <Keywords>Dermal absorption</Keywords>
      <Keywords>Human skin</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Operator exposure</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Plant protection products</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Aggarwal</Name>
        <Affiliation>Dow AgroSciences Ltd, UK. Electronic address: maggarwal@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>P. Fisher</Name>
        <Affiliation>Bayer SAS, Bayer CropScience, France.</Affiliation>
      </Author>
      <Author>
        <Name>A. Hüser</Name>
        <Affiliation>Dr. Knoell Consult GmbH, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>F. M. Kluxen</Name>
        <Affiliation>Dr. Knoell Consult GmbH, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>R. Parr-Dobrzanski</Name>
        <Affiliation>Syngenta Ltd, UK.</Affiliation>
      </Author>
      <Author>
        <Name>M. Soufi</Name>
        <Affiliation>DuPont de Nemours GmbH, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>C. Strupp</Name>
        <Affiliation>ADAMA MAH BV Amsterdam NL Schaffhausen Branch, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>C. Wiemann</Name>
        <Affiliation>BASF Österreich GmbH, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>R. Billington</Name>
        <Affiliation>Dow AgroSciences Ltd, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pre-clinical toxicity evaluation of MB-102, a novel fluorescent tracer agent for real-time measurement of glomerular filtration rate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25728979</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.018</DOI>
    <KeywordList>
      <Keywords>Fluorescence</Keywords>
      <Keywords>GFR</Keywords>
      <Keywords>Optical monitoring</Keywords>
      <Keywords>Preclinical evaluation</Keywords>
      <Keywords>Pyrazine</Keywords>
      <Keywords>Renal clearance</Keywords>
      <Keywords>Renal function</Keywords>
      <Keywords>Single-dose toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joseph E. Bugaj</Name>
        <Affiliation>MediBeacon, LLC, 1100 Corporate Square Drive, St. Louis, MO 63132, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard B. Dorshow</Name>
        <Affiliation>MediBeacon, LLC, 1100 Corporate Square Drive, St. Louis, MO 63132, USA. Electronic address: rbdorshow@medibeacon.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of the human-identical milk monosaccharide, l-fucose.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25728407</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.016</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Human milk monosaccharide</Keywords>
      <Keywords>Infant formula</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>l-Fucose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sharon S. H. Choi</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, Ontario L5N 2X7, Canada. Electronic address: sharon.choi@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Barry S. Lynch</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Road, Suite 201, Mississauga, Ontario L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Nigel Baldwin</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, Room 1036, Building A8, Cody Technology Park, Ively Road, Farnborough, Hampshire GU14 0LX, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Emily W. Dakoulas</Name>
        <Affiliation>BioReliance Corporation, 9630 Medical Center Drive, Rockville, MD 20850, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shambhu Roy</Name>
        <Affiliation>BioReliance Corporation, 9630 Medical Center Drive, Rockville, MD 20850, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carey Moore</Name>
        <Affiliation>MPI Research, Inc., 54943 North Main Street, Mattawan, MI 49071-8353, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bjorn A. Thorsrud</Name>
        <Affiliation>MPI Research, Inc., 54943 North Main Street, Mattawan, MI 49071-8353, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christoph H. Röhrig</Name>
        <Affiliation>Glycom A/S, Diplomvej 373, DK-2800 Kongens Lyngby, Denmark.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and subchronic (28 days) oral toxicity studies of Codonopsis lanceolata extract in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25724632</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.014</DOI>
    <KeywordList>
      <Keywords>Codonopsis lanceolata</Keywords>
      <Keywords>Hematology</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Serum biochemistry</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jong Seok Lee</Name>
        <Affiliation>Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 200-701, South Korea; National Institute of Biological Resources, Incheon 404-708, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Hyun Kim</Name>
        <Affiliation>Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 200-701, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Bi Kim</Name>
        <Affiliation>Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 200-701, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gi Hae Shin</Name>
        <Affiliation>Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 200-701, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Ha Lee</Name>
        <Affiliation>Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 200-701, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ju Hyun Cho</Name>
        <Affiliation>Hurum Central Research Institute, Ochang 363-883, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Boo Yong Lee</Name>
        <Affiliation>Department of Food Science and Biotechnology, CHA University, Seongnam 463-836, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ok Hwan Lee</Name>
        <Affiliation>Department of Food Science and Biotechnology, Kangwon National University, Chuncheon 200-701, South Korea. Electronic address: loh99@kangwon.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluating the validity and applicable domain of the toxic load model: impact of concentration vs. time profile on inhalation lethality of hydrogen cyanide.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25720732</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.015</DOI>
    <KeywordList>
      <Keywords>Acute lethality</Keywords>
      <Keywords>Hydrogen cyanide</Keywords>
      <Keywords>Non-constant concentrations</Keywords>
      <Keywords>Nose-only inhalation</Keywords>
      <Keywords>Pulsed exposures</Keywords>
      <Keywords>Toxic load model</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lisa M. Sweeney</Name>
        <Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Naval Medical Research Unit Dayton, Wright Patterson Air Force Base, OH 45433, United States. Electronic address: lisa.sweeney.3.ctr@us.af.mil.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas R. Sommerville</Name>
        <Affiliation>U.S. Army Edgewood Chemical Biological Center, Aberdeen Proving Ground, MD 21010, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen R. Channel</Name>
        <Affiliation>Leidos, Linton, IN 47441, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Brian C. Sharits</Name>
        <Affiliation>CAMRIS, Naval Medical Research Unit Dayton, Wright Patterson Air Force Base, OH 45433, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Nathan M. Gargas</Name>
        <Affiliation>CAMRIS, Naval Medical Research Unit Dayton, Wright Patterson Air Force Base, OH 45433, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Chester P. Gut</Name>
        <Affiliation>CAMRIS, Naval Medical Research Unit Dayton, Wright Patterson Air Force Base, OH 45433, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mode of action and human relevance of pronamide-induced rat thyroid tumors.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25707858</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.012</DOI>
    <KeywordList>
      <Keywords>Hepatic metabolism</Keywords>
      <Keywords>Human relevance framework</Keywords>
      <Keywords>Liver enzyme induction</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Pronamide</Keywords>
      <Keywords>Thyroid follicular cell adenomas</Keywords>
      <Keywords>Uridine diphosphate glucuronosyltransferase</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sabitha Papineni</Name>
        <Affiliation>Dow AgroSciences, LLC, Indianapolis, IN 46268, USA. Electronic address: SPapineni@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Sue Marty</Name>
        <Affiliation>Toxicology &amp; Environmental Research and Consulting, The Dow Chemical Company, 1803 Building, Midland, MI 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Reza J. Rasoulpour</Name>
        <Affiliation>Dow AgroSciences, LLC, Indianapolis, IN 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew J. LeBaron</Name>
        <Affiliation>Toxicology &amp; Environmental Research and Consulting, The Dow Chemical Company, 1803 Building, Midland, MI 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lynn H. Pottenger</Name>
        <Affiliation>Toxicology &amp; Environmental Research and Consulting, The Dow Chemical Company, 1803 Building, Midland, MI 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David L. Eisenbrandt</Name>
        <Affiliation>Dow AgroSciences, LLC, Indianapolis, IN 46268, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tissue concentrations of sulfamethazine and tetracycline hydrochloride of swine (Sus scrofa domestica) as it relates to withdrawal methods for international export.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25707857</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.013</DOI>
    <KeywordList>
      <Keywords>FDA tolerance limit method</Keywords>
      <Keywords>Maximum residue limit</Keywords>
      <Keywords>Monte Carlo method</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Population</Keywords>
      <Keywords>Sulfamethazine</Keywords>
      <Keywords>Swine</Keywords>
      <Keywords>Tetracycline</Keywords>
      <Keywords>Withdrawal interval</Keywords>
      <Keywords>Withdrawal time</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sharon E. Mason</Name>
        <Affiliation>Department of Biological Sciences, Campbell University, Buies Creek, NC, USA. Electronic address: masons@campbell.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Huali Wu</Name>
        <Affiliation>Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jim E. Yeatts</Name>
        <Affiliation>Center for Chemical Toxicology Research and Pharmacokinetics, and North Carolina State University, Raleigh, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald E. Baynes</Name>
        <Affiliation>Center for Chemical Toxicology Research and Pharmacokinetics, and North Carolina State University, Raleigh, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25707856</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.011</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Adverse outcome pathway (AOP)</Keywords>
      <Keywords>Exposure:activity ratio (EAR)</Keywords>
      <Keywords>Integrated approaches to testing and assessment (IATA)</Keywords>
      <Keywords>Mode of action (MoA)</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Scientific confidence framework (SCF)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>DuPont Haskell Global Centers for Health and Environmental Sciences, 1090 Elkton Road, Newark, DE 19711, USA. Electronic address: patlewig@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ted W. Simon</Name>
        <Affiliation>Ted Simon LLC, 4184 Johnston Road, Winston, GA 30187, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Craig Rowlands</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research &amp; Consulting, 1803 Building Washington Street, Midland, MI 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert A. Budinsky</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research &amp; Consulting, 1803 Building Washington Street, Midland, MI 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Becker</Name>
        <Affiliation>Regulatory and Technical Affairs Department, American Chemistry Council (ACC), Washington, DC 20002, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Is the shape of the decline in risk following quitting smoking similar for squamous cell carcinoma and adenocarcinoma of the lung? A quantitative review using the negative exponential model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25703436</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.010</DOI>
    <KeywordList>
      <Keywords>Cessation of smoking</Keywords>
      <Keywords>Histological type</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Meta-analysis</Keywords>
      <Keywords>Negative exponential model</Keywords>
      <Keywords>Review</Keywords>
      <Keywords>Smoking</Keywords>
      <Keywords>Statistical models</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John S. Fry</Name>
        <Affiliation>P N Lee Statistics and Computing Ltd, Sutton, Surrey, United Kingdom. Electronic address: JohnFry@pnlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P N Lee Statistics and Computing Ltd, Sutton, Surrey, United Kingdom. Electronic address: PeterLee@pnlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara A. Forey</Name>
        <Affiliation>P N Lee Statistics and Computing Ltd, Sutton, Surrey, United Kingdom. Electronic address: BarbaraForey@pnlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Katharine J. Coombs</Name>
        <Affiliation>P N Lee Statistics and Computing Ltd, Sutton, Surrey, United Kingdom. Electronic address: Katharine@thecoombses.co.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25701184</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.009</DOI>
    <KeywordList>
      <Keywords>Allergen extract</Keywords>
      <Keywords>Allergen specific immunotherapy</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Japanese cedar pollen</Keywords>
      <Keywords>Oral mucosal irritation</Keywords>
      <Keywords>Repeated toxicity</Keywords>
      <Keywords>Safety evaluation</Keywords>
      <Keywords>Sublingual immunotherapy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuko Mitobe</Name>
        <Affiliation>Research Laboratory, Torii Pharmaceutical Co., Ltd., 2183-1 Teranosaku, Ota, Sakura, Chiba 285-0808, Japan; Graduate School of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan. Electronic address: yuko.mitobe@torii.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuki Yokomoto</Name>
        <Affiliation>Toxicology Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 23-Naganuki, Hadanoshi, Kanagawa 257-0014, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Katsuyo Ohashi-Doi</Name>
        <Affiliation>Research Laboratory, Torii Pharmaceutical Co., Ltd., 2183-1 Teranosaku, Ota, Sakura, Chiba 285-0808, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A study to investigate changes in the levels of biomarkers of exposure to selected cigarette smoke constituents in Japanese adult male smokers who switched to a non-combustion inhaler type of tobacco product.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25683775</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.007</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Cigarette</Keywords>
      <Keywords>Clinical study</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Smokeless tobacco</Keywords>
      <Keywords>Smoking</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Naoki Miura</Name>
        <Affiliation>Product Science Division, R&amp;D Group, Japan Tobacco Inc., Yokohama, Kanagawa, Japan. Electronic address: naoki.miura@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dai Yuki</Name>
        <Affiliation>Product Science Division, R&amp;D Group, Japan Tobacco Inc., Yokohama, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Naoki Minami</Name>
        <Affiliation>Product Science Division, R&amp;D Group, Japan Tobacco Inc., Yokohama, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Aoi Kakehi</Name>
        <Affiliation>Product Science Division, R&amp;D Group, Japan Tobacco Inc., Yokohama, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuyuki Futamura</Name>
        <Affiliation>Product Science Division, R&amp;D Group, Japan Tobacco Inc., Yokohama, Kanagawa, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Authors' Response to Letter to the Editor by Heinemann et al. "Response to 'A 28-day oral toxicity evaluation of small interfering RNAs and a long double-stranded RNA targeting vacuolar ATPase in mice.'" 2015.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25683774</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.004</DOI>
    <AuthorList>
      <Author>
        <Name>Jay S. Petrick</Name>
        <Affiliation>Monsanto Company, St. Louis, MO 63167, USA. Electronic address: jay.s.petrick@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>William M. Moore</Name>
        <Affiliation>Monsanto Company, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William F. Heydens</Name>
        <Affiliation>Monsanto Company, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael S. Koch</Name>
        <Affiliation>Monsanto Company, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James H. Sherman</Name>
        <Affiliation>Monsanto Company, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shawna L. Lemke</Name>
        <Affiliation>Monsanto Company, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A first-generation physiologically based pharmacokinetic (PBPK) model of alpha-tocopherol in human influenza vaccine adjuvant.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25683773</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.005</DOI>
    <KeywordList>
      <Keywords>AS03®</Keywords>
      <Keywords>Adjuvants</Keywords>
      <Keywords>Alpha-tocopherol</Keywords>
      <Keywords>Emulsion</Keywords>
      <Keywords>Vaccines</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Million A. Tegenge</Name>
        <Affiliation>Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, United States. Electronic address: million.tegenge@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Robert J. Mitkus</Name>
        <Affiliation>Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Response to "A 28-day oral toxicity evaluation of small interfering RNAs and a long double-stranded RNA targeting vacuolar ATPase in mice.".</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25680264</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.003</DOI>
    <KeywordList>
      <Keywords>RNAi</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>dsRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jack A. Heinemann</Name>
        <Affiliation>Centre for Integrated Research in Biosafety, School of Biological Sciences, University of Canterbury, Christchurch, New Zealand. Electronic address: jack.heinemann@canterbury.ac.nz.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Z. Agapito-Tenfen</Name>
        <Affiliation>CropScience Department, Federal University of Santa Catarina, Rod. Admar Gonzaga 1346, 88034000 Florianopolis, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Brigitta Kurenbach</Name>
        <Affiliation>Centre for Integrated Research in Biosafety, School of Biological Sciences, University of Canterbury, Christchurch, New Zealand.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A critical examination of the mode of action of quinacrine in the reproductive tract in a 2-year rat cancer bioassay and its implications for human clinical use.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25680263</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.006</DOI>
    <KeywordList>
      <Keywords>Biological relevance</Keywords>
      <Keywords>Carcinogenicity bioassay (CaBio)</Keywords>
      <Keywords>Chronic inflammation</Keywords>
      <Keywords>Contraception</Keywords>
      <Keywords>Maximum tolerated dose (MTD)</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Quinacrine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joseph K. Haseman</Name>
        <Affiliation>J.K. Haseman Consulting, 1054 Tacketts Pond Drive, Raleigh, NC 27614-7886, United States. Electronic address: hasemanjk@aol.com.</Affiliation>
      </Author>
      <Author>
        <Name>Roger G. Growe</Name>
        <Affiliation>International Federation for Family Health, 1127 River Forest Road, Pittsboro, NC 27312, United States. Electronic address: growe.roger@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Errol Zeiger</Name>
        <Affiliation>Errol Zeiger Consulting, 800 Indian Springs Road, Chapel Hill, NC 27514, United States. Electronic address: zeiger@nc.rr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ernest E. McConnell</Name>
        <Affiliation>Toxpath, Inc., 3028 Ethan Lane, Raleigh, NC 27613, United States. Electronic address: toxpathmcc@bellsouth.net.</Affiliation>
      </Author>
      <Author>
        <Name>Michael I. Luster</Name>
        <Affiliation>M.I. Luster Associates, 39 Quail Road, Morgantown, WV 26508, United States. Electronic address: miklus22@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Jack Lippes</Name>
        <Affiliation>State University of New York at Buffalo, School of Medicine, 31 Hampton Hill Drive, Buffalo, NY 14221, USA. Electronic address: jlip@buffalo.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of metal exposure from commonly used moisturizing and skin-lightening creams in Nigeria.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25667956</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.015</DOI>
    <KeywordList>
      <Keywords>Body creams</Keywords>
      <Keywords>Contact dermatitis</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Nigeria</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chukwujindu M. A. Iwegbue</Name>
        <Affiliation>Metals and Trace Organics Research Group, Department of Chemistry, Delta State University, P.M.B. 1, Abraka, Nigeria; School of Chemistry and Physics, University of KwaZulu-Natal, Westville Campus, Private Bag X54001, Durban, South Africa. Electronic address: maxipriestley@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Francisca I. Bassey</Name>
        <Affiliation>Department of Chemistry, University of Calabar, P.M.B. 1115, Calabar, Cross-Rivers State, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Godswill O. Tesi</Name>
        <Affiliation>Metals and Trace Organics Research Group, Department of Chemistry, Delta State University, P.M.B. 1, Abraka, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Sunday O. Onyeloni</Name>
        <Affiliation>Faculty of Pharmacy, Delta State University, P.M.B. 1, Abraka, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Obi</Name>
        <Affiliation>Department of Chemistry, Federal University of Petroleum Resource, Effurun, Delta State, Nigeria.</Affiliation>
      </Author>
      <Author>
        <Name>Bice S. Martincigh</Name>
        <Affiliation>School of Chemistry and Physics, University of KwaZulu-Natal, Westville Campus, Private Bag X54001, Durban, South Africa.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Do group responses mask the effects of air pollutants on potentially sensitive individuals in controlled human exposure studies?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25667955</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.002</DOI>
    <KeywordList>
      <Keywords>Asthma</Keywords>
      <Keywords>Controlled exposure studies</Keywords>
      <Keywords>Lung function</Keywords>
      <Keywords>National Ambient Air Quality Standards</Keywords>
      <Keywords>Nitrogen dioxide</Keywords>
      <Keywords>Ozone</Keywords>
      <Keywords>Sulfur dioxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, United States. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mara Seeley</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rosemary Mattuck</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sagar Thakali</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxicity studies on the root extract of Polygala tenuifolia Willdenow.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25666111</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.016</DOI>
    <KeywordList>
      <Keywords>Chromosomal aberration</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Micronucleus test</Keywords>
      <Keywords>Polygala tenuifolia Willdenow</Keywords>
      <Keywords>Reverse mutation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ki Young Shin</Name>
        <Affiliation>Research &amp; Development Center, Braintropia Co. Ltd., Anyang-si, Gyeonggi-do 431-716, Republic of Korea; Department of Microbiology, College of Natural Science, Dankook University, Cheonan-si, Chungnam 330-714, Republic of Korea. Electronic address: newsky73@braintropia.com.</Affiliation>
      </Author>
      <Author>
        <Name>Beom Young Won</Name>
        <Affiliation>Research &amp; Development Center, Braintropia Co. Ltd., Anyang-si, Gyeonggi-do 431-716, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Jee Ha</Name>
        <Affiliation>Research &amp; Development Center, Braintropia Co. Ltd., Anyang-si, Gyeonggi-do 431-716, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yeo Sang Yun</Name>
        <Affiliation>Research &amp; Development Center, Braintropia Co. Ltd., Anyang-si, Gyeonggi-do 431-716, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Gun Lee</Name>
        <Affiliation>Research &amp; Development Center, Braintropia Co. Ltd., Anyang-si, Gyeonggi-do 431-716, Republic of Korea.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Increased use in propofol and reported patterns of adverse events among anesthetics in Korea.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25666110</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.02.001</DOI>
    <KeywordList>
      <Keywords>Adverse drug reactions (ADRs)</Keywords>
      <Keywords>Anesthetic</Keywords>
      <Keywords>Consumption</Keywords>
      <Keywords>Propofol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyo Ju Park</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management, Seoul 110-750, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ju Young Shin</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management, Seoul 110-750, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Hee Kim</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management, Seoul 110-750, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Joo Park</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management, Seoul 110-750, South Korea; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 110-744, South Korea. Electronic address: bjpark@drugsafe.or.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An FDA oncology analysis of antibody-drug conjugates.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25661711</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.014</DOI>
    <KeywordList>
      <Keywords>Antibody-drug conjugates</Keywords>
      <Keywords>First-in-human start dose selection</Keywords>
      <Keywords>Oncology drug development</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haleh Saber</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John K. Leighton</Name>
        <Affiliation>US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD 20903, United States. Electronic address: john.leighton@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of read-across and computer-based predictive analysis for the safety assessment of PEG cocamines.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25659490</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.013</DOI>
    <KeywordList>
      <Keywords>Chemical analog identification</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Polyethylene glycol cocamine</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Structure activity relationship (SAR)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julie A. Skare</Name>
        <Affiliation>The Procter &amp; Gamble Company, Central Product Safety, Cincinnati, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Karen Blackburn</Name>
        <Affiliation>The Procter &amp; Gamble Company, Central Product Safety, Cincinnati, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Shengde Wu</Name>
        <Affiliation>The Procter &amp; Gamble Company, Central Product Safety, Cincinnati, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas A. Re</Name>
        <Affiliation>L'Oreal Research &amp; Innovation, Clark, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Duche</Name>
        <Affiliation>L'Oreal Research &amp; Innovation, Aulnay-Sous-Bois, France.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie Ringeissen</Name>
        <Affiliation>L'Oreal Research &amp; Innovation, Aulnay-Sous-Bois, France.</Affiliation>
      </Author>
      <Author>
        <Name>Donald L. Bjerke</Name>
        <Affiliation>The Procter &amp; Gamble Company, Central Product Safety, Cincinnati, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Viny Srinivasan</Name>
        <Affiliation>L'Oreal Research &amp; Innovation, Clark, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Carol Eisenmann</Name>
        <Affiliation>The Personal Care Products Council, Washington, DC, United States. Electronic address: eisenmannc@personalcarecouncil.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prescribing patterns of the four most commonly used sedatives in endoscopic examination in Korea: propofol, midazolam, diazepam, and lorazepam.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25659208</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.007</DOI>
    <KeywordList>
      <Keywords>Abuse</Keywords>
      <Keywords>Diazepam</Keywords>
      <Keywords>Endoscopic examination</Keywords>
      <Keywords>Lorazepam</Keywords>
      <Keywords>Midazolam</Keywords>
      <Keywords>Propofol</Keywords>
      <Keywords>Sedatives</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ju Young Shin</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management (KIDS), 136 Changgyeonggung-ro, Jongno-gu, Seoul 110-750, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Shin Haeng Lee</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management (KIDS), 136 Changgyeonggung-ro, Jongno-gu, Seoul 110-750, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Mi Shin</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management (KIDS), 136 Changgyeonggung-ro, Jongno-gu, Seoul 110-750, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Hee Kim</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management (KIDS), 136 Changgyeonggung-ro, Jongno-gu, Seoul 110-750, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Geon Park</Name>
        <Affiliation>Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 108 Pyeong-dong, Jongno-gu, Seoul 110-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Joo Park</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management (KIDS), 136 Changgyeonggung-ro, Jongno-gu, Seoul 110-750, Republic of Korea; Department of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, Republic of Korea. Electronic address: bjpark@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An evaluation of in-house and off-the-shelf in silico models: implications on guidance for mutagenicity assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25656493</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.010</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>Consensus analysis</Keywords>
      <Keywords>Derek Nexus</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>In silico models</Keywords>
      <Keywords>Leadscope</Keywords>
      <Keywords>Mutagenicity prediction</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Support Vector Machine</Keywords>
      <Keywords>Toxicity prediction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Robert Jolly</Name>
        <Affiliation>Health/Safety/Environmental, Lilly Research Laboratories, Indianapolis, IN, United States. Electronic address: Jollyra@lilly.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kausar Begam Riaz Ahmed</Name>
        <Affiliation>MD Anderson Cancer Center, Austin, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Craig Zwickl</Name>
        <Affiliation>Non-Clinical Safety Assessment, Lilly Research Laboratories, Indianapolis, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Watson</Name>
        <Affiliation>Advanced Analytics, Lilly Research Laboratories, Indianapolis, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Vijay Gombar</Name>
        <Affiliation>Drug Disposition, Lilly Research Laboratories, Indianapolis, IN, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25656492</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.008</DOI>
    <KeywordList>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Estrogen assays</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Exposure:activity ratio</Keywords>
      <Keywords>Genistein</Keywords>
      <Keywords>Potency</Keywords>
      <Keywords>Relative estrogenic exposure:activity quotient</Keywords>
      <Keywords>Tox21</Keywords>
      <Keywords>ToxCast™</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard A. Becker</Name>
        <Affiliation>American Chemistry Council, 700 2nd St., NE, Washington, DC, United States. Electronic address: rick_becker@americanchemistry.com.</Affiliation>
      </Author>
      <Author>
        <Name>Katie Paul Friedman</Name>
        <Affiliation>Bayer CropScience LP, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ted W. Simon</Name>
        <Affiliation>Ted Simon LLC, Winston, GA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>M. Sue Marty</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>DuPont Haskell Global Centers for Health and Environmental Sciences, Newark, DE, United States.</Affiliation>
      </Author>
      <Author>
        <Name>J. Craig Rowlands</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of a triazine compound nitromezuril by assessing bacterial reverse mutation, sperm abnormalities, micronucleus and chromosomal aberration.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25645284</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.011</DOI>
    <KeywordList>
      <Keywords>Anticoccidials</Keywords>
      <Keywords>Bacterial reverse mutation (Ames)</Keywords>
      <Keywords>Bone marrow micronucleus</Keywords>
      <Keywords>Chromosome aberration</Keywords>
      <Keywords>Coccidiosis</Keywords>
      <Keywords>Nitromezuril</Keywords>
      <Keywords>Sperm abnormalities</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chenzhong Fei</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Zhang</Name>
        <Affiliation>Chinese Medicine Hospital of Pudong New Area, Shanghai 201200, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Lin</Name>
        <Affiliation>Institute of Veterinary Feed Control of Zhengzhou, Henan 450003, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyang Wang</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Keyu Zhang</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lifang Zhang</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenli Zheng</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Wang</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Li</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Sui Xiao</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Feiqun Xue</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, PR China. Electronic address: fqxue@shvri.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei Wang</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxicity and subchronic toxicity of Sophorae radix in rats: hepatotoxic and genotoxic potential.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25640205</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.012</DOI>
    <KeywordList>
      <Keywords>Anemia</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Sophorae radix</Keywords>
      <Keywords>Subchronic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeong Hwan Che</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Biomedical Center for Animal Resource and Development, Bio-Max Institute, Seoul National University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Won Yun</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Soon Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyun Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Ran You</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ja June Jang</Name>
        <Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hee Chan Kim</Name>
        <Affiliation>Department of Biomedical Engineering, College of Medicine and Institute of Medical and Biological Engineering, Medical Research Center, Seoul National University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyeon Hoe Kim</Name>
        <Affiliation>Department of Urology, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: hhkim@snu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Byeong Cheol Kang</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Biomedical Center for Animal Resource and Development, Bio-Max Institute, Seoul National University, Seoul, Republic of Korea; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Designed Animal and Transplantation Research Institute, Seoul National University, Pyeongchang-gun, Gangwon-do, Republic of Korea. Electronic address: bckang@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimating skin sensitization potency from a single dose LLNA.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25625585</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.009</DOI>
    <KeywordList>
      <Keywords>Contact dermatitis</Keywords>
      <Keywords>Full local lymph node assay (LLNA)</Keywords>
      <Keywords>Probit analysis</Keywords>
      <Keywords>Reduced LLNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David W. Roberts</Name>
        <Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool L3 3AF, England, United Kingdom. Electronic address: D.W.Roberts@ljmu.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Variation in tobacco and mainstream smoke toxicant yields from selected commercial cigarette products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25620723</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.006</DOI>
    <KeywordList>
      <Keywords>Cigarette filler blend constituents</Keywords>
      <Keywords>Mainstream cigarette smoke</Keywords>
      <Keywords>Measurement variability</Keywords>
      <Keywords>Smoke toxicant emissions</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Eldridge</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Southampton, UK. Electronic address: alison_eldridge@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>T. R. Betson</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Southampton, UK.</Affiliation>
      </Author>
      <Author>
        <Name>M. Vinicius Gama</Name>
        <Affiliation>Souza Cruz S.A/British American Tobacco, PC-Americas, Cachoeirinha, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>K. McAdam</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Southampton, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hazard assessment of nitrosamine and nitramine by-products of amine-based CCS: alternative approaches.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25604881</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.01.017</DOI>
    <KeywordList>
      <Keywords>Carbon capture and storage</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Cell transformation assay</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Nitramines</Keywords>
      <Keywords>Nitrosamines</Keywords>
      <Keywords>Predictive in vitro models</Keywords>
      <Keywords>Predictive in vivo models</Keywords>
      <Keywords>QSARs</Keywords>
      <Keywords>Transgenic animal test</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. E. Buist</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, Netherlands. Electronic address: Harrie.Buist@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>S. Devito</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>R. A. Goldbohm</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>R. H. Stierum</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>J. Venhorst</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>E. D. Kroese</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Long-term toxicity study of rAd5-hTERTC27 in SD rats and Cynomolgus monkeys by intravenous injection.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25592546</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.022</DOI>
    <KeywordList>
      <Keywords>Gene therapy</Keywords>
      <Keywords>HCC</Keywords>
      <Keywords>Preclinical evaluation</Keywords>
      <Keywords>Repeat-dose toxicity</Keywords>
      <Keywords>hTERTC27</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pei jian Yue</Name>
        <Affiliation>Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, No. 107, Yan Jiang Xi Road, Guangzhou 510120, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei He</Name>
        <Affiliation>Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, No. 107, Yan Jiang Xi Road, Guangzhou 510120, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing yu Shen</Name>
        <Affiliation>Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, No. 107, Yan Jiang Xi Road, Guangzhou 510120, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu wei Qiu</Name>
        <Affiliation>Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, No. 107, Yan Jiang Xi Road, Guangzhou 510120, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao ming Rong</Name>
        <Affiliation>Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, No. 107, Yan Jiang Xi Road, Guangzhou 510120, China.</Affiliation>
      </Author>
      <Author>
        <Name>Han xian Gong</Name>
        <Affiliation>Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, No. 107, Yan Jiang Xi Road, Guangzhou 510120, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Peng</Name>
        <Affiliation>Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, No. 107, Yan Jiang Xi Road, Guangzhou 510120, China; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-sen University, No. 107, Yan Jiang Xi Road, Guangzhou 510120, China. Electronic address: docpengy123@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Causes of drug shortages in the legal pharmaceutical framework.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25591547</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.005</DOI>
    <KeywordList>
      <Keywords>Drug shortages</Keywords>
      <Keywords>Legal framework</Keywords>
      <Keywords>Market authorization</Keywords>
      <Keywords>Parallel trade</Keywords>
      <Keywords>Pricing</Keywords>
      <Keywords>Quality requirements</Keywords>
      <Keywords>Quota</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elfi De Weerdt</Name>
        <Affiliation>KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Herestraat 49, PO Box 521, 3000 Leuven, Belgium. Electronic address: elfi.deweerdt@pharm.kuleuven.be.</Affiliation>
      </Author>
      <Author>
        <Name>Steven Simoens</Name>
        <Affiliation>KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Herestraat 49, PO Box 521, 3000 Leuven, Belgium. Electronic address: steven.simoens@pharm.kuleuven.be.</Affiliation>
      </Author>
      <Author>
        <Name>Luc Hombroeckx</Name>
        <Affiliation>KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Herestraat 49, PO Box 420, 3000 Leuven, Belgium. Electronic address: luc.hombroeckx@pharm.kuleuven.be.</Affiliation>
      </Author>
      <Author>
        <Name>Minne Casteels</Name>
        <Affiliation>KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Herestraat 49, PO Box 521, 3000 Leuven, Belgium. Electronic address: minne.casteels@kuleuven.be.</Affiliation>
      </Author>
      <Author>
        <Name>Isabelle Huys</Name>
        <Affiliation>KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Herestraat 49, PO Box 521, 3000 Leuven, Belgium. Electronic address: Isabelle.huys@pharm.kuleuven.be.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of toxicity to triclosan in rats following 28 days of exposure to aerosol inhalation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25591546</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.004</DOI>
    <KeywordList>
      <Keywords>Inhalation</Keywords>
      <Keywords>NOAEC</Keywords>
      <Keywords>Nose-only exposure</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>Triclosan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Young Su Yang</Name>
        <Affiliation>Jeonbuk Department of Inhalation Research, Korea Institute of Toxicology, Jeonbuk 580-185, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Taek Kwon</Name>
        <Affiliation>Environmental Health Research Department, National Institute of Environmental Research, Incheon 404-708, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ilseob Shim</Name>
        <Affiliation>Environmental Health Research Department, National Institute of Environmental Research, Incheon 404-708, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Mi Kim</Name>
        <Affiliation>Environmental Health Research Department, National Institute of Environmental Research, Incheon 404-708, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Pilje Kim</Name>
        <Affiliation>Environmental Health Research Department, National Institute of Environmental Research, Incheon 404-708, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Choon Kim</Name>
        <Affiliation>College of Veterinary Medicine, Chonnam National University, Gwangju 500-757, Republic of Korea. Electronic address: toxkim@jnu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Kyuhong Lee</Name>
        <Affiliation>Jeonbuk Department of Inhalation Research, Korea Institute of Toxicology, Jeonbuk 580-185, Republic of Korea. Electronic address: khlee@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Utilizing relative potency factors (RPF) and threshold of toxicological concern (TTC) concepts to assess hazard and human risk assessment profiles of environmental metabolites: a case study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25584438</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.010</DOI>
    <KeywordList>
      <Keywords>Agrochemical</Keywords>
      <Keywords>Groundwater</Keywords>
      <Keywords>Hazard</Keywords>
      <Keywords>Metabolites</Keywords>
      <Keywords>Pesticide</Keywords>
      <Keywords>Plant protection products</Keywords>
      <Keywords>Relative potency</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>TTC</Keywords>
      <Keywords>Threshold of toxicological concern</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. Terry</Name>
        <Affiliation>Dow AgroSciences LLC, Oxfordshire, UK. Electronic address: cterry@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>R. J. Rasoulpour</Name>
        <Affiliation>Dow AgroSciences LLC, Indianapolis, Indiana, United States.</Affiliation>
      </Author>
      <Author>
        <Name>S. Knowles</Name>
        <Affiliation>Dow AgroSciences LLC, Oxfordshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>R. Billington</Name>
        <Affiliation>Dow AgroSciences LLC, Oxfordshire, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The combination of two novel tobacco blends and filter technologies to reduce the in vitro genotoxicity and cytotoxicity of prototype cigarettes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25584437</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.001</DOI>
    <KeywordList>
      <Keywords>Blend treated tobacco</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Particulate matter</Keywords>
      <Keywords>Reduced toxicant prototype</Keywords>
      <Keywords>Tobacco sheet substitute</Keywords>
      <Keywords>Tobacco smoke</Keywords>
      <Keywords>Toxicant</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ian Crooks</Name>
        <Affiliation>British American Tobacco (Investments) Ltd., GR&amp;D Centre, Regents Park Road, Southampton SO16 8TL, UK. Electronic address: ian_crooks@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ken Scott</Name>
        <Affiliation>British American Tobacco (Investments) Ltd., GR&amp;D Centre, Regents Park Road, Southampton SO16 8TL, UK. Electronic address: ken_scott@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Annette Dalrymple</Name>
        <Affiliation>British American Tobacco (Investments) Ltd., GR&amp;D Centre, Regents Park Road, Southampton SO16 8TL, UK. Electronic address: annette_dalrymple@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Debbie Dillon</Name>
        <Affiliation>British American Tobacco (Investments) Ltd., GR&amp;D Centre, Regents Park Road, Southampton SO16 8TL, UK. Electronic address: debbie_dillon@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Clive Meredith</Name>
        <Affiliation>British American Tobacco (Investments) Ltd., GR&amp;D Centre, Regents Park Road, Southampton SO16 8TL, UK. Electronic address: clive_meredith@bat.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Endocrine activity of alternatives to BPA found in thermal paper in Switzerland.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25579646</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2015.01.002</DOI>
    <KeywordList>
      <Keywords>BPA alternatives</Keywords>
      <Keywords>Endocrine activity</Keywords>
      <Keywords>H295R steroidogenesis assay</Keywords>
      <Keywords>Thermal paper</Keywords>
      <Keywords>VirtualToxLab™</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniela M. Goldinger</Name>
        <Affiliation>Federal Office of Public Health, Division Chemical Products, 3003 Bern, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Laure Demierre</Name>
        <Affiliation>Federal Office of Public Health, Division Chemical Products, 3003 Bern, Switzerland. Electronic address: anne-laure.demierre@bag.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Otmar Zoller</Name>
        <Affiliation>Federal Food Safety and Veterinary Office, 3003 Bern, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Heinz Rupp</Name>
        <Affiliation>Federal Food Safety and Veterinary Office, 3003 Bern, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Reinhard</Name>
        <Affiliation>Federal Food Safety and Veterinary Office, 3003 Bern, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Roxane Magnin</Name>
        <Affiliation>Federal Food Safety and Veterinary Office, 3003 Bern, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas W. Becker</Name>
        <Affiliation>PhaToCon (Pharm/Tox Concept) GmbH, 82152 Martinsried, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martine Bourqui-Pittet</Name>
        <Affiliation>Federal Office of Public Health, Division Chemical Products, 3003 Bern, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Magnitudes of biomarker reductions in response to controlled reductions in cigarettes smoked per day: a one-week clinical confinement study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25572415</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.023</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Cessation</Keywords>
      <Keywords>Cigarettes</Keywords>
      <Keywords>Clinical confinement</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eugenia H. Theophilus</Name>
        <Affiliation>R.J. Reynolds Tobacco Co., 950 Reynolds Boulevard, Winston-Salem, NC 27105, United States. Electronic address: theophe@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher R. E. Coggins</Name>
        <Affiliation>Carson Watts Consulting, 1266 Carson Watts Road, King, NC 27021, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Chen</Name>
        <Affiliation>R.J. Reynolds Tobacco Co., 950 Reynolds Boulevard, Winston-Salem, NC 27105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Eckhardt Schmidt</Name>
        <Affiliation>R.J. Reynolds Tobacco Co., 950 Reynolds Boulevard, Winston-Salem, NC 27105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael F. Borgerding</Name>
        <Affiliation>R.J. Reynolds Tobacco Co., 950 Reynolds Boulevard, Winston-Salem, NC 27105, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Introducing conformal prediction in predictive modeling for regulatory purposes. A transparent and flexible alternative to applicability domain determination.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25559551</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.021</DOI>
    <KeywordList>
      <Keywords>Applicability domain</Keywords>
      <Keywords>CAESAR</Keywords>
      <Keywords>Confidence predictor</Keywords>
      <Keywords>Conformal prediction</Keywords>
      <Keywords>Conformity score</Keywords>
      <Keywords>MOE descriptors</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Random forest</Keywords>
      <Keywords>Signature descriptors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ulf Norinder</Name>
        <Affiliation>Swedish Toxicology Sciences Research Center, SE-151 36 Södertälje, Sweden. Electronic address: ulf.norinder@swetox.se.</Affiliation>
      </Author>
      <Author>
        <Name>Lars Carlsson</Name>
        <Affiliation>AstraZeneca Research and Development, SE-431 83 Mölndal, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Boyer</Name>
        <Affiliation>Swedish Toxicology Sciences Research Center, SE-151 36 Södertälje, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Eklund</Name>
        <Affiliation>AstraZeneca Research and Development, SE-431 83 Mölndal, Sweden; Dept. Surgery, University of California at San Francisco (UCSF), San Francisco, CA 94115, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Relationship between lethal toxicity in oral administration and injection to mice: effect of exposure routes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25558060</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.019</DOI>
    <KeywordList>
      <Keywords>Absorption</Keywords>
      <Keywords>Correlation</Keywords>
      <Keywords>Exposure route</Keywords>
      <Keywords>Kinetics</Keywords>
      <Keywords>Lethal critical concentration</Keywords>
      <Keywords>Metabolism</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Wang</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhong H. Ning</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong W. Tai</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuang Long</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei C. Qin</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Li M. Su</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan H. Zhao</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China. Electronic address: zhaoyh@nenu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Animal rights activists: misconceived proposals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25556689</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.020</DOI>
    <AuthorList>
      <Author>
        <Name>Fabio Vivarelli</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via S. Donato 15, 40126 Bologna, Italy. Electronic address: fabio.vivarelli3@unibo.it.</Affiliation>
      </Author>
      <Author>
        <Name>Donatella Canistro</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via S. Donato 15, 40126 Bologna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Clara Babot Marquillas</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via S. Donato 15, 40126 Bologna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Sapone</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via S. Donato 15, 40126 Bologna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Moreno Paolini</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via S. Donato 15, 40126 Bologna, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25555996</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.018</DOI>
    <KeywordList>
      <Keywords>Animal alternatives</Keywords>
      <Keywords>Animal ban</Keywords>
      <Keywords>Cosmetics ingredients</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Safety evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. P. Vinardell</Name>
        <Affiliation>Dept. Fisiologia, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain. Electronic address: mpvinardellmh@ub.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Consumption patterns and biomarkers of exposure in cigarette smokers switched to Snus, various dissolvable tobacco products, Dual use, or tobacco abstinence.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25549549</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.016</DOI>
    <KeywordList>
      <Keywords>Biomarkers of exposure</Keywords>
      <Keywords>Clinical</Keywords>
      <Keywords>Dissolvable tobacco</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Smokeless tobacco</Keywords>
      <Keywords>Snus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>George R. Krautter</Name>
        <Affiliation>R.J. Reynolds Tobacco Company, Winston-Salem, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Peter X. Chen</Name>
        <Affiliation>R.J. Reynolds Tobacco Company, Winston-Salem, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael F. Borgerding</Name>
        <Affiliation>R.J. Reynolds Tobacco Company, Winston-Salem, NC, USA. Electronic address: borgerm@rjrt.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Purification, characterization and safety assessment of the introduced cold shock protein B in DroughtGard maize.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25545317</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.014</DOI>
    <KeywordList>
      <Keywords>Cold shock protein B</Keywords>
      <Keywords>Digestibility</Keywords>
      <Keywords>DroughtGard™</Keywords>
      <Keywords>Equivalence</Keywords>
      <Keywords>History of safe use</Keywords>
      <Keywords>Protein purification</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cunxi Wang</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, United States. Electronic address: cunxi.wang@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>Luis A. Burzio</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael S. Koch</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andre Silvanovich</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Erin Bell</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Blvd, St. Louis, MO 63167, United States. Electronic address: Erin.bell@monsanto.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lead isotope profiling in dairy calves.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25545316</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.015</DOI>
    <KeywordList>
      <Keywords>Agriculture</Keywords>
      <Keywords>Cattle</Keywords>
      <Keywords>Dairy</Keywords>
      <Keywords>ICP-MS</Keywords>
      <Keywords>Isotopes</Keywords>
      <Keywords>Lead</Keywords>
      <Keywords>Paint</Keywords>
      <Keywords>Soil</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John Buchweitz</Name>
        <Affiliation>Diagnostic Center for Population and Animal Health, Michigan State University, 4125 Beaumont Rd, Lansing, MI 48910, United States; Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, 784 Wilson Rd, East Lansing, MI 48824, United States. Electronic address: buchweitzj@dcpah.msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Kimberly McClure-Brinton</Name>
        <Affiliation>Country Companion Veterinary Services, 116 Old Amity Rd, Bethany, CT 06524, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Justin Zyskowski</Name>
        <Affiliation>Diagnostic Center for Population and Animal Health, Michigan State University, 4125 Beaumont Rd, Lansing, MI 48910, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lauren Stensen</Name>
        <Affiliation>Diagnostic Center for Population and Animal Health, Michigan State University, 4125 Beaumont Rd, Lansing, MI 48910, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Lehner</Name>
        <Affiliation>Diagnostic Center for Population and Animal Health, Michigan State University, 4125 Beaumont Rd, Lansing, MI 48910, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>(Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25545315</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.012</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Drug impurities</Keywords>
      <Keywords>ICH M7</Keywords>
      <Keywords>Mutagenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark W. Powley</Name>
        <Affiliation>Division of Antiviral Products, Office of New Drugs, Center for Drug Evaluation and Research, US FDA, WO 22/RM 6389, 10903 New Hampshire Ave., Silver Spring, MD 20993, United States. Electronic address: mark.powley@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Local tolerance and systemic toxicity of single and repeated intramuscular administrations of two different formulations of the RTS,S malaria candidate vaccine in rabbits.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25545314</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.017</DOI>
    <KeywordList>
      <Keywords>AS01</Keywords>
      <Keywords>AS02</Keywords>
      <Keywords>Adjuvant</Keywords>
      <Keywords>Malaria</Keywords>
      <Keywords>RTS,S</Keywords>
      <Keywords>Rabbit</Keywords>
      <Keywords>Toxicity study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lawrence Segal</Name>
        <Affiliation>GSK Vaccines, Rixensart, Belgium. Electronic address: lawrence.m.segal@gsk.com.</Affiliation>
      </Author>
      <Author>
        <Name>Danielle Morelle</Name>
        <Affiliation>GSK Vaccines, Rixensart, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Blee</Name>
        <Affiliation>Huntingdon Life Sciences, Ltd., Cambridgeshire, England, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Emma Moore</Name>
        <Affiliation>Huntingdon Life Sciences, Ltd., Cambridgeshire, England, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Micaela Damsten</Name>
        <Affiliation>GSK Vaccines, Rixensart, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Chiu Liu</Name>
        <Affiliation>Huntingdon Life Sciences, Ltd., Cambridgeshire, England, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Destexhe</Name>
        <Affiliation>GSK Vaccines, Rixensart, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalie Garçon</Name>
        <Affiliation>GSK Vaccines, Rixensart, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of human Biomonitoring Guidance Values for chlorpyrifos using a physiologically based pharmacokinetic and pharmacodynamic model of cholinesterase inhibition.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25543108</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.013</DOI>
    <KeywordList>
      <Keywords>Acetylcholinesterase inhibition</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring Guidance Value</Keywords>
      <Keywords>Chlorpyrifos</Keywords>
      <Keywords>Physiologically based pharmacokinetic/pharmacodynamic model</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Scott M. Arnold</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, United States. Electronic address: smarnold@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alistair Morriss</Name>
        <Affiliation>Dow AgroSciences Ltd., Milton Park, Abingdon, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph Velovitch</Name>
        <Affiliation>Dow AgroSciences, Indianapolis, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daland Juberg</Name>
        <Affiliation>Dow AgroSciences, Indianapolis, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Carol J. Burns</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Bartels</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Manoj Aggarwal</Name>
        <Affiliation>Dow AgroSciences Ltd., Milton Park, Abingdon, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Torka Poet</Name>
        <Affiliation>Summit Toxicology, LLP, Richland, WA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sean Hays</Name>
        <Affiliation>Summit Toxicology, LLP, Lyons, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Price</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Introduction: Toxicological assessment of kretek cigarettes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25542403</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.12.011</DOI>
    <AuthorList />
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of aromatic amines with different purities and different solvent vehicles in the Ames test.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25542092</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.009</DOI>
    <KeywordList>
      <Keywords>Ames test</Keywords>
      <Keywords>Aromatic amines</Keywords>
      <Keywords>DMSO solvent</Keywords>
      <Keywords>Effect purification</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Mutagenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alexander P. Harding</Name>
        <Affiliation>Manchester Institute of Biotechnology (MIB), 131 Princess Street, Manchester M1 7DN, UK; School of Chemistry, Univ. of Manchester, Oxford Road, Manchester M13 9PL, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Paul L. A. Popelier</Name>
        <Affiliation>Manchester Institute of Biotechnology (MIB), 131 Princess Street, Manchester M1 7DN, UK; School of Chemistry, Univ. of Manchester, Oxford Road, Manchester M13 9PL, UK. Electronic address: pla@manchester.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>James Harvey</Name>
        <Affiliation>Safety Assessment, GlaxoSmithKline, Park Road, Ware SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda Giddings</Name>
        <Affiliation>Safety Assessment, GlaxoSmithKline, Park Road, Ware SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Graham Foster</Name>
        <Affiliation>Molecular Discovery Research, GlaxoSmithKline, Gunnelswood Road, Stevenage SG1 2NY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Kranz</Name>
        <Affiliation>Molecular Discovery Research, GlaxoSmithKline, Gunnelswood Road, Stevenage SG1 2NY, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing skin sensitization hazard in mice and men using non-animal test methods.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25541156</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.008</DOI>
    <KeywordList>
      <Keywords>(modified) MUSST</Keywords>
      <Keywords>Adverse outcome pathway (AOP)</Keywords>
      <Keywords>Allergic contact dermatitis (ACD)</Keywords>
      <Keywords>DPRA</Keywords>
      <Keywords>Database</Keywords>
      <Keywords>Integrated testing strategy (ITS)</Keywords>
      <Keywords>KeratinoSens™</Keywords>
      <Keywords>LuSens</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>h-CLAT</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniel Urbisch</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Annette Mehling</Name>
        <Affiliation>BASF Personal Care and Nutrition GmbH, Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Katharina Guth</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tzutzuy Ramirez</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Naveed Honarvar</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Kolle</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany. Electronic address: robert.landsiedel@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Jaworska</Name>
        <Affiliation>Procter &amp; Gamble NV, 100 Temselaan, 1853 Strombeek-Bever, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Petra S. Kern</Name>
        <Affiliation>Procter &amp; Gamble Technology (Beijing) Co., Ltd., China.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Gerberick</Name>
        <Affiliation>Procter &amp; Gamble Company, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Natsch</Name>
        <Affiliation>Givaudan Schweiz AG, Ueberlandstraße 138, CH-8600 Dübendorf, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Roger Emter</Name>
        <Affiliation>Givaudan Schweiz AG, Ueberlandstraße 138, CH-8600 Dübendorf, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Takao Ashikaga</Name>
        <Affiliation>Shiseido Research Center, Shiseido Co., Ltd., 2-2-1 Hayabuchi, Tsuzuki-ku, Yokohama-shi, Kanagawa 224-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masaaki Miyazawa</Name>
        <Affiliation>Safety Science Research Laboratories, Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi 321-349, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hitoshi Sakaguchi</Name>
        <Affiliation>Safety Science Research Laboratories, Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi 321-349, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The toxicokinetic profile of curdione in pregnant SD rats and its transference in a placental barrier system detected by LC-MS/MS.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25527910</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.005</DOI>
    <KeywordList>
      <Keywords>Curdione</Keywords>
      <Keywords>Drug distribution</Keywords>
      <Keywords>Toxicokinetics</Keywords>
      <Keywords>Transferring capability</Keywords>
      <Keywords>Vaginitis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiang Meng</Name>
        <Affiliation>School of Pharmacy, Fudan University, Shanghai, China; Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Zhang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Li</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Pan</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Jiang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongwei Luo</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liming Chong</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sichong Xu</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Zhou</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zuyue Sun</Name>
        <Affiliation>School of Pharmacy, Fudan University, Shanghai, China; Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China. Electronic address: sunzy64@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The safety of a dry spearmint extract in vitro and in vivo.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25527048</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.007</DOI>
    <KeywordList>
      <Keywords>Chromosome aberration</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Rosmarinic acid</Keywords>
      <Keywords>Spearmint</Keywords>
      <Keywords>Subchronic study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joanne A. Lasrado</Name>
        <Affiliation>Kemin Foods, L.C., 601 E. Locust Avenue, Ste 203, Des Moines, IA, United States. Electronic address: joanne.hollis@kemin.com.</Affiliation>
      </Author>
      <Author>
        <Name>Debbie Trinker</Name>
        <Affiliation>Kemin Foods, L.C., 601 E. Locust Avenue, Ste 203, Des Moines, IA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael A. Ceddia</Name>
        <Affiliation>M.A.C, The Scotts Miracle-Gro Company, 14111 Scottslawn Road, Marysville, OH 43041, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kelli A. Herrlinger</Name>
        <Affiliation>Kemin Foods, L.C., 601 E. Locust Avenue, Ste 203, Des Moines, IA, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mirabel: an integrated project for risk and cost/benefit analysis of peanut allergy.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25523940</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.006</DOI>
    <KeywordList>
      <Keywords>Allergic consumer behaviors</Keywords>
      <Keywords>Allergy</Keywords>
      <Keywords>Food labelling</Keywords>
      <Keywords>Peanut allergen</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Risk management</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Crépet</Name>
        <Affiliation>Risk Assessment Department (DER), French Agency for Food, Environmental and Occupational Health Safety (ANSES), Maisons-Alfort, France. Electronic address: amelie.crepet@anses.fr.</Affiliation>
      </Author>
      <Author>
        <Name>A. Papadopoulos</Name>
        <Affiliation>Risk Assessment Department (DER), French Agency for Food, Environmental and Occupational Health Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>C. F. Elegbede</Name>
        <Affiliation>Risk Assessment Department (DER), French Agency for Food, Environmental and Occupational Health Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>S. Ait-Dahmane</Name>
        <Affiliation>Risk Assessment Department (DER), French Agency for Food, Environmental and Occupational Health Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>C. Loynet</Name>
        <Affiliation>Risk Assessment Department (DER), French Agency for Food, Environmental and Occupational Health Safety (ANSES), Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>G. Millet</Name>
        <Affiliation>Public Economy Unit, National Institute of Agronomic Research (INRA), Thiverval-Grignon, France.</Affiliation>
      </Author>
      <Author>
        <Name>X. Van Der Brempt</Name>
        <Affiliation>Clinic Saint-Luc, Bouge, Namur, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>O. Bruyère</Name>
        <Affiliation>Liège University, Liège, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>S. Marette</Name>
        <Affiliation>Public Economy Unit, National Institute of Agronomic Research (INRA), Thiverval-Grignon, France.</Affiliation>
      </Author>
      <Author>
        <Name>D. A. Moneret-Vautrin</Name>
        <Affiliation>Allergyvigilance Network, Vandoeuvre les Nancy, France; Faculty of Medicine, Nancy, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of exposure factors for infant lactational exposure to persistent organic pollutants (POPs).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25510832</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.003</DOI>
    <KeywordList>
      <Keywords>Breast milk</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Exposure factor</Keywords>
      <Keywords>Infant</Keywords>
      <Keywords>Infant:mother ratio</Keywords>
      <Keywords>PBPK modeling</Keywords>
      <Keywords>Persistent organic pollutants</Keywords>
      <Keywords>Pharmacokinetic</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Variability</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sami Haddad</Name>
        <Affiliation>Department of Environmental and Occupational Health, School of Public Health, Université de Montréal, Montréal, QC, Canada; Université de Montréal Public Health Research Institute (IRSPUM), Université de Montréal, Montréal, QC, Canada; Chair in Toxicological Risk Assessment and Management, Université de Montréal, Montreal, QC, Canada. Electronic address: sami.haddad@umontreal.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Pierre Ayotte</Name>
        <Affiliation>Axe santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Québec, QC, Canada; Département de médecine sociale et préventive, Université Laval, Québec, QC, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Marc Andre Verner</Name>
        <Affiliation>Department of Environmental and Occupational Health, School of Public Health, Université de Montréal, Montréal, QC, Canada; Université de Montréal Public Health Research Institute (IRSPUM), Université de Montréal, Montréal, QC, Canada; Chair in Toxicological Risk Assessment and Management, Université de Montréal, Montreal, QC, Canada; Department of Environmental Health, Harvard School of Public Health, Boston, MA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimation of the chemical-induced eye injury using a Weight-of-Evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): part II: corrosion potential.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25510831</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.004</DOI>
    <KeywordList>
      <Keywords>Artificial neural network</Keywords>
      <Keywords>Eye corrosion</Keywords>
      <Keywords>QSAR-21</Keywords>
      <Keywords>Weight of evidence</Keywords>
      <Keywords>c-QSAR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rajeshwar P. Verma</Name>
        <Affiliation>Office of Cosmetics and Colors, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, United States; Office of Food Additive Safety, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, United States. Electronic address: Rajeshwar.Verma@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Edwin J. Matthews</Name>
        <Affiliation>Office of Food Additive Safety, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment of kretek cigarettes: Part 1: background, assessment approach, and summary of findings.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25498000</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.11.015</DOI>
    <KeywordList>
      <Keywords>Clove cigarettes</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Eugenol</Keywords>
      <Keywords>Ingredients</Keywords>
      <Keywords>Inhalation toxicity</Keywords>
      <Keywords>Kretek cigarettes</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Smoke chemistry</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>E. Roemer</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>R. Dempsey</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland. Electronic address: Ruth.Dempsey@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. K. Schorp</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Article series: Safety of esterified propoxylated glycerol (EPG), a nonabsorbable fat replacer.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25497999</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.11.010</DOI>
    <KeywordList>
      <Keywords>EPG</Keywords>
      <Keywords>Esterified propoxylated glycerol</Keywords>
      <Keywords>Fat substitute</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David H. Bechtel</Name>
        <Affiliation>Best Foods, Division of CPC International, 150 Pierce St., Somerset, NJ 08873, United States. Electronic address: david.bechtel@intertek.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the effect of esterified propoxylated glycerol (EPG) on the status of fat-soluble vitamins and select water-soluble nutrients following dietary administration to humans for 8 weeks.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25497998</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.11.009</DOI>
    <KeywordList>
      <Keywords>Clinical trial</Keywords>
      <Keywords>EPG</Keywords>
      <Keywords>Esterified propoxylated glycerol</Keywords>
      <Keywords>Fat substitute</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael H. Davidson</Name>
        <Affiliation>The University of Chicago Pritzker School of Medicine, 150 E. Huron St., Chicago, IL 60611, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David H. Bechtel</Name>
        <Affiliation>Best Foods, Division of CPC International, 150 Pierce St., Somerset, NJ 08873, United States. Electronic address: david.bechtel@intertek.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxicity testing of esterified propoxylated glycerol (EPG).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25497997</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.11.013</DOI>
    <KeywordList>
      <Keywords>EPG</Keywords>
      <Keywords>Esterified propoxylated glycerol</Keywords>
      <Keywords>Fat substitute</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Mutagenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David H. Bechtel</Name>
        <Affiliation>Best Foods, Division of CPC International, 150 Pierce St., Somerset, NJ 08873, USA. Electronic address: david.bechtel@intertek.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Navigating through orphan medicinal product regulations in EU and US--similarities and differences.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25497996</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.11.006</DOI>
    <KeywordList>
      <Keywords>Committee for Orphan Medicinal Products</Keywords>
      <Keywords>Office of Orphan Products Development</Keywords>
      <Keywords>Orphan Drug Act</Keywords>
      <Keywords>Orphan designation</Keywords>
      <Keywords>Orphan drugs</Keywords>
      <Keywords>Rare diseases</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jyoti Tiwari</Name>
        <Affiliation>Glenmark Pharmaceuticals Ltd., Glenmark House, HDO - Corporate Building, BD Sawant Marg, Chakala, Andheri (E), Mumbai 400 099, Maharashtra, India. Electronic address: jyoti.tiwari@glenmarkpharma.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25497995</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.12.002</DOI>
    <KeywordList>
      <Keywords>Allergic asthma</Keywords>
      <Keywords>Anti-immunoglobulin E</Keywords>
      <Keywords>Dosing table</Keywords>
      <Keywords>Modeling and simulation</Keywords>
      <Keywords>Omalizumab</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Philip J. Lowe</Name>
        <Affiliation>Novartis Pharma AG, Basel, Switzerland. Electronic address: phil.lowe@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Panayiotis Georgiou</Name>
        <Affiliation>Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Janice Canvin</Name>
        <Affiliation>Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>90-day dietary toxicity study with esterified propoxylated glycerol (EPG) in micropigs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25497994</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.11.012</DOI>
    <KeywordList>
      <Keywords>EPG</Keywords>
      <Keywords>Esterified propoxylated glycerol</Keywords>
      <Keywords>Fat substitute</Keywords>
      <Keywords>Subchronic oral toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John Wedig</Name>
        <Affiliation>T.P.S, Inc., 10424 Middle Mt. Vernon Rd, Mt. Vernon, IN 47620, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David H. Bechtel</Name>
        <Affiliation>Best Foods, Division of CPC International, 150 Pierce St., Somerset, NJ 08873, United States. Electronic address: david.bechtel@intertek.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment of kretek cigarettes: Part 2: kretek and American-blended cigarettes, smoke chemistry and in vitro toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25497993</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.12.001</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Eugenol</Keywords>
      <Keywords>Kretek</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Smoke chemistry</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. J. Piadé</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>E. Roemer</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>R. Dempsey</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland. Electronic address: Ruth.Dempsey@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>G. Hornig</Name>
        <Affiliation>Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>A. Deger Evans</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Quai Jeanrenaud 56, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>H. Völkel</Name>
        <Affiliation>Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>H. Schramke</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>E. Trelles-Sticken</Name>
        <Affiliation>Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>S. Wittke</Name>
        <Affiliation>Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>S. Weber</Name>
        <Affiliation>Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>M. K. Schorp</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developmental toxicity evaluation of esterified propoxylated glycerol (EPG) administered in the diet to New Zealand white rabbits.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25497992</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.11.014</DOI>
    <KeywordList>
      <Keywords>EPG</Keywords>
      <Keywords>Esterified propoxylated glycerol</Keywords>
      <Keywords>Fat substitute</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Teratogenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rochelle W. Tyl</Name>
        <Affiliation>RTI International, 3040 E. Cornwallis Road, Research Triangle Park, PO Box 12194, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David H. Bechtel</Name>
        <Affiliation>Best Foods, Division of CPC International, 150 Pierce St., Somerset, NJ 08873, United States. Electronic address: david.bechtel@intertek.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>90-day dietary toxicity study with esterified propoxylated glycerol (EPG) in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25497991</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.11.017</DOI>
    <KeywordList>
      <Keywords>EPG</Keywords>
      <Keywords>Esterified propoxylated glycerol</Keywords>
      <Keywords>Fat substitute</Keywords>
      <Keywords>Subchronic oral toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brian J. Christian</Name>
        <Affiliation>Hazelton Wisconsin, Inc., 3301 Kinsman Blvd, Madison, WI 53704, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David H. Bechtel</Name>
        <Affiliation>Best Foods, Division of CPC International, 150 Pierce St., Somerset, NJ 08873, United States. Electronic address: david.bechtel@intertek.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimation of the chemical-induced eye injury using a weight-of-evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): part I: irritation potential.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25497990</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.11.011</DOI>
    <KeywordList>
      <Keywords>Artificial neural network</Keywords>
      <Keywords>Eye irritation</Keywords>
      <Keywords>QSAR-21</Keywords>
      <Keywords>Weight of evidence</Keywords>
      <Keywords>c-QSAR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rajeshwar P. Verma</Name>
        <Affiliation>Office of Cosmetics and Colors, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, United States; Office of Food Additive Safety, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, United States. Electronic address: Rajeshwar.Verma@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Edwin J. Matthews</Name>
        <Affiliation>Office of Food Additive Safety, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>One-generation reproduction study of esterified propoxylated glycerol (EPG) administered in the feed to CD® (Sprague-Dawley) rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25496811</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.11.018</DOI>
    <KeywordList>
      <Keywords>EPG</Keywords>
      <Keywords>Esterified propoxylated glycerol</Keywords>
      <Keywords>Fat substitute</Keywords>
      <Keywords>One-generation</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rochelle W. Tyl</Name>
        <Affiliation>RTI International, 3040 E. Cornwallis Road, Research Triangle Park, NC, PO Box 12194, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David H. Bechtel</Name>
        <Affiliation>Best Foods, Division of CPC International, 150 Pierce St., Somerset, NJ 08873, United States. Electronic address: david.bechtel@intertek.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment of kretek cigarettes Part 6: the impact of ingredients added to kretek cigarettes on smoke chemistry and in vitro toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25496764</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.11.016</DOI>
    <KeywordList>
      <Keywords>Clove cigarette</Keywords>
      <Keywords>Flavor</Keywords>
      <Keywords>In vitro toxicology</Keywords>
      <Keywords>Ingredient</Keywords>
      <Keywords>Kretek</Keywords>
      <Keywords>Smoke chemistry</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>E. Roemer</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>R. Dempsey</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland. Electronic address: Ruth.Dempsey@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Hirter</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>A. Deger Evans</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Quai Jeanrenaud 56, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>S. Weber</Name>
        <Affiliation>Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>A. Ode</Name>
        <Affiliation>Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>S. Wittke</Name>
        <Affiliation>Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>M. K. Schorp</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety and mutagenicity evaluation of Vigiis 101 powder made from Lactobacillus paracasei subsp. paracasei NTU 101.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25481278</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.11.008</DOI>
    <KeywordList>
      <Keywords>Lactobacillus paracasei subsp. paracasei NTU 101</Keywords>
      <Keywords>No observed adverse effect level</Keywords>
      <Keywords>Probiotic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Ting Tseng</Name>
        <Affiliation>Department of Biochemical Science &amp; Technology, College of Life Sciences, National Taiwan University, Taipei 106, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Tsung Wei Shih</Name>
        <Affiliation>SunWay Biotech Co., Taipei 112, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shing Hwa Liu</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei 106, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Tzu Ming Pan</Name>
        <Affiliation>Department of Biochemical Science &amp; Technology, College of Life Sciences, National Taiwan University, Taipei 106, Taiwan. Electronic address: tmpan@ntu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and sub-chronic toxicity studies of honokiol microemulsion.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25481277</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.11.007</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Honokiol microemulsion</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qianqian Zhang</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Li</Name>
        <Affiliation>Drug Safety Evaluation Center, China Institute for Radiation Protection, Taiyuan 030006, China; Shanxi Key Laboratory of Drug Toxicology and Drug for Radiation Injury, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhang</Name>
        <Affiliation>Drug Safety Evaluation Center, China Institute for Radiation Protection, Taiyuan 030006, China; Shanxi Key Laboratory of Drug Toxicology and Drug for Radiation Injury, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Quan An</Name>
        <Affiliation>Drug Safety Evaluation Center, China Institute for Radiation Protection, Taiyuan 030006, China; Shanxi Key Laboratory of Drug Toxicology and Drug for Radiation Injury, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianhua Wen</Name>
        <Affiliation>Drug Safety Evaluation Center, China Institute for Radiation Protection, Taiyuan 030006, China; Shanxi Key Laboratory of Drug Toxicology and Drug for Radiation Injury, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Aiping Wang</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongtao Jin</Name>
        <Affiliation>New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China. Electronic address: jinhongtao@imm.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shizhong Chen</Name>
        <Affiliation>School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Electronic address: chenshizhong66@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25460033</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.11.004</DOI>
    <KeywordList>
      <Keywords>Carbon monoxide</Keywords>
      <Keywords>Cardiovascular function</Keywords>
      <Keywords>Electronic cigarette</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Smoking</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>X. Sherwin Yan</Name>
        <Affiliation>Scientific Affairs, A.W. Spears Research Center, Lorillard Tobacco Company, Greensboro, NC, United States. Electronic address: syan@lortobco.com.</Affiliation>
      </Author>
      <Author>
        <Name>Carl D'Ruiz</Name>
        <Affiliation>Scientific Affairs, A.W. Spears Research Center, Lorillard Tobacco Company, Greensboro, NC, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of Cramer classification between Toxtree, the OECD QSAR Toolbox and expert judgment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25460032</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.11.005</DOI>
    <KeywordList>
      <Keywords>Cramer classification</Keywords>
      <Keywords>OECD QSAR Toolbox</Keywords>
      <Keywords>TTC</Keywords>
      <Keywords>Toxtree</Keywords>
      <Keywords>in silico</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sneha Bhatia</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Blvd., Woodcliff Lake, NJ 07677, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Terry Schultz</Name>
        <Affiliation>The University of Tennessee, College of Veterinary, 2407 River Dr., Knoxville, TN 37996, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Roberts</Name>
        <Affiliation>Liverpool John Moores University, Liverpool L3 3AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Shen</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Blvd., Woodcliff Lake, NJ 07677, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lambros Kromidas</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Blvd., Woodcliff Lake, NJ 07677, USA. Electronic address: lkromidas@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Marie Api</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Blvd., Woodcliff Lake, NJ 07677, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment of kretek cigarettes Part 5: mechanistic investigations, inhalation toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25455231</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.015</DOI>
    <KeywordList>
      <Keywords>Clove cigarettes</Keywords>
      <Keywords>Eugenol</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Kreteks</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>E. Roemer</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>R. Dempsey</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland. Electronic address: ruth.dempsey@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>F. J. Van Overveld</Name>
        <Affiliation>Philip Morris Research Laboratories bvba, Grauwmeer 14, 3001 Leuven, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>A. Berges</Name>
        <Affiliation>Philip Morris Research Laboratories bvba, Grauwmeer 14, 3001 Leuven, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>J. Pype</Name>
        <Affiliation>Philip Morris Research Laboratories bvba, Grauwmeer 14, 3001 Leuven, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>H. Weiler</Name>
        <Affiliation>Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>P. Vanscheeuwijck</Name>
        <Affiliation>Philip Morris Research Laboratories bvba, Grauwmeer 14, 3001 Leuven, Belgium; Philip Morris International, Philip Morris Products SA, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>M. K. Schorp</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment of kretek cigarettes Part 4: mechanistic investigations, smoke chemistry and in vitro toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25455230</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.012</DOI>
    <KeywordList>
      <Keywords>Clove cigarettes</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Eugenol</Keywords>
      <Keywords>Kretek</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Smoke chemistry</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>E. Roemer</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>R. Dempsey</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland. Electronic address: Ruth.Dempsey@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Lawless-Pyne</Name>
        <Affiliation>PT HM Sampoerna Tbk, Surabaya, Indonesia.</Affiliation>
      </Author>
      <Author>
        <Name>S. Lukman</Name>
        <Affiliation>PT HM Sampoerna Tbk, Surabaya, Indonesia.</Affiliation>
      </Author>
      <Author>
        <Name>A. Deger Evans</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Quai Jeanrenaud 56, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>E. Trelles-Sticken</Name>
        <Affiliation>Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>S. Wittke</Name>
        <Affiliation>Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>M. K. Schorp</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The "bottom-up" approach does not necessarily bound low-dose risk.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25455229</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.10.008</DOI>
    <AuthorList>
      <Author>
        <Name>Kenny S. Crump</Name>
        <Affiliation>2220 S. Vienna Street, Ruston, LA 71270, United States. Electronic address: KennyCrump@email.com.</Affiliation>
      </Author>
      <Author>
        <Name>D. A. Bussard</Name>
        <Affiliation>U.S. Environmental Protection Agency, United States. Electronic address: Bussard.David@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>C. Chen</Name>
        <Affiliation>U.S. Environmental Protection Agency (retired), United States. Electronic address: chaochen25@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>J. Jinot</Name>
        <Affiliation>U.S. Environmental Protection Agency, United States. Electronic address: Jinot.Jennifer@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>R. Subramaniam</Name>
        <Affiliation>U.S. Environmental Protection Agency, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Response to Crump et al.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25455228</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.10.007</DOI>
    <AuthorList>
      <Author>
        <Name>Thomas B. Starr</Name>
        <Affiliation>TBS Associates, 7500 Rainwater Road, Raleigh, NC 27615, USA; Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, 166 Rosenau Hall, CB #7431, Chapel Hill, NC 27599-7431, USA. Electronic address: tbstarr@mindspring.com.</Affiliation>
      </Author>
      <Author>
        <Name>James A. Swenberg</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, 166 Rosenau Hall, CB #7431, Chapel Hill, NC 27599-7431, USA. Electronic address: jswenber@amail.unc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Purification, characterization and anti-diabetic activity of a polysaccharide from mulberry leaf.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25455227</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.10.006</DOI>
    <KeywordList>
      <Keywords>Diabetes mellitus</Keywords>
      <Keywords>Hypoglycemic</Keywords>
      <Keywords>Hypolipidemic</Keywords>
      <Keywords>Mulberry leaf</Keywords>
      <Keywords>Polysaccharide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yao Zhang</Name>
        <Affiliation>College of Forestry, Shandong Agricultural University, Taian 271018, China; College of Life Science, Shandong Agricultural University, Taian 271018, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunjiu Ren</Name>
        <Affiliation>College of Forestry, Shandong Agricultural University, Taian 271018, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guobing Lu</Name>
        <Affiliation>College of Forestry, Shandong Agricultural University, Taian 271018, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weizheng Cui</Name>
        <Affiliation>College of Forestry, Shandong Agricultural University, Taian 271018, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhimei Mu</Name>
        <Affiliation>College of Forestry, Shandong Agricultural University, Taian 271018, China. Electronic address: lz20011022@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Huiju Gao</Name>
        <Affiliation>College of Forestry, Shandong Agricultural University, Taian 271018, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanwen Wang</Name>
        <Affiliation>College of Forestry, Shandong Agricultural University, Taian 271018, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment of kretek cigarettes Part 3: kretek and American-blended cigarettes, inhalation toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25455226</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.013</DOI>
    <KeywordList>
      <Keywords>Clove</Keywords>
      <Keywords>Eugenol</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Kretek</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Smoke</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. J. Piadé</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>E. Roemer</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>R. Dempsey</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland. Electronic address: Ruth.Dempsey@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>H. Weiler</Name>
        <Affiliation>Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>K. Meurrens</Name>
        <Affiliation>Philip Morris Research Laboratories bvba, Grauwmeer 14, 3001 Leuven, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>P. Vanscheeuwijck</Name>
        <Affiliation>Philip Morris Research Laboratories bvba, Grauwmeer 14, 3001 Leuven, Belgium; Philip Morris International, Philip Morris Products SA, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>M. K. Schorp</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hep-2 cell based indirect immunofluorescence assay for antinuclear antibodies as a potential diagnosis of drug-induced autoimmunity in nonclinical toxicity testing.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25455225</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.10.005</DOI>
    <KeywordList>
      <Keywords>Age-related ANAs</Keywords>
      <Keywords>Antinuclear antibodies (ANAs)</Keywords>
      <Keywords>Biomarker</Keywords>
      <Keywords>Drug-induced autoimmunity (DIA)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Min Hong</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, China Food and Drug Administration, 100176 Beijing, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ben Ma</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, China Food and Drug Administration, 100176 Beijing, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Lin</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, China Food and Drug Administration, 100176 Beijing, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaobing Zhou</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, China Food and Drug Administration, 100176 Beijing, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xingchao Geng</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, China Food and Drug Administration, 100176 Beijing, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Lianzhong Shen</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, China Food and Drug Administration, 100176 Beijing, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Li</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, China Food and Drug Administration, 100176 Beijing, People's Republic of China. Electronic address: libo@nifdc.org.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Total mercury concentrations in the general Korean population, 2008-2011.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25455224</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.10.004</DOI>
    <KeywordList>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Human biomonitoring</Keywords>
      <Keywords>Korean</Keywords>
      <Keywords>Mercury</Keywords>
      <Keywords>Methylmercury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jae Hong Park</Name>
        <Affiliation>Food Safety Risk Assessment Division, National Institute of Food &amp; Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong-eup, Cheongwon-gun, Chungcheongbuk-do 363-700, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Myung Sil Hwang</Name>
        <Affiliation>Food Safety Risk Assessment Division, National Institute of Food &amp; Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong-eup, Cheongwon-gun, Chungcheongbuk-do 363-700, South Korea. Electronic address: hwang1963@korea.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Ahra Ko</Name>
        <Affiliation>Food Safety Risk Assessment Division, National Institute of Food &amp; Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong-eup, Cheongwon-gun, Chungcheongbuk-do 363-700, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Da Hyun Jeong</Name>
        <Affiliation>Food Safety Risk Assessment Division, National Institute of Food &amp; Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong-eup, Cheongwon-gun, Chungcheongbuk-do 363-700, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Seung Kang</Name>
        <Affiliation>Food Safety Risk Assessment Division, National Institute of Food &amp; Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong-eup, Cheongwon-gun, Chungcheongbuk-do 363-700, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hae Jung Yoon</Name>
        <Affiliation>Food Contaminants Division, National Institute of Food &amp; Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong-eup, Cheongwon-gun, Chungcheongbuk-do 363-700, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Hwan Hong</Name>
        <Affiliation>Food Safety Risk Assessment Division, National Institute of Food &amp; Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong-eup, Cheongwon-gun, Chungcheongbuk-do 363-700, South Korea.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Thyroid tumor formation in the male mouse induced by fluopyram is mediated by activation of hepatic CAR/PXR nuclear receptors.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25455223</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.10.003</DOI>
    <KeywordList>
      <Keywords>Car/Pxr nuclear receptors</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Mouse thyroid carcinogen</Keywords>
      <Keywords>Threshold carcinogen</Keywords>
      <Keywords>Thyroid follicular cell proliferation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>D. Rouquié</Name>
        <Affiliation>Bayer SAS, Bayer CropScience, 355 rue Dostoïevski, CS 90153, 06906 Sophia Antipolis, France. Electronic address: david.rouquie@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>H. Tinwell</Name>
        <Affiliation>Bayer SAS, Bayer CropScience, 355 rue Dostoïevski, CS 90153, 06906 Sophia Antipolis, France.</Affiliation>
      </Author>
      <Author>
        <Name>O. Blanck</Name>
        <Affiliation>Bayer SAS, Bayer CropScience, 355 rue Dostoïevski, CS 90153, 06906 Sophia Antipolis, France.</Affiliation>
      </Author>
      <Author>
        <Name>F. Schorsch</Name>
        <Affiliation>Bayer SAS, Bayer CropScience, 355 rue Dostoïevski, CS 90153, 06906 Sophia Antipolis, France.</Affiliation>
      </Author>
      <Author>
        <Name>D. Geter</Name>
        <Affiliation>Bayer SAS, Bayer CropScience, 355 rue Dostoïevski, CS 90153, 06906 Sophia Antipolis, France.</Affiliation>
      </Author>
      <Author>
        <Name>S. Wason</Name>
        <Affiliation>Bayer SAS, Bayer CropScience, 355 rue Dostoïevski, CS 90153, 06906 Sophia Antipolis, France.</Affiliation>
      </Author>
      <Author>
        <Name>R. Bars</Name>
        <Affiliation>Bayer SAS, Bayer CropScience, 355 rue Dostoïevski, CS 90153, 06906 Sophia Antipolis, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The sub-chronic oral toxicity of dearomatized hydrocarbon solvents in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25455222</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.10.002</DOI>
    <KeywordList>
      <Keywords>Cholestasis</Keywords>
      <Keywords>Dearomatized hydrocarbon solvent</Keywords>
      <Keywords>Hydrocarbon solvent</Keywords>
      <Keywords>Isoalkane</Keywords>
      <Keywords>Isoparaffin</Keywords>
      <Keywords>Oral toxicity</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>UVCB</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David Adenuga</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 Route 22 E., Annandale, NJ 08801, USA. Electronic address: moyinoluwa.d.adenuga@exxonmobil.com.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Carlos Carrillo</Name>
        <Affiliation>Shell Health, Shell International B.V., P.O. Box 162, 2501 AN The Hague, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Richard H. Mckee</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 Route 22 E., Annandale, NJ 08801, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Animals and ethical research.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25455221</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.10.001</DOI>
    <AuthorList>
      <Author>
        <Name>Gio Batta Gori</Name>
        <Affiliation>Regulatory Toxicology and Pharmacology, United States. Electronic address: gorigb@msn.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment of kretek cigarettes. Part 7: the impact of ingredients added to kretek cigarettes on inhalation toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25455220</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.014</DOI>
    <KeywordList>
      <Keywords>Clove cigarette</Keywords>
      <Keywords>Flavor</Keywords>
      <Keywords>In vivo</Keywords>
      <Keywords>Ingredient</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Kretek</Keywords>
      <Keywords>Micronucleus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. Schramke</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland. Electronic address: Heike.Schramke@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>E. Roemer</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>R. Dempsey</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>J. Hirter</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>K. Meurrens</Name>
        <Affiliation>Philip Morris Research Laboratories bvba, Grauwmeer 14, 3001 Leuven, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>A. Berges</Name>
        <Affiliation>Philip Morris Research Laboratories bvba, Grauwmeer 14, 3001 Leuven, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>H. Weiler</Name>
        <Affiliation>Philip Morris Research Laboratories GmbH, Fuggerstrasse 3, 51149 Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>P. Vanscheeuwijck</Name>
        <Affiliation>Philip Morris Research Laboratories bvba, Grauwmeer 14, 3001 Leuven, Belgium; Philip Morris International, Philip Morris Products SA, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>M. K. Schorp</Name>
        <Affiliation>Philip Morris International, Philip Morris Products SA, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Transfluthrin: comparative efficacy and toxicity of reference and generic versions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25448443</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.11.003</DOI>
    <KeywordList>
      <Keywords>Bayothrin</Keywords>
      <Keywords>Permethric acid derivatives</Keywords>
      <Keywords>Relevant impurities</Keywords>
      <Keywords>Risk characterization</Keywords>
      <Keywords>Sensitization</Keywords>
      <Keywords>Transfluthrin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juergen Pauluhn</Name>
        <Affiliation>Global Drug Discovery, Bayer HealthCare, Bayer Pharma AG, Wuppertal, Germany; Hanover Medical School, Hanover, Germany. Electronic address: juergen.pauluhn@iCLOUD.com.</Affiliation>
      </Author>
      <Author>
        <Name>Keisuke Ozaki</Name>
        <Affiliation>Sumitomo Chemical Co., Ltd., Environmental Health Division, Tokyo, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A 28-day oral toxicity evaluation of small interfering RNAs and a long double-stranded RNA targeting vacuolar ATPase in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25445299</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.10.016</DOI>
    <KeywordList>
      <Keywords>Biotech crop</Keywords>
      <Keywords>Biotechnology-derived crop</Keywords>
      <Keywords>GM crop</Keywords>
      <Keywords>Gene suppression</Keywords>
      <Keywords>Plant incorporated protectant</Keywords>
      <Keywords>RNAi</Keywords>
      <Keywords>Small RNA</Keywords>
      <Keywords>dsRNA</Keywords>
      <Keywords>siRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jay S. Petrick</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA. Electronic address: jay.s.petrick@monsanto.com.</Affiliation>
      </Author>
      <Author>
        <Name>William M. Moore</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William F. Heydens</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael S. Koch</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James H. Sherman</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shawna L. Lemke</Name>
        <Affiliation>Monsanto Company, 800 North Lindbergh Boulevard, Creve Coeur, MO 63167, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of essential oil from Minthostachys verticillata (Griseb.) Epling (peperina): 90-days oral subchronic toxicity study in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25445298</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.11.001</DOI>
    <KeywordList>
      <Keywords>90-Day subchronic toxicity</Keywords>
      <Keywords>Essential oil</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Minthostachys verticillata</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Franco Matías Escobar</Name>
        <Affiliation>Departamento de Microbiología e Inmunología, Universidad Nacional de Río Cuarto, Ruta 36 Km 601, Río Cuarto, CP 5800 Córdoba, Argentina. Electronic address: fescobar@exa.unrc.edu.ar.</Affiliation>
      </Author>
      <Author>
        <Name>María Carola Sabini</Name>
        <Affiliation>Departamento de Microbiología e Inmunología, Universidad Nacional de Río Cuarto, Ruta 36 Km 601, Río Cuarto, CP 5800 Córdoba, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Noelia Cariddi</Name>
        <Affiliation>Departamento de Microbiología e Inmunología, Universidad Nacional de Río Cuarto, Ruta 36 Km 601, Río Cuarto, CP 5800 Córdoba, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Liliana Inés Sabini</Name>
        <Affiliation>Departamento de Microbiología e Inmunología, Universidad Nacional de Río Cuarto, Ruta 36 Km 601, Río Cuarto, CP 5800 Córdoba, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Mañas</Name>
        <Affiliation>Departamento de Clínica Animal, Universidad Nacional de Río Cuarto, Ruta 36 Km 601, Río Cuarto, CP 5800 Córdoba, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Cristofolini</Name>
        <Affiliation>Departamento de Patología Animal, Universidad Nacional de Río Cuarto, Ruta 36 Km 601, Río Cuarto, CP 5800 Córdoba, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Guillermo Bagnis</Name>
        <Affiliation>Departamento de Patología Animal, Universidad Nacional de Río Cuarto, Ruta 36 Km 601, Río Cuarto, CP 5800 Córdoba, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Mauro Nicolas Gallucci</Name>
        <Affiliation>Centro de Investigación y Transferencia de Santiago del Estero (CITSE), CP G4200AQF, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Lilia Renée Cavaglieri</Name>
        <Affiliation>Departamento de Microbiología e Inmunología, Universidad Nacional de Río Cuarto, Ruta 36 Km 601, Río Cuarto, CP 5800 Córdoba, Argentina.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Airborne asbestos exposures associated with gasket and packing replacement: a simulation study of flange and valve repair work and an assessment of exposure variables.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25445297</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.10.017</DOI>
    <KeywordList>
      <Keywords>Bonnet</Keywords>
      <Keywords>Equipment</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Flange</Keywords>
      <Keywords>Installation</Keywords>
      <Keywords>Removal</Keywords>
      <Keywords>Valve</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amy K. Madl</Name>
        <Affiliation>Cardno ChemRisk, LLC, 130 Vantis, Suite 170, Aliso Viejo, CA 92656, United States. Electronic address: Amy.Madl@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kathryn D. Devlin</Name>
        <Affiliation>Cardno ChemRisk, LLC, 4840 Pearl East Circle, Suite 300 West, Boulder, CO 80301, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Angela L. Perez</Name>
        <Affiliation>Cardno ChemRisk, LLC, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dana M. Hollins</Name>
        <Affiliation>Cardno ChemRisk, LLC, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dallas M. Cowan</Name>
        <Affiliation>Cardno ChemRisk, LLC, 130 Vantis, Suite 170, Aliso Viejo, CA 92656, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paul K. Scott</Name>
        <Affiliation>Cardno ChemRisk, LLC, 20 Stanwix Street, Suite 505, Pittsburgh, PA 15222, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Katherine White</Name>
        <Affiliation>Cardno ChemRisk, LLC, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Thales J. Cheng</Name>
        <Affiliation>Cardno ChemRisk, LLC, 130 Vantis, Suite 170, Aliso Viejo, CA 92656, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John L. Henshaw</Name>
        <Affiliation>Cardno ChemRisk, LLC, 1101 Periwinkle Way, Suite #101, Sanibel, FL 33957, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>13-week oral toxicity study of vinyl laurate in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25445296</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.10.015</DOI>
    <KeywordList>
      <Keywords>CAS 2146-71-6</Keywords>
      <Keywords>Repeated dose toxicity</Keywords>
      <Keywords>Vinyl laurate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ben A. R. Lina</Name>
        <Affiliation>TNO Triskelion BV, Utrechtseweg 48, 3700 AV Zeist, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Horst Messinger</Name>
        <Affiliation>Bioresco Ltd., Bundesstrasse 29, 4054 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Albert Bär</Name>
        <Affiliation>Bioresco Ltd., Bundesstrasse 29, 4054 Basel, Switzerland. Electronic address: contact@bioresco.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of dose-dependent absorption into target tissues to more accurately predict cancer risk at low oral doses of hexavalent chromium.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25445295</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.11.002</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Chromium</Keywords>
      <Keywords>Hexavalent</Keywords>
      <Keywords>Oral</Keywords>
      <Keywords>Regulatory</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Haney</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), Austin, TX, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory acceptance and use of the Extended One Generation Reproductive Toxicity Study within Europe.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25445002</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.10.012</DOI>
    <KeywordList>
      <Keywords>Barriers and drivers</Keywords>
      <Keywords>EOGRTS</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Regulatory acceptance and use</Keywords>
      <Keywords>Reproductive toxicity testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marie Jeanne W. A. Schiffelers</Name>
        <Affiliation>Utrecht University School of Governance, Bijlhouwerstraat 6, 3511 ZC Utrecht, The Netherlands. Electronic address: m.j.w.a.schiffelers@uu.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Bas J. Blaauboer</Name>
        <Affiliation>Utrecht University, Institute for Risk Assessment Sciences (IRAS), P.O. Box 80.178, 3508 TD Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Wieger E. Bakker</Name>
        <Affiliation>Utrecht University School of Governance, Bijlhouwerstraat 6, 3511 ZC Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Coenraad F. M. Hendriksen</Name>
        <Affiliation>Utrecht University, Faculty of Veterinary Medicine, Department Animals in Science and Society, P.O. Box 80.163, 3508 TD Utrecht, The Netherlands; Institute for Translational Vaccinology (Intravacc), P.O. Box 450, 3720 AL Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Cyrille Krul</Name>
        <Affiliation>TNO, P.O. Box 360, 3700 AJ Zeist, The Netherlands; University of Applied Sciences Utrecht, Life Sciences &amp; Chemistry, F.C. Dondersstraat 65, 3572 JE Utrecht, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of vinyl laurate in a battery of in vitro and in vivo tests for genotoxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25445001</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.09.016</DOI>
    <KeywordList>
      <Keywords>Acetaldehyde</Keywords>
      <Keywords>Ames test</Keywords>
      <Keywords>CAS 2146-71-6</Keywords>
      <Keywords>Chromosome aberration</Keywords>
      <Keywords>Clastogenicity</Keywords>
      <Keywords>HPRT mutation assay</Keywords>
      <Keywords>Micronucleus test</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Vinyl laurate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Frédérique van Acker</Name>
        <Affiliation>TNO Triskelion BV, P.O. Box 844, 3700 AV Zeist, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Horst Messinger</Name>
        <Affiliation>Bioresco Ltd., Bundesstrasse 29, 4054 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Albert Bär</Name>
        <Affiliation>Bioresco Ltd., Bundesstrasse 29, 4054 Basel, Switzerland. Electronic address: horst.messinger@bioresco.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An analysis of legal warnings after drug approval in Thailand.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25445000</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.10.013</DOI>
    <KeywordList>
      <Keywords>Adverse drug reactions</Keywords>
      <Keywords>Drug risk management</Keywords>
      <Keywords>Drug safety</Keywords>
      <Keywords>Legal warnings</Keywords>
      <Keywords>Pharmacovigilance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pakawadee Sriphiromya</Name>
        <Affiliation>Health Product Vigilance Center, Food and Drug Administration, Ministry of Public Health, Thailand; Chulalongkorn University, Phayathai Road, Bangkok, Thailand. Electronic address: pspakawadee@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anuchai Theeraroungchaisri</Name>
        <Affiliation>Chulalongkorn University, Phayathai Road, Bangkok, Thailand.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of Se-methylselenocysteine as nutritional selenium supplement: acute toxicity, genotoxicity and subchronic toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25444999</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.10.014</DOI>
    <KeywordList>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Food supplements</Keywords>
      <Keywords>Safety evaluation</Keywords>
      <Keywords>Se-methylselenocysteine</Keywords>
      <Keywords>Selenium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hui Yang</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing 100021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xudong Jia</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing 100021, China. Electronic address: jiaxudong@cfsa.net.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of a category approach to predict the testicular toxicity of chemical substances structurally related to ethylene glycol methyl ether.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25444998</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.10.011</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Category approach</Keywords>
      <Keywords>Methoxyacetic acid</Keywords>
      <Keywords>Repeated-dose toxicity</Keywords>
      <Keywords>Testicular toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Takashi Yamada</Name>
        <Affiliation>Chemical Management Center, National Institute of Technology and Evaluation, 2-49-10, Nishihara, Shibuya-ku, Tokyo 151-0066, Japan. Electronic address: yamada-takashi@nite.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yushiro Tanaka</Name>
        <Affiliation>Chemical Management Center, National Institute of Technology and Evaluation, 2-49-10, Nishihara, Shibuya-ku, Tokyo 151-0066, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ryuichi Hasegawa</Name>
        <Affiliation>Chemical Management Center, National Institute of Technology and Evaluation, 2-49-10, Nishihara, Shibuya-ku, Tokyo 151-0066, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuki Sakuratani</Name>
        <Affiliation>Chemical Management Center, National Institute of Technology and Evaluation, 2-49-10, Nishihara, Shibuya-ku, Tokyo 151-0066, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasushi Yamazoe</Name>
        <Affiliation>Food Safety Commission of Japan, 5-2-20, Akasaka, Minato-ku, Tokyo 107-6122, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Atsushi Ono</Name>
        <Affiliation>Biological Safety Research Center, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akihiko Hirose</Name>
        <Affiliation>Biological Safety Research Center, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Hayashi</Name>
        <Affiliation>Biosafety Research Center, 582-2, Shioshinden, Iwata, Shizuoka 437-1213, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of select analytes in aerosol from e-cigarettes with smoke from conventional cigarettes and with ambient air.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25444997</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.10.010</DOI>
    <KeywordList>
      <Keywords>Electronic cigarette</Keywords>
      <Keywords>Harmful and potentially harmful constituents (HPHC)</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Smoking</Keywords>
      <Keywords>Tobacco</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rana Tayyarah</Name>
        <Affiliation>Lorillard Tobacco Company, PO Box 21688, Greensboro, NC, USA. Electronic address: rtayyarah@lortobco.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gerald A. Long</Name>
        <Affiliation>Lorillard Tobacco Company, PO Box 21688, Greensboro, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A subchronic toxicity study, preceded by an in utero exposure phase, with refined arachidonic acid-rich oil (RAO) derived from Mortierella alpina XM027 in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25444996</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.10.009</DOI>
    <KeywordList>
      <Keywords>Mortierella alpina (M. alpina) XM027</Keywords>
      <Keywords>Refined arachidonic acid-rich oil (RAO)</Keywords>
      <Keywords>Reproductive performance</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yonglin Gao</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai, Shandong 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunmei Li</Name>
        <Affiliation>School of Pharmacy, Yantai University, Yantai, Shandong 264005, PR China. Electronic address: gylbill@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Le Kang</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai, Shandong 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Hang</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai, Shandong 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengjun Yan</Name>
        <Affiliation>School of Pharmacy, Yantai University, Yantai, Shandong 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shenjun Li</Name>
        <Affiliation>School of Pharmacy, Yantai University, Yantai, Shandong 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Haizhu Jin</Name>
        <Affiliation>School of Life Sciences, Yantai University, Yantai, Shandong 264005, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Albert W. Lee</Name>
        <Affiliation>NutraSource, Inc., Royal Oak, MI 48073, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susan S. Cho</Name>
        <Affiliation>NutraSource, Inc., Clarksville, MD 21029, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Liver tumor formation in female rat induced by fluopyram is mediated by CAR/PXR nuclear receptor activation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25305127</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.011</DOI>
    <KeywordList>
      <Keywords>CAR/PXR nuclear receptors</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Rodent liver</Keywords>
      <Keywords>Threshold carcinogen</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. Tinwell</Name>
        <Affiliation>Bayer SAS, 16 Rue Jean-Marie Leclair, 69009 Lyon, France. Electronic address: helen.tinwell@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>D. Rouquié</Name>
        <Affiliation>Bayer SAS, 16 Rue Jean-Marie Leclair, 69009 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>F. Schorsch</Name>
        <Affiliation>Bayer SAS, 16 Rue Jean-Marie Leclair, 69009 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>D. Geter</Name>
        <Affiliation>Bayer SAS, 16 Rue Jean-Marie Leclair, 69009 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>S. Wason</Name>
        <Affiliation>Bayer SAS, 16 Rue Jean-Marie Leclair, 69009 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>R. Bars</Name>
        <Affiliation>Bayer SAS, 16 Rue Jean-Marie Leclair, 69009 Lyon, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Smoking behaviour and compensation: a review of the literature with meta-analysis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25277253</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.008</DOI>
    <KeywordList>
      <Keywords>Cigarette smoking</Keywords>
      <Keywords>Compensation</Keywords>
      <Keywords>Meta-analysis</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Puffing behaviour</Keywords>
      <Keywords>Standard smoking regimes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gerhard Scherer</Name>
        <Affiliation>ABF Analytisch-Biologisches Forschungslabor GmbH, Goethestraße 20, 80336 Munich, Germany. Electronic address: gerhard.scherer@abf-lab.com.</Affiliation>
      </Author>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd, 17 Cedar Road, Sutton, Surrey SM2 5DA, UK. Electronic address: PeterLee@pnlee.co.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The use of MRI to assist the section selections for classical pathology assessment of neurotoxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25265367</pubmedLink>
    <GrantList>
      <Grant>E0741801</Grant>
    </GrantList>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.010</DOI>
    <KeywordList>
      <Keywords>MRI</Keywords>
      <Keywords>MRS</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>T(2) signal</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joseph Hanig</Name>
        <Affiliation>Food &amp; Drug Administration, Office of Testing &amp; Research, Center for Drug Evaluation and Research, Silver Spring, MD 20993, United States. Electronic address: joseph.hanig@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Merle G. Paule</Name>
        <Affiliation>Division of Neurotoxicology, National Center for Toxicological Research, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jaivijay Ramu</Name>
        <Affiliation>Division of Neurotoxicology, National Center for Toxicological Research, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Larry Schmued</Name>
        <Affiliation>Division of Neurotoxicology, National Center for Toxicological Research, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tetyana Konak</Name>
        <Affiliation>Division of Neurotoxicology, National Center for Toxicological Research, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Srinivasulu Chigurupati</Name>
        <Affiliation>Division of Neurotoxicology, National Center for Toxicological Research, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>William Slikker</Name>
        <Affiliation>National Center for Toxicological Research, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sumit Sarkar</Name>
        <Affiliation>Division of Neurotoxicology, National Center for Toxicological Research, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Serguei Liachenko</Name>
        <Affiliation>Division of Neurotoxicology, National Center for Toxicological Research, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gastrointestinal absorption of uranium compounds--a review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25263405</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.yrtph.2014.08.012</DOI>
    <KeywordList>
      <Keywords>Absorption</Keywords>
      <Keywords>Species differences</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Uranium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rainer Konietzka</Name>
        <Affiliation>Federal Environment Agency, Toxicology of Drinking Water and Swimming Pool Water, Wörlitzer Platz 1, 06844 Dessau-Roßlau, Germany. Electronic address: rainer.konietzka@uba.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25261300</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.009</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Adverse Outcome Pathway (AOP)</Keywords>
      <Keywords>Cross species extrapolation</Keywords>
      <Keywords>High content screening (HCS)</Keywords>
      <Keywords>High throughput screening (HTS)</Keywords>
      <Keywords>Integrated Approaches to Testing and Assessment (IATA)</Keywords>
      <Keywords>Read-across</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Knut Erik Tollefsen</Name>
        <Affiliation>Norwegian Institute for Water Research (NIVA), Gaustadalléen 21, N-0349 Oslo, Norway. Electronic address: knut.erik.tollefsen@niva.no.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Scholz</Name>
        <Affiliation>UFZ - Helmholtz Centre for Environmental Research, Department of Bioanalytical Ecotoxicology, Permoserstr. 15, 04318 Leipzig, Germany. Electronic address: stefan.scholz@ufz.de.</Affiliation>
      </Author>
      <Author>
        <Name>Mark T. Cronin</Name>
        <Affiliation>Liverpool John Moores University, School of Pharmacy and Biomolecular Sciences, Byrom Street, Liverpool L3 3AF, UK. Electronic address: M.T.Cronin@ljmu.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen W. Edwards</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Research and Development (ORD), Research Triangle Park (RTP), NC 2771, USA. Electronic address: Edwards.Stephen@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Joop de Knecht</Name>
        <Affiliation>Environment Health and Safety Division, Environment Directorate, Organisation for Economic Co-operation and Development (OECD), 2 rue André Pascal, 75775 Paris Cedex 16, France. Electronic address: Joop.DEKNECHT@oecd.org.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Crofton</Name>
        <Affiliation>U.S. Environmental Protection Agency, Office of Research and Development (ORD), Research Triangle Park (RTP), NC 2771, USA. Electronic address: Crofton.Kevin@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Natalia Garcia-Reyero</Name>
        <Affiliation>Institute for Genomics, Biocomputing &amp; Biotechnology, Mississippi State University, Starkville, MS, USA. Electronic address: natalia@icnanotox.org.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Hartung</Name>
        <Affiliation>Johns Hopkins University, Bloomberg School of Public Health, Center for Alternatives to Animal Testing (CAAT), 615 N Wolfe St, Baltimore, MD 21205, USA. Electronic address: thartung@jhsph.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Worth</Name>
        <Affiliation>European Commission-Joint Research Centre, Institute for Health &amp; Consumer Protection, Systems Toxicology Unit, Via E. Fermi, Ispra, Varese, Italy. Electronic address: Andrew.WORTH@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>DuPont Haskell Global Centers for Health and Environmental Sciences, Stine-Haskell 320/212, 1090 Elkton Road, Newark, DE 19711, USA. Electronic address: patlewig@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of three approaches for regulatory decision making on pesticides with endocrine disrupting properties.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25239592</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.001</DOI>
    <KeywordList>
      <Keywords>Decision criteria</Keywords>
      <Keywords>Endocrine Disruption</Keywords>
      <Keywords>Pesticides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>P. Marx-Stoelting</Name>
        <Affiliation>Bundesinstitut für Risikobewertung (Federal Institute for Risk Assessment), Max-Dohrn-Str 8-10, 10589 Berlin, Germany. Electronic address: philip.marx-stoelting@bfr.bund.de.</Affiliation>
      </Author>
      <Author>
        <Name>L. Niemann</Name>
        <Affiliation>Bundesinstitut für Risikobewertung (Federal Institute for Risk Assessment), Max-Dohrn-Str 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>V. Ritz</Name>
        <Affiliation>Bundesinstitut für Risikobewertung (Federal Institute for Risk Assessment), Max-Dohrn-Str 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>B. Ulbrich</Name>
        <Affiliation>Bundesinstitut für Risikobewertung (Federal Institute for Risk Assessment), Max-Dohrn-Str 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>A. Gall</Name>
        <Affiliation>Bundesinstitut für Risikobewertung (Federal Institute for Risk Assessment), Max-Dohrn-Str 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>K. I. Hirsch-Ernst</Name>
        <Affiliation>Bundesinstitut für Risikobewertung (Federal Institute for Risk Assessment), Max-Dohrn-Str 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>R. Pfeil</Name>
        <Affiliation>Bundesinstitut für Risikobewertung (Federal Institute for Risk Assessment), Max-Dohrn-Str 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>R. Solecki</Name>
        <Affiliation>Bundesinstitut für Risikobewertung (Federal Institute for Risk Assessment), Max-Dohrn-Str 8-10, 10589 Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25236535</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.007</DOI>
    <KeywordList>
      <Keywords>Acute liver failure</Keywords>
      <Keywords>Aging</Keywords>
      <Keywords>Cholestatic injury</Keywords>
      <Keywords>Data-mining</Keywords>
      <Keywords>Drug-induced liver injury</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Lipophilicity</Keywords>
      <Keywords>Mitochondrial dysfunction</Keywords>
      <Keywords>Pediatric</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christine M. Hunt</Name>
        <Affiliation>Division of Gastroenterology, Duke University Medical Center, Durham, NC, United States; Durham Veterans Administration Medical Center, Durham, NC, United States. Electronic address: Christine.M.Hunt@earthlink.net.</Affiliation>
      </Author>
      <Author>
        <Name>Nancy A. Yuen</Name>
        <Affiliation>Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Heide A. Stirnadel-Farrant</Name>
        <Affiliation>Worldwide Epidemiology, GlaxoSmithKline, Stockley Park, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ayako Suzuki</Name>
        <Affiliation>Division of Gastroenterology, University of Arkansas for Medical Sciences, Little Rock, AR, United States; Division of Gastroenterology, Central Arkansas Veterans Healthcare System, Little Rock, AR, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicologic assessment of Paecilomyces tenuipes in rats: renal toxicity and mutagenic potential.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25223566</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.003</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Karyomegaly</Keywords>
      <Keywords>Kidney</Keywords>
      <Keywords>Paecilomyces tenuipes</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeong Hwan Che</Name>
        <Affiliation>Biomedical Center for Animal Resource and Development, Bio-Max Institute, Seoul National University, Seoul, Republic of Korea; Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Won Yun</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Young Cho</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyun Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Soon Kim</Name>
        <Affiliation>Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Woo Ho Kim</Name>
        <Affiliation>Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Hak Park</Name>
        <Affiliation>Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Woo Chan Son</Name>
        <Affiliation>Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Kyung Kim</Name>
        <Affiliation>Biofood Network, Ewha Womans University, Seoul, Republic of Korea; BiofoodCRO, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byeong Cheol Kang</Name>
        <Affiliation>Biomedical Center for Animal Resource and Development, Bio-Max Institute, Seoul National University, Seoul, Republic of Korea; Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: bckang@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Response to "what constitutes scientific justification for inclusion of recovery assessment in pre-clinical studies supporting first time in man (FTIM)?" Sally Robinson and Ruth Roberts, Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25223565</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.006</DOI>
    <AuthorList>
      <Author>
        <Name>David R. Jones</Name>
        <Affiliation>MHRA, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>What constitutes scientific justification for inclusion of recovery assessment in pre-clinical studies supporting first time in man (FTIM)?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25223564</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.005</DOI>
    <AuthorList>
      <Author>
        <Name>Sally Robinson</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Roberts</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK. Electronic address: ruth.roberts@astrazeneca.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An FDA overview of rodent carcinogenicity studies of angiotensin II AT-1 receptor blockers: pulmonary adenomas and carcinomas.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25223563</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.002</DOI>
    <KeywordList>
      <Keywords>Angiotensin II-AT1 receptor blockers</Keywords>
      <Keywords>Lung tumors</Keywords>
      <Keywords>RAS and angiogenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>William T. Link</Name>
        <Affiliation>Division of Cardiovascular and Renal Drug Products, Center for Drug Evaluation and Research, Office of New Drugs, US Food and Drug Administration, Silver Spring, MD, United States. Electronic address: William.link@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Albert De Felice</Name>
        <Affiliation>Division of Cardiovascular and Renal Drug Products, Center for Drug Evaluation and Research, Office of New Drugs, US Food and Drug Administration, Silver Spring, MD, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development and validation of an OECD reproductive toxicity test guideline with the pond snail Lymnaea stagnalis (Mollusca, Gastropoda).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25220624</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.09.004</DOI>
    <KeywordList>
      <Keywords>Fecundity</Keywords>
      <Keywords>Mollusk</Keywords>
      <Keywords>OECD Conceptual Framework for Testing and Assessment of Endocrine Disrupters</Keywords>
      <Keywords>OECD test guidelines</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Virginie Ducrot</Name>
        <Affiliation>INRA, UMR 0985 Ecologie et Santé des Ecosystèmes, Equipe Ecotoxicologie et Qualité des Milieux Aquatiques, 65 rue de Saint-Brieuc, CS 84215, F-35042 Rennes Cedex, France. Electronic address: Virginie.ducrot@rennes.inra.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Clare Askem</Name>
        <Affiliation>CEFAS Lowestoft Laboratory, Pakefield Road, Lowestoft NR33 0HT, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Didier Azam</Name>
        <Affiliation>INRA, Unité Expérimentale d'Ecologie et d'Ecotoxicologie, 65 rue de Saint-Brieuc, CS 84215, F-35042 Rennes Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Denise Brettschneider</Name>
        <Affiliation>Goethe University Frankfurt am Main, Department of Aquatic Ecotoxicology, Biological Sciences Division, Max-von-Laue-Str. 13, 60348 Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca Brown</Name>
        <Affiliation>Brixham Environmental Laboratory, AstraZeneca, Freshwater Quarry, Brixham, Devon TQ5 8BA, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Sandrine Charles</Name>
        <Affiliation>Université de Lyon, F-69000 Lyon, France; Université Lyon 1, France; CNRS, UMR5558, Laboratoire de Biométrie et Biologie Évolutive, F-69622 Villeurbanne, France; Institut Universitaire de France, 103 bd Saint-Michel, 75005 Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Maïra Coke</Name>
        <Affiliation>INRA, Unité Expérimentale d'Ecologie et d'Ecotoxicologie, 65 rue de Saint-Brieuc, CS 84215, F-35042 Rennes Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Marc Collinet</Name>
        <Affiliation>INRA, UMR 0985 Ecologie et Santé des Ecosystèmes, Equipe Ecotoxicologie et Qualité des Milieux Aquatiques, 65 rue de Saint-Brieuc, CS 84215, F-35042 Rennes Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Laure Delignette-Muller</Name>
        <Affiliation>Université de Lyon, F-69000 Lyon, France; Université Lyon 1, France; CNRS, UMR5558, Laboratoire de Biométrie et Biologie Évolutive, F-69622 Villeurbanne, France; VetAgro Sup Campus Vétérinaire de Lyon, F-69280 Marcy l'Etoile, France.</Affiliation>
      </Author>
      <Author>
        <Name>Carole Forfait-Dubuc</Name>
        <Affiliation>Université de Lyon, F-69000 Lyon, France; Université Lyon 1, France; CNRS, UMR5558, Laboratoire de Biométrie et Biologie Évolutive, F-69622 Villeurbanne, France.</Affiliation>
      </Author>
      <Author>
        <Name>Henrik Holbech</Name>
        <Affiliation>Department of Biology, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Hutchinson</Name>
        <Affiliation>CEFAS Weymouth Laboratory, Barrack Road, Weymouth DT4 8UB, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Arne Jach</Name>
        <Affiliation>BASF SE, Crop Protection - Ecotoxicology, Speyerer Strasse 2, D-67117 Limburgerhof, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Karin L. Kinnberg</Name>
        <Affiliation>Department of Biology, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Cédric Lacoste</Name>
        <Affiliation>INRA, Unité Expérimentale d'Ecologie et d'Ecotoxicologie, 65 rue de Saint-Brieuc, CS 84215, F-35042 Rennes Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Gareth Le Page</Name>
        <Affiliation>Brixham Environmental Laboratory, AstraZeneca, Freshwater Quarry, Brixham, Devon TQ5 8BA, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Matthiessen</Name>
        <Affiliation>Old School House, Brow Edge, Backbarrow, Ulverston, Cumbria LA128QX, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Jörg Oehlmann</Name>
        <Affiliation>Goethe University Frankfurt am Main, Department of Aquatic Ecotoxicology, Biological Sciences Division, Max-von-Laue-Str. 13, 60348 Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lynsey Rice</Name>
        <Affiliation>Brixham Environmental Laboratory, AstraZeneca, Freshwater Quarry, Brixham, Devon TQ5 8BA, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Edward Roberts</Name>
        <Affiliation>CEFAS Weymouth Laboratory, Barrack Road, Weymouth DT4 8UB, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Katharina Ruppert</Name>
        <Affiliation>Goethe University Frankfurt am Main, Department of Aquatic Ecotoxicology, Biological Sciences Division, Max-von-Laue-Str. 13, 60348 Frankfurt, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica Elphinstone Davis</Name>
        <Affiliation>CEFAS Weymouth Laboratory, Barrack Road, Weymouth DT4 8UB, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Clemence Veauvy</Name>
        <Affiliation>CEFAS Weymouth Laboratory, Barrack Road, Weymouth DT4 8UB, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Lennart Weltje</Name>
        <Affiliation>BASF SE, Crop Protection - Ecotoxicology, Speyerer Strasse 2, D-67117 Limburgerhof, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Wortham</Name>
        <Affiliation>CEFAS Lowestoft Laboratory, Pakefield Road, Lowestoft NR33 0HT, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Laurent Lagadic</Name>
        <Affiliation>INRA, UMR 0985 Ecologie et Santé des Ecosystèmes, Equipe Ecotoxicologie et Qualité des Milieux Aquatiques, 65 rue de Saint-Brieuc, CS 84215, F-35042 Rennes Cedex, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Socio-economic analysis for the authorisation of chemicals under REACH: a case of very high concern?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25220186</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.08.013</DOI>
    <KeywordList>
      <Keywords>Authorisation of chemicals</Keywords>
      <Keywords>Decision-support</Keywords>
      <Keywords>Persistent chemicals</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Socio-economic analysis</Keywords>
      <Keywords>Stock pollution effects</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Silke Gabbert</Name>
        <Affiliation>Wageningen University, Department of Social Sciences, Environmental Economics and Natural Resources Group, Hollandseweg 1, 6700 EW Wageningen, The Netherlands. Electronic address: silke.gabbert@wur.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Scheringer</Name>
        <Affiliation>ETH Zürich, Institute for Chemical and Bioengineering, Wolfgang-Pauli-Str. 10, 8093 Zürich, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Carla A. Ng</Name>
        <Affiliation>ETH Zürich, Institute for Chemical and Bioengineering, Wolfgang-Pauli-Str. 10, 8093 Zürich, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Christian Stolzenberg</Name>
        <Affiliation>Federal Environment Agency (Umweltbundesamt), International Chemicals Management (Section IV1.1), Wörlitzer Pl. 1, 06844 Dessau-Roßlau, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands. A comparison of the risks of GBL versus GHB.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25204614</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.08.014</DOI>
    <KeywordList>
      <Keywords>Addiction</Keywords>
      <Keywords>Illicit drugs</Keywords>
      <Keywords>Legislation</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jan van Amsterdam</Name>
        <Affiliation>Amsterdam Institute for Addiction Research, Academic Medical Center University of Amsterdam, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands; Amsterdam Institute for Addiction Research, Academic Medical Center, P.O. Box 75867, 1070 AW Amsterdam, The Netherlands. Electronic address: jan.van.amsterdam@amc.uva.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Tibor Brunt</Name>
        <Affiliation>Trimbos Institute (Netherlands Institute of Mental Health and Addiction), Da Costakade 45, 3521 VS Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ed Pennings</Name>
        <Affiliation>The Maastricht Forensic Institute, P.O. Box 616, 6200 MD Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Wim van den Brink</Name>
        <Affiliation>Amsterdam Institute for Addiction Research, Academic Medical Center University of Amsterdam, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands; Amsterdam Institute for Addiction Research, Academic Medical Center, P.O. Box 75867, 1070 AW Amsterdam, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lactic acidosis treatment by nanomole level of spermidine in an animal model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25201010</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.08.015</DOI>
    <KeywordList>
      <Keywords>Biogenic polyamine</Keywords>
      <Keywords>Lactic acidosis</Keywords>
      <Keywords>Phenformin</Keywords>
      <Keywords>Spermidine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mozhgan Sedigh-Ardekani</Name>
        <Affiliation>Department of Medical Physics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Nanomedicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran; Pharmaceutical Science Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Ali Sahmeddini</Name>
        <Affiliation>Shiraz Anesthesiology and Intensive Care Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Naghmeh Sattarahmady</Name>
        <Affiliation>Department of Medical Physics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Nanomedicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran; Nanomedicine and Nanobiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: nsattar@sums.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Hossein Mirkhani</Name>
        <Affiliation>Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; Nanomedicine and Nanobiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carcinogenicity of metamifop, a novel herbicide, in Wistar rats following oral administration for 104 weeks.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25194188</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.08.011</DOI>
    <KeywordList>
      <Keywords>Aryloxyphenoxypropionic acid</Keywords>
      <Keywords>Carcinogenicity study</Keywords>
      <Keywords>Herbicide</Keywords>
      <Keywords>Metamifop</Keywords>
      <Keywords>Rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyun Ji Choi</Name>
        <Affiliation>Asan Institute for Life Sciences, Asan Medical Center, Seoul 138-736, Republic of Korea; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Kyu Park</Name>
        <Affiliation>Asan Institute for Life Sciences, Asan Medical Center, Seoul 138-736, Republic of Korea; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Woori Jo</Name>
        <Affiliation>Asan Institute for Life Sciences, Asan Medical Center, Seoul 138-736, Republic of Korea; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Eun Ryu</Name>
        <Affiliation>Asan Institute for Life Sciences, Asan Medical Center, Seoul 138-736, Republic of Korea; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sungwoong Jang</Name>
        <Affiliation>Asan Institute for Life Sciences, Asan Medical Center, Seoul 138-736, Republic of Korea; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hee Kyung Gu</Name>
        <Affiliation>Dongbu Farm Hannong, Daejeon 305-708, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Sung Kim</Name>
        <Affiliation>Dongbu Farm Hannong, Daejeon 305-708, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Bong Jin Chung</Name>
        <Affiliation>Dongbu Farm Hannong, Daejeon 305-708, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Woo Chan Son</Name>
        <Affiliation>Asan Institute for Life Sciences, Asan Medical Center, Seoul 138-736, Republic of Korea; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Republic of Korea. Electronic address: wcson@amc.seoul.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rebuttal to the commentary regarding: The sympathy of policy-makers towards animal rights activists, and the future of biomedical research.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25167971</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.08.009</DOI>
    <AuthorList>
      <Author>
        <Name>Julia Baines</Name>
        <Affiliation>People for the Ethical Treatment of Animals Foundation, PO Box 70315, London N1P 2RG, United Kingdom. Electronic address: juliab@peta.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Gilly Stoddart</Name>
        <Affiliation>People for the Ethical Treatment of Animals Foundation, PO Box 70315, London N1P 2RG, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetics and effects on serum cholinesterase activities of organophosphorus pesticides acephate and chlorpyrifos in chimeric mice transplanted with human hepatocytes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25158275</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.08.010</DOI>
    <KeywordList>
      <Keywords>Allometric scaling</Keywords>
      <Keywords>Lowest-observed-adverse-effect level</Keywords>
      <Keywords>Physiologically based pharmacokinetic model</Keywords>
      <Keywords>Serum cholinesterase activities</Keywords>
      <Keywords>Transplanted human liver cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hiroshi Suemizu</Name>
        <Affiliation>Central Institute for Experimental Animals, Kawasaki-ku, Kawasaki 210-0821, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shigeto Sota</Name>
        <Affiliation>Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Miyuki Kuronuma</Name>
        <Affiliation>Central Institute for Experimental Animals, Kawasaki-ku, Kawasaki 210-0821, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makiko Shimizu</Name>
        <Affiliation>Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Yamazaki</Name>
        <Affiliation>Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan. Electronic address: hyamazak@ac.shoyaku.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Introduction: Gasoline health effects and risk management.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25151183</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.08.007</DOI>
    <AuthorList />
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Appendix: Alternative Tier 2 Health Effects Testing Requirements for Gasoline and Oxygenated Gasolines.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25149684</pubmedLink>
    <Year>2014</Year>
    <DOI>S0273-2300(14)00186-X</DOI>
    <KeywordList>
      <Keywords>Clean Air Act</Keywords>
      <Keywords>Gasoline evaporative emissions</Keywords>
      <Keywords>Toxicity testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Charles R. Clark</Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Relationship between cigarette format and mouth-level exposure to tar and nicotine in smokers of Russian king-size cigarettes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25146962</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.08.002</DOI>
    <KeywordList>
      <Keywords>Cigarette smoke constituents</Keywords>
      <Keywords>Cigarettes</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Smokers</Keywords>
      <Keywords>Smokers mouth-level exposure</Keywords>
      <Keywords>Tar</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Madeleine Ashley</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton SO15 8TL, UK. Electronic address: madeleine_ashley@bat.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mike Dixon</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton SO15 8TL, UK. Electronic address: dixon.consultancy@hotmail.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Krishna Prasad</Name>
        <Affiliation>British American Tobacco, Group Research and Development, Regents Park Road, Southampton SO15 8TL, UK. Electronic address: krishna_prasad@bat.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reducing the number of fish in bioconcentration studies with general chemicals by reducing the number of test concentrations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25128673</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.08.008</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>BCF</Keywords>
      <Keywords>Bioconcentration</Keywords>
      <Keywords>Chemicals</Keywords>
      <Keywords>Fish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Natalie Burden</Name>
        <Affiliation>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London NW1 2BE, UK. Electronic address: Natalie.Burden@nc3rs.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Stuart Creton</Name>
        <Affiliation>Environmental Protection Authority, 215 Lambton Quay, Wellington 6011, New Zealand.</Affiliation>
      </Author>
      <Author>
        <Name>Lennart Weltje</Name>
        <Affiliation>BASF SE, Crop Protection - Ecotoxicology, Speyerer Strasse 2, D-67117 Limburgerhof, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel K. Maynard</Name>
        <Affiliation>Syngenta Ltd, Product Safety, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>James R. Wheeler</Name>
        <Affiliation>Dow AgroSciences, 3B Park Square, Milton Park, Abingdon, Oxfordshire OX14 4RN, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The impact of REACH on classification for human health hazards.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25128672</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.08.005</DOI>
    <KeywordList>
      <Keywords>Classification</Keywords>
      <Keywords>Human health</Keywords>
      <Keywords>Inventory</Keywords>
      <Keywords>PRODCOM database</Keywords>
      <Keywords>REACH Regulation</Keywords>
      <Keywords>Statistical evaluation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Oltmanns</Name>
        <Affiliation>Forschungs- und Beratungsinstitut Gefahrstoffe GmbH (FoBiG), Klarastraße 63, 79106 Freiburg, Germany. Electronic address: jan.oltmanns@fobig.de.</Affiliation>
      </Author>
      <Author>
        <Name>D. Bunke</Name>
        <Affiliation>Öko-Institut e.V., Institut für angewandte Ökologie, Merzhauser Straße 173, 79100 Freiburg, Germany. Electronic address: d.bunke@oeko.de.</Affiliation>
      </Author>
      <Author>
        <Name>W. Jenseit</Name>
        <Affiliation>Öko-Institut e.V., Institut für angewandte Ökologie, Rheinstraße 95, 64295 Darmstadt, Germany. Electronic address: w.jenseit@oeko.de.</Affiliation>
      </Author>
      <Author>
        <Name>C. Heidorn</Name>
        <Affiliation>European Commission, Eurostat, Office C2-617, BECH Building, 5 rue Alphonse Weicker, 2721 Luxembourg, Luxembourg. Electronic address: christian.heidorn@ec.europa.eu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Global Summit on Regulatory Science 2013.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25128336</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.08.004</DOI>
    <KeywordList>
      <Keywords>Global Summit on Regulatory Science</Keywords>
      <Keywords>Regulatory agencies</Keywords>
      <Keywords>Regulatory science</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul C. Howard</Name>
        <Affiliation>National Center for Toxicological Research, U.S. Food &amp; Drug Administration, Jefferson, AR, USA. Electronic address: Paul.Howard@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Weida Tong</Name>
        <Affiliation>National Center for Toxicological Research, U.S. Food &amp; Drug Administration, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Weichold</Name>
        <Affiliation>Office of the Chief Scientist, U.S. Food &amp; Drug Administration, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marion Healy</Name>
        <Affiliation>Food Standards Australia New Zealand, Canberra BC, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>William Slikker</Name>
        <Affiliation>National Center for Toxicological Research, U.S. Food &amp; Drug Administration, Jefferson, AR, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Measures of initiation and progression to increased smoking among current menthol compared to non-menthol cigarette smokers based on data from four U.S. government surveys.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25111576</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.08.001</DOI>
    <KeywordList>
      <Keywords>Age</Keywords>
      <Keywords>Cigarette</Keywords>
      <Keywords>Cigarette type preference</Keywords>
      <Keywords>Daily smoking</Keywords>
      <Keywords>Menthol</Keywords>
      <Keywords>Smoking initiation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Geoffrey M. Curtin</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: curting@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra I. Sulsky</Name>
        <Affiliation>ENVIRON International Corporation, 28 Amity Street, Suite 2A, Amherst, MA 01002, United States. Electronic address: ssulsky@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cynthia Van Landingham</Name>
        <Affiliation>ENVIRON International Corporation, 1900 North 18th Street, Suite 804, Monroe, LA 71201, United States. Electronic address: cvanlandingham@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin M. Marano</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: maranok@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Monica J. Graves</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: gravesm1@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael W. Ogden</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: ogdenm@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Swauger</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: swaugej@rjrt.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of the human-identical milk monosaccharide sialic acid (N-acetyl-d-neuraminic acid) in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25111575</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.08.003</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Human milk oligosaccharide</Keywords>
      <Keywords>Infant formula</Keywords>
      <Keywords>N-Acetyl-d-neuraminic acid</Keywords>
      <Keywords>Sialic acid</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sharon S. H. Choi</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Road, Suite 308, Mississauga, Ontario L5N 2X7, Canada. Electronic address: sharon.choi@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nigel Baldwin</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, Room 1036, Building A8, Cody Technology Park, Ively Road, Farnborough, Hampshire GU14 0LX, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Valentine O. Wagner</Name>
        <Affiliation>BioReliance Corporation, 9630 Medical Center Drive, Rockville, MD 20850, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shambhu Roy</Name>
        <Affiliation>BioReliance Corporation, 9630 Medical Center Drive, Rockville, MD 20850, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer Rose</Name>
        <Affiliation>MPI Research, Inc., 54943 North Main Street, Mattawan, MI 49071-8353, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bjorn A. Thorsrud</Name>
        <Affiliation>MPI Research, Inc., 54943 North Main Street, Mattawan, MI 49071-8353, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Phoukham Phothirath</Name>
        <Affiliation>Nestlé Research Center, Vers-chez-les-Blanc, 1000 Lausanne 26, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Christoph H. Röhrig</Name>
        <Affiliation>Glycom A/S, Diplomvej 373, DK-2800 Kongens Lyngby, Denmark.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A critical appraisal of existing concepts for the grouping of nanomaterials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25108058</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.025</DOI>
    <KeywordList>
      <Keywords>Biokinetics</Keywords>
      <Keywords>Characterization</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Grouping of substances</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Physico-chemical characterization</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxic Substances Control Act</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Josje H. E. Arts</Name>
        <Affiliation>AkzoNobel, Technology and Engineering, Arnhem, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Mackenzie Hadi</Name>
        <Affiliation>Shell Health, Shell International B.V., The Hague, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Athena M. Keene</Name>
        <Affiliation>Afton Chemical, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Reinhard Kreiling</Name>
        <Affiliation>Clariant Produkte GmbH, Sulzbach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Delina Lyon</Name>
        <Affiliation>Shell Health, Shell Oil Company, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Monika Maier</Name>
        <Affiliation>Evonik Degussa GmbH, Hanau, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Michel</Name>
        <Affiliation>Henkel AG &amp; Co. KGaA, Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Petry</Name>
        <Affiliation>Toxminds BVBA, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula G. Sauer</Name>
        <Affiliation>Scientific Consultancy - Animal Welfare, Neubiberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>David Warheit</Name>
        <Affiliation>DuPont Haskell Global Centers For HES, Newark, DE, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Wiench</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany. Electronic address: robert.landsiedel@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and subchronic toxicities of QX100626, a 5-HT4 receptor agonist, in rodents and Beagle dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25108057</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.024</DOI>
    <KeywordList>
      <Keywords>5-HT(4) receptor agonist</Keywords>
      <Keywords>Dyspepsia</Keywords>
      <Keywords>GERT</Keywords>
      <Keywords>QX100626</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaofang Zhang</Name>
        <Affiliation>Center for Evaluation of Drug Safety, Second Military Medical University, 800 Xiang Yin Road, Shanghai 200433, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bojun Yuan</Name>
        <Affiliation>Center for Evaluation of Drug Safety, Second Military Medical University, 800 Xiang Yin Road, Shanghai 200433, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Mao</Name>
        <Affiliation>Center for Evaluation of Drug Safety, Second Military Medical University, 800 Xiang Yin Road, Shanghai 200433, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyu Dai</Name>
        <Affiliation>Center for Evaluation of Drug Safety, Second Military Medical University, 800 Xiang Yin Road, Shanghai 200433, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodong Zhang</Name>
        <Affiliation>Center for Evaluation of Drug Safety, Second Military Medical University, 800 Xiang Yin Road, Shanghai 200433, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guocai Lu</Name>
        <Affiliation>Center for Evaluation of Drug Safety, Second Military Medical University, 800 Xiang Yin Road, Shanghai 200433, PR China. Electronic address: guocailu1@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Public health decisions: actions and consequences.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25092130</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.023</DOI>
    <KeywordList>
      <Keywords>Chemical regulations</Keywords>
      <Keywords>Gasoline additives</Keywords>
      <Keywords>Insecticides</Keywords>
      <Keywords>Risk management decisions</Keywords>
      <Keywords>Wood preservatives</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. R. Pohl</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta GA, USA. Electronic address: hpohl@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>D. E. Jones</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. S. Holler</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>H. E. Murray</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, Atlanta GA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Incorporating potency into EU classification for carcinogenicity and reproductive toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25092129</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.022</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Classification</Keywords>
      <Keywords>Degree of hazard</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Hazard communication</Keywords>
      <Keywords>Potency</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. Hennes</Name>
        <Affiliation>ECETOC AISBL, Avenue E. van Nieuwenhuyse 2 Bte 8, Brussels B-1160, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>M. Batke</Name>
        <Affiliation>Fraunhofer Institute for Toxicology &amp; Experimental Medicine, Nikolai-Fuchs-Str. 1, 30625 Hannover, Germany. Electronic address: monika.batke@item.fraunhofer.de.</Affiliation>
      </Author>
      <Author>
        <Name>W. Bomann</Name>
        <Affiliation>Bayer CropScience AG, Alfred-Nobel-Straße 50, D-40789 Monheim/Rhein, Germany. Electronic address: info@tox-consult.com.</Affiliation>
      </Author>
      <Author>
        <Name>S. Duhayon</Name>
        <Affiliation>Total Research and Technology Feluy, Zone Industrielle Feluy C, 7181 Seneffe, Belgium. Electronic address: sophie.duhayon@total.com.</Affiliation>
      </Author>
      <Author>
        <Name>K. Kosemund</Name>
        <Affiliation>Procter &amp; Gamble Service GmbH, Berliner Allee 65, 64295 Darmstadt, Germany. Electronic address: kosemund.k@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>V. Politano</Name>
        <Affiliation>Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA. Electronic address: vpolitano@rifm.org.</Affiliation>
      </Author>
      <Author>
        <Name>S. Stinchcombe</Name>
        <Affiliation>Product Safety, Regulations, Toxicology and Ecology, BASF SE, GUP/PP - Z470, 67056 Ludwigshafen, Germany. Electronic address: stefan.stinchcombe@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Doe</Name>
        <Affiliation>Parker Doe Partnership LLP, PO Box 139, Frodsham, Cheshire WA6 1AZ, United Kingdom. Electronic address: john.doe@parkerdoe.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oral dietary developmental toxicity study with polyvinyl acetate phthalate (PVAP) in the rat.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25084367</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.021</DOI>
    <KeywordList>
      <Keywords>Developmental study</Keywords>
      <Keywords>Enteric coating</Keywords>
      <Keywords>Enteric polymer</Keywords>
      <Keywords>Modified release coating</Keywords>
      <Keywords>PVAP</Keywords>
      <Keywords>PVAP-T</Keywords>
      <Keywords>Pharmaceutical excipient</Keywords>
      <Keywords>Polyvinyl acetate phthalate</Keywords>
      <Keywords>Polyvinyl acetate phthalate and titanium dioxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. C. DeMerlis</Name>
        <Affiliation>Colorcon, Inc., 275 Ruth Road, Harleysville, PA 19438, USA. Electronic address: cdemerlis@colorcon.com.</Affiliation>
      </Author>
      <Author>
        <Name>D. R. Schoneker</Name>
        <Affiliation>Colorcon, Inc., 275 Ruth Road, Harleysville, PA 19438, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. F. Borzelleca</Name>
        <Affiliation>School of Medicine, Virginia Commonwealth University, Richmond, VA 23229, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25078890</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.018</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Dog</Keywords>
      <Keywords>Non-clinical</Keywords>
      <Keywords>Primate</Keywords>
      <Keywords>Recovery</Keywords>
      <Keywords>Reduction</Keywords>
      <Keywords>Regulatory toxicology</Keywords>
      <Keywords>Repeat-dose studies</Keywords>
      <Keywords>Reversibility</Keywords>
      <Keywords>Rodent</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fiona Sewell</Name>
        <Affiliation>UK National Centre for the Replacement, Refinement &amp; Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London NW1 2BE, UK. Electronic address: fiona.sewell@nc3rs.org.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Kathryn Chapman</Name>
        <Affiliation>UK National Centre for the Replacement, Refinement &amp; Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London NW1 2BE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Baldrick</Name>
        <Affiliation>Covance Laboratories Ltd, Otley Road, Harrogate HG3 1PY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Brewster</Name>
        <Affiliation>Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Broadmeadow</Name>
        <Affiliation>Huntingdon Life Sciences Ltd, Occold, Eye, Suffolk IP23 7PX, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Brown</Name>
        <Affiliation>Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Leigh Ann Burns-Naas</Name>
        <Affiliation>Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Janet Clarke</Name>
        <Affiliation>Biogen Idec, Cambridge, MA 02142, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alex Constan</Name>
        <Affiliation>Infinity Pharmaceuticals, 780 Memorial Drive, Cambridge, MA 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica Couch</Name>
        <Affiliation>Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Oliver Czupalla</Name>
        <Affiliation>Bayer Pharma AG, Müllerstrasse 170, 13353 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andy Danks</Name>
        <Affiliation>Charles River Laboratories, Preclinical Services, Tranent, Edinburgh EH33 2NE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph DeGeorge</Name>
        <Affiliation>Merck, 770 Sumneytown Pike, Mailstop WP45-201, West Point, PA 19486, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lolke de Haan</Name>
        <Affiliation>MedImmune, Granta Park, Cambridge CB21 6GH, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Klaudia Hettinger</Name>
        <Affiliation>Austrian Agency for Health and Food Safety, Traisengasse 5, 1200 Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Marilyn Hill</Name>
        <Affiliation>Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Matthias Festag</Name>
        <Affiliation>Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, CH - 4070 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Abby Jacobs</Name>
        <Affiliation>Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Jacobson-Kram</Name>
        <Affiliation>Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephan Kopytek</Name>
        <Affiliation>Celgene, 86 Morris Avenue, Summit, NJ 07901, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Helga Lorenz</Name>
        <Affiliation>AbbVie Deutschland GmbH &amp; Co. KG, Knollstrasse, 67061 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sophia Gry Moesgaard</Name>
        <Affiliation>Novo Nordisk A/S, Novo Nordisk Park, Maaloev, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Emma Moore</Name>
        <Affiliation>Huntingdon Life Sciences Ltd, Alconbury, Huntingdon, Cambridgeshire PE28 4HS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Markku Pasanen</Name>
        <Affiliation>University of Eastern Finland, Faculty of Health Sciences, School of Pharmacy, Kuopio, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Rick Perry</Name>
        <Affiliation>Pfizer Drug Safety Research and Development, 455 Eastern Point Rd., Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Ragan</Name>
        <Affiliation>Board member, NC3Rs, Gibbs Building, 215 Euston Road, London NW1 2BE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sally Robinson</Name>
        <Affiliation>AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Petra M. Schmitt</Name>
        <Affiliation>Paul-Ehrlich-Institute, Federal Agency for Vaccines and Biomedicines, Langen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Short</Name>
        <Affiliation>Allergan, Drug Safety Evaluation, 2525 Dupont Dr, RD-2A, Irvine, CA 92612-1599, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Beatriz Silva Lima</Name>
        <Affiliation>iMED, UL, University of Lisbon, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Diane Smith</Name>
        <Affiliation>Millenium: The Takeda Oncology Company, 40 Landsdowne St., Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sue Sparrow</Name>
        <Affiliation>GlaxoSmithKline, Park Road, Ware, Hertfordshire SG12 0DP, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Yvette van Bekkum</Name>
        <Affiliation>Janssen Research &amp; Development, Turnhoutseweg 30, 2340 Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>David Jones</Name>
        <Affiliation>Medicines Healthcare Products Regulatory Agency (MHRA), UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk assessment study of dioxins in sanitary napkins produced in Japan.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25078889</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.020</DOI>
    <KeywordList>
      <Keywords>Dermal exposure</Keywords>
      <Keywords>Dioxins</Keywords>
      <Keywords>GC/MS</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Sanitary napkin</Keywords>
      <Keywords>Tolerable daily intake</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Satoko Ishii</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Tokyo, Japan. Electronic address: ishii-satoko@ceri.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Ritsuko Katagiri</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshiyuki Kataoka</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mitsuhiro Wada</Name>
        <Affiliation>Unicharm Corporation, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shigeo Imai</Name>
        <Affiliation>Unicharm Corporation, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kanji Yamasaki</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Tokyo, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicology and the chemical foundation of plants of Erycibe.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25073109</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.019</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Baogongteng A</Keywords>
      <Keywords>Baogongteng C</Keywords>
      <Keywords>Erycibe</Keywords>
      <Keywords>Erycibe ellipptimba</Keywords>
      <Keywords>Erycibe obtusifolia</Keywords>
      <Keywords>Erycibe schmidtii</Keywords>
      <Keywords>Subacute toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhiyong Chen</Name>
        <Affiliation>Department of Pharmacognosy, China Pharmaceutical University, Nanjing 210038, People's Republic of China. Electronic address: chenzhiyong0612@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Li Wang</Name>
        <Affiliation>Department of Pharmacognosy, China Pharmaceutical University, Nanjing 210038, People's Republic of China; The MOE Key Laboratory for Standardization of Chinese Medicines and The Shanghai Key Laboratory for Compound Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201210, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Liping Liao</Name>
        <Affiliation>The MOE Key Laboratory for Standardization of Chinese Medicines and The Shanghai Key Laboratory for Compound Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201210, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Zijia Zhang</Name>
        <Affiliation>The MOE Key Laboratory for Standardization of Chinese Medicines and The Shanghai Key Laboratory for Compound Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201210, People's Republic of China; Shanghai R&amp;D Center for Standardization of Chinese Medicines, Shanghai 201210, People's Republic of China. Electronic address: 18721608946@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengtao Wang</Name>
        <Affiliation>Department of Pharmacognosy, China Pharmaceutical University, Nanjing 210038, People's Republic of China; The MOE Key Laboratory for Standardization of Chinese Medicines and The Shanghai Key Laboratory for Compound Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201210, People's Republic of China; Shanghai R&amp;D Center for Standardization of Chinese Medicines, Shanghai 201210, People's Republic of China. Electronic address: wangzht@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lowest adverse effects concentrations (LOAECs) for formaldehyde exposure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25073108</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.016</DOI>
    <KeywordList>
      <Keywords>Cell proliferation</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Histopathological alterations</Keywords>
      <Keywords>LOAEC</Keywords>
      <Keywords>Polypoid adenomas</Keywords>
      <Keywords>RAC opinion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heinz Peter Gelbke</Name>
        <Affiliation>CinTox, France. Electronic address: heinz-peter.gelbke@gmx.de.</Affiliation>
      </Author>
      <Author>
        <Name>Sibylle Gröters</Name>
        <Affiliation>BASF SE, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Morfeld</Name>
        <Affiliation>Institute for Occupational Epidemiology and Risk Assessment of Evonik Industries AG, Essen, Germany; Institute and Policlinic for Occupational Medicine, Environmental Medicine and Preventive Research, University of Cologne, Cologne, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biomonitoring Equivalents for selenium.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25068883</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.017</DOI>
    <KeywordList>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring Equivalents</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Selenium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sean M. Hays</Name>
        <Affiliation>Summit Toxicology, LLP, Allenspark, CO, USA. Electronic address: shays@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Macey</Name>
        <Affiliation>Health Canada, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Andy Nong</Name>
        <Affiliation>Health Canada, Ottawa, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Lesa L. Aylward</Name>
        <Affiliation>Summit Toxicology, LLP, Falls Church, VA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The acute effects of daily nicotine intake on heart rate--a toxicokinetic and toxicodynamic modelling study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25066669</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.015</DOI>
    <KeywordList>
      <Keywords>Nicotine</Keywords>
      <Keywords>Physiologically-based toxicodynamic (PBTD) modelling</Keywords>
      <Keywords>Physiologically-based toxicokinetic (PBTK) modelling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Gajewska</Name>
        <Affiliation>Systems Toxicology Unit and EURL ECVAM, Institute for Health and Consumer Protection, European Commission, Joint Research Centre, 21027 Ispra, VA, Italy; University of Milano Bicocca, Dep. of Earth and Environmental Sciences, Piazza della Scienza 1, Milano, Italy; TUM, Wissenschaftszentrum Weihenstephan für Ernährung und Landnutzung, Department für Biowissenschaften, Weihenstephaner Steig 23, 85350 Freising, Germany. Electronic address: Monika.Gajewska@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>A. Worth</Name>
        <Affiliation>Systems Toxicology Unit and EURL ECVAM, Institute for Health and Consumer Protection, European Commission, Joint Research Centre, 21027 Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>C. Urani</Name>
        <Affiliation>University of Milano Bicocca, Dep. of Earth and Environmental Sciences, Piazza della Scienza 1, Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>H. Briesen</Name>
        <Affiliation>TUM, Wissenschaftszentrum Weihenstephan für Ernährung und Landnutzung, Lehrstuhl für Systemverfahrenstechnik, Weihenstephaner Steig 23, 85350 Freising, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>K. W. Schramm</Name>
        <Affiliation>TUM, Wissenschaftszentrum Weihenstephan für Ernährung und Landnutzung, Department für Biowissenschaften, Weihenstephaner Steig 23, 85350 Freising, Germany; Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Molecular EXposomics (MEX), Ingolstädter Landstr.1, D-85764 Neuherberg, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of animals for toxicology testing is necessary to ensure patient safety in pharmaceutical development.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25058855</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.014</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>DruSafe</Keywords>
      <Keywords>In vivo toxicology testing</Keywords>
      <Keywords>Predictivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Raja Mangipudy</Name>
        <Affiliation>Bristol-Myers Squibb, New Brunswick, New Jersey, 1 Squibb Drive, New Brunswick, NJ 08903, United States. Electronic address: raja.mangipudy@bms.com.</Affiliation>
      </Author>
      <Author>
        <Name>John Burkhardt</Name>
        <Affiliation>AbbVie, Preclinical Safety, 1 North Waukegan Road, R46G, North Chicago, IL 60044, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Vivek J. Kadambi</Name>
        <Affiliation>BluePrint Medicines, Nonclinical Development, 215 First Street Cambridge, MA 02142, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Automated and reproducible read-across like models for predicting carcinogenic potency.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25047023</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.010</DOI>
    <KeywordList>
      <Keywords>Alternative method</Keywords>
      <Keywords>Cancer potency (TD(50))</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Quantitative structure activity relationship (QSAR)</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elena Lo Piparo</Name>
        <Affiliation>Chemical Food Safety Group, Nestlé Research Center, Lausanne, Switzerland. Electronic address: elena.lopiparo@rdls.nestle.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Maunz</Name>
        <Affiliation>In Silico Toxicology GmbH, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Christoph Helma</Name>
        <Affiliation>In Silico Toxicology GmbH, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>David Vorgrimmler</Name>
        <Affiliation>In Silico Toxicology GmbH, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Benoît Schilter</Name>
        <Affiliation>Chemical Food Safety Group, Nestlé Research Center, Lausanne, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of plant varieties using transcriptomics profiling and a one-class classifier.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25046166</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.013</DOI>
    <KeywordList>
      <Keywords>Chemometrics</Keywords>
      <Keywords>Food safety evaluation</Keywords>
      <Keywords>GM plants</Keywords>
      <Keywords>One-class classifiers</Keywords>
      <Keywords>Profiling</Keywords>
      <Keywords>Transcriptomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeroen P. van Dijk</Name>
        <Affiliation>RIKILT, Wageningen UR, Wageningen, The Netherlands. Electronic address: jeroen.vandijk@wur.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Carla Souza de Mello</Name>
        <Affiliation>RIKILT, Wageningen UR, Wageningen, The Netherlands; Federal University of Santa Catarina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marleen M. Voorhuijzen</Name>
        <Affiliation>RIKILT, Wageningen UR, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald C. B. Hutten</Name>
        <Affiliation>Plant Breeding, Wageningen UR, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Carolina Maisonnave Arisi</Name>
        <Affiliation>Federal University of Santa Catarina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jeroen J. Jansen</Name>
        <Affiliation>Institute for Molecules and Materials, Radboud University Nijmegen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Lutgarde M. C. Buydens</Name>
        <Affiliation>Institute for Molecules and Materials, Radboud University Nijmegen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Hilko van der Voet</Name>
        <Affiliation>Biometris, Wageningen UR, Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Esther J. Kok</Name>
        <Affiliation>Federal University of Santa Catarina, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Considerations for non-clinical safety studies of therapeutic peptide vaccines.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25042360</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.029</DOI>
    <KeywordList>
      <Keywords>Cellular immunity</Keywords>
      <Keywords>Cytotoxic T-cells (CTLs)</Keywords>
      <Keywords>Guidelines</Keywords>
      <Keywords>Human leukocyte antigen (HLA)</Keywords>
      <Keywords>Non-clinical safety study</Keywords>
      <Keywords>Off-target toxicity</Keywords>
      <Keywords>On-target toxicity</Keywords>
      <Keywords>Prophylactic vaccines against infectious diseases</Keywords>
      <Keywords>Therapeutic peptide vaccines</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mineo Matsumoto</Name>
        <Affiliation>Review Division, Pharmaceuticals &amp; Medical Devices Agency (PMDA), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan. Electronic address: matsumoto-mineo@pmda.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Shinichi Komatsu</Name>
        <Affiliation>Pre-Clinical Development, GlaxoSmithKline K.K., Sendagaya 4-6-15, Shibuya-ku, Tokyo 151-8566, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mayumi Tsuchimoto</Name>
        <Affiliation>Research &amp; Development, Sanofi K.K., Nishi Shinjuku 3-20-2, Shinjuku-ku, Tokyo 163-1488, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hajime Matsui</Name>
        <Affiliation>Pathology Department, The Chemo-Sero-Therapeutic Research Institute, Kyokushi Kawabe 1314-1, Kikuchi-shi, Kumamoto 869-1298, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuto Watanabe</Name>
        <Affiliation>Research Division, Chugai Pharmaceutical Co. Ltd., Komakado, 1-135, Gotemba, Shizuoka 412-8513, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuichi Nakamura</Name>
        <Affiliation>Global Regulatory Affairs Department, Shionogi Co. Ltd., Shibuya 2-17-5, Shibuya-ku, Tokyo 150-8673, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kohei Amakasu</Name>
        <Affiliation>Review Division, Pharmaceuticals &amp; Medical Devices Agency (PMDA), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kanako Ito</Name>
        <Affiliation>Review Division, Pharmaceuticals &amp; Medical Devices Agency (PMDA), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Osamu Fueki</Name>
        <Affiliation>Review Division, Pharmaceuticals &amp; Medical Devices Agency (PMDA), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Ichi Sawada</Name>
        <Affiliation>Review Division, Pharmaceuticals &amp; Medical Devices Agency (PMDA), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazushige Maki</Name>
        <Affiliation>Review Division, Pharmaceuticals &amp; Medical Devices Agency (PMDA), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Onodera</Name>
        <Affiliation>Review Division, Pharmaceuticals &amp; Medical Devices Agency (PMDA), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Seventy day safety assessment of an orally ingested, l-glutamine-containing oat and yeast supplement for horses.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25042359</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.011</DOI>
    <KeywordList>
      <Keywords>Equine nutraceutical</Keywords>
      <Keywords>Hematology</Keywords>
      <Keywords>Oat oil</Keywords>
      <Keywords>Oral supplement</Keywords>
      <Keywords>Plasma chemistry</Keywords>
      <Keywords>l-Glutamine</Keywords>
      <Keywords>l-Threonine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael I. Lindinger</Name>
        <Affiliation>The Nutraceutical Alliance, 10526 4th Line, Campbellville, ON L0P 1B0, Canada. Electronic address: mi.lindinger@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Scott C. Anderson</Name>
        <Affiliation>Freedom Health LLC, 65 Aurora Industrial Parkway, Aurora, OH 44202, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An integrative risk assessment approach for persistent chemicals: a case study on dioxins, furans and dioxin-like PCBs in France.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25038565</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.004</DOI>
    <KeywordList>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Biomarker</Keywords>
      <Keywords>Cumulative risk assessment</Keywords>
      <Keywords>Dioxins</Keywords>
      <Keywords>PCBs</Keywords>
      <Keywords>Pharmacokinetic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Camille Béchaux</Name>
        <Affiliation>ANSES, French Agency for Food, Environmental and Occupational Health Safety, 27-31 Avenue du Général Leclerc, 94701 Maisons-Alfort, France. Electronic address: camille.bechaux@anses.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Zeilmaker</Name>
        <Affiliation>RIVM, National Institute for Public Health and the Environment, Centre for Nutrition, Prevention and Health, PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Mathilde Merlo</Name>
        <Affiliation>ANSES, French Agency for Food, Environmental and Occupational Health Safety, 27-31 Avenue du Général Leclerc, 94701 Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>Bas Bokkers</Name>
        <Affiliation>RIVM, National Institute for Public Health and the Environment, Centre for Safety of Substances and Products, PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Amélie Crépet</Name>
        <Affiliation>ANSES, French Agency for Food, Environmental and Occupational Health Safety, 27-31 Avenue du Général Leclerc, 94701 Maisons-Alfort, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonclinical safety assessment of Efinaconazole Solution (10%) for onychomycosis treatment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25038564</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.012</DOI>
    <KeywordList>
      <Keywords>Antifungal</Keywords>
      <Keywords>Efinaconazole</Keywords>
      <Keywords>Onychomycosis</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>William Jo</Name>
        <Affiliation>Dow Pharmaceutical Sciences, A Division of Valeant Pharmaceuticals International, 1330 Redwood Way, Petaluma, CA 94954, USA. Electronic address: wjo@dowpharmsci.com.</Affiliation>
      </Author>
      <Author>
        <Name>Marian Glynn</Name>
        <Affiliation>Dow Pharmaceutical Sciences, A Division of Valeant Pharmaceuticals International, 1330 Redwood Way, Petaluma, CA 94954, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroaki Nejishima</Name>
        <Affiliation>Kaken Pharmaceutical Co., Ltd., 301, Gensuke, Fujieda, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hisakazu Sanada</Name>
        <Affiliation>Kaken Pharmaceutical Co., Ltd., 301, Gensuke, Fujieda, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kenji Minowa</Name>
        <Affiliation>Kaken Pharmaceutical Co., Ltd., 301, Gensuke, Fujieda, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Calvarese</Name>
        <Affiliation>Dow Pharmaceutical Sciences, A Division of Valeant Pharmaceuticals International, 1330 Redwood Way, Petaluma, CA 94954, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hisato Senda</Name>
        <Affiliation>Kaken Pharmaceutical Co., Ltd., 301, Gensuke, Fujieda, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Radhakrishnan Pillai</Name>
        <Affiliation>Dow Pharmaceutical Sciences, A Division of Valeant Pharmaceuticals International, 1330 Redwood Way, Petaluma, CA 94954, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Linda Mutter</Name>
        <Affiliation>Dow Pharmaceutical Sciences, A Division of Valeant Pharmaceuticals International, 1330 Redwood Way, Petaluma, CA 94954, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Target organ profiles in toxicity studies supporting human dosing: an assessment of recovery and chronic dosing.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25020275</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.008</DOI>
    <KeywordList>
      <Keywords>Candidate drugs</Keywords>
      <Keywords>Chronic toxicology studies</Keywords>
      <Keywords>Nonclinical studies</Keywords>
      <Keywords>Recovery groups</Keywords>
      <Keywords>Reversibility</Keywords>
      <Keywords>Target organs</Keywords>
      <Keywords>Toxicities</Keywords>
      <Keywords>Toxicity profile</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Steve Horner</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sally Robinson</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK.</Affiliation>
      </Author>
      <Author>
        <Name>David Lees</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Callander</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Roberts</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield, UK. Electronic address: ruth.roberts@astrazeneca.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health assessment of gasoline and fuel oxygenate vapors: subchronic inhalation toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25020274</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.003</DOI>
    <KeywordList>
      <Keywords>Diisopropyl ether</Keywords>
      <Keywords>Ethanol</Keywords>
      <Keywords>Ethyl t-butyl ether</Keywords>
      <Keywords>Evaporative emissions</Keywords>
      <Keywords>Fuel oxygenates</Keywords>
      <Keywords>Gasoline vapor condensates</Keywords>
      <Keywords>Methyl tertiary butyl ether</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
      <Keywords>T-amyl methyl ether</Keywords>
      <Keywords>T-butyl alcohol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Charles R. Clark</Name>
        <Affiliation>Phillips 66 Co., 420 S. Keeler Avenue, Bartlesville, OK, United States. Electronic address: okietox@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ceinwen A. Schreiner</Name>
        <Affiliation>C&amp;C Consulting in Toxicology, 1950 Briarcliff Ave, Meadowbrook, PA 19046, United States. Electronic address: castox@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Craig M. Parker</Name>
        <Affiliation>Marathon Petroleum, United States. Electronic address: cmjkparker@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas M. Gray</Name>
        <Affiliation>American Petroleum Institute, 1220 L Street NW, Washington, DC 20005, United States. Electronic address: tmgray@reagan.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gary M. Hoffman</Name>
        <Affiliation>Huntingdon Life Sciences, Princeton Research Center, 100 Mettlers Road, East Millstone, NJ 08873, United States. Electronic address: hoffmang@princeton.huntingdon.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of estrogenic binary mixtures in the yeast estrogen screen (YES).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25017362</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.006</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Endocrine active compounds</Keywords>
      <Keywords>Estrogenic mixtures</Keywords>
      <Keywords>Genistein</Keywords>
      <Keywords>Loewe additivity model</Keywords>
      <Keywords>Trenbolone</Keywords>
      <Keywords>Yeast based assay</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tzutzuy Ramirez</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Carl-Bosch Str. 38, 67056 Ludwigshafen am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Buechse</Name>
        <Affiliation>BASF SE Scientific Computing, Carl-Bosch Str. 38, 67056 Ludwigshafen am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Dammann</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Carl-Bosch Str. 38, 67056 Ludwigshafen am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie Melching-Kollmuß</Name>
        <Affiliation>BASF SE Product Safety, Carl-Bosch Str. 38, 67056 Ludwigshafen am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Woitkowiak</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Carl-Bosch Str. 38, 67056 Ludwigshafen am Rhein, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Bennard van Ravenzwaay</Name>
        <Affiliation>BASF SE Experimental Toxicology and Ecology, Carl-Bosch Str. 38, 67056 Ludwigshafen am Rhein, Germany. Electronic address: bennard.ravenzwaay@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluating the association between menthol cigarette use and the likelihood of being a former versus current smoker.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25017361</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.009</DOI>
    <KeywordList>
      <Keywords>Cigarette</Keywords>
      <Keywords>Cigarette type preference</Keywords>
      <Keywords>Former smokers</Keywords>
      <Keywords>Menthol</Keywords>
      <Keywords>Quitting smoking</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sandra I. Sulsky</Name>
        <Affiliation>ENVIRON International Corporation, 28 Amity Street, Amherst, MA 01002, United States. Electronic address: ssulsky@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>William G. Fuller</Name>
        <Affiliation>ENVIRON International Corporation, 1900 North 18th Street, Suite 804, Monroe, LA 71201, United States. Electronic address: wfuller@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cynthia Van Landingham</Name>
        <Affiliation>ENVIRON International Corporation, 1900 North 18th Street, Suite 804, Monroe, LA 71201, United States. Electronic address: cvanlandingham@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael W. Ogden</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: ogdenm@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Swauger</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: swaugej@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Geoffrey M. Curtin</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: curting@rjrt.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The sympathy of policy-makers towards animal-rights activists, and the future of biomedical research.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25016178</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.005</DOI>
    <AuthorList>
      <Author>
        <Name>Fabio Vivarelli</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via S.Donato 15-40126, Bologna, Italy. Electronic address: fabio.vivarelli3@unibo.it.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Sapone</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via S.Donato 15-40126, Bologna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Donatella Canistro</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via S.Donato 15-40126, Bologna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Moreno Paolini</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via S.Donato 15-40126, Bologna, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human plasma concentrations of herbicidal carbamate molinate extrapolated from the pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and physiologically based pharmacokinetic modeling.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25016177</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.028</DOI>
    <KeywordList>
      <Keywords>Allometric scaling</Keywords>
      <Keywords>Lowest-observed-adverse-effect level</Keywords>
      <Keywords>Physiologically based pharmacokinetic model</Keywords>
      <Keywords>Simulation</Keywords>
      <Keywords>Transplanted human liver cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Masanao Yamashita</Name>
        <Affiliation>Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Suemizu</Name>
        <Affiliation>Central Institute for Experimental Animals, Kawasaki-ku, Kawasaki 210-0821, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Norie Murayama</Name>
        <Affiliation>Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Sayako Nishiyama</Name>
        <Affiliation>Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makiko Shimizu</Name>
        <Affiliation>Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Yamazaki</Name>
        <Affiliation>Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan. Electronic address: hyamazak@ac.shoyaku.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Conotoxins and their regulatory considerations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25013992</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.027</DOI>
    <KeywordList>
      <Keywords>Conotoxins</Keywords>
      <Keywords>Cyclic peptides</Keywords>
      <Keywords>Peptides</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Select agents</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Parashar Thapa</Name>
        <Affiliation>Department of Molecular Biosciences and Bioengineering, College of Tropical Agriculture and Human Resources, University of Hawai'i, Honolulu, HI 96822, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Espiritu</Name>
        <Affiliation>Department of Molecular Biosciences and Bioengineering, College of Tropical Agriculture and Human Resources, University of Hawai'i, Honolulu, HI 96822, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chino C. Cabalteja</Name>
        <Affiliation>Department of Molecular Biosciences and Bioengineering, College of Tropical Agriculture and Human Resources, University of Hawai'i, Honolulu, HI 96822, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jon Paul Bingham</Name>
        <Affiliation>Department of Molecular Biosciences and Bioengineering, College of Tropical Agriculture and Human Resources, University of Hawai'i, Honolulu, HI 96822, USA. Electronic address: jbingham@hawaii.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The sub-chronic toxicity of regular White Spirit in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25013991</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.007</DOI>
    <KeywordList>
      <Keywords>Alkanes</Keywords>
      <Keywords>Aromatic hydrocarbons</Keywords>
      <Keywords>Hydrocarbon solvent</Keywords>
      <Keywords>Inhalation toxicity</Keywords>
      <Keywords>Liver enlargement</Keywords>
      <Keywords>Occupational exposure limit</Keywords>
      <Keywords>Stoddard solvent</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
      <Keywords>UVCB</Keywords>
      <Keywords>White spirit</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juan Carlos Carrillo</Name>
        <Affiliation>Shell Health, Shell International B.V., P.O. Box 162, 2501 AN The Hague, The Netherlands. Electronic address: juan-carlos.carrillo@shell.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. David Adenuga</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 Route 22 E., Annandale, NJ 08801, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard H. Mckee</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 Route 22 E., Annandale, NJ 08801, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A constrained maximum likelihood approach to evaluate the impact of dose metric on cancer risk assessment: application to β-chloroprene.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25010378</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.001</DOI>
    <KeywordList>
      <Keywords>Constrained likelihood approach</Keywords>
      <Keywords>Physiologically based kinetic modeling</Keywords>
      <Keywords>β-Chloroprene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>B. C. Allen</Name>
        <Affiliation>Independent Consultant, 101 Corbin Hill Circle, Chapel Hill, NC 27514, United States. Electronic address: Bruce.C.Allen@outlook.com.</Affiliation>
      </Author>
      <Author>
        <Name>C. Van Landingham</Name>
        <Affiliation>ENVIRON International Corporation, 1900 North 18th St. Monroe, LA 71201, United States. Electronic address: cvanlandingham@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Y. Yang</Name>
        <Affiliation>Center for Human Health Assessment, The Hamner Institutes for Health Sciences, 6 Davis Drive (PO Box 12137), Research Triangle Park, NC 27703, United States. Electronic address: yyang@thehamner.org.</Affiliation>
      </Author>
      <Author>
        <Name>A. O. Youk</Name>
        <Affiliation>Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, 130 De Soto St., Pittsburgh, PA 15261, United States. Electronic address: ayouk@pitt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>G. M. Marsh</Name>
        <Affiliation>Center for Occupational Biostatistics and Epidemiology, Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, 130 De Soto St., Pittsburgh, PA 15261, United States. Electronic address: gmarsh@pitt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>N. Esmen</Name>
        <Affiliation>Occupational and Environmental Health Sciences, School of Public Health, University of Illinois at Chicago, 2121 West Taylor Street, Chicago, IL 60622, United States. Electronic address: nesmen@uic.edu.</Affiliation>
      </Author>
      <Author>
        <Name>P. R. Gentry</Name>
        <Affiliation>ENVIRON International Corporation, 1900 North 18th St. Monroe, LA 71201, United States. Electronic address: rgentry@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>H. J. Clewell</Name>
        <Affiliation>Center for Human Health Assessment, The Hamner Institutes for Health Sciences, 6 Davis Drive (PO Box 12137), Research Triangle Park, NC 27703, United States. Electronic address: hclewell@thehamner.org.</Affiliation>
      </Author>
      <Author>
        <Name>M. W. Himmelstein</Name>
        <Affiliation>DuPont Haskell Global Centers for Health &amp; Environmental Sciences, PO Box 30, 1090 Elkton Road, Newark, DE 19711, United States. Electronic address: matthew.w.himmelstein@dupont.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>More methemoglobin is produced by benzocaine treatment than lidocaine treatment in human in vitro systems.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/25010377</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.07.002</DOI>
    <KeywordList>
      <Keywords>Benzocaine</Keywords>
      <Keywords>Benzocaine hydroxylamine</Keywords>
      <Keywords>Lidocaine</Keywords>
      <Keywords>Methemoglobin</Keywords>
      <Keywords>Methemoglobinemia</Keywords>
      <Keywords>Xylidine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Neil R. Hartman</Name>
        <Affiliation>Division of Applied Regulatory Science, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, USA. Electronic address: neil.hartman@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Jinzhe J. Mao</Name>
        <Affiliation>Division of Applied Regulatory Science, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hongfei Zhou</Name>
        <Affiliation>Division of Applied Regulatory Science, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael T. Boyne</Name>
        <Affiliation>Division of Pharmaceutical Analysis, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Adam M. Wasserman</Name>
        <Affiliation>Division of Anesthesia, Analgesia and Addiction Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kellie Taylor</Name>
        <Affiliation>Division of Medication Error Prevention and Analysis, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Judith A. Racoosin</Name>
        <Affiliation>Division of Anesthesia, Analgesia and Addiction Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vikram Patel</Name>
        <Affiliation>Division of Applied Regulatory Science, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Colatsky</Name>
        <Affiliation>Division of Applied Regulatory Science, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Flatworm models in pharmacological research: the importance of compound stability testing.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24999090</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.026</DOI>
    <KeywordList>
      <Keywords>Assay design</Keywords>
      <Keywords>Flatworms</Keywords>
      <Keywords>Quality practices</Keywords>
      <Keywords>Stability testing</Keywords>
      <Keywords>Stem cells</Keywords>
      <Keywords>Toxico-pharmacological test</Keywords>
      <Keywords>U(H)PLC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sofie Stalmans</Name>
        <Affiliation>Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460 (Second Floor), 9000 Ghent, Belgium. Electronic address: Sofie.Stalmans@UGent.be.</Affiliation>
      </Author>
      <Author>
        <Name>Maxime Willems</Name>
        <Affiliation>Laboratory of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460 (Third Floor), 9000 Ghent, Belgium. Electronic address: Maxime.Willems@UGent.be.</Affiliation>
      </Author>
      <Author>
        <Name>Els Adriaens</Name>
        <Affiliation>Laboratory of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460 (Third Floor), 9000 Ghent, Belgium. Electronic address: Els.Adriaens@UGent.be.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Paul Remon</Name>
        <Affiliation>Laboratory of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460 (Third Floor), 9000 Ghent, Belgium. Electronic address: JeanPaul.Remon@UGent.be.</Affiliation>
      </Author>
      <Author>
        <Name>Matthias D'Hondt</Name>
        <Affiliation>Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460 (Second Floor), 9000 Ghent, Belgium. Electronic address: Matthias.Dhondt@UGent.be.</Affiliation>
      </Author>
      <Author>
        <Name>Bart De Spiegeleer</Name>
        <Affiliation>Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460 (Second Floor), 9000 Ghent, Belgium. Electronic address: Bart.Despiegeleer@UGent.be.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cancer risk of immunosuppressants in manufacturing.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24997232</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.025</DOI>
    <KeywordList>
      <Keywords>Cancer risk</Keywords>
      <Keywords>Cyclosporine</Keywords>
      <Keywords>Immunosuppression</Keywords>
      <Keywords>Occupational exposure</Keywords>
      <Keywords>Pharmaceutical production</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ester Lovsin Barle</Name>
        <Affiliation>Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland. Electronic address: ester.lovsin_barle@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gian Christian Winkler</Name>
        <Affiliation>Novartis Pharma AG NIBR, Postfach, CH-4002 Basel, Switzerland. Electronic address: gian_christian.winkler@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Ulrich</Name>
        <Affiliation>Novartis Pharma AG NIBR, Postfach, CH-4002 Basel, Switzerland. Electronic address: peter.ulrich@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Perino</Name>
        <Affiliation>Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936, United States. Electronic address: christopher.perino@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Kuster</Name>
        <Affiliation>Novartis International AG, Postfach, CH-4002 Basel, Switzerland. Electronic address: martin.kuster@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Probst</Name>
        <Affiliation>Novartis Pharma AG NIBR, Postfach, CH-4002 Basel, Switzerland. Electronic address: alessandro.probst@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Silke Thielen</Name>
        <Affiliation>Novartis Tiergesundheit AG, CH-4002 Basel, Switzerland. Electronic address: silke.thielen@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rudolf Bechter</Name>
        <Affiliation>Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland. Electronic address: rudolf.bechter@novartis.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Locust bean gum safety in neonates and young infants: an integrated review of the toxicological database and clinical evidence.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24997231</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.023</DOI>
    <KeywordList>
      <Keywords>Carob bean gum</Keywords>
      <Keywords>Gastro-oesophageal reflux</Keywords>
      <Keywords>Infant formula</Keywords>
      <Keywords>Infants</Keywords>
      <Keywords>Locust bean gum</Keywords>
      <Keywords>Regurgitation</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Thickener</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Leo Meunier</Name>
        <Affiliation>Danone Food Safety Center, Utrecht, The Netherlands. Electronic address: leo.meunier@danone.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jossie A. Garthoff</Name>
        <Affiliation>Danone Food Safety Center, Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Schaafsma</Name>
        <Affiliation>FrieslandCampina, Amersfoort, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Lisette Krul</Name>
        <Affiliation>TNO, Zeist, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jaap Schrijver</Name>
        <Affiliation>Danone Nutricia Early Life Nutrition, Schiphol Airport, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Johannes B. van Goudoever</Name>
        <Affiliation>Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands; Department of Pediatrics, VU University Medical Center, Amsterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Gerrit Speijers</Name>
        <Affiliation>General Health Effects Toxicology Safety Food (GETS), Nieuwegein, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Yvan Vandenplas</Name>
        <Affiliation>Department of Pediatrics, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Patterns of menthol cigarette use among current smokers, overall and within demographic strata, based on data from four U.S. government surveys.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24997230</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.018</DOI>
    <KeywordList>
      <Keywords>Cigarette</Keywords>
      <Keywords>Current age category</Keywords>
      <Keywords>Demographics</Keywords>
      <Keywords>Gender</Keywords>
      <Keywords>Menthol</Keywords>
      <Keywords>Preference</Keywords>
      <Keywords>Race/ethnicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Geoffrey M. Curtin</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: curting@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra I. Sulsky</Name>
        <Affiliation>ENVIRON International Corporation, 28 Amity Street, Suite 2A, Amherst, MA 01002, United States. Electronic address: ssulsky@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cynthia Van Landingham</Name>
        <Affiliation>ENVIRON International Corporation, 1900 North 18th Street, Suite 804, Monroe, LA 71201, United States. Electronic address: cvanlandingham@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin M. Marano</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: maranok@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Monica J. Graves</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: gravesm1@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael W. Ogden</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: ogdenm@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Swauger</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: swaugej@rjrt.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and subchronic toxicity studies of pyrroloquinoline quinone (PQQ) disodium salt (BioPQQ™) in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24995591</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.024</DOI>
    <KeywordList>
      <Keywords>Acute</Keywords>
      <Keywords>BioPQQ™</Keywords>
      <Keywords>PQQ</Keywords>
      <Keywords>Pyrroloquinoline quinone disodium salt</Keywords>
      <Keywords>Renal toxicity</Keywords>
      <Keywords>Subchronic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Masahiko Nakano</Name>
        <Affiliation>NC Planning &amp; Development Division, Mitsubishi Gas Chemical Co., Inc., 5-2, Marunouchi 2-chome, Chiyoda-ku, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hisaaki Takahashi</Name>
        <Affiliation>Central Laboratories, New Drug Research Center, Inc., 452-1, Toiso, Eniwa-shi, Hokkaido, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Seiko Koura</Name>
        <Affiliation>Central Laboratories, New Drug Research Center, Inc., 452-1, Toiso, Eniwa-shi, Hokkaido, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Chung</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Rd., Suite 308, Mississauga, Ontario L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Shahrzad Tafazoli</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Rd., Suite 308, Mississauga, Ontario L5N 2X7, Canada. Electronic address: shahrzad.tafazoli@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ashley Roberts</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Rd., Suite 308, Mississauga, Ontario L5N 2X7, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gasoline risk management: a compendium of regulations, standards, and industry practices.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24995590</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.022</DOI>
    <KeywordList>
      <Keywords>Best management practices</Keywords>
      <Keywords>Gasoline lifecycle</Keywords>
      <Keywords>Gasoline regulation</Keywords>
      <Keywords>Risk management</Keywords>
      <Keywords>Voluntary standards</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Derek Swick</Name>
        <Affiliation>American Petroleum Institute, 1220 L Street, N.W., Washington, DC 20005, United States. Electronic address: swickd@api.org.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Jaques</Name>
        <Affiliation>RegNet, 1250 Connecticut Avenue, N.W., Suite 700, Washington, DC 20036, United States. Electronic address: ajaques@regnet.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. C. Walker</Name>
        <Affiliation>Keller and Heckman LLP, 1001 G Street, N.W., Suite 500W, Washington, DC 20001, United States. Electronic address: walker@khlaw.com.</Affiliation>
      </Author>
      <Author>
        <Name>Herb Estreicher</Name>
        <Affiliation>Keller and Heckman LLP, 1001 G Street, N.W., Suite 500W, Washington, DC 20001, United States. Electronic address: estreicher@khlaw.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health assessment of gasoline and fuel oxygenate vapors: developmental toxicity in mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24979735</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.011</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Ectopia cordis</Keywords>
      <Keywords>Evaporative emissions</Keywords>
      <Keywords>Fuel oxygenates</Keywords>
      <Keywords>Gasoline vapor condensates</Keywords>
      <Keywords>Gastroschisis</Keywords>
      <Keywords>Methyl tertiary butyl ether (MTBE)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>L. G. Roberts</Name>
        <Affiliation>Chevron Energy Technology Company, 6001 Bollinger Canyon Road, San Ramon, CA 94583, United States. Electronic address: LRoberts@chevron.com.</Affiliation>
      </Author>
      <Author>
        <Name>T. M. Gray</Name>
        <Affiliation>American Petroleum Institute (retired), 1220 L Street NW, Washington, DC 20005, United States. Electronic address: tmgray@reagan.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. C. Marr</Name>
        <Affiliation>RTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709, United States. Electronic address: mcm@rti.org.</Affiliation>
      </Author>
      <Author>
        <Name>R. W. Tyl</Name>
        <Affiliation>RTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709, United States. Electronic address: rwt@rti.org.</Affiliation>
      </Author>
      <Author>
        <Name>G. W. Trimmer</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc.(Retired), 1545 US Highway 22, East Annandale, NJ 08801-3059, United States. Electronic address: hermit55@prodigy.net.</Affiliation>
      </Author>
      <Author>
        <Name>G. M. Hoffman</Name>
        <Affiliation>Huntingdon Life Sciences, Princeton Research Center, 100 Mettlers Road, East Millstone, NJ 08873, United States. Electronic address: hoffmang@princeton.huntingdon.com.</Affiliation>
      </Author>
      <Author>
        <Name>F. J. Murray</Name>
        <Affiliation>Murray &amp; Associates, 5529 Perugia Circle, San Jose, CA 95138, United States. Electronic address: jmurray2@sbcglobal.net.</Affiliation>
      </Author>
      <Author>
        <Name>C. R. Clark</Name>
        <Affiliation>Phillips 66 (Retired), 5901 Woodland Road, Bartlesville, OK 74006, United States. Electronic address: okietox@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>C. A. Schreiner</Name>
        <Affiliation>C&amp;C Consulting in Toxicology, 1950 Briarcliff Ave, Meadowbrook, PA 19046, United States. Electronic address: castox@comcast.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inter-laboratory validation of bioaccessibility testing for metals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24979734</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.021</DOI>
    <KeywordList>
      <Keywords>Alloys</Keywords>
      <Keywords>Bioaccessibility</Keywords>
      <Keywords>Bioelution</Keywords>
      <Keywords>Classification</Keywords>
      <Keywords>Inter-laboratory validation</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>UVCBs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rayetta G. Henderson</Name>
        <Affiliation>ToxStrategies, Inc., 9650 Strickland Rd., Suite 103-195, Raleigh, NC 27615, USA. Electronic address: rhenderson@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>Violaine Verougstraete</Name>
        <Affiliation>Eurometaux, Avenue de Broqueville 12, 1150 Brussels, Belgium. Electronic address: verougstraete@eurometaux.be.</Affiliation>
      </Author>
      <Author>
        <Name>Kim Anderson</Name>
        <Affiliation>Oregon State University, Corvallis, OR 97331, USA. Electronic address: kim.anderson@oregonstate.edu.</Affiliation>
      </Author>
      <Author>
        <Name>José J. Arbildua</Name>
        <Affiliation>CECM, Adolfo Ibañez University, Diagonal Las Torres 2640, Peñalolen, Santiago, Chile. Electronic address: jose.arbildua@uai.cl.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas O. Brock</Name>
        <Affiliation>Duke University, 2200 West Main Street, Suite 400, Durham, NC 27705, USA. Electronic address: thomas.brock@duke.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Tony Brouwers</Name>
        <Affiliation>ECTX bvba, Havenstraat 46/0.01, B-3500 Hasselt, Belgium. Electronic address: tony.brouwers@ectx.be.</Affiliation>
      </Author>
      <Author>
        <Name>Danielle Cappellini</Name>
        <Affiliation>Kirby Memorial Health Center, 71 North Franklin Street, Wilkes-Barre, PA 18701, USA. Electronic address: dcappellini@epix.net.</Affiliation>
      </Author>
      <Author>
        <Name>Katrien Delbeke</Name>
        <Affiliation>European Copper Institute, 168 Avenue de Tervueren, 1150 Brussels, Belgium. Electronic address: katrien.delbeke@copperalliance.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Gunilla Herting</Name>
        <Affiliation>KTH Royal Institute of Technology, Drottning Kristinas väg 51, SE-10044 Stockholm, Sweden. Electronic address: herting@kth.se.</Affiliation>
      </Author>
      <Author>
        <Name>Greg Hixon</Name>
        <Affiliation>ToxStrategies, Inc., 9650 Strickland Rd., Suite 103-195, Raleigh, NC 27615, USA. Electronic address: ghixon@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>Inger Odnevall Wallinder</Name>
        <Affiliation>KTH Royal Institute of Technology, Drottning Kristinas väg 51, SE-10044 Stockholm, Sweden. Electronic address: ingero@kth.se.</Affiliation>
      </Author>
      <Author>
        <Name>Patricio H. Rodriguez</Name>
        <Affiliation>CECM, Adolfo Ibañez University, Diagonal Las Torres 2640, Peñalolen, Santiago, Chile. Electronic address: Patricio.rodriguez@uai.cl.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Van Assche</Name>
        <Affiliation>International Zinc Association, Avenue de Tervueren 168/Box 4, B-1150, Belgium. Electronic address: fvanassche@zinc.org.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Wilrich</Name>
        <Affiliation>Freie Universität Berlin, Promenadenstr. 16 A, D-12207 Berlin, Germany. Electronic address: wilrich@wiwiss.fu-berlin.de.</Affiliation>
      </Author>
      <Author>
        <Name>Adriana R. Oller</Name>
        <Affiliation>Nickel Producers Environmental Research Association, Inc., 2525 Meridian Parkway, Suite 240, Durham, NC 27713, USA. Electronic address: aoller@nipera.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation on baseline toxicity to rats based on aliphatic compounds and comparison with toxicity to fish: effect of exposure routes on toxicity.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24973504</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.019</DOI>
    <KeywordList>
      <Keywords>Baseline</Keywords>
      <Keywords>Bioconcentration</Keywords>
      <Keywords>Exposure route</Keywords>
      <Keywords>Intestinal absorption</Keywords>
      <Keywords>Lethal critical concentration</Keywords>
      <Keywords>Threshold</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jia He</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Fu</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Wang</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin J. Li</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao H. Wang</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Li M. Su</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China. Electronic address: sulm932@nenu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Lian X. Sheng</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan H. Zhao</Name>
        <Affiliation>State Environmental Protection Key Laboratory of Wetland Ecology and Vegetation Restoration, School of Environment, Northeast Normal University, Changchun, Jilin 130117, PR China. Electronic address: zhaoyh@nenu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Insights from analysis for harmful and potentially harmful constituents (HPHCs) in tobacco products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24973503</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.017</DOI>
    <KeywordList>
      <Keywords>Assay variability</Keywords>
      <Keywords>Cigarettes</Keywords>
      <Keywords>Harmful and potentially harmful constituents</Keywords>
      <Keywords>Smokeless tobacco</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael J. Oldham</Name>
        <Affiliation>Altria Client Services, 601 East Jackson Street, Richmond, VA 23261, USA. Electronic address: Michael.J.Oldham@altria.com.</Affiliation>
      </Author>
      <Author>
        <Name>Darren J. DeSoi</Name>
        <Affiliation>Altria Client Services, 601 East Jackson Street, Richmond, VA 23261, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lonnie T. Rimmer</Name>
        <Affiliation>Altria Client Services, 601 East Jackson Street, Richmond, VA 23261, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karl A. Wagner</Name>
        <Affiliation>Altria Client Services, 601 East Jackson Street, Richmond, VA 23261, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Morton</Name>
        <Affiliation>Altria Client Services, 601 East Jackson Street, Richmond, VA 23261, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A quantitative assessment of risks of heavy metal residues in laundered shop towels and their use by workers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24973502</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.020</DOI>
    <KeywordList>
      <Keywords>Dermal</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Leachate</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Shop towels</Keywords>
      <Keywords>Synthetic sweat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kevin Connor</Name>
        <Affiliation>ARCADIS U.S., Inc., One Executive Drive, Suite 303, Chelmsford, MA 01824, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Magee</Name>
        <Affiliation>ARCADIS U.S., Inc., One Executive Drive, Suite 303, Chelmsford, MA 01824, USA. Electronic address: Brian.Magee@arcadis-us.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gasoline toxicology: overview of regulatory and product stewardship programs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24956589</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.016</DOI>
    <KeywordList>
      <Keywords>Clean Air Act</Keywords>
      <Keywords>Gasoline toxicology</Keywords>
      <Keywords>Gasoline vapors</Keywords>
      <Keywords>Hazard characterization</Keywords>
      <Keywords>High Production Volume (HPV) Challenge Program</Keywords>
      <Keywords>Product stewardship</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Derek Swick</Name>
        <Affiliation>American Petroleum Institute, 1220 L Street, N.W., Washington, DC 20005, United States. Electronic address: swickd@api.org.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Jaques</Name>
        <Affiliation>RegNet, 1250 Connecticut Avenue, N.W., Suite 700, Washington, DC 20036, United States. Electronic address: ajaques@regnet.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. C. Walker</Name>
        <Affiliation>Keller and Heckman LLP, 1001 G Street, N.W., Suite 500W, Washington, DC 20001, United States. Electronic address: walker@khlaw.com.</Affiliation>
      </Author>
      <Author>
        <Name>Herb Estreicher</Name>
        <Affiliation>Keller and Heckman LLP, 1001 G Street, N.W., Suite 500W, Washington, DC 20001, United States. Electronic address: estreicher@khlaw.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A review of the evidence on smoking bans and incidence of heart disease.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24956588</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.014</DOI>
    <KeywordList>
      <Keywords>Cessation</Keywords>
      <Keywords>Heart disease</Keywords>
      <Keywords>Smoking bans</Keywords>
      <Keywords>Tobacco</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd., 17 Cedar Road, Sutton, Surrey SM2 5DA, UK. Electronic address: PeterLee@pnlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>John S. Fry</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd., 17 Cedar Road, Sutton, Surrey SM2 5DA, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara A. Forey</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd., 17 Cedar Road, Sutton, Surrey SM2 5DA, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the skin sensitising potency of the lower alkyl methacrylate esters.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24956587</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.013</DOI>
    <KeywordList>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Lower alkyl methacrylate esters</Keywords>
      <Keywords>Methyl methacrylate</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Life Sciences, University of Manchester, Manchester, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mark A. Pemberton</Name>
        <Affiliation>Systox Ltd, Wilmslow, Cheshire, UK. Electronic address: markpemberton@systox.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic toxicity, toxicity to reproduction and prenatal developmental toxicity of vinyl laurate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24956586</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.015</DOI>
    <KeywordList>
      <Keywords>CAS 2146-71-6</Keywords>
      <Keywords>Prenatal development toxicity</Keywords>
      <Keywords>Repeated dose toxicity</Keywords>
      <Keywords>Reproduction toxicity</Keywords>
      <Keywords>Vinyl laurate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Horst Messinger</Name>
        <Affiliation>Bioresco Ltd., Bundesstrasse 29, 4054 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Albert Bär</Name>
        <Affiliation>Bioresco Ltd., Bundesstrasse 29, 4054 Basel, Switzerland. Electronic address: contact@bioresco.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Functional differentiation of cytotoxic cancer drugs and targeted cancer therapeutics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24956585</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.012</DOI>
    <KeywordList>
      <Keywords>Antineoplastic drugs</Keywords>
      <Keywords>Cytotoxic cancer drugs</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>Functional definition</Keywords>
      <Keywords>Occupational health</Keywords>
      <Keywords>Pharmaceutical manufacturing</Keywords>
      <Keywords>Selective oncology drugs</Keywords>
      <Keywords>Targeted therapeutics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gian C. Winkler</Name>
        <Affiliation>Novartis Pharma AG NIBR, Postfach, CH-4002 Basel, Switzerland. Electronic address: gian_christian.winkler@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ester Lovsin Barle</Name>
        <Affiliation>Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland. Electronic address: ester.lovsin_barle@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Giuseppe Galati</Name>
        <Affiliation>Patheon Inc., 2100 Syntex Court, Mississauga, Ontario L5N 7K9, Canada. Electronic address: joe.galati@patheon.com.</Affiliation>
      </Author>
      <Author>
        <Name>William M. Kluwe</Name>
        <Affiliation>Novartis Pharmaceuticals Corporation, NIBR, One Health Plaza, East Hanover, NJ 07936-1080, USA. Electronic address: william.kluwe@novartis.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Signal detection for Thai traditional medicine: examination of national pharmacovigilance data using reporting odds ratio and reported population attributable risk.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24945744</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.007</DOI>
    <KeywordList>
      <Keywords>ADR</Keywords>
      <Keywords>Herbal medicine</Keywords>
      <Keywords>Reporting odds ratio</Keywords>
      <Keywords>Serious ADR</Keywords>
      <Keywords>Thai traditional medicine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sareeya Wechwithan</Name>
        <Affiliation>Health Product Vigilance Center, Food and Drug Administration, Ministry of Public Health, 11000, Thailand; Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla 90110, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Wimon Suwankesawong</Name>
        <Affiliation>Health Product Vigilance Center, Food and Drug Administration, Ministry of Public Health, 11000, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Vorasith Sornsrivichai</Name>
        <Affiliation>Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla 90110, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Edward B. McNeil</Name>
        <Affiliation>Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla 90110, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Chuleeporn Jiraphongsa</Name>
        <Affiliation>Field Epidemiology Training Program (FETP), Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health, 11000, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Virasakdi Chongsuvivatwong</Name>
        <Affiliation>Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla 90110, Thailand. Electronic address: cvirasak@medicine.psu.ac.th.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of phytase 50104 enzyme preparation (also known as VR003), expressed in Pseudomonas fluorescens, intended for increasing digestibility of phytate in monogastrics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24945743</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.010</DOI>
    <KeywordList>
      <Keywords>Enzyme</Keywords>
      <Keywords>Phosphorus</Keywords>
      <Keywords>Phytase</Keywords>
      <Keywords>Poultry</Keywords>
      <Keywords>Pseudomonas fluorescens</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Swine</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Scott Krygier</Name>
        <Affiliation>Verenium Corporation, 3550 John Hopkins Ct, San Diego, CA 92121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Arne Solbak</Name>
        <Affiliation>Verenium Corporation, 3550 John Hopkins Ct, San Diego, CA 92121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Diane Shanahan</Name>
        <Affiliation>Verenium Corporation, 3550 John Hopkins Ct, San Diego, CA 92121, USA. Electronic address: diane.shanahan@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vince Ciofalo</Name>
        <Affiliation>Shoreline Toxicology, LLC, 53 River Walk, Branford, CT 06405, USA. Electronic address: vbc6@juno.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Measurement of endogenous allergens in genetically modified soybeans--short communication.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24945742</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.006</DOI>
    <KeywordList>
      <Keywords>Analytical methods</Keywords>
      <Keywords>Endogenous allergens</Keywords>
      <Keywords>Genetically modified crops</Keywords>
      <Keywords>Soybean</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gregory S. Ladics</Name>
        <Affiliation>DuPont Pioneer Agricultural Biotechnology, DuPont Experimental Station, 200 Powder Mill Road, Wilmington, DE 19803-0400, USA. Electronic address: Gregory.s.ladics@usa.dupont.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory J. Budziszewski</Name>
        <Affiliation>BASF Plant Science, 26 Davis Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rod A. Herman</Name>
        <Affiliation>Dow AgroSciences, 9330 Zionsville Rd, Indianapolis, IN 46077, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Corinne Herouet-Guicheney</Name>
        <Affiliation>Bayer SAS, Bayer CropScience, 355 rue Dostoievski, CS 90153 Valbonne 06906 Sophia Antipolis, France.</Affiliation>
      </Author>
      <Author>
        <Name>Saurabh Joshi</Name>
        <Affiliation>Monsanto Company, Product Characterization Center, 800 North Lindbergh Blvd., St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth A. Lipscomb</Name>
        <Affiliation>BASF Plant Science, 26 Davis Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott McClain</Name>
        <Affiliation>Syngenta Crop Protection, LLC, 3054 E. Cornwallis Road, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jason M. Ward</Name>
        <Affiliation>Monsanto Company, Product Characterization Center, 800 North Lindbergh Blvd., St. Louis, MO 63167, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integrating asthma hazard characterization methods for consumer products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24937810</pubmedLink>
    <GrantList>
      <Grant>P30 ES013508</Grant>
    </GrantList>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.009</DOI>
    <KeywordList>
      <Keywords>Asthma</Keywords>
      <Keywords>Consumer products</Keywords>
      <Keywords>Hazard characterization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Maier</Name>
        <Affiliation>University of Cincinnati, 3223 Eden Avenue, Cincinnati, OH 45267, United States. Electronic address: maierma@ucmail.uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>M. J. Vincent</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, 2300 Montana Avenue, Suite 409, Cincinnati, OH 45211, United States.</Affiliation>
      </Author>
      <Author>
        <Name>B. Gadagbui</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, 2300 Montana Avenue, Suite 409, Cincinnati, OH 45211, United States.</Affiliation>
      </Author>
      <Author>
        <Name>J. Patterson</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, 2300 Montana Avenue, Suite 409, Cincinnati, OH 45211, United States.</Affiliation>
      </Author>
      <Author>
        <Name>W. Beckett</Name>
        <Affiliation>Mount Auburn Hospital and Harvard Medical School, 330 Mount Auburn St., Cambridge, MA 02138, United States.</Affiliation>
      </Author>
      <Author>
        <Name>P. Dalton</Name>
        <Affiliation>Monell Chemical Senses Center, 3500 Market St., Philadelphia, PA 19104, United States.</Affiliation>
      </Author>
      <Author>
        <Name>I. Kimber</Name>
        <Affiliation>University of Manchester, Faculty of Life Sciences, Manchester M13 9PT, UK.</Affiliation>
      </Author>
      <Author>
        <Name>M. J. K. Selgrade</Name>
        <Affiliation>ICF International, 2222 East NC-54 Hwy, Durham, NC 27713, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oral 4-week and 13-week toxicity studies of polyvinyl acetate vinyl laurate copolymer in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24932800</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.008</DOI>
    <KeywordList>
      <Keywords>CAS 108-05-4</Keywords>
      <Keywords>CAS 2146-71-6</Keywords>
      <Keywords>CAS 26354-30-3</Keywords>
      <Keywords>Polyvinyl acetate vinyl laurate copolymer</Keywords>
      <Keywords>Repeated dose toxicity</Keywords>
      <Keywords>Vinyl acetate</Keywords>
      <Keywords>Vinyl laurate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Horst Messinger</Name>
        <Affiliation>Bioresco Ltd., Bundesstrasse 29, 4054 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Albert Bär</Name>
        <Affiliation>Bioresco Ltd., Bundesstrasse 29, 4054 Basel, Switzerland. Electronic address: contact@bioresco.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of genotoxicity testing of FDA approved large molecule therapeutics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24932799</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.005</DOI>
    <KeywordList>
      <Keywords>Antibody-drug conjugate</Keywords>
      <Keywords>Biologics</Keywords>
      <Keywords>Genetic toxicity studies</Keywords>
      <Keywords>ICH S6(R1)</Keywords>
      <Keywords>Large molecule therapeutics</Keywords>
      <Keywords>Monoclonal antibodies</Keywords>
      <Keywords>Peptides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Satin G. Sawant</Name>
        <Affiliation>Comparative Biology and Safety Sciences, Amgen Inc., Thousand Oaks, CA 91320, United States. Electronic address: ssawant@amgen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mark R. Fielden</Name>
        <Affiliation>Comparative Biology and Safety Sciences, Amgen Inc., Thousand Oaks, CA 91320, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kurt A. Black</Name>
        <Affiliation>Comparative Biology and Safety Sciences, Amgen Inc., Thousand Oaks, CA 91320, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Extensive review of fish embryo acute toxicities for the prediction of GHS acute systemic toxicity categories.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24929227</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.004</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Acute systemic toxicity</Keywords>
      <Keywords>Animal experiments</Keywords>
      <Keywords>Fish embryo test</Keywords>
      <Keywords>Global harmonisation system</Keywords>
      <Keywords>LD(50)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stefan Scholz</Name>
        <Affiliation>UFZ - Helmholtz Centre for Environmental Research, Department of Bioanalytical Ecotoxicology, Permoserstr. 15, 04318 Leipzig, Germany. Electronic address: stefan.scholz@ufz.de.</Affiliation>
      </Author>
      <Author>
        <Name>Julia Ortmann</Name>
        <Affiliation>UFZ - Helmholtz Centre for Environmental Research, Department of Bioanalytical Ecotoxicology, Permoserstr. 15, 04318 Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Nils Klüver</Name>
        <Affiliation>UFZ - Helmholtz Centre for Environmental Research, Department of Bioanalytical Ecotoxicology, Permoserstr. 15, 04318 Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Marc Léonard</Name>
        <Affiliation>L'ORÉAL Advanced Research, Environmental Research Department, 1 avenue Eugène Schueller, 93601 Aulnay sous Bois, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic safety evaluation of CMS-1 (a botanical antihypertensive product derived from Semen Cnidium monnieri) in Sprague-Dawley rats and beagle dogs.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24928566</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.025</DOI>
    <KeywordList>
      <Keywords>Beagle dogs</Keywords>
      <Keywords>CMS-1</Keywords>
      <Keywords>Imperatorin</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Subchronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xue Lian Gong</Name>
        <Affiliation>Department of Hygiene and Health Toxicology, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Ting Gao</Name>
        <Affiliation>Department of Hygiene and Health Toxicology, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Jun Zhao</Name>
        <Affiliation>Department of Respiratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hai Zhu</Name>
        <Affiliation>Department of Hygiene and Health Toxicology, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Na Xia</Name>
        <Affiliation>Department of Hygiene and Health Toxicology, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Lu</Name>
        <Affiliation>Research &amp; Engineering Center for Natural Medicine, Xi'an Jiaotong University, Xi'an 710061, China. Electronic address: lvlu2004@mail.xjtu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Cai Lu</Name>
        <Affiliation>Department of Hygiene and Health Toxicology, Second Military Medical University, Shanghai 200433, China. Electronic address: newdrug@smmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Towards AOP application--implementation of an integrated approach to testing and assessment (IATA) into a pipeline tool for skin sensitization.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24928565</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.001</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>Adverse Outcome Pathway (AOP)</Keywords>
      <Keywords>Expert systems</Keywords>
      <Keywords>Integrated Approaches to Testing and Assessment (IATA)</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>TIMES-SS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>DuPont Haskell Global Centers for Health and Environmental Sciences, 1090 Elkton Road, Newark, DE 19711, USA. Electronic address: patlewig@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chanita Kuseva</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, University "Prof As Zlatarov", 1 Yakim Street, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Antonia Kesova</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, University "Prof As Zlatarov", 1 Yakim Street, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Ioanna Popova</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, University "Prof As Zlatarov", 1 Yakim Street, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Teodor Zhechev</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, University "Prof As Zlatarov", 1 Yakim Street, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>Todor Pavlov</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, University "Prof As Zlatarov", 1 Yakim Street, Bourgas, Bulgaria.</Affiliation>
      </Author>
      <Author>
        <Name>David W. Roberts</Name>
        <Affiliation>Liverpool John Moores University, School of Pharmacy and Biomolecular Sciences, Byrom Street, Liverpool L3 3AF, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ovanes Mekenyan</Name>
        <Affiliation>Laboratory of Mathematical Chemistry, University "Prof As Zlatarov", 1 Yakim Street, Bourgas, Bulgaria.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Utility and importance of animal data in drug product labels.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24928564</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.003</DOI>
    <KeywordList>
      <Keywords>Animal data</Keywords>
      <Keywords>Drug labels</Keywords>
      <Keywords>Package Insert</Keywords>
      <Keywords>Summary of product characteristics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul Baldrick</Name>
        <Affiliation>Regulatory Strategy, Covance Laboratories Ltd., Otley Road, Harrogate HG3 1PY, North Yorkshire, United Kingdom. Electronic address: paul.baldrick@covance.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of an oral reference dose (RfD) for the plasticizer, di-(2-propylheptyl)phthalate (Palatinol® 10-P).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24925829</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.06.002</DOI>
    <KeywordList>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>DPHP</Keywords>
      <Keywords>Di-(2-propylheptyl)phthalate</Keywords>
      <Keywords>Palatinol® 10-P</Keywords>
      <Keywords>Phthalate</Keywords>
      <Keywords>Plasticizer</Keywords>
      <Keywords>Reference dose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Virunya S. Bhat</Name>
        <Affiliation>NSF International, 789 N. Dixboro Road, Ann Arbor, MI 48105, USA. Electronic address: bhat@nsf.org.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer L. Durham</Name>
        <Affiliation>NSF International, 789 N. Dixboro Road, Ann Arbor, MI 48105, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Caroline English</Name>
        <Affiliation>NSF International, 789 N. Dixboro Road, Ann Arbor, MI 48105, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human risk assessment of dermal and inhalation exposures to chemicals assessed by route-to-route extrapolation: the necessity of kinetic data.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24912090</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.024</DOI>
    <KeywordList>
      <Keywords>Oral absorption</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Route-to-route extrapolation</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liesbeth Geraets</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: Liesbeth.Geraets@RIVM.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Jos G. M. Bessems</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Marco J. Zeilmaker</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Peter M. J. Bos</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dissolution of glass wool, rock wool and alkaline earth silicate wool: morphological and chemical changes in fibers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24910419</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.023</DOI>
    <KeywordList>
      <Keywords>AES wools</Keywords>
      <Keywords>Acellular test</Keywords>
      <Keywords>Biopersistence</Keywords>
      <Keywords>Biosolubility</Keywords>
      <Keywords>Dissolution rate</Keywords>
      <Keywords>In vitro assessment</Keywords>
      <Keywords>Length-weighted geometric mean diameter</Keywords>
      <Keywords>Scanning electron microscopy</Keywords>
      <Keywords>Synthetic vitreous fibers</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Antonella Campopiano</Name>
        <Affiliation>Italian Workers' Compensation Authority, Research Area, Department of Occupational Hygiene, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Annapaola Cannizzaro</Name>
        <Affiliation>Italian Workers' Compensation Authority, Research Area, Department of Occupational Hygiene, Rome, Italy. Electronic address: a.cannizzaro@inail.it.</Affiliation>
      </Author>
      <Author>
        <Name>Federica Angelosanto</Name>
        <Affiliation>Italian Workers' Compensation Authority, Research Area, Department of Occupational Hygiene, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Luisa Astolfi</Name>
        <Affiliation>"La Sapienza", University of Rome, Chemistry Department, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Deborah Ramires</Name>
        <Affiliation>Italian Workers' Compensation Authority, Research Area, Department of Occupational Hygiene, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Angelo Olori</Name>
        <Affiliation>Italian Workers' Compensation Authority, Research Area, Department of Occupational Hygiene, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Canepari</Name>
        <Affiliation>"La Sapienza", University of Rome, Chemistry Department, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Sergio Iavicoli</Name>
        <Affiliation>Italian Workers' Compensation Authority, Research Area, Department of Occupational Hygiene, Rome, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Consideration of criteria required for assignment of a (skin) sensitiser a substance of very high concern (SVHC) under the REACH regulation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24893346</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.022</DOI>
    <KeywordList>
      <Keywords>Hazard and risk categorisation</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Respiratory sensitisers</Keywords>
      <Keywords>SVHC</Keywords>
      <Keywords>Sensitisation potency</Keywords>
      <Keywords>Skin sensitisers</Keywords>
      <Keywords>Substances of very high concern</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd., Sharnbrook, Bedfordshire MK44 1PR, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mind the gap: Concerns using endpoints from endocrine screening assays in risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24887212</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.021</DOI>
    <KeywordList>
      <Keywords>Endocrine</Keywords>
      <Keywords>Environmental</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Screening</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James R. Wheeler</Name>
        <Affiliation>Syngenta Ltd, Product Safety, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK. Electronic address: jrwheeler@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lennart Weltje</Name>
        <Affiliation>BASF SE, Crop Protection - Ecotoxicology, Speyerer-Strasse 2, D-67117 Limburgerhof, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Richard M. Green</Name>
        <Affiliation>Syngenta Ltd, Product Safety, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Elusive reproducibility.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24882687</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.020</DOI>
    <AuthorList>
      <Author>
        <Name>Gio Batta Gori</Name>
        <Affiliation>Regulatory Toxicology and Pharmacology, Bethesda, MD, United States. Electronic address: gorigb@msn.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health assessment of gasoline and fuel oxygenate vapors: neurotoxicity evaluation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24879970</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.002</DOI>
    <KeywordList>
      <Keywords>Astrogliosis</Keywords>
      <Keywords>Diisopropyl ether</Keywords>
      <Keywords>Ethanol</Keywords>
      <Keywords>Ethyl t-butyl ether</Keywords>
      <Keywords>Gasoline vapor condensates</Keywords>
      <Keywords>Glial fibrillary acidic protein (GFAP)</Keywords>
      <Keywords>Methyl tertiary butyl ether</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>t-Amyl methyl ether</Keywords>
      <Keywords>t-Butyl alcohol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James P. O'Callaghan</Name>
        <Affiliation>Centers for Disease Control and Prevention-NIOSH, 1095 Willowdale Rd, MS-L3014, Morgantown, WV 26505, United States. Electronic address: jdo5@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Wayne C. Daughtrey</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 US Highway 22, East Annandale, NJ 08801-3059, United States. Electronic address: wayne.c.daughtrey@exxonmobil.com.</Affiliation>
      </Author>
      <Author>
        <Name>Charles R. Clark</Name>
        <Affiliation>Phillips 66 Co. (retired), 420 S. Keeler Avenue, Bartlesville, OK, United States. Electronic address: okietox@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ceinwen A. Schreiner</Name>
        <Affiliation>C&amp;C Consulting in Toxicology, 1950 Briarcliff Ave, Meadowbrook, PA 19046, United States. Electronic address: castox@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Russell White</Name>
        <Affiliation>American Petroleum Institute, 1220 L. Street NW, Washington, DC 20005, United States. Electronic address: whiter@api.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pre-clinical toxicokinetics and safety study of M2ES, a PEGylated recombinant human endostatin, in rhesus monkeys.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24878240</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.019</DOI>
    <KeywordList>
      <Keywords>M(2)ES</Keywords>
      <Keywords>Pre-clinical</Keywords>
      <Keywords>Rhesus monkeys</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lifang Guo</Name>
        <Affiliation>School of Life Sciences, Lanzhou University, Lanzhou 730000, China; National Engineering Laboratory for Anti-tumor Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, China; Beijing Key Laboratory for Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, China; Cancer Biology Laboratory, School of Life Sciences, Tsinghua University, Beijing 100084, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xingchao Geng</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Chen</Name>
        <Affiliation>National Engineering Laboratory for Anti-tumor Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, China; Beijing Key Laboratory for Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, China; Cancer Biology Laboratory, School of Life Sciences, Tsinghua University, Beijing 100084, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feifei Qi</Name>
        <Affiliation>National Engineering Laboratory for Anti-tumor Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, China; Beijing Key Laboratory for Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, China; Cancer Biology Laboratory, School of Life Sciences, Tsinghua University, Beijing 100084, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Liu</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufa Miao</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Lin</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Yu</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zuogang Li</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Fu</Name>
        <Affiliation>National Engineering Laboratory for Anti-tumor Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, China; Beijing Key Laboratory for Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, China; Cancer Biology Laboratory, School of Life Sciences, Tsinghua University, Beijing 100084, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Li</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China. Electronic address: libo@nifdc.org.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yongzhang Luo</Name>
        <Affiliation>National Engineering Laboratory for Anti-tumor Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, China; Beijing Key Laboratory for Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, China; Cancer Biology Laboratory, School of Life Sciences, Tsinghua University, Beijing 100084, China. Electronic address: yluo@mail.tsinghua.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and subchronic toxicity of arprinocid in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24878239</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.017</DOI>
    <KeywordList>
      <Keywords>Acute</Keywords>
      <Keywords>Arprinocid</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hao Wu</Name>
        <Affiliation>Laboratory of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu Province, PR China; Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenlong Xiao</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Keyu Zhang</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, PR China. Electronic address: z_cole@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Feiqun Xue</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chong Zhang</Name>
        <Affiliation>Laboratory of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Yan</Name>
        <Affiliation>Laboratory of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyang Wang</Name>
        <Affiliation>Key Laboratory of Veterinary Drug Safety Evaluation and Residues Research, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shanxiang Jiang</Name>
        <Affiliation>Laboratory of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu Province, PR China. Electronic address: nauvy@sina.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>OECD validation study to assess intra- and inter-laboratory reproducibility of the zebrafish embryo toxicity test for acute aquatic toxicity testing.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24874798</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.018</DOI>
    <KeywordList>
      <Keywords>Alternative method</Keywords>
      <Keywords>Aquatic acute toxicity</Keywords>
      <Keywords>Reproducibility</Keywords>
      <Keywords>Validation</Keywords>
      <Keywords>Zebrafish embryo</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>François Busquet</Name>
        <Affiliation>European Commission Joint Research Centre, Institute for Health and Consumer Protection, via E. Fermi 2749, 21027 Ispra (VA), Italy. Electronic address: caat-eu-policy@uni-konstanz.de.</Affiliation>
      </Author>
      <Author>
        <Name>Ruben Strecker</Name>
        <Affiliation>University of Heidelberg, COS, Aquatic Ecology &amp; Toxicology, Im Neuenheimer Feld 230, 69120 Heidelberg, Germany. Electronic address: rubenstrecker@gmx.de.</Affiliation>
      </Author>
      <Author>
        <Name>Jane M. Rawlings</Name>
        <Affiliation>The Procter &amp; Gamble Company, Global Product Stewardship, Mason, OH 45040, USA. Electronic address: rawlings.jm@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Scott E. Belanger</Name>
        <Affiliation>The Procter &amp; Gamble Company, Global Product Stewardship, Mason, OH 45040, USA. Electronic address: belanger.se@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Braunbeck</Name>
        <Affiliation>University of Heidelberg, COS, Aquatic Ecology &amp; Toxicology, Im Neuenheimer Feld 230, 69120 Heidelberg, Germany. Electronic address: braunbeck@uni-hd.de.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory J. Carr</Name>
        <Affiliation>The Procter &amp; Gamble Company, Mason Quantitative Sciences, OH 45040, USA. Electronic address: carr.gj@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Cenijn</Name>
        <Affiliation>VU University Amsterdam, Institute for Environmental Studies, De Boelelaan 1087, 1081 HV Amsterdam, The Netherlands. Electronic address: peter.cenijn@vu.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Przemyslaw Fochtman</Name>
        <Affiliation>Institute of Industrial Organic Chemistry Branch Pszczyna, Doswiadczalna 27, 43-200 Pszczyna, Poland. Electronic address: fochtman@ipo-pszczyna.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Gourmelon</Name>
        <Affiliation>Organisation for Economic Co-operation and Development, 2, rue André Pascal, 75775 Paris Cedex 16, France. Electronic address: anne.gourmelon@oecd.org.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Hübler</Name>
        <Affiliation>Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany. Electronic address: nicole.huebler@merckgroup.com.</Affiliation>
      </Author>
      <Author>
        <Name>André Kleensang</Name>
        <Affiliation>European Commission Joint Research Centre, Institute for Health and Consumer Protection, via E. Fermi 2749, 21027 Ispra (VA), Italy. Electronic address: akleens1@jhu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Melanie Knöbel</Name>
        <Affiliation>UFZ - Helmholtz Centre for Environmental Research, 04318 Leipzig, Germany. Electronic address: melanie.knoebel@eawag.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Carola Kussatz</Name>
        <Affiliation>Federal Environment Agency (UBA), Versuchsfeld Marienfelde, Schichauweg 58, 12307 Berlin, Germany. Electronic address: carola.kussatz@uba.de.</Affiliation>
      </Author>
      <Author>
        <Name>Juliette Legler</Name>
        <Affiliation>VU University Amsterdam, Institute for Environmental Studies, De Boelelaan 1087, 1081 HV Amsterdam, The Netherlands. Electronic address: juliette.legler@vu.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Adam Lillicrap</Name>
        <Affiliation>Norwegian Institute for Water Research (NIVA), Gaustadalléen 21, 0349 Oslo, Norway. Electronic address: adam.lillicrap@niva.no.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Martínez-Jerónimo</Name>
        <Affiliation>Instituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, Lab. de Hidrobiología Experimental, Prol. Carpio esq. Plan de Ayala S/N, Col. Santo Tomas, México, D.F. 11340, Mexico. Electronic address: ferjeronimo@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Polleichtner</Name>
        <Affiliation>Federal Environment Agency (UBA), Versuchsfeld Marienfelde, Schichauweg 58, 12307 Berlin, Germany. Electronic address: christian.polleichtner@uba.de.</Affiliation>
      </Author>
      <Author>
        <Name>Helena Rzodeczko</Name>
        <Affiliation>Institute of Industrial Organic Chemistry Branch Pszczyna, Doswiadczalna 27, 43-200 Pszczyna, Poland. Electronic address: ew@ipo-pszczyna.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Edward Salinas</Name>
        <Affiliation>BASF SE, 67056 Ludwigshafen, Germany. Electronic address: edward.salinas@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Katharina E. Schneider</Name>
        <Affiliation>BASF SE, 67056 Ludwigshafen, Germany. Electronic address: katharina.schneider@cos.uni-heidelberg.de.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Scholz</Name>
        <Affiliation>UFZ - Helmholtz Centre for Environmental Research, 04318 Leipzig, Germany. Electronic address: stefan.scholz@ufz.de.</Affiliation>
      </Author>
      <Author>
        <Name>Evert Jan van den Brandhof</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Environmental Quality, 3720 BA Bilthoven, The Netherlands. Electronic address: evert-jan.van.den.brandhof@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Leo T. M. van der Ven</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Centre for Health Protection, 3720 BA Bilthoven, The Netherlands. Electronic address: leo.van.der.ven@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Walter-Rohde</Name>
        <Affiliation>Federal Environment Agency (UBA), P.O. 1406, 06813 Dessau-Roßlau, Germany. Electronic address: susanne.walter-rohde@uba.de.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Weigt</Name>
        <Affiliation>Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany. Electronic address: stefan.weigt@merckgroup.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hilda Witters</Name>
        <Affiliation>Flemish Institute for Technological Research (VITO), Environmental Risk &amp; Health, Team Applied Bio &amp; Molecular Systems (ABS), Boeretang 200, 2400 Mol, Belgium. Electronic address: hilda.witters@vito.be.</Affiliation>
      </Author>
      <Author>
        <Name>Marlies Halder</Name>
        <Affiliation>European Commission Joint Research Centre, Institute for Health and Consumer Protection, via E. Fermi 2749, 21027 Ispra (VA), Italy. Electronic address: marlies.halder@ec.europa.eu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reproductive and possible hormonal effects of carbendazim.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24863245</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.016</DOI>
    <KeywordList>
      <Keywords>Carbendazim</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elkiane Macedo Rama</Name>
        <Affiliation>Brazilian National Health Surveillance Agency (ANVISA), Brasília, DF, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Simone Bortolan</Name>
        <Affiliation>Department of Physiological Sciences, State University of Londrina (UEL), Londrina, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Milene Leivas Vieira</Name>
        <Affiliation>Department of Physiological Sciences, State University of Londrina (UEL), Londrina, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela Cristina Ceccatto Gerardin</Name>
        <Affiliation>Department of Physiological Sciences, State University of Londrina (UEL), Londrina, PR, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Estefania Gastaldello Moreira</Name>
        <Affiliation>Department of Physiological Sciences, State University of Londrina (UEL), Londrina, PR, Brazil. Electronic address: egmoreira@uel.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cannabis, pesticides and conflicting laws: the dilemma for legalized States and implications for public health.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24859075</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.015</DOI>
    <KeywordList>
      <Keywords>Cannabis</Keywords>
      <Keywords>Marijuana</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Public health</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Risk</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dave Stone</Name>
        <Affiliation>Oregon State University, Department of Environmental and Molecular Toxicology, Corvallis, OR 97331, United States. Electronic address: Dave.Stone@oregonstate.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk Assessment of residual monomer migrating from acrylic polymers and causing Allergic Contact Dermatitis during normal handling and use.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24859074</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.013</DOI>
    <KeywordList>
      <Keywords>Acrylic polymer</Keywords>
      <Keywords>Allergic Contact Dermatitis</Keywords>
      <Keywords>Consumer exposure</Keywords>
      <Keywords>Methyl Methacrylate</Keywords>
      <Keywords>Migration</Keywords>
      <Keywords>PMMA</Keywords>
      <Keywords>Residual monomer</Keywords>
      <Keywords>Risk Assessment</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mark A. Pemberton</Name>
        <Affiliation>Systox Ltd, Wilmslow, Cheshire, UK. Electronic address: markpemberton@systox.com.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara S. Lohmann</Name>
        <Affiliation>CFCS-Consult GmbH, Essen, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metals in cosmetics: an a posteriori safety evaluation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24852494</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.005</DOI>
    <KeywordList>
      <Keywords>Contamination</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Personal care products</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marina Marinovich</Name>
        <Affiliation>Lab. of Toxicology and Risk Assessment, Department of Pharmacological and Biomolecular Sciences, University of Milan, via Balzaretti 9, 20133 Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Serena Boraso</Name>
        <Affiliation>Lab. of Toxicology and Risk Assessment, Department of Pharmacological and Biomolecular Sciences, University of Milan, via Balzaretti 9, 20133 Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Emanuela Testai</Name>
        <Affiliation>Istituto Superiore di Sanità, Department of Environment and Primary Prevention, Mechanisms of Toxicity Unit, Viale Regina Elena 299, 00161 Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Corrado L. Galli</Name>
        <Affiliation>Lab. of Toxicology and Risk Assessment, Department of Pharmacological and Biomolecular Sciences, University of Milan, via Balzaretti 9, 20133 Milan, Italy. Electronic address: corrado.galli@unimi.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health assessment of gasoline and fuel oxygenate vapors: generation and characterization of test materials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24852493</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.012</DOI>
    <KeywordList>
      <Keywords>Clean Air Act</Keywords>
      <Keywords>Diisopropyl ether (DIPE)</Keywords>
      <Keywords>Ethanol (EtOH)</Keywords>
      <Keywords>Ethyl tert butyl ether (ETBE)</Keywords>
      <Keywords>Evaporative emissions</Keywords>
      <Keywords>Fuels and fuel additives</Keywords>
      <Keywords>Gasoline vapor condensates</Keywords>
      <Keywords>Methyl tert-butyl ether (MTBE)</Keywords>
      <Keywords>t-Amyl methyl ether (TAME)</Keywords>
      <Keywords>t-Butyl alcohol (TBA)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael Henley</Name>
        <Affiliation>Chevron Energy Technology Company, 100 Chevron Way, Richmond, CA 94801-2016, USA. Electronic address: mikeandroxann@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel J. Letinski</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 US Highway 22, East Annandale, NJ 08801-3059, USA. Electronic address: Daniel.j.letinski@exxonmobil.com.</Affiliation>
      </Author>
      <Author>
        <Name>John Carr</Name>
        <Affiliation>Chevron Energy Technology Company, 100 Chevron Way, Richmond, CA 94801-2016, USA. Electronic address: JohnCarr@Chevron.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mario L. Caro</Name>
        <Affiliation>Chevron Energy Technology Company, 100 Chevron Way, Richmond, CA 94801-2016, USA. Electronic address: MarioCaro@chevron.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wayne Daughtrey</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 US Highway 22, East Annandale, NJ 08801-3059, USA. Electronic address: wayne.c.daughtrey@exxonmobil.com.</Affiliation>
      </Author>
      <Author>
        <Name>Russell White</Name>
        <Affiliation>American Petroleum Institute, 1220 L. Street NW, Washington, DC 20005, USA. Electronic address: whiter@api.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Testing the coherence between occupational exposure limits for inhalation and their biological limit values with a generalized PBPK-model: the case of 2-propanol and acetone.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24852492</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.004</DOI>
    <KeywordList>
      <Keywords>2-Propanol</Keywords>
      <Keywords>Acetone</Keywords>
      <Keywords>Biological limit values</Keywords>
      <Keywords>Coherence</Keywords>
      <Keywords>Occupational exposure limits</Keywords>
      <Keywords>PBPK model</Keywords>
      <Keywords>Uncertainty</Keywords>
      <Keywords>Variability</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daan Huizer</Name>
        <Affiliation>Department of Environmental Science, Institute for Water and Wetland Research, Faculty of Science, Radboud University Nijmegen, PO Box 9010, 6500 GL Nijmegen, The Netherlands; Caesar Consult Nijmegen, PO Box 31070, 6503 CB Nijmegen, The Netherlands. Electronic address: d.huizer@science.ru.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Mark A. J. Huijbregts</Name>
        <Affiliation>Department of Environmental Science, Institute for Water and Wetland Research, Faculty of Science, Radboud University Nijmegen, PO Box 9010, 6500 GL Nijmegen, The Netherlands. Electronic address: m.huijbregts@science.ru.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Joost G. M. van Rooij</Name>
        <Affiliation>Caesar Consult Nijmegen, PO Box 31070, 6503 CB Nijmegen, The Netherlands. Electronic address: joost.vanrooij@caesar-consult.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Ad M. J. Ragas</Name>
        <Affiliation>Department of Environmental Science, Institute for Water and Wetland Research, Faculty of Science, Radboud University Nijmegen, PO Box 9010, 6500 GL Nijmegen, The Netherlands; School of Science, Open Universiteit, PO Box 2960, 6401 DL Heerlen, The Netherlands. Electronic address: a.ragas@science.ru.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health assessment of gasoline and fuel oxygenate vapors: micronucleus and sister chromatid exchange evaluations.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24852491</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.014</DOI>
    <KeywordList>
      <Keywords>Bromodeoxyuridine (BrdU)</Keywords>
      <Keywords>Diisopropyl ether (DIPE)</Keywords>
      <Keywords>Ethanol (EtOH)</Keywords>
      <Keywords>Ethyl tert butyl ether (ETBE)</Keywords>
      <Keywords>Methyl tert-butyl ether (MTBE)</Keywords>
      <Keywords>Micronucleated immature erythrocytes (MIE)</Keywords>
      <Keywords>Micronucleus</Keywords>
      <Keywords>Sister chromatid exchange (SCE)</Keywords>
      <Keywords>t-Amyl methyl ether (TAME)</Keywords>
      <Keywords>t-Butyl alcohol (TBA)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ceinwen A. Schreiner</Name>
        <Affiliation>C&amp;C Consulting in Toxicology, 1950 Briarcliff Ave, Meadowbrook, PA 19046, United States. Electronic address: castox@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Gary M. Hoffman</Name>
        <Affiliation>Huntingdon Life Sciences Inc, 100 Mettlers Road, East Millstone, NJ 08875, United States. Electronic address: hoffmang@princeton.huntingdon.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ramadevi Gudi</Name>
        <Affiliation>U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research, 10903 New Hampshire Ave, Silver Spring, MD 20993, United States. Electronic address: ramadevi.gudi@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Charles R. Clark</Name>
        <Affiliation>Phillips 66 Co (retired), 420 S. Keeler Ave, Bartlesville, OK 74004, United States. Electronic address: okietox@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Primary measures of dependence among menthol compared to non-menthol cigarette smokers in the United States.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24852490</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.011</DOI>
    <KeywordList>
      <Keywords>Cigarette</Keywords>
      <Keywords>Cigarettes per day</Keywords>
      <Keywords>Dependence</Keywords>
      <Keywords>Menthol</Keywords>
      <Keywords>Time to first cigarette</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Geoffrey M. Curtin</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: curting@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra I. Sulsky</Name>
        <Affiliation>ENVIRON International Corporation, 28 Amity Street, Suite 2A, Amherst, MA 01002, United States. Electronic address: ssulsky@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cynthia Van Landingham</Name>
        <Affiliation>ENVIRON International Corporation, 1900 North 18th Street, Suite 804, Monroe, LA 71201, United States. Electronic address: cvanlandingham@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin M. Marano</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: maranok@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Monica J. Graves</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: gravesm1@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael W. Ogden</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: ogdenm@rjrt.com.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Swauger</Name>
        <Affiliation>RAI Services Company, 401 North Main Street, P.O. Box 464, Winston-Salem, NC 27102, United States. Electronic address: swaugej@rjrt.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of haematological and clinical pathology effects of blood microsampling in suckling and weaned juvenile rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24852489</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.006</DOI>
    <KeywordList>
      <Keywords>Clinical chemistry</Keywords>
      <Keywords>Clinical pathology</Keywords>
      <Keywords>Haematology</Keywords>
      <Keywords>Juvenile</Keywords>
      <Keywords>Microsampling</Keywords>
      <Keywords>Pups</Keywords>
      <Keywords>Suckling</Keywords>
      <Keywords>Weaned</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicola Powles-Glover</Name>
        <Affiliation>Astrazeneca, Mereside, Alderley Park, Alderley Edge SK10 4TG, UK. Electronic address: Nicola.powlesglover@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Kirk</Name>
        <Affiliation>Astrazeneca, Mereside, Alderley Park, Alderley Edge SK10 4TG, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Lynne Jardine</Name>
        <Affiliation>Charles River Laboratories, Tranent, Edinburgh EH33 2NE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie Clubb</Name>
        <Affiliation>Charles River Laboratories, Tranent, Edinburgh EH33 2NE, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Stewart</Name>
        <Affiliation>Astrazeneca, Mereside, Alderley Park, Alderley Edge SK10 4TG, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evidence from pharmacology and pathophysiology suggests that chemicals with dissimilar mechanisms of action could be of bigger concern in the toxicological risk assessment of chemical mixtures than chemicals with a similar mechanism of action.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24845244</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.007</DOI>
    <KeywordList>
      <Keywords>Dissimilar mechanism of action</Keywords>
      <Keywords>Dose addition</Keywords>
      <Keywords>Generalised concentration addition</Keywords>
      <Keywords>Independent action</Keywords>
      <Keywords>Mixture toxicology</Keywords>
      <Keywords>Similar mechanism of action</Keywords>
      <Keywords>Toxicological risk assessment</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Niels Hadrup</Name>
        <Affiliation>Division of Toxicology and Risk Assessment, National Food Institute, Technical University of Denmark, Mørkhøj Bygade 19, DK 2860 Søborg, Denmark. Electronic address: nilha@food.dtu.dk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developing scientific confidence in HTS-derived prediction models: lessons learned from an endocrine case study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24845243</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.010</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathways</Keywords>
      <Keywords>Endocrine</Keywords>
      <Keywords>High throughput/high content assays</Keywords>
      <Keywords>Prediction models</Keywords>
      <Keywords>Validation framework</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Louis Anthony Cox</Name>
        <Affiliation>Cox Associates, 503 Franklin St, Denver, CO 80218, USA. Electronic address: tcoxdenver@aol.com.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas Popken</Name>
        <Affiliation>Cox Associates, 503 Franklin St, Denver, CO 80218, USA. Electronic address: doug@cox-associates.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Sue Marty</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research &amp; Consulting, 1803 Building Washington Street, Midland, MI 48674, USA. Electronic address: MSMarty@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Craig Rowlands</Name>
        <Affiliation>The Dow Chemical Company, Toxicology &amp; Environmental Research &amp; Consulting, 1803 Building Washington Street, Midland, MI 48674, USA. Electronic address: JCRowlands@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>DuPont Haskell Global Centers for Health and Environmental Sciences, Stine 320/212, 1090 Elkton Road, Newark, DE 19711, USA. Electronic address: patlewig@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Katy O. Goyak</Name>
        <Affiliation>ExxonMobil Biomedical Sciences Inc., 1545 Route 22, East Annandale, NJ 08801, USA. Electronic address: katy.o.goyak@exxonmobil.com.</Affiliation>
      </Author>
      <Author>
        <Name>Richard A. Becker</Name>
        <Affiliation>Regulatory and Technical Affairs Department, American Chemistry Council (ACC), 700, 2nd Street NE, Washington, DC 20002, USA. Electronic address: Rick_Becker@americanchemistry.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health assessment of gasoline and fuel oxygenate vapors: developmental toxicity in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24845242</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.009</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Diisopropyl ether (DIPE)</Keywords>
      <Keywords>Ethanol (EtOH)</Keywords>
      <Keywords>Ethyl t-butyl ether (ETBE)</Keywords>
      <Keywords>Evaporative emissions</Keywords>
      <Keywords>Fuel oxygenates</Keywords>
      <Keywords>Gasoline vapor condensates</Keywords>
      <Keywords>Methyl tertiary butyl ether (MTBE)</Keywords>
      <Keywords>t-Amyl methyl ether (TAME)</Keywords>
      <Keywords>t-Butyl alcohol (TBA)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Linda G. Roberts</Name>
        <Affiliation>Chevron Energy Technology Company, 6001 Bollinger Canyon Road, San Ramon, CA 94583, United States. Electronic address: LRoberts@chevron.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas M. Gray</Name>
        <Affiliation>American Petroleum Institute, 20360 Clover Field Terrace, Potomac Falls, VA 20165, United States. Electronic address: tmgray@reagan.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gary W. Trimmer</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 US Highway 22, East Annandale, NJ 08801-3059, United States. Electronic address: hermit55@prodigy.net.</Affiliation>
      </Author>
      <Author>
        <Name>Robert M. Parker</Name>
        <Affiliation>Huntingdon Life Sciences, Princeton Research Center, P.O. Box 2360, 100 Mettlers Road, East Millstone, NJ 08875-2360, United States. Electronic address: parkerr@princeton.huntingdon.com.</Affiliation>
      </Author>
      <Author>
        <Name>F. Jay Murray</Name>
        <Affiliation>Murray &amp; Associates, 5529 Perugia Circle, San Jose, CA 95138, United States. Electronic address: jmurray2@sbcglobal.net.</Affiliation>
      </Author>
      <Author>
        <Name>Ceinwen A. Schreiner</Name>
        <Affiliation>C&amp;C Consulting in Toxicology, 1950 Briarcliff Ave, Meadowbrook, PA 19046, United States. Electronic address: castox@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Charles R. Clark</Name>
        <Affiliation>Phillips 66, 5901 Woodland Road, Bartlesville, OK 74006, United States. Electronic address: okietox@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A new method for generating distributions of biomonitoring equivalents to support exposure assessment and prioritization.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24845241</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.008</DOI>
    <KeywordList>
      <Keywords>Biomarker</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Biomonitoring equivalent</Keywords>
      <Keywords>NHANES</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>Perchlorate</Keywords>
      <Keywords>Prioritization</Keywords>
      <Keywords>Urine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Martin B. Phillips</Name>
        <Affiliation>U.S. Environmental Protection Agency, National Exposure Research Laboratory, 109 TW Alexander Dr, Research Triangle Park, NC 27709, USA. Electronic address: phillips.martin@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Jon R. Sobus</Name>
        <Affiliation>U.S. Environmental Protection Agency, National Exposure Research Laboratory, 109 TW Alexander Dr, Research Triangle Park, NC 27709, USA. Electronic address: sobus.jon@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara J. George</Name>
        <Affiliation>U.S. Environmental Protection Agency, National Health and Environmental Effects Research Laboratory, 109 TW Alexander Dr, Research Triangle Park, NC 27709, USA. Electronic address: george.bj@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Isaacs</Name>
        <Affiliation>U.S. Environmental Protection Agency, National Exposure Research Laboratory, 109 TW Alexander Dr, Research Triangle Park, NC 27709, USA. Electronic address: isaacs.kristin@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Rory Conolly</Name>
        <Affiliation>U.S. Environmental Protection Agency, National Health and Environmental Effects Research Laboratory, 109 TW Alexander Dr, Research Triangle Park, NC 27709, USA. Electronic address: conolly.rory@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Mei Tan</Name>
        <Affiliation>U.S. Environmental Protection Agency, National Exposure Research Laboratory, 109 TW Alexander Dr, Research Triangle Park, NC 27709, USA. Electronic address: tan.cecilia@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of a whey protein fraction containing a concentrated amount of naturally occurring TGF-β2.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24842704</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.003</DOI>
    <KeywordList>
      <Keywords>TGF-β2</Keywords>
      <Keywords>TM0601p</Keywords>
      <Keywords>Transforming growth factor</Keywords>
      <Keywords>Whey protein isolate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Roy Forster</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux Cedex, France. Electronic address: roy.forster@fr.citoxlab.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michel Bourtourault</Name>
        <Affiliation>Armor Protéines, Le Pont, 35460 Saint-Brice-en-Coglès, France. Electronic address: michel.bourtourault@armor-proteines.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Joo Chung</Name>
        <Affiliation>Nestlé Research Center, Nestec, Vers-chez-les-Blanc, 1000 Lausanne, 26, Switzerland. Electronic address: YongJoo.Chung@rd.nestle.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jérémy Silvano</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux Cedex, France. Electronic address: jeremy.silvano@fr.citoxlab.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guillaume Sire</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux Cedex, France. Electronic address: guillaume.sire@fr.citoxlab.com.</Affiliation>
      </Author>
      <Author>
        <Name>François Spezia</Name>
        <Affiliation>CiToxLAB France, 27005 Evreux Cedex, France. Electronic address: francois.spezia@fr.citoxlab.com.</Affiliation>
      </Author>
      <Author>
        <Name>Caroline Puel</Name>
        <Affiliation>Armor Protéines, Le Pont, 35460 Saint-Brice-en-Coglès, France. Electronic address: caroline.puel@soredab.org.</Affiliation>
      </Author>
      <Author>
        <Name>Jacques Descotes</Name>
        <Affiliation>Lyon Poison Center, 162, Avenue Lacassagne, 69424 Lyon Cedex 03, France. Electronic address: descotes@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>Takashi Mikogami</Name>
        <Affiliation>Armor Protéines, Le Pont, 35460 Saint-Brice-en-Coglès, France. Electronic address: takashi.mikogami@armor-proteines.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vivo safety evaluation of UP780, a standardized composition of aloe chromone aloesin formulated with an Aloe vera inner leaf fillet.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24830776</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.05.001</DOI>
    <KeywordList>
      <Keywords>Aloe vera</Keywords>
      <Keywords>Aloesin</Keywords>
      <Keywords>Qmatrix</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mesfin Yimam</Name>
        <Affiliation>Unigen, Inc., 3005 1st Avenue, Seattle, WA 98121, USA. Electronic address: myimam@unigen.net.</Affiliation>
      </Author>
      <Author>
        <Name>Lidia Brownell</Name>
        <Affiliation>Unigen, Inc., 3005 1st Avenue, Seattle, WA 98121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Jia</Name>
        <Affiliation>Unigen, Inc., 3005 1st Avenue, Seattle, WA 98121, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure evaluation of adult male Japanese smokers switched to a heated cigarette in a controlled clinical setting.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24819671</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.016</DOI>
    <KeywordList>
      <Keywords>Biomarker of exposure</Keywords>
      <Keywords>Cigarette smoke exposure</Keywords>
      <Keywords>Heated cigarette</Keywords>
      <Keywords>Smoking</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chikako Sakaguchi</Name>
        <Affiliation>Japan Tobacco Inc., Product Science Division, R&amp;D Group, Yokohama, Kanagawa, Japan. Electronic address: chikako.sakaguchi@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Aoi Kakehi</Name>
        <Affiliation>Japan Tobacco Inc., Product Science Division, R&amp;D Group, Yokohama, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Naoki Minami</Name>
        <Affiliation>Japan Tobacco Inc., Product Science Division, R&amp;D Group, Yokohama, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akira Kikuchi</Name>
        <Affiliation>Japan Tobacco Inc., Product Science Division, R&amp;D Group, Yokohama, Kanagawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuyuki Futamura</Name>
        <Affiliation>Japan Tobacco Inc., Product Science Division, R&amp;D Group, Yokohama, Kanagawa, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Generation of hazard indices for cumulative exposure to phthalates for use in cumulative risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24815596</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.019</DOI>
    <KeywordList>
      <Keywords>Cumulative risk</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Phthalates</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Krista L. Y. Christensen</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, United States Environmental Protection Agency, Washington, DC, USA. Electronic address: Christensen.Krista@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Susan L. Makris</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, United States Environmental Protection Agency, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Lorber</Name>
        <Affiliation>National Center for Environmental Assessment, Office of Research and Development, United States Environmental Protection Agency, Washington, DC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hypothesis-driven weight of evidence analysis to determine potential endocrine activity of MTBE.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24813373</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.017</DOI>
    <KeywordList>
      <Keywords>Androgen</Keywords>
      <Keywords>Endocrine</Keywords>
      <Keywords>Estrogen</Keywords>
      <Keywords>Hypothesis</Keywords>
      <Keywords>MTBE</Keywords>
      <Keywords>Methyl t-butyl ether</Keywords>
      <Keywords>Steroidogenesis</Keywords>
      <Keywords>Thyroid</Keywords>
      <Keywords>Weight-of-evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ann de Peyster</Name>
        <Affiliation>Graduate School of Public Health, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, United States. Electronic address: adepeyst@mail.sdsu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen Mihaich</Name>
        <Affiliation>Environmental and Regulatory Resources, LLC, 6807 Lipscomb Drive, Durham, NC 27712, United States. Electronic address: emihaich@nc.rr.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluating the performance of integrated approaches for hazard identification of skin sensitizing chemicals.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24813372</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.018</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Animal-free testing</Keywords>
      <Keywords>DPRA</Keywords>
      <Keywords>Integrated testing strategy</Keywords>
      <Keywords>Keratinocytes</Keywords>
      <Keywords>LLNA</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Skin sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jochem W. van der Veen</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, NL-3720BA Bilthoven, The Netherlands; Department of Toxicogenomics, Maastricht University, PO Box 616, NL-6200 MD Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Emiel Rorije</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, NL-3720BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Roger Emter</Name>
        <Affiliation>Givaudan Schweiz AG, Ueberlandstrasse 138, CH-8600 Dübendorf, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Natsch</Name>
        <Affiliation>Givaudan Schweiz AG, Ueberlandstrasse 138, CH-8600 Dübendorf, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Henk van Loveren</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, NL-3720BA Bilthoven, The Netherlands; Department of Toxicogenomics, Maastricht University, PO Box 616, NL-6200 MD Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Janine Ezendam</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, NL-3720BA Bilthoven, The Netherlands. Electronic address: Janine.ezendam@rivm.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health assessment of gasoline and fuel oxygenate vapors: reproductive toxicity assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24813181</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.014</DOI>
    <KeywordList>
      <Keywords>Diisopropyl ether (DIPE)</Keywords>
      <Keywords>Ethanol (EtOH)</Keywords>
      <Keywords>Ethyl tert butyl ether (ETBE)</Keywords>
      <Keywords>Fuel oxygenates</Keywords>
      <Keywords>Gasoline vapor condensates</Keywords>
      <Keywords>Glial fibrillary acid protein</Keywords>
      <Keywords>Methyl tert-butyl ether (MTBE)</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>t-Amyl methyl ether (TAME)</Keywords>
      <Keywords>t-Butyl alcohol (TBA)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas M. Gray</Name>
        <Affiliation>American Petroleum Institute, 20360 Clover Field Terrace, Potomac Falls, VA 20165, United States. Electronic address: tmgray@reagan.com.</Affiliation>
      </Author>
      <Author>
        <Name>David Steup</Name>
        <Affiliation>Shell Oil Company, One Shell Plaza, 910 Louisiana St., Houston, TX 77002, United States. Electronic address: david.steup@shell.com.</Affiliation>
      </Author>
      <Author>
        <Name>Linda G. Roberts</Name>
        <Affiliation>Chevron Energy Technology Company, 6001 Bollinger Canyon Road, San Ramon, CA 94583, United States. Electronic address: LRoberts@chevron.com.</Affiliation>
      </Author>
      <Author>
        <Name>James P. O'Callaghan</Name>
        <Affiliation>Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 1095 Willowdale Rd., Morgantown, WV 26505, United States. Electronic address: jdo5@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Gary Hoffman</Name>
        <Affiliation>Huntingdon Life Sciences, Princeton Research Center, 100 Mettlers Road, East Millstone, NJ 08873, United States. Electronic address: hoffmang@princeton.huntingdon.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ceinwen A. Schreiner</Name>
        <Affiliation>C&amp;C Consulting in Toxicology, 1950 Briarcliff Ave, Meadowbrook, PA 19046, United States. Electronic address: castox@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Charles R. Clark</Name>
        <Affiliation>Phillips 66, 5901 Woodland Road, Bartlesville, OK 74006, United States. Electronic address: okietox@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reevaluation of the Munro dataset to derive more specific TTC thresholds.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24799087</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.015</DOI>
    <KeywordList>
      <Keywords>Health limit value</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Reevaluation</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>TTC</Keywords>
      <Keywords>Threshold</Keywords>
      <Keywords>Threshold of toxicological concern</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Winfried R. Leeman</Name>
        <Affiliation>TNO, Utrechtseweg 48, PO Box 360, NL-3700 AJ Zeist, The Netherlands. Electronic address: Winfried.leeman@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Lisette Krul</Name>
        <Affiliation>TNO, Utrechtseweg 48, PO Box 360, NL-3700 AJ Zeist, The Netherlands. Electronic address: Lisette.krul@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Geert F. Houben</Name>
        <Affiliation>TNO, Utrechtseweg 48, PO Box 360, NL-3700 AJ Zeist, The Netherlands. Electronic address: Geert.houben@tno.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health assessment of gasoline and fuel oxygenate vapors: immunotoxicity evaluation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24793263</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.010</DOI>
    <KeywordList>
      <Keywords>Diisopropyl ether</Keywords>
      <Keywords>Ethanol</Keywords>
      <Keywords>Ethyl t-butyl ether</Keywords>
      <Keywords>Evaporative emissions</Keywords>
      <Keywords>Gasoline vapor condensates</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Methyl tertiary butyl ether</Keywords>
      <Keywords>Plaque assay</Keywords>
      <Keywords>t-Amyl methyl ether</Keywords>
      <Keywords>t-Butyl alcohol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kimber L. White</Name>
        <Affiliation>ImmunoTox®, Inc., 800 East Leigh Street, Richmond, VA 23298, United States. Electronic address: kwhite@immunotox.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vanessa L. Peachee</Name>
        <Affiliation>ImmunoTox®, Inc., 800 East Leigh Street, Richmond, VA 23298, United States. Electronic address: vpeachee@immunotox.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah R. Armstrong</Name>
        <Affiliation>Cambridge Environmental, Inc., United States. Electronic address: SarahAMarshall99@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Lorraine E. Twerdok</Name>
        <Affiliation>Twerdok Consulting, LLC, 1613 Featherwood Street, Silver Spring, MD 20904, United States. Electronic address: letwerdok@verizon.net.</Affiliation>
      </Author>
      <Author>
        <Name>Charles R. Clark</Name>
        <Affiliation>Phillips 66 Co., 420 S. Keeler Ave, Bartlesville, OK 74006, United States. Electronic address: okietox@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ceinwen A. Schreiner</Name>
        <Affiliation>C&amp;C Consulting in Toxicology, 1950 Briarcliff Ave, Meadowbrook, PA 19046, United States. Electronic address: castox@comcast.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The ex-vivo intestinal absorption rate of uranium is a two-phase function of supply.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24793262</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.012</DOI>
    <KeywordList>
      <Keywords>Absorption</Keywords>
      <Keywords>Ex vivo</Keywords>
      <Keywords>Small intestine</Keywords>
      <Keywords>Uranium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rainer Konietzka</Name>
        <Affiliation>Federal Environment Agency, Toxicology of Drinking Water and Swimming Pool Water and Health-related Environmental Monitoring, Wörlitzer Platz 1, 06844 Dessau-Roßlau, Germany. Electronic address: rainer.konietzka@uba.de.</Affiliation>
      </Author>
      <Author>
        <Name>Rita Heinze</Name>
        <Affiliation>Federal Environment Agency, Toxicology of Drinking Water and Swimming Pool Water and Health-related Environmental Monitoring, Wörlitzer Platz 1, 06844 Dessau-Roßlau, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Margarete Seiwert</Name>
        <Affiliation>Federal Environment Agency, Toxicology of Drinking Water and Swimming Pool Water and Health-related Environmental Monitoring, Wörlitzer Platz 1, 06844 Dessau-Roßlau, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Hermann H. Dieter</Name>
        <Affiliation>Federal Environment Agency, Toxicology of Drinking Water and Swimming Pool Water and Health-related Environmental Monitoring, Wörlitzer Platz 1, 06844 Dessau-Roßlau, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification of non-regulated aromatic amines of toxicological concern which can be cleaved from azo dyes used in clothing textiles.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24793261</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.011</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>Textile dyes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Beat J. Brüschweiler</Name>
        <Affiliation>Federal Food Safety and Veterinary Office, Schwarzenburgstrasse 155, CH-3003 Bern, Switzerland. Electronic address: beat.brueschweiler@blv.admin.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Küng</Name>
        <Affiliation>FRIEDLIPARTNER AG, Nansenstrasse 5, CH-8050 Zürich, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Bürgi</Name>
        <Affiliation>FRIEDLIPARTNER AG, Nansenstrasse 5, CH-8050 Zürich, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Lorenz Muralt</Name>
        <Affiliation>Official Food Control Authority of the Canton Bern, Muesmattstrasse 19, CH-3012 Bern, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Erich Nyfeler</Name>
        <Affiliation>Official Food Control Authority of the Canton Bern, Muesmattstrasse 19, CH-3012 Bern, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Vanadium pentoxide: risk assessment implications of a treatment- but not dose-related tumorigenic response in B6C3F1 mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24793260</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.013</DOI>
    <KeywordList>
      <Keywords>Poly-3-adjusted trend test</Keywords>
      <Keywords>Quantitative dose–response assessment</Keywords>
      <Keywords>Unit risk estimate</Keywords>
      <Keywords>Vanadium pentoxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas B. Starr</Name>
        <Affiliation>TBS Associates, 7500 Rainwater Road, Raleigh, NC 27615, USA. Electronic address: tbstarr@mindspring.com.</Affiliation>
      </Author>
      <Author>
        <Name>Judith A. MacGregor</Name>
        <Affiliation>Toxicology Consulting Services, 26881 Wedgewood Dr, Bonita Springs, FL 34134, USA. Electronic address: jamacgregor101@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ecological risk assessment of the presence of pharmaceutical residues in a French national water survey.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24768990</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.006</DOI>
    <KeywordList>
      <Keywords>Environment</Keywords>
      <Keywords>Pharmaceuticals</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Water resource</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Camille Bouissou-Schurtz</Name>
        <Affiliation>Agence Nationale de Sécurité du Médicament (ANSM), 143/147 Boulevard Anatole France, 93285 Saint-Denis, France.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Houeto</Name>
        <Affiliation>Agence Nationale de Sécurité du Médicament (ANSM), 143/147 Boulevard Anatole France, 93285 Saint-Denis, France. Electronic address: paul.houeto@ansm.sante.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Michel Guerbet</Name>
        <Affiliation>ABTE EA 4651, Université de Rouen, 22 Boulevard Gambetta, 76183 Rouen, France; UFR Médecine Pharmacie, Université de Rouen, 22 Boulevard Gambetta, 76183 Rouen, France.</Affiliation>
      </Author>
      <Author>
        <Name>Morgane Bachelot</Name>
        <Affiliation>Agence Nationale de Sécurité Sanitaire (ANSES), 27/31 Avenue du Général Leclerc, F-94701 Maisons-Alfort Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Claude Casellas</Name>
        <Affiliation>Hydrosciences Montpellier UMR 5569, Faculté de Pharmacie, Université Montpellier 1, Avenue Charles Flahault, 34093 Montpellier Cedex 05, France.</Affiliation>
      </Author>
      <Author>
        <Name>Anne Cécile Mauclaire</Name>
        <Affiliation>Agence Nationale de Sécurité du Médicament (ANSM), 143/147 Boulevard Anatole France, 93285 Saint-Denis, France.</Affiliation>
      </Author>
      <Author>
        <Name>Pascale Panetier</Name>
        <Affiliation>Agence Nationale de Sécurité Sanitaire (ANSES), 27/31 Avenue du Général Leclerc, F-94701 Maisons-Alfort Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Cécile Delval</Name>
        <Affiliation>Agence Nationale de Sécurité du Médicament (ANSM), 143/147 Boulevard Anatole France, 93285 Saint-Denis, France.</Affiliation>
      </Author>
      <Author>
        <Name>Dominique Masset</Name>
        <Affiliation>Agence Nationale de Sécurité du Médicament (ANSM), 143/147 Boulevard Anatole France, 93285 Saint-Denis, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Airborne asbestos exposures associated with gasket and packing replacement: a simulation study and meta-analysis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24768989</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.007</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>Equipment</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Gasket</Keywords>
      <Keywords>Packing</Keywords>
      <Keywords>Task</Keywords>
      <Keywords>Tool</Keywords>
      <Keywords>Valve</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amy K. Madl</Name>
        <Affiliation>Cardno ChemRisk, 130 Vantis, Suite 170, Aliso Viejo, CA 92656, United States. Electronic address: amy.madl@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dana M. Hollins</Name>
        <Affiliation>Cardno ChemRisk, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kathryn D. Devlin</Name>
        <Affiliation>Cardno ChemRisk, 4840 Pearl East Circle, Suite 300 West, Boulder, CO 80301, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen P. Donovan</Name>
        <Affiliation>Cardno ChemRisk, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Pamela J. Dopart</Name>
        <Affiliation>Cardno ChemRisk, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paul K. Scott</Name>
        <Affiliation>Cardno ChemRisk, 20 Stanwix Street, Suite 505, Pittsburgh, PA 15222, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Angela L. Perez</Name>
        <Affiliation>Cardno ChemRisk, 101 2nd Street, Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The added value of the 90-day repeated dose oral toxicity test for industrial chemicals with a low (sub)acute toxicity profile in a high quality dataset.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24768988</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.008</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Alternatives</Keywords>
      <Keywords>Chemicals legislation</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Repeated dose</Keywords>
      <Keywords>Sub-acute</Keywords>
      <Keywords>Sub-chronic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katy Taylor</Name>
        <Affiliation>BUAV Charitable Trust, 16a Crane Grove, London N7 8NN, United Kingdom. Electronic address: katy.taylor@buav.org.</Affiliation>
      </Author>
      <Author>
        <Name>David J. Andrew</Name>
        <Affiliation>TSGE Consulting Ltd., Concordia House, St James Business Park, Knaresborough HG5 8QB, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Rego</Name>
        <Affiliation>BUAV Charitable Trust, 16a Crane Grove, London N7 8NN, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of the calcium-binding protein, apoaequorin, expressed by Escherichia coli.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24768935</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.004</DOI>
    <KeywordList>
      <Keywords>Allergenicity</Keywords>
      <Keywords>Apoaequorin</Keywords>
      <Keywords>Bioinformatic</Keywords>
      <Keywords>Calcium-binding protein</Keywords>
      <Keywords>Safety assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniel L. Moran</Name>
        <Affiliation>Quincy Bioscience LLC, Suite 200, 301 South Westfield Road, Madison, WI 53717, United States. Electronic address: dmoran@quincybioscience.com.</Affiliation>
      </Author>
      <Author>
        <Name>Afua O. Tetteh</Name>
        <Affiliation>Food Allergy Research and Resource Program, 351 Food Industry Complex, University of Nebraska, Lincoln, NE 68583-0919, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Richard E. Goodman</Name>
        <Affiliation>Food Allergy Research and Resource Program, 351 Food Industry Complex, University of Nebraska, Lincoln, NE 68583-0919, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Y. Underwood</Name>
        <Affiliation>Quincy Bioscience LLC, Suite 200, 301 South Westfield Road, Madison, WI 53717, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Advancing the 3Rs in regulatory toxicology - Carcinogenicity testing: Scope for harmonisation and advancing the 3Rs in regulated sectors of the European Union.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24768934</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.009</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Chemicals</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Pharmaceuticals</Keywords>
      <Keywords>Plant protection</Keywords>
      <Keywords>Reduction</Keywords>
      <Keywords>Refinement</Keywords>
      <Keywords>Replacement</Keywords>
      <Keywords>Transgenic</Keywords>
      <Keywords>Veterinary drugs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Erwin Annys</Name>
        <Affiliation>CEFIC, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Billington</Name>
        <Affiliation>Dow AgroSciences, Abingdon, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Rick Clayton</Name>
        <Affiliation>IFAH-Europe, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus Dieter Bremm</Name>
        <Affiliation>Bayer Pharma AG, Wuppertal, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Graziano</Name>
        <Affiliation>Bristol Myers Squibb, Princeton, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jo McKelvie</Name>
        <Affiliation>Evita Services, Craigavon, Northern Ireland, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Ragan</Name>
        <Affiliation>European Partnership for Alternatives to Animal Testing (EPAA), Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Schwarz</Name>
        <Affiliation>University of Tübingen, Tübingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Willem van der Laan</Name>
        <Affiliation>Medicines Evaluation Board, Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Charles Wood</Name>
        <Affiliation>Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mattias Öberg</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Piet Wester</Name>
        <Affiliation>RIVM, Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin N. Woodward</Name>
        <Affiliation>TSGE Consulting Ltd Knaresborough, UK. Electronic address: Kevin.Woodward@TSGEurope.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>New challenges and opportunities in nonclinical safety testing of biologics.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24755365</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.005</DOI>
    <KeywordList>
      <Keywords>Biologics</Keywords>
      <Keywords>Bispecifics</Keywords>
      <Keywords>Distribution</Keywords>
      <Keywords>Minipigs</Keywords>
      <Keywords>Non-clinical safety</Keywords>
      <Keywords>PEGylated proteins</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andreas Baumann</Name>
        <Affiliation>Bayer Pharma AG, Berlin, Germany. Electronic address: andreas.baumann@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kelly Flagella</Name>
        <Affiliation>Genentech, South San Francisco, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Roy Forster</Name>
        <Affiliation>CiToxLAB, Evreux, France.</Affiliation>
      </Author>
      <Author>
        <Name>Lolke de Haan</Name>
        <Affiliation>MedImmune, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sven Kronenberg</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Mathias Locher</Name>
        <Affiliation>Covagen AG, Zuerich, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang F. Richter</Name>
        <Affiliation>F. Hoffmann-La Roche Ltd, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Peter Theil</Name>
        <Affiliation>UCB Pharma, Braine-l'Alleud, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Marque Todd</Name>
        <Affiliation>Pfizer, La Jolla, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carcinogenicity study of CKD-501, a novel dual peroxisome proliferator-activated receptors α and γ agonist, following oral administration to Sprague Dawley rats for 94-101 weeks.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24747398</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.003</DOI>
    <KeywordList>
      <Keywords>CKD-501</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Dual PPARα/γ agonist</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hee Su Lee</Name>
        <Affiliation>Department of Pathology, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Minsun Chang</Name>
        <Affiliation>Department of Medical and Pharmaceutical Science, Sookmyung Women's University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Eun Lee</Name>
        <Affiliation>Department of Pathology, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea; College of Veterinary Medicine, Chonnam National University, Gwangju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Woojin Kim</Name>
        <Affiliation>Department of Pathology, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>In Chang Hwang</Name>
        <Affiliation>Chong Kun Dang Research Institute, CKD Pharmaceuticals Inc., Kyunggi-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dal Hyun Kim</Name>
        <Affiliation>Chong Kun Dang Research Institute, CKD Pharmaceuticals Inc., Kyunggi-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Kyu Park</Name>
        <Affiliation>Department of Pathology, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Ji Choi</Name>
        <Affiliation>Department of Pathology, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Woori Jo</Name>
        <Affiliation>Department of Pathology, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Shin Woo Cha</Name>
        <Affiliation>Division of Non-clinical Studies, Korea Institute of Toxicology (KIT), Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Woo Chan Son</Name>
        <Affiliation>Department of Pathology, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. Electronic address: wcson@amc.seoul.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human health risk assessment of nitrosamines and nitramines for potential application in CO2 capture.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24747397</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.002</DOI>
    <KeywordList>
      <Keywords>CO(2) capture</Keywords>
      <Keywords>Carcinogenic</Keywords>
      <Keywords>DMEL</Keywords>
      <Keywords>Extrapolation modeling</Keywords>
      <Keywords>Genotoxic</Keywords>
      <Keywords>Nitramines</Keywords>
      <Keywords>Nitrosamines</Keywords>
      <Keywords>Non-threshold substances</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>T25</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Ravnum</Name>
        <Affiliation>Health Effects Laboratory, Environmental Chemistry Department, NILU, PO Box 100, Instituttveien 18, N-2027 Kjeller, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>E. Rundén-Pran</Name>
        <Affiliation>Health Effects Laboratory, Environmental Chemistry Department, NILU, PO Box 100, Instituttveien 18, N-2027 Kjeller, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>L. M. Fjellsbø</Name>
        <Affiliation>Health Effects Laboratory, Environmental Chemistry Department, NILU, PO Box 100, Instituttveien 18, N-2027 Kjeller, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>M. Dusinska</Name>
        <Affiliation>Health Effects Laboratory, Environmental Chemistry Department, NILU, PO Box 100, Instituttveien 18, N-2027 Kjeller, Norway. Electronic address: maria.dusinska@nilu.no.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Single dose acute toxicity testing for N,N-bis(2-mercaptoethyl)-N',N' diethylethylenediamine in beagles.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24721389</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.04.001</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>N,N-Bis(2-mercaptoethyl)-N′,N′-diethylenediamine</Keywords>
      <Keywords>The (188)Re-liposome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Si Yen Liu</Name>
        <Affiliation>Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Hsien Chang</Name>
        <Affiliation>Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Te Wei Lee</Name>
        <Affiliation>Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan. Electronic address: twlee@iner.gov.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute toxicity of high concentrations of carbon dioxide in rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24713210</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.03.008</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>CO(2)</Keywords>
      <Keywords>Carbon dioxide</Keywords>
      <Keywords>Concentration–time–mortality relation</Keywords>
      <Keywords>Greenhouse gas</Keywords>
      <Keywords>Mortality</Keywords>
      <Keywords>Probit function</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. Muijser</Name>
        <Affiliation>TNO Triskelion, Utrechtseweg 48, Zeist, The Netherlands. Electronic address: hans.muijser@tno.triskelion.nl.</Affiliation>
      </Author>
      <Author>
        <Name>J. J. van Triel</Name>
        <Affiliation>TNO Triskelion, Utrechtseweg 48, Zeist, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>E. Duistermaat</Name>
        <Affiliation>TNO Triskelion, Utrechtseweg 48, Zeist, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>P. M. J. Bos</Name>
        <Affiliation>RIVM, Antonie van Leeuwenhoeklaan 9, Bilthoven, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Formaldehyde and methylene glycol equivalence: critical assessment of chemical and toxicological aspects.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24709515</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.03.007</DOI>
    <KeywordList>
      <Keywords>Chemical equivalence</Keywords>
      <Keywords>Equilibrium constant</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Formalin</Keywords>
      <Keywords>Methylene glycol</Keywords>
      <Keywords>Sensory irritation</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>R. Golden</Name>
        <Affiliation>ToxLogic LLC, Gaithersburg, MD, USA. Electronic address: rgolden124@aol.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Valentini</Name>
        <Affiliation>Analytical Sciences, Petaluma, CA, USA. Electronic address: mark@analyticalsciences.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The sub-chronic oral toxicity of 1,3,5-trimethylbenzene in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24704044</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.03.006</DOI>
    <KeywordList>
      <Keywords>C9 aromatics</Keywords>
      <Keywords>Hydrocarbon solvent</Keywords>
      <Keywords>Liver enlargement</Keywords>
      <Keywords>Mesitylene</Keywords>
      <Keywords>Occupational exposure limit</Keywords>
      <Keywords>Oral toxicity</Keywords>
      <Keywords>RfD</Keywords>
      <Keywords>Trimethylbenzene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David Adenuga</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 Route 22 E., Annandale, NJ 08801, USA. Electronic address: moyinoluwa.d.adenuga@exxonmobil.com.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Carlos Carrillo</Name>
        <Affiliation>Shell Health, Shell International B.V., P.O. Box 162, 2501 AN The Hague, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Richard H. Mckee</Name>
        <Affiliation>ExxonMobil Biomedical Sciences, Inc., 1545 Route 22 E., Annandale, NJ 08801, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Implications of retinal effects observed in chronic toxicity studies on the clinical development of a CNS-active drug candidate.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24680767</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.03.005</DOI>
    <KeywordList>
      <Keywords>Drug development</Keywords>
      <Keywords>Electroretinogram</Keywords>
      <Keywords>Ocular</Keywords>
      <Keywords>Retina</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>G. Eichenbaum</Name>
        <Affiliation>Janssen Research &amp; Development, LLC, A Division of Janssen Pharmaceutical Companies of Johnson &amp; Johnson, Department: 1000 Route 202 South, Raritan, NJ 08869, USA. Electronic address: geichenb@its.jnj.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Zhou</Name>
        <Affiliation>Janssen Research &amp; Development, LLC, A Division of Janssen Pharmaceutical Companies of Johnson &amp; Johnson, Department: 1000 Route 202 South, Raritan, NJ 08869, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. F. Kelley</Name>
        <Affiliation>Janssen Research &amp; Development, LLC, A Division of Janssen Pharmaceutical Companies of Johnson &amp; Johnson, PO Box 776, Welsh &amp; McKean Roads, Spring House, PA 19382, USA.</Affiliation>
      </Author>
      <Author>
        <Name>W. Roosen</Name>
        <Affiliation>Janssen Research &amp; Development, A Division of Janssen Pharmaceutica N.V., Turnhoutseweg 30, B-2340 Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>P. Costa-Giomi</Name>
        <Affiliation>Janssen Research &amp; Development, LLC, A Division of Janssen Pharmaceutical Companies of Johnson &amp; Johnson, Department: 1000 Route 202 South, Raritan, NJ 08869, USA.</Affiliation>
      </Author>
      <Author>
        <Name>C. Louden</Name>
        <Affiliation>Janssen Research &amp; Development, LLC, A Division of Janssen Pharmaceutical Companies of Johnson &amp; Johnson, PO Box 776, Welsh &amp; McKean Roads, Spring House, PA 19382, USA.</Affiliation>
      </Author>
      <Author>
        <Name>N. A. Di Prospero</Name>
        <Affiliation>Janssen Research &amp; Development, LLC, A Division of Janssen Pharmaceutical Companies of Johnson &amp; Johnson, Department: 1000 Route 202 South, Raritan, NJ 08869, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. Pandina</Name>
        <Affiliation>Janssen Research &amp; Development, LLC, A Division of Janssen Pharmaceutical Companies of Johnson &amp; Johnson, 1125 Trenton-Harbourton Road, Titusville, NJ 08560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. B. Singh</Name>
        <Affiliation>Janssen Research &amp; Development, LLC, A Division of Janssen Pharmaceutical Companies of Johnson &amp; Johnson, 1125 Trenton-Harbourton Road, Titusville, NJ 08560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>L. Ford</Name>
        <Affiliation>Janssen Research &amp; Development, LLC, A Division of Janssen Pharmaceutical Companies of Johnson &amp; Johnson, 1125 Trenton-Harbourton Road, Titusville, NJ 08560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. A. Moyer</Name>
        <Affiliation>Janssen Research &amp; Development, LLC, A Division of Janssen Pharmaceutical Companies of Johnson &amp; Johnson, 1125 Trenton-Harbourton Road, Titusville, NJ 08560, USA.</Affiliation>
      </Author>
      <Author>
        <Name>T. M. Nork</Name>
        <Affiliation>Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave F4/336, Madison, WI 53792-3220, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. N. Ver Hoeve</Name>
        <Affiliation>Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave F4/336, Madison, WI 53792-3220, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. D. Aguirre</Name>
        <Affiliation>Section of Ophthalmology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Current modeling practice may lead to falsely high benchmark dose estimates.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24662478</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.03.004</DOI>
    <KeywordList>
      <Keywords>Benchmark dose</Keywords>
      <Keywords>Dose–effect</Keywords>
      <Keywords>Point of departure</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Simulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joakim Ringblom</Name>
        <Affiliation>Karolinska Institutet, Institute of Environmental Medicine, Unit of Work Environment Toxicology, P.O. Box 210, SE-171 77 Stockholm, Sweden. Electronic address: joakim.ringblom@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>Gunnar Johanson</Name>
        <Affiliation>Karolinska Institutet, Institute of Environmental Medicine, Unit of Work Environment Toxicology, P.O. Box 210, SE-171 77 Stockholm, Sweden. Electronic address: gunnar.johanson@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>Mattias Öberg</Name>
        <Affiliation>Karolinska Institutet, Institute of Environmental Medicine, Unit of Work Environment Toxicology, P.O. Box 210, SE-171 77 Stockholm, Sweden. Electronic address: mattias.oberg@ki.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characteristics and safety assessment of intractable proteins in genetically modified crops.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24662477</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.03.003</DOI>
    <KeywordList>
      <Keywords>Food safety</Keywords>
      <Keywords>Genetically modified (GM) crops</Keywords>
      <Keywords>Intractable proteins</Keywords>
      <Keywords>Membrane proteins</Keywords>
      <Keywords>N-glycosylated proteins</Keywords>
      <Keywords>Resistance proteins</Keywords>
      <Keywords>Signaling proteins</Keywords>
      <Keywords>Transcription factors</Keywords>
      <Keywords>Weight-of-evidence approach</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dean F. Bushey</Name>
        <Affiliation>Bayer CropScience, 2 T.W. Alexander Drive, P.O. Box 12014, Research Triangle Park, NC 27709-2014, USA. Electronic address: dean.bushey@bayer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gary A. Bannon</Name>
        <Affiliation>Monsanto Company, Global Regulatory, 800 North Lindbergh Boulevard, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan F. Delaney</Name>
        <Affiliation>DuPont Pioneer, 7300 NW 62nd Avenue, P.O. Box 1004, Johnston, IA 50131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gerson Graser</Name>
        <Affiliation>Syngenta Biotechnology, Inc., P.O. Box 12257, 3054 East Cornwallis Road, Research Triangle Park, NC 27709-2257, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Hefford</Name>
        <Affiliation>Centre for Biologics Research, Sir Frederick G. Banting Research Centre, 251 Promenade Sir Frederick Banting Driveway, Ottawa, Ontario K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoxu Jiang</Name>
        <Affiliation>BASF Plant Science, L.P., Regulatory Science, 26 Davis Drive, Research Triangle Park, NC 27709-3528, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas C. Lee</Name>
        <Affiliation>Monsanto Company, Global Regulatory, 800 North Lindbergh Boulevard, St. Louis, MO 63167, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Krishna M. Madduri</Name>
        <Affiliation>Dow AgroSciences, 9330 Zionsville Road, Indianapolis, IN 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Pariza</Name>
        <Affiliation>Department of Food Science, University of Wisconsin-Madison, 1550 Linden Drive, Madison, WI 53706, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura S. Privalle</Name>
        <Affiliation>BASF Plant Science, L.P., Regulatory Science, 26 Davis Drive, Research Triangle Park, NC 27709-3528, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rakesh Ranjan</Name>
        <Affiliation>Bayer CropScience, 2 T.W. Alexander Drive, P.O. Box 12014, Research Triangle Park, NC 27709-2014, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gloria Saab-Rincon</Name>
        <Affiliation>Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México, AP 510-3, CP 62250 Cuernavaca, Morelos, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Barry W. Schafer</Name>
        <Affiliation>Dow AgroSciences, 9330 Zionsville Road, Indianapolis, IN 46268, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jay J. Thelen</Name>
        <Affiliation>University of Missouri, Division of Biochemistry, Christopher S. Bond Life Sciences Center, Columbia, MO 65211, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John X. Q. Zhang</Name>
        <Affiliation>DuPont Pioneer, 7300 NW 62nd Avenue, P.O. Box 1004, Johnston, IA 50131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marc S. Harper</Name>
        <Affiliation>DuPont Pioneer, 7300 NW 62nd Avenue, P.O. Box 1004, Johnston, IA 50131, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Individual methylmercury intake estimates from local seafood of the Mediterranean Sea, in Italy.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24657489</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.03.002</DOI>
    <KeywordList>
      <Keywords>Food safety</Keywords>
      <Keywords>Food security</Keywords>
      <Keywords>Intake</Keywords>
      <Keywords>Mediterranean Sea</Keywords>
      <Keywords>Methylmercury</Keywords>
      <Keywords>Seafood</Keywords>
      <Keywords>Sensitive groups</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elena Dellatte</Name>
        <Affiliation>Istituto Superiore di Sanità, Toxicological Chemistry Unit, Viale Regina Elena 299, I-00161 Rome, Italy. Electronic address: elena.dellatte@iss.it.</Affiliation>
      </Author>
      <Author>
        <Name>Gianfranco Brambilla</Name>
        <Affiliation>Istituto Superiore di Sanità, Toxicological Chemistry Unit, Viale Regina Elena 299, I-00161 Rome, Italy. Electronic address: gianfranco.brambilla@iss.it.</Affiliation>
      </Author>
      <Author>
        <Name>Roberto Miniero</Name>
        <Affiliation>Istituto Superiore di Sanità, Toxicological Chemistry Unit, Viale Regina Elena 299, I-00161 Rome, Italy. Electronic address: roberto.miniero@iss.it.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Cesarina Abete</Name>
        <Affiliation>Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, Via Bologna 148, I-10154 Turin, Italy. Electronic address: mariacesarina.abete@izsto.it.</Affiliation>
      </Author>
      <Author>
        <Name>Roberta Orletti</Name>
        <Affiliation>Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche, Via Cupa di Posatora 3, I-60100 Ancona, Italy. Electronic address: r.orletti@izsum.it.</Affiliation>
      </Author>
      <Author>
        <Name>Giannina Chessa</Name>
        <Affiliation>Istituto Zooprofilattico Sperimentale della Sardegna, Via Vienna 2, I-79100 Sassari, Italy. Electronic address: giannina.chessa@izs-sardegna.it.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Ubaldi</Name>
        <Affiliation>Istituto Zooprofilattico Sperimentale del Lazio e della Toscana, Via Appia Nuova 1411, I-00178 Rome, Italy. Electronic address: alessandro.ubaldi@izslt.it.</Affiliation>
      </Author>
      <Author>
        <Name>Eugenio Chiaravalle</Name>
        <Affiliation>Istituto Zooprofilattico Sperimentale della Puglia e Basilicata, Via Manfredonia 20, I-71121 Foggia, Italy. Electronic address: izsfgchimica@tiscali.it.</Affiliation>
      </Author>
      <Author>
        <Name>Micaela Tiso</Name>
        <Affiliation>Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle D'Aosta, Piazza Borgo Pila 39, I-16129 Genoa, Italy. Electronic address: micaela.tiso@unige.it.</Affiliation>
      </Author>
      <Author>
        <Name>Angelo Ferrari</Name>
        <Affiliation>Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle D'Aosta, Piazza Borgo Pila 39, I-16129 Genoa, Italy. Electronic address: angelo.ferrari@izsto.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Adjustment factors for toluene, styrene and methyl chloride by population modeling of toxicokinetic variability.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24613484</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.02.015</DOI>
    <KeywordList>
      <Keywords>Assessment factor</Keywords>
      <Keywords>Chloromethane</Keywords>
      <Keywords>Monte Carlo simulation</Keywords>
      <Keywords>Organic solvent</Keywords>
      <Keywords>PBPK model</Keywords>
      <Keywords>PBTK model</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Safety factor</Keywords>
      <Keywords>Uncertainty factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anna Karin Mörk</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: anna-karin.mork@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>Fredrik Jonsson</Name>
        <Affiliation>Pharsight, a Certara™ Company, St. Louis, MO, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gunnar Johanson</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Photoprotective characteristics of natural antioxidant polyphenols.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24607767</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.02.014</DOI>
    <KeywordList>
      <Keywords>Antioxidants</Keywords>
      <Keywords>Polyphenols</Keywords>
      <Keywords>Sunscreens</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Roberto Stevanato</Name>
        <Affiliation>Department of Molecular Sciences and Nanosystems, University Ca' Foscari of Venice, Dorsoduro 2137, 30123 Venice, Italy. Electronic address: roberto.stevanato@unive.it.</Affiliation>
      </Author>
      <Author>
        <Name>Mariangela Bertelle</Name>
        <Affiliation>Department of Molecular Sciences and Nanosystems, University Ca' Foscari of Venice, Dorsoduro 2137, 30123 Venice, Italy. Electronic address: bertelle@unive.it.</Affiliation>
      </Author>
      <Author>
        <Name>Sabrina Fabris</Name>
        <Affiliation>Department of Molecular Sciences and Nanosystems, University Ca' Foscari of Venice, Dorsoduro 2137, 30123 Venice, Italy. Electronic address: sabri@unive.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human health risk evaluation of selected VOC, SVOC and particulate emissions from scented candles.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24582651</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.02.010</DOI>
    <KeywordList>
      <Keywords>Candle emissions</Keywords>
      <Keywords>Chamber emission studies</Keywords>
      <Keywords>Consumer exposure modeling</Keywords>
      <Keywords>Human health assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas Petry</Name>
        <Affiliation>ToxMinds BVBA, Product Safety &amp; Regulatory Affairs, Brussels, Belgium. Electronic address: thomas.petry@toxminds.com.</Affiliation>
      </Author>
      <Author>
        <Name>Danielle Vitale</Name>
        <Affiliation>Research Institute for Fragrance Materials Inc., Woodcliff Lake, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Fred J. Joachim</Name>
        <Affiliation>SC Johnson &amp; Son, Racine, WI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ben Smith</Name>
        <Affiliation>Firmenich SA, Geneva, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Lynn Cruse</Name>
        <Affiliation>Procter &amp; Gamble, Cincinnati, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Reuben Mascarenhas</Name>
        <Affiliation>Reckitt-Benckiser, Hull, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Scott Schneider</Name>
        <Affiliation>Firmenich SA, Princeton, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Madhuri Singal</Name>
        <Affiliation>Research Institute for Fragrance Materials Inc., Woodcliff Lake, NJ, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of urinary speciated arsenic in NHANES: issues in interpretation in the context of potential inorganic arsenic exposure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24582650</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.02.011</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>NHANES</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lesa L. Aylward</Name>
        <Affiliation>Summit Toxicology, LLP, Falls Church, VA, USA. Electronic address: laylward@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>Santhini Ramasamy</Name>
        <Affiliation>Office of Water, US Environmental Protection Agency, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sean M. Hays</Name>
        <Affiliation>Summit Toxicology, LLP, Lyons, CO, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rita Schoeny</Name>
        <Affiliation>Office of Science Policy, Office of Research and Development, US Environmental Protection Agency, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher R. Kirman</Name>
        <Affiliation>Summit Toxicology, LLP, Orange Village, OH, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of fish protein hydrolysate supplementation in malnourished children.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24569051</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.02.009</DOI>
    <KeywordList>
      <Keywords>Amizate®</Keywords>
      <Keywords>Children</Keywords>
      <Keywords>Fish protein hydrolysate</Keywords>
      <Keywords>Growth</Keywords>
      <Keywords>Malnutrition</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Knut Olav Nesse</Name>
        <Affiliation>Zymtech Production AS, Industriparken, NO-2665, Lesja, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>A. P. Nagalakshmi</Name>
        <Affiliation>Consortium Clinical Research Pvt. Ltd., No. 9/41, Sri Kalki Gardens, Sugunapuram, Kuniyamuthur P.O., Coimbatore 641008, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>P. Marimuthu</Name>
        <Affiliation>Department of Biostatistics, National Institute of Mental Health and Neuro Sciences (NIMHANS), Hosur Road, Bangalore 560029, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mamta Singh</Name>
        <Affiliation>Department of Biosciences, Jamia Milia Islamia, Jamia Nagar, New Delhi 110025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Preetida J. Bhetariya</Name>
        <Affiliation>Department of Biosciences, Jamia Milia Islamia, Jamia Nagar, New Delhi 110025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Manki Ho</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Road, Suite 308, Mississauga, Ontario L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ryan R. Simon</Name>
        <Affiliation>Intertek Scientific &amp; Regulatory Consultancy, 2233 Argentia Road, Suite 308, Mississauga, Ontario L5N 2X7, Canada. Electronic address: ryan.simon@intertek.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The T-cell-dependent antibody response assay in nonclinical studies of pharmaceuticals and chemicals: study design, data analysis, interpretation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24566336</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.02.008</DOI>
    <KeywordList>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Nonclinical studies</Keywords>
      <Keywords>TDAR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hervé Lebrec</Name>
        <Affiliation>Amgen, Seattle, WA, USA. Electronic address: hlebrec@amgen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Brigitte Molinier</Name>
        <Affiliation>Sanofi-Aventis R&amp;D, Montpellier, France.</Affiliation>
      </Author>
      <Author>
        <Name>Darrell Boverhof</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Collinge</Name>
        <Affiliation>Pfizer, Inc., Groton, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wendy Freebern</Name>
        <Affiliation>Bristol-Myers Squibb Company, New Brunswick, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin Henson</Name>
        <Affiliation>Novartis Institutes for Biomedical Research Inc., East Hanover, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel T. Mytych</Name>
        <Affiliation>Amgen, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hans D. Ochs</Name>
        <Affiliation>Department of Pediatrics, University of Washington, and Seattle Children's Research Institute, Seattle, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald Wange</Name>
        <Affiliation>Food and Drug Administration, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yung Yang</Name>
        <Affiliation>Office of Pesticides Programs, US Environmental Protection Agency, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Zhou</Name>
        <Affiliation>Amgen, Thousand Oaks, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joshua Arrington</Name>
        <Affiliation>Covance Inc., Madison, WI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Soleil Christin-Piché</Name>
        <Affiliation>Charles River Laboratories, Montreal, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jacintha Shenton</Name>
        <Affiliation>MedImmune Ltd., Cambridge, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Vertical allometry: fact or fiction?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24534003</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.02.005</DOI>
    <KeywordList>
      <Keywords>Allometric scaling</Keywords>
      <Keywords>Clearance</Keywords>
      <Keywords>Vertical allometry</Keywords>
      <Keywords>Volume of distribution</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Iftekhar Mahmood</Name>
        <Affiliation>Office of Blood Review &amp; Research (OBRR), Center for Biologic Evaluation and Research, Food &amp; Drug Administration, 1401 Rockville Pike, Rockville, MD, USA. Electronic address: Iftekhar.mahmood@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Harold Boxenbaum</Name>
        <Affiliation>Office of Blood Review &amp; Research (OBRR), Center for Biologic Evaluation and Research, Food &amp; Drug Administration, 1401 Rockville Pike, Rockville, MD, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Categorisation of protein respiratory allergens: the case of Subtilisin.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24534002</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.02.004</DOI>
    <KeywordList>
      <Keywords>Hazard and risk categorisation</Keywords>
      <Keywords>Protein respiratory allergens</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Respiratory sensitization</Keywords>
      <Keywords>Sensitization potency</Keywords>
      <Keywords>Substances of Very High Concern</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK. Electronic address: ian.kimber@manchester.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>David A. Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd, Sharnbrook, Bedfordshire MK44 1PR, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The impact of recent advances in research on arsenic cancer risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24534001</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.02.006</DOI>
    <KeywordList>
      <Keywords>Adaptive</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Cancer risk</Keywords>
      <Keywords>Dose–response</Keywords>
      <Keywords>Non-linear</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>P. Robinan Gentry</Name>
        <Affiliation>ENVIRON International, 1900 N. 18th St., Monroe, LA 71201, USA. Electronic address: rgentry@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, Research Triangle Park, NC 27709, USA. Electronic address: HClewell@thehamner.org.</Affiliation>
      </Author>
      <Author>
        <Name>Tracy B. Greene</Name>
        <Affiliation>ENVIRON International, 1900 N. 18th St., Monroe, LA 71201, USA. Electronic address: tgreene@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Allison C. Franzen</Name>
        <Affiliation>ENVIRON International, 1900 N. 18th St., Monroe, LA 71201, USA. Electronic address: afranzen@environcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Janice W. Yager</Name>
        <Affiliation>University of New Mexico, Albuquerque, NM 87131-00001, USA; ENVIRON International, 2200 Powell Street, Emeryville, CA 94608. Electronic address: JWYAGER@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory acceptance and use of 3R models for pharmaceuticals and chemicals: expert opinions on the state of affairs and the way forward.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24534000</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.02.007</DOI>
    <KeywordList>
      <Keywords>3R models</Keywords>
      <Keywords>Chemicals</Keywords>
      <Keywords>Drivers and barriers</Keywords>
      <Keywords>Multilevel perspective on technology transitions</Keywords>
      <Keywords>Pharmaceuticals</Keywords>
      <Keywords>Regulatory acceptance and use</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marie Jeanne W. A. Schiffelers</Name>
        <Affiliation>Utrecht University School of Governance (USBO), Bijlhouwerstraat 6, 3511 ZC Utrecht, The Netherlands. Electronic address: m.j.w.a.schiffelers@uu.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Bas J. Blaauboer</Name>
        <Affiliation>Utrecht University, Institute for Risk Assessment Sciences (IRAS), P.O. Box 80.178, 3508 TD Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Wieger E. Bakker</Name>
        <Affiliation>Utrecht University School of Governance (USBO), Bijlhouwerstraat 6, 3511 ZC Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Sonja Beken</Name>
        <Affiliation>Federal Agency for Medicines and Health Products (FAMHP), Victor Hortaplein 40/40, 1060 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Coenraad F. M. Hendriksen</Name>
        <Affiliation>Institute for Translational Vaccinology (InTraVacc), P.O. Box 450, 3720 AL Bilthoven, The Netherlands; Utrecht University, Faculty of Veterinary Medicine, Department Animals in Science and Society, P.O. Box 80.166, 3508 TD Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Herman B. W. M. Koëter</Name>
        <Affiliation>Orange House Partnership (OHP), Kampendaal 83, 1653 Dworp (Beersel), Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Cyrille Krul</Name>
        <Affiliation>TNO, P.O. Box 360, 3700 AJ Zeist, The Netherlands; University of Applied Sciences Utrecht (HU), Life Sciences &amp; Chemistry, F.C. Donderstraat 65, 3572 JE Utrecht, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24530840</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.02.002</DOI>
    <KeywordList>
      <Keywords>Causation</Keywords>
      <Keywords>Disease trends</Keywords>
      <Keywords>Endocrine-disrupting chemicals (EDCs)</Keywords>
      <Keywords>Low-dose effects</Keywords>
      <Keywords>Non-monotonic dose response (NMDR)</Keywords>
      <Keywords>State of the science</Keywords>
      <Keywords>Weight of evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James C. Lamb</Name>
        <Affiliation>Exponent, 1800 Diagonal Road, Suite #500, Alexandria, VA 22314, USA. Electronic address: jlamb@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paolo Boffetta</Name>
        <Affiliation>The Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, 17 East 102 Street Floor West Tower, 5th Floor Room 5-142, New York, NY 10029, USA. Electronic address: paolo.boffetta@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Warren G. Foster</Name>
        <Affiliation>Department of Obstetrics &amp; Gynecology, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada. Electronic address: foster@mcmaster.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Karyn L. Hentz</Name>
        <Affiliation>Exponent, 1800 Diagonal Road, Suite #500, Alexandria, VA 22314, USA. Electronic address: khentz@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lorenz R. Rhomberg</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, USA. Electronic address: lrhomberg@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Staveley</Name>
        <Affiliation>Exponent, 1800 Diagonal Road, Suite #500, Alexandria, VA 22314, USA. Electronic address: jstaveley@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gerard Swaen</Name>
        <Affiliation>Exponent, The Lenz, 1st Floor, Hornbeam Park, Harrogate HG2 8RE, UK. Electronic address: gswaen@exponent.com.</Affiliation>
      </Author>
      <Author>
        <Name>Glen Van Der Kraak</Name>
        <Affiliation>Department of Integrative Biology, University of Guelph, Guelph, ON N1G 2W1, Canada. Electronic address: gvanderk@uoguelph.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Amy L. Williams</Name>
        <Affiliation>Exponent, 1800 Diagonal Road, Suite #500, Alexandria, VA 22314, USA. Electronic address: awilliams@exponent.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxic metals contained in cosmetics: a status report.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24530804</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.02.003</DOI>
    <KeywordList>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Dermal exposure</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Systemic effects</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Beatrice Bocca</Name>
        <Affiliation>Italian National Institute for Health, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Pino</Name>
        <Affiliation>Italian National Institute for Health, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Alimonti</Name>
        <Affiliation>Italian National Institute for Health, Rome, Italy. Electronic address: alessandro.alimonti@iss.it.</Affiliation>
      </Author>
      <Author>
        <Name>Giovanni Forte</Name>
        <Affiliation>Italian National Institute for Health, Rome, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of an occupational exposure limit for inorganic borates using a weight of evidence approach.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24525063</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.02.001</DOI>
    <KeywordList>
      <Keywords>Borate</Keywords>
      <Keywords>OEL</Keywords>
      <Keywords>Occupational exposure limit</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Maier</Name>
        <Affiliation>University of Cincinnati, 3223 Eden Avenue, Cincinnati, OH 45267-0056, United States. Electronic address: maierma@ucmail.uc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>M. Vincent</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, 2300 Montana Avenue, Suite 409, Cincinnati, OH 45211, United States.</Affiliation>
      </Author>
      <Author>
        <Name>E. Hack</Name>
        <Affiliation>The Henry Jackson Foundation, 6720 Rockledge Drive, Suite 100, Bethesda, MD 20817, United States.</Affiliation>
      </Author>
      <Author>
        <Name>P. Nance</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, 2300 Montana Avenue, Suite 409, Cincinnati, OH 45211, United States.</Affiliation>
      </Author>
      <Author>
        <Name>W. Ball</Name>
        <Affiliation>Rio Tinto Minerals, 8051 Maplewood Avenue, Building 4, Greenwood Village, CO 80111, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Implementation of the nutrition and health claim regulation - the case of antioxidants.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24525062</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.014</DOI>
    <KeywordList>
      <Keywords>Antioxidants</Keywords>
      <Keywords>EFSA</Keywords>
      <Keywords>European Commission</Keywords>
      <Keywords>Food law</Keywords>
      <Keywords>Functional ingredients</Keywords>
      <Keywords>Multifactorial</Keywords>
      <Keywords>Nutrition research</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Scientific substantiation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alie de Boer</Name>
        <Affiliation>Department of Toxicology, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands. Electronic address: a.deboer@maastrichtuniversity.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen Vos</Name>
        <Affiliation>Department of European and International Law, Faculty of Law, Maastricht University, Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aalt Bast</Name>
        <Affiliation>Department of Toxicology, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>History and evolution of warning labels for automotive friction products.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24518387</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.015</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>Brakes</Keywords>
      <Keywords>Chrysotile</Keywords>
      <Keywords>Clutches</Keywords>
      <Keywords>Encapsulated</Keywords>
      <Keywords>Friction</Keywords>
      <Keywords>Labeling</Keywords>
      <Keywords>Warnings</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Luda M. Kopelovich</Name>
        <Affiliation>Cardno ChemRisk, 101 2nd St., Suite 700, San Francisco, CA 94105, United States. Electronic address: Luda.Kopelovich@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kerry A. Thuett</Name>
        <Affiliation>Cardno ChemRisk, 101 2nd St., Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Pamela S. Chapman</Name>
        <Affiliation>Cardno ChemRisk, 101 2nd St., Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dennis J. Paustenbach</Name>
        <Affiliation>Cardno ChemRisk, 101 2nd St., Suite 700, San Francisco, CA 94105, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory decision-making under uncertainty: are costs proportionate to benefits when restricting dangerous chemicals on European markets?</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24518386</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.016</DOI>
    <KeywordList>
      <Keywords>Dangerous chemicals</Keywords>
      <Keywords>Decision-making under uncertainty</Keywords>
      <Keywords>Economic feasibility</Keywords>
      <Keywords>Proportionality</Keywords>
      <Keywords>REACH</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Roy Brouwer</Name>
        <Affiliation>Department of Environmental Economics, Institute for Environmental Studies, Vrije Universiteit Amsterdam, The Netherlands. Electronic address: r.brouwer@vu.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Cauchi</Name>
        <Affiliation>Department of Environmental Economics, Institute for Environmental Studies, Vrije Universiteit Amsterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Julia Verhoeven</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Agreement of label information of cardiovascular drugs in pregnancy among Korea, the USA, the UK, and Japan.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24513085</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.013</DOI>
    <KeywordList>
      <Keywords>Cardiovascular drugs</Keywords>
      <Keywords>Label</Keywords>
      <Keywords>Pregnancy</Keywords>
      <Keywords>Safety information</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shin Haeng Lee</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management, 136 Changgyeonggung-ro, Jongno-gu, Seoul 110-750, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ju Young Shin</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management, 136 Changgyeonggung-ro, Jongno-gu, Seoul 110-750, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Ju Park</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management, 136 Changgyeonggung-ro, Jongno-gu, Seoul 110-750, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Joo Park</Name>
        <Affiliation>Korea Institute of Drug Safety and Risk Management, 136 Changgyeonggung-ro, Jongno-gu, Seoul 110-750, Republic of Korea; Department of Preventive Medicine, College of Medicine, Seoul National University, 103 Daehak-ro, Chongno-gu, Seoul 110-799, Republic of Korea. Electronic address: bjpark@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mode of action analysis for liver tumors from oral 1,4-dioxane exposures and evidence-based dose response assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24491968</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.011</DOI>
    <KeywordList>
      <Keywords>Dioxane</Keywords>
      <Keywords>Dose–response assessment</Keywords>
      <Keywords>Liver hyperplasia</Keywords>
      <Keywords>Liver toxicity</Keywords>
      <Keywords>Maximum contaminant level goal (MCLG)</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Oral reference dose (RfD)</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael Dourson</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, 2300 Montana Ave., Suite 409, Cincinnati, OH 45211, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John Reichard</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, 2300 Montana Ave., Suite 409, Cincinnati, OH 45211, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Nance</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, 2300 Montana Ave., Suite 409, Cincinnati, OH 45211, United States. Electronic address: nance@tera.org.</Affiliation>
      </Author>
      <Author>
        <Name>Heather Burleigh-Flayer</Name>
        <Affiliation>PPG Industries, One PPG Place, Pittsburgh, PA 15272, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ann Parker</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, 2300 Montana Ave., Suite 409, Cincinnati, OH 45211, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Melissa Vincent</Name>
        <Affiliation>Toxicology Excellence for Risk Assessment, 2300 Montana Ave., Suite 409, Cincinnati, OH 45211, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ernest E. McConnell</Name>
        <Affiliation>ToxPath, Inc., 3028 Ethan Lane, Laurdane Est., Raleigh, NC 27613, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of in vitro human dermal absorption studies on pesticides to determine default values, opportunities for read-across and influence of dilution on absorption.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24491967</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.012</DOI>
    <KeywordList>
      <Keywords>Agrochemicals</Keywords>
      <Keywords>Dermal absorption</Keywords>
      <Keywords>Human skin</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Plant protection products</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Aggarwal</Name>
        <Affiliation>Dow AgroSciences Ltd., 3B Park Square, Milton Park, Abingdon, OX14 4RN Oxfordshire, UK. Electronic address: maggarwal@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Battalora</Name>
        <Affiliation>E. I. du Pont de Nemours and Company, DuPont Crop Protection, Stine-Haskell Research Center, P.O. Box 30, Newark, Delaware 19714-0030, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. Fisher</Name>
        <Affiliation>Bayer SAS, Bayer CropScience, 355 rue dostoievski, CS 90153 Valbonne, 06906 Sophia Antipolis, France.</Affiliation>
      </Author>
      <Author>
        <Name>A. Hüser</Name>
        <Affiliation>Dr. Knoell Consult GmbH, 8 Marie-Curie Street, Leverkusen, 51377, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>R. Parr-Dobrzanski</Name>
        <Affiliation>Syngenta Ltd., Bracknell, Berkshire, RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>M. Soufi</Name>
        <Affiliation>DuPont de Nemours GmbH Deutschland, 173-175 Hugenottenallee, Neu-Isenburg 63263, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>V. Mostert</Name>
        <Affiliation>Dr. Knoell Consult GmbH, 8 Marie-Curie Street, Leverkusen, 51377, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>C. Strupp</Name>
        <Affiliation>Makhteshim Agan Europe, Makhteshim Agan Holding B.V., Schaffhausen, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>P. Whalley</Name>
        <Affiliation>Syngenta Ltd., Bracknell, Berkshire, RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>C. Wiemann</Name>
        <Affiliation>BASF Oesterreich GmbH, Millennium Tower, 25, Handelskai 94-96, Wien 1200, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>R. Billington</Name>
        <Affiliation>Dow AgroSciences Ltd., 3B Park Square, Milton Park, Abingdon, OX14 4RN Oxfordshire, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An approach for the delineation of a generic cut-off value for local respiratory tract irritation by irritating or corrosive substances as a pragmatic tool to fulfill REACH requirements.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24486623</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.009</DOI>
    <KeywordList>
      <Keywords>Corrosion</Keywords>
      <Keywords>Cut-off limit</Keywords>
      <Keywords>DNEL</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Irritation</Keywords>
      <Keywords>REACH</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. Messinger</Name>
        <Affiliation>Bioresco Food Scientific and Regulatory Services, Jülicherstr. 369, 52070 Aachen, Germany. Electronic address: hmessing@arcor.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The metrics of MWCNT-induced pulmonary inflammation are dependent on the selected testing regimen.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24486532</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.010</DOI>
    <KeywordList>
      <Keywords>Aggregates</Keywords>
      <Keywords>Disposition</Keywords>
      <Keywords>Multi-walled carbon nanotubes</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Repeated inhalation exposure</Keywords>
      <Keywords>Volume displacement lung overload</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jürgen Pauluhn</Name>
        <Affiliation>Toxicology, Bayer Pharma, 42096 Wuppertal, Germany. Electronic address: juergen.pauluhn@bayer.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subchronic, reproductive, and maternal toxicity studies with tertiary butyl acetate (TBAC).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24486531</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.006</DOI>
    <KeywordList>
      <Keywords>Maternal toxicity</Keywords>
      <Keywords>Reproductive</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Tertiary-butyl acetate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Willem Faber</Name>
        <Affiliation>WFTC, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Kirkpatrick</Name>
        <Affiliation>WIL Research Laboratories, Ashland, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Pragati Coder</Name>
        <Affiliation>WIL Research Laboratories, Ashland, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Abby Li</Name>
        <Affiliation>Exponent, San Francisco, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Borghoff</Name>
        <Affiliation>Integrated Laboratory Systems, RTP, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Marcy Banton</Name>
        <Affiliation>LyondellBasell Industries, Houston, TX, United States. Electronic address: marcy.banton@lyondellbasell.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and sub-chronic toxicity studies of the extract of Thunberg Fritillary Bulb.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24486111</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.007</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
      <Keywords>Thunberg Fritillary Bulb</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zehui Li</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China; Department of Biomedicine Science, College of Medicine, University of Toledo, Toledo 43614, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Qiao</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Li</Name>
        <Affiliation>Drug Safety Evaluation Center, China Institute for Radiation Protection, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao An</Name>
        <Affiliation>Department of Oncology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kaiwen Hu</Name>
        <Affiliation>Department of Oncology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China.</Affiliation>
      </Author>
      <Author>
        <Name>Minke Tang</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China. Electronic address: tangmk@bucm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Non-clinical safety assessment of Hwangryunhaedok-tang: 13-week toxicity in Crl:CD Sprague Dawley rats.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24480795</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.008</DOI>
    <KeywordList>
      <Keywords>Hwangryunhaedok-tang</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Traditional herbal medicine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mee Young Lee</Name>
        <Affiliation>Basic Herbal Research Group, Korea Institute of Oriental Medicine, 483 Expo-ro, Yusung-gu, Daejeon 305-811, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Seob Seo</Name>
        <Affiliation>Basic Herbal Research Group, Korea Institute of Oriental Medicine, 483 Expo-ro, Yusung-gu, Daejeon 305-811, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Bum Kim</Name>
        <Affiliation>Division of Non-clinical Studies, Korea Institute of Toxicology, P.O. Box 123, 100 Jangdong, Yusung-gu, Daejeon 305-343, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>In Sik Shin</Name>
        <Affiliation>Basic Herbal Research Group, Korea Institute of Oriental Medicine, 483 Expo-ro, Yusung-gu, Daejeon 305-811, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyeun Kyoo Shin</Name>
        <Affiliation>Basic Herbal Research Group, Korea Institute of Oriental Medicine, 483 Expo-ro, Yusung-gu, Daejeon 305-811, Republic of Korea. Electronic address: hkshin@kiom.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Workshop report: strategies for setting occupational exposure limits for engineered nanomaterials.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24462629</pubmedLink>
    <GrantList>
      <Grant>R13 OH010337</Grant>
    </GrantList>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.005</DOI>
    <KeywordList>
      <Keywords>Alternatives</Keywords>
      <Keywords>ENM</Keywords>
      <Keywords>Engineered nanomaterial</Keywords>
      <Keywords>OEL</Keywords>
      <Keywords>Occupational exposure limit</Keywords>
      <Keywords>Strategies</Keywords>
      <Keywords>Workshop</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Steven C. Gordon</Name>
        <Affiliation>3M Company, Toxicology Assessment and Compliance Assurance, 3M Center, Bldg. 220-6E-03, Saint Paul, MN 55144, USA. Electronic address: scgordon@mmm.com.</Affiliation>
      </Author>
      <Author>
        <Name>John H. Butala</Name>
        <Affiliation>Toxicology Consultants, Inc., 7 Glasgow Road, Gibsonia, PA 15044, USA. Electronic address: butala@jhbutala.com.</Affiliation>
      </Author>
      <Author>
        <Name>Janet M. Carter</Name>
        <Affiliation>U.S. Department of Labor, Occupational Safety &amp; Health Administration, 200 Constitution Avenue, Washington, DC 20210, USA. Electronic address: carter.janet@dol.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Alison Elder</Name>
        <Affiliation>University of Rochester, School of Medicine and Dentistry, Dept. of Environmental Medicine, 601 Elmwood Ave, Box EHSC, Rochester, NY 14642, USA. Electronic address: alison_elder@urmc.rochester.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Terry Gordon</Name>
        <Affiliation>New York University School of Medicine, Department of Environmental Medicine, 57 Old Forge Road, Tuxedo Park, NY 10987, USA. Electronic address: terry.gordon@nyumc.org.</Affiliation>
      </Author>
      <Author>
        <Name>George Gray</Name>
        <Affiliation>George Washington University, School of Public Health and Health Services, Dept. of Environmental and Occupational Health and Center for Risk Science and Public Health, 2100 M Street NW, Suite 203A, Washington, DC 20037, USA. Electronic address: gmgray@gwu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Philip G. Sayre</Name>
        <Affiliation>U.S. Environmental Protection Agency (Mail Code 7403), 1200 Pennsylvania Avenue NW, Washington, DC 20460, USA. Electronic address: sayre.phil@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Paul A. Schulte</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 4676 Columbia Parkway, Cincinnati, OH 45226, USA. Electronic address: pas4@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Candace S. Tsai</Name>
        <Affiliation>Purdue University, School of Health Sciences, Delon and Elizabeth Hampton Hall of Civil Engineering, 550 Stadium Mall Drive, West Lafayette, IN 47907, USA. Electronic address: tsai51@purdue.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jay West</Name>
        <Affiliation>American Chemistry Council, Nanotechnology Panel, 700 2nd Street NE, Washington, DC 20002, USA. Electronic address: jay_west@americanchemistry.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>WITHDRAWN: Hazard assessment of nitrosamine and nitramine by-products of amine-based CCS: an alternative approach.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24462580</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.003</DOI>
    <AuthorList>
      <Author>
        <Name>H. E. Buist</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, Netherlands. Electronic address: Harrie.Buist@tno.nl.</Affiliation>
      </Author>
      <Author>
        <Name>R. A. Bausch-Goldbohm</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>S. Devito</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>J. Venhorst</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>R. H. Stierum</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>E. D. Kroese</Name>
        <Affiliation>TNO, PO Box 360, 3700 AJ Zeist, Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A framework to facilitate consistent characterization of read across uncertainty.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24457134</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.004</DOI>
    <KeywordList>
      <Keywords>Chemical analogue identification</Keywords>
      <Keywords>Chemical grouping</Keywords>
      <Keywords>Read across</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Structural-similarity</Keywords>
      <Keywords>Structure activity relationship (SAR)</Keywords>
      <Keywords>Uncertainty</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Karen Blackburn</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Road, Cincinnati, OH 45040, United States. Electronic address: blackburn.kl@pg.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sharon B. Stuard</Name>
        <Affiliation>Central Product Safety Department, The Procter &amp; Gamble Company, Mason Business Center, 8700 Mason Montgomery Road, Cincinnati, OH 45040, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Critical review on the Environmental Risk Assessment of medicinal products for human use in the centralised procedure.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24447908</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.002</DOI>
    <KeywordList>
      <Keywords>EPAR</Keywords>
      <Keywords>ERA</Keywords>
      <Keywords>European Medicines Agency</Keywords>
      <Keywords>Marketing authorisation</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laura Caneva</Name>
        <Affiliation>European Medicines Agency, Specialised Scientific Disciplines Department, 7 Westferry Circus, Canary Wharf, London E14 4HB, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Milton Bonelli</Name>
        <Affiliation>European Medicines Agency, Specialised Scientific Disciplines Department, 7 Westferry Circus, Canary Wharf, London E14 4HB, United Kingdom. Electronic address: Milton.Bonelli@ema.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Marisa Papaluca-Amati</Name>
        <Affiliation>European Medicines Agency, Specialised Scientific Disciplines Department, 7 Westferry Circus, Canary Wharf, London E14 4HB, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Marc Vidal</Name>
        <Affiliation>European Medicines Agency, Specialised Scientific Disciplines Department, 7 Westferry Circus, Canary Wharf, London E14 4HB, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of toxicological effects of blood microsampling in the vehicle dosed adult rat.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24434616</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2014.01.001</DOI>
    <KeywordList>
      <Keywords>Blood</Keywords>
      <Keywords>Clinical chemistry parameters</Keywords>
      <Keywords>Haematology</Keywords>
      <Keywords>Microsampling</Keywords>
      <Keywords>Rodent</Keywords>
      <Keywords>Toxicokinetic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicola Powles-Glover</Name>
        <Affiliation>AstraZeneca, Innovative Medicines, Drug Safety Metabolism, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom. Electronic address: Nicola.powlesglover@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Kirk</Name>
        <Affiliation>AstraZeneca, Innovative Medicines, Drug Safety Metabolism, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Wilkinson</Name>
        <Affiliation>AstraZeneca, Innovative Medicines, Drug Safety Metabolism, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Sally Robinson</Name>
        <Affiliation>AstraZeneca, Innovative Medicines, Drug Safety Metabolism, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Stewart</Name>
        <Affiliation>AstraZeneca, Innovative Medicines, Drug Safety Metabolism, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment of enzyme-treated asparagus extract in rat acute and subchronic oral toxicity studies and genotoxicity tests.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24389363</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.12.011</DOI>
    <KeywordList>
      <Keywords>5-Hydroximethyl-2-furfural</Keywords>
      <Keywords>Acute</Keywords>
      <Keywords>Asfural</Keywords>
      <Keywords>Asparagus</Keywords>
      <Keywords>ETAS</Keywords>
      <Keywords>HSP70</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>Subchronic</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tomohiro Ito</Name>
        <Affiliation>Amino Up Chemical Co., Ltd., 363-22 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoko Ono</Name>
        <Affiliation>Amino Up Chemical Co., Ltd., 363-22 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Atsuya Sato</Name>
        <Affiliation>Amino Up Chemical Co., Ltd., 363-22 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazunori Goto</Name>
        <Affiliation>Amino Up Chemical Co., Ltd., 363-22 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takehito Miura</Name>
        <Affiliation>Amino Up Chemical Co., Ltd., 363-22 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Koji Wakame</Name>
        <Affiliation>Amino Up Chemical Co., Ltd., 363-22 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Nishioka</Name>
        <Affiliation>Amino Up Chemical Co., Ltd., 363-22 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takahiro Maeda</Name>
        <Affiliation>Amino Up Chemical Co., Ltd., 363-22 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan. Electronic address: maeda@aminoup.co.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24389362</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.12.010</DOI>
    <KeywordList>
      <Keywords>C57BL/6J mice</Keywords>
      <Keywords>Dopamine</Keywords>
      <Keywords>MPTP</Keywords>
      <Keywords>Paraquat</Keywords>
      <Keywords>Substantia nigra</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniel J. Minnema</Name>
        <Affiliation>Syngenta Crop Protection, LLC, P.O. Box 18300, Greensboro, NC 27419-8300, USA. Electronic address: daniel.minnema@syngenta.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kim Z. Travis</Name>
        <Affiliation>Syngenta Limited, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Charles B. Breckenridge</Name>
        <Affiliation>Syngenta Crop Protection, LLC, P.O. Box 18300, Greensboro, NC 27419-8300, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nicholas C. Sturgess</Name>
        <Affiliation>Syngenta Limited, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Butt</Name>
        <Affiliation>Tox Path Specialists, LLC, 8420 Gas House Pike, Frederick, MD 21701-2607, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey C. Wolf</Name>
        <Affiliation>Experimental Pathology Laboratories, Inc., 45600 Terminal Drive, Sterling, VA 20166, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Zadory</Name>
        <Affiliation>Experimental Pathology Laboratories, Inc., 45600 Terminal Drive, Sterling, VA 20166, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melissa J. Beck</Name>
        <Affiliation>WIL Research Laboratories, Ltd., Ashland, OH 44805, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James M. Mathews</Name>
        <Affiliation>RTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709-2194, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Merrill O. Tisdel</Name>
        <Affiliation>Syngenta Crop Protection, LLC, P.O. Box 18300, Greensboro, NC 27419-8300, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew R. Cook</Name>
        <Affiliation>Syngenta Limited, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Philip A. Botham</Name>
        <Affiliation>Syngenta Limited, Jealott's Hill International Research Centre, Bracknell, Berkshire RG42 6EY, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Lewis L. Smith</Name>
        <Affiliation>University of Leicester, University Road, Leicester, LE1 7RH, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Current concepts on integrative safety assessment of active substances of botanical, mineral or chemical origin in homeopathic medicinal products within the European regulatory framework.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24384395</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.12.008</DOI>
    <KeywordList>
      <Keywords>Homeopathic medicinal products</Keywords>
      <Keywords>Lowest Human Recommended Dose (LHRD)</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Threshold of Toxicological Concern (TTC)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marie Luise Buchholzer</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany(1). Electronic address: Marie-Luise.Buchholzer@bfarm.de.</Affiliation>
      </Author>
      <Author>
        <Name>Christine Werner</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany(1). Electronic address: Christine.Werner@bfarm.de.</Affiliation>
      </Author>
      <Author>
        <Name>Werner Knoess</Name>
        <Affiliation>Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany(1). Electronic address: Werner.Knoess@bfarm.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigating predictability of in vitro toxicological assessments of cigarettes: analysis of 7 years of regulatory submissions to Canadian regulatory authorities.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24384394</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.12.009</DOI>
    <KeywordList>
      <Keywords>In vitro results</Keywords>
      <Keywords>Prediction</Keywords>
      <Keywords>Regulatory submissions</Keywords>
      <Keywords>Smoke constituent yields</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Belushkin</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Rue des Usines 90, 2000 Neuchâtel, Switzerland. Electronic address: Maxim.Belushkin@pmi.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. J. Piadé</Name>
        <Affiliation>Philip Morris International R&amp;D, Philip Morris Products S.A., Rue des Usines 90, 2000 Neuchâtel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>S. Chapman</Name>
        <Affiliation>Rothmans, Benson &amp; Hedges Inc., 174 Kennedy Road South, L6W 3G6 Brampton, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>G. Fazekas</Name>
        <Affiliation>Rothmans, Benson &amp; Hedges Inc., 174 Kennedy Road South, L6W 3G6 Brampton, Ontario, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The challenge of using read-across within the EU REACH regulatory framework; how much uncertainty is too much? Dipropylene glycol methyl ether acetate, an exemplary case study.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24378700</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.12.007</DOI>
    <KeywordList>
      <Keywords>CAS No. 88917-22-0</Keywords>
      <Keywords>Dipropylene glycol methyl ether acetate (DPMA)</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Read-across</Keywords>
      <Keywords>Uncertainty</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicholas Ball</Name>
        <Affiliation>Toxicology &amp; Environmental Research and Consulting (TERC), Dow Europe GmbH, Bachtobelstrasse 3, CH-8810 Horgen, Switzerland. Electronic address: nball@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Bartels</Name>
        <Affiliation>Toxicology &amp; Environmental Research and Consulting (TERC), The Dow Chemical Company, 1803 Bldg, Washington Street, Midland, MI 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Budinsky</Name>
        <Affiliation>Toxicology &amp; Environmental Research and Consulting (TERC), The Dow Chemical Company, 1803 Bldg, Washington Street, Midland, MI 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Klapacz</Name>
        <Affiliation>Toxicology &amp; Environmental Research and Consulting (TERC), The Dow Chemical Company, 1803 Bldg, Washington Street, Midland, MI 48674, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sean Hays</Name>
        <Affiliation>Summit Toxicology, 165 Valley Road, Lyons, CO 80540, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Kirman</Name>
        <Affiliation>Summit Toxicology, 29449 Pike Drive Orange Village, OH 44022, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Grace Patlewicz</Name>
        <Affiliation>DuPont Haskell Global Centers for Health and Environmental Sciences, 1090 Elkton Road, Newark, DE 19711, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro metabolism of rebaudioside B, D, and M under anaerobic conditions: comparison with rebaudioside A.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24361573</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.12.004</DOI>
    <KeywordList>
      <Keywords>Anaerobic</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>In vitro metabolism</Keywords>
      <Keywords>Rebaudiosides</Keywords>
      <Keywords>Steviol</Keywords>
      <Keywords>Steviolbioside</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sidd Purkayastha</Name>
        <Affiliation>PureCircle Limited, 915 Harger Road, Suite 250, Oak Brook, IL 60523, USA.</Affiliation>
      </Author>
      <Author>
        <Name>George Pugh</Name>
        <Affiliation>The Coca-Cola Company, One Coca-Cola Plaza, Atlanta, GA 30126, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Barry Lynch</Name>
        <Affiliation>Intertek Cantox, 2233 Argentia Rd., Suite 308, Mississauga, ON L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ashley Roberts</Name>
        <Affiliation>Intertek Cantox, 2233 Argentia Rd., Suite 308, Mississauga, ON L5N 2X7, Canada. Electronic address: ashley.roberts@intertek.com.</Affiliation>
      </Author>
      <Author>
        <Name>David Kwok</Name>
        <Affiliation>BRI Biopharmaceutical Research Inc., 101-8898 Heather St., Vancouver, BC V6P 3S8, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Stanley M. Tarka</Name>
        <Affiliation>The Tarka Group Inc., 210 N. Old Stonehouse Road, Carlisle, PA 17015, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimating the decline in excess risk of chronic obstructive pulmonary disease following quitting smoking - a systematic review based on the negative exponential model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24361344</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.12.006</DOI>
    <KeywordList>
      <Keywords>COPD</Keywords>
      <Keywords>Negative exponential model</Keywords>
      <Keywords>Quitting smoking</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd, Sutton, Surrey, United Kingdom. Electronic address: PeterLee@pnlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>John S. Fry</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd, Sutton, Surrey, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara A. Forey</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd, Sutton, Surrey, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of an inhalation unit risk factor for hexavalent chromium.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24361343</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.12.005</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Chromium</Keywords>
      <Keywords>Hexavalent</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Mortality</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Respiratory</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joseph T. Haney</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), Toxicology Division, MC-168, P.O. Box 13087, Austin, TX 78711-3087, United States. Electronic address: Joseph.Haney@tceq.texas.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Neeraja Erraguntla</Name>
        <Affiliation>Texas Commission on Environmental Quality (TCEQ), Toxicology Division, MC-168, P.O. Box 13087, Austin, TX 78711-3087, United States. Electronic address: Neeraja.Erraguntla@tceq.texas.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Robert L. Sielken</Name>
        <Affiliation>Sielken &amp; Associates Consulting Inc., 3833 Texas Avenue, Bryan, TX 77802, United States. Electronic address: SielkenAssoc@aol.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ciriaco Valdez-Flores</Name>
        <Affiliation>Sielken &amp; Associates Consulting Inc., 3833 Texas Avenue, Bryan, TX 77802, United States. Electronic address: SielkenAssoc@aol.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Strengthening the foundation of next generation risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24342233</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.12.002</DOI>
    <KeywordList>
      <Keywords>Adversity</Keywords>
      <Keywords>Critical reviews</Keywords>
      <Keywords>Next Generation</Keywords>
      <Keywords>Omics</Keywords>
      <Keywords>Ozone</Keywords>
      <Keywords>Relevance</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxicity testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, 20 University Rd., 5th Floor, Cambridge, MA 02138, United States. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Petito Boyce</Name>
        <Affiliation>Gradient, 600 Stewart St., Suite 803, Seattle, WA 98101, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daniella M. Pizzurro</Name>
        <Affiliation>Gradient, 20 University Rd., 5th Floor, Cambridge, MA 02138, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lorenz R. Rhomberg</Name>
        <Affiliation>Gradient, 20 University Rd., 5th Floor, Cambridge, MA 02138, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dermal toxicity, eye and dermal irritation and skin sensitization evaluation of a new formulation of Bacillus thuringiensis var israelensis SH-14.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24342232</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.12.003</DOI>
    <KeywordList>
      <Keywords>Bacillus thuringiensis israelensis SH-14</Keywords>
      <Keywords>Biological control</Keywords>
      <Keywords>Dermal toxicity</Keywords>
      <Keywords>Irritation</Keywords>
      <Keywords>Sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. E. Arteaga</Name>
        <Affiliation>National Center for Laboratory Animals Breeding (CENPALAB), Habana, Cuba.</Affiliation>
      </Author>
      <Author>
        <Name>A. Mancebo</Name>
        <Affiliation>National Center for Laboratory Animals Breeding (CENPALAB), Habana, Cuba. Electronic address: axel.mancebo@cenpalab.inf.cu.</Affiliation>
      </Author>
      <Author>
        <Name>T. Molier</Name>
        <Affiliation>LABIOFAM, Habana, Cuba.</Affiliation>
      </Author>
      <Author>
        <Name>D. Gómez</Name>
        <Affiliation>National Center for Laboratory Animals Breeding (CENPALAB), Habana, Cuba.</Affiliation>
      </Author>
      <Author>
        <Name>C. González</Name>
        <Affiliation>National Center for Laboratory Animals Breeding (CENPALAB), Habana, Cuba.</Affiliation>
      </Author>
      <Author>
        <Name>A. M. Bada</Name>
        <Affiliation>National Center for Laboratory Animals Breeding (CENPALAB), Habana, Cuba.</Affiliation>
      </Author>
      <Author>
        <Name>B. González</Name>
        <Affiliation>National Center for Laboratory Animals Breeding (CENPALAB), Habana, Cuba.</Affiliation>
      </Author>
      <Author>
        <Name>N. M. Rojas</Name>
        <Affiliation>Microbiology Department, Faculty of Biology, Habana University, Cuba.</Affiliation>
      </Author>
      <Author>
        <Name>G. Rodríguez</Name>
        <Affiliation>LABIOFAM, Habana, Cuba.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Thirteen-week oral dose toxicity study of Oligonol containing oligomerized polyphenols extracted from lychee and green tea.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24326174</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.12.001</DOI>
    <KeywordList>
      <Keywords>ANOVA</Keywords>
      <Keywords>Catechin</Keywords>
      <Keywords>EGCG</Keywords>
      <Keywords>GTE</Keywords>
      <Keywords>H&amp;E</Keywords>
      <Keywords>Hematoxylin &amp; Eosin</Keywords>
      <Keywords>IACUC</Keywords>
      <Keywords>Institutional Animal Care and Use Committees</Keywords>
      <Keywords>LD(50)</Keywords>
      <Keywords>LFP</Keywords>
      <Keywords>LOAEL</Keywords>
      <Keywords>Low molecular polyphenols</Keywords>
      <Keywords>MOS</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Nasal cavity</Keywords>
      <Keywords>Oligonol</Keywords>
      <Keywords>Toxicology</Keywords>
      <Keywords>UV</Keywords>
      <Keywords>body weight</Keywords>
      <Keywords>bw</Keywords>
      <Keywords>epigallocatechin gallate</Keywords>
      <Keywords>green tea extract</Keywords>
      <Keywords>lowest-observed-adverse-effect level</Keywords>
      <Keywords>lychee fruit extract</Keywords>
      <Keywords>margin-of-safety</Keywords>
      <Keywords>median lethal dose</Keywords>
      <Keywords>no-observed-adverse-effect level</Keywords>
      <Keywords>one-way analysis of variance</Keywords>
      <Keywords>ultraviolet</Keywords>
      <Keywords>v/v</Keywords>
      <Keywords>volume to volume</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kentaro Kitadate</Name>
        <Affiliation>Amino Up Chemical Co., Ltd., 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kohei Homma</Name>
        <Affiliation>Amino Up Chemical Co., Ltd., 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ashley Roberts</Name>
        <Affiliation>Intertek Cantox, 2233 Argentia Rd., Suite 308, Mississauga, ON L5N 2X7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Takahiro Maeda</Name>
        <Affiliation>Amino Up Chemical Co., Ltd., 363-32 Shin-ei, Kiyota-ku, Sapporo 004-0839, Japan. Electronic address: maeda@aminoup.co.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Crystalline silica in heated man-made vitreous fibres: a review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24296106</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.014</DOI>
    <KeywordList>
      <Keywords>Cristobalite</Keywords>
      <Keywords>Crystalline silica</Keywords>
      <Keywords>Devitrification</Keywords>
      <Keywords>Man-made vitreous fibres</Keywords>
      <Keywords>Refractory ceramic fibres</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Terry P. Brown</Name>
        <Affiliation>Institute of Environment and Health, Cranfield Health, Cranfield University, Milton Keynes, Bedfordshire MK43 0AL, United Kingdom. Electronic address: t.p.brown@cranfield.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Paul T. C. Harrison</Name>
        <Affiliation>Institute of Environment and Health, Cranfield Health, Cranfield University, Milton Keynes, Bedfordshire MK43 0AL, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimating the decline in excess risk of cerebrovascular disease following quitting smoking--a systematic review based on the negative exponential model.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24291341</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.013</DOI>
    <KeywordList>
      <Keywords>CI</Keywords>
      <Keywords>DF</Keywords>
      <Keywords>H</Keywords>
      <Keywords>IARC</Keywords>
      <Keywords>IHD</Keywords>
      <Keywords>International Agency for Research on Cancer</Keywords>
      <Keywords>Negative exponential model</Keywords>
      <Keywords>Quitting smoking</Keywords>
      <Keywords>REF</Keywords>
      <Keywords>RR</Keywords>
      <Keywords>SE</Keywords>
      <Keywords>Stroke</Keywords>
      <Keywords>confidence interval</Keywords>
      <Keywords>degrees of freedom</Keywords>
      <Keywords>half-life</Keywords>
      <Keywords>ischaemic heart disease</Keywords>
      <Keywords>relative risk</Keywords>
      <Keywords>standard error</Keywords>
      <Keywords>unique reference code for study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P N Lee Statistics and Computing Ltd, Sutton, Surrey, United Kingdom. Electronic address: PeterLee@pnlee.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>John S. Fry</Name>
        <Affiliation>P N Lee Statistics and Computing Ltd, Sutton, Surrey, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Alison J. Thornton</Name>
        <Affiliation>Independent Consultant, Exeter, Devon, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24287156</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.008</DOI>
    <KeywordList>
      <Keywords>AD</Keywords>
      <Keywords>Development stage</Keywords>
      <Keywords>In silico (QSAR) tools</Keywords>
      <Keywords>In vitro methods</Keywords>
      <Keywords>PBTK</Keywords>
      <Keywords>SPME</Keywords>
      <Keywords>Tier 1 model</Keywords>
      <Keywords>applicability domain</Keywords>
      <Keywords>physiologically-based toxicokinetic</Keywords>
      <Keywords>solid phase microextraction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jos G. Bessems</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands. Electronic address: jos.bessems@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>George Loizou</Name>
        <Affiliation>Health and Safety Laboratories, Mathematical Sciences Unit, Buxton, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Kannan Krishnan</Name>
        <Affiliation>Département de Santé Environnementale et Santé au Travail, Faculté de Médecine, Université de Montréal, Montréal, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Camilla Bernasconi</Name>
        <Affiliation>Systems Toxicology Unit/EURL ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Frederic Bois</Name>
        <Affiliation>Compiegne University of Technology, Chair of Mathematical Modelling for Systems Toxicology, Compiegne &amp; INERIS, DRC/VIVA/METO, Verneuil en Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra Coecke</Name>
        <Affiliation>Systems Toxicology Unit/EURL ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Eva Maria Collnot</Name>
        <Affiliation>Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Walter Diembeck</Name>
        <Affiliation>Beiersdorf AG, Unnastr. 48, D-20245 Hamburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Lucian Romeo Farcal</Name>
        <Affiliation>Systems Toxicology Unit/EURL ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Liesbeth Geraets</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula Gundert-Remy</Name>
        <Affiliation>Department Clinical Pharmacology and Toxicology, Medical School (Charité), Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Nynke Kramer</Name>
        <Affiliation>Institute for Risk Assessment Sciences, Utrecht University, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriele Küsters</Name>
        <Affiliation>European Partnership for Alternative Approaches to Animal Testing (EPAA), 15b Avenue Herrmann Debroux, 1160 Bruxelles, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Sofia B. Leite</Name>
        <Affiliation>Systems Toxicology Unit/EURL ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy; Instituto de Biologia Experimental e Tecnológica (IBET)/Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa (ITQB-UNL), Oeiras, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Olavi R. Pelkonen</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Klaus Schröder</Name>
        <Affiliation>BioMed-zet Life Science GmbH/Centre for Alternative and Complementary Methods to Animal Testing (ZET), Linz, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Emanuela Testai</Name>
        <Affiliation>Istituto Superiore di Sanità, Viale Regina Elena, 299, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Iwona Wilk-Zasadna</Name>
        <Affiliation>Systems Toxicology Unit/EURL ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>José Manuel Zaldívar-Comenges</Name>
        <Affiliation>Systems Toxicology Unit/EURL ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra (VA), Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reassessing the two-year rodent carcinogenicity bioassay: a review of the applicability to human risk and current perspectives.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24287155</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.011</DOI>
    <KeywordList>
      <Keywords>2-Year carcinogenicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Human risk assessment</Keywords>
      <Keywords>Prediction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Palma Ann Marone</Name>
        <Affiliation>Product Safety Labs, 2394 Highway 130, Dayton, NJ 08810, USA. Electronic address: PamMarone@ProductSafetyLabs.com.</Affiliation>
      </Author>
      <Author>
        <Name>William C. Hall</Name>
        <Affiliation>Hall Consulting, Inc., 110 Shady Brook Circle #300, St. Simons Island, GA 31522, USA. Electronic address: hallconsulting@earthlink.net.</Affiliation>
      </Author>
      <Author>
        <Name>A. Wallace Hayes</Name>
        <Affiliation>Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA. Electronic address: awallacehayes@comcast.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24280359</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.012</DOI>
    <KeywordList>
      <Keywords>2,4-D</Keywords>
      <Keywords>2,4-dichlorophenoxyacetic acid</Keywords>
      <Keywords>ACD</Keywords>
      <Keywords>ACSA</Keywords>
      <Keywords>AFC</Keywords>
      <Keywords>CP</Keywords>
      <Keywords>CT</Keywords>
      <Keywords>DART</Keywords>
      <Keywords>DIT</Keywords>
      <Keywords>ELISA</Keywords>
      <Keywords>EOGRTS</Keywords>
      <Keywords>EPA</Keywords>
      <Keywords>EU</Keywords>
      <Keywords>Environmental chemicals</Keywords>
      <Keywords>European union</Keywords>
      <Keywords>FDA</Keywords>
      <Keywords>HESI</Keywords>
      <Keywords>ICH</Keywords>
      <Keywords>ILSI</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>KLH</Keywords>
      <Keywords>LLNA</Keywords>
      <Keywords>NIEHS</Keywords>
      <Keywords>NIOSH</Keywords>
      <Keywords>NK</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>NRC</Keywords>
      <Keywords>NTP</Keywords>
      <Keywords>OECD</Keywords>
      <Keywords>PND</Keywords>
      <Keywords>RIVM</Keywords>
      <Keywords>SRBC</Keywords>
      <Keywords>STS</Keywords>
      <Keywords>T-cell dependent antibody reaction</Keywords>
      <Keywords>TDAR</Keywords>
      <Keywords>Testing</Keywords>
      <Keywords>US</Keywords>
      <Keywords>United States</Keywords>
      <Keywords>WoE</Keywords>
      <Keywords>agricultural chemical safety assessment</Keywords>
      <Keywords>allergic contact dermatitis</Keywords>
      <Keywords>antibody forming cell</Keywords>
      <Keywords>carbon tetrachloride</Keywords>
      <Keywords>cyclophosphamide</Keywords>
      <Keywords>developmental and reproductive toxicology</Keywords>
      <Keywords>developmental immunotoxicity</Keywords>
      <Keywords>dutch national institute of public health and the environment</Keywords>
      <Keywords>environmental protection agency</Keywords>
      <Keywords>enzyme linked immunosorbent assay</Keywords>
      <Keywords>extended one-generation reproductive toxicity study</Keywords>
      <Keywords>food and drug administration</Keywords>
      <Keywords>health and environmental sciences institute</Keywords>
      <Keywords>international conference on harmonization</Keywords>
      <Keywords>international life sciences institute</Keywords>
      <Keywords>keyhole limpet hemocyanin</Keywords>
      <Keywords>local lymph node assay</Keywords>
      <Keywords>national institute for occupational safety and health</Keywords>
      <Keywords>national institute of environmental health sciences</Keywords>
      <Keywords>national research council</Keywords>
      <Keywords>national toxicology program</Keywords>
      <Keywords>natural killer</Keywords>
      <Keywords>no observed adverse effect level</Keywords>
      <Keywords>organisation for economic cooperation and development</Keywords>
      <Keywords>postnatal day</Keywords>
      <Keywords>sheep red blood cells</Keywords>
      <Keywords>standard toxicology studies</Keywords>
      <Keywords>weight-of-evidence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Darrell R. Boverhof</Name>
        <Affiliation>The Dow Chemical Company, Midland, MI, United States. Electronic address: rboverhof@dow.com.</Affiliation>
      </Author>
      <Author>
        <Name>Greg Ladics</Name>
        <Affiliation>DuPont Pioneer, Wilmington, DE, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bob Luebke</Name>
        <Affiliation>Cardiopulmonary and Immunotoxicology Branch, US Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Botham</Name>
        <Affiliation>Syngenta Ltd., Macclesfield, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Emanuela Corsini</Name>
        <Affiliation>Laboratory of Toxicology, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen Evans</Name>
        <Affiliation>Pfizer, Inc., Groton, CT, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dori Germolec</Name>
        <Affiliation>National Toxicology Program, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Holsapple</Name>
        <Affiliation>Battelle Memorial Institute, Columbus, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Scott E. Loveless</Name>
        <Affiliation>DuPont Haskell Global Centers for Health and Environmental Sciences, Newark, DE, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Haitian Lu</Name>
        <Affiliation>Dow AgroSciences, Indianapolis, IN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Willem van der Laan</Name>
        <Affiliation>Medicines Evaluation Board, Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Kimber L. White</Name>
        <Affiliation>ImmunoTox® Inc., Richmond, VA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yung Yang</Name>
        <Affiliation>Office of Pesticides Programs, US Environmental Protection Agency, Washington, DC, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Respiratory safety pharmacology - current practice and future directions.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24280358</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.010</DOI>
    <KeywordList>
      <Keywords>ICHS7A</Keywords>
      <Keywords>Methods</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>PharmaPendium™</Keywords>
      <Keywords>Regulatory</Keywords>
      <Keywords>Respiratory</Keywords>
      <Keywords>Safety pharmacology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dennis J. Murphy</Name>
        <Affiliation>Department of Safety Pharmacology, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA, USA. Electronic address: dennis.j.murphy@gsk.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivation of a No-Significant-Risk-Level (NSRL) for diethanolamine (DEA).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24275050</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.009</DOI>
    <KeywordList>
      <Keywords>Benchmark dose modeling</Keywords>
      <Keywords>Cancer risk assessment</Keywords>
      <Keywords>Diethanolamine</Keywords>
      <Keywords>Life stage adjustment</Keywords>
      <Keywords>NSRL</Keywords>
      <Keywords>Proposition 65</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bingxuan Wang</Name>
        <Affiliation>ToxServices LLC, United States. Electronic address: bwang@toxservices.com.</Affiliation>
      </Author>
      <Author>
        <Name>David E. Amacher</Name>
        <Affiliation>ToxServices LLC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Margaret H. Whittaker</Name>
        <Affiliation>ToxServices LLC, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Standardized UV-vis spectra as the foundation for a threshold-based, integrated photosafety evaluation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24269723</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.007</DOI>
    <KeywordList>
      <Keywords>Irradiation</Keywords>
      <Keywords>Molar absorptivity</Keywords>
      <Keywords>Molar extinction coefficient</Keywords>
      <Keywords>Photoreactivity</Keywords>
      <Keywords>Photosafety</Keywords>
      <Keywords>Phototoxicity</Keywords>
      <Keywords>Sunlight</Keywords>
      <Keywords>Threshold</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniel Bauer</Name>
        <Affiliation>Novartis Institutes of BioMedical Research, Preclinical Safety, WKL-136.1.16, 4002 Basel, Switzerland. Electronic address: daniel_manfred.bauer@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lacey A. Averett</Name>
        <Affiliation>GSK, GlaxoSmithKline, Platform Technology and Sciences, King of Prussia, PA 19406, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ann De Smedt</Name>
        <Affiliation>Janssen Research and Development, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Mark H. Kleinman</Name>
        <Affiliation>GSK, GlaxoSmithKline, Projects Clinical Platform and Sciences, King of Prussia, PA 19406, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Muster</Name>
        <Affiliation>Hoffmann-La Roche, Non-Clinical Drug Safety, 4070 Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Betty A. Pettersen</Name>
        <Affiliation>Pfizer, Global Research and Development, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Robles</Name>
        <Affiliation>Sanofi R&amp;D, Montpellier, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative analysis of toxicological evaluations for dermal exposure performed under two different EU regulatory frameworks.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24269627</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.006</DOI>
    <KeywordList>
      <Keywords>Cosmetics regulation</Keywords>
      <Keywords>DNEL</Keywords>
      <Keywords>Derived no effect levels</Keywords>
      <Keywords>ECHA</Keywords>
      <Keywords>European Chemicals Agency</Keywords>
      <Keywords>LD</Keywords>
      <Keywords>LOAEL</Keywords>
      <Keywords>MoS</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Regulation</Keywords>
      <Keywords>Risk management</Keywords>
      <Keywords>SCCS</Keywords>
      <Keywords>Scientific Committee on Consumer Safety</Keywords>
      <Keywords>derived no effect level</Keywords>
      <Keywords>lethal dose</Keywords>
      <Keywords>lowest observed adverse effect level</Keywords>
      <Keywords>margin of safety</Keywords>
      <Keywords>no observed adverse effect level</Keywords>
      <Keywords>registration, evaluation, authorization and restriction of chemicals</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Emma Westerholm</Name>
        <Affiliation>Department of Philosophy and History, Royal Institute of Technology, Teknikringen 78b, 100 44 Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Linda Schenk</Name>
        <Affiliation>Department of Philosophy and History, Royal Institute of Technology, Teknikringen 78b, 100 44 Stockholm, Sweden; Institute of Environmental Medicine, Karolinska Institutet, Nobels väg 13, 171 77 Stockholm, Sweden. Electronic address: schenk@kth.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pre-clinical safety evaluation of the synthetic human milk, nature-identical, oligosaccharide 2'-O-Fucosyllactose (2'FL).</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24262411</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.005</DOI>
    <KeywordList>
      <Keywords>2-Fucosyllactose</Keywords>
      <Keywords>2′-O-Fucosyllactose</Keywords>
      <Keywords>2′FL</Keywords>
      <Keywords>AG ratio</Keywords>
      <Keywords>ALAT</Keywords>
      <Keywords>ALP</Keywords>
      <Keywords>ASAT</Keywords>
      <Keywords>Alb</Keywords>
      <Keywords>Bili</Keywords>
      <Keywords>CP</Keywords>
      <Keywords>Ca</Keywords>
      <Keywords>Chol</Keywords>
      <Keywords>Creat</Keywords>
      <Keywords>DRF</Keywords>
      <Keywords>FOS</Keywords>
      <Keywords>GOS</Keywords>
      <Keywords>Gavage</Keywords>
      <Keywords>Glob</Keywords>
      <Keywords>HMO</Keywords>
      <Keywords>Hb</Keywords>
      <Keywords>Human milk oligosaccharide</Keywords>
      <Keywords>IF</Keywords>
      <Keywords>Infant formula</Keywords>
      <Keywords>Juvenile rats</Keywords>
      <Keywords>K</Keywords>
      <Keywords>LNnT</Keywords>
      <Keywords>MCH</Keywords>
      <Keywords>MCHC</Keywords>
      <Keywords>MCV</Keywords>
      <Keywords>MF</Keywords>
      <Keywords>MLA</Keywords>
      <Keywords>MMS</Keywords>
      <Keywords>MoE</Keywords>
      <Keywords>Mutagenicity</Keywords>
      <Keywords>NOAEL</Keywords>
      <Keywords>Na</Keywords>
      <Keywords>No Observed Adverse Effect Level</Keywords>
      <Keywords>PCV</Keywords>
      <Keywords>PND</Keywords>
      <Keywords>Prot</Keywords>
      <Keywords>RBC</Keywords>
      <Keywords>RS</Keywords>
      <Keywords>RTG</Keywords>
      <Keywords>Reti</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
      <Keywords>TFT</Keywords>
      <Keywords>TK</Keywords>
      <Keywords>WBC</Keywords>
      <Keywords>alanine amino-transferase</Keywords>
      <Keywords>albumin</Keywords>
      <Keywords>albumin/globulin ratio</Keywords>
      <Keywords>alkaline phosphatase</Keywords>
      <Keywords>aspartate aminotransferase</Keywords>
      <Keywords>calcium</Keywords>
      <Keywords>creatinine</Keywords>
      <Keywords>cyclophosphamide</Keywords>
      <Keywords>dose range finding</Keywords>
      <Keywords>fructooligosaccharide</Keywords>
      <Keywords>galactooligosaccharide</Keywords>
      <Keywords>globulin</Keywords>
      <Keywords>hemoglobin</Keywords>
      <Keywords>human milk oligosaccharide</Keywords>
      <Keywords>infant formulae</Keywords>
      <Keywords>lacto-N-neotetraose</Keywords>
      <Keywords>margin of exposure</Keywords>
      <Keywords>mean corpuscular hemoglobin</Keywords>
      <Keywords>mean corpuscular hemoglobin concentration</Keywords>
      <Keywords>mean corpuscular volume</Keywords>
      <Keywords>methyl methanesulfonate</Keywords>
      <Keywords>mouse lymphoma assay</Keywords>
      <Keywords>mutant frequency for 10(6)cells</Keywords>
      <Keywords>pack cell volume</Keywords>
      <Keywords>postnatal day</Keywords>
      <Keywords>potassium</Keywords>
      <Keywords>red blood cells</Keywords>
      <Keywords>relative survival</Keywords>
      <Keywords>relative total growth</Keywords>
      <Keywords>reticulocytes</Keywords>
      <Keywords>sodium</Keywords>
      <Keywords>thymidine kinase</Keywords>
      <Keywords>total bilirubin</Keywords>
      <Keywords>total cholesterol</Keywords>
      <Keywords>total protein</Keywords>
      <Keywords>trifluorothymidine</Keywords>
      <Keywords>white blood cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Myriam Coulet</Name>
        <Affiliation>Nestlé Research Center, Vers-chez-les-Blanc, PO Box 44, 1000 Lausanne 26, Switzerland. Electronic address: myriam.coulet@rdls.nestle.com.</Affiliation>
      </Author>
      <Author>
        <Name>Phoukham Phothirath</Name>
        <Affiliation>Nestlé Research Center, Vers-chez-les-Blanc, PO Box 44, 1000 Lausanne 26, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Linda Allais</Name>
        <Affiliation>Wil Research Europe, 329 Impasse du Domaine Rozier, Les Oncins, 69210 St Germain sur L'Arbresle, France.</Affiliation>
      </Author>
      <Author>
        <Name>Benoit Schilter</Name>
        <Affiliation>Nestlé Research Center, Vers-chez-les-Blanc, PO Box 44, 1000 Lausanne 26, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute toxicity classification for ethylene glycol mono-n-butyl ether under the Globally Harmonized System.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24246505</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.004</DOI>
    <KeywordList>
      <Keywords>2-Butoxyethanol</Keywords>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>CAS No. 111-76-2</Keywords>
      <Keywords>Ethylene glycol mono-n-butyl ether</Keywords>
      <Keywords>GHS classification</Keywords>
      <Keywords>Guinea pig</Keywords>
      <Keywords>Hemolysis</Keywords>
      <Keywords>Species difference</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rodney Boatman</Name>
        <Affiliation>Boatman Toxicology Consulting LLC, 8 Osage Trail, Spencerport, NY 14559, USA. Electronic address: rboatman@rochester.rr.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Kelsey</Name>
        <Affiliation>Chemsage Limited, PO Box 431, Fleet, Hampshire GU51 9BP, United Kingdom. Electronic address: jeff@chemsage.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Nicholas Ball</Name>
        <Affiliation>Toxicology &amp; Environmental Research and Consulting (TERC), Environment, Health and Safety (EH&amp;S), Dow Europe GmbH, Bachtobelstrasse 3, CH-8810 Horgen, Switzerland. Electronic address: NBall@dow.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genotoxicity assessment of some cosmetic and food additives.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24239523</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.003</DOI>
    <KeywordList>
      <Keywords>Comet assay</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Lilial®</Keywords>
      <Keywords>Micronuclei</Keywords>
      <Keywords>Point mutations</Keywords>
      <Keywords>α-Hexylcinnamaldheide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Antonella Di Sotto</Name>
        <Affiliation>Department of Physiology and Pharmacology "Vittorio Erspamer", "Sapienza" University, P.le Aldo Moro 5, 00185 Rome, Italy. Electronic address: antonella.disotto@uniroma1.it.</Affiliation>
      </Author>
      <Author>
        <Name>Francesca Maffei</Name>
        <Affiliation>Department of Sciences for Life Quality Studies, Alma Mater Studiorum - University of Bologna, Corso D'Augusto 237, 47921 Rimini, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Patrizia Hrelia</Name>
        <Affiliation>Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Via Irnerio 48, 40126 Bologna, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Di Giacomo</Name>
        <Affiliation>Department of Physiology and Pharmacology "Vittorio Erspamer", "Sapienza" University, P.le Aldo Moro 5, 00185 Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Ester Pagano</Name>
        <Affiliation>Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80132 Naples, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Francesca Borrelli</Name>
        <Affiliation>Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80132 Naples, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriela Mazzanti</Name>
        <Affiliation>Department of Physiology and Pharmacology "Vittorio Erspamer", "Sapienza" University, P.le Aldo Moro 5, 00185 Rome, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oral toxicity of silver ions, silver nanoparticles and colloidal silver--a review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24231525</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.002</DOI>
    <KeywordList>
      <Keywords>Ag</Keywords>
      <Keywords>Argyria</Keywords>
      <Keywords>Cardiac hypertrophy</Keywords>
      <Keywords>Colloidal</Keywords>
      <Keywords>Nanoparticle</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Neurotransmitter</Keywords>
      <Keywords>Silver</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Niels Hadrup</Name>
        <Affiliation>Division of Toxicology and Risk Assessment, National Food Institute, Technical University of Denmark, Mørkhøj Bygade 19, DK 2860 Søborg, Denmark. Electronic address: nilha@food.dtu.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Henrik R. Lam</Name>
        <Affiliation>Environment and Toxicology, DHI, Agern Allé 5, DK 2970 Hørsholm, Denmark. Electronic address: hrl@dhigroup.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the California Safer Consumer Products Regulation and the impact on consumers and product manufacturers.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24231524</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.11.001</DOI>
    <KeywordList>
      <Keywords>Alternatives analysis</Keywords>
      <Keywords>Candidate Chemicals</Keywords>
      <Keywords>Chemicals of concern</Keywords>
      <Keywords>Green chemistry</Keywords>
      <Keywords>Priority product</Keywords>
      <Keywords>Product risk assessment</Keywords>
      <Keywords>Product sustainability</Keywords>
      <Keywords>Safer consumer products</Keywords>
      <Keywords>Sustainable chemistry</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dallas M. Cowan</Name>
        <Affiliation>Cardno ChemRisk, LLC, Aliso Viejo, CA, USA. Electronic address: Dallas.Cowan@Cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tony Kingsbury</Name>
        <Affiliation>Cardno ChemRisk, LLC, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Angela L. Perez</Name>
        <Affiliation>Cardno ChemRisk, LLC, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tyler A. Woods</Name>
        <Affiliation>Cardno ChemRisk, LLC, Aliso Viejo, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Kovochich</Name>
        <Affiliation>Cardno ChemRisk, LLC, Aliso Viejo, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Denise S. Hill</Name>
        <Affiliation>Cardno ENTRIX, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amy K. Madl</Name>
        <Affiliation>Cardno ChemRisk, LLC, Aliso Viejo, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dennis J. Paustenbach</Name>
        <Affiliation>Cardno ChemRisk, LLC, San Francisco, CA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A human life-stage physiologically based pharmacokinetic and pharmacodynamic model for chlorpyrifos: development and validation.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24200834</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.10.005</DOI>
    <KeywordList>
      <Keywords>Life-stage sensitivity</Keywords>
      <Keywords>Pesticide</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jordan Ned Smith</Name>
        <Affiliation>Battelle, Pacific Northwest Division, Richland, WA 99354, USA. Electronic address: jordan.smith@pnnl.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Paul M. Hinderliter</Name>
        <Affiliation>Battelle, Pacific Northwest Division, Richland, WA 99354, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Charles Timchalk</Name>
        <Affiliation>Battelle, Pacific Northwest Division, Richland, WA 99354, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Bartels</Name>
        <Affiliation>Dow Chemical Company, Midland, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Torka S. Poet</Name>
        <Affiliation>Battelle, Pacific Northwest Division, Richland, WA 99354, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Electricians' chrysotile asbestos exposure from electrical products and risks of mesothelioma and lung cancer.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24189076</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.10.008</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>Chrysotile</Keywords>
      <Keywords>Electricians</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Mesothelioma</Keywords>
      <Keywords>Occupational</Keywords>
      <Keywords>Review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julie E. Goodman</Name>
        <Affiliation>Gradient, 20 University Rd., Cambridge, MA 02138, United States. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Michael K. Peterson</Name>
        <Affiliation>Gradient, 600 Stewart St., Suite 803, Seattle, WA 98101, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa A. Bailey</Name>
        <Affiliation>Gradient, 20 University Rd., Cambridge, MA 02138, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Laura E. Kerper</Name>
        <Affiliation>Gradient, 20 University Rd., Cambridge, MA 02138, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David G. Dodge</Name>
        <Affiliation>Gradient, 600 Stewart St., Suite 803, Seattle, WA 98101, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health risks related to dual use of cigarettes and snus - a systematic review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24184647</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.10.007</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Circulatory disease</Keywords>
      <Keywords>Smokeless</Keywords>
      <Keywords>Tobacco</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter N. Lee</Name>
        <Affiliation>P.N. Lee Statistics and Computing Ltd., 17 Cedar Road, Sutton, Surrey SM2 5DA, UK. Electronic address: PeterLee@pnlee.co.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Anti-androgenicity can only be evaluated using a weight of evidence approach.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24184466</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.10.004</DOI>
    <KeywordList>
      <Keywords>Anti-androgen</Keywords>
      <Keywords>Body weight</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>OECD 416</Keywords>
      <Keywords>PND</Keywords>
      <Keywords>PPS</Keywords>
      <Keywords>Preputial separation</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Two-generation toxicity study</Keywords>
      <Keywords>Weight-of-evidence</Keywords>
      <Keywords>p.p.</Keywords>
      <Keywords>post-partum</Keywords>
      <Keywords>postnatal day</Keywords>
      <Keywords>preputial separation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stephanie Melching-Kollmuß</Name>
        <Affiliation>BASF SE, Product Safety, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Karma C. Fussell</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Roland Buesen</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Dammann</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Steffen Schneider</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Henk Tennekes</Name>
        <Affiliation>Experimental Toxicology Services (ETS) Nederland BV, Frankensteeg 4, 7201KN Zutphen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Bennard van Ravenzwaay</Name>
        <Affiliation>BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen, Germany. Electronic address: bennard.ravenzwaay@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of uremic serum and uremic toxins on drug metabolism in human microsomes.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24184159</pubmedLink>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.10.006</DOI>
    <KeywordList>
      <Keywords>Chronic renal failure</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Uremic serum</Keywords>
      <Keywords>Uremic toxins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Donna A. Volpe</Name>
        <Affiliation>Division of Drug Safety Research, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: donna.volpe@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Grainne A. Tobin</Name>
        <Affiliation>Division of Drug Safety Research, Food and Drug Administration, Silver Spring, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fatemeh Tavakkoli</Name>
        <Affiliation>School of Pharmacy, University of Maryland, Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas C. Dowling</Name>
        <Affiliation>School of Pharmacy, University of Maryland, Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul D. Light</Name>
        <Affiliation>School of Medicine, University of Maryland, Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert J. Parker</Name>
        <Affiliation>Division of Drug Safety Research, Food and Drug Administration, Silver Spring, MD, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A European perspective on alternatives to animal testing for environmental hazard identification and risk assessment.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24161465</pubmedLink>
    <Year>2013</Year>
    <DOI>10.1016/j.yrtph.2013.10.003</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Bioconcentration</Keywords>
      <Keywords>Cell lines</Keywords>
      <Keywords>Chronic toxicity</Keywords>
      <Keywords>Endocrine disruption</Keywords>
      <Keywords>Exposure-based waiving</Keywords>
      <Keywords>Fish embryo test</Keywords>
      <Keywords>QSAR</Keywords>
      <Keywords>Read-across</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stefan Scholz</Name>
        <Affiliation>UFZ - Helmholtz Centre for Environmental Research, Department of Bioanalytical Ecotoxicology, 04318 Leipzig, Germany. Electronic address: stefan.scholz@ufz.de.</Affiliation>
      </Author>
      <Author>
        <Name>Erika Sela</Name>
      </Author>
      <Author>
        <Name>Ludek Blaha</Name>
      </Author>
      <Author>
        <Name>Thomas Braunbeck</Name>
      </Author>
      <Author>
        <Name>Malyka Galay-Burgos</Name>
      </Author>
      <Author>
        <Name>Mauricio García-Franco</Name>
      </Author>
      <Author>
        <Name>Joaquin Guinea</Name>
      </Author>
      <Author>
        <Name>Nils Klüver</Name>
      </Author>
      <Author>
        <Name>Kristin Schirmer</Name>
      </Author>
      <Author>
        <Name>Katrin Tanneberger</Name>
      </Author>
      <Author>
        <Name>Marysia Tobor-Kapłon</Name>
      </Author>
      <Author>
        <Name>Hilda Witters</Name>
      </Author>
      <Author>
        <Name>Scott Belanger</Name>
      </Author>
      <Author>
        <Name>Emilio Benfenati</Name>
      </Author>
      <Author>
        <Name>Stuart Creton</Name>
      </Author>
      <Author>
        <Name>Mark T. D. Cronin</Name>
      </Author>
      <Author>
        <Name>Rik I. L. Eggen</Name>
      </Author>
      <Author>
        <Name>Michelle Embry</Name>
      </Author>
      <Author>
        <Name>Drew Ekman</Name>
      </Author>
      <Author>
        <Name>Anne Gourmelon</Name>
      </Author>
      <Author>
        <Name>Marlies Halder</Name>
      </Author>
      <Author>
        <Name>Barry Hardy</Name>
      </Author>
      <Author>
        <Name>Thomas Hartung</Name>
      </Author>
      <Author>
        <Name>Bruno Hubesch</Name>
      </Author>
      <Author>
        <Name>Dirk Jungmann</Name>
      </Author>
      <Author>
        <Name>Mark A. Lampi</Name>
      </Author>
      <Author>
        <Name>Lucy Lee</Name>
      </Author>
      <Author>
        <Name>Marc Léonard</Name>
      </Author>
      <Author>
        <Name>Eberhard Küster</Name>
      </Author>
      <Author>
        <Name>Adam Lillicrap</Name>
      </Author>
      <Author>
        <Name>Till Luckenbach</Name>
      </Author>
      <Author>
        <Name>Albertinka J. Murk</Name>
      </Author>
      <Author>
        <Name>José M. Navas</Name>
      </Author>
      <Author>
        <Name>Willie Peijnenburg</Name>
      </Author>
      <Author>
        <Name>Guillermo Repetto</Name>
      </Author>
      <Author>
        <Name>Edward Salinas</Name>
      </Author>
      <Author>
        <Name>Gerrit Schüürmann</Name>
      </Author>
      <Author>
        <Name>Horst Spielmann</Name>
      </Author>
      <Author>
        <Name>Knut Erik Tollefsen</Name>
      </Author>
      <Author>
        <Name>Susanne Walter-Rohde</Name>
      </Author>
      <Author>
        <Name>Graham Whale</Name>
      </Author>
      <Author>
        <Name>James R. Wheeler</Name>
      </Author>
      <Author>
        <Name>Matthew J. Winter</Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Skin sensitisation--moving forward with non-animal testing strategies for regulatory purposes in the EU.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24140884</pubmedLink>
    <Year>2013</Year>
    <DOI>10.1016/j.yrtph.2013.10.002</DOI>
    <KeywordList>
      <Keywords>Hazard characterisation</Keywords>
      <Keywords>Hazard classification</Keywords>
      <Keywords>In vitro alternatives</Keywords>
      <Keywords>Skin sensitisation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David Basketter</Name>
        <Affiliation>DABMEB Consultancy Ltd., Sharnbrook MK44 1PR, UK. Electronic address: dabmebconsultancyltd@me.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalie Alépée</Name>
      </Author>
      <Author>
        <Name>Silvia Casati</Name>
      </Author>
      <Author>
        <Name>Jonathan Crozier</Name>
      </Author>
      <Author>
        <Name>Dorothea Eigler</Name>
      </Author>
      <Author>
        <Name>Peter Griem</Name>
      </Author>
      <Author>
        <Name>Bruno Hubesch</Name>
      </Author>
      <Author>
        <Name>Joop de Knecht</Name>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
      </Author>
      <Author>
        <Name>Kimmo Louekari</Name>
      </Author>
      <Author>
        <Name>Irene Manou</Name>
      </Author>
      <Author>
        <Name>Gavin Maxwell</Name>
      </Author>
      <Author>
        <Name>Annette Mehling</Name>
      </Author>
      <Author>
        <Name>Tatiana Netzeva</Name>
      </Author>
      <Author>
        <Name>Thomas Petry</Name>
      </Author>
      <Author>
        <Name>Laura H. Rossi</Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro safety cardiovascular pharmacology studies: impact of formulation preparation and analysis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24120820</pubmedLink>
    <Year>2013</Year>
    <DOI>10.1016/j.yrtph.2013.10.001</DOI>
    <KeywordList>
      <Keywords>Adsorption</Keywords>
      <Keywords>Formulation analysis</Keywords>
      <Keywords>Purkinje</Keywords>
      <Keywords>Solubility</Keywords>
      <Keywords>Stability</Keywords>
      <Keywords>hERG</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sonia Goineau</Name>
        <Affiliation>Porsolt, Z.A. de Glatigné, 53940 Le Genest-Saint-Isle, France. Electronic address: sgoineau-brissieux@porsolt.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Laurent Lacaud</Name>
      </Author>
      <Author>
        <Name>Christophe Legrand</Name>
      </Author>
      <Author>
        <Name>Emilie Eveilleaux</Name>
      </Author>
      <Author>
        <Name>Vincent Castagné</Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimation of mouth level exposure to smoke constituents of cigarettes with different tar levels using filter analysis.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24113618</pubmedLink>
    <Year>2013</Year>
    <DOI>10.1016/j.yrtph.2013.09.009</DOI>
    <KeywordList>
      <Keywords>(4-methylnitrosoamino)-1-(3-pyridyl)-1-butanone</Keywords>
      <Keywords>CO</Keywords>
      <Keywords>Cigarette</Keywords>
      <Keywords>FTC</Keywords>
      <Keywords>Federal Trade Commission</Keywords>
      <Keywords>Filter analysis</Keywords>
      <Keywords>GC</Keywords>
      <Keywords>GC with mass spectrometry</Keywords>
      <Keywords>GC–MS</Keywords>
      <Keywords>HCI</Keywords>
      <Keywords>HPLC</Keywords>
      <Keywords>HPLC with fluorescence detection</Keywords>
      <Keywords>HPLC-FLD</Keywords>
      <Keywords>HSD</Keywords>
      <Keywords>Health Canada Intense</Keywords>
      <Keywords>ISO</Keywords>
      <Keywords>International Organization for Standardization</Keywords>
      <Keywords>Japan</Keywords>
      <Keywords>LC</Keywords>
      <Keywords>LOD</Keywords>
      <Keywords>LOQ</Keywords>
      <Keywords>MLE</Keywords>
      <Keywords>Mouth Level Exposure</Keywords>
      <Keywords>Mouth level exposure</Keywords>
      <Keywords>N-nitrosonornicotine</Keywords>
      <Keywords>NNK</Keywords>
      <Keywords>NNN</Keywords>
      <Keywords>Ranking</Keywords>
      <Keywords>Smoke constituents</Keywords>
      <Keywords>TPM</Keywords>
      <Keywords>TobReg</Keywords>
      <Keywords>Tobacco Product Regulation</Keywords>
      <Keywords>Total Particulate Matter</Keywords>
      <Keywords>WHO</Keywords>
      <Keywords>World Health Organization</Keywords>
      <Keywords>carbon monoxide</Keywords>
      <Keywords>gas chromatography</Keywords>
      <Keywords>high performance liquid chromatography</Keywords>
      <Keywords>honestly significant difference</Keywords>
      <Keywords>limit of detection</Keywords>
      <Keywords>limit of quantification</Keywords>
      <Keywords>liquid chromatography</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>T. Hyodo</Name>
        <Affiliation>Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa 2278512, Japan. Electronic address: takatsugu.hyodo@jt.com.</Affiliation>
      </Author>
      <Author>
        <Name>K. Minagawa</Name>
      </Author>
      <Author>
        <Name>T. Inoue</Name>
      </Author>
      <Author>
        <Name>J. Fujimoto</Name>
      </Author>
      <Author>
        <Name>N. Minami</Name>
      </Author>
      <Author>
        <Name>R. Bito</Name>
      </Author>
      <Author>
        <Name>A. Mikita</Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identifying important life stages for monitoring and assessing risks from exposures to environmental contaminants: results of a World Health Organization review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24099754</pubmedLink>
    <GrantList>
      <Grant>001</Grant>
    </GrantList>
    <Year>2014</Year>
    <DOI>10.1016/j.yrtph.2013.09.008</DOI>
    <KeywordList>
      <Keywords>Childhood life stages</Keywords>
      <Keywords>Cultural and geographic modifying factors</Keywords>
      <Keywords>Developmental changes in children</Keywords>
      <Keywords>Exposure assessment</Keywords>
      <Keywords>Exposure factors</Keywords>
      <Keywords>Exposure to environmental contaminants</Keywords>
      <Keywords>Harmonized early life age groups</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Windows of exposure</Keywords>
      <Keywords>Windows of susceptibility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elaine A. Cohen Hubal</Name>
        <Affiliation>National Center for Computational Toxicology, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: Hubal.Elaine@epamail.epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Thea de Wet</Name>
        <Affiliation>Centre for Anthropological Research and Department of Anthropology and Development Studies, The University of Johannesburg, Auckland Park, South Africa. Electronic address: tdewet@uj.ac.za.</Affiliation>
      </Author>
      <Author>
        <Name>Lilo Du Toit</Name>
        <Affiliation>Centre for Rural Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: Lilo.Dutoit@wits.ac.za.</Affiliation>
      </Author>
      <Author>
        <Name>Michael P. Firestone</Name>
        <Affiliation>Regulatory Support &amp; Science Policy Division, Office of Children's Health Protection (MC 1107T), Office of the Administrator, U.S. Environmental Protection Agency, Room 1130 EPA West Building, 1200 Pennsylvania Avenue, N.W., Washington, DC 20460, USA. Electronic address: Firestone.michael@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Mathuros Ruchirawat</Name>
        <Affiliation>Office of Research, Chulabhorn Research Institute, 54 Kamphaeng-phet 6 Road, Laksi, Bangkok 10210, Thailand. Electronic address: mathuros@cri.or.th.</Affiliation>
      </Author>
      <Author>
        <Name>Jacqueline van Engelen</Name>
        <Affiliation>Center for Sustainability, Environment and Health, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: jacqueline.van.engelen@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Carolyn Vickers</Name>
        <Affiliation>International Programme on Chemical Safety, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland. Electronic address: vickersc@who.int.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Computer models versus reality: how well do in silico models currently predict the sensitization potential of a substance.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24090701</pubmedLink>
    <Year>2013</Year>
    <DOI>10.1016/j.yrtph.2013.09.007</DOI>
    <KeywordList>
      <Keywords>(Q)SAR</Keywords>
      <Keywords>ACD</Keywords>
      <Keywords>AOP</Keywords>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Case Ultra</Keywords>
      <Keywords>ECHA</Keywords>
      <Keywords>European Chemicals Agency</Keywords>
      <Keywords>GHS</Keywords>
      <Keywords>LLNA</Keywords>
      <Keywords>LMW</Keywords>
      <Keywords>OECD</Keywords>
      <Keywords>OECD toolbox</Keywords>
      <Keywords>Organisation for Economic Cooperation and Development</Keywords>
      <Keywords>REACH</Keywords>
      <Keywords>Registration Evaluation Authorisation and Restriction of Chemicals</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>TIMES-SS</Keywords>
      <Keywords>TOPKAT</Keywords>
      <Keywords>Toxtree</Keywords>
      <Keywords>Vega</Keywords>
      <Keywords>adverse outcome pathway</Keywords>
      <Keywords>allergic contact dermatitis</Keywords>
      <Keywords>globally harmonized system of classification and labeling of chemicals</Keywords>
      <Keywords>local lymph node assay</Keywords>
      <Keywords>low molecular weight</Keywords>
      <Keywords>quantitative structure–activity relationship</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wera Teubner</Name>
        <Affiliation>BASF Schweiz AG, Basel, Switzerland. Electronic address: wera.teubner@basf.com.</Affiliation>
      </Author>
      <Author>
        <Name>Anette Mehling</Name>
      </Author>
      <Author>
        <Name>Paul Xaver Schuster</Name>
      </Author>
      <Author>
        <Name>Katharina Guth</Name>
      </Author>
      <Author>
        <Name>Andrew Worth</Name>
      </Author>
      <Author>
        <Name>Julien Burton</Name>
      </Author>
      <Author>
        <Name>Bennard van Ravenzwaay</Name>
      </Author>
      <Author>
        <Name>Robert Landsiedel</Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modes of action of three disinfectant active substances: a review.</ArticleTitle>
    <JournalTitle>Regulatory toxicology and pharmacology : RTP</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/24080225</pubmedLink>
    <Year>2013</Year>
    <DOI>10.1016/j.yrtph.2013.09.006</DOI>
    <KeywordList>
      <Keywords>Antimicrobial resistance</Keywords>
      <Keywords>Biocide</Keywords>
      <Keywords>Disinfectant</Keywords>
      <Keywords>European directive</Keywords>
      <Keywords>European regulation</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>PHMB</Keywords>
      <Keywords>Peracetic acid</Keywords>
      <Keywords>Quaternary ammonium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stephen Wessels</Name>
        <Affiliation>DHI, Agern Allé 5, DK-2970 Hørsholm, Denmark. Electronic address: s.wessels0@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hanne Ingmer</Name>
      </Author>
    </AuthorList>
  </PubmedArticle>
</PubmedArticleSet>
